ID   CLCB_DICDI              Reviewed;         815 AA.
AC   Q86AZ6; Q550H1;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   07-JUN-2017, entry version 87.
DE   RecName: Full=Chloride channel protein B;
GN   Name=clcB; ORFNames=DDB_G0276865;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A.,
RA   Bankier A.T., Dear P.H., Lehmann R., Baumgart C., Parra G.,
RA   Abril J.F., Guigo R., Kumpf K., Tunggal B., Cox E.C., Quail M.A.,
RA   Platzer M., Rosenthal A., Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000019; EAL68934.1; -; Genomic_DNA.
DR   RefSeq; XP_642961.1; XM_637869.1.
DR   ProteinModelPortal; Q86AZ6; -.
DR   STRING; 44689.DDB0233305; -.
DR   PaxDb; Q86AZ6; -.
DR   EnsemblProtists; EAL68934; EAL68934; DDB_G0276865.
DR   GeneID; 8620831; -.
DR   KEGG; ddi:DDB_G0276865; -.
DR   dictyBase; DDB_G0276865; clcB.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q86AZ6; -.
DR   KO; K05016; -.
DR   OMA; CHALNRF; -.
DR   PhylomeDB; Q86AZ6; -.
DR   PRO; PR:Q86AZ6; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 1.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    815       Chloride channel protein B.
FT                                /FTId=PRO_0000328044.
FT   TOPO_DOM      1     96       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
FT   TRANSMEM    340    360       Helical. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TRANSMEM    474    494       Helical. {ECO:0000255}.
FT   TRANSMEM    506    526       Helical. {ECO:0000255}.
FT   DOMAIN      607    714       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      768    815       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   COMPBIAS    660    689       Poly-Asn.
SQ   SEQUENCE   815 AA;  91016 MW;  33257A31E2047AAF CRC64;
     MSNNYKAGTA INGNDYLLLN IDGNKDCDTD NGFFSGKNFF GGNQTSITHR RHHKMTTKTD
     RELMSHFESL DFNAIDNIIH RKYTFEKKKY QKILKTLGKW VICTLIGVVV GLVCYCLKES
     VDQLQSLKLT QVKKFYSTES TIFIPFLVYL GFNLCYGLIS GLLVCIFGPM SSSSGLPEVK
     GYLNGIRISK AFNLKTVLGK LVSLIFSFSS GLVLGPEGPM FHIGAGIGSS MSQFKSKTLK
     FHLKSFWIFQ NDSDKRDFIS CGAAAGIAAA FGAPIGGVLF CLEEGSSFWS RQLTWRTFFS
     CLIATMTANL FLQGFTQQIH DYGVLTFGVS KSYLYTYTEL IPFMIMGIIG GLLGAIFVHV
     NVRVNHWRKK LFANKSKLYK MIEVCVIVIL SSVVCFFPAL LADCRPISGI SGLTPGTCDP
     GDDSTLILNQ FNCAEGYYNP MATLTLTTLE NSLQIVFSRS TNIFTAQTLL TFSIFYYVLT
     IITSGLYVAS GIFIPMMLIG SSWGRLIGIF LSKYFTSIDP SIYALIGAAS MMAGSLRMTI
     SLVVIIVELT ETTQYLLPVI LSVMVGKWCG DIFNESIYEH LIELKHIPYL NSQPPNHLRK
     KTVAEAMSTD VKTLPEIVKV KTALTILETC PHNGFPVVML PQLHSNSNLN DSNQLSLSLN
     LNNNNNNNNN NNNNNNNNNN NNNNNNNNNI LCGLILRSQL SVLLRRKIFN SPEDLKNIDF
     ISDKGYNLPI DHTEFSQELA SKIPPIHELS KLITKEDLDM YIDLRPYMNF AVVSIKNYSS
     LSEAYQIFRQ VGLRHMVVIN VFNNVVGMLT RKDLC
//
ID   CLCA_DICDI              Reviewed;         863 AA.
AC   Q54AX6; Q95VF8;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 1.
DT   07-JUN-2017, entry version 77.
DE   RecName: Full=Chloride channel protein A;
GN   Name=clcA; ORFNames=DDB_G0294096;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AX3-1;
RA   Wang C.W., Liu C.I., Chang W.T.;
RT   "Molecular analyses and functional studies of chloride channel protein
RT   ClcA in Dictyostelium.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A.,
RA   Bankier A.T., Dear P.H., Lehmann R., Baumgart C., Parra G.,
RA   Abril J.F., Guigo R., Kumpf K., Tunggal B., Cox E.C., Quail M.A.,
RA   Platzer M., Rosenthal A., Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF414428; AAL07438.1; -; mRNA.
DR   EMBL; AAFI02000006; EAL60414.1; -; Genomic_DNA.
DR   RefSeq; XP_628848.1; XM_628846.1.
DR   ProteinModelPortal; Q54AX6; -.
DR   STRING; 44689.DDB0215359; -.
DR   PaxDb; Q54AX6; -.
DR   EnsemblProtists; EAL60414; EAL60414; DDB_G0294096.
DR   GeneID; 8617995; -.
DR   KEGG; ddi:DDB_G0294096; -.
DR   dictyBase; DDB_G0294096; clcA.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q54AX6; -.
DR   KO; K05016; -.
DR   OMA; CCCRWCC; -.
DR   PhylomeDB; Q54AX6; -.
DR   PRO; PR:Q54AX6; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   2: Evidence at transcript level;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    863       Chloride channel protein A.
FT                                /FTId=PRO_0000328043.
FT   TOPO_DOM      1    124       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TRANSMEM    171    191       Helical. {ECO:0000255}.
FT   TRANSMEM    228    248       Helical. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TRANSMEM    367    387       Helical. {ECO:0000255}.
FT   TRANSMEM    408    428       Helical. {ECO:0000255}.
FT   TRANSMEM    518    538       Helical. {ECO:0000255}.
FT   TRANSMEM    539    559       Helical. {ECO:0000255}.
FT   TRANSMEM    561    581       Helical. {ECO:0000255}.
FT   DOMAIN      661    742       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      816    863       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   COMPBIAS      4     14       Poly-Asn.
FT   COMPBIAS     53     57       Poly-Asn.
FT   COMPBIAS     60     63       Poly-Asn.
FT   COMPBIAS     66     69       Poly-Asn.
SQ   SEQUENCE   863 AA;  97298 MW;  575CEE036AE0A435 CRC64;
     MFRNNNNDNN NNDNGFDDEN KGIFLDSKIE ISDETSLIHK PYHDDYDENG LINNNNNSHN
     NNNGGNNNNH GPSKVTHRRG KHTFTEADKL KMTKFESLDF PIIDNQIYRE YIRRTSKLNH
     MLKTFGKWII CFMIGVLVGI TAYLVKQSVE FVNEFKFDQS GKYLEDERKF IAFLVYYSIN
     ILFGVSASLV IIPVGQIASG SGIPEVKGYL NGIRIPQSMN VKTLVGKLVS LILAYSSGLI
     LGPEGPMIHI GSMLGGAIGQ VKSKTLKWYP KVLWKYHNDR DRRDFISTGA AAGVAAAFGA
     PIGGVLFGFE EASSFWSRQL TWRTFFACLI ATFTTNIILQ GFDMQLHDYG VLKFGLSNKY
     LYKYSELIPF ALIGVAGGLF GALFVNLNAH LSQWRSKFFA NKKIYLRVLE VFILITITST
     ILYCCAAFTP CRSKTQANGS QTNSLDTSSS SILSSSGDNS KNSTKLFKLL NNASGEDKQE
     DKFIAFFCEQ GEYNQMAGLS FNSLDAALRL LFSTSTDIFT IPTLAVFSLI SFILTTITSG
     LMLASGLFIP MMLVGATFGR LVGQVIALFV SVDPCIYALV GASAMMAGFS RMTISLAIIM
     VELTEGTQYM LPVILSVMIA KWVGDFFNES IYEHLIEQKC YPFLQSQPPK SMIKLGVVDI
     MKTEVVTLHE VERVSKVIEV LKSEQHFHNG FPVIERPRPL DPNRKDAYGN LEYYEDETTY
     SGLILRNQLI CLLYYRIFCH EQPLPQNPRL LGGNSNRRYN QRRFGRPTEY GYAPADPRMT
     YELMTQSLAR HFPPIDKMNL KKEEIETMYI DLRPYMNLST IVANETYSYS ETYSIFRTIG
     LRHLPVVNKK NEVVGIVTRK DLL
//
ID   GEF1_YEAST              Reviewed;         779 AA.
AC   P37020; D6VWL1;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   20-DEC-2017, entry version 168.
DE   RecName: Full=Anion/proton exchange transporter GEF1;
DE   AltName: Full=CLC protein GEF1;
DE   AltName: Full=ClC-A;
DE   AltName: Full=ClC-Y1;
DE   AltName: Full=Voltage-gated chloride channel;
DE   Contains:
DE     RecName: Full=GEF1 N-terminal;
DE   Contains:
DE     RecName: Full=GEF1 C-terminal;
DE   Flags: Precursor;
GN   Name=GEF1; Synonyms=CLCY1; OrderedLocusNames=YJR040W; ORFNames=J1616;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7505388; DOI=10.1007/BF00279896;
RA   Greene J.R., Brown N.H., Didomenico B.J., Kaplan J., Eide D.J.;
RT   "The GEF1 gene of Saccharomyces cerevisiae encodes an integral
RT   membrane protein; mutations in which have effects on respiration and
RT   iron-limited growth.";
RL   Mol. Gen. Genet. 241:542-553(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7932715; DOI=10.1006/jmbi.1994.1607;
RA   Huang M.-E., Chuat J.-C., Galibert F.;
RT   "A voltage-gated chloride channel in the yeast Saccharomyces
RT   cerevisiae.";
RL   J. Mol. Biol. 242:595-598(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7668047; DOI=10.1002/yea.320110809;
RA   Huang M.-E., Chuat J.-C., Galibert F.;
RT   "Analysis of a 42.5 kb DNA sequence of chromosome X reveals three tRNA
RT   genes and 14 new open reading frames including a gene most probably
RT   belonging to the family of ubiquitin-protein ligases.";
RL   Yeast 11:775-781(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8641269;
RA   Galibert F., Alexandraki D., Baur A., Boles E., Chalwatzis N.,
RA   Chuat J.-C., Coster F., Cziepluch C., de Haan M., Domdey H.,
RA   Durand P., Entian K.-D., Gatius M., Goffeau A., Grivell L.A.,
RA   Hennemann A., Herbert C.J., Heumann K., Hilger F., Hollenberg C.P.,
RA   Huang M.-E., Jacq C., Jauniaux J.-C., Katsoulou C., Kirchrath L.,
RA   Kleine K., Kordes E., Koetter P., Liebl S., Louis E.J., Manus V.,
RA   Mewes H.-W., Miosga T., Obermaier B., Perea J., Pohl T.M.,
RA   Portetelle D., Pujol A., Purnelle B., Ramezani Rad M., Rasmussen S.W.,
RA   Rose M., Rossau R., Schaaff-Gerstenschlaeger I., Smits P.H.M.,
RA   Scarcez T., Soriano N., To Van D., Tzermia M., Van Broekhoven A.,
RA   Vandenbol M., Wedler H., von Wettstein D., Wambutt R., Zagulski M.,
RA   Zollner A., Karpfinger-Hartl L.;
RT   "Complete nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   X.";
RL   EMBO J. 15:2031-2049(1996).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9614122; DOI=10.1074/jbc.273.24.15110;
RA   Schwappach B., Stobrawa S., Hechenberger M., Steinmeyer K.,
RA   Jentsch T.J.;
RT   "Golgi localization and functionally important domains in the NH2 and
RT   COOH terminus of the yeast CLC putative chloride channel Gef1p.";
RL   J. Biol. Chem. 273:15110-15118(1998).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9520490; DOI=10.1073/pnas.95.7.4046;
RA   Gaxiola R.A., Yuan D.S., Klausner R.D., Fink G.R.;
RT   "The yeast CLC chloride channel functions in cation homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4046-4050(1998).
RN   [8]
RP   FUNCTION.
RX   PubMed=12074596; DOI=10.1016/S0006-291X(02)00610-1;
RA   Flis K., Bednarczyk P., Hordejuk R., Szewczyk A., Berest V.,
RA   Dolowy K., Edelman A., Kurlandzka A.;
RT   "The Gef1 protein of Saccharomyces cerevisiae is associated with
RT   chloride channel activity.";
RL   Biochem. Biophys. Res. Commun. 294:1144-1150(2002).
RN   [9]
RP   CLEAVAGE BY KEX2, AND SUBCELLULAR LOCATION.
RX   PubMed=15710404; DOI=10.1016/j.febslet.2005.01.011;
RA   Wachter A., Schwappach B.;
RT   "The yeast CLC chloride channel is proteolytically processed by the
RT   furin-like protease Kex2p in the first extracellular loop.";
RL   FEBS Lett. 579:1149-1153(2005).
RN   [10]
RP   INTERACTION WITH GET3.
RX   PubMed=16260785; DOI=10.1074/jbc.M507481200;
RA   Metz J., Waechter A., Schmidt B., Bujnicki J.M., Schwappach B.;
RT   "The yeast Arr4p ATPase binds the chloride transporter Gef1p when
RT   copper is available in the cytosol.";
RL   J. Biol. Chem. 281:410-417(2006).
RN   [11]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 208353 / W303-1A;
RX   PubMed=16847258; DOI=10.1073/pnas.0604075103;
RA   Kim H., Melen K., Oesterberg M., von Heijne G.;
RT   "A global topology map of the Saccharomyces cerevisiae membrane
RT   proteome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11142-11147(2006).
RN   [12]
RP   FUNCTION.
RX   PubMed=17662057; DOI=10.1111/j.1567-1364.2007.00279.x;
RA   Lopez-Rodriguez A., Trejo A.C., Coyne L., Halliwell R.F., Miledi R.,
RA   Martinez-Torres A.;
RT   "The product of the gene GEF1 of Saccharomyces cerevisiae transports
RT   Cl- across the plasma membrane.";
RL   FEMS Yeast Res. 7:1218-1229(2007).
CC   -!- FUNCTION: Anion/proton exchange transporter involved in iron and
CC       copper cation homeostasis. Involved in intracellular iron
CC       metabolism during growth on fermentable and non fermentable carbon
CC       sources. Required for proper copper-loading and maturation of
CC       multicopper oxidase FET3. Important for adjusting intracellular
CC       compartment pH to more alkaline pH under iron limitation. May also
CC       transport chloride ions through the plasma membrane.
CC       {ECO:0000269|PubMed:12074596, ECO:0000269|PubMed:17662057,
CC       ECO:0000269|PubMed:7505388, ECO:0000269|PubMed:9520490,
CC       ECO:0000269|PubMed:9614122}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with GET3.
CC       {ECO:0000250, ECO:0000269|PubMed:16260785}.
CC   -!- INTERACTION:
CC       Q12154:GET3; NbExp=6; IntAct=EBI-7552, EBI-2989;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:9614122}; Multi-pass membrane protein
CC       {ECO:0000255}. Endosome membrane {ECO:0000305|PubMed:9520490};
CC       Multi-pass membrane protein {ECO:0000255}. Prevacuolar compartment
CC       membrane {ECO:0000269|PubMed:12074596}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- PTM: Proteolytically processed in the secretory pathway by
CC       protease KEX2 within the first extracellular loop. However, both
CC       the N- and C-terminal products of the cleavage reaction are
CC       required for assembly of a functional channel.
CC       {ECO:0000269|PubMed:15710404}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a voltage-gated ClC-type
CC       chloride channel. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z23117; CAA80663.1; -; Genomic_DNA.
DR   EMBL; L29347; AAA53399.1; -; Genomic_DNA.
DR   EMBL; Z49540; CAA89567.1; -; Genomic_DNA.
DR   EMBL; L36344; AAA88741.1; -; Genomic_DNA.
DR   EMBL; BK006943; DAA08827.1; -; Genomic_DNA.
DR   PIR; S50054; S50054.
DR   RefSeq; NP_012574.1; NM_001181698.1.
DR   ProteinModelPortal; P37020; -.
DR   SMR; P37020; -.
DR   BioGrid; 33791; 114.
DR   DIP; DIP-3949N; -.
DR   IntAct; P37020; 7.
DR   MINT; MINT-492781; -.
DR   STRING; 4932.YJR040W; -.
DR   TCDB; 2.A.49.1.1; the chloride carrier/channel (clc) family.
DR   MaxQB; P37020; -.
DR   PRIDE; P37020; -.
DR   EnsemblFungi; YJR040W; YJR040W; YJR040W.
DR   GeneID; 853497; -.
DR   KEGG; sce:YJR040W; -.
DR   EuPathDB; FungiDB:YJR040W; -.
DR   SGD; S000003801; GEF1.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000164493; -.
DR   InParanoid; P37020; -.
DR   KO; K05012; -.
DR   OMA; YFCALVA; -.
DR   OrthoDB; EOG092C14Y0; -.
DR   BioCyc; YEAST:G3O-31675-MONOMER; -.
DR   Reactome; R-SCE-2672351; Stimuli-sensing channels.
DR   PRO; PR:P37020; -.
DR   Proteomes; UP000002311; Chromosome X.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:SGD.
DR   GO; GO:0005768; C:endosome; IDA:SGD.
DR   GO; GO:0000324; C:fungal-type vacuole; IDA:SGD.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:SGD.
DR   GO; GO:0005797; C:Golgi medial cisterna; IDA:SGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:SGD.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IDA:SGD.
DR   GO; GO:0006878; P:cellular copper ion homeostasis; IMP:SGD.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IMP:SGD.
DR   GO; GO:0034756; P:regulation of iron ion transport; IMP:CACAO.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 3.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Chloride; Chloride channel; Complete proteome; Endosome;
KW   Golgi apparatus; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    779       Anion/proton exchange transporter GEF1.
FT                                /FTId=PRO_0000094472.
FT   CHAIN         1    136       GEF1 N-terminal.
FT                                /FTId=PRO_0000419270.
FT   CHAIN       137    779       GEF1 C-terminal.
FT                                /FTId=PRO_0000419271.
FT   TOPO_DOM      1     75       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     76     96       Helical. {ECO:0000255}.
FT   TOPO_DOM     97    154       Lumenal. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
FT   TOPO_DOM    176    177       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical. {ECO:0000255}.
FT   TOPO_DOM    199    203       Lumenal. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical. {ECO:0000255}.
FT   TOPO_DOM    225    264       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical. {ECO:0000255}.
FT   TOPO_DOM    286    296       Lumenal. {ECO:0000255}.
FT   TRANSMEM    297    319       Helical. {ECO:0000255}.
FT   TOPO_DOM    320    336       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical. {ECO:0000255}.
FT   TOPO_DOM    358    369       Lumenal. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical. {ECO:0000255}.
FT   TOPO_DOM    391    436       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    465       Lumenal. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   TOPO_DOM    487    500       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    501    523       Helical. {ECO:0000255}.
FT   TOPO_DOM    524    529       Lumenal. {ECO:0000255}.
FT   TRANSMEM    530    552       Helical. {ECO:0000255}.
FT   TOPO_DOM    553    779       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      591    659       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      688    744       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   SITE        136    137       Cleavage; by KEX2.
FT   SITE        230    230       Mediates proton transfer from the outer
FT                                aqueous phase to the interior of the
FT                                protein; involved in linking H(+) and
FT                                Cl(-) transport. {ECO:0000250}.
FT   SITE        287    287       Mediates proton transfer from the protein
FT                                to the inner aqueous phase.
FT                                {ECO:0000250}.
FT   CONFLICT     13     13       G -> R (in Ref. 1; CAA80663).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       F -> L (in Ref. 1; CAA80663).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       S -> T (in Ref. 1; CAA80663).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       I -> L (in Ref. 1; CAA80663).
FT                                {ECO:0000305}.
FT   CONFLICT    497    497       T -> I (in Ref. 1; CAA80663).
FT                                {ECO:0000305}.
SQ   SEQUENCE   779 AA;  87592 MW;  544C751402D32E19 CRC64;
     MPTTYVPINQ PIGDGEDVID TNRFTNIPET QNFDQFVTID KIAEENRPLS VDSDREFLNS
     KYRHYREVIW DRAKTFITLS STAIVIGCIA GFLQVFTETL VNWKTGHCQR NWLLNKSFCC
     NGVVNEVTST SNLLLKRQEF ECEAQGLWIA WKGHVSPFII FMLLSVLFAL ISTLLVKYVA
     PMATGSGISE IKVWVSGFEY NKEFLGFLTL VIKSVALPLA ISSGLSVGKE GPSVHYATCC
     GYLLTKWLLR DTLTYSSQYE YITAASGAGV AVAFGAPIGG VLFGLEEIAS ANRFNSSTLW
     KSYYVALVAI TTLKYIDPFR NGRVILFNVT YDRDWKVQEI PIFIALGIFG GLYGKYISKW
     NINFIHFRKM YLSSWPVQEV LFLATLTALI SYFNEFLKLD MTESMGILFH ECVKNDNTST
     FSHRLCQLDE NTHAFEFLKI FTSLCFATVI RALLVVVSYG ARVPAGIFVP SMAVGATFGR
     AVSLLVERFI SGPSVITPGA YAFLGAAATL SGITNLTLTV VVIMFELTGA FMYIIPLMIV
     VAITRIILST SGISGGIADQ MIMVNGFPYL EDEQDEEEEE TLEKYTAEQL MSSKLITINE
     TIYLSELESL LYDSASEYSV HGFPITKDED KFEKEKRCIG YVLKRHLASK IMMQSVNSTK
     AQTTLVYFNK SNEELGHREN CIGFKDIMNE SPISVKKAVP VTLLFRMFKE LGCKTIIVEE
     SGILKGLVTA KDILRFKRIK YREVHGAKFT YNEALDRRCW SVIHFIIKRF TTNRNGNVI
//
ID   CICH_TETCF              Reviewed;         810 AA.
AC   P35522;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 89.
DE   RecName: Full=Chloride channel protein;
DE   AltName: Full=ClC-0;
OS   Tetronarce californica (Pacific electric ray) (Torpedo californica).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes;
OC   Elasmobranchii; Batoidea; Torpediniformes; Torpedinidae; Tetronarce.
OX   NCBI_TaxID=7787;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Electric organ;
RX   PubMed=1721838; DOI=10.1016/0167-4781(91)90228-E;
RA   O'Neill G.P., Grygorczyk R., Adam M., Ford-Hutchinson A.W.;
RT   "The nucleotide sequence of a voltage-gated chloride channel from the
RT   electric organ of Torpedo californica.";
RL   Biochim. Biophys. Acta 1129:131-134(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-11, AND CHARACTERIZATION.
RC   TISSUE=Electric organ;
RX   PubMed=7947726; DOI=10.1021/bi00249a005;
RA   Middleton R.E., Pheasant D.J., Miller C.;
RT   "Purification, reconstitution, and subunit composition of a voltage-
RT   gated chloride channel from Torpedo electroplax.";
RL   Biochemistry 33:13189-13198(1994).
RN   [3]
RP   CHARACTERIZATION, AND MUTAGENESIS OF GLU-166.
RX   PubMed=12649487; DOI=10.1126/science.1082708;
RA   Dutzler R., Campbell E.B., MacKinnon R.;
RT   "Gating the selectivity filter in ClC chloride channels.";
RL   Science 300:108-112(2003).
CC   -!- FUNCTION: Voltage-gated chloride channel. This channel is thought
CC       to ensure the high conductance of the non-innervated membrane of
CC       the electrocyte necessary for efficient current generation caused
CC       by sodium influx through the acetylcholine receptor at the
CC       innervated membrane.
CC   -!- SUBUNIT: Homodimer. Each subunit has channel activity ("Double
CC       barreled channel").
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- MISCELLANEOUS: The CLC channel family contains both chloride
CC       channels and proton-coupled anion transporters that exchange
CC       chloride or another anion for protons. The absence of conserved
CC       gating glutamate residues is typical for family members that
CC       function as channels (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClC-0 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60433; CAA42960.1; -; mRNA.
DR   PIR; S19725; S19725.
DR   ProteinModelPortal; P35522; -.
DR   DIP; DIP-29258N; -.
DR   TCDB; 2.A.49.2.11; the chloride carrier/channel (clc) family.
DR   HOVERGEN; HBG005332; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002242; Cl_channel-0.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01111; CLCHANNEL0.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Chloride; Chloride channel; Direct protein sequencing;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7947726}.
FT   CHAIN         2    810       Chloride channel protein.
FT                                /FTId=PRO_0000094463.
FT   TOPO_DOM      2     48       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     49     86       Helical. {ECO:0000250}.
FT   TRANSMEM     93    116       Helical. {ECO:0000250}.
FT   INTRAMEM    125    132       Helical. {ECO:0000250}.
FT   TRANSMEM    141    160       Helical. {ECO:0000250}.
FT   TRANSMEM    166    184       Helical. {ECO:0000250}.
FT   INTRAMEM    201    213       Helical. {ECO:0000250}.
FT   INTRAMEM    217    225       Helical. {ECO:0000250}.
FT   TRANSMEM    237    254       Helical. {ECO:0000250}.
FT   TRANSMEM    283    311       Helical. {ECO:0000250}.
FT   TRANSMEM    320    339       Helical. {ECO:0000250}.
FT   TRANSMEM    389    408       Helical. {ECO:0000250}.
FT   TRANSMEM    416    439       Helical. {ECO:0000250}.
FT   INTRAMEM    456    470       Helical. {ECO:0000250}.
FT   INTRAMEM    471    472       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   INTRAMEM    473    484       Helical. {ECO:0000250}.
FT   INTRAMEM    485    489       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   TRANSMEM    490    506       Helical. {ECO:0000250}.
FT   TOPO_DOM    507    810       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      543    601       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      724    781       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOTIF       122    126       Selectivity filter part_1. {ECO:0000250}.
FT   MOTIF       164    168       Selectivity filter part_2. {ECO:0000250}.
FT   MOTIF       416    420       Selectivity filter part_3. {ECO:0000250}.
FT   BINDING     123    123       Chloride. {ECO:0000250}.
FT   BINDING     418    418       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     512    512       Chloride. {ECO:0000250}.
FT   SITE        166    166       Gate.
FT   CARBOHYD    365    365       N-linked (GlcNAc...) asparagine.
FT   MUTAGEN     166    166       E->A,Q,V: Gating function is lost. The
FT                                channel is always open.
FT                                {ECO:0000269|PubMed:12649487}.
SQ   SEQUENCE   810 AA;  89447 MW;  BD3954973D6C99EA CRC64;
     MSHEKNEASG NPEAQSWKAQ EAMLGVKTEV SRWRAVKNCL YRHLVKVLGE DWIFLLLLGA
     LMALVSWAMD FIGSRGLRFY KYLFAMVEGN LGLQYLVWVC YPLILILFSS LFCQIVSPQA
     VGSGIPELKT IIRGAVLHEY LTLRTFVAKT VGLTVALSAG FPLGKEGPFV HIASICATLL
     NQLLCFISGR REEPYYLRAD ILTVGCALGI SCCFGTPLAG VLFSIEVTCS HFGVRSYWRG
     FLGGAFSAFI FRVLSVWVKD TVTLTALFKT NFRGDIPFDL QELPAFAIIG IASGFFGALF
     VYLNRQIIVF MRKKNFVTKI LKKQRLIYPA VVTFVLATLR FPPGVGQFFG AGLMPRETIN
     SLFDNYTWTK TIDPRGLGNS AQWFIPHLNI FIVMALYFVM HFWMAALAVT MPVPCGAFVP
     VFNLGAVLGR FVGELMALLF PDGLVSNGNL YHILPGEYAV IGAAAMTGAV THAVSTAVIC
     FELTGQISHV LPMMVAVILA NMVAQGLQPS LYDSIIQIKK LPYLPELSWS SANKYNIQVG
     DIMVRDVTSI ASTSTYGDLL HVLRQTKLKF FPFVDTPETN TLLGSIERTE VEGLLQRRIS
     AYRRQPATAA EAEEEGRNGE RGASFTGDVP GEAETSFAYI DQEEAEGQQQ REGLEAVKVQ
     TEDPRPPSPV PAEEPTQTSG IYQKKHKGTG QVASRFEEML TLEEIYQWEQ REKNVVVNFE
     TCRIDQSPFQ LVEGTSLQKT HTLFSLLGLD RAYVTSMGKL VGVVALAEIQ AAIEGSYQKG
     FRLPPPLASF RDAKNARNSG RTATSNSSGK
//
ID   CLCF_DICDI              Reviewed;         809 AA.
AC   Q54C67;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   27-SEP-2017, entry version 73.
DE   RecName: Full=Chloride channel protein F;
GN   Name=clcF; ORFNames=DDB_G0293130;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000199; EAL60917.1; -; Genomic_DNA.
DR   RefSeq; XP_629352.1; XM_629350.1.
DR   ProteinModelPortal; Q54C67; -.
DR   STRING; 44689.DDB0233307; -.
DR   PaxDb; Q54C67; -.
DR   EnsemblProtists; EAL60917; EAL60917; DDB_G0293130.
DR   GeneID; 8629076; -.
DR   KEGG; ddi:DDB_G0293130; -.
DR   dictyBase; DDB_G0293130; clcF.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q54C67; -.
DR   OMA; TAYYQTY; -.
DR   PhylomeDB; Q54C67; -.
DR   PRO; PR:Q54C67; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    809       Chloride channel protein F.
FT                                /FTId=PRO_0000328048.
FT   TOPO_DOM      1     65       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     66     86       Helical. {ECO:0000255}.
FT   TRANSMEM    110    130       Helical. {ECO:0000255}.
FT   TRANSMEM    152    172       Helical. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical. {ECO:0000255}.
FT   TRANSMEM    246    266       Helical. {ECO:0000255}.
FT   TRANSMEM    295    315       Helical. {ECO:0000255}.
FT   TRANSMEM    333    353       Helical. {ECO:0000255}.
FT   TRANSMEM    395    415       Helical. {ECO:0000255}.
FT   TRANSMEM    425    445       Helical. {ECO:0000255}.
FT   TRANSMEM    459    479       Helical. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   DOMAIN      539    597       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      756    809       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   COMPBIAS    615    647       Poly-Asn.
FT   COMPBIAS    689    694       Poly-Asn.
FT   COMPBIAS    698    730       Poly-Asn.
SQ   SEQUENCE   809 AA;  89427 MW;  3D30D340562465A2 CRC64;
     MSTSKYSKMI SSKHGYKKTR IKNNTSDSDL FNLVMPKADV VGFKSKQGGI SRQAISWAKF
     ARLNNFYIWL FLAAVGLLGS IYLVAVDLIF KYVVFSWREA FMSLTENYFL QYLSFIAWTV
     ALATGSCFII KKICPAAVGS GIPDLKSIFS GFWNPFVVAP MVLLWKTIGL LLSYGSGLSI
     GKEGPYIHIS ATLANTLLSI KPFKSIAQND TQRSQLLAAC CALGVAATFG SPIGGVLFSI
     EATGTFYLIS NYWRAFFTAT VGAVGIKILL SNPSNDLLES FRTHFADLNL ASAQLIAFII
     LGVLCGLLAS LFISLYTKIY NWKKHNAELF KKITPFGEVI IVAAATAILS FPLKFLRLDH
     ATAVHTMFTA TPDSDNSEVL SELAVWTDSM PFNHGIILAC FLYVVVKLVL TAVSITLPIP
     YGIYIPLFAI GSAVGRFVGE LMLVLFPNSK EIYPTGYAVV GAAALCGGAT RTVSSAMIIL
     ELTNDLTYMV PVLLGVVLSC GIGNLLNHSI YDCFLKNKNL PYLPFYKAKS DSLIARDVMK
     RDLYYVCQNT TLSQISNLLK RVDEHSIPVV SSDNDLQLIG TISTTTLEEV IAYHERLHSY
     SKSPLSLSDN GIDINDNDNN DNINNNQNNN NNNNNNNNNN NSNNQNNSLV SEAIEMNVLS
     DSDNDENNNL IPNIPINDNN IIIQNNIRNN NNNNFSDNNN NYNNNNYNNN NNNNNDNNTN
     NDNNINNNSN DINESISEET TIDLVQMELQ NPWVVIDSSP FQIQETMPVR KIVFMFMMLG
     GNILYVTNKG KLTGVVAKTE LVHQNNNKH
//
ID   GBRT_HUMAN              Reviewed;         632 AA.
AC   Q9UN88; A6NFN1; Q32MB4; Q9NZK8;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 2.
DT   20-DEC-2017, entry version 151.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit theta;
DE   AltName: Full=GABA(A) receptor subunit theta;
DE   Flags: Precursor;
GN   Name=GABRQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-478.
RX   PubMed=10804200;
RA   Sinkkonen S.T., Hanna M.C., Kirkness E.F., Korpi E.R.;
RT   "GABAA receptor epsilon and theta subunits display unusual structural
RT   variation between species and are enriched in the rat locus
RT   ceruleus.";
RL   J. Neurosci. 20:3588-3595(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-478.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-632.
RX   PubMed=10449790; DOI=10.1073/pnas.96.17.9891;
RA   Bonnert T.P., McKernan R.M., Farrar S., le Bourdelles B.,
RA   Heavens R.P., Smith D.W., Hewson L., Rigby M.R.,
RA   Sirinathsinghji D.J.S., Brown N., Wafford K.A., Whiting P.J.;
RT   "Theta, a novel gamma-aminobutyric acid type A receptor subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9891-9896(1999).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. This subunit coassembles with
CC       alpha-2, beta-1 and gamma-1.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRQ sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF189259; AAF70380.1; -; mRNA.
DR   EMBL; AF002997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471169; EAW99424.1; -; Genomic_DNA.
DR   EMBL; BC109210; AAI09211.1; -; mRNA.
DR   EMBL; BC109211; AAI09212.1; -; mRNA.
DR   EMBL; AF144648; AAD51172.1; -; mRNA.
DR   CCDS; CCDS14707.1; -.
DR   RefSeq; NP_061028.3; NM_018558.3.
DR   UniGene; Hs.283081; -.
DR   ProteinModelPortal; Q9UN88; -.
DR   SMR; Q9UN88; -.
DR   IntAct; Q9UN88; 1.
DR   STRING; 9606.ENSP00000359329; -.
DR   ChEMBL; CHEMBL2093872; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; Q9UN88; -.
DR   PhosphoSitePlus; Q9UN88; -.
DR   DMDM; 13959382; -.
DR   PaxDb; Q9UN88; -.
DR   PeptideAtlas; Q9UN88; -.
DR   PRIDE; Q9UN88; -.
DR   Ensembl; ENST00000598523; ENSP00000469332; ENSG00000268089.
DR   GeneID; 55879; -.
DR   KEGG; hsa:55879; -.
DR   UCSC; uc004ffp.2; human.
DR   CTD; 55879; -.
DR   DisGeNET; 55879; -.
DR   EuPathDB; HostDB:ENSG00000268089.2; -.
DR   GeneCards; GABRQ; -.
DR   H-InvDB; HIX0056145; -.
DR   HGNC; HGNC:14454; GABRQ.
DR   HPA; HPA002063; -.
DR   MIM; 300349; gene.
DR   neXtProt; NX_Q9UN88; -.
DR   PharmGKB; PA28504; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   HOGENOM; HOG000049189; -.
DR   HOVERGEN; HBG051708; -.
DR   InParanoid; Q9UN88; -.
DR   KO; K05192; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q9UN88; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; GABRQ; -.
DR   GenomeRNAi; 55879; -.
DR   PRO; PR:Q9UN88; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000268089; -.
DR   CleanEx; HS_GABRQ; -.
DR   Genevisible; Q9UN88; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0005326; F:neurotransmitter transporter activity; TAS:ProtInc.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008101; GABAAt_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01725; GABAARTHETA.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Postsynaptic cell membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    632       Gamma-aminobutyric acid receptor subunit
FT                                theta.
FT                                /FTId=PRO_0000000495.
FT   TOPO_DOM     22    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TRANSMEM    327    347       Helical. {ECO:0000255}.
FT   TRANSMEM    612    632       Helical. {ECO:0000255}.
FT   CARBOHYD    127    127       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    183    197       {ECO:0000250}.
FT   VARIANT      15     15       L -> I (in dbSNP:rs4996045).
FT                                /FTId=VAR_030761.
FT   VARIANT     478    478       F -> I (in dbSNP:rs3810651).
FT                                {ECO:0000269|PubMed:10804200,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030762.
SQ   SEQUENCE   632 AA;  72022 MW;  C13267AC9212118B CRC64;
     MGIRGMLRAA VILLLIRTWL AEGNYPSPIP KFHFEFSSAV PEVVLNLFNC KNCANEAVVQ
     KILDRVLSRY DVRLRPNFGG APVPVRISIY VTSIEQISEM NMDYTITMFF HQTWKDSRLA
     YYETTLNLTL DYRMHEKLWV PDCYFLNSKD AFVHDVTVEN RVFQLHPDGT VRYGIRLTTT
     AACSLDLHKF PMDKQACNLV VESYGYTVED IILFWDDNGN AIHMTEELHI PQFTFLGRTI
     TSKEVYFYTG SYIRLILKFQ VQREVNSYLV QVYWPTVLTT ITSWISFWMN YDSSAARVTI
     GLTSMLILTT IDSHLRDKLP NISCIKAIDI YILVCLFFVF LSLLEYVYIN YLFYSRGPRR
     QPRRHRRPRR VIARYRYQQV VVGNVQDGLI NVEDGVSSLP ITPAQAPLAS PESLGSLTST
     SEQAQLATSE SLSPLTSLSG QAPLATGESL SDLPSTSEQA RHSYGVRFNG FQADDSIFPT
     EIRNRVEAHG HGVTHDHEDS NESLSSDERH GHGPSGKPML HHGEKGVQEA GWDLDDNNDK
     SDCLAIKEQF KCDTNSTWGL NDDELMAHGQ EKDSSSESED SCPPSPGCSF TEGFSFDLFN
     PDYVPKVDKW SRFLFPLAFG LFNIVYWVYH MY
//
ID   YHYB_SCHPO              Reviewed;         766 AA.
AC   O60159;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Putative anion/proton exchange transporter C19C7.11;
GN   ORFNames=SPBC19C7.11;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   REVISION OF GENE MODEL.
RX   PubMed=21511999; DOI=10.1126/science.1203357;
RA   Rhind N., Chen Z., Yassour M., Thompson D.A., Haas B.J., Habib N.,
RA   Wapinski I., Roy S., Lin M.F., Heiman D.I., Young S.K., Furuya K.,
RA   Guo Y., Pidoux A., Chen H.M., Robbertse B., Goldberg J.M., Aoki K.,
RA   Bayne E.H., Berlin A.M., Desjardins C.A., Dobbs E., Dukaj L., Fan L.,
RA   FitzGerald M.G., French C., Gujja S., Hansen K., Keifenheim D.,
RA   Levin J.Z., Mosher R.A., Mueller C.A., Pfiffner J., Priest M.,
RA   Russ C., Smialowska A., Swoboda P., Sykes S.M., Vaughn M.,
RA   Vengrova S., Yoder R., Zeng Q., Allshire R., Baulcombe D.,
RA   Birren B.W., Brown W., Ekwall K., Kellis M., Leatherwood J., Levin H.,
RA   Margalit H., Martienssen R., Nieduszynski C.A., Spatafora J.W.,
RA   Friedman N., Dalgaard J.Z., Baumann P., Niki H., Regev A., Nusbaum C.;
RT   "Comparative functional genomics of the fission yeasts.";
RL   Science 332:930-936(2011).
CC   -!- FUNCTION: Anion/proton exchange transporter involved in iron and
CC       copper cation homeostasis. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}. Endosome membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329671; CAA19579.2; -; Genomic_DNA.
DR   PIR; T39817; T39817.
DR   RefSeq; NP_596167.2; NM_001022087.2.
DR   STRING; 4896.SPBC19C7.11.1; -.
DR   iPTMnet; O60159; -.
DR   MaxQB; O60159; -.
DR   PRIDE; O60159; -.
DR   EnsemblFungi; SPBC19C7.11.1; SPBC19C7.11.1:pep; SPBC19C7.11.
DR   GeneID; 2540750; -.
DR   KEGG; spo:SPBC19C7.11; -.
DR   EuPathDB; FungiDB:SPBC19C7.11; -.
DR   PomBase; SPBC19C7.11; -.
DR   HOGENOM; HOG000164493; -.
DR   InParanoid; O60159; -.
DR   KO; K05012; -.
DR   OMA; YFCALVA; -.
DR   OrthoDB; EOG092C14Y0; -.
DR   Reactome; R-SPO-2672351; Stimuli-sensing channels.
DR   PRO; PR:O60159; -.
DR   Proteomes; UP000002485; Chromosome II.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000324; C:fungal-type vacuole; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:PomBase.
DR   GO; GO:0005886; C:plasma membrane; ISO:PomBase.
DR   GO; GO:0005774; C:vacuolar membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; ISO:PomBase.
DR   GO; GO:0006878; P:cellular copper ion homeostasis; IBA:GO_Central.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:PomBase.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Endoplasmic reticulum; Endosome; Golgi apparatus;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    766       Putative anion/proton exchange
FT                                transporter C19C7.11.
FT                                /FTId=PRO_0000310340.
FT   TOPO_DOM      1     78       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     79     99       Helical. {ECO:0000255}.
FT   TOPO_DOM    100    144       Lumenal. {ECO:0000250}.
FT   TRANSMEM    145    165       Helical. {ECO:0000255}.
FT   TOPO_DOM    166    167       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    168    188       Helical. {ECO:0000255}.
FT   TOPO_DOM    189    196       Lumenal. {ECO:0000250}.
FT   TRANSMEM    197    217       Helical. {ECO:0000255}.
FT   TOPO_DOM    218    252       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    253    273       Helical. {ECO:0000255}.
FT   TOPO_DOM    274    284       Lumenal. {ECO:0000250}.
FT   TRANSMEM    285    305       Helical. {ECO:0000255}.
FT   TOPO_DOM    306    322       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    323    343       Helical. {ECO:0000255}.
FT   TOPO_DOM    344    362       Lumenal. {ECO:0000250}.
FT   TRANSMEM    363    383       Helical. {ECO:0000255}.
FT   TOPO_DOM    384    418       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    419    439       Helical. {ECO:0000255}.
FT   TOPO_DOM    440    442       Lumenal. {ECO:0000250}.
FT   TRANSMEM    443    463       Helical. {ECO:0000255}.
FT   TOPO_DOM    464    486       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    487    507       Helical. {ECO:0000255}.
FT   TOPO_DOM    508    520       Lumenal. {ECO:0000250}.
FT   TRANSMEM    521    543       Helical. {ECO:0000255}.
FT   TOPO_DOM    544    766       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      580    641       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      676    734       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   SITE        218    218       Mediates proton transfer from the outer
FT                                aqueous phase to the interior of the
FT                                protein; involved in linking H(+) and
FT                                Cl(-) transport. {ECO:0000250}.
FT   SITE        275    275       Mediates proton transfer from the protein
FT                                to the inner aqueous phase.
FT                                {ECO:0000250}.
SQ   SEQUENCE   766 AA;  85162 MW;  43733DCF104C0AF0 CRC64;
     MSSQKRADSS SSFDQAERRS LDENERKKKY FFNREGSGID NFETDDRVNE IINEQNEENV
     IDQSRWSKLW RIWNVGYSWF ILSIIGTTVG FAAYMLDIVT SWLSDIRRGY CTSHWYYNEK
     FCCWYSETMG SSCTAWKPWT YKFSLNYLIY TAFALLFVLC AAIMVRDVAP LAAGSGISEI
     KCIISGFLRD SFLSFRVMLV KCVGLPLAIA SGLSVGKEGP SVHLATTIGH NISKIFKYAR
     EGSIRYRDIC VASAASGVAV AFGSPIGGVL FGIEEMSGGY DPKMIVYSFF CCLSAVGVLH
     MLNPFRTGQV VLFEVRYSGS WHFFELLFFC FLGIFGGLYG EFVMRLFFLI QKLRKKYLSR
     WGVLDAAFVT VITSLVSFLN PWLRLDMTLG MELLFQECKS SSSPELINLC DPSLRTKNTI
     LLLIATFART IFVTFSYGAK VPAGIFVPSM AVGASFGYMI GLIAEMIYQR FPNSVLFLAC
     HGSESCITPG TYALLGAAAS LSGIMHLTVT IVVIMFELTG ALNFILPTVL VVALANSIGN
     MLGKTGIADR SIEINGLPLL EPEKSINSSN TINIPITEVM ASNLITIPSI GFTWRKLLGM
     MEGYDFSGYP VVLDSRSNYL IGYLKKSSLK SSFEAAKLEP SFTFDQQLCF GKVDSVGDSK
     SSKFGESDRI DLSAYMDVNP ISVLHTQSIA NVAVLFEVLS PSVIFIEKDG NLVGLISKKD
     LLLASKYYQE DNDLVNPANR HRAVSTERIN DSYENIELKP LKLNIE
//
ID   CLIC6_MOUSE             Reviewed;         596 AA.
AC   Q8BHB9;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   25-OCT-2017, entry version 119.
DE   RecName: Full=Chloride intracellular channel protein 6;
GN   Name=Clic6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=14597386; DOI=10.1016/S0378-1119(03)00830-8;
RA   Friedli M., Guipponi M., Bertrand S., Bertrand D., Neerman-Arbez M.,
RA   Scott H.S., Antonarakis S.E., Reymond A.;
RT   "Identification of a novel member of the CLIC family, CLIC6, mapping
RT   to 21q22.12.";
RL   Gene 320:31-40(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: May insert into membranes and form chloride ion
CC       channels. May play a critical role in water-secreting cells,
CC       possibly through the regulation of chloride ion transport (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with dopamine receptors DRD2, DRD3 and DRD4.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.
CC       Note=Predominantly cytoplasmic. Upon chloride ion efflux from the
CC       cell, it is translocated to the plasma membrane (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF448440; AAN76731.1; -; mRNA.
DR   EMBL; AK077599; BAC36890.1; -; mRNA.
DR   EMBL; BC075706; AAH75706.1; -; mRNA.
DR   CCDS; CCDS28338.1; -.
DR   RefSeq; NP_766057.1; NM_172469.3.
DR   UniGene; Mm.44747; -.
DR   ProteinModelPortal; Q8BHB9; -.
DR   SMR; Q8BHB9; -.
DR   IntAct; Q8BHB9; 1.
DR   MINT; MINT-4091042; -.
DR   STRING; 10090.ENSMUSP00000023670; -.
DR   iPTMnet; Q8BHB9; -.
DR   PhosphoSitePlus; Q8BHB9; -.
DR   MaxQB; Q8BHB9; -.
DR   PaxDb; Q8BHB9; -.
DR   PeptideAtlas; Q8BHB9; -.
DR   PRIDE; Q8BHB9; -.
DR   Ensembl; ENSMUST00000023670; ENSMUSP00000023670; ENSMUSG00000022949.
DR   GeneID; 209195; -.
DR   KEGG; mmu:209195; -.
DR   UCSC; uc007zzg.1; mouse.
DR   CTD; 54102; -.
DR   MGI; MGI:2146607; Clic6.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000013008; -.
DR   HOVERGEN; HBG050996; -.
DR   InParanoid; Q8BHB9; -.
DR   KO; K05026; -.
DR   OMA; PGQEHDI; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; Q8BHB9; -.
DR   TreeFam; TF315438; -.
DR   ChiTaRS; Clic6; mouse.
DR   PRO; PR:Q8BHB9; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   Bgee; ENSMUSG00000022949; -.
DR   CleanEx; MM_CLIC6; -.
DR   ExpressionAtlas; Q8BHB9; baseline and differential.
DR   Genevisible; Q8BHB9; MM.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    596       Chloride intracellular channel protein 6.
FT                                /FTId=PRO_0000144218.
FT   TRANSMEM    381    401       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN      448    596       GST C-terminal.
FT   COMPBIAS      3    354       Glu-rich.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q811Q2}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q811Q2}.
SQ   SEQUENCE   596 AA;  62886 MW;  34B57EDC543841DA CRC64;
     MAEATEPKEV APGSQGQPEG ATIEGPGEPG AADLEGREAS EEAAEAPRDL GAGVEARASG
     KEEGGCGQDE GTGGAQAQDP RTGPEAETPG ASGAPGEAEA AERDPEGAIP QGAEEAPSAQ
     QVQGMSSGLD SQGEAPEVPG DSRREPEDPT ASEAGEEAES GQEAQGGGAL GLQINPEVQG
     LAGDNMDTEA PAGGPLGSES EPQGGGESSP QPQDEAIEIV TTEIGGNESG ELAGASAADA
     AGEGETLGKD GSEEAASEDA RVDAHENGDQ GKLQEETGEE EARPEPELKG PCEGAIQEKP
     PDGSLDGEEA KSTEHEEESQ AELSNHLAEE PSVQGGEELG RVNGRRENGP ALEEGDPGQE
     HDITLFVKAG YDGESIGNCP FSQRLFMILW LKGVIFNVTT VDLKRKPADL QNLAPGTNPP
     FMTFDGEVKT DVNKIEEFLE EKLVPPRYPK LGTQHPESNS AGNDVFAKFS AFIKNTKKDA
     NEIYEKNLLR ALKKLDSYLN SPLPDEIDAD SSEDVTVSQR KFLDGDELTL ADCNLLPKLH
     IIKIVAKKYR DFEFPSEMTG IWRYLNNAYA RDEFTNTCPA DREIEHAYSD AAKRMK
//
ID   YOO2_SCHPO              Reviewed;         696 AA.
AC   O94287;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   25-OCT-2017, entry version 100.
DE   RecName: Full=Uncharacterized chloride channel protein C887.02;
GN   ORFNames=SPBC887.02;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales;
OC   Schizosaccharomycetaceae; Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M.,
RA   Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A.,
RA   Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G.,
RA   Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K.,
RA   James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J.,
RA   Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C.,
RA   Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E.,
RA   Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S.,
RA   Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K.,
RA   Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S.,
RA   Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B.,
RA   Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D.,
RA   Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R.,
RA   Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B.,
RA   Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S.,
RA   Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M.,
RA   Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G.,
RA   Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J.,
RA   Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L.,
RA   Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J.,
RA   Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   REVISION OF GENE MODEL.
RX   PubMed=21511999; DOI=10.1126/science.1203357;
RA   Rhind N., Chen Z., Yassour M., Thompson D.A., Haas B.J., Habib N.,
RA   Wapinski I., Roy S., Lin M.F., Heiman D.I., Young S.K., Furuya K.,
RA   Guo Y., Pidoux A., Chen H.M., Robbertse B., Goldberg J.M., Aoki K.,
RA   Bayne E.H., Berlin A.M., Desjardins C.A., Dobbs E., Dukaj L., Fan L.,
RA   FitzGerald M.G., French C., Gujja S., Hansen K., Keifenheim D.,
RA   Levin J.Z., Mosher R.A., Mueller C.A., Pfiffner J., Priest M.,
RA   Russ C., Smialowska A., Swoboda P., Sykes S.M., Vaughn M.,
RA   Vengrova S., Yoder R., Zeng Q., Allshire R., Baulcombe D.,
RA   Birren B.W., Brown W., Ekwall K., Kellis M., Leatherwood J., Levin H.,
RA   Margalit H., Martienssen R., Nieduszynski C.A., Spatafora J.W.,
RA   Friedman N., Dalgaard J.Z., Baumann P., Niki H., Regev A., Nusbaum C.;
RT   "Comparative functional genomics of the fission yeasts.";
RL   Science 332:930-936(2011).
CC   -!- FUNCTION: Voltage-gated chloride channel. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CU329671; CAA21887.2; -; Genomic_DNA.
DR   PIR; T40727; T40727.
DR   RefSeq; NP_596476.2; NM_001022396.2.
DR   STRING; 4896.SPBC887.02.1; -.
DR   MaxQB; O94287; -.
DR   PRIDE; O94287; -.
DR   EnsemblFungi; SPBC887.02.1; SPBC887.02.1:pep; SPBC887.02.
DR   GeneID; 2541132; -.
DR   KEGG; spo:SPBC887.02; -.
DR   EuPathDB; FungiDB:SPBC887.02; -.
DR   PomBase; SPBC887.02; -.
DR   InParanoid; O94287; -.
DR   KO; K05012; -.
DR   OMA; WAIFNSW; -.
DR   OrthoDB; EOG092C1PD8; -.
DR   PRO; PR:O94287; -.
DR   Proteomes; UP000002485; Chromosome II.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISM:PomBase.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    696       Uncharacterized chloride channel protein
FT                                C887.02.
FT                                /FTId=PRO_0000314105.
FT   TRANSMEM     38     58       Helical. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical. {ECO:0000255}.
FT   TRANSMEM    245    265       Helical. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical. {ECO:0000255}.
FT   TRANSMEM    329    349       Helical. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TRANSMEM    402    422       Helical. {ECO:0000255}.
FT   TRANSMEM    433    453       Helical. {ECO:0000255}.
FT   TRANSMEM    457    477       Helical. {ECO:0000255}.
FT   DOMAIN      527    587       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      617    674       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
SQ   SEQUENCE   696 AA;  76606 MW;  F5CB336E4F6A16CE CRC64;
     MKDDQLIDWI HERYEEQKSA NRLAGRFRFL GLETKYSIIS IISGIFIGLT AALLNALASL
     LNSFREGYCT VNILFDKQTC CSTLTEDYEC QEFFFWRNNH SVFVSCLIYV SVSVGFAFIA
     TTLGYVVAPA ARASGIPTIK AILSGYKYPD MNVFFSIKTL CSKSLAVCFS VASGLWVGKE
     GPFVHIATNI IYLVERIAPS LADSEIFTRQ LLAAAMASGI AASFNAPVGG VIFALEQLAS
     SSFPSLFTGS IWYEFLCSAS SVVALQLIRS WHTDVGYLSY VSLDRRWSYK DTLPFIFISI
     LCGCLGSVLI YLNMKFASKT KGFSKISNVF FVIFLSLITS LTAYAILGES ELLFNPMELF
     PQVINSCSPS SSTVLCETTF WVTAIVLFTS ALLGLLLTSA TFGAAIPTGI IVPSLAIGAC
     IGRAVGTLLK SRFPSLAGTS IYGVIGSIAF LSSTTRLVVA LVVILFELTG ALNIALPLML
     ATLISKWVSD SIIETSIYDA WIQFRNIPYF PSSNSLKFSI PLNFPVRSPE QLVRLPIRSC
     SIEELERAMH DSSQSFFVVL KNDTEFFEGF ISRNKVSELL NRRPMSSNMQ TTDNTGLDPL
     RSASAPVDST FDLFDYIHPT TFTLNYDTPP VLMLKLFKDA GITNLALLNH GKLHGVLTKI
     DIIEYAKKCK THTGNTYSEL PTGVTYETDI FNRADD
//
ID   GBRG3_HUMAN             Reviewed;         467 AA.
AC   Q99928; G3V594; Q9HD46; Q9NYT2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 2.
DT   20-DEC-2017, entry version 161.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit gamma-3;
DE   AltName: Full=GABA(A) receptor subunit gamma-3;
DE   Flags: Precursor;
GN   Name=GABRG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=8719414; DOI=10.1016/0922-4106(95)90070-5;
RA   Hadingham K.L., Wafford K.A., Thompson S.A., Palmer K.J.,
RA   Whiting P.J.;
RT   "Expression and pharmacology of human GABAA receptors containing gamma
RT   3 subunits.";
RL   Eur. J. Pharmacol. 291:301-309(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Han M.K., Chen Y.-H., Nurmi E.L., Sutcliffe J.S.;
RT   "Gene structure and organization of the GABAA receptor gamma 3 subunit
RT   (GABRG3) gene.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 19-467.
RA   Kim S.-J., Gonen D., Yang Z.-Y., Reliford A., Dy A., Leventhal B.L.,
RA   Cook E.H. Jr.;
RT   "Genomic organization of GABAA receptor gamma 3 subunit gene
RT   (GABRG3).";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   VARIANT ALA-352.
RX   PubMed=26566883; DOI=10.1136/jmedgenet-2015-103179;
RA   Rafiullah R., Aslamkhan M., Paramasivam N., Thiel C., Mustafa G.,
RA   Wiemann S., Schlesner M., Wade R.C., Rappold G.A., Berkel S.;
RT   "Homozygous missense mutation in the LMAN2L gene segregates with
RT   intellectual disability in a large consanguineous Pakistani family.";
RL   J. Med. Genet. 53:138-144(2016).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99928-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99928-2; Sequence=VSP_047543, VSP_047544;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: May be palmitoylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: This subunit carries the benzodiazepine binding
CC       site.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRG3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S82769; AAB39369.1; -; mRNA.
DR   EMBL; AF269144; AAF99698.1; -; Genomic_DNA.
DR   EMBL; AF269135; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269136; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269137; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269138; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269139; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269140; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269141; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269142; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AF269143; AAF99698.1; JOINED; Genomic_DNA.
DR   EMBL; AC104002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136896; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC145436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EU606049; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471151; EAW57658.1; -; Genomic_DNA.
DR   EMBL; BC045709; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AH009226; AAF63215.1; -; Genomic_DNA.
DR   CCDS; CCDS45195.1; -. [Q99928-1]
DR   CCDS; CCDS59251.1; -. [Q99928-2]
DR   RefSeq; NP_001257802.1; NM_001270873.1. [Q99928-2]
DR   RefSeq; NP_150092.2; NM_033223.4. [Q99928-1]
DR   UniGene; Hs.569475; -.
DR   ProteinModelPortal; Q99928; -.
DR   SMR; Q99928; -.
DR   BioGrid; 108841; 1.
DR   STRING; 9606.ENSP00000331912; -.
DR   ChEMBL; CHEMBL2093872; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; Q99928; -.
DR   PhosphoSitePlus; Q99928; -.
DR   BioMuta; GABRG3; -.
DR   DMDM; 13959689; -.
DR   PaxDb; Q99928; -.
DR   PRIDE; Q99928; -.
DR   Ensembl; ENST00000555083; ENSP00000452244; ENSG00000182256. [Q99928-2]
DR   Ensembl; ENST00000615808; ENSP00000479113; ENSG00000182256. [Q99928-1]
DR   GeneID; 2567; -.
DR   KEGG; hsa:2567; -.
DR   UCSC; uc001zbf.5; human. [Q99928-1]
DR   CTD; 2567; -.
DR   DisGeNET; 2567; -.
DR   EuPathDB; HostDB:ENSG00000182256.12; -.
DR   GeneCards; GABRG3; -.
DR   GeneReviews; GABRG3; -.
DR   H-InvDB; HIX0026811; -.
DR   HGNC; HGNC:4088; GABRG3.
DR   HPA; HPA054010; -.
DR   MIM; 600233; gene.
DR   neXtProt; NX_Q99928; -.
DR   OpenTargets; ENSG00000182256; -.
DR   PharmGKB; PA28502; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; Q99928; -.
DR   KO; K05186; -.
DR   OMA; MYWQDFE; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q99928; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   ChiTaRS; GABRG3; human.
DR   GeneWiki; GABRG3; -.
DR   GenomeRNAi; 2567; -.
DR   PRO; PR:Q99928; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000182256; -.
DR   CleanEx; HS_GABRG3; -.
DR   ExpressionAtlas; Q99928; baseline and differential.
DR   Genevisible; Q99928; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR005440; GABBAg3_rcpt.
DR   InterPro; IPR005437; GABBAg_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01620; GABAARGAMMA.
DR   PRINTS; PR01623; GABAARGAMMA3.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Polymorphism; Postsynaptic cell membrane; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    467       Gamma-aminobutyric acid receptor subunit
FT                                gamma-3.
FT                                /FTId=PRO_0000000481.
FT   TOPO_DOM     18    254       Extracellular. {ECO:0000305}.
FT   TRANSMEM    255    277       Helical. {ECO:0000305}.
FT   TRANSMEM    281    303       Helical. {ECO:0000305}.
FT   TRANSMEM    315    337       Helical. {ECO:0000305}.
FT   TOPO_DOM    338    443       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    444    467       Helical. {ECO:0000305}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    171    185       {ECO:0000250}.
FT   VAR_SEQ     239    253       DYVVMTIYFELSRRM -> RNLLKEAQLSKAREA (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047543.
FT   VAR_SEQ     254    467       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047544.
FT   VARIANT     352    352       T -> A (found in a patient with MRT52;
FT                                unknown pathological significance;
FT                                dbSNP:rs2066712).
FT                                {ECO:0000269|PubMed:26566883}.
FT                                /FTId=VAR_033957.
FT   CONFLICT    172    172       Q -> R (in Ref. 5; BC045709).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       T -> P (in Ref. 1; AAB39369).
FT                                {ECO:0000305}.
SQ   SEQUENCE   467 AA;  54289 MW;  1B22D145166438D6 CRC64;
     MAPKLLLLLC LFSGLHARSR KVEEDEYEDS SSNQKWVLAP KSQDTDVTLI LNKLLREYDK
     KLRPDIGIKP TVIDVDIYVN SIGPVSSINM EYQIDIFFAQ TWTDSRLRFN STMKILTLNS
     NMVGLIWIPD TIFRNSKTAE AHWITTPNQL LRIWNDGKIL YTLRLTINAE CQLQLHNFPM
     DEHSCPLIFS SYGYPKEEMI YRWRKNSVEA ADQKSWRLYQ FDFMGLRNTT EIVTTSAGDY
     VVMTIYFELS RRMGYFTIQT YIPCILTVVL SWVSFWIKKD ATPARTALGI TTVLTMTTLS
     TIARKSLPRV SYVTAMDLFV TVCFLFVFAA LMEYATLNYY SSCRKPTTTK KTTSLLHPDS
     SRWIPERISL QAPSNYSLLD MRPPPTAMIT LNNSVYWQEF EDTCVYECLD GKDCQSFFCC
     YEECKSGSWR KGRIHIDILE LDSYSRVFFP TSFLLFNLVY WVGYLYL
//
ID   GBRB4_CHICK             Reviewed;         488 AA.
AC   P24045; Q6LBM6;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-4;
DE   AltName: Full=GABA(A) receptor subunit beta-4;
DE   Flags: Precursor;
GN   Name=GABRB4;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS BETA-4 AND
RP   BETA-4').
RC   STRAIN=Rhode Island; TISSUE=Brain, and Liver;
RX   PubMed=1848280; DOI=10.1111/j.1471-4159.1991.tb11443.x;
RA   Bateson A.N., Lasham A., Darlison M.G.;
RT   "Gamma-aminobutyric acid A receptor heterogeneity is increased by
RT   alternative splicing of a novel beta-subunit gene transcript.";
RL   J. Neurochem. 56:1437-1440(1991).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-4';
CC         IsoId=P24045-1; Sequence=Displayed;
CC       Name=Beta-4;
CC         IsoId=P24045-2; Sequence=VSP_000089;
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X56647; CAA39969.1; -; mRNA.
DR   EMBL; X56648; CAA39970.1; ALT_SEQ; mRNA.
DR   EMBL; X56646; CAA39968.1; -; Genomic_DNA.
DR   PIR; JH0359; JH0359.
DR   RefSeq; NP_001161175.1; NM_001167703.1. [P24045-1]
DR   RefSeq; NP_001161176.1; NM_001167704.1. [P24045-2]
DR   UniGene; Gga.428; -.
DR   ProteinModelPortal; P24045; -.
DR   SMR; P24045; -.
DR   STRING; 9031.ENSGALP00000011732; -.
DR   PaxDb; P24045; -.
DR   Ensembl; ENSGALT00000055905; ENSGALP00000058040; ENSGALG00000033183. [P24045-1]
DR   GeneID; 396288; -.
DR   KEGG; gga:396288; -.
DR   CTD; 55879; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P24045; -.
DR   KO; K05192; -.
DR   OMA; GMSIHIS; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P24045; -.
DR   TreeFam; TF315453; -.
DR   PRO; PR:P24045; -.
DR   Proteomes; UP000000539; Chromosome 4.
DR   Bgee; ENSGALG00000007255; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25
FT   CHAIN        26    488       Gamma-aminobutyric acid receptor subunit
FT                                beta-4.
FT                                /FTId=PRO_0000000466.
FT   TOPO_DOM     26    244       Extracellular. {ECO:0000305}.
FT   TRANSMEM    245    266       Helical. {ECO:0000305}.
FT   TRANSMEM    271    292       Helical. {ECO:0000305}.
FT   TRANSMEM    304    326       Helical. {ECO:0000305}.
FT   TOPO_DOM    327    465       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    466    487       Helical. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    160    174       {ECO:0000250}.
FT   VAR_SEQ     361    364       Missing (in isoform Beta-4).
FT                                {ECO:0000303|PubMed:1848280}.
FT                                /FTId=VSP_000089.
SQ   SEQUENCE   488 AA;  56069 MW;  164A75314BDB2C12 CRC64;
     MWTFQADRLS GIVSALAALC VACCAQSPST GNISVVKEIV DKLLKGYDVR LRPDFGGNPV
     TVGMSIHISS IDQISEVNMD YTITMYFQQS WRDKRLAYND LPLNLTLDNR VADQLWLPDT
     YFLNDKKSFL HGVTVKNRMI RLHPDGTVLY GLRITTTAAC MMDLRRYPLD QQNCTLEIES
     YGYTVDDIVF FWQGNDSAVT GMEVLELPQF TIIEQRLVSR EVVFTTGSYL RLSLSFRIKR
     NIGYFILQTY MPSILITILS WVSFWINYDA SAARVALGVT TVLTMTTINT HLRETLPKIP
     YVKAIDVYLM GCFVFVFLAL LEYAFVNYIF FGRGPRQQKK QSERISKANN ERHRYEEKRV
     REQVDPYGNI LLSTLDMNNE LLATDMMSSV GDSRNSVMSF EGSGIQFRKP LASRDGFGHH
     PTLDRHVPLT HHAAARNRAN CRLRRRSSKL KLKIPDLTDV STIDKWSRII FPITFGFFNL
     VYWLYYVN
//
ID   CLCC1_HUMAN             Reviewed;         551 AA.
AC   Q96S66; O94861; Q8WYP8; Q8WYP9; Q9BU25;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 117.
DE   RecName: Full=Chloride channel CLIC-like protein 1;
DE   AltName: Full=Mid-1-related chloride channel protein 1;
DE   Flags: Precursor;
GN   Name=CLCC1; Synonyms=KIAA0761, MCLC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=11279057; DOI=10.1074/jbc.M100366200;
RA   Nagasawa M., Kanzaki M., Iino Y., Morishita Y., Kojima I.;
RT   "Identification of a novel chloride channel expressed in the
RT   endoplasmic reticulum, Golgi apparatus, and nucleus.";
RL   J. Biol. Chem. 276:20413-20418(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438; SER-464; SER-509;
RP   SER-524 AND SER-532, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-482; SER-524 AND
RP   SER-532, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-509, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438; THR-482; SER-509;
RP   SER-524 AND SER-532, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Seems to act as a chloride ion channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Endoplasmic reticulum. Golgi apparatus.
CC       Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=hMCLC-1;
CC         IsoId=Q96S66-1; Sequence=Displayed;
CC       Name=2; Synonyms=hMCLC-2;
CC         IsoId=Q96S66-2; Sequence=VSP_027349;
CC       Name=3; Synonyms=hMCLC-3;
CC         IsoId=Q96S66-3; Sequence=VSP_027348;
CC       Name=4; Synonyms=hMCLC-4;
CC         IsoId=Q96S66-4; Sequence=VSP_027347;
CC   -!- SIMILARITY: Belongs to the chloride channel MCLC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB052915; BAB59018.1; -; mRNA.
DR   EMBL; AB052916; BAB79261.1; -; mRNA.
DR   EMBL; AB052917; BAB79262.1; -; mRNA.
DR   EMBL; AB052918; BAB79263.1; -; mRNA.
DR   EMBL; AB018304; BAA34481.2; -; mRNA.
DR   EMBL; AL449266; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56345.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56346.1; -; Genomic_DNA.
DR   EMBL; BC002939; AAH02939.1; -; mRNA.
DR   CCDS; CCDS41362.1; -. [Q96S66-1]
DR   CCDS; CCDS60214.1; -. [Q96S66-4]
DR   CCDS; CCDS60215.1; -. [Q96S66-3]
DR   CCDS; CCDS793.1; -. [Q96S66-2]
DR   RefSeq; NP_001041675.1; NM_001048210.2. [Q96S66-1]
DR   RefSeq; NP_001265131.1; NM_001278202.1. [Q96S66-3]
DR   RefSeq; NP_001265132.1; NM_001278203.1. [Q96S66-4]
DR   RefSeq; NP_055942.1; NM_015127.4. [Q96S66-2]
DR   UniGene; Hs.658489; -.
DR   ProteinModelPortal; Q96S66; -.
DR   BioGrid; 116769; 31.
DR   IntAct; Q96S66; 11.
DR   STRING; 9606.ENSP00000349456; -.
DR   TCDB; 1.A.36.1.1; the intracellular chloride channel (icc) family.
DR   iPTMnet; Q96S66; -.
DR   PhosphoSitePlus; Q96S66; -.
DR   SwissPalm; Q96S66; -.
DR   DMDM; 74752121; -.
DR   EPD; Q96S66; -.
DR   MaxQB; Q96S66; -.
DR   PaxDb; Q96S66; -.
DR   PeptideAtlas; Q96S66; -.
DR   PRIDE; Q96S66; -.
DR   DNASU; 23155; -.
DR   Ensembl; ENST00000302500; ENSP00000306552; ENSG00000121940. [Q96S66-3]
DR   Ensembl; ENST00000348264; ENSP00000337243; ENSG00000121940. [Q96S66-4]
DR   Ensembl; ENST00000356970; ENSP00000349456; ENSG00000121940. [Q96S66-1]
DR   Ensembl; ENST00000369968; ENSP00000358985; ENSG00000121940. [Q96S66-4]
DR   Ensembl; ENST00000369969; ENSP00000358986; ENSG00000121940. [Q96S66-3]
DR   Ensembl; ENST00000369970; ENSP00000358987; ENSG00000121940. [Q96S66-2]
DR   GeneID; 23155; -.
DR   KEGG; hsa:23155; -.
DR   UCSC; uc009wes.2; human. [Q96S66-1]
DR   CTD; 23155; -.
DR   DisGeNET; 23155; -.
DR   EuPathDB; HostDB:ENSG00000121940.15; -.
DR   GeneCards; CLCC1; -.
DR   HGNC; HGNC:29675; CLCC1.
DR   HPA; HPA009087; -.
DR   HPA; HPA013210; -.
DR   MIM; 617539; gene.
DR   neXtProt; NX_Q96S66; -.
DR   OpenTargets; ENSG00000121940; -.
DR   PharmGKB; PA142672105; -.
DR   eggNOG; ENOG410IJAP; Eukaryota.
DR   eggNOG; ENOG41108E0; LUCA.
DR   GeneTree; ENSGT00390000016611; -.
DR   HOGENOM; HOG000231351; -.
DR   HOVERGEN; HBG060364; -.
DR   InParanoid; Q96S66; -.
DR   KO; K22188; -.
DR   OMA; NWMYLYK; -.
DR   OrthoDB; EOG091G0BRS; -.
DR   PhylomeDB; Q96S66; -.
DR   TreeFam; TF328890; -.
DR   GeneWiki; CLCC1; -.
DR   GenomeRNAi; 23155; -.
DR   PRO; PR:Q96S66; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000121940; -.
DR   CleanEx; HS_CLCC1; -.
DR   ExpressionAtlas; Q96S66; baseline and differential.
DR   Genevisible; Q96S66; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR009231; Chloride_chnl_CLIC-like.
DR   PANTHER; PTHR34093; PTHR34093; 1.
DR   Pfam; PF05934; MCLC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chloride; Chloride channel; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Ion channel; Ion transport;
KW   Membrane; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    551       Chloride channel CLIC-like protein 1.
FT                                /FTId=PRO_0000297682.
FT   TRANSMEM    185    205       Helical. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical. {ECO:0000255}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     464    464       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     482    482       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     509    509       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     532    532       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     114    298       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027347.
FT   VAR_SEQ     114    234       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027348.
FT   VAR_SEQ     114    163       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11279057,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027349.
FT   VARIANT     368    368       S -> R (in dbSNP:rs168107).
FT                                /FTId=VAR_034673.
SQ   SEQUENCE   551 AA;  62023 MW;  08709A80E99F2E15 CRC64;
     MLCSLLLCEC LLLVAGYAHD DDWIDPTDML NYDAASGTMR KSQAKYGISG EKDVSPDLSC
     ADEISECYHK LDSLTYKIDE CEKKKREDYE SQSNPVFRRY LNKILIEAGK LGLPDENKGD
     MHYDAEIILK RETLLEIQKF LNGEDWKPGA LDDALSDILI NFKFHDFETW KWRFEDSFGV
     DPYNVLMVLL CLLCIVVLVA TELWTYVRWY TQLRRVLIIS FLFSLGWNWM YLYKLAFAQH
     QAEVAKMEPL NNVCAKKMDW TGSIWEWFRS SWTYKDDPCQ KYYELLLVNP IWLVPPTKAL
     AVTFTTFVTE PLKHIGKGTG EFIKALMKEI PALLHLPVLI IMALAILSFC YGAGKSVHVL
     RHIGGPESEP PQALRPRDRR RQEEIDYRPD GGAGDADFHY RGQMGPTEQG PYAKTYEGRR
     EILRERDVDL RFQTGNKSPE VLRAFDVPDA EAREHPTVVP SHKSPVLDTK PKETGGILGE
     GTPKESSTES SQSAKPVSGQ DTSGNTEGSP AAEKAQLKSE AAGSPDQGST YSPARGVAGP
     RGQDPVSSPC G
//
ID   GBRA5_HUMAN             Reviewed;         462 AA.
AC   P31644; A8K338; Q14DC2; Q53XL6; Q9NYT3; Q9NYT4; Q9NYT5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   20-DEC-2017, entry version 178.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-5;
DE   AltName: Full=GABA(A) receptor subunit alpha-5;
DE   Flags: Precursor;
GN   Name=GABRA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8388764; DOI=10.1093/hmg/2.2.183;
RA   Knoll J.H., Sinnett D., Wagstaff J., Glatt K.A., Wilcox A.S.,
RA   Whiting P.J., Wingrove P., Sikela J.M., Lalande M.;
RT   "FISH ordering of reference markers and of the gene for the alpha 5
RT   subunit of the gamma-aminobutyric acid receptor (GABRA5) within the
RT   Angelman and Prader-Willi syndrome chromosomal regions.";
RL   Hum. Mol. Genet. 2:183-189(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1321750; DOI=10.1042/bst020018s;
RA   Wingrove P., Hadingham K., Wafford K., Kemp J.A., Ragan C.I.,
RA   Whiting P.;
RT   "Cloning and expression of a cDNA encoding the human GABA-A receptor
RT   alpha 5 subunit.";
RL   Biochem. Soc. Trans. 20:18S-18S(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RC   TISSUE=Fetal brain;
RX   PubMed=9205108; DOI=10.1006/geno.1997.4770;
RA   Kim Y., Glatt H., Xie W., Sinnett D., Lalande M.;
RT   "Human gamma-aminobutyric acid-type A receptor alpha5 subunit gene
RT   (GABRA5): characterization and structural organization of the 5'
RT   flanking region.";
RL   Genomics 42:378-387(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 71-166; 195-241 AND 294-363.
RA   Kim S.-J., Gonen D., Yang Z.-Y., Reliford A., Dy A., Leventhal B.L.,
RA   Cook E.H. Jr.;
RT   "Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5
RT   subunit gene (GABRA5).";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-355, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=17370265; DOI=10.1002/pmic.200600410;
RA   Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
RT   "Tryptic digestion of ubiquitin standards reveals an improved strategy
RT   for identifying ubiquitinated proteins by mass spectrometry.";
RL   Proteomics 7:868-874(2007).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA5 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L08485; AAA58490.1; -; mRNA.
DR   EMBL; AK290453; BAF83142.1; -; mRNA.
DR   EMBL; BT009830; AAP88832.1; -; mRNA.
DR   EMBL; BC111979; AAI11980.1; -; mRNA.
DR   EMBL; BC113422; AAI13423.1; -; mRNA.
DR   EMBL; AF061785; AAC31809.1; -; Genomic_DNA.
DR   EMBL; AF228447; AAF62508.1; -; Genomic_DNA.
DR   EMBL; AF228448; AAF62509.1; -; Genomic_DNA.
DR   EMBL; AF228449; AAF62510.1; -; Genomic_DNA.
DR   CCDS; CCDS45194.1; -.
DR   PIR; A48933; A48933.
DR   RefSeq; NP_000801.1; NM_000810.3.
DR   RefSeq; NP_001158509.1; NM_001165037.1.
DR   RefSeq; XP_005268315.1; XM_005268258.2.
DR   RefSeq; XP_006720522.1; XM_006720459.2.
DR   UniGene; Hs.24969; -.
DR   PDB; 5O8F; X-ray; 3.20 A; A/B/C/D/E=261-346, A/B/C/D/E=424-462.
DR   PDBsum; 5O8F; -.
DR   ProteinModelPortal; P31644; -.
DR   SMR; P31644; -.
DR   BioGrid; 108832; 1.
DR   STRING; 9606.ENSP00000335592; -.
DR   BindingDB; P31644; -.
DR   ChEMBL; CHEMBL5112; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 408; -.
DR   iPTMnet; P31644; -.
DR   PhosphoSitePlus; P31644; -.
DR   BioMuta; GABRA5; -.
DR   DMDM; 399519; -.
DR   EPD; P31644; -.
DR   MaxQB; P31644; -.
DR   PaxDb; P31644; -.
DR   PeptideAtlas; P31644; -.
DR   PRIDE; P31644; -.
DR   DNASU; 2558; -.
DR   Ensembl; ENST00000335625; ENSP00000335592; ENSG00000186297.
DR   Ensembl; ENST00000355395; ENSP00000347557; ENSG00000186297.
DR   Ensembl; ENST00000400081; ENSP00000382953; ENSG00000186297.
DR   GeneID; 2558; -.
DR   KEGG; hsa:2558; -.
DR   UCSC; uc001zbd.3; human.
DR   CTD; 2558; -.
DR   DisGeNET; 2558; -.
DR   EuPathDB; HostDB:ENSG00000186297.11; -.
DR   GeneCards; GABRA5; -.
DR   GeneReviews; GABRA5; -.
DR   HGNC; HGNC:4079; GABRA5.
DR   HPA; HPA077031; -.
DR   MIM; 137142; gene.
DR   neXtProt; NX_P31644; -.
DR   OpenTargets; ENSG00000186297; -.
DR   PharmGKB; PA28493; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P31644; -.
DR   KO; K05175; -.
DR   OMA; MTHPPNI; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P31644; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; GABRA5; -.
DR   GenomeRNAi; 2558; -.
DR   PRO; PR:P31644; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000186297; -.
DR   CleanEx; HS_GABRA5; -.
DR   ExpressionAtlas; P31644; baseline and differential.
DR   Genevisible; P31644; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0032809; C:neuronal cell body membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0050811; F:GABA receptor binding; IEA:Ensembl.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:Ensembl.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0008306; P:associative learning; IEA:Ensembl.
DR   GO; GO:0001662; P:behavioral fear response; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:0060119; P:inner ear receptor cell development; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005435; GABBAa5_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01618; GABAARALPHA5.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Isopeptide bond; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32    462       Gamma-aminobutyric acid receptor subunit
FT                                alpha-5.
FT                                /FTId=PRO_0000000444.
FT   TOPO_DOM     32    259       Extracellular. {ECO:0000255}.
FT   TRANSMEM    260    281       Helical. {ECO:0000255}.
FT   TRANSMEM    286    307       Helical. {ECO:0000255}.
FT   TRANSMEM    319    341       Helical. {ECO:0000255}.
FT   TOPO_DOM    342    427       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    428    449       Helical. {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    236    236       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    173    187       {ECO:0000250}.
FT   CROSSLNK    355    355       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:17370265}.
SQ   SEQUENCE   462 AA;  52146 MW;  260A8B554113AFF9 CRC64;
     MDNGMFSGFI MIKNLLLFCI SMNLSSHFGF SQMPTSSVKD ETNDNITIFT RILDGLLDGY
     DNRLRPGLGE RITQVRTDIY VTSFGPVSDT EMEYTIDVFF RQSWKDERLR FKGPMQRLPL
     NNLLASKIWT PDTFFHNGKK SIAHNMTTPN KLLRLEDDGT LLYTMRLTIS AECPMQLEDF
     PMDAHACPLK FGSYAYPNSE VVYVWTNGST KSVVVAEDGS RLNQYHLMGQ TVGTENISTS
     TGEYTIMTAH FHLKRKIGYF VIQTYLPCIM TVILSQVSFW LNRESVPART VFGVTTVLTM
     TTLSISARNS LPKVAYATAM DWFIAVCYAF VFSALIEFAT VNYFTKRGWA WDGKKALEAA
     KIKKKREVIL NKSTNAFTTG KMSHPPNIPK EQTPAGTSNT TSVSVKPSEE KTSESKKTYN
     SISKIDKMSR IVFPVLFGTF NLVYWATYLN REPVIKGAAS PK
//
ID   TTY2_DROME              Reviewed;         655 AA.
AC   Q9W5A5; A8WHI0; O97175; Q8IRY1; Q8IRY2; Q8IRY3; Q9U1L5;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   30-AUG-2017, entry version 108.
DE   RecName: Full=Protein tweety-2;
DE            Short=Dttyh2;
GN   ORFNames=CG3638;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Oregon-R;
RX   PubMed=10731137; DOI=10.1126/science.287.5461.2220;
RA   Benos P.V., Gatt M.K., Ashburner M., Murphy L., Harris D.,
RA   Barrell B.G., Ferraz C., Vidal S., Brun C., Demailles J., Cadieu E.,
RA   Dreano S., Gloux S., Lelaure V., Mottier S., Galibert F., Borkova D.,
RA   Minana B., Kafatos F.C., Louis C., Siden-Kiamos I., Bolshakov S.,
RA   Papagiannakis G., Spanos L., Cox S., Madueno E., de Pablos B.,
RA   Modolell J., Peter A., Schoettler P., Werner M., Mourkioti F.,
RA   Beinert N., Dowe G., Schaefer U., Jaeckle H., Bucheton A.,
RA   Callister D.M., Campbell L.A., Darlamitsou A., Henderson N.S.,
RA   McMillan P.J., Salles C., Tait E.A., Valenti P., Saunders R.D.C.,
RA   Glover D.M.;
RT   "From sequence to chromosome: the tip of the X chromosome of D.
RT   melanogaster.";
RL   Science 287:2220-2222(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Carlson J.W., Frise E., Kapadia B., Park S., Wan K.H.,
RA   Yu C., Celniker S.E.;
RL   Submitted (NOV-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16219661; DOI=10.1113/expphysiol.2005.031773;
RA   Suzuki M.;
RT   "The Drosophila tweety family: molecular candidates for large-
RT   conductance Ca2+-activated Cl- channels.";
RL   Exp. Physiol. 91:141-147(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-597 AND SER-599, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
CC   -!- FUNCTION: Probable chloride channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A {ECO:0000312|FlyBase:FBgn0261444};
CC         IsoId=Q9W5A5-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=B {ECO:0000312|FlyBase:FBgn0261444};
CC         IsoId=Q9W5A5-2; Sequence=VSP_029776;
CC         Note=No experimental confirmation available.;
CC   -!- DISRUPTION PHENOTYPE: Death during development.
CC       {ECO:0000269|PubMed:16219661}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN09036.3; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB65886.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014298; AAF45597.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09036.3; ALT_SEQ; Genomic_DNA.
DR   EMBL; AE014298; AAN09038.1; -; Genomic_DNA.
DR   EMBL; AL121806; CAB65886.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BT031126; ABX00748.1; -; mRNA.
DR   RefSeq; NP_001245460.1; NM_001258531.2. [Q9W5A5-2]
DR   RefSeq; NP_726720.3; NM_166872.3.
DR   RefSeq; NP_726721.1; NM_166873.3. [Q9W5A5-2]
DR   RefSeq; NP_726722.1; NM_166874.3. [Q9W5A5-1]
DR   UniGene; Dm.12259; -.
DR   STRING; 7227.FBpp0303238; -.
DR   TCDB; 1.A.48.1.5; the anion channel tweety (tweety) family.
DR   iPTMnet; Q9W5A5; -.
DR   PaxDb; Q9W5A5; -.
DR   PRIDE; Q9W5A5; -.
DR   EnsemblMetazoa; FBtr0070249; FBpp0070239; FBgn0261444. [Q9W5A5-2]
DR   EnsemblMetazoa; FBtr0308707; FBpp0300913; FBgn0261444. [Q9W5A5-2]
DR   EnsemblMetazoa; FBtr0336978; FBpp0307920; FBgn0261444. [Q9W5A5-1]
DR   GeneID; 31071; -.
DR   KEGG; dme:Dmel_CG3638; -.
DR   UCSC; CG3638-RA; d. melanogaster. [Q9W5A5-1]
DR   FlyBase; FBgn0261444; CG3638.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   InParanoid; Q9W5A5; -.
DR   OrthoDB; EOG091G0IBL; -.
DR   PhylomeDB; Q9W5A5; -.
DR   Reactome; R-DME-2672351; Stimuli-sensing channels.
DR   GenomeRNAi; 31071; -.
DR   PRO; PR:Q9W5A5; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0261444; -.
DR   ExpressionAtlas; Q9W5A5; differential.
DR   Genevisible; Q9W5A5; DM.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0005254; F:chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; ISS:FlyBase.
DR   GO; GO:0002121; P:inter-male aggressive behavior; IMP:FlyBase.
DR   GO; GO:0016319; P:mushroom body development; IMP:FlyBase.
DR   GO; GO:0006909; P:phagocytosis; IMP:FlyBase.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    655       Protein tweety-2.
FT                                /FTId=PRO_0000312257.
FT   TOPO_DOM      1     54       Extracellular. {ECO:0000255}.
FT   TRANSMEM     55     75       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     76     95       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     96    116       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    117    231       Extracellular. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    253    258       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    259    279       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    280    401       Extracellular. {ECO:0000255}.
FT   TRANSMEM    402    422       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    423    655       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    483    523       Gly-rich.
FT   MOD_RES     597    597       Phosphoserine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   MOD_RES     599    599       Phosphoserine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   CARBOHYD     18     18       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     25     25       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    171    171       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    188    188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    211    211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    326    326       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    372    372       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      38     53       Missing (in isoform B).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_029776.
SQ   SEQUENCE   655 AA;  71406 MW;  5422371D52542D94 CRC64;
     MEQPSILVKI LHSIPHVNYT FRRVNDTFNP DSDVYLEPTN NKLQCQQKGI ELQSLVILAS
     IPAGLLIGSL LGLLLYLLTR CCDRRQRKPS AQRCQSCSLV IITLMTCAAI GLGLYGNDDF
     HNGLLQAFGS GKSVEGLVLT LKRQTESIKH DLETRMAGHK VEQLVEKPHY NQTVVMLLIE
     TSRLVTENTS RAVASLDSMV HYFMKAKGSE NDTSLMGLLQ LGEFYESIRW PATLAFLTVL
     LLLCTVLVIG VARRSRCTLI FFSVSGLFCI IICWLLAGVY LASSVAAGDF CMRPHDYMCR
     QVGMRSPYVD FLNCGTPRNR FILRLNESRD LVDRARESVE HMQRMSQETY PHIDIQRTLN
     AMDNDLEITL RNLTTLSATL DRRTIDMHYE EALRGLCGGG LLGLSLMMVA GLLTSFLLTI
     LVYADSHAWI YLTKRPTLDA DKSETAPLFP ASNAPSASIS PTAPLSTGTI NRTLLHHQQA
     SSGGGSGTLP GSGGGAGAGG GVGANGHNGV GPYRNGSAGL RQGLASPSSQ SSHTSSTATY
     NNGTTSYHNS HQQHNNHLYS NHYSHSNNHY NNTQHRTNPA AGAVAAAVGV VSSGQRSPSP
     PPVYDLVHGT RSGHHTLGRL PSHHQQSATY LPGPNNGKYA TLSKQCKTLE SNDFY
//
ID   BST24_CAEEL             Reviewed;         632 AA.
AC   P34672;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   20-DEC-2017, entry version 104.
DE   RecName: Full=Bestrophin homolog 24;
GN   Name=best-24; ORFNames=ZK688.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080277; CCD62533.1; -; Genomic_DNA.
DR   PIR; S44917; S44917.
DR   RefSeq; NP_498717.1; NM_066316.5.
DR   UniGene; Cel.9521; -.
DR   ProteinModelPortal; P34672; -.
DR   SMR; P34672; -.
DR   IntAct; P34672; 1.
DR   MINT; MINT-3384533; -.
DR   STRING; 6239.ZK688.2; -.
DR   iPTMnet; P34672; -.
DR   EPD; P34672; -.
DR   PaxDb; P34672; -.
DR   PeptideAtlas; P34672; -.
DR   EnsemblMetazoa; ZK688.2; ZK688.2; WBGene00022797.
DR   GeneID; 176110; -.
DR   KEGG; cel:CELE_ZK688.2; -.
DR   UCSC; ZK688.2; c. elegans.
DR   CTD; 176110; -.
DR   WormBase; ZK688.2; CE00460; WBGene00022797; best-24.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; P34672; -.
DR   KO; K22204; -.
DR   OMA; RYCELAQ; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; P34672; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:P34672; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00022797; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 2.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    632       Bestrophin homolog 24.
FT                                /FTId=PRO_0000143135.
FT   TRANSMEM     28     48       Helical. {ECO:0000255}.
FT   TRANSMEM     83    103       Helical. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
SQ   SEQUENCE   632 AA;  73829 MW;  0ABDD1755EF11642 CRC64;
     MTINYNLAVS TSKPWTLFKL LLKWRGSIWK AVILELAVWL VLYGILSVIY RTALNPGQQR
     TFERIVQYCD SRLSYIPLNF MLGFFVTAVV NRWTYLYQII GFIDNIGLMA AEYVRGRTEQ
     ARMYRRNIVR YCELAQVLVF RDISMRTRRR FPTLDTVVAA GFMMPHEKDR FDEIQYKYSK
     YWVPFQWAFS LTYEARKKGL IESDYYQVVV QDEIKKFRTG LAWICNYDWV PIPIMYPQLV
     CLAVHTYFLV CLLARQYVVS EHADNKTEID LYFPIMSTLQ FIFYMGWMKV AEAMLNPFGE
     DDDDFECNAL IDRNITMVLM MVDQGYDRAP DLKRDDFWDE EVEPLYSEET AKIPNNPLKG
     SVSDVKLPEY VHEIKMVPHC DDASPLVPGD EMRRRRVSVV PVKPSDQQHH HHGHRTRTSL
     GNIEMFRSFK NKIERSFSKP HLHDDLGRKT FSHGMLENME FEGSNTNIAD GSHANNNSFT
     NSAFVNSGED LSNKRIDTSS SQPQLATGKR GSEHPFQHHV LDDVLEDDES DENQLTIRKK
     SSVLQPAITL VERFNEATGQ LETEVKRDEK KKKEEELREE GDNGKEEKDN KEDKKEEQDR
     PSRPTRPFFI GVVRSESEDH SHPHLRPPTK FE
//
ID   GBRP_HUMAN              Reviewed;         440 AA.
AC   O00591; A8KA36; D3DQL2; Q32MJ1;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   25-OCT-2017, entry version 152.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit pi;
DE   AltName: Full=GABA(A) receptor subunit pi;
DE   Flags: Precursor;
GN   Name=GABRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9182563; DOI=10.1074/jbc.272.24.15346;
RA   Hedblom E., Kirkness E.F.;
RT   "A novel class of GABAA receptor subunit in tissues of the
RT   reproductive system.";
RL   J. Biol. Chem. 272:15346-15350(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Johnson E.K., Hedblom E., Kirkness E.F.;
RT   "Structure and localization of the gene encoding the human GABA-A
RT   receptor pi subunit (GABRP).";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-391.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-416.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel. In the uterus, the function of the receptor appears to be
CC       related to tissue contractility. The binding of this pI subunit
CC       with other GABA(A) receptor subunits alters the sensitivity of
CC       recombinant receptors to modulatory agents such as pregnanolone.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and epsilon. A sixth
CC       class of subunit: Rho form homomeric GABA receptors that do not
CC       appear to coexist with GABA(A) receptor subunits but with GABA(C)
CC       receptor subunits. Subunit Pi can also bind this complex.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Most abundant in the uterus, also expressed in
CC       lung, thymus and prostate.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRP sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U95367; AAC51357.1; -; mRNA.
DR   EMBL; AF009702; AAC24194.1; -; Genomic_DNA.
DR   EMBL; AF009694; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009695; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009696; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009697; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009698; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009699; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009700; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AF009701; AAC24194.1; JOINED; Genomic_DNA.
DR   EMBL; AK292901; BAF85590.1; -; mRNA.
DR   EMBL; CH471062; EAW61467.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61468.1; -; Genomic_DNA.
DR   EMBL; BC074810; AAH74810.1; -; mRNA.
DR   EMBL; BC074865; AAH74865.1; -; mRNA.
DR   EMBL; BC109105; AAI09106.1; -; mRNA.
DR   EMBL; BC109106; AAI09107.1; -; mRNA.
DR   CCDS; CCDS4375.1; -.
DR   RefSeq; NP_001278914.1; NM_001291985.1.
DR   RefSeq; NP_055026.1; NM_014211.2.
DR   UniGene; Hs.26225; -.
DR   ProteinModelPortal; O00591; -.
DR   STRING; 9606.ENSP00000265294; -.
DR   ChEMBL; CHEMBL2093872; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; O00591; -.
DR   PhosphoSitePlus; O00591; -.
DR   BioMuta; GABRP; -.
DR   MaxQB; O00591; -.
DR   PaxDb; O00591; -.
DR   PeptideAtlas; O00591; -.
DR   PRIDE; O00591; -.
DR   Ensembl; ENST00000265294; ENSP00000265294; ENSG00000094755.
DR   Ensembl; ENST00000518525; ENSP00000430100; ENSG00000094755.
DR   GeneID; 2568; -.
DR   KEGG; hsa:2568; -.
DR   UCSC; uc003mau.4; human.
DR   CTD; 2568; -.
DR   DisGeNET; 2568; -.
DR   EuPathDB; HostDB:ENSG00000094755.16; -.
DR   GeneCards; GABRP; -.
DR   HGNC; HGNC:4089; GABRP.
DR   HPA; CAB014883; -.
DR   MIM; 602729; gene.
DR   neXtProt; NX_O00591; -.
DR   OpenTargets; ENSG00000094755; -.
DR   PharmGKB; PA28503; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O00591; -.
DR   KO; K05189; -.
DR   OMA; NDVEFSW; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O00591; -.
DR   TreeFam; TF315453; -.
DR   ChiTaRS; GABRP; human.
DR   GeneWiki; GABRP; -.
DR   GenomeRNAi; 2568; -.
DR   PRO; PR:O00591; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000094755; -.
DR   CleanEx; HS_GABRP; -.
DR   ExpressionAtlas; O00591; baseline and differential.
DR   Genevisible; O00591; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008100; GABAAp_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF33; PTHR18945:SF33; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01724; GABAARPI.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Polymorphism; Postsynaptic cell membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    440       Gamma-aminobutyric acid receptor subunit
FT                                pi.
FT                                /FTId=PRO_0000000492.
FT   TOPO_DOM     17    242       Extracellular. {ECO:0000255}.
FT   TRANSMEM    243    266       Helical. {ECO:0000255}.
FT   TRANSMEM    270    292       Helical. {ECO:0000255}.
FT   TRANSMEM    305    327       Helical. {ECO:0000255}.
FT   TOPO_DOM    328    416       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    417    438       Helical. {ECO:0000255}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    196    196       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    160    174       {ECO:0000250}.
FT   VARIANT     391    391       F -> L (in dbSNP:rs1063310).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020323.
FT   VARIANT     416    416       H -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036034.
SQ   SEQUENCE   440 AA;  50640 MW;  92CA66C264560718 CRC64;
     MNYSLHLAFV CLSLFTERMC IQGSQFNVEV GRSDKLSLPG FENLTAGYNK FLRPNFGGEP
     VQIALTLDIA SISSISESNM DYTATIYLRQ RWMDQRLVFE GNKSFTLDAR LVEFLWVPDT
     YIVESKKSFL HEVTVGNRLI RLFSNGTVLY ALRITTTVAC NMDLSKYPMD TQTCKLQLES
     WGYDGNDVEF TWLRGNDSVR GLEHLRLAQY TIERYFTLVT RSQQETGNYT RLVLQFELRR
     NVLYFILETY VPSTFLVVLS WVSFWISLDS VPARTCIGVT TVLSMTTLMI GSRTSLPNTN
     CFIKAIDVYL GICFSFVFGA LLEYAVAHYS SLQQMAAKDR GTTKEVEEVS ITNIINSSIS
     SFKRKISFAS IEISSDNVDY SDLTMKTSDK FKFVFREKMG RIVDYFTIQN PSNVDHYSKL
     LFPLIFMLAN VFYWAYYMYF
//
ID   BEST1_MOUSE             Reviewed;         551 AA.
AC   O88870; B2RSY6; Q6H1V0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   25-OCT-2017, entry version 124.
DE   RecName: Full=Bestrophin-1;
DE   AltName: Full=Vitelliform macular dystrophy protein 2 homolog;
GN   Name=Best1; Synonyms=Bmd1, Vmd2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=15218265; DOI=10.1159/000078016;
RA   Kraemer F., Stoehr H., Weber B.H.F.;
RT   "Cloning and characterization of the murine Vmd2 RFP-TM gene family.";
RL   Cytogenet. Genome Res. 105:107-114(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 178-258.
RX   PubMed=9662395; DOI=10.1038/915;
RA   Petrukhin K., Koisti M.J., Bakall B., Li W., Xie G., Marknell T.,
RA   Sandgren O., Forsman K., Holmgren G., Andreasson S., Vujic M.,
RA   Bergen A.A.B., McGarty-Dugan V., Figueroa D., Austin C.P.,
RA   Metzker M.L., Caskey C.T., Wadelius C.;
RT   "Identification of the gene responsible for Best macular dystrophy.";
RL   Nat. Genet. 19:241-247(1998).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to
CC       bicarbonate (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Tetramer or pentamers. May interact with PPP2CB and
CC       PPP2R1B (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Basolateral cell membrane {ECO:0000250}.
CC   -!- PTM: Phosphorylated by PP2A. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY450427; AAS09922.1; -; mRNA.
DR   EMBL; BC139060; AAI39061.1; -; mRNA.
DR   EMBL; BC139061; AAI39062.1; -; mRNA.
DR   EMBL; AF057171; AAC64345.1; -; mRNA.
DR   CCDS; CCDS29568.1; -.
DR   RefSeq; NP_036043.2; NM_011913.2.
DR   UniGene; Mm.31577; -.
DR   ProteinModelPortal; O88870; -.
DR   SMR; O88870; -.
DR   STRING; 10090.ENSMUSP00000113053; -.
DR   PhosphoSitePlus; O88870; -.
DR   EPD; O88870; -.
DR   PaxDb; O88870; -.
DR   PRIDE; O88870; -.
DR   Ensembl; ENSMUST00000117346; ENSMUSP00000113053; ENSMUSG00000037418.
DR   GeneID; 24115; -.
DR   KEGG; mmu:24115; -.
DR   UCSC; uc008gou.2; mouse.
DR   CTD; 7439; -.
DR   MGI; MGI:1346332; Best1.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   HOVERGEN; HBG044928; -.
DR   InParanoid; O88870; -.
DR   KO; K13878; -.
DR   OMA; RSGYHSA; -.
DR   OrthoDB; EOG091G06XO; -.
DR   TreeFam; TF315803; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   PRO; PR:O88870; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   Bgee; ENSMUSG00000037418; -.
DR   CleanEx; MM_BEST1; -.
DR   Genevisible; O88870; MM.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; ISO:MGI.
DR   GO; GO:0005254; F:chloride channel activity; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0006821; P:chloride transport; ISO:MGI.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:MGI.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:MGI.
DR   GO; GO:0030321; P:transepithelial chloride transport; ISO:MGI.
DR   InterPro; IPR033041; Best1.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   PANTHER; PTHR10736:SF4; PTHR10736:SF4; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    551       Bestrophin-1.
FT                                /FTId=PRO_0000143116.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     70       Extracellular. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TOPO_DOM     92    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       {ECO:0000255}.
FT   TOPO_DOM    250    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    551       Cytoplasmic. {ECO:0000255}.
FT   CONFLICT    255    255       R -> K (in Ref. 1; AAS09922 and 3;
FT                                AAC64345). {ECO:0000305}.
SQ   SEQUENCE   551 AA;  63684 MW;  0898D6DE08FEEFB9 CRC64;
     MTITYTNKVA NARLGSFSSL LLCWRGSIYK LLYGEFLVFI FLYYSIRGLY RMVLSSDQQL
     LFEKLALYCD SYIQLIPISF VLGFYVTLVV SRWWSQYENL PWPDRLMIQV SSFVEGKDEE
     GRLLRRTLIR YAILGQVLIL RSISTSVYKR FPTLHHLVLA GFMTHGEHKQ LQKLGLPHNT
     FWVPWVWFAN LSMKAYLGGR IRDTVLLQSL MNEVCTLRTQ CGQLYAYDWI SIPLVYTQVV
     TVAVYSFFLA CLIGRQFLNP NKDYPGHEMD LVVPVFTILQ FLFYMGWLKV AEQLINPFGE
     DDDDFETNWI IDRNLQVSLL SVDGMHQNLP PMERDMYWNE AAPQPPYTAA SARSRRHSFM
     GSTFNISLKK EDLELWSKEE ADTDKKESGY SSTIGCFLGL QPKNYHLPLK DLKTKLLCSK
     NPLLEGQCKD ANQKNQKDVW KFKGLDFLKC VPRFKRRGSH CGPQAPSSHP TEQSAPSSSD
     TGDGPSTDYQ EICHMKKKTV EFNLNIPESP TEHLQQRRLD QMSTNIQALM KEHAESYPYR
     DEAGTKPVLY E
//
ID   GLUCL_DROME             Reviewed;         456 AA.
AC   Q94900; O77295; Q0Q0M3; Q2PDQ5; Q59DV9; Q8IN68; Q9GQ52; Q9GQ53;
AC   Q9VDU5;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   22-NOV-2017, entry version 133.
DE   RecName: Full=Glutamate-gated chloride channel;
DE            Short=DrosGluCl;
DE   Flags: Precursor;
GN   Name=GluClalpha; Synonyms=GluCl {ECO:0000312|EMBL:AAC47266.1};
GN   ORFNames=CG7535;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC47266.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), FUNCTION, SUBUNIT,
RP   DEVELOPMENTAL STAGE, AND RNA EDITING OF POSITIONS 27; 241 AND 345.
RC   STRAIN=Oregon-R {ECO:0000312|EMBL:AAC47266.1};
RC   TISSUE=Head {ECO:0000312|EMBL:AAC47266.1};
RX   PubMed=8702744; DOI=10.1074/jbc.271.33.20187;
RA   Cully D.F., Paress P.S., Liu K.K., Schaeffer J.M., Arena J.P.;
RT   "Identification of a Drosophila melanogaster glutamate-gated chloride
RT   channel sensitive to the antiparasitic agent avermectin.";
RL   J. Biol. Chem. 271:20187-20191(1996).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAA05260.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), VARIANT SER-299, AND RNA
RP   EDITING OF POSITIONS 27; 63; 66 AND 241.
RC   TISSUE=Head {ECO:0000269|PubMed:9886055};
RX   PubMed=9886055; DOI=10.1046/j.1471-4159.1999.0720066.x;
RA   Semenov E.P., Pak W.L.;
RT   "Diversification of Drosophila chloride channel gene by multiple
RT   posttranscriptional mRNA modifications.";
RL   J. Neurochem. 72:66-72(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAG40735.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1-336 (ISOFORM B), FUNCTION, VARIANT SER-299, AND RNA EDITING OF
RP   POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=11095718; DOI=10.1073/pnas.240464697;
RA   Kane N.S., Hirschberg B., Qian S., Hunt D., Thomas B., Brochu R.,
RA   Ludmerer S.W., Zheng Y., Smith M., Arena J.P., Cohen C.J., Schmatz D.,
RA   Warmke J., Cully D.F.;
RT   "Drug-resistant Drosophila indicate glutamate-gated chloride channels
RT   are targets for the antiparasitics nodulisporic acid and ivermectin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:13949-13954(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D), AND RNA EDITING OF POSITIONS
RP   27; 63; 66; 241 AND 345.
RA   Wang X., Xiang W., Wang X., Jiang L., Lin S., Gao A., Wang L., Sun L.,
RA   Jing B., Xi D.;
RT   "Cloning and functional expression of a Drosophila melanogaster
RT   glutamate-gated chloride channel.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND RNA EDITING OF
RP   POSITION 63; 66 AND 345.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [7] {ECO:0000305}
RP   RNA EDITING OF POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=10966106; DOI=10.1016/S0092-8674(00)00049-0;
RA   Palladino M.J., Keegan L.P., O'Connell M.A., Reenan R.A.;
RT   "A-to-I pre-mRNA editing in Drosophila is primarily involved in adult
RT   nervous system function and integrity.";
RL   Cell 102:437-449(2000).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit. Glutamate
CC       binding triggers a rapidly reversible current, while the anti-
CC       helmintic drug ivermectin triggers a permanently open channel
CC       configuration. {ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744}.
CC   -!- SUBUNIT: Pentamer (By similarity). Homomultimer.
CC       {ECO:0000250|UniProtKB:G5EBR3, ECO:0000269|PubMed:8702744}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=F;
CC         IsoId=Q94900-1; Sequence=Displayed;
CC       Name=A {ECO:0000303|PubMed:10731132};
CC         IsoId=Q94900-3; Sequence=VSP_051645;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=B {ECO:0000269|PubMed:9886055};
CC         IsoId=Q94900-2; Sequence=VSP_051644, VSP_051646, VSP_051647;
CC         Note=No experimental confirmation available.;
CC       Name=C;
CC         IsoId=Q94900-4; Sequence=VSP_026113, VSP_051646, VSP_051647;
CC         Note=No experimental confirmation available.;
CC       Name=D;
CC         IsoId=Q94900-5; Sequence=VSP_051644, VSP_026114, VSP_051647;
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development.
CC       {ECO:0000269|PubMed:8702744}.
CC   -!- RNA EDITING: Modified_positions=27 {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:8702744,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 63
CC       {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 66 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 241
CC       {ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 345 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|Ref.4}; Note=Partially
CC       edited. Edited by Adar. {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:9886055};
CC   -!- MISCELLANEOUS: Channels desensitize rapidly in the continued
CC       presence of glutamate and are activated by the glutamate analog
CC       ibotenate. In Xenopus oocytes, avermectins and nodulisporic acid
CC       directly activate channel conductance.
CC       {ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:8702744}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U58776; AAC47266.1; -; mRNA.
DR   EMBL; AJ002232; CAA05260.1; -; mRNA.
DR   EMBL; AF297500; AAG40735.1; -; mRNA.
DR   EMBL; AF297501; AAG40736.1; -; mRNA.
DR   EMBL; DQ665648; ABG57261.1; -; mRNA.
DR   EMBL; AE014297; AAF55695.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13808.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52967.1; -; Genomic_DNA.
DR   EMBL; AE014297; ABC66182.1; -; Genomic_DNA.
DR   RefSeq; NP_001014641.2; NM_001014641.4.
DR   RefSeq; NP_001034061.2; NM_001038972.4.
DR   RefSeq; NP_650827.3; NM_142570.4.
DR   RefSeq; NP_732447.2; NM_169873.4.
DR   UniGene; Dm.20644; -.
DR   ProteinModelPortal; Q94900; -.
DR   BioGrid; 67340; 2.
DR   MINT; MINT-813042; -.
DR   STRING; 7227.FBpp0099473; -.
DR   TCDB; 1.A.9.4.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q94900; -.
DR   PRIDE; Q94900; -.
DR   GeneID; 42350; -.
DR   KEGG; dme:Dmel_CG7535; -.
DR   UCSC; CG7535-RA; d. melanogaster. [Q94900-1]
DR   CTD; 42350; -.
DR   FlyBase; FBgn0024963; GluClalpha.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   InParanoid; Q94900; -.
DR   KO; K05273; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q94900; -.
DR   Reactome; R-DME-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GenomeRNAi; 42350; -.
DR   PRO; PR:Q94900; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0024963; -.
DR   ExpressionAtlas; Q94900; differential.
DR   Genevisible; Q94900; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IC:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008068; F:extracellular-glutamate-gated chloride channel activity; IDA:FlyBase.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; RNA editing;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    456       Glutamate-gated chloride channel.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000000497.
FT   TOPO_DOM     23    245       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    246    268       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    269    273       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    274    295       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    296    302       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    303    323       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    324    426       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    427    450       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    451    456       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      71     71       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      90     90       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     154    154       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     183    183       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    163    177       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    222    233       {ECO:0000250|UniProtKB:G5EBR3}.
FT   VAR_SEQ      60     79       GPAIVRINLFVRSIMTISDI -> NKATNVSVNMFLRSISK
FT                                IDDY (in isoform C). {ECO:0000305}.
FT                                /FTId=VSP_026113.
FT   VAR_SEQ      68     80       LFVRSIMTISDIK -> IFVRSISKIDDVT (in
FT                                isoform B and isoform D).
FT                                {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_051644.
FT   VAR_SEQ     230    232       EYS -> T (in isoform A).
FT                                {ECO:0000303|PubMed:10731132}.
FT                                /FTId=VSP_051645.
FT   VAR_SEQ     335    341       GSNKANM -> DV (in isoform D).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_026114.
FT   VAR_SEQ     417    420       Missing (in isoform B and isoform C).
FT                                {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055}.
FT                                /FTId=VSP_051646.
FT   VAR_SEQ     456    456       E -> ETF (in isoform B, isoform C and
FT                                isoform D). {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_051647.
FT   VARIANT      27     27       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT      63     63       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106}.
FT   VARIANT      66     66       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106}.
FT   VARIANT     241    241       K -> R (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT     299    299       P -> S (resistant to nodulisporic acid).
FT                                {ECO:0000269|PubMed:11095718,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT     345    345       S -> N (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   CONFLICT     50     50       I -> V (in Ref. 4; ABG57261).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       P -> S (in Ref. 3; AAG40736).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       V -> A (in Ref. 4; ABG57261).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  52307 MW;  AE892B338B79A060 CRC64;
     MGSGHYFWAI LYFASLCSAS LANNAKINFR EKEKKVLDQI LGAGKYDARI RPSGINGTDG
     PAIVRINLFV RSIMTISDIK MEYSVQLTFR EQWTDERLKF DDIQGRLKYL TLTEANRVWM
     PDLFFSNEKE GHFHNIIMPN VYIRIFPNGS VLYSIRISLT LACPMNLKLY PLDRQICSLR
     MASYGWTTND LVFLWKEGDP VQVVKNLHLP RFTLEKFLTD YCNSKTNTGE YSCLKVDLLF
     KREFSYYLIQ IYIPCCMLVI VSWVSFWLDQ GAVPARVSLG VTTLLTMATQ TSGINASLPP
     VSYTKAIDVW TGVCLTFVFG ALLEFALVNY ASRSGSNKAN MHKESMKKKR RDLEQASLDA
     ASDLLDTDSN ATFAMKPLVR HPGDPLALEK RLQCEVHMQA PKRPNCCKTW LSKFPTRQCS
     RSKRIDVISR ITFPLVFALF NLVYWSTYLF REEEDE
//
ID   TTYH2_HUMAN             Reviewed;         534 AA.
AC   Q9BSA4; B3KX97; Q3B7H8; Q3B7R9; Q6AWB4; Q8NBB7; Q96PK1;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   27-SEP-2017, entry version 120.
DE   RecName: Full=Protein tweety homolog 2;
DE            Short=hTTY2;
GN   Name=TTYH2; Synonyms=C17orf29;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11597145; DOI=10.1006/geno.2001.6629;
RA   Rae F.K., Hooper J.D., Eyre H.J., Sutherland G.R., Nicol D.L.,
RA   Clements J.A.;
RT   "TTYH2, a human homologue of the Drosophila melanogaster gene tweety,
RT   is located on 17q24 and upregulated in renal cell carcinoma.";
RL   Genomics 77:200-207(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 97-534 (ISOFORM 1), AND VARIANTS
RP   ALA-265 AND GLU-423.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   THR-262; ALA-265 AND GLU-423.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 269-534 (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=15010458; DOI=10.1074/jbc.M313813200;
RA   Suzuki M., Mizuno A.;
RT   "A novel human Cl(-) channel family related to Drosophila flightless
RT   locus.";
RL   J. Biol. Chem. 279:22461-22468(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-199, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=17569141; DOI=10.3748/wjg.v13.i19.2717;
RA   Toiyama Y., Mizoguchi A., Kimura K., Hiro J., Inoue Y., Tutumi T.,
RA   Miki C., Kusunoki M.;
RT   "TTYH2, a human homologue of the Drosophila melanogaster gene tweety,
RT   is up-regulated in colon carcinoma and involved in cell proliferation
RT   and cell aggregation.";
RL   World J. Gastroenterol. 13:2717-2721(2007).
CC   -!- FUNCTION: Probable large-conductance Ca(2+)-activated chloride
CC       channel. May play a role in Ca(2+) signal transduction. May be
CC       involved in cell proliferation and cell aggregation.
CC       {ECO:0000269|PubMed:15010458}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BSA4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BSA4-2; Sequence=VSP_040567;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at higher level in brain and testis
CC       and at lower levels in heart, ovary, spleen and peripheral blood
CC       leukocytes. Up-regulated in 13 of 16 renal cell carcinoma samples
CC       examined. Up-regulated in colon carcinoma.
CC       {ECO:0000269|PubMed:11597145, ECO:0000269|PubMed:17569141}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH05168.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC03579.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF319952; AAL16784.1; -; mRNA.
DR   EMBL; AK126955; BAG54409.1; -; mRNA.
DR   EMBL; AK091085; BAC03579.1; ALT_INIT; mRNA.
DR   EMBL; AC100786; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005168; AAH05168.1; ALT_INIT; mRNA.
DR   EMBL; BC107492; AAI07493.1; -; mRNA.
DR   EMBL; BC107602; AAI07603.1; -; mRNA.
DR   EMBL; BX647912; CAH10576.1; -; mRNA.
DR   CCDS; CCDS32717.1; -. [Q9BSA4-1]
DR   CCDS; CCDS45770.1; -. [Q9BSA4-2]
DR   RefSeq; NP_116035.5; NM_032646.5. [Q9BSA4-1]
DR   RefSeq; NP_443101.1; NM_052869.1. [Q9BSA4-2]
DR   UniGene; Hs.27935; -.
DR   ProteinModelPortal; Q9BSA4; -.
DR   BioGrid; 125087; 5.
DR   IntAct; Q9BSA4; 3.
DR   MINT; MINT-2814893; -.
DR   STRING; 9606.ENSP00000269346; -.
DR   TCDB; 1.A.48.1.3; the anion channel tweety (tweety) family.
DR   iPTMnet; Q9BSA4; -.
DR   PhosphoSitePlus; Q9BSA4; -.
DR   BioMuta; TTYH2; -.
DR   DMDM; 296453009; -.
DR   EPD; Q9BSA4; -.
DR   PaxDb; Q9BSA4; -.
DR   PeptideAtlas; Q9BSA4; -.
DR   PRIDE; Q9BSA4; -.
DR   Ensembl; ENST00000269346; ENSP00000269346; ENSG00000141540. [Q9BSA4-1]
DR   Ensembl; ENST00000441391; ENSP00000394576; ENSG00000141540. [Q9BSA4-2]
DR   GeneID; 94015; -.
DR   KEGG; hsa:94015; -.
DR   UCSC; uc002jkc.4; human. [Q9BSA4-1]
DR   CTD; 94015; -.
DR   DisGeNET; 94015; -.
DR   EuPathDB; HostDB:ENSG00000141540.10; -.
DR   GeneCards; TTYH2; -.
DR   HGNC; HGNC:13877; TTYH2.
DR   MIM; 608855; gene.
DR   neXtProt; NX_Q9BSA4; -.
DR   OpenTargets; ENSG00000141540; -.
DR   PharmGKB; PA37823; -.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   HOVERGEN; HBG102014; -.
DR   InParanoid; Q9BSA4; -.
DR   OMA; YVEYYRW; -.
DR   OrthoDB; EOG091G05MR; -.
DR   PhylomeDB; Q9BSA4; -.
DR   TreeFam; TF319025; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; TTYH2; human.
DR   GenomeRNAi; 94015; -.
DR   PRO; PR:Q9BSA4; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141540; -.
DR   CleanEx; HS_TTYH2; -.
DR   ExpressionAtlas; Q9BSA4; baseline and differential.
DR   Genevisible; Q9BSA4; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    534       Protein tweety homolog 2.
FT                                /FTId=PRO_0000312246.
FT   TOPO_DOM      1     44       Extracellular. {ECO:0000255}.
FT   TRANSMEM     45     65       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     66     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    109    213       Extracellular. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    235    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    262    388       Extracellular. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    410    534       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    423    431       Poly-Asp.
FT   MOD_RES     199    199       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TH73}.
FT   CARBOHYD     31     31       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    321       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040567.
FT   VARIANT      11     11       P -> H (in dbSNP:rs11538875).
FT                                /FTId=VAR_037460.
FT   VARIANT      85     85       H -> D (in dbSNP:rs11538876).
FT                                /FTId=VAR_037461.
FT   VARIANT     262    262       A -> T (in dbSNP:rs35682745).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037462.
FT   VARIANT     265    265       S -> A (in dbSNP:rs35999669).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037463.
FT   VARIANT     409    409       A -> E (in dbSNP:rs9892705).
FT                                /FTId=VAR_057791.
FT   VARIANT     419    419       T -> I (in dbSNP:rs12600564).
FT                                /FTId=VAR_037464.
FT   VARIANT     423    423       D -> E (in dbSNP:rs9899862).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037465.
FT   CONFLICT      4      4       A -> S (in Ref. 1; AAL16784).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       V -> I (in Ref. 1; AAL16784 and 2;
FT                                BAC03579). {ECO:0000305}.
FT   CONFLICT    388    388       G -> V (in Ref. 2; BAG54409).
FT                                {ECO:0000305}.
SQ   SEQUENCE   534 AA;  58772 MW;  CD59065DD53B309C CRC64;
     MQAARVDYIA PWWVVWLHSV PHVGLRLQPV NSTFSPGDES YQESLLFLGL VAAVCLGLNL
     IFLVAYLVCA CHCRRDDAVQ TKQHHSCCIT WTAVVAGLIC CAAVGVGFYG NSETNDGAYQ
     LMYSLDDANH TFSGIDALVS GTTQKMKVDL EQHLARLSEI FAARGDYLQT LKFIQQMAGS
     VVVQLSGLPV WREVTMELTK LSDQTGYVEY YRWLSYLLLF ILDLVICLIA CLGLAKRSKC
     LLASMLCCGA LSLLLSWASL AADGSAAVAT SDFCVAPDTF ILNVTEGQIS TEVTRYYLYC
     SQSGSSPFQQ TLTTFQRALT TMQIQVAGLL QFAVPLFSTA EEDLLAIQLL LNSSESSLHQ
     LTAMVDCRGL HKDYLDALAG ICYDGLQGLL YLGLFSFLAA LAFSTMICAG PRAWKHFTTR
     NRDYDDIDDD DPFNPQAWRM AAHSPPRGQL HSFCSYSSGL GSQTSLQPPA QTISNAPVSE
     YMNQAMLFGR NPRYENVPLI GRASPPPTYS PSMRATYLSV ADEHLRHYGN QFPA
//
ID   GBRA1_HUMAN             Reviewed;         456 AA.
AC   P14867; D3DQK6; Q8N629;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-JAN-2003, sequence version 3.
DT   20-DEC-2017, entry version 193.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-1;
DE   AltName: Full=GABA(A) receptor subunit alpha-1;
DE   Flags: Precursor;
GN   Name=GABRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=2465923; DOI=10.1016/0014-5793(89)80563-0;
RA   Schofield P.R., Pritchett D.B., Sontheimer H., Kettenmann H.,
RA   Seeburg P.H.;
RT   "Sequence and expression of human GABAA receptor alpha 1 and beta 1
RT   subunits.";
RL   FEBS Lett. 244:361-364(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-365.
RC   TISSUE=Cerebellum;
RX   PubMed=2847710; DOI=10.1016/S0006-291X(88)80949-5;
RA   Garrett K.M., Duman R.S., Saito N., Blume A.J., Vitek M.P.,
RA   Tallman J.F.;
RT   "Isolation of a cDNA clone for the alpha subunit of the human GABA-A
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 156:1039-1045(1988).
RN   [5]
RP   INVOLVEMENT IN EIG13, VARIANT EIG13 ASN-219, AND CHARACTERIZATION OF
RP   VARIANT EIG13 ASN-219.
RX   PubMed=21714819; DOI=10.1111/j.1460-9568.2011.07767.x;
RA   Lachance-Touchette P., Brown P., Meloche C., Kinirons P., Lapointe L.,
RA   Lacasse H., Lortie A., Carmant L., Bedford F., Bowie D., Cossette P.;
RT   "Novel alpha1 and gamma2 GABAA receptor subunit mutations in families
RT   with idiopathic generalized epilepsy.";
RL   Eur. J. Neurosci. 34:237-249(2011).
RN   [6]
RP   INVOLVEMENT IN EIEE19, AND VARIANTS EIEE19 GLN-112; SER-251 AND
RP   THR-306.
RX   PubMed=24623842; DOI=10.1212/WNL.0000000000000291;
RA   Carvill G.L., Weckhuysen S., McMahon J.M., Hartmann C., Moller R.S.,
RA   Hjalgrim H., Cook J., Geraghty E., O'Roak B.J., Petrou S., Clarke A.,
RA   Gill D., Sadleir L.G., Muhle H., von Spiczak S., Nikanorova M.,
RA   Hodgson B.L., Gazina E.V., Suls A., Shendure J., Dibbens L.M.,
RA   De Jonghe P., Helbig I., Berkovic S.F., Scheffer I.E., Mefford H.C.;
RT   "GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.";
RL   Neurology 82:1245-1253(2014).
RN   [7]
RP   VARIANT EJM5 ASP-322.
RX   PubMed=11992121; DOI=10.1038/ng885;
RA   Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M.,
RA   Saint-Hilaire J.-M., Carmant L., Verner A., Lu W.-Y., Tian Wang Y.,
RA   Rouleau G.A.;
RT   "Mutation of GABRA1 in an autosomal dominant form of juvenile
RT   myoclonic epilepsy.";
RL   Nat. Genet. 31:184-189(2002).
RN   [8]
RP   INVOLVEMENT IN ECA4.
RX   PubMed=16718694; DOI=10.1002/ana.20874;
RA   Maljevic S., Krampfl K., Cobilanschi J., Tilgen N., Beyer S.,
RA   Weber Y.G., Schlesinger F., Ursu D., Melzer W., Cossette P.,
RA   Bufler J., Lerche H., Heils A.;
RT   "A mutation in the GABA(A) receptor alpha(1)-subunit is associated
RT   with absence epilepsy.";
RL   Ann. Neurol. 59:983-987(2006).
RN   [9]
RP   VARIANT EIEE19 MET-146.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta,
CC       gamma, delta and rho chains. Interacts with UBQLN1. Interacts with
CC       TRAK1. Interacts with KIF21B. {ECO:0000250|UniProtKB:P62812,
CC       ECO:0000250|UniProtKB:P62813}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:2465923}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:P62813}.
CC   -!- DISEASE: Epilepsy, childhood absence 4 (ECA4) [MIM:611136]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Absence
CC       seizures may either remit or persist into adulthood.
CC       {ECO:0000269|PubMed:16718694}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136]:
CC       A disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain. Seizure types
CC       include juvenile myoclonic seizures, absence seizures, and
CC       generalized tonic-clonic seizures. {ECO:0000269|PubMed:21714819}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136]: A
CC       subtype of idiopathic generalized epilepsy. Patients have afebrile
CC       seizures only, with onset in adolescence (rather than in
CC       childhood) and myoclonic jerks which usually occur after awakening
CC       and are triggered by sleep deprivation and fatigue.
CC       {ECO:0000269|PubMed:11992121}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 19 (EIEE19)
CC       [MIM:615744]: A severe neurologic disorder characterized by onset
CC       of seizures in the first months of life and usually associated
CC       with EEG abnormalities. Affected infants have convulsive seizures
CC       (hemiclonic or generalized) that are often prolonged and triggered
CC       by fever. Other seizure types include focal, myoclonic, absence
CC       seizures, and drop attacks. Development is normal in the first
CC       year of life with later slowing and intellectual disability.
CC       {ECO:0000269|PubMed:24623842, ECO:0000269|PubMed:27864847}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA1 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14766; CAA32874.1; -; mRNA.
DR   EMBL; CH471062; EAW61538.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61539.1; -; Genomic_DNA.
DR   EMBL; BC030696; AAH30696.1; -; mRNA.
DR   EMBL; X13584; CAA31925.1; -; mRNA.
DR   CCDS; CCDS4357.1; -.
DR   PIR; A31588; A31588.
DR   PIR; A60652; A60652.
DR   RefSeq; NP_000797.2; NM_000806.5.
DR   RefSeq; NP_001121115.1; NM_001127643.1.
DR   RefSeq; NP_001121116.1; NM_001127644.1.
DR   RefSeq; NP_001121117.1; NM_001127645.1.
DR   RefSeq; NP_001121120.1; NM_001127648.1.
DR   UniGene; Hs.175934; -.
DR   ProteinModelPortal; P14867; -.
DR   SMR; P14867; -.
DR   BioGrid; 108828; 8.
DR   CORUM; P14867; -.
DR   IntAct; P14867; 1.
DR   STRING; 9606.ENSP00000023897; -.
DR   BindingDB; P14867; -.
DR   ChEMBL; CHEMBL1962; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB01341; Dihydroquinidine barbiturate.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB00474; Methohexital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00466; Picrotoxin.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00837; Progabide.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01346; Quinidine barbiturate.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB01154; Thiamylal.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB00962; Zaleplon.
DR   DrugBank; DB00425; Zolpidem.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 404; -.
DR   TCDB; 1.A.9.5.4; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P14867; -.
DR   PhosphoSitePlus; P14867; -.
DR   BioMuta; GABRA1; -.
DR   DMDM; 27808653; -.
DR   EPD; P14867; -.
DR   MaxQB; P14867; -.
DR   PaxDb; P14867; -.
DR   PeptideAtlas; P14867; -.
DR   PRIDE; P14867; -.
DR   DNASU; 2554; -.
DR   Ensembl; ENST00000023897; ENSP00000023897; ENSG00000022355.
DR   Ensembl; ENST00000393943; ENSP00000377517; ENSG00000022355.
DR   Ensembl; ENST00000428797; ENSP00000393097; ENSG00000022355.
DR   Ensembl; ENST00000437025; ENSP00000415441; ENSG00000022355.
DR   Ensembl; ENST00000635880; ENSP00000489738; ENSG00000022355.
DR   Ensembl; ENST00000636573; ENSP00000490320; ENSG00000022355.
DR   Ensembl; ENST00000637827; ENSP00000490804; ENSG00000022355.
DR   Ensembl; ENST00000638112; ENSP00000489839; ENSG00000022355.
DR   GeneID; 2554; -.
DR   KEGG; hsa:2554; -.
DR   UCSC; uc003lyx.5; human.
DR   CTD; 2554; -.
DR   DisGeNET; 2554; -.
DR   EuPathDB; HostDB:ENSG00000022355.15; -.
DR   GeneCards; GABRA1; -.
DR   HGNC; HGNC:4075; GABRA1.
DR   HPA; CAB022502; -.
DR   HPA; HPA055746; -.
DR   MalaCards; GABRA1; -.
DR   MIM; 137160; gene.
DR   MIM; 611136; phenotype.
DR   MIM; 615744; phenotype.
DR   neXtProt; NX_P14867; -.
DR   OpenTargets; ENSG00000022355; -.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   Orphanet; 33069; Dravet syndrome.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   PharmGKB; PA28489; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P14867; -.
DR   KO; K05175; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P14867; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; Gamma-aminobutyric_acid_(GABA)_A_receptor,_alpha_1; -.
DR   GeneWiki; Gamma-aminobutyric_acid_receptor_subunit_alpha-1; -.
DR   GenomeRNAi; 2554; -.
DR   PRO; PR:P14867; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000022355; -.
DR   CleanEx; HS_GABRA1; -.
DR   ExpressionAtlas; P14867; baseline and differential.
DR   Genevisible; P14867; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1902710; C:GABA receptor complex; ISS:BHF-UCL.
DR   GO; GO:1902711; C:GABA-A receptor complex; IDA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008144; F:drug binding; ISS:BHF-UCL.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:ProtInc.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; IEA:Ensembl.
DR   GO; GO:0071420; P:cellular response to histamine; IEA:Ensembl.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:GO_Central.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005431; GABBAa1_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01614; GABAARALPHA1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Cytoplasmic vesicle; Disease mutation;
KW   Disulfide bond; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    456       Gamma-aminobutyric acid receptor subunit
FT                                alpha-1.
FT                                /FTId=PRO_0000000428.
FT   TOPO_DOM     28    251       Extracellular. {ECO:0000305}.
FT   TRANSMEM    252    273       Helical. {ECO:0000305}.
FT   TRANSMEM    279    300       Helical. {ECO:0000305}.
FT   TRANSMEM    313    334       Helical. {ECO:0000305}.
FT   TOPO_DOM    335    421       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    422    443       Helical. {ECO:0000305}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    166    180       {ECO:0000250}.
FT   VARIANT     112    112       R -> Q (in EIEE19; dbSNP:rs587777308).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071809.
FT   VARIANT     146    146       L -> M (in EIEE19).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078222.
FT   VARIANT     219    219       D -> N (in EIG13; the mutant protein is
FT                                partially retained in the endoplasmic
FT                                reticulum and has decreased expression at
FT                                the plasma membrane; causes decreased
FT                                current amplitude in response to GABA
FT                                compared to wild-type and alters receptor
FT                                gating kinetics including faster
FT                                desensitization; dbSNP:rs587777364).
FT                                {ECO:0000269|PubMed:21714819}.
FT                                /FTId=VAR_071810.
FT   VARIANT     251    251       G -> S (in EIEE19; dbSNP:rs587777307).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071811.
FT   VARIANT     306    306       K -> T (in EIEE19; dbSNP:rs587777309).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071812.
FT   VARIANT     322    322       A -> D (in EJM5; dbSNP:rs121434579).
FT                                {ECO:0000269|PubMed:11992121}.
FT                                /FTId=VAR_013642.
FT   CONFLICT    122    122       W -> R (in Ref. 1; CAA32874).
FT                                {ECO:0000305}.
FT   CONFLICT    128    140       Missing (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    204    204       R -> H (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       W -> WDW (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    362    365       IKKN -> FPNS (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  51802 MW;  F81EC9ECBE64E94D CRC64;
     MRKSPGLSDC LWAWILLLST LTGRSYGQPS LQDELKDNTT VFTRILDRLL DGYDNRLRPG
     LGERVTEVKT DIFVTSFGPV SDHDMEYTID VFFRQSWKDE RLKFKGPMTV LRLNNLMASK
     IWTPDTFFHN GKKSVAHNMT MPNKLLRITE DGTLLYTMRL TVRAECPMHL EDFPMDAHAC
     PLKFGSYAYT RAEVVYEWTR EPARSVVVAE DGSRLNQYDL LGQTVDSGIV QSSTGEYVVM
     TTHFHLKRKI GYFVIQTYLP CIMTVILSQV SFWLNRESVP ARTVFGVTTV LTMTTLSISA
     RNSLPKVAYA TAMDWFIAVC YAFVFSALIE FATVNYFTKR GYAWDGKSVV PEKPKKVKDP
     LIKKNNTYAP TATSYTPNLA RGDPGLATIA KSATIEPKEV KPETKPPEPK KTFNSVSKID
     RLSRIAFPLL FGIFNLVYWA TYLNREPQLK APTPHQ
//
ID   GBRE_HUMAN              Reviewed;         506 AA.
AC   P78334; E7ET93; O15345; O15346; Q6PCD2; Q99520;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   25-OCT-2017, entry version 158.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit epsilon;
DE   AltName: Full=GABA(A) receptor subunit epsilon;
DE   Flags: Precursor;
GN   Name=GABRE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-102.
RX   PubMed=9039914; DOI=10.1038/385820a0;
RA   Davies P.A., Hanna M.C., Hales T.G., Kirkness E.F.;
RT   "Insensitivity to anaesthetic agents conferred by a class of GABA(A)
RT   receptor subunit.";
RL   Nature 385:820-823(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9339354; DOI=10.1006/geno.1997.4885;
RA   Wilke K., Gaul R., Klauck S.M., Poustka A.;
RT   "A gene in human chromosome band Xq28 (GABRE) defines a putative new
RT   subunit class of the GABAA neurotransmitter receptor.";
RL   Genomics 45:1-10(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-102.
RX   PubMed=9084408;
RA   Garret M., Bascles L., Boue-Grabot E., Sartor P., Charron G.,
RA   Bloch B., Margolskee R.F.;
RT   "An mRNA encoding a putative GABA-gated chloride channel is expressed
RT   in the human cardiac conduction system.";
RL   J. Neurochem. 68:1382-1389(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hanna M.C., Hales T.G., Kirkness E.F.;
RT   "Alternative transcripts of a gene encoding the GABA-A receptor
RT   epsilon subunit on chromosome Xq28.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS PHE-9
RP   AND ALA-102.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. Associates with alpha and beta
CC       subunits.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78334-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78334-2; Sequence=VSP_055776, VSP_055777;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues. Highest levels of
CC       expression in adult heart and placenta.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRE sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66661; AAB49284.1; -; mRNA.
DR   EMBL; Y09763; CAA70903.1; -; Genomic_DNA.
DR   EMBL; Y09764; CAA70903.1; JOINED; Genomic_DNA.
DR   EMBL; Y09765; CAA70904.1; -; mRNA.
DR   EMBL; Y07637; CAA68914.1; -; mRNA.
DR   EMBL; U92283; AAB94645.1; -; Genomic_DNA.
DR   EMBL; U92281; AAB94645.1; JOINED; Genomic_DNA.
DR   EMBL; U92282; AAB94645.1; JOINED; Genomic_DNA.
DR   EMBL; AF274855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026337; AAH26337.1; -; mRNA.
DR   EMBL; BC047108; AAH47108.1; -; mRNA.
DR   EMBL; BC059376; AAH59376.1; -; mRNA.
DR   CCDS; CCDS14703.1; -. [P78334-1]
DR   RefSeq; NP_004952.2; NM_004961.3. [P78334-1]
DR   UniGene; Hs.22785; -.
DR   ProteinModelPortal; P78334; -.
DR   SMR; P78334; -.
DR   BioGrid; 108838; 42.
DR   STRING; 9606.ENSP00000359353; -.
DR   ChEMBL; CHEMBL2093872; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; P78334; -.
DR   PhosphoSitePlus; P78334; -.
DR   BioMuta; GABRE; -.
DR   DMDM; 13124728; -.
DR   PaxDb; P78334; -.
DR   PeptideAtlas; P78334; -.
DR   PRIDE; P78334; -.
DR   DNASU; 2564; -.
DR   Ensembl; ENST00000370328; ENSP00000359353; ENSG00000102287. [P78334-1]
DR   GeneID; 2564; -.
DR   KEGG; hsa:2564; -.
DR   UCSC; uc004ffi.3; human. [P78334-1]
DR   CTD; 2564; -.
DR   DisGeNET; 2564; -.
DR   EuPathDB; HostDB:ENSG00000102287.16; -.
DR   GeneCards; GABRE; -.
DR   HGNC; HGNC:4085; GABRE.
DR   HPA; HPA045918; -.
DR   MIM; 300093; gene.
DR   neXtProt; NX_P78334; -.
DR   OpenTargets; ENSG00000102287; -.
DR   PharmGKB; PA28499; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P78334; -.
DR   KO; K05185; -.
DR   OMA; CALMEFA; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P78334; -.
DR   TreeFam; TF315453; -.
DR   ChiTaRS; GABRE; human.
DR   GeneWiki; GABRE; -.
DR   GenomeRNAi; 2564; -.
DR   PRO; PR:P78334; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102287; -.
DR   CleanEx; HS_GABRE; -.
DR   ExpressionAtlas; P78334; baseline and differential.
DR   Genevisible; P78334; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IDA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:GO_Central.
DR   GO; GO:2001226; P:negative regulation of chloride transport; IDA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008099; GABAAe_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01723; GABAAREPSLON.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    506       Gamma-aminobutyric acid receptor subunit
FT                                epsilon.
FT                                /FTId=PRO_0000000471.
FT   TOPO_DOM     23    253       Extracellular. {ECO:0000305}.
FT   TRANSMEM    254    274       Helical. {ECO:0000255}.
FT   TRANSMEM    281    301       Helical. {ECO:0000255}.
FT   TRANSMEM    344    364       Helical. {ECO:0000255}.
FT   TOPO_DOM    365    485       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    252    252       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    195    209       {ECO:0000250}.
FT   VAR_SEQ     365    365       I -> M (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055776.
FT   VAR_SEQ     366    506       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055777.
FT   VARIANT       9      9       L -> F (in dbSNP:rs17855708).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_071089.
FT   VARIANT     102    102       S -> A (in dbSNP:rs1139916).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9039914,
FT                                ECO:0000269|PubMed:9084408}.
FT                                /FTId=VAR_048175.
FT   CONFLICT    245    245       F -> L (in Ref. 2; CAA70903).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       Missing (in Ref. 3; CAA68914).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       G -> A (in Ref. 2; CAA70903).
FT                                {ECO:0000305}.
FT   CONFLICT    502    502       V -> F (in Ref. 2; CAA70903).
FT                                {ECO:0000305}.
SQ   SEQUENCE   506 AA;  57972 MW;  013EE136EECFCC73 CRC64;
     MLSKVLPVLL GILLILQSRV EGPQTESKNE ASSRDVVYGP QPQPLENQLL SEETKSTETE
     TGSRVGKLPE ASRILNTILS NYDHKLRPGI GEKPTVVTVE ISVNSLGPLS ILDMEYTIDI
     IFSQTWYDER LCYNDTFESL VLNGNVVSQL WIPDTFFRNS KRTHEHEITM PNQMVRIYKD
     GKVLYTIRMT IDAGCSLHML RFPMDSHSCP LSFSSFSYPE NEMIYKWENF KLEINEKNSW
     KLFQFDFTGV SNKTEIITTP VGDFMVMTIF FNVSRRFGYV AFQNYVPSSV TTMLSWVSFW
     IKTESAPART SLGITSVLTM TTLGTFSRKN FPRVSYITAL DFYIAICFVF CFCALLEFAV
     LNFLIYNQTK AHASPKLRHP RINSRAHART RARSRACARQ HQEAFVCQIV TTEGSDGEER
     PSCSAQQPPS PGSPEGPRSL CSKLACCEWC KRFKKYFCMV PDCEGSTWQQ GRLCIHVYRL
     DNYSRVVFPV TFFFFNVLYW LVCLNL
//
ID   CLCC1_RAT               Reviewed;         541 AA.
AC   Q9WU61; Q66HQ5; Q8VIE8; Q8VIE9; Q8VIF0; Q8VIF1;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-NOV-2017, entry version 91.
DE   RecName: Full=Chloride channel CLIC-like protein 1;
DE   AltName: Full=Mid-1-related chloride channel protein 1;
DE   Flags: Precursor;
GN   Name=Clcc1; Synonyms=Mclc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), FUNCTION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11279057; DOI=10.1074/jbc.M100366200;
RA   Nagasawa M., Kanzaki M., Iino Y., Morishita Y., Kojima I.;
RT   "Identification of a novel chloride channel expressed in the
RT   endoplasmic reticulum, Golgi apparatus, and nucleus.";
RL   J. Biol. Chem. 276:20413-20418(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar; TISSUE=Brain;
RA   Fukuhara C., Inouye S.T., Aoki K.;
RT   "Isolation of a set of genes which was expressed specifically in the
RT   rat suprachiasmatic nucleus.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Seems to act as a chloride ion channel.
CC       {ECO:0000269|PubMed:11279057}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Endoplasmic reticulum. Golgi apparatus.
CC       Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=rMCLC-1;
CC         IsoId=Q9WU61-1; Sequence=Displayed;
CC       Name=2; Synonyms=rMCLC-2;
CC         IsoId=Q9WU61-2; Sequence=VSP_027350;
CC       Name=3; Synonyms=rMCLC-3;
CC         IsoId=Q9WU61-3; Sequence=VSP_027352, VSP_027353;
CC       Name=4; Synonyms=rMCLC-4;
CC         IsoId=Q9WU61-4; Sequence=VSP_027350, VSP_027352, VSP_027353;
CC       Name=5; Synonyms=rMCLC-5;
CC         IsoId=Q9WU61-5; Sequence=VSP_027351, VSP_027354;
CC   -!- TISSUE SPECIFICITY: Expressed in testis (spermatocytes), liver and
CC       lung (at protein level). Expressed in spleen, liver, testis,
CC       kidney, heart, brain and lung. {ECO:0000269|PubMed:11279057}.
CC   -!- SIMILARITY: Belongs to the chloride channel MCLC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB052919; BAB79264.1; -; mRNA.
DR   EMBL; AB052920; BAB79265.1; -; mRNA.
DR   EMBL; AB052921; BAB79266.1; -; mRNA.
DR   EMBL; AB052922; BAB59019.1; -; mRNA.
DR   EMBL; AB052923; BAB79267.1; -; mRNA.
DR   EMBL; AF117330; AAD26207.1; -; mRNA.
DR   EMBL; BC081736; AAH81736.1; -; mRNA.
DR   RefSeq; NP_596905.1; NM_133414.1. [Q9WU61-1]
DR   RefSeq; XP_006233189.1; XM_006233127.2.
DR   RefSeq; XP_006233190.1; XM_006233128.3.
DR   UniGene; Rn.26586; -.
DR   STRING; 10116.ENSRNOP00000042185; -.
DR   iPTMnet; Q9WU61; -.
DR   PhosphoSitePlus; Q9WU61; -.
DR   PaxDb; Q9WU61; -.
DR   PeptideAtlas; Q9WU61; -.
DR   PRIDE; Q9WU61; -.
DR   GeneID; 170927; -.
DR   KEGG; rno:170927; -.
DR   UCSC; RGD:708359; rat. [Q9WU61-1]
DR   CTD; 23155; -.
DR   RGD; 708359; Clcc1.
DR   eggNOG; ENOG410IJAP; Eukaryota.
DR   eggNOG; ENOG41108E0; LUCA.
DR   HOGENOM; HOG000231351; -.
DR   HOVERGEN; HBG060364; -.
DR   InParanoid; Q9WU61; -.
DR   KO; K22188; -.
DR   PhylomeDB; Q9WU61; -.
DR   PRO; PR:Q9WU61; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC.
DR   GO; GO:0005783; C:endoplasmic reticulum; IMP:HGNC.
DR   GO; GO:0005794; C:Golgi apparatus; IMP:HGNC.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC.
DR   GO; GO:0005254; F:chloride channel activity; IDA:RGD.
DR   GO; GO:0006821; P:chloride transport; IDA:HGNC.
DR   InterPro; IPR009231; Chloride_chnl_CLIC-like.
DR   PANTHER; PTHR34093; PTHR34093; 1.
DR   Pfam; PF05934; MCLC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chloride; Chloride channel; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Ion channel; Ion transport;
KW   Membrane; Nucleus; Phosphoprotein; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    541       Chloride channel CLIC-like protein 1.
FT                                /FTId=PRO_0000297684.
FT   TRANSMEM    185    205       Helical. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical. {ECO:0000255}.
FT   COMPBIAS    525    530       Poly-Ala.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99LI2}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96S66}.
FT   MOD_RES     482    482       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q96S66}.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96S66}.
FT   VAR_SEQ      44     77       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027350.
FT   VAR_SEQ     394    395       GD -> EP (in isoform 5).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027351.
FT   VAR_SEQ     394    394       G -> A (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027352.
FT   VAR_SEQ     395    541       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027353.
FT   VAR_SEQ     396    541       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11279057}.
FT                                /FTId=VSP_027354.
FT   CONFLICT     57     57       G -> D (in Ref. 3; AAH81736).
FT                                {ECO:0000305}.
FT   CONFLICT    167    167       A -> S (in Ref. 3; AAH81736).
FT                                {ECO:0000305}.
FT   CONFLICT    417    417       V -> A (in Ref. 3; AAH81736).
FT                                {ECO:0000305}.
SQ   SEQUENCE   541 AA;  61174 MW;  07954FC608C8FF40 CRC64;
     MLCSLLLCGC LLLITGYAHD DDWIDPTDML NYDAASGTMR KSQAKYGTSE KKEVNPGLSD
     AQELSDCLQR LDSLTHKVDD CEKKKMKDYE SQSNPVFRRY LNKILIEAGK LGLPDEDRVD
     VRYDAEILLT RQTLLEIQKF LSGEEWKPGA LDDALSDILT NFKSHDAEAW KWQFEDYFGV
     DPYNVFMVLL CLLCIVALVA TELWTYVRWH TQLKRVCIIS FLVSLGWNWI YLYKVAFAQH
     QANVAKMAPL NDVCAKKMDW TENLWEWFRI SWTYKDDPCQ KYYELLIVNP IWLVPPTKAL
     AVTFTNFVTE PLKYIGKGTG EFIKALMKEI PVLLQIPVLV ILALAVLGFC YGAGQSVPML
     RHFRGPEREP PRALEPDDRR RQKELDYRFH GGAGDADFSY RGPAGSIEQG PYDKMHVCER
     DVLRQRQVNM RFPSGNKSPE VLRAFDLPDT EAQEHPEVVP SHKPSIVNTS LKETSELPRE
     STLAECSQCA KDGSGQVPST AESSPIVEKA QLKTDSECRP HSTEAAAAAA RGTDPVSSPC
     G
//
ID   TTYH1_HUMAN             Reviewed;         450 AA.
AC   Q9H313; B0VJY3; B0VJY4; B0VJY5; B2VAL9; Q5U682; Q68A17; Q6L750;
AC   Q6ZTE5; Q8WUU2;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-NOV-2017, entry version 113.
DE   RecName: Full=Protein tweety homolog 1;
DE            Short=hTTY1;
GN   Name=TTYH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10950931; DOI=10.1006/geno.2000.6259;
RA   Campbell H.D., Kamei M., Claudianos C., Woollatt E., Sutherland G.R.,
RA   Suzuki Y., Hida M., Sugano S., Young I.G.;
RT   "Human and mouse homologues of the Drosophila melanogaster tweety
RT   (tty) gene: a novel gene family encoding predicted transmembrane
RT   proteins.";
RL   Genomics 68:89-92(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND FUNCTION (ISOFORM 3).
RX   PubMed=15010458; DOI=10.1074/jbc.M313813200;
RA   Suzuki M., Mizuno A.;
RT   "A novel human Cl(-) channel family related to Drosophila flightless
RT   locus.";
RL   J. Biol. Chem. 279:22461-22468(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Sugiyama A., Inoue H., Oka M.;
RT   "Homo sapiens mRNA.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 5).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=17116230; DOI=10.1111/j.1471-4159.2006.04237.x;
RA   Matthews C.A., Shaw J.E., Hooper J.A., Young I.G., Crouch M.F.,
RA   Campbell H.D.;
RT   "Expression and evolution of the mammalian brain gene Ttyh1.";
RL   J. Neurochem. 100:693-707(2007).
CC   -!- FUNCTION: Probable chloride channel. May be involved in cell
CC       adhesion (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: Isoform 3 may be a Ca(2+)-independent and swelling-
CC       activated chloride channel, possibly involved in regulation of
CC       cell volume.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9H313-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H313-2; Sequence=VSP_029760;
CC       Name=3; Synonyms=TTYH1s;
CC         IsoId=Q9H313-3; Sequence=VSP_029759;
CC       Name=4;
CC         IsoId=Q9H313-4; Sequence=VSP_029753, VSP_029757, VSP_029760;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9H313-5; Sequence=VSP_029754, VSP_029755, VSP_029756,
CC                                  VSP_029758;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, eye, ovary and testis, and
CC       at lower levels in muscle, placenta, liver and lung.
CC       {ECO:0000269|PubMed:17116230}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF177909; AAG02580.1; -; mRNA.
DR   EMBL; AB162930; BAD20189.1; -; mRNA.
DR   EMBL; AB188496; BAD37142.1; -; mRNA.
DR   EMBL; AK126690; BAC86645.1; -; mRNA.
DR   EMBL; AK289468; BAF82157.1; -; mRNA.
DR   EMBL; CU207370; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CU467002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471135; EAW72240.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72242.1; -; Genomic_DNA.
DR   EMBL; BC011347; AAH11347.1; -; mRNA.
DR   EMBL; BC019358; AAH19358.1; -; mRNA.
DR   CCDS; CCDS12893.1; -. [Q9H313-1]
DR   CCDS; CCDS33106.1; -. [Q9H313-3]
DR   CCDS; CCDS56102.1; -. [Q9H313-2]
DR   RefSeq; NP_001005367.1; NM_001005367.2. [Q9H313-3]
DR   RefSeq; NP_001188390.1; NM_001201461.1. [Q9H313-2]
DR   RefSeq; NP_065710.1; NM_020659.3. [Q9H313-1]
DR   UniGene; Hs.268728; -.
DR   ProteinModelPortal; Q9H313; -.
DR   BioGrid; 121494; 1.
DR   TCDB; 1.A.48.1.2; the anion channel tweety (tweety) family.
DR   iPTMnet; Q9H313; -.
DR   PhosphoSitePlus; Q9H313; -.
DR   BioMuta; TTYH1; -.
DR   DMDM; 74718142; -.
DR   PaxDb; Q9H313; -.
DR   PeptideAtlas; Q9H313; -.
DR   PRIDE; Q9H313; -.
DR   Ensembl; ENST00000301194; ENSP00000301194; ENSG00000167614. [Q9H313-2]
DR   Ensembl; ENST00000376530; ENSP00000365713; ENSG00000167614. [Q9H313-1]
DR   Ensembl; ENST00000376531; ENSP00000365714; ENSG00000167614. [Q9H313-3]
DR   Ensembl; ENST00000611133; ENSP00000480177; ENSG00000276887. [Q9H313-2]
DR   Ensembl; ENST00000611471; ENSP00000484881; ENSG00000275650. [Q9H313-3]
DR   Ensembl; ENST00000611711; ENSP00000484774; ENSG00000276887. [Q9H313-1]
DR   Ensembl; ENST00000614387; ENSP00000484077; ENSG00000276887. [Q9H313-4]
DR   Ensembl; ENST00000614458; ENSP00000484835; ENSG00000276887. [Q9H313-3]
DR   Ensembl; ENST00000616929; ENSP00000479779; ENSG00000276537. [Q9H313-2]
DR   Ensembl; ENST00000619450; ENSP00000480769; ENSG00000275650. [Q9H313-1]
DR   Ensembl; ENST00000619453; ENSP00000484548; ENSG00000276537. [Q9H313-3]
DR   Ensembl; ENST00000619591; ENSP00000481601; ENSG00000275650. [Q9H313-2]
DR   Ensembl; ENST00000620133; ENSP00000483288; ENSG00000276887. [Q9H313-5]
DR   Ensembl; ENST00000620298; ENSP00000481138; ENSG00000276537. [Q9H313-1]
DR   Ensembl; ENST00000622771; ENSP00000482372; ENSG00000276537. [Q9H313-4]
DR   GeneID; 57348; -.
DR   KEGG; hsa:57348; -.
DR   UCSC; uc002qfq.4; human. [Q9H313-1]
DR   CTD; 57348; -.
DR   DisGeNET; 57348; -.
DR   EuPathDB; HostDB:ENSG00000167614.13; -.
DR   GeneCards; TTYH1; -.
DR   HGNC; HGNC:13476; TTYH1.
DR   HPA; HPA023617; -.
DR   HPA; HPA050655; -.
DR   MIM; 605784; gene.
DR   neXtProt; NX_Q9H313; -.
DR   OpenTargets; ENSG00000167614; -.
DR   PharmGKB; PA37778; -.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   HOVERGEN; HBG108621; -.
DR   InParanoid; Q9H313; -.
DR   OMA; ESKRFVQ; -.
DR   OrthoDB; EOG091G05MR; -.
DR   PhylomeDB; Q9H313; -.
DR   TreeFam; TF319025; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; TTYH1; human.
DR   GenomeRNAi; 57348; -.
DR   PRO; PR:Q9H313; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167614; -.
DR   ExpressionAtlas; Q9H313; baseline and differential.
DR   Genevisible; Q9H313; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0031527; C:filopodium membrane; IEA:Ensembl.
DR   GO; GO:0032433; C:filopodium tip; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030868; C:smooth endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0005254; F:chloride channel activity; TAS:Reactome.
DR   GO; GO:0005381; F:iron ion transmembrane transporter activity; NAS:UniProtKB.
DR   GO; GO:0072320; F:volume-sensitive chloride channel activity; IDA:FlyBase.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0031589; P:cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0006821; P:chloride transport; IDA:FlyBase.
DR   GO; GO:0046847; P:filopodium assembly; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006826; P:iron ion transport; NAS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    450       Protein tweety homolog 1.
FT                                /FTId=PRO_0000312239.
FT   TOPO_DOM      1     43       Extracellular. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     65     88       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     89    109       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    110    214       Extracellular. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    236    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    262    390       Extracellular. {ECO:0000255}.
FT   TRANSMEM    391    411       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    412    450       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    424    433       Poly-Asp.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3A9}.
FT   CARBOHYD    130    130       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    284    284       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    212       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029753.
FT   VAR_SEQ       1     85       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029754.
FT   VAR_SEQ      86    101       GGGCVTWSCIVALLAG -> MEKVRLWRGSESRAAI (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029755.
FT   VAR_SEQ     140    142       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029756.
FT   VAR_SEQ     213    213       R -> M (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029757.
FT   VAR_SEQ     376    450       DYGAALRGLCEDALEGLLFLLLFSLLSAGALATALCSLPRA
FT                                WALFPPSDDYDDTDDDDPFNPQESKRFVQWQSSI -> VKP
FT                                LPSQFLLPRGASVSTHRTTSSFSLDPCHCA (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029758.
FT   VAR_SEQ     423    450       SDDYDDTDDDDPFNPQESKRFVQWQSSI -> RNPSALCSG
FT                                SRLSEPLLPAGLEPGSPLRSFPGCRRRPH (in isoform
FT                                3). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15010458,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029759.
FT   VAR_SEQ     437    437       P -> PQ (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_029760.
FT   CONFLICT    380    380       A -> S (in Ref. 2; BAD20189).
FT                                {ECO:0000305}.
SQ   SEQUENCE   450 AA;  49051 MW;  AD3DA4569F083657 CRC64;
     MGAPPGYRPS AWVHLLHQLP RADFQLRPVP SVFAPQEQEY QQALLLVAAL AGLGLGLSLI
     FIAVYLIRFC CCRPPEPPGS KIPSPGGGCV TWSCIVALLA GCTGIGIGFY GNSETSDGVS
     QLSSALLHAN HTLSTIDHLV LETVERLGEA VRTELTTLEE VLEPRTELVA AARGARRQAE
     AAAQQLQGLA FWQGVPLSPL QVAENVSFVE EYRWLAYVLL LLLELLVCLF TLLGLAKQSK
     WLVIVMTVMS LLVLVLSWGS MGLEAATAVG LSDFCSNPDP YVLNLTQEET GLSSDILSYY
     LLCNRAVSNP FQQRLTLSQR ALANIHSQLL GLEREAVPQF PSAQKPLLSL EETLNVTEGN
     FHQLVALLHC RSLHKDYGAA LRGLCEDALE GLLFLLLFSL LSAGALATAL CSLPRAWALF
     PPSDDYDDTD DDDPFNPQES KRFVQWQSSI
//
ID   BST25_CAEEL             Reviewed;         602 AA.
AC   O18303;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   20-DEC-2017, entry version 100.
DE   RecName: Full=Bestrophin homolog 25;
GN   Name=best-25; ORFNames=ZK849.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z82095; CAB05027.2; -; Genomic_DNA.
DR   PIR; T28037; T28037.
DR   RefSeq; NP_493479.1; NM_061078.1.
DR   UniGene; Cel.28670; -.
DR   ProteinModelPortal; O18303; -.
DR   SMR; O18303; -.
DR   STRING; 6239.ZK849.4; -.
DR   PaxDb; O18303; -.
DR   EnsemblMetazoa; ZK849.4; ZK849.4; WBGene00014102.
DR   GeneID; 191437; -.
DR   KEGG; cel:CELE_ZK849.4; -.
DR   UCSC; ZK849.4; c. elegans.
DR   CTD; 191437; -.
DR   WormBase; ZK849.4; CE25696; WBGene00014102; best-25.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; O18303; -.
DR   KO; K22204; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; O18303; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:O18303; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00014102; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 2.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    602       Bestrophin homolog 25.
FT                                /FTId=PRO_0000143136.
FT   TRANSMEM     50     70       Helical. {ECO:0000255}.
FT   TRANSMEM     85    105       Helical. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255}.
FT   TRANSMEM    356    376       Helical. {ECO:0000255}.
SQ   SEQUENCE   602 AA;  67608 MW;  458AB78802BD6B3A CRC64;
     MHKVHIIYSR IFQMTVTYNR AVSTESIHNF VSIMSYWHGS LVKSIWKEYA IWIVLYHLIL
     FIYRVVMPIF GWADYCKKVI ENWTPHQDMT IPLEFLLGFF VTTVIDRWRK AFQNIPYIEI
     CAFAVAAAIP GRIRIINKKQ NEVRAPGGQD LRDVPAVEVN HPVQRGPEAP AAALPMPGAP
     ERPAVALPMP GAPEGPAAIQ QPSVDVKLTA RRTIIRYLVL SQILLFREIS TKVKKRFVDL
     KCLVDSKFLT DEELKILSKE VKCDHYDSYF LPINWAFSIL QEHKVKSNPE FINAWNVIRD
     WQVKLSLLRN GDFIPIPLAY PQAVFLAIRF YFLVCLFTRQ HLDMDDKKSI DYYFPLMTSL
     QFIFIVGWMK VAEILLNPMG EDDDDFELNN IIDKNLYIGL AIVDTECGKH PEIVKDTIGK
     DCLPFYPQND DDNERNRALV GSTKNINLSG RSDTPAASPS VFYVNINVKV ENPTPVIVDG
     ARPPPSPPAL PPALPNPNEP PPPPPPAEAL RADQPRHSLI HEVGAQADPA EANGAQALSP
     VLPNPNERAD EHGHSPVIDN EAQPSPPPAE ANRAPIPNQQ PQVNGNAAPA SPRQAKVPDD
     PH
//
ID   CACLC_ARATH             Reviewed;         665 AA.
AC   A0MFS9; Q5XVG1; Q9SSM5;
DT   25-JAN-2012, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 1.
DT   25-OCT-2017, entry version 76.
DE   RecName: Full=Anoctamin-like protein At1g73020;
GN   OrderedLocusNames=At1g73020; ORFNames=F3N23.22;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Xiao Y.-L., Underwood B.A., Moskal W.A. Jr., Wang W., Redman J.C.,
RA   Wu H.C., Utterback T., Town C.D.;
RT   "Reconstruction of cDNA sequences for hypothetical genes in
RT   Arabidopsis thaliana from 5' and 3' RACE products.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=17147637; DOI=10.1111/j.1467-7652.2006.00183.x;
RA   Underwood B.A., Vanderhaeghen R., Whitford R., Town C.D., Hilson P.;
RT   "Simultaneous high-throughput recombinational cloning of open reading
RT   frames in closed and open configurations.";
RL   Plant Biotechnol. J. 4:317-324(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19376835; DOI=10.1104/pp.109.138677;
RA   Reiland S., Messerli G., Baerenfaller K., Gerrits B., Endler A.,
RA   Grossmann J., Gruissem W., Baginsky S.;
RT   "Large-scale Arabidopsis phosphoproteome profiling reveals novel
RT   chloroplast kinase substrates and phosphorylation networks.";
RL   Plant Physiol. 150:889-903(2009).
CC   -!- FUNCTION: May act as a calcium-activated chloride channel.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the anoctamin (TC 1.A.17) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD55649.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008017; AAD55649.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE35404.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE35405.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM58018.1; -; Genomic_DNA.
DR   EMBL; AY735561; AAU44431.1; -; mRNA.
DR   EMBL; DQ653406; ABK28785.1; -; mRNA.
DR   PIR; F96755; F96755.
DR   RefSeq; NP_001185388.1; NM_001198459.1.
DR   RefSeq; NP_001320486.1; NM_001334561.1.
DR   RefSeq; NP_177445.2; NM_105960.5.
DR   UniGene; At.50964; -.
DR   ProteinModelPortal; A0MFS9; -.
DR   STRING; 3702.AT1G73020.1; -.
DR   TCDB; 1.A.17.1.11; the calcium-dependent chloride channel (ca-clc) family.
DR   iPTMnet; A0MFS9; -.
DR   PaxDb; A0MFS9; -.
DR   PRIDE; A0MFS9; -.
DR   EnsemblPlants; AT1G73020.1; AT1G73020.1; AT1G73020.
DR   EnsemblPlants; AT1G73020.2; AT1G73020.2; AT1G73020.
DR   EnsemblPlants; AT1G73020.3; AT1G73020.3; AT1G73020.
DR   GeneID; 843633; -.
DR   Gramene; AT1G73020.1; AT1G73020.1; AT1G73020.
DR   Gramene; AT1G73020.2; AT1G73020.2; AT1G73020.
DR   Gramene; AT1G73020.3; AT1G73020.3; AT1G73020.
DR   KEGG; ath:AT1G73020; -.
DR   Araport; AT1G73020; -.
DR   TAIR; locus:2032763; AT1G73020.
DR   eggNOG; KOG2513; Eukaryota.
DR   eggNOG; ENOG410XPYE; LUCA.
DR   HOGENOM; HOG000036631; -.
DR   InParanoid; A0MFS9; -.
DR   KO; K19327; -.
DR   OMA; DTWYTRF; -.
DR   OrthoDB; EOG0936080V; -.
DR   PhylomeDB; A0MFS9; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:A0MFS9; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; A0MFS9; baseline and differential.
DR   Genevisible; A0MFS9; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR007632; Anoctamin.
DR   PANTHER; PTHR12308; PTHR12308; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   1: Evidence at protein level;
KW   Calcium; Chloride; Chloride channel; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    665       Anoctamin-like protein At1g73020.
FT                                /FTId=PRO_0000415285.
FT   TRANSMEM    200    220       Helical. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical. {ECO:0000255}.
FT   TRANSMEM    322    342       Helical. {ECO:0000255}.
FT   TRANSMEM    344    364       Helical. {ECO:0000255}.
FT   TRANSMEM    392    412       Helical. {ECO:0000255}.
FT   TRANSMEM    508    528       Helical. {ECO:0000255}.
FT   TRANSMEM    551    571       Helical. {ECO:0000255}.
FT   TRANSMEM    591    611       Helical. {ECO:0000255}.
FT   CONFLICT    243    243       W -> R (in Ref. 3; AAU44431).
FT                                {ECO:0000305}.
SQ   SEQUENCE   665 AA;  76805 MW;  74A337290D492D39 CRC64;
     MNGSNGEERV VHEVAMVVPK RVLEEEEGDC VEVLVTELRK KGMVVDRVVG LAHEFLKVAA
     PSEILGNAAA ELHIRKPTRL GIDLPFEMQG SEAFIRQPDG LLFSWFERFR CYQHLIYGIV
     NSGGHDVTLK LDGREFCWTA GESLLRRLES EGVIKQMFPL HDELKRKELL QNWALNWWNC
     TNQPIDQIYS YFGAKIGVYF SFLGMYTQWL IFPALLGFIV QMVDFGSLQF LALPSFFVGT
     ILWAALFLQF WKRKNAALLA RWQINCLVGP SQGYRFLGME WSSLPFPKEL IKNLGNERAK
     EKEAYQRYEW FAYRKRFRND VLVIMSIICL QLPFELAYAH IFEIITSDII KYVLTAIYLL
     IIQYLTRLGG KVSVKLINRE INESVEYRAN SLIYKVFGLY FMQTYIGIFY HVLLHRNFMT
     LRQVLIQRLI ISQVFWTLMD GSLPYLKYSY RKYRARTKKK MEDGSSTGKI QIASRVEKEY
     FKPTYSASIG VELEDGLFDD SLELALQFGM IMMFACAFPL AFALAAVSNV MEIRTNALKL
     LVTLRRPLPR AAATIGAWLN IWQFLVVMSI CTNSALLVCL YDQEGKWKIE PGLAAILIME
     HVLLLLKFGL SRLVPEEPAW VRASRVKNVT QAQDMYCKQL LRSISGEFNS LTKPEQEQQQ
     DSERF
//
ID   ACC3_CAEEL              Reviewed;         517 AA.
AC   G5EDN0;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   20-DEC-2017, entry version 64.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-3 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-3 {ECO:0000312|WormBase:F55D10.5};
GN   ORFNames=F55D10.5 {ECO:0000312|WormBase:F55D10.5};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Probable acetylcholine-gated chloride channel regulatory
CC       subunit. Does not have ion channel activity alone as a
CC       homopentamer, but forms a functional heteropentameric ion channel
CC       with acc-1. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Does not form a functional homopentameric ion channel.
CC       Forms a functional heteropentameric ion channel composed of acc-1
CC       and acc-3. May interact with acc-2; the interaction does not
CC       result in significant heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY849796; AAW34234.1; -; mRNA.
DR   EMBL; BX284606; CCD67091.1; -; Genomic_DNA.
DR   PIR; T16458; T16458.
DR   RefSeq; NP_508810.2; NM_076409.4.
DR   UniGene; Cel.25513; -.
DR   STRING; 6239.F55D10.5; -.
DR   EnsemblMetazoa; F55D10.5; F55D10.5; WBGene00018880.
DR   GeneID; 186307; -.
DR   KEGG; cel:CELE_F55D10.5; -.
DR   CTD; 186307; -.
DR   WormBase; F55D10.5; CE38372; WBGene00018880; acc-3.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   OMA; IFQAYIP; -.
DR   OrthoDB; EOG091G07NS; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00018880; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    517       Acetylcholine-gated chloride channel
FT                                subunit acc-3. {ECO:0000305}.
FT                                /FTId=PRO_5008958394.
FT   TOPO_DOM     20    277       Extracellular. {ECO:0000305}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    304       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    305    324       Helical. {ECO:0000255}.
FT   TOPO_DOM    325    338       Extracellular. {ECO:0000305}.
FT   TRANSMEM    339    359       Helical. {ECO:0000255}.
FT   TOPO_DOM    360    494       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    495    515       Helical. {ECO:0000255}.
FT   TOPO_DOM    516    517       Extracellular. {ECO:0000305}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    191    205       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   517 AA;  59497 MW;  689E41C60A78C2F2 CRC64;
     MIRTRHVFLF AVLLAFASSQ TPTPEAKSSE QSLEENKFFP LPPTTPFPTN AVAATDEDGE
     ELCTSDKTII EKLLNNYKSF RTPSESGVIV WIEVWVQEVN SVNEITSDFD MDIYVTELWM
     DSALRYEHLN PCKYNLSLNS EILDQIWKPN TVFINSKSAN IHKSPFKNVF LMIYPNGTVW
     VNYRVQVKGP CSMDFSAFPM DQQSCHLTLE SFSYNNQEVD MQWMNWTTPL SLLKKEIVLP
     DFVMSNYSTS LKHEIYPAGV WNELTMTFVF SRRYGWYIFQ AYIPTYLTIF ISWISFCLGP
     KMIPARTMLG VNSLLALTFQ FGNIMRNLPR VSYVKALDVW MLVCLTFVFC SLLELAIIGS
     MGARSENRQA QQQKQQDEEA TKHQKGRENS TCSHLMSPSS CPNSPRICRN HIPNDVPQSF
     KSYGSTDPRM RKRLIIASSS TISHAPNANR SEKVLLLDGL EETQFSQVET KFSSMASIKM
     KKHWTTEEID RLSMIMFPGL FTLFNIIYWT YYLTVNT
//
ID   CLIC1_HUMAN             Reviewed;         241 AA.
AC   O00299; Q15089; Q502X1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-NOV-2017, entry version 191.
DE   RecName: Full=Chloride intracellular channel protein 1;
DE   AltName: Full=Chloride channel ABP;
DE   AltName: Full=Nuclear chloride ion channel 27;
DE            Short=NCC27;
DE   AltName: Full=Regulatory nuclear chloride ion channel protein;
DE            Short=hRNCC;
GN   Name=CLIC1; Synonyms=G6, NCC27;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Lymphoma;
RX   PubMed=9139710; DOI=10.1074/jbc.272.19.12575;
RA   Valenzuela S.M., Martin D.K., Por S.B., Robbins J.M., Warton K.,
RA   Bootcov M.R., Schofield P.R., Campbell T.J., Breit S.N.;
RT   "Molecular cloning and expression of a chloride ion channel of cell
RT   nuclei.";
RL   J. Biol. Chem. 272:12575-12582(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RA   Noh Y.H., Hahn M.J.;
RT   "Cloning and sequence analysis of the gene encoding the xxx-binding
RT   protein.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10191309;
RA   Chuang J.Z., Milner T.A., Zhu M., Sung C.H.;
RT   "A 29 kDa intracellular chloride channel p64H1 is associated with
RT   large dense-core vesicles in rat hippocampal neurons.";
RL   J. Neurosci. 19:2919-2928(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10384126;
RA   Ribas G., Neville M., Wixon J.L., Cheng J., Campbell R.D.;
RT   "Genes encoding three new members of the leukocyte antigen 6
RT   superfamily and a novel member of Ig superfamily, together with genes
RT   encoding the regulatory nuclear chloride ion channel protein (hRNCC)
RT   and an N omega-N omega-dimethylarginine dimethylaminohydrolase
RT   homologue, are found in a 30-kb segment of the MHC class III region.";
RL   J. Immunol. 163:278-287(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-13, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (JUL-2004) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-241.
RA   Borsani G.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   FUNCTION.
RX   PubMed=10834939;
RA   Tonini R., Ferroni A., Valenzuela S.M., Warton K., Campbell T.J.,
RA   Breit S.N., Mazzanti M.;
RT   "Functional characterization of the NCC27 nuclear protein in stable
RT   transfected CHO-K1 cells.";
RL   FASEB J. 14:1171-1178(2000).
RN   [13]
RP   FUNCTION.
RX   PubMed=11195932; DOI=10.1111/j.1469-7793.2000.00541.x;
RA   Valenzuela S.M., Mazzanti M., Tonini R., Qiu M.R., Warton K.,
RA   Musgrove E.A., Campbell T.J., Breit S.N.;
RT   "The nuclear chloride ion channel NCC27 is involved in regulation of
RT   the cell cycle.";
RL   J. Physiol. (Lond.) 529:541-552(2000).
RN   [14]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10793131; DOI=10.1091/mbc.11.5.1509;
RA   Berryman M., Bretscher A.;
RT   "Identification of a novel member of the chloride intracellular
RT   channel gene family (CLIC5) that associates with the actin
RT   cytoskeleton of placental microvilli.";
RL   Mol. Biol. Cell 11:1509-1521(2000).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11940526; DOI=10.1152/ajpcell.00402.2001;
RA   Tulk B.M., Kapadia S., Edwards J.C.;
RT   "CLIC1 inserts from the aqueous phase into phospholipid membranes,
RT   where it functions as an anion channel.";
RL   Am. J. Physiol. 282:C1103-C1112(2002).
RN   [16]
RP   FUNCTION.
RX   PubMed=11978800; DOI=10.1074/jbc.M203666200;
RA   Warton K., Tonini R., Fairlie W.D., Matthews J.M., Valenzuela S.M.,
RA   Qiu M.R., Wu W.M., Pankhurst S., Bauskin A.R., Harrop S.J.,
RA   Campbell T.J., Curmi P.M., Breit S.N., Mazzanti M.;
RT   "Recombinant CLIC1 (NCC27) assembles in lipid bilayers via a pH-
RT   dependent two-state process to form chloride ion channels with
RT   identical characteristics to those observed in Chinese hamster ovary
RT   cells expressing CLIC1.";
RL   J. Biol. Chem. 277:26003-26011(2002).
RN   [17]
RP   INTERACTION WITH WITH AKAP9.
RX   PubMed=12163479; DOI=10.1074/jbc.M112277200;
RA   Shanks R.A., Larocca M.C., Berryman M., Edwards J.C., Urushidani T.,
RA   Navarre J., Goldenring J.R.;
RT   "AKAP350 at the Golgi apparatus. II. Association of AKAP350 with a
RT   novel chloride intracellular channel (CLIC) family member.";
RL   J. Biol. Chem. 277:40973-40980(2002).
RN   [18]
RP   INTERACTION WITH TRAPPC2, AND SUBCELLULAR LOCATION.
RX   PubMed=12681486; DOI=10.1016/S0014-5793(03)00228-X;
RA   Fan L., Yu W., Zhu X.;
RT   "Interaction of sedlin with chloride intracellular channel proteins.";
RL   FEBS Lett. 540:77-80(2003).
RN   [19]
RP   DOMAIN.
RX   PubMed=18850721; DOI=10.1021/bi801147r;
RA   Fanucchi S., Adamson R.J., Dirr H.W.;
RT   "Formation of an unfolding intermediate state of soluble chloride
RT   intracellular channel protein CLIC1 at acidic pH.";
RL   Biochemistry 47:11674-11681(2008).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-119 AND LYS-131, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-156 AND
RP   SER-211, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE,
RP   FUNCTION, SUBCELLULAR LOCATION, PREDICTED MEMBRANE TOPOLOGY, AND
RP   PREDICTED TRANSMEMBRANE DOMAIN.
RX   PubMed=11551966; DOI=10.1074/jbc.M107804200;
RA   Harrop S.J., DeMaere M.Z., Fairlie W.D., Reztsova T., Valenzuela S.M.,
RA   Mazzanti M., Tonini R., Qiu M.R., Jankova L., Warton K., Bauskin A.R.,
RA   Wu W.M., Pankhurst S., Campbell T.J., Breit S.N., Curmi P.M.G.;
RT   "Crystal structure of a soluble form of the intracellular chloride ion
RT   channel CLIC1 (NCC27) at 1.4-A resolution.";
RL   J. Biol. Chem. 276:44993-45000(2001).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS), FUNCTION, SUBUNIT, DOMAIN,
RP   MUTAGENESIS OF CYS-24 AND CYS-59, GLUTATHIONYLATION AT CYS-24,
RP   DISULFIDE BOND, PREDICTED MEMBRANE TOPOLOGY, AND PREDICTED
RP   TRANSMEMBRANE DOMAIN.
RX   PubMed=14613939; DOI=10.1074/jbc.M308444200;
RA   Littler D.R., Harrop S.J., Fairlie W.D., Brown L.J., Pankhurst G.J.,
RA   Pankhurst S., DeMaere M.Z., Campbell T.J., Bauskin A.R., Tonini R.,
RA   Mazzanti M., Breit S.N., Curmi P.M.G.;
RT   "The intracellular chloride ion channel protein CLIC1 undergoes a
RT   redox-controlled structural transition.";
RL   J. Biol. Chem. 279:9298-9305(2004).
CC   -!- FUNCTION: Can insert into membranes and form chloride ion
CC       channels. Channel activity depends on the pH. Membrane insertion
CC       seems to be redox-regulated and may occur only under oxydizing
CC       conditions. Involved in regulation of the cell cycle.
CC       {ECO:0000269|PubMed:10834939, ECO:0000269|PubMed:11195932,
CC       ECO:0000269|PubMed:11551966, ECO:0000269|PubMed:11940526,
CC       ECO:0000269|PubMed:11978800, ECO:0000269|PubMed:14613939,
CC       ECO:0000269|PubMed:9139710}.
CC   -!- SUBUNIT: Monomer. Homodimer (in vitro). Interacts with TRAPPC2.
CC       Dimerization requires a conformation change that leads to the
CC       exposure of a large hydrophobic surface. In vivo, this may lead to
CC       membrane insertion. Interacts with AKAP9.
CC       {ECO:0000269|PubMed:11551966, ECO:0000269|PubMed:12163479,
CC       ECO:0000269|PubMed:12681486, ECO:0000269|PubMed:14613939}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus membrane {ECO:0000305};
CC       Single-pass membrane protein {ECO:0000305}. Cytoplasm. Cell
CC       membrane {ECO:0000305}; Single-pass membrane protein
CC       {ECO:0000305}. Note=Mostly in the nucleus including in the nuclear
CC       membrane. Small amount in the cytoplasm and the plasma membrane.
CC       Exists both as soluble cytoplasmic protein and as membrane protein
CC       with probably a single transmembrane domain.
CC   -!- TISSUE SPECIFICITY: Expression is prominent in heart, placenta,
CC       liver, kidney and pancreas. {ECO:0000269|PubMed:10793131}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion. {ECO:0000269|PubMed:14613939,
CC       ECO:0000269|PubMed:18850721}.
CC   -!- PTM: Hydrogen peroxide treatment causes a conformation change,
CC       leading to dimerization and formation of an intramolecular
CC       disulfide bond between Cys-24 and Cys-59.
CC   -!- MISCELLANEOUS: The protein seems to have very low affinity for
CC       glutathione, even though glutathione binding was observed in
CC       protein crystals.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLIC1ID50543ch6p21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U93205; AAC25675.1; -; mRNA.
DR   EMBL; AF034607; AAD20437.1; -; mRNA.
DR   EMBL; AF109197; AAD26137.1; -; mRNA.
DR   EMBL; AJ012008; CAB46078.1; -; Genomic_DNA.
DR   EMBL; CR542071; CAG46868.1; -; mRNA.
DR   EMBL; AF129756; AAD18073.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63376.1; -; Genomic_DNA.
DR   EMBL; AL662899; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC064527; AAH64527.1; -; mRNA.
DR   EMBL; BC095469; AAH95469.1; -; mRNA.
DR   EMBL; X87689; CAA61020.1; -; mRNA.
DR   CCDS; CCDS4719.1; -.
DR   RefSeq; NP_001274522.1; NM_001287593.1.
DR   RefSeq; NP_001274523.1; NM_001287594.1.
DR   RefSeq; NP_001279.2; NM_001288.4.
DR   UniGene; Hs.414565; -.
DR   PDB; 1K0M; X-ray; 1.40 A; A/B=1-241.
DR   PDB; 1K0N; X-ray; 1.80 A; A/B=1-241.
DR   PDB; 1K0O; X-ray; 1.75 A; A/B=1-241.
DR   PDB; 1RK4; X-ray; 1.79 A; A/B=1-241.
DR   PDB; 3O3T; X-ray; 1.70 A; A=1-241.
DR   PDB; 3P8W; X-ray; 2.00 A; A=1-241.
DR   PDB; 3P90; X-ray; 2.30 A; A=1-241.
DR   PDB; 3QR6; X-ray; 1.78 A; A=1-241.
DR   PDB; 3SWL; X-ray; 2.35 A; A=6-241.
DR   PDB; 3TGZ; X-ray; 2.30 A; A/B=1-241.
DR   PDB; 3UVH; X-ray; 1.84 A; A/B=1-241.
DR   PDB; 4IQA; X-ray; 2.49 A; A/B=6-241.
DR   PDB; 4JZQ; X-ray; 1.35 A; A/B=1-241.
DR   PDB; 4K0G; X-ray; 1.40 A; A=2-241.
DR   PDB; 4K0N; X-ray; 1.25 A; A=1-241.
DR   PDBsum; 1K0M; -.
DR   PDBsum; 1K0N; -.
DR   PDBsum; 1K0O; -.
DR   PDBsum; 1RK4; -.
DR   PDBsum; 3O3T; -.
DR   PDBsum; 3P8W; -.
DR   PDBsum; 3P90; -.
DR   PDBsum; 3QR6; -.
DR   PDBsum; 3SWL; -.
DR   PDBsum; 3TGZ; -.
DR   PDBsum; 3UVH; -.
DR   PDBsum; 4IQA; -.
DR   PDBsum; 4JZQ; -.
DR   PDBsum; 4K0G; -.
DR   PDBsum; 4K0N; -.
DR   ProteinModelPortal; O00299; -.
DR   SMR; O00299; -.
DR   BioGrid; 107604; 59.
DR   IntAct; O00299; 43.
DR   MINT; MINT-1033423; -.
DR   STRING; 9606.ENSP00000364934; -.
DR   TCDB; 1.A.12.1.2; the intracellular chloride channel (clic) family.
DR   iPTMnet; O00299; -.
DR   PhosphoSitePlus; O00299; -.
DR   SwissPalm; O00299; -.
DR   BioMuta; CLIC1; -.
DR   OGP; O00299; -.
DR   SWISS-2DPAGE; O00299; -.
DR   EPD; O00299; -.
DR   PaxDb; O00299; -.
DR   PeptideAtlas; O00299; -.
DR   PRIDE; O00299; -.
DR   TopDownProteomics; O00299; -.
DR   DNASU; 1192; -.
DR   Ensembl; ENST00000375779; ENSP00000364934; ENSG00000213719.
DR   Ensembl; ENST00000375780; ENSP00000364935; ENSG00000213719.
DR   Ensembl; ENST00000375784; ENSP00000364940; ENSG00000213719.
DR   Ensembl; ENST00000383404; ENSP00000372896; ENSG00000206394.
DR   Ensembl; ENST00000383405; ENSP00000372897; ENSG00000206394.
DR   Ensembl; ENST00000395892; ENSP00000379229; ENSG00000213719.
DR   Ensembl; ENST00000400052; ENSP00000382926; ENSG00000206394.
DR   Ensembl; ENST00000400058; ENSP00000382931; ENSG00000206394.
DR   Ensembl; ENST00000415179; ENSP00000409247; ENSG00000226248.
DR   Ensembl; ENST00000418285; ENSP00000407791; ENSG00000226417.
DR   Ensembl; ENST00000420458; ENSP00000410965; ENSG00000226651.
DR   Ensembl; ENST00000422167; ENSP00000407429; ENSG00000226248.
DR   Ensembl; ENST00000423055; ENSP00000406968; ENSG00000226417.
DR   Ensembl; ENST00000423143; ENSP00000404589; ENSG00000223639.
DR   Ensembl; ENST00000423804; ENSP00000409979; ENSG00000230685.
DR   Ensembl; ENST00000425464; ENSP00000401292; ENSG00000223639.
DR   Ensembl; ENST00000431921; ENSP00000408357; ENSG00000226248.
DR   Ensembl; ENST00000433916; ENSP00000391395; ENSG00000226651.
DR   Ensembl; ENST00000434202; ENSP00000400532; ENSG00000226651.
DR   Ensembl; ENST00000435242; ENSP00000412217; ENSG00000226417.
DR   Ensembl; ENST00000438708; ENSP00000406088; ENSG00000226248.
DR   Ensembl; ENST00000438750; ENSP00000404037; ENSG00000223639.
DR   Ensembl; ENST00000442045; ENSP00000400280; ENSG00000226417.
DR   Ensembl; ENST00000447338; ENSP00000413330; ENSG00000230685.
DR   Ensembl; ENST00000447369; ENSP00000408094; ENSG00000230685.
DR   Ensembl; ENST00000451546; ENSP00000416211; ENSG00000223639.
DR   Ensembl; ENST00000456863; ENSP00000406335; ENSG00000226651.
DR   Ensembl; ENST00000457485; ENSP00000398056; ENSG00000230685.
DR   Ensembl; ENST00000614673; ENSP00000480256; ENSG00000230685.
DR   Ensembl; ENST00000614982; ENSP00000477623; ENSG00000206394.
DR   Ensembl; ENST00000616760; ENSP00000479808; ENSG00000213719.
DR   Ensembl; ENST00000618288; ENSP00000479501; ENSG00000226417.
DR   Ensembl; ENST00000619727; ENSP00000482255; ENSG00000226651.
DR   Ensembl; ENST00000621055; ENSP00000478930; ENSG00000226248.
DR   Ensembl; ENST00000622613; ENSP00000484581; ENSG00000223639.
DR   GeneID; 1192; -.
DR   KEGG; hsa:1192; -.
DR   CTD; 1192; -.
DR   DisGeNET; 1192; -.
DR   EuPathDB; HostDB:ENSG00000213719.8; -.
DR   GeneCards; CLIC1; -.
DR   HGNC; HGNC:2062; CLIC1.
DR   HPA; CAB020825; -.
DR   HPA; CAB040557; -.
DR   MIM; 602872; gene.
DR   neXtProt; NX_O00299; -.
DR   OpenTargets; ENSG00000213719; -.
DR   PharmGKB; PA26588; -.
DR   eggNOG; ENOG410INGZ; Eukaryota.
DR   eggNOG; ENOG410ZZZX; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000231548; -.
DR   HOVERGEN; HBG050994; -.
DR   InParanoid; O00299; -.
DR   KO; K05021; -.
DR   OMA; LWRYLNA; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; O00299; -.
DR   TreeFam; TF315438; -.
DR   SignaLink; O00299; -.
DR   ChiTaRS; CLIC1; human.
DR   EvolutionaryTrace; O00299; -.
DR   GeneWiki; CLIC1; -.
DR   GenomeRNAi; 1192; -.
DR   PRO; PR:O00299; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000213719; -.
DR   CleanEx; HS_CLIC1; -.
DR   ExpressionAtlas; O00299; baseline and differential.
DR   Genevisible; O00299; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; TAS:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IDA:MGI.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005254; F:chloride channel activity; IDA:MGI.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006821; P:chloride transport; IDA:MGI.
DR   GO; GO:0070527; P:platelet aggregation; IMP:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:InterPro.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030259; CLIC-1.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF2; PTHR43920:SF2; 1.
DR   Pfam; PF13409; GST_N_2; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Glutathionylation; Ion channel; Ion transport;
KW   Membrane; Nucleus; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.10}.
FT   CHAIN         2    241       Chloride intracellular channel protein 1.
FT                                /FTId=PRO_0000144201.
FT   TRANSMEM     26     46       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN       93    233       GST C-terminal.
FT   REGION        2     90       Required for insertion into the membrane.
FT   BINDING      64     64       Glutathione; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:11551966}.
FT   BINDING      77     77       Glutathione.
FT                                {ECO:0000269|PubMed:11551966}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.10}.
FT   MOD_RES      13     13       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      24     24       S-glutathionyl cysteine; alternate.
FT                                {ECO:0000269|PubMed:14613939}.
FT   MOD_RES     119    119       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     131    131       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     233    233       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9Z1Q5}.
FT   DISULFID     24     59       Alternate. {ECO:0000269|PubMed:14613939}.
FT   MUTAGEN      24     24       C->S: Loss of dimerization and of ion
FT                                transport activity.
FT                                {ECO:0000269|PubMed:14613939}.
FT   MUTAGEN      59     59       C->S: Loss of dimerization and of ion
FT                                transport activity.
FT                                {ECO:0000269|PubMed:14613939}.
FT   CONFLICT     63     63       Q -> E (in Ref. 1; AAC25675 and 3;
FT                                AAD26137). {ECO:0000305}.
FT   STRAND        8     14       {ECO:0000244|PDB:4K0N}.
FT   STRAND       18     21       {ECO:0000244|PDB:4K0N}.
FT   HELIX        25     37       {ECO:0000244|PDB:4K0N}.
FT   STRAND       42     46       {ECO:0000244|PDB:4K0N}.
FT   STRAND       48     50       {ECO:0000244|PDB:1K0N}.
FT   HELIX        53     58       {ECO:0000244|PDB:4K0N}.
FT   STRAND       64     69       {ECO:0000244|PDB:4K0N}.
FT   STRAND       72     76       {ECO:0000244|PDB:4K0N}.
FT   HELIX        77     87       {ECO:0000244|PDB:4K0N}.
FT   TURN         90     92       {ECO:0000244|PDB:4K0N}.
FT   HELIX       101    104       {ECO:0000244|PDB:4K0N}.
FT   TURN        105    109       {ECO:0000244|PDB:4K0N}.
FT   HELIX       110    119       {ECO:0000244|PDB:4K0N}.
FT   HELIX       123    125       {ECO:0000244|PDB:4K0N}.
FT   HELIX       126    145       {ECO:0000244|PDB:4K0N}.
FT   HELIX       149    151       {ECO:0000244|PDB:4K0N}.
FT   HELIX       157    159       {ECO:0000244|PDB:4JZQ}.
FT   STRAND      166    172       {ECO:0000244|PDB:4K0N}.
FT   HELIX       175    195       {ECO:0000244|PDB:4K0N}.
FT   HELIX       204    214       {ECO:0000244|PDB:4K0N}.
FT   HELIX       217    220       {ECO:0000244|PDB:4K0N}.
FT   HELIX       226    232       {ECO:0000244|PDB:4K0N}.
FT   HELIX       234    237       {ECO:0000244|PDB:4K0N}.
SQ   SEQUENCE   241 AA;  26923 MW;  163EEB7481826A0A CRC64;
     MAEEQPQVEL FVKAGSDGAK IGNCPFSQRL FMVLWLKGVT FNVTTVDTKR RTETVQKLCP
     GGQLPFLLYG TEVHTDTNKI EEFLEAVLCP PRYPKLAALN PESNTAGLDI FAKFSAYIKN
     SNPALNDNLE KGLLKALKVL DNYLTSPLPE EVDETSAEDE GVSQRKFLDG NELTLADCNL
     LPKLHIVQVV CKKYRGFTIP EAFRGVHRYL SNAYAREEFA STCPDDEEIE LAYEQVAKAL
     K
//
ID   CLD4_HUMAN              Reviewed;         209 AA.
AC   O14493;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 150.
DE   RecName: Full=Claudin-4;
DE   AltName: Full=Clostridium perfringens enterotoxin receptor {ECO:0000303|PubMed:9334247};
DE            Short=CPE-R {ECO:0000303|PubMed:9334247};
DE            Short=CPE-receptor {ECO:0000303|PubMed:9334247};
DE   AltName: Full=Williams-Beuren syndrome chromosomal region 8 protein;
GN   Name=CLDN4;
GN   Synonyms=CPER {ECO:0000303|PubMed:9334247},
GN   CPETR1 {ECO:0000303|PubMed:9334247}, WBSCR8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=9334247; DOI=10.1074/jbc.272.42.26652;
RA   Katahira J., Sugiyama H., Inoue N., Horiguchi Y., Matsuda M.,
RA   Sugimoto N.;
RT   "Clostridium perfringens enterotoxin utilizes two structurally related
RT   membrane proteins as functional receptors in vivo.";
RL   J. Biol. Chem. 272:26652-26658(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH EPHA2 AND TJP1, MUTAGENESIS OF TYR-208, AND
RP   PHOSPHORYLATION AT TYR-208 BY EPHA2.
RX   PubMed=16236711; DOI=10.1074/jbc.M503786200;
RA   Tanaka M., Kamata R., Sakai R.;
RT   "EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates
RT   paracellular permeability.";
RL   J. Biol. Chem. 280:42375-42382(2005).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CLDN1.
RX   PubMed=20375010; DOI=10.1074/jbc.M110.104836;
RA   Harris H.J., Davis C., Mullins J.G., Hu K., Goodall M., Farquhar M.J.,
RA   Mee C.J., McCaffrey K., Young S., Drummer H., Balfe P.,
RA   McKeating J.A.;
RT   "Claudin association with CD81 defines hepatitis C virus entry.";
RL   J. Biol. Chem. 285:21092-21102(2010).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Channel-forming tight junction protein that mediates
CC       paracellular chloride transport in the kidney. Plays a critical
CC       role in the paracellular reabsorption of filtered chloride in the
CC       kidney collecting ducts. Claudins play a major role in tight
CC       junction-specific obliteration of the intercellular space, through
CC       calcium-independent cell-adhesion activity.
CC       {ECO:0000250|UniProtKB:O35054}.
CC   -!- SUBUNIT: Directly interacts with TJP1/ZO-1 (PubMed:16236711).
CC       Interacts with TJP2/ZO-2 and TJP3/ZO-3 (By similarity). Interacts
CC       with EPHA2; phosphorylates CLDN4 and may regulate tight junctions
CC       (PubMed:16236711). Interacts with CLDN1 (PubMed:20375010).
CC       Interacts with CLDN4 (By similarity).
CC       {ECO:0000250|UniProtKB:O35054, ECO:0000269|PubMed:16236711,
CC       ECO:0000269|PubMed:20375010}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000250|UniProtKB:O35054}. Cell membrane
CC       {ECO:0000269|PubMed:20375010}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=CLDN4 is required for tight junction
CC       localization in the kidney. {ECO:0000250|UniProtKB:O35054}.
CC   -!- PTM: Phosphorylated. Phosphorylation by EPHA2 is stimulated by
CC       EFNA1 and alters interaction with TJP1.
CC       {ECO:0000269|PubMed:16236711}.
CC   -!- DISEASE: Note=CLDN4 is located in the Williams-Beuren syndrome
CC       (WBS) critical region. WBS results from a hemizygous deletion of
CC       several genes on chromosome 7q11.23, thought to arise as a
CC       consequence of unequal crossing over between highly homologous
CC       low-copy repeat sequences flanking the deleted region.
CC   -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLDN4ID42975ch7q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000712; BAA22984.1; -; mRNA.
DR   EMBL; BT006989; AAP35635.1; -; mRNA.
DR   EMBL; BC000671; AAH00671.1; -; mRNA.
DR   CCDS; CCDS5560.1; -.
DR   RefSeq; NP_001296.1; NM_001305.4.
DR   UniGene; Hs.647036; -.
DR   UniGene; Hs.729359; -.
DR   PDB; 5B2G; X-ray; 3.50 A; A/C/E/G=1-183.
DR   PDBsum; 5B2G; -.
DR   ProteinModelPortal; O14493; -.
DR   SMR; O14493; -.
DR   BioGrid; 107756; 2.
DR   IntAct; O14493; 3.
DR   STRING; 9606.ENSP00000342445; -.
DR   TCDB; 1.H.1.1.6; the claudin tight junction (claudin1) family.
DR   iPTMnet; O14493; -.
DR   PhosphoSitePlus; O14493; -.
DR   EPD; O14493; -.
DR   PaxDb; O14493; -.
DR   PeptideAtlas; O14493; -.
DR   PRIDE; O14493; -.
DR   DNASU; 1364; -.
DR   Ensembl; ENST00000340958; ENSP00000342445; ENSG00000189143.
DR   Ensembl; ENST00000431918; ENSP00000388639; ENSG00000189143.
DR   Ensembl; ENST00000435050; ENSP00000409544; ENSG00000189143.
DR   GeneID; 1364; -.
DR   KEGG; hsa:1364; -.
DR   CTD; 1364; -.
DR   DisGeNET; 1364; -.
DR   EuPathDB; HostDB:ENSG00000189143.9; -.
DR   GeneCards; CLDN4; -.
DR   HGNC; HGNC:2046; CLDN4.
DR   HPA; CAB002610; -.
DR   MIM; 602909; gene.
DR   neXtProt; NX_O14493; -.
DR   OpenTargets; ENSG00000189143; -.
DR   PharmGKB; PA26572; -.
DR   eggNOG; ENOG410IIJR; Eukaryota.
DR   eggNOG; ENOG410YA61; LUCA.
DR   GeneTree; ENSGT00760000118928; -.
DR   HOGENOM; HOG000220937; -.
DR   HOVERGEN; HBG000643; -.
DR   InParanoid; O14493; -.
DR   KO; K06087; -.
DR   OMA; TAHNVIR; -.
DR   OrthoDB; EOG091G0MMR; -.
DR   PhylomeDB; O14493; -.
DR   TreeFam; TF331936; -.
DR   Reactome; R-HSA-420029; Tight junction interactions.
DR   ChiTaRS; CLDN4; human.
DR   GeneWiki; CLDN4; -.
DR   GenomeRNAi; 1364; -.
DR   PRO; PR:O14493; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000189143; -.
DR   CleanEx; HS_CLDN4; -.
DR   ExpressionAtlas; O14493; baseline and differential.
DR   Genevisible; O14493; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0061436; P:establishment of skin barrier; IMP:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0070293; P:renal absorption; ISS:UniProtKB.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   InterPro; IPR006187; Claudin.
DR   InterPro; IPR003550; Claudin4.
DR   InterPro; IPR017974; Claudin_CS.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   PANTHER; PTHR12002; PTHR12002; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01379; CLAUDIN4.
DR   PROSITE; PS01346; CLAUDIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Reference proteome; Tight junction;
KW   Transmembrane; Transmembrane helix; Transport;
KW   Williams-Beuren syndrome.
FT   CHAIN         1    209       Claudin-4.
FT                                /FTId=PRO_0000144743.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TOPO_DOM     29     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical. {ECO:0000255}.
FT   TOPO_DOM    103    117       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    160       Extracellular. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TOPO_DOM    182    209       Cytoplasmic. {ECO:0000255}.
FT   REGION        1    103       Interaction with EPHA2.
FT                                {ECO:0000269|PubMed:16236711}.
FT   REGION      208    209       Interactions with TJP1, TJP2 and TJP3.
FT                                {ECO:0000250}.
FT   MOD_RES     208    208       Phosphotyrosine; by EPHA2.
FT                                {ECO:0000269|PubMed:16236711}.
FT   MUTAGEN     208    208       Y->F: Loss of phosphorylation by EPHA2.
FT                                {ECO:0000269|PubMed:16236711}.
FT   STRAND        1      3       {ECO:0000244|PDB:5B2G}.
FT   HELIX         7     26       {ECO:0000244|PDB:5B2G}.
FT   STRAND       30     35       {ECO:0000244|PDB:5B2G}.
FT   STRAND       44     48       {ECO:0000244|PDB:5B2G}.
FT   STRAND       50     61       {ECO:0000244|PDB:5B2G}.
FT   STRAND       63     66       {ECO:0000244|PDB:5B2G}.
FT   HELIX        75     96       {ECO:0000244|PDB:5B2G}.
FT   TURN        102    106       {ECO:0000244|PDB:5B2G}.
FT   HELIX       117    148       {ECO:0000244|PDB:5B2G}.
FT   STRAND      154    160       {ECO:0000244|PDB:5B2G}.
FT   HELIX       163    182       {ECO:0000244|PDB:5B2G}.
SQ   SEQUENCE   209 AA;  22077 MW;  0659A93AA5F0E4C5 CRC64;
     MASMGLQVMG IALAVLGWLA VMLCCALPMW RVTAFIGSNI VTSQTIWEGL WMNCVVQSTG
     QMQCKVYDSL LALPQDLQAA RALVIISIIV AALGVLLSVV GGKCTNCLED ESAKAKTMIV
     AGVVFLLAGL MVIVPVSWTA HNIIQDFYNP LVASGQKREM GASLYVGWAA SGLLLLGGGL
     LCCNCPPRTD KPYSAKYSAA RSAAASNYV
//
ID   GBRD_HUMAN              Reviewed;         452 AA.
AC   O14764; Q8N4N9;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 2.
DT   20-DEC-2017, entry version 171.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit delta;
DE   AltName: Full=GABA(A) receptor subunit delta;
DE   Flags: Precursor;
GN   Name=GABRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-220.
RA   Day T.M., Hartnett C., Blankenbiller K., Ramabhadran T.V.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS GEFS+5 ALA-177 AND CYS-220, VARIANT HIS-220, CHARACTERIZATION
RP   OF VARIANTS GEFS+5 ALA-177 AND CYS-220, AND CHARACTERIZATION OF
RP   VARIANT HIS-220.
RX   PubMed=15115768; DOI=10.1093/hmg/ddh146;
RA   Dibbens L.M., Feng H.-J., Richards M.C., Harkin L.A., Hodgson B.L.,
RA   Scott D., Jenkins M., Petrou S., Sutherland G.R., Scheffer I.E.,
RA   Berkovic S.F., Macdonald R.L., Mulley J.C.;
RT   "GABRD encoding a protein for extra- or peri-synaptic GABAA receptors
RT   is a susceptibility locus for generalized epilepsies.";
RL   Hum. Mol. Genet. 13:1315-1319(2004).
RN   [5]
RP   VARIANT ILE-370.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
RN   [6]
RP   VARIANT SER-62.
RX   PubMed=27932480; DOI=10.1681/ASN.2016040387;
RG   NephroS;
RG   UK study of Nephrotic Syndrome;
RA   Bierzynska A., Soderquest K., Dean P., Colby E., Rollason R.,
RA   Jones C., Inward C.D., McCarthy H.J., Simpson M.A., Lord G.M.,
RA   Williams M., Welsh G.I., Koziell A.B., Saleem M.A.;
RT   "MAGI2 mutations cause congenital nephrotic syndrome.";
RL   J. Am. Soc. Nephrol. 28:1614-1621(2017).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- INTERACTION:
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-744352, EBI-945833;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-744352, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-744352, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- DISEASE: Generalized epilepsy with febrile seizures plus 5
CC       (GEFS+5) [MIM:613060]: A rare autosomal dominant, familial
CC       condition with incomplete penetrance and large intrafamilial
CC       variability. Patients display febrile seizures persisting
CC       sometimes beyond the age of 6 years and/or a variety of afebrile
CC       seizure types. This disease combines febrile seizures, generalized
CC       seizures often precipitated by fever at age 6 years or more, and
CC       partial seizures, with a variable degree of severity.
CC       {ECO:0000269|PubMed:15115768}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 10 (EIG10) [MIM:613060]:
CC       A disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Juvenile myoclonic epilepsy 7 (EJM7) [MIM:613060]: A
CC       subtype of idiopathic generalized epilepsy. Patients have afebrile
CC       seizures only, with onset in adolescence (rather than in
CC       childhood) and myoclonic jerks which usually occur after awakening
CC       and are triggered by sleep deprivation and fatigue. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRD sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016917; AAB70007.1; -; mRNA.
DR   EMBL; AL391845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033801; AAH33801.1; -; mRNA.
DR   CCDS; CCDS36.1; -.
DR   RefSeq; NP_000806.2; NM_000815.4.
DR   UniGene; Hs.113882; -.
DR   ProteinModelPortal; O14764; -.
DR   BioGrid; 108837; 17.
DR   IntAct; O14764; 4.
DR   MINT; MINT-1461496; -.
DR   STRING; 9606.ENSP00000367848; -.
DR   ChEMBL; CHEMBL3591; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; O14764; -.
DR   PhosphoSitePlus; O14764; -.
DR   BioMuta; GABRD; -.
DR   PaxDb; O14764; -.
DR   PeptideAtlas; O14764; -.
DR   PRIDE; O14764; -.
DR   DNASU; 2563; -.
DR   Ensembl; ENST00000378585; ENSP00000367848; ENSG00000187730.
DR   GeneID; 2563; -.
DR   KEGG; hsa:2563; -.
DR   UCSC; uc001aip.3; human.
DR   CTD; 2563; -.
DR   DisGeNET; 2563; -.
DR   EuPathDB; HostDB:ENSG00000187730.7; -.
DR   GeneCards; GABRD; -.
DR   HGNC; HGNC:4084; GABRD.
DR   HPA; HPA044371; -.
DR   MalaCards; GABRD; -.
DR   MIM; 137163; gene.
DR   MIM; 613060; phenotype.
DR   neXtProt; NX_O14764; -.
DR   OpenTargets; ENSG00000187730; -.
DR   Orphanet; 1606; 1p36 deletion syndrome.
DR   Orphanet; 36387; Generalized epilepsy with febrile seizures-plus.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   PharmGKB; PA28498; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O14764; -.
DR   KO; K05184; -.
DR   OMA; TMTTLMV; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O14764; -.
DR   TreeFam; TF315453; -.
DR   GeneWiki; GABRD; -.
DR   GenomeRNAi; 2563; -.
DR   PRO; PR:O14764; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000187730; -.
DR   CleanEx; HS_GABRD; -.
DR   ExpressionAtlas; O14764; baseline and differential.
DR   Genevisible; O14764; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008098; GABAAd_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF34; PTHR18945:SF34; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01722; GABAARDELTA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disease mutation; Disulfide bond; Epilepsy;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Postsynaptic cell membrane; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    452       Gamma-aminobutyric acid receptor subunit
FT                                delta.
FT                                /FTId=PRO_0000000468.
FT   TOPO_DOM     17    248       Extracellular. {ECO:0000305}.
FT   TRANSMEM    249    271       Helical. {ECO:0000305}.
FT   TRANSMEM    275    297       Helical. {ECO:0000305}.
FT   TRANSMEM    309    331       Helical. {ECO:0000305}.
FT   TOPO_DOM    332    429       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    430    452       Helical. {ECO:0000305}.
FT   MOD_RES     390    390       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18506}.
FT   CARBOHYD    103    103       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    164    178       {ECO:0000250}.
FT   VARIANT      62     62       P -> S. {ECO:0000269|PubMed:27932480}.
FT                                /FTId=VAR_079270.
FT   VARIANT     177    177       E -> A (in GEFS+5; reduced receptor
FT                                current amplitudes; dbSNP:rs121434580).
FT                                {ECO:0000269|PubMed:15115768}.
FT                                /FTId=VAR_043151.
FT   VARIANT     220    220       R -> C (in GEFS+5; unknown pathological
FT                                significance; does not affect receptor
FT                                current amplitudes; dbSNP:rs139300921).
FT                                {ECO:0000269|PubMed:15115768}.
FT                                /FTId=VAR_043152.
FT   VARIANT     220    220       R -> H (polymorphism; is a risk factor
FT                                for epilepsy; reduced receptor current
FT                                amplitudes; dbSNP:rs41307846).
FT                                {ECO:0000269|PubMed:15115768,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_043153.
FT   VARIANT     370    370       V -> I (found in a patient with childhood
FT                                onset epileptic encephalopathy; unknown
FT                                pathological significance;
FT                                dbSNP:rs1057519556).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078225.
SQ   SEQUENCE   452 AA;  50708 MW;  682501DE93144CE4 CRC64;
     MDAPARLLAP LLLLCAQQLR GTRAMNDIGD YVGSNLEISW LPNLDGLIAG YARNFRPGIG
     GPPVNVALAL EVASIDHISE ANMEYTMTVF LHQSWRDSRL SYNHTNETLG LDSRFVDKLW
     LPDTFIVNAK SAWFHDVTVE NKLIRLQPDG VILYSIRITS TVACDMDLAK YPMDEQECML
     DLESYGYSSE DIVYYWSESQ EHIHGLDKLQ LAQFTITSYR FTTELMNFKS AGQFPRLSLH
     FHLRRNRGVY IIQSYMPSVL LVAMSWVSFW ISQAAVPARV SLGITTVLTM TTLMVSARSS
     LPRASAIKAL DVYFWICYVF VFAALVEYAF AHFNADYRKK QKAKVKVSRP RAEMDVRNAI
     VLFSLSAAGV TQELAISRRQ RRVPGNLMGS YRSVGVETGE TKKEGAARSG GQGGIRARLR
     PIDADTIDIY ARAVFPAAFA AVNVIYWAAY AM
//
ID   CLIC2_HUMAN             Reviewed;         247 AA.
AC   O15247; A8K9S0; O15174; Q5JT80; Q8TCE3;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 3.
DT   25-OCT-2017, entry version 158.
DE   RecName: Full=Chloride intracellular channel protein 2;
DE   AltName: Full=XAP121;
GN   Name=CLIC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9339381; DOI=10.1006/geno.1997.4922;
RA   Heiss N.S., Poustka A.;
RT   "Genomic structure of a novel chloride channel gene, CLIC2, in Xq28.";
RL   Genomics 45:224-228(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH TRAPPC2.
RX   PubMed=12681486; DOI=10.1016/S0014-5793(03)00228-X;
RA   Fan L., Yu W., Zhu X.;
RT   "Interaction of sedlin with chloride intracellular channel proteins.";
RL   FEBS Lett. 540:77-80(2003).
RN   [7]
RP   FUNCTION, SUBUNIT, 3D-STRUCTURE MODELING, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH RYR2.
RX   PubMed=15147738; DOI=10.1016/j.biocel.2004.01.026;
RA   Board P.G., Coggan M., Watson S., Gage P.W., Dulhunty A.F.;
RT   "CLIC-2 modulates cardiac ryanodine receptor Ca2+ release channels.";
RL   Int. J. Biochem. Cell Biol. 36:1599-1612(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RYR2.
RX   PubMed=15916532; DOI=10.1042/BJ20042113;
RA   Dulhunty A.F., Pouliquin P., Coggan M., Gage P.W., Board P.G.;
RT   "A recently identified member of the glutathione transferase
RT   structural family modifies cardiac RyR2 substate activity, coupled
RT   gating and activation by Ca2+ and ATP.";
RL   Biochem. J. 390:333-343(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   TISSUE SPECIFICITY, VARIANT MRXS32 GLN-101, AND CHARACTERIZATION OF
RP   VARIANT MRXS32 GLN-101.
RX   PubMed=22814392; DOI=10.1093/hmg/dds292;
RA   Takano K., Liu D., Tarpey P., Gallant E., Lam A., Witham S.,
RA   Alexov E., Chaubey A., Stevenson R.E., Schwartz C.E., Board P.G.,
RA   Dulhunty A.F.;
RT   "An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation
RT   enhancing ryanodine receptor channel activity.";
RL   Hum. Mol. Genet. 21:4497-4507(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE,
RP   SUBUNIT, FUNCTION, PH DEPENDENCE, AND DISULFIDE BOND.
RX   PubMed=17945253; DOI=10.1016/j.jmb.2007.09.041;
RA   Cromer B.A., Gorman M.A., Hansen G., Adams J.J., Coggan M.,
RA   Littler D.R., Brown L.J., Mazzanti M., Breit S.N., Curmi P.M.G.,
RA   Dulhunty A.F., Board P.G., Parker M.W.;
RT   "Structure of the Janus protein human CLIC2.";
RL   J. Mol. Biol. 374:719-731(2007).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND DISULFIDE BOND.
RX   PubMed=18186468; DOI=10.1002/prot.21922;
RA   Mi W., Liang Y.-H., Li L., Su X.-D.;
RT   "The crystal structure of human chloride intracellular channel protein
RT   2: a disulfide bond with functional implications.";
RL   Proteins 71:509-513(2008).
CC   -!- FUNCTION: Can insert into membranes and form chloride ion
CC       channels. Channel activity depends on the pH. Membrane insertion
CC       seems to be redox-regulated and may occur only under oxydizing
CC       conditions. Modulates the activity of RYR2 and inhibits calcium
CC       influx. {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:15916532,
CC       ECO:0000269|PubMed:17945253}.
CC   -!- SUBUNIT: Monomer. Interacts with TRAPPC2 and RYR2.
CC       {ECO:0000269|PubMed:12681486, ECO:0000269|PubMed:15147738,
CC       ECO:0000269|PubMed:15916532, ECO:0000269|PubMed:17945253}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15916532}.
CC       Membrane {ECO:0000305|PubMed:15916532}; Single-pass membrane
CC       protein {ECO:0000305|PubMed:15916532}. Note=Exists both as soluble
CC       cytoplasmic protein and as membrane protein with probably a single
CC       transmembrane domain.
CC   -!- TISSUE SPECIFICITY: Expressed in adult and fetal brain, heart,
CC       skeletal muscle, liver, lung, and spleen. Detected in adult
CC       stomach and testis. Expressed in fetal thymus and kidney.
CC       {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:22814392}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion.
CC   -!- DISEASE: Mental retardation, X-linked, syndromic, 32 (MRXS32)
CC       [MIM:300886]: A mental retardation syndrome characterized by
CC       profound intellectual deficit, delayed psychomotor development
CC       beginning in infancy and little or no speech development.
CC       Additional features include seizures, large joint contractures,
CC       and abnormal positioning of the thumbs. Mental retardation is
CC       defined by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period.
CC       {ECO:0000269|PubMed:22814392}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA73228.1; Type=Frameshift; Positions=244; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12696; CAA73228.1; ALT_FRAME; mRNA.
DR   EMBL; AJ000217; CAA03948.1; -; Genomic_DNA.
DR   EMBL; AJ000218; CAA03948.1; JOINED; Genomic_DNA.
DR   EMBL; AJ000219; CAA03948.1; JOINED; Genomic_DNA.
DR   EMBL; AK292785; BAF85474.1; -; mRNA.
DR   EMBL; AL356738; CAI41464.1; -; Genomic_DNA.
DR   EMBL; CH471172; EAW72624.1; -; Genomic_DNA.
DR   EMBL; BC022305; AAH22305.1; -; mRNA.
DR   CCDS; CCDS14767.1; -.
DR   RefSeq; NP_001280.3; NM_001289.5.
DR   UniGene; Hs.655445; -.
DR   PDB; 2PER; X-ray; 2.00 A; A=1-247.
DR   PDB; 2R4V; X-ray; 1.85 A; A=1-247.
DR   PDB; 2R5G; X-ray; 1.86 A; A=1-247.
DR   PDBsum; 2PER; -.
DR   PDBsum; 2R4V; -.
DR   PDBsum; 2R5G; -.
DR   ProteinModelPortal; O15247; -.
DR   SMR; O15247; -.
DR   BioGrid; 107605; 6.
DR   IntAct; O15247; 1.
DR   MINT; MINT-4713986; -.
DR   STRING; 9606.ENSP00000358460; -.
DR   TCDB; 1.A.12.1.5; the intracellular chloride channel (clic) family.
DR   iPTMnet; O15247; -.
DR   PhosphoSitePlus; O15247; -.
DR   EPD; O15247; -.
DR   MaxQB; O15247; -.
DR   PaxDb; O15247; -.
DR   PeptideAtlas; O15247; -.
DR   PRIDE; O15247; -.
DR   DNASU; 1193; -.
DR   Ensembl; ENST00000369449; ENSP00000358460; ENSG00000155962.
DR   GeneID; 1193; -.
DR   KEGG; hsa:1193; -.
DR   UCSC; uc004fnf.5; human.
DR   CTD; 1193; -.
DR   DisGeNET; 1193; -.
DR   EuPathDB; HostDB:ENSG00000155962.12; -.
DR   GeneCards; CLIC2; -.
DR   HGNC; HGNC:2063; CLIC2.
DR   HPA; HPA047381; -.
DR   HPA; HPA060101; -.
DR   MalaCards; CLIC2; -.
DR   MIM; 300138; gene.
DR   MIM; 300886; phenotype.
DR   neXtProt; NX_O15247; -.
DR   OpenTargets; ENSG00000155962; -.
DR   Orphanet; 324410; X-linked intellectual disability - cardiomegaly - congestive heart failure.
DR   PharmGKB; PA26589; -.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000231548; -.
DR   HOVERGEN; HBG050994; -.
DR   InParanoid; O15247; -.
DR   KO; K05022; -.
DR   OMA; SHTCPAD; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; O15247; -.
DR   TreeFam; TF315438; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   EvolutionaryTrace; O15247; -.
DR   GeneWiki; CLIC2; -.
DR   GenomeRNAi; 1193; -.
DR   PRO; PR:O15247; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000155962; -.
DR   CleanEx; HS_CLIC2; -.
DR   ExpressionAtlas; O15247; baseline and differential.
DR   Genevisible; O15247; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0051099; P:positive regulation of binding; IDA:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030253; CLIC-2.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF4; PTHR43920:SF4; 1.
DR   Pfam; PF13409; GST_N_2; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Disease mutation; Disulfide bond; Ion channel;
KW   Ion transport; Membrane; Mental retardation; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    247       Chloride intracellular channel protein 2.
FT                                /FTId=PRO_0000144205.
FT   TRANSMEM     32     52       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN       99    239       GST C-terminal.
FT   REGION        1     96       Required for insertion into the membrane.
FT                                {ECO:0000250}.
FT   REGION        1     94       N-terminal.
FT   REGION       95    106       Joint loop.
FT   REGION      107    247       C-terminal.
FT   REGION      151    171       Foot loop.
FT   DISULFID     30     33       In soluble form.
FT                                {ECO:0000269|PubMed:17945253,
FT                                ECO:0000269|PubMed:18186468}.
FT   VARIANT     101    101       H -> Q (in MRXS32; results in stimulation
FT                                of RYR channels activity with channels
FT                                remaining open for longer times; the
FT                                mutation may impair insertion of the
FT                                protein into the membrane to form a
FT                                functioning ion channel;
FT                                dbSNP:rs398122917).
FT                                {ECO:0000269|PubMed:22814392}.
FT                                /FTId=VAR_068898.
FT   CONFLICT    109    109       S -> C (in Ref. 1; CAA03948).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       E -> G (in Ref. 1; CAA73228).
FT                                {ECO:0000305}.
FT   STRAND       14     20       {ECO:0000244|PDB:2R4V}.
FT   STRAND       24     27       {ECO:0000244|PDB:2R4V}.
FT   HELIX        31     43       {ECO:0000244|PDB:2R4V}.
FT   STRAND       48     52       {ECO:0000244|PDB:2R4V}.
FT   HELIX        57     60       {ECO:0000244|PDB:2R5G}.
FT   STRAND       68     70       {ECO:0000244|PDB:2R4V}.
FT   STRAND       72     75       {ECO:0000244|PDB:2R4V}.
FT   STRAND       78     80       {ECO:0000244|PDB:2R4V}.
FT   HELIX        83     93       {ECO:0000244|PDB:2R4V}.
FT   TURN         96     98       {ECO:0000244|PDB:2R4V}.
FT   HELIX       108    111       {ECO:0000244|PDB:2R4V}.
FT   TURN        112    115       {ECO:0000244|PDB:2R4V}.
FT   HELIX       116    125       {ECO:0000244|PDB:2R4V}.
FT   HELIX       129    131       {ECO:0000244|PDB:2R4V}.
FT   HELIX       132    151       {ECO:0000244|PDB:2R4V}.
FT   TURN        160    162       {ECO:0000244|PDB:2R4V}.
FT   STRAND      163    165       {ECO:0000244|PDB:2R5G}.
FT   STRAND      172    178       {ECO:0000244|PDB:2R4V}.
FT   HELIX       181    201       {ECO:0000244|PDB:2R4V}.
FT   HELIX       210    220       {ECO:0000244|PDB:2R4V}.
FT   HELIX       223    226       {ECO:0000244|PDB:2R4V}.
FT   HELIX       232    239       {ECO:0000244|PDB:2R4V}.
FT   TURN        240    242       {ECO:0000244|PDB:2R4V}.
SQ   SEQUENCE   247 AA;  28356 MW;  9DB896034DD103E8 CRC64;
     MSGLRPGTQV DPEIELFVKA GSDGESIGNC PFCQRLFMIL WLKGVKFNVT TVDMTRKPEE
     LKDLAPGTNP PFLVYNKELK TDFIKIEEFL EQTLAPPRYP HLSPKYKESF DVGCNLFAKF
     SAYIKNTQKE ANKNFEKSLL KEFKRLDDYL NTPLLDEIDP DSAEEPPVSR RLFLDGDQLT
     LADCSLLPKL NIIKVAAKKY RDFDIPAEFS GVWRYLHNAY AREEFTHTCP EDKEIENTYA
     NVAKQKS
//
ID   GBRB_CAEEL              Reviewed;         550 AA.
AC   O18276; Q8ITG2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 3.
DT   22-NOV-2017, entry version 123.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor subunit beta;
DE   Flags: Precursor;
GN   Name=gab-1; ORFNames=ZC482.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=12421359; DOI=10.1046/j.1471-4159.2002.01199.x;
RA   Feng X.-P., Hayashi J., Beech R.N., Prichard R.K.;
RT   "Study of the nematode putative GABA type-A receptor subunits:
RT   evidence for modulation by ivermectin.";
RL   J. Neurochem. 83:870-878(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. {ECO:0000250, ECO:0000269|PubMed:12421359}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF498370; AAN65376.1; -; mRNA.
DR   EMBL; Z93397; CAB07719.3; -; Genomic_DNA.
DR   PIR; T27614; T27614.
DR   RefSeq; NP_499661.2; NM_067260.3.
DR   UniGene; Cel.9592; -.
DR   ProteinModelPortal; O18276; -.
DR   SMR; O18276; -.
DR   STRING; 6239.ZC482.1; -.
DR   PaxDb; O18276; -.
DR   EnsemblMetazoa; ZC482.1; ZC482.1; WBGene00001512.
DR   GeneID; 176691; -.
DR   KEGG; cel:CELE_ZC482.1; -.
DR   UCSC; ZC482.1; c. elegans.
DR   CTD; 176691; -.
DR   WormBase; ZC482.1; CE33742; WBGene00001512; gab-1.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   InParanoid; O18276; -.
DR   KO; K05181; -.
DR   OMA; EIPIDEM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O18276; -.
DR   Reactome; R-CEL-977441; GABA A receptor activation.
DR   PRO; PR:O18276; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00001512; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IC:WormBase.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IDA:WormBase.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:WormBase.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:WormBase.
DR   GO; GO:0006811; P:ion transport; IDA:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    550       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000255714.
FT   TOPO_DOM     25    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical. {ECO:0000255}.
FT   TRANSMEM    292    311       Helical. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TOPO_DOM    345    527       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    528    548       Helical. {ECO:0000255}.
FT   COMPBIAS    355    360       Poly-Gly.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    193    193       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    180    194       {ECO:0000250}.
FT   CONFLICT     16     16       L -> S (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       P -> S (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    267    267       Q -> E (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       V -> D (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
SQ   SEQUENCE   550 AA;  62457 MW;  5DF089E1101438E5 CRC64;
     MRRSKTRRIF HVSITLLLVS TIFCQNGTKP HNNSTSDQMS SSWSNRSQTM YSNASSLLSD
     LLLDYDIRLR PGFGGDALLL TMDIIIASFD SISEVDMDYT LTMYLHQYWT DERLRWSNEI
     PIDEMTLSGE FSQNIWVPDT FLANDKHSYL HEVTERNKML RINVDGKVAY GMRLTSTLSC
     SMNLRNFPLD SQNCTVEIES YGYTTSEVLM KWNYPLAVHG VEQADVPQFT ITGFHTEDSI
     VSTATGSYQR LSLVFQLRRS VGYFIFQTYL PCVLIVMLSW VSFWINHEAT SARVALGITT
     VLTMTTISTG VRQSLPRISY VKSIDIYLVM CFVFVFAALL EYAAVNYSYW GRERGKGGGG
     NEWPVNGANK EDRESAVNVQ KWVPSGLMDG VPQPQDRRVE ALEEAMSTSN TAAQNNNFES
     TSKPKKRSSS PIPPLCRAGN TISEESESPD YPRYSTTSLK GARPHASLNH KTHHLKGRSS
     ARAKRRMTLA RMNVSMKQSI SGIGRRARKV IPTIRVRDVN LIDKYSRVVF PVCFIVFNLF
     YWSYYMMVPS
//
ID   BST26_CAEEL             Reviewed;         411 AA.
AC   O18304;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Bestrophin homolog 26;
GN   Name=best-26; ORFNames=ZK849.5;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z82095; CAB05028.1; -; Genomic_DNA.
DR   PIR; T28038; T28038.
DR   RefSeq; NP_493478.1; NM_061077.3.
DR   UniGene; Cel.16132; -.
DR   ProteinModelPortal; O18304; -.
DR   STRING; 6239.ZK849.5; -.
DR   PaxDb; O18304; -.
DR   EnsemblMetazoa; ZK849.5; ZK849.5; WBGene00014103.
DR   GeneID; 173291; -.
DR   KEGG; cel:CELE_ZK849.5; -.
DR   UCSC; ZK849.5; c. elegans.
DR   CTD; 173291; -.
DR   WormBase; ZK849.5; CE16750; WBGene00014103; best-26.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; O18304; -.
DR   KO; K22204; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; O18304; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:O18304; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00014103; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    411       Bestrophin homolog 26.
FT                                /FTId=PRO_0000143137.
FT   TRANSMEM     30     50       Helical. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TRANSMEM    272    292       Helical. {ECO:0000255}.
SQ   SEQUENCE   411 AA;  48236 MW;  80FA40FEE2F166DB CRC64;
     MTVPYYRDVP TGNALRNFFK IMLKRKGNLF TAIFKELCLF LGLYFLFMVI YRLVLPKSGG
     QREIRKIVEN LLSHQEFTIP LEFLLGFFVS SVVDRWRKSL DSLAYIESCA HAVVIGFPPN
     SNGSDKNLLI RRTIIRYLVV SQILLYREIS LKVRRRFKKL TILGKAKLLN QNEIDKLNKL
     ECKHYDIYFL PISWALSLIE DKIDKENLAN EFTILWGQIK EWQTKLSLLR NCDYIPIPLA
     YPQAVFLAVR CYFAVCVFTR QHLDRYDSKM HTWITFFPVL TTFQYIFMMG WMKVAEILLN
     PMGEDEDDFE LNFIIDNNLK NGLDIVSGLC GNHRKLAEHE IENDCRPYYQ TNEQDRKKNR
     APPESLKNVE FKSFTMEKAS KDSPMVVKSE SVCCLRRRFN SSAKKHHDSK V
//
ID   CLD4_MOUSE              Reviewed;         210 AA.
AC   O35054;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 128.
DE   RecName: Full=Claudin-4 {ECO:0000303|PubMed:20921420};
DE   AltName: Full=Clostridium perfringens enterotoxin receptor {ECO:0000303|PubMed:9334247};
DE            Short=CPE-R {ECO:0000303|PubMed:9334247};
DE            Short=CPE-receptor {ECO:0000303|PubMed:9334247};
GN   Name=Cldn4 {ECO:0000312|MGI:MGI:1313314};
GN   Synonyms=Cper {ECO:0000303|PubMed:9334247},
GN   Cpetr1 {ECO:0000303|PubMed:9334247};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9334247; DOI=10.1074/jbc.272.42.26652;
RA   Katahira J., Sugiyama H., Inoue N., Horiguchi Y., Matsuda M.,
RA   Sugimoto N.;
RT   "Clostridium perfringens enterotoxin utilizes two structurally related
RT   membrane proteins as functional receptors in vivo.";
RL   J. Biol. Chem. 272:26652-26658(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=9892664; DOI=10.1073/pnas.96.2.511;
RA   Morita K., Furuse M., Fujimoto K., Tsukita S.;
RT   "Claudin multigene family encoding four-transmembrane domain protein
RT   components of tight junction strands.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:511-516(1999).
RN   [3]
RP   INTERACTION WITH TJP1; TJP2 AND TJP3.
RX   PubMed=10601346; DOI=10.1083/jcb.147.6.1351;
RA   Itoh M., Furuse M., Morita K., Kubota K., Saitou M., Tsukita S.;
RT   "Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2,
RT   and ZO-3, with the COOH termini of claudins.";
RL   J. Cell Biol. 147:1351-1363(1999).
RN   [4]
RP   INTERACTION WITH TJP1.
RX   PubMed=16236711; DOI=10.1074/jbc.M503786200;
RA   Tanaka M., Kamata R., Sakai R.;
RT   "EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates
RT   paracellular permeability.";
RL   J. Biol. Chem. 280:42375-42382(2005).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH
RP   CLDN8, AND MUTAGENESIS OF ARG-31; GLU-48; LYS-65; ASP-68 AND ASP-76.
RX   PubMed=20921420; DOI=10.1073/pnas.1009399107;
RA   Hou J., Renigunta A., Yang J., Waldegger S.;
RT   "Claudin-4 forms paracellular chloride channel in the kidney and
RT   requires claudin-8 for tight junction localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18010-18015(2010).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25831548; DOI=10.1073/pnas.1421441112;
RA   Gong Y., Wang J., Yang J., Gonzales E., Perez R., Hou J.;
RT   "KLHL3 regulates paracellular chloride transport in the kidney by
RT   ubiquitination of claudin-8.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4340-4345(2015).
CC   -!- FUNCTION: Channel-forming tight junction protein that mediates
CC       paracellular chloride transport in the kidney (PubMed:20921420).
CC       Plays a critical role in the paracellular reabsorption of filtered
CC       chloride in the kidney collecting ducts (PubMed:20921420).
CC       Claudins play a major role in tight junction-specific obliteration
CC       of the intercellular space, through calcium-independent cell-
CC       adhesion activity. {ECO:0000269|PubMed:20921420}.
CC   -!- SUBUNIT: Interacts with EPHA2; phosphorylates CLDN4 and may
CC       regulate tight junctions (By similarity). Directly interacts with
CC       TJP1/ZO-1, TJP2/ZO-2 and TJP3/ZO-3 (PubMed:10601346,
CC       PubMed:16236711). Interacts with CLDN1 (By similarity). Interacts
CC       with CLDN4 (PubMed:20921420). {ECO:0000250|UniProtKB:O14493,
CC       ECO:0000269|PubMed:10601346, ECO:0000269|PubMed:16236711,
CC       ECO:0000269|PubMed:20921420}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000269|PubMed:20921420, ECO:0000269|PubMed:25831548,
CC       ECO:0000269|PubMed:9892664}. Cell membrane
CC       {ECO:0000269|PubMed:20921420, ECO:0000269|PubMed:9892664}; Multi-
CC       pass membrane protein {ECO:0000255}. Note=CLDN4 is required for
CC       tight junction localization in the kidney (PubMed:20921420,
CC       PubMed:25831548). {ECO:0000269|PubMed:20921420,
CC       ECO:0000269|PubMed:25831548}.
CC   -!- TISSUE SPECIFICITY: Expressed primarily in lung and kidney
CC       (PubMed:9892664). Present in both cortical and medullar collecting
CC       ducts (at protein level) (PubMed:20921420).
CC       {ECO:0000269|PubMed:20921420, ECO:0000269|PubMed:9892664}.
CC   -!- PTM: Phosphorylated. Phosphorylation by EPHA2 is stimulated by
CC       EFNA1 and alters interaction with TJP1 (By similarity).
CC       {ECO:0000250|UniProtKB:O14493}.
CC   -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000713; BAA22985.1; -; mRNA.
DR   EMBL; AF087822; AAD09757.1; -; mRNA.
DR   CCDS; CCDS19728.1; -.
DR   RefSeq; NP_034033.1; NM_009903.2.
DR   UniGene; Mm.7339; -.
DR   ProteinModelPortal; O35054; -.
DR   DIP; DIP-40781N; -.
DR   IntAct; O35054; 1.
DR   MINT; MINT-113301; -.
DR   STRING; 10090.ENSMUSP00000053420; -.
DR   iPTMnet; O35054; -.
DR   PhosphoSitePlus; O35054; -.
DR   PaxDb; O35054; -.
DR   PRIDE; O35054; -.
DR   Ensembl; ENSMUST00000051401; ENSMUSP00000053420; ENSMUSG00000047501.
DR   GeneID; 12740; -.
DR   KEGG; mmu:12740; -.
DR   UCSC; uc008zxd.3; mouse.
DR   CTD; 1364; -.
DR   MGI; MGI:1313314; Cldn4.
DR   eggNOG; ENOG410IIJR; Eukaryota.
DR   eggNOG; ENOG410YA61; LUCA.
DR   GeneTree; ENSGT00760000118928; -.
DR   HOGENOM; HOG000220937; -.
DR   HOVERGEN; HBG000643; -.
DR   InParanoid; O35054; -.
DR   KO; K06087; -.
DR   OMA; TAHNVIR; -.
DR   OrthoDB; EOG091G0MMR; -.
DR   PhylomeDB; O35054; -.
DR   TreeFam; TF331936; -.
DR   ChiTaRS; Cldn4; mouse.
DR   PRO; PR:O35054; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000047501; -.
DR   CleanEx; MM_CLDN4; -.
DR   ExpressionAtlas; O35054; baseline and differential.
DR   Genevisible; O35054; MM.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005254; F:chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0061436; P:establishment of skin barrier; ISO:MGI.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0070293; P:renal absorption; IMP:UniProtKB.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   InterPro; IPR006187; Claudin.
DR   InterPro; IPR003550; Claudin4.
DR   InterPro; IPR017974; Claudin_CS.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   PANTHER; PTHR12002; PTHR12002; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01379; CLAUDIN4.
DR   PROSITE; PS01346; CLAUDIN; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Tight junction; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    210       Claudin-4.
FT                                /FTId=PRO_0000144744.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TOPO_DOM     29     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical. {ECO:0000255}.
FT   TOPO_DOM    103    116       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    117    137       Helical. {ECO:0000255}.
FT   TOPO_DOM    138    160       Extracellular. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TOPO_DOM    182    210       Cytoplasmic. {ECO:0000255}.
FT   REGION        1    103       Interaction with EPHA2. {ECO:0000250}.
FT   REGION      209    210       Interactions with TJP1, TJP2 and TJP3.
FT                                {ECO:0000250}.
FT   MOD_RES     209    209       Phosphotyrosine; by EPHA2.
FT                                {ECO:0000250|UniProtKB:O14493}.
FT   MUTAGEN      31     31       R->T: No effect.
FT                                {ECO:0000269|PubMed:20921420}.
FT   MUTAGEN      48     48       E->Q: No effect.
FT                                {ECO:0000269|PubMed:20921420}.
FT   MUTAGEN      65     65       K->T: Abolishes ability to form
FT                                paracellular chloride channel.
FT                                {ECO:0000269|PubMed:20921420}.
FT   MUTAGEN      68     68       D->N: No effect.
FT                                {ECO:0000269|PubMed:20921420}.
FT   MUTAGEN      76     76       D->N: No effect.
FT                                {ECO:0000269|PubMed:20921420}.
SQ   SEQUENCE   210 AA;  22339 MW;  3B6D571EC71D6564 CRC64;
     MASMGLQVLG ISLAVLGWLG IILSCALPMW RVTAFIGSNI VTAQTSWEGL WMNCVVQSTG
     QMQCKMYDSM LALPQDLQAA RALMVISIIV GALGMLLSVV GGKCTNCMED ETVKAKIMIT
     AGAVFIVASM LIMVPVSWTA HNVIRDFYNP MVASGQKREM GASLYVGWAA SGLLLLGGGL
     LCCSCPPRSN DKPYSAKYSA ARSVPASNYV
//
ID   BST12_CAEEL             Reviewed;         434 AA.
AC   O45363;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   20-DEC-2017, entry version 89.
DE   RecName: Full=Bestrophin homolog 12;
GN   Name=best-12; ORFNames=F14H3.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z83105; CAB05483.1; -; Genomic_DNA.
DR   PIR; T20922; T20922.
DR   RefSeq; NP_507036.1; NM_074635.1.
DR   UniGene; Cel.4093; -.
DR   ProteinModelPortal; O45363; -.
DR   SMR; O45363; -.
DR   STRING; 6239.F14H3.2; -.
DR   PaxDb; O45363; -.
DR   EnsemblMetazoa; F14H3.2; F14H3.2; WBGene00008821.
DR   GeneID; 184489; -.
DR   KEGG; cel:CELE_F14H3.2; -.
DR   UCSC; F14H3.2; c. elegans.
DR   CTD; 184489; -.
DR   WormBase; F14H3.2; CE15827; WBGene00008821; best-12.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; O45363; -.
DR   KO; K22204; -.
DR   OMA; RFAINET; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; O45363; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:O45363; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00008821; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    434       Bestrophin homolog 12.
FT                                /FTId=PRO_0000143129.
FT   TRANSMEM     31     51       Helical. {ECO:0000255}.
FT   TRANSMEM     76     96       Helical. {ECO:0000255}.
FT   TRANSMEM    244    264       Helical. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
SQ   SEQUENCE   434 AA;  50338 MW;  ABB144F08C968FF1 CRC64;
     MTIPYLADLK DQTECKTCPK ILTRCKGSLY KVILHEFLMT AGAYFGVFLV FRFAINETQR
     EYAAEVFKKL KEQQNVCIPM QMMLAFFIAT VADQWEKIFE NVGYIENAAL AVATFLPDGK
     EKRDNNGNVI LAKVDNSNVR RNIIRYLVLS QILGIRDVSE LVKKRFANYD MIKATGVLQD
     HEEPLLKKVP CKTYAESFVP ITWIMSILQK FASKNEENLY YDTVYLEITD FYKKIIKLTR
     YDLIPIPLAY PQAVFLAVRI YFFFCLFTRQ HLDLEENWAL SHWGFPLLTT LQFIFLVGCM
     KVAEILLNPM GQDDENFECN YVMDKNLFVG LTIVSSEHTE CPELEEVIGD DYVPWYPDDC
     KSKEEKNQEE LKKYLESVDF QAVTSSDQGE NDEVSTMMKV EQNSLLVCGR EKFYEGGGFR
     NSDVYPKQRA NYPH
//
ID   BST13_CAEEL             Reviewed;         413 AA.
AC   O45435;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   20-DEC-2017, entry version 96.
DE   RecName: Full=Bestrophin homolog 13;
GN   Name=best-13; ORFNames=F32B6.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z81074; CAB03043.1; -; Genomic_DNA.
DR   PIR; T21644; T21644.
DR   RefSeq; NP_501784.1; NM_069383.1.
DR   UniGene; Cel.13036; -.
DR   ProteinModelPortal; O45435; -.
DR   SMR; O45435; -.
DR   STRING; 6239.F32B6.9; -.
DR   iPTMnet; O45435; -.
DR   EPD; O45435; -.
DR   PaxDb; O45435; -.
DR   PeptideAtlas; O45435; -.
DR   EnsemblMetazoa; F32B6.9; F32B6.9; WBGene00009323.
DR   GeneID; 185198; -.
DR   KEGG; cel:CELE_F32B6.9; -.
DR   UCSC; F32B6.9; c. elegans.
DR   CTD; 185198; -.
DR   WormBase; F32B6.9; CE09864; WBGene00009323; best-13.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; O45435; -.
DR   KO; K22204; -.
DR   OMA; SIWRTVW; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; O45435; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:O45435; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00009323; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    413       Bestrophin homolog 13.
FT                                /FTId=PRO_0000143130.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TRANSMEM    272    292       Helical. {ECO:0000255}.
SQ   SEQUENCE   413 AA;  48965 MW;  A66E69A83C78790B CRC64;
     MTISYSGNVI RILLRWKGSI WRTAWKELLI YLILYYSVRV FYLKGIDLID DDEDDRLKMR
     RMFETFCRQC DSYTRLIPLT FLLGFYVSNV VARWWRQFET LYWPEDILSV LCTVLHQHDE
     KSKRRRHTIA RYLNLANALA WRDISSKIRL RFPSVHSLIE SGLLTEKEYQ ILEAMHAENE
     SSRWITPLHW IQLIMRQVEE EHKPTASLFN QFVGELRIFR QSLRKLYSYD WVCVPLVYTQ
     VAALATYSFF FFTLFGRQPL FPDIETGKEL DLVVPVFTIV QFLFFVGWFK VGQDLMRPFG
     LDDDDIELNY ILDRNVRISF AIVNQLQESP IPDFESNDDK LWHEMHPPTK DGETSPIPRI
     PQLPHSKYSK QLSEHPPRLH AYVPIDDGKG SIKDLESHHG CVSLKKDKKH ISW
//
ID   GLRA3_HUMAN             Reviewed;         464 AA.
AC   O75311; D3DP44; O75816; Q5D0E3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 172.
DE   RecName: Full=Glycine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=GLRA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS ALPHA-3K AND
RP   ALPHA-3L), FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9677400; DOI=10.1074/jbc.273.31.19708;
RA   Nikolic Z., Laube B., Weber R.G., Lichter P., Kioschis P., Poustka A.,
RA   Muelhardt C., Becker C.-M.;
RT   "The human glycine receptor subunit alpha3. GLRA3 gene structure,
RT   chromosomal localization, and functional characterization of
RT   alternative transcripts.";
RL   J. Biol. Chem. 273:19708-19714(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-3L).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000244|PDB:5CFB}
RP   X-RAY CRYSTALLOGRAPHY (3.04 ANGSTROMS) OF 34-342 AND 419-460 IN
RP   COMPLEX WITH STRYCHNINE, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, DISULFIDE BONDS, GLYCOSYLATION AT ASN-71, AND DOMAIN.
RX   PubMed=26416729; DOI=10.1038/nature14972;
RA   Huang X., Chen H., Michelsen K., Schneider S., Shaffer P.L.;
RT   "Crystal structure of human glycine receptor-alpha3 bound to
RT   antagonist strychnine.";
RL   Nature 526:277-280(2015).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine
CC       (PubMed:9677400, PubMed:26416729). Channel characteristics depend
CC       on the subunit composition; heteropentameric channels display
CC       faster channel closure (By similarity). Plays an important role in
CC       the down-regulation of neuronal excitability (By similarity).
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (By similarity). Contributes to increased pain perception in
CC       response to increased prostaglandin E2 levels (By similarity).
CC       Plays a role in cellular responses to ethanol (By similarity).
CC       {ECO:0000250|UniProtKB:P24524, ECO:0000250|UniProtKB:Q91XP5,
CC       ECO:0000269|PubMed:26416729, ECO:0000269|PubMed:9677400}.
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:26416729). Heteropentamer
CC       composed of GLRA3 and GLRB. Both homopentamers and heteropentamers
CC       form functional ion channels, but their characteristics are subtly
CC       different (By similarity). {ECO:0000250|UniProtKB:P24524,
CC       ECO:0000269|PubMed:26416729}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:P24524}; Multi-pass membrane
CC       protein {ECO:0000305}. Perikaryon {ECO:0000250|UniProtKB:P24524}.
CC       Cell projection, dendrite {ECO:0000250|UniProtKB:P24524}. Cell
CC       junction, synapse {ECO:0000250|UniProtKB:P24524}. Cell membrane
CC       {ECO:0000269|PubMed:26416729, ECO:0000269|PubMed:9677400}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:26416729}.
CC       Note=Partially colocalizes with GPHN that is known to mediate
CC       receptor clustering at postsynaptic membranes.
CC       {ECO:0000250|UniProtKB:P24524}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-3L;
CC         IsoId=O75311-1; Sequence=Displayed;
CC       Name=Alpha-3K;
CC         IsoId=O75311-2; Sequence=VSP_000084;
CC   -!- TISSUE SPECIFICITY: Widely distributed throughout the central
CC       nervous system. {ECO:0000269|PubMed:9677400}.
CC   -!- DOMAIN: The N-terminal domain carries structural determinants
CC       essential for agonist and antagonist binding. The channel pore is
CC       formed by pentameric assembly of the second transmembrane domain
CC       from all five subunits (PubMed:26416729). The cytoplasmic loop is
CC       an important determinant of channel inactivation kinetics.
CC       {ECO:0000269|PubMed:26416729, ECO:0000305}.
CC   -!- PTM: Phosphorylated by PKA; this causes down-regulation of channel
CC       activity. {ECO:0000250|UniProtKB:P24524}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:26416729}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA3 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF017724; AAC39919.1; -; Genomic_DNA.
DR   EMBL; AF017715; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017716; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017717; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017718; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017719; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017720; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017721; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017722; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017723; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; U93917; AAC39917.1; -; mRNA.
DR   EMBL; CH471056; EAX04730.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04732.1; -; Genomic_DNA.
DR   EMBL; BC036086; AAH36086.1; -; mRNA.
DR   CCDS; CCDS3822.1; -. [O75311-1]
DR   CCDS; CCDS43283.1; -. [O75311-2]
DR   RefSeq; NP_001036008.1; NM_001042543.2. [O75311-2]
DR   RefSeq; NP_006520.2; NM_006529.3. [O75311-1]
DR   UniGene; Hs.413099; -.
DR   PDB; 5CFB; X-ray; 3.04 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5TIN; X-ray; 2.61 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5TIO; X-ray; 3.25 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5VDH; X-ray; 2.85 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5VDI; X-ray; 3.10 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDBsum; 5CFB; -.
DR   PDBsum; 5TIN; -.
DR   PDBsum; 5TIO; -.
DR   PDBsum; 5VDH; -.
DR   PDBsum; 5VDI; -.
DR   ProteinModelPortal; O75311; -.
DR   SMR; O75311; -.
DR   BioGrid; 113705; 1.
DR   DIP; DIP-61773N; -.
DR   STRING; 9606.ENSP00000274093; -.
DR   BindingDB; O75311; -.
DR   ChEMBL; CHEMBL1075092; -.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00431; Lindane.
DR   DrugBank; DB00466; Picrotoxin.
DR   GuidetoPHARMACOLOGY; 425; -.
DR   TCDB; 1.A.9.3.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; O75311; -.
DR   PhosphoSitePlus; O75311; -.
DR   PaxDb; O75311; -.
DR   PRIDE; O75311; -.
DR   DNASU; 8001; -.
DR   Ensembl; ENST00000274093; ENSP00000274093; ENSG00000145451. [O75311-1]
DR   Ensembl; ENST00000340217; ENSP00000345284; ENSG00000145451. [O75311-2]
DR   GeneID; 8001; -.
DR   KEGG; hsa:8001; -.
DR   UCSC; uc003ity.3; human. [O75311-1]
DR   CTD; 8001; -.
DR   DisGeNET; 8001; -.
DR   EuPathDB; HostDB:ENSG00000145451.12; -.
DR   GeneCards; GLRA3; -.
DR   HGNC; HGNC:4328; GLRA3.
DR   MIM; 600421; gene.
DR   neXtProt; NX_O75311; -.
DR   OpenTargets; ENSG00000145451; -.
DR   PharmGKB; PA28729; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O75311; -.
DR   KO; K05195; -.
DR   OMA; MPMSPSD; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O75311; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; GLRA3; -.
DR   GenomeRNAi; 8001; -.
DR   PRO; PR:O75311; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145451; -.
DR   CleanEx; HS_GLRA3; -.
DR   Genevisible; O75311; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016935; C:glycine-gated chloride channel complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IEA:InterPro.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IBA:GO_Central.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008130; Glycine_rcpt_A3.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01676; GLYRALPHA3.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34    464       Glycine receptor subunit alpha-3.
FT                                /FTId=PRO_0000000419.
FT   TOPO_DOM     34    255       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    256    277       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    278    282       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    283    303       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    304    314       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    315    335       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    336    430       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    431    451       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    452    464       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   REGION      235    240       Strychnine-binding.
FT                                {ECO:0000269|PubMed:26416729}.
FT   METAL       225    225       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       227    227       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       248    248       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   SITE        294    294       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:26416729}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91XP5}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91XP5}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5CFB, ECO:0000255,
FT                                ECO:0000269|PubMed:26416729}.
FT   DISULFID    171    185       {ECO:0000244|PDB:5CFB,
FT                                ECO:0000269|PubMed:26416729}.
FT   DISULFID    231    242       {ECO:0000244|PDB:5CFB,
FT                                ECO:0000269|PubMed:26416729}.
FT   VAR_SEQ     358    372       Missing (in isoform Alpha-3K).
FT                                {ECO:0000303|PubMed:9677400}.
FT                                /FTId=VSP_000084.
FT   CONFLICT    460    460       H -> HH (in Ref. 1; AAC39919).
FT                                {ECO:0000305}.
FT   HELIX        43     51       {ECO:0000244|PDB:5TIN}.
FT   TURN         53     55       {ECO:0000244|PDB:5TIN}.
FT   TURN         63     66       {ECO:0000244|PDB:5TIN}.
FT   STRAND       70     85       {ECO:0000244|PDB:5TIN}.
FT   TURN         86     89       {ECO:0000244|PDB:5TIN}.
FT   STRAND       90    102       {ECO:0000244|PDB:5TIN}.
FT   HELIX       104    106       {ECO:0000244|PDB:5TIN}.
FT   STRAND      114    118       {ECO:0000244|PDB:5TIN}.
FT   HELIX       120    125       {ECO:0000244|PDB:5TIN}.
FT   STRAND      131    133       {ECO:0000244|PDB:5TIN}.
FT   STRAND      136    141       {ECO:0000244|PDB:5TIN}.
FT   STRAND      144    146       {ECO:0000244|PDB:5TIN}.
FT   STRAND      149    154       {ECO:0000244|PDB:5TIN}.
FT   STRAND      157    170       {ECO:0000244|PDB:5TIN}.
FT   TURN        176    179       {ECO:0000244|PDB:5TIN}.
FT   STRAND      182    193       {ECO:0000244|PDB:5TIN}.
FT   TURN        196    198       {ECO:0000244|PDB:5TIN}.
FT   STRAND      199    203       {ECO:0000244|PDB:5TIN}.
FT   STRAND      208    211       {ECO:0000244|PDB:5TIN}.
FT   STRAND      218    222       {ECO:0000244|PDB:5TIN}.
FT   STRAND      227    230       {ECO:0000244|PDB:5TIN}.
FT   STRAND      233    235       {ECO:0000244|PDB:5TIN}.
FT   STRAND      238    240       {ECO:0000244|PDB:5TIN}.
FT   STRAND      242    251       {ECO:0000244|PDB:5TIN}.
FT   HELIX       254    259       {ECO:0000244|PDB:5TIN}.
FT   HELIX       261    273       {ECO:0000244|PDB:5TIN}.
FT   HELIX       274    276       {ECO:0000244|PDB:5TIN}.
FT   HELIX       282    302       {ECO:0000244|PDB:5TIN}.
FT   TURN        303    306       {ECO:0000244|PDB:5TIN}.
FT   HELIX       315    340       {ECO:0000244|PDB:5TIN}.
FT   HELIX       419    450       {ECO:0000244|PDB:5TIN}.
SQ   SEQUENCE   464 AA;  53800 MW;  8E17A30B3C6E648D CRC64;
     MAHVRHFRTL VSGFYFWEAA LLLSLVATKE TDSARSRSAP MSPSDFLDKL MGRTSGYDAR
     IRPNFKGPPV NVTCNIFINS FGSIAETTMD YRVNIFLRQK WNDPRLAYSE YPDDSLDLDP
     SMLDSIWKPD LFFANEKGAN FHEVTTDNKL LRIFKNGNVL YSIRLTLTLS CPMDLKNFPM
     DVQTCIMQLE SFGYTMNDLI FEWQDEAPVQ VAEGLTLPQF LLKEEKDLRY CTKHYNTGKF
     TCIEVRFHLE RQMGYYLIQM YIPSLLIVIL SWVSFWINMD AAPARVALGI TTVLTMTTQS
     SGSRASLPKV SYVKAIDIWM AVCLLFVFSA LLEYAAVNFV SRQHKELLRF RRKRKNKTEA
     FALEKFYRFS DMDDEVRESR FSFTAYGMGP CLQAKDGMTP KGPNHPVQVM PKSPDEMRKV
     FIDRAKKIDT ISRACFPLAF LIFNIFYWVI YKILRHEDIH QQQD
//
ID   BEST1_HUMAN             Reviewed;         585 AA.
AC   O76090; A8K0W6; B7Z3J8; B7Z736; O75904; Q53YQ9; Q8IUR9; Q8IZ80;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Bestrophin-1;
DE   AltName: Full=TU15B;
DE   AltName: Full=Vitelliform macular dystrophy protein 2;
GN   Name=BEST1; Synonyms=VMD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VMD2.
RX   PubMed=9700209; DOI=10.1093/hmg/7.9.1517;
RA   Marquardt A., Stoehr H., Passmore L.A., Kraemer F., Rivera A.,
RA   Weber B.H.F.;
RT   "Mutations in a novel gene, VMD2, encoding a protein of unknown
RT   properties cause juvenile-onset vitelliform macular dystrophy (Best's
RT   disease).";
RL   Hum. Mol. Genet. 7:1517-1525(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VMD2 PRO-6;
RP   HIS-85; CYS-93; ASN-227 AND GLU-299.
RX   PubMed=9662395; DOI=10.1038/915;
RA   Petrukhin K., Koisti M.J., Bakall B., Li W., Xie G., Marknell T.,
RA   Sandgren O., Forsman K., Holmgren G., Andreasson S., Vujic M.,
RA   Bergen A.A.B., McGarty-Dugan V., Figueroa D., Austin C.P.,
RA   Metzker M.L., Caskey C.T., Wadelius C.;
RT   "Identification of the gene responsible for Best macular dystrophy.";
RL   Nat. Genet. 19:241-247(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TOPOLOGY.
RX   PubMed=12907679; DOI=10.1074/jbc.M306150200;
RA   Tsunenari T., Sun H., Williams J., Cahill H., Smallwood P., Yau K.-W.,
RA   Nathans J.;
RT   "Structure-function analysis of the bestrophin family of anion
RT   channels.";
RL   J. Biol. Chem. 278:41114-41125(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND VARIANT
RP   VAL-357.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 52-585 (ISOFORM 1).
RC   TISSUE=Amygdala, Subthalamic nucleus, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=11904445; DOI=10.1073/pnas.052692999;
RA   Sun H., Tsunenari T., Yau K.-W., Nathans J.;
RT   "The vitelliform macular dystrophy protein defines a new family of
RT   chloride channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:4008-4013(2002).
RN   [8]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANTS VMD2 HIS-85; CYS-92 AND
RP   CYS-93.
RX   PubMed=18400985; DOI=10.1152/ajpcell.00398.2007;
RA   Qu Z., Hartzell H.C.;
RT   "Bestrophin Cl- channels are highly permeable to HCO3-.";
RL   Am. J. Physiol. 294:C1371-C1377(2008).
RN   [9]
RP   SUBCELLULAR LOCATION, VARIANTS RP50 VAL-140; THR-205; CYS-227 AND
RP   ASN-228, CHARACTERIZATION OF VARIANTS RP50 VAL-140; THR-205 AND
RP   ASN-228, AND CHARACTERIZATION OF VARIANT ARB ASN-312.
RX   PubMed=19853238; DOI=10.1016/j.ajhg.2009.09.015;
RA   Davidson A.E., Millar I.D., Urquhart J.E., Burgess-Mullan R.,
RA   Shweikh Y., Parry N., O'Sullivan J., Maher G.J., McKibbin M.,
RA   Downes S.M., Lotery A.J., Jacobson S.G., Brown P.D., Black G.C.,
RA   Manson F.D.;
RT   "Missense mutations in a retinal pigment epithelium protein,
RT   bestrophin-1, cause retinitis pigmentosa.";
RL   Am. J. Hum. Genet. 85:581-592(2009).
RN   [10]
RP   VARIANTS VMD2 HIS-13; CYS-93; CYS-218; ASP-300; GLU-301 AND ILE-307.
RX   PubMed=10331951; DOI=10.1006/geno.1999.5808;
RA   Caldwell G.M., Kakuk L.E., Griesinger I.B., Simpson S.A., Nowak N.J.,
RA   Small K.W., Maumenee I.H., Rosenfeld P.J., Sieving P.A., Shows T.B.,
RA   Ayyagari R.;
RT   "Bestrophin gene mutations in patients with Best vitelliform macular
RT   dystrophy.";
RL   Genomics 58:98-101(1999).
RN   [11]
RP   VARIANTS VMD2 VAL-10; VAL-82; CYS-92; HIS-96; SER-135; CYS-218;
RP   SER-218 AND LYS-293.
RX   PubMed=10394929; DOI=10.1007/s004390050972;
RA   Bakall B., Marknell T., Ingvast S., Koisti M.J., Sandgren O., Li W.,
RA   Bergen A.A.B., Andreasson S., Rosenberg T., Petrukhin K., Wadelius C.;
RT   "The mutation spectrum of the bestrophin protein -- functional
RT   implications.";
RL   Hum. Genet. 104:383-389(1999).
RN   [12]
RP   VARIANTS VMD2 LYS-146; SER-297 AND ASP-300, AND VARIANTS GLN-119;
RP   ILE-216; ALA-525; LYS-557; ALA-561 AND PHE-567.
RX   PubMed=10453731; DOI=10.1007/s004390050986;
RA   Allikmets R., Seddon J.M., Bernstein P.S., Hutchinson A., Atkinson A.,
RA   Sharma S., Gerrard B., Li W., Metzker M.L., Wadelius C., Caskey C.T.,
RA   Dean M., Petrukhin K.;
RT   "Evaluation of the Best disease gene in patients with age-related
RT   macular degeneration and other maculopathies.";
RL   Hum. Genet. 104:449-453(1999).
RN   [13]
RP   VARIANT VMD2 TRP-221.
RX   PubMed=10682987; DOI=10.1016/S0002-9394(99)00327-X;
RA   Palomba G., Rozzo C., Angius A., Pierrottet C.O., Orzalesi N.,
RA   Pirastu M.;
RT   "A novel spontaneous missense mutation in VMD2 gene is a cause of a
RT   Best macular dystrophy sporadic case.";
RL   Am. J. Ophthalmol. 129:260-262(2000).
RN   [14]
RP   VARIANT VAL-222.
RX   PubMed=10766140; DOI=10.1001/archopht.118.4.538;
RA   Lotery A.J., Namperumalsamy P., Jacobson S.G., Weleber R.G.,
RA   Fishman G.A., Musarella M.A., Hoyt C.S., Heon E., Levin A., Jan J.,
RA   Lam B., Carr R.E., Franklin A., Radha S., Andorf J.L., Sheffield V.C.,
RA   Stone E.M.;
RT   "Mutation analysis of 3 genes in patients with Leber congenital
RT   amaurosis.";
RL   Arch. Ophthalmol. 118:538-543(2000).
RN   [15]
RP   VARIANTS AGE-RELATED MACULAR DEGENERATION CYS-105 AND ILE-275, AND
RP   VARIANTS VMD2 THR-201; ILE-207; PRO-224; THR-243; LEU-276; HIS-296;
RP   GLY-302; VAL-302; ASP-306; GLY-306 AND ALA-307.
RX   PubMed=10798642;
RA   Lotery A.J., Munier F.L., Fishman G.A., Weleber R.G., Jacobson S.G.,
RA   Affatigato L.M., Nichols B.E., Schorderet D.F., Sheffield V.C.,
RA   Stone E.M.;
RT   "Allelic variation in the VMD2 gene in best disease and age-related
RT   macular degeneration.";
RL   Invest. Ophthalmol. Vis. Sci. 41:1291-1296(2000).
RN   [16]
RP   VARIANTS VMD2 PHE-16; CYS-17; ASN-73; HIS-92; CYS-218; HIS-218;
RP   LEU-235 AND SER-296.
RX   PubMed=11241846; DOI=10.1002/humu.9;
RA   Marchant D., Gogat K., Boutboul S., Pequignot M., Sternberg C.,
RA   Dureau P., Roche O., Uteza Y., Hache J.C., Puech B., Puech V.,
RA   Dumur V., Mouillon M., Munier F.L., Schorderet D.F., Marsac C.,
RA   Dufier J.-L., Abitbol M.;
RT   "Identification of novel VMD2 gene mutations in patients with Best
RT   vitelliform macular dystrophy.";
RL   Hum. Mutat. 17:235-235(2001).
RN   [17]
RP   VARIANT VMD2 ALA-89.
RX   PubMed=11449320; DOI=10.1076/opge.22.2.107.2226;
RA   Eksandh L., Bakall B., Bauer B., Wadelius C., Andreasson S.;
RT   "Best's vitelliform macular dystrophy caused by a new mutation
RT   (Val89Ala) in the VMD2 gene.";
RL   Ophthalmic Genet. 22:107-115(2001).
RN   [18]
RP   VARIANT VMD2 THR-295.
RX   PubMed=12187431; DOI=10.1076/opge.23.2.129.2213;
RA   Yanagi Y., Sekine H., Mori M.;
RT   "Identification of a novel VMD2 mutation in Japanese patients with
RT   Best disease.";
RL   Ophthalmic Genet. 23:129-133(2002).
RN   [19]
RP   VARIANTS VMD2 HIS-302; GLU-303 AND SER-308.
RX   PubMed=12324875; DOI=10.1076/opge.23.3.167.7880;
RA   Marchant D., Gogat K., Dureau P., Sainton K., Sternberg C., Gadin S.,
RA   Dollfus H., Brasseur G., Hache J.C., Dumur V., Puech V., Munier F.L.,
RA   Schorderet D.F., Marsac C., Menasche M., Dufier J.-L., Abitbol M.;
RT   "Use of denaturing HPLC and automated sequencing to screen the VMD2
RT   gene for mutations associated with Best's vitelliform macular
RT   dystrophy.";
RL   Ophthalmic Genet. 23:167-174(2002).
RN   [20]
RP   VARIANTS VMD2 ILE-11; ARG-26; HIS-29; PRO-41; ARG-102; HIS-104;
RP   ASN-241; VAL-294 AND SER-298.
RX   PubMed=14517959; DOI=10.1002/humu.9189;
RA   Kraemer F., Mohr N., Kellner U., Rudolph G., Weber B.H.F.;
RT   "Ten novel mutations in VMD2 associated with Best macular dystrophy
RT   (BMD).";
RL   Hum. Mutat. 22:418-418(2003).
RN   [21]
RP   VARIANTS VMD2 SER-297 AND ASP-300.
RX   PubMed=13129869; DOI=10.1016/S0161-6420(03)00575-X;
RA   Seddon J.M., Sharma S., Chong S., Hutchinson A., Allikmets R.,
RA   Adelman R.A.;
RT   "Phenotype and genotype correlations in two best families.";
RL   Ophthalmology 110:1724-1731(2003).
RN   [22]
RP   VARIANT VMD2 LEU-113.
RX   PubMed=15176385;
RA   Li Y., Wang G.L., Dong B.;
RT   "Gene Symbol: VMD2. Disease: Best vitelliform macular dystrophy
RT   (VMD2).";
RL   Hum. Genet. 114:608-608(2004).
RN   [23]
RP   VARIANTS ADVIRC MET-86; CYS-236 AND MET-239.
RX   PubMed=15452077; DOI=10.1167/iovs.04-0550;
RA   Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B.,
RA   Messiaen L.M., Perveen R., Reddy M.A., Bhattacharya S.S.,
RA   Traboulsi E., Baralle D., De Laey J.-J., Puech B., Kestelyn P.,
RA   Moore A.T., Manson F.D.C., Black G.C.M.;
RT   "Mutations of VMD2 splicing regulators cause nanophthalmos and
RT   autosomal dominant vitreoretinochoroidopathy (ADVIRC).";
RL   Invest. Ophthalmol. Vis. Sci. 45:3683-3689(2004).
RN   [24]
RP   VARIANTS ARB PRO-41; HIS-141; ALA-152; ASN-312; MET-317 AND THR-325,
RP   AND CHARACTERIZATION OF VARIANTS ARB HIS-141 AND ALA-152.
RX   PubMed=18179881; DOI=10.1016/j.ajhg.2007.08.004;
RA   Burgess R., Millar I.D., Leroy B.P., Urquhart J.E., Fearon I.M.,
RA   De Baere E., Brown P.D., Robson A.G., Wright G.A., Kestelyn P.,
RA   Holder G.E., Webster A.R., Manson F.D.C., Black G.C.M.;
RT   "Biallelic mutation of BEST1 causes a distinct retinopathy in
RT   humans.";
RL   Am. J. Hum. Genet. 82:19-31(2008).
RN   [25]
RP   VARIANTS VMD2 CYS-218 AND MET-242.
RX   PubMed=18766995; DOI=10.1080/13816810802087394;
RA   Atchaneeyasakul L.O., Jinda W., Sakolsatayadorn N., Trinavarat A.,
RA   Ruangvoravate N., Thanasombatskul N., Thongnoppakhun W., Limwongse C.;
RT   "Mutation analysis of the VMD2 gene in Thai families with Best macular
RT   dystrophy.";
RL   Ophthalmic Genet. 29:139-144(2008).
RN   [26]
RP   VARIANTS VMD2 THR-3; PRO-6; VAL-82; ASN-227; VAL-243; ALA-299 AND
RP   302-ASP--ASP-304 DEL.
RX   PubMed=19357557; DOI=10.1097/IAE.0b013e31819d4fda;
RA   Boon C.J.F., Theelen T., Hoefsloot E.H., van Schooneveld M.J.,
RA   Keunen J.E.E., Cremers F.P.M., Klevering B.J., Hoyng C.B.;
RT   "Clinical and molecular genetic analysis of Best vitelliform macular
RT   dystrophy.";
RL   Retina 29:835-847(2009).
RN   [27]
RP   CHARACTERIZATION OF VARIANTS ARB PRO-41; VAL-140; HIS-141; ALA-152;
RP   VAL-195; TRP-202; ASN-312; MET-317 AND THR-325, AND CHARACTERIZATION
RP   OF VARIANTS VMD2 HIS-85 AND ARG-237.
RX   PubMed=21330666; DOI=10.1167/iovs.10-6707;
RA   Davidson A.E., Millar I.D., Burgess-Mullan R., Maher G.J.,
RA   Urquhart J.E., Brown P.D., Black G.C., Manson F.D.;
RT   "Functional characterization of bestrophin-1 missense mutations
RT   associated with autosomal recessive bestrophinopathy.";
RL   Invest. Ophthalmol. Vis. Sci. 52:3730-3736(2011).
RN   [28]
RP   VARIANT ARB HIS-141, CHARACTERIZATION OF VARIANT ARB HIS-141,
RP   SUBCELLULAR LOCATION, AND OLIGOMERIZATION.
RX   PubMed=26200502; DOI=10.1167/iovs.15-16910;
RA   Johnson A.A., Bachman L.A., Gilles B.J., Cross S.D., Stelzig K.E.,
RA   Resch Z.T., Marmorstein L.Y., Pulido J.S., Marmorstein A.D.;
RT   "Autosomal recessive bestrophinopathy is not associated with the loss
RT   of bestrophin-1 anion channel function in a patient with a novel BEST1
RT   mutation.";
RL   Invest. Ophthalmol. Vis. Sci. 56:4619-4630(2015).
RN   [29]
RP   VARIANTS ARB PRO-40 AND VAL-195, AND CHARACTERIZATION OF VARIANTS ARB
RP   PRO-40; CYS-93 AND VAL-195.
RX   PubMed=26720466; DOI=10.1167/iovs.15-18168;
RA   Lee C.S., Jun I., Choi S.I., Lee J.H., Lee M.G., Lee S.C., Kim E.K.;
RT   "A novel BEST1 mutation in autosomal recessive bestrophinopathy.";
RL   Invest. Ophthalmol. Vis. Sci. 56:8141-8150(2015).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Highly
CC       permeable to bicarbonate. {ECO:0000269|PubMed:11904445,
CC       ECO:0000269|PubMed:12907679, ECO:0000269|PubMed:18400985}.
CC   -!- SUBUNIT: Homooligomer (tetramer or pentamer) (PubMed:26200502).
CC       May interact with PPP2CB and PPP2R1B (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:26200502}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-11693370, EBI-11693370;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19853238,
CC       ECO:0000269|PubMed:26200502}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19853238}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:19853238, ECO:0000269|PubMed:26200502}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O76090-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=O76090-3; Sequence=VSP_008973, VSP_008974;
CC       Name=4;
CC         IsoId=O76090-4; Sequence=VSP_008973, VSP_008975;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the basolateral
CC       membrane of the retinal pigment epithelium.
CC   -!- PTM: Phosphorylated by PP2A. {ECO:0000250}.
CC   -!- DISEASE: Macular dystrophy, vitelliform, 2 (VMD2) [MIM:153700]: An
CC       autosomal dominant form of macular degeneration that usually
CC       begins in childhood or adolescence. VMD2 is characterized by
CC       typical 'egg-yolk' macular lesions due to abnormal accumulation of
CC       lipofuscin within and beneath the retinal pigment epithelium
CC       cells. Progression of the disease leads to destruction of the
CC       retinal pigment epithelium and vision loss.
CC       {ECO:0000269|PubMed:10331951, ECO:0000269|PubMed:10394929,
CC       ECO:0000269|PubMed:10453731, ECO:0000269|PubMed:10682987,
CC       ECO:0000269|PubMed:10798642, ECO:0000269|PubMed:11241846,
CC       ECO:0000269|PubMed:11449320, ECO:0000269|PubMed:12187431,
CC       ECO:0000269|PubMed:12324875, ECO:0000269|PubMed:13129869,
CC       ECO:0000269|PubMed:14517959, ECO:0000269|PubMed:15176385,
CC       ECO:0000269|PubMed:18400985, ECO:0000269|PubMed:18766995,
CC       ECO:0000269|PubMed:19357557, ECO:0000269|PubMed:21330666,
CC       ECO:0000269|PubMed:9662395, ECO:0000269|PubMed:9700209}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Retinitis pigmentosa 50 (RP50) [MIM:613194]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:19853238}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bestrophinopathy, autosomal recessive (ARB) [MIM:611809]:
CC       A retinopathy characterized by loss of central vision, an absent
CC       electro-oculogram light rise, and electroretinogram anomalies.
CC       {ECO:0000269|PubMed:18179881, ECO:0000269|PubMed:19853238,
CC       ECO:0000269|PubMed:21330666, ECO:0000269|PubMed:26200502,
CC       ECO:0000269|PubMed:26720466}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Vitreoretinochoroidopathy, autosomal dominant (ADVIRC)
CC       [MIM:193220]: A disorder characterized by vitreoretinochoroidal
CC       dystrophy. The clinical presentation is variable. VRCP may be
CC       associated with cataract, nanophthalmos, microcornea, shallow
CC       anterior chamber, and glaucoma. {ECO:0000269|PubMed:15452077}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAH12234.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAH13472.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=VMD2 mutation database;
CC       URL="http://www-huge.uni-regensburg.de/VMD2_database/index.php?select_db=VMD2";
CC   -!- WEB RESOURCE: Name=Mutations of the BEST1 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/mutations-best1-gene";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF073500; AAC64926.1; -; Genomic_DNA.
DR   EMBL; AF073491; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073492; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073493; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073494; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073495; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073496; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073497; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073498; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF073499; AAC64926.1; JOINED; Genomic_DNA.
DR   EMBL; AF057169; AAC64343.1; -; mRNA.
DR   EMBL; AF057170; AAC64344.1; -; mRNA.
DR   EMBL; AF073501; AAC33766.1; -; mRNA.
DR   EMBL; AY515704; AAR99654.1; -; mRNA.
DR   EMBL; CH471076; EAW73982.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW73985.1; -; Genomic_DNA.
DR   EMBL; BC015220; AAH15220.1; -; mRNA.
DR   EMBL; BC041664; AAH41664.1; -; mRNA.
DR   EMBL; AK289681; BAF82370.1; -; mRNA.
DR   EMBL; AK295998; BAH12234.1; ALT_INIT; mRNA.
DR   EMBL; AK301392; BAH13472.1; ALT_INIT; mRNA.
DR   CCDS; CCDS31580.1; -. [O76090-1]
DR   CCDS; CCDS44623.1; -. [O76090-3]
DR   RefSeq; NP_001132915.1; NM_001139443.1. [O76090-3]
DR   RefSeq; NP_001287715.1; NM_001300786.1. [O76090-4]
DR   RefSeq; NP_001287716.1; NM_001300787.1.
DR   RefSeq; NP_004174.1; NM_004183.3. [O76090-1]
DR   RefSeq; XP_005274272.1; XM_005274215.3.
DR   RefSeq; XP_016873718.1; XM_017018229.1.
DR   UniGene; Hs.524910; -.
DR   UniGene; Hs.712676; -.
DR   ProteinModelPortal; O76090; -.
DR   SMR; O76090; -.
DR   BioGrid; 113279; 1.
DR   MINT; MINT-239943; -.
DR   STRING; 9606.ENSP00000399709; -.
DR   TCDB; 1.A.46.1.1; the anion channel-forming bestrophin (bestrophin) family.
DR   iPTMnet; O76090; -.
DR   PhosphoSitePlus; O76090; -.
DR   BioMuta; BEST1; -.
DR   EPD; O76090; -.
DR   PaxDb; O76090; -.
DR   PeptideAtlas; O76090; -.
DR   PRIDE; O76090; -.
DR   Ensembl; ENST00000378043; ENSP00000367282; ENSG00000167995. [O76090-1]
DR   Ensembl; ENST00000449131; ENSP00000399709; ENSG00000167995. [O76090-3]
DR   GeneID; 7439; -.
DR   KEGG; hsa:7439; -.
DR   UCSC; uc001nsr.3; human. [O76090-1]
DR   CTD; 7439; -.
DR   DisGeNET; 7439; -.
DR   EuPathDB; HostDB:ENSG00000167995.15; -.
DR   GeneCards; BEST1; -.
DR   GeneReviews; BEST1; -.
DR   H-InvDB; HIX0036211; -.
DR   HGNC; HGNC:12703; BEST1.
DR   HPA; HPA057464; -.
DR   MalaCards; BEST1; -.
DR   MIM; 153700; phenotype.
DR   MIM; 193220; phenotype.
DR   MIM; 607854; gene.
DR   MIM; 611809; phenotype.
DR   MIM; 613194; phenotype.
DR   neXtProt; NX_O76090; -.
DR   OpenTargets; ENSG00000167995; -.
DR   Orphanet; 99000; Adult-onset foveomacular vitelliform dystrophy.
DR   Orphanet; 3086; Autosomal dominant vitreoretinochoroidopathy.
DR   Orphanet; 139455; Autosomal recessive bestrophinopathy.
DR   Orphanet; 1243; Best vitelliform macular dystrophy.
DR   Orphanet; 263347; MRCS syndrome.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA162377454; -.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOVERGEN; HBG044928; -.
DR   InParanoid; O76090; -.
DR   KO; K13878; -.
DR   OMA; RSGYHSA; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; O76090; -.
DR   TreeFam; TF315803; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SIGNOR; O76090; -.
DR   ChiTaRS; BEST1; human.
DR   GeneWiki; Bestrophin_1; -.
DR   GenomeRNAi; 7439; -.
DR   PRO; PR:O76090; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000167995; -.
DR   CleanEx; HS_BEST1; -.
DR   ExpressionAtlas; O76090; baseline and differential.
DR   Genevisible; O76090; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:HGNC.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005254; F:chloride channel activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; TAS:Reactome.
DR   GO; GO:0006821; P:chloride transport; IDA:MGI.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0030321; P:transepithelial chloride transport; IDA:HGNC.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   InterPro; IPR033041; Best1.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   PANTHER; PTHR10736:SF4; PTHR10736:SF4; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disease mutation; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Retinitis pigmentosa; Sensory transduction;
KW   Transmembrane; Transmembrane helix; Transport; Vision.
FT   CHAIN         1    585       Bestrophin-1.
FT                                /FTId=PRO_0000143114.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     70       Extracellular. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TOPO_DOM     92    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       {ECO:0000255}.
FT   TOPO_DOM    250    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    585       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ       1     60       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008973.
FT   VAR_SEQ     290    316       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008975.
FT   VAR_SEQ     581    585       DEAHS -> SVLHLNQGHCIALCPTPASLALSLPFLHNFLG
FT                                FHHCQSTLDLRPALAWGIYLATFTGILGKCSGPFLTSPWYH
FT                                PEDFLGPGEGR (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008974.
FT   VARIANT       3      3       I -> T (in VMD2).
FT                                {ECO:0000269|PubMed:19357557}.
FT                                /FTId=VAR_058273.
FT   VARIANT       6      6       T -> P (in VMD2; dbSNP:rs28940275).
FT                                {ECO:0000269|PubMed:19357557,
FT                                ECO:0000269|PubMed:9662395}.
FT                                /FTId=VAR_000830.
FT   VARIANT       6      6       T -> R (in VMD2; dbSNP:rs281865204).
FT                                /FTId=VAR_017366.
FT   VARIANT       9      9       V -> A (in VMD2; dbSNP:rs281865205).
FT                                /FTId=VAR_000831.
FT   VARIANT       9      9       V -> M (in VMD2; dbSNP:rs28940276).
FT                                /FTId=VAR_000832.
FT   VARIANT      10     10       A -> T (in VMD2; dbSNP:rs281865206).
FT                                /FTId=VAR_000833.
FT   VARIANT      10     10       A -> V (in VMD2; dbSNP:rs281865207).
FT                                {ECO:0000269|PubMed:10394929}.
FT                                /FTId=VAR_010468.
FT   VARIANT      11     11       N -> I (in VMD2; dbSNP:rs281865208).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_017367.
FT   VARIANT      13     13       R -> H (in VMD2; dbSNP:rs281865209).
FT                                {ECO:0000269|PubMed:10331951}.
FT                                /FTId=VAR_010469.
FT   VARIANT      16     16       S -> F (in VMD2; dbSNP:rs281865210).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010470.
FT   VARIANT      17     17       F -> C (in VMD2; dbSNP:rs281865211).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010471.
FT   VARIANT      21     21       L -> V (in VMD2; dbSNP:rs281865212).
FT                                /FTId=VAR_000834.
FT   VARIANT      24     24       W -> C (in VMD2; dbSNP:rs281865213).
FT                                /FTId=VAR_000835.
FT   VARIANT      25     25       R -> Q (in VMD2; dbSNP:rs281865215).
FT                                /FTId=VAR_000836.
FT   VARIANT      25     25       R -> W (in VMD2; dbSNP:rs281865214).
FT                                /FTId=VAR_000837.
FT   VARIANT      26     26       G -> R (in VMD2).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_017368.
FT   VARIANT      27     27       S -> R (in VMD2; dbSNP:rs281865216).
FT                                /FTId=VAR_000838.
FT   VARIANT      29     29       Y -> H (in VMD2; dbSNP:rs281865217).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_017369.
FT   VARIANT      30     30       K -> R (in VMD2; dbSNP:rs281865218).
FT                                /FTId=VAR_017370.
FT   VARIANT      40     40       L -> P (in ARB; unknown pathological
FT                                significance; no effect on subcellular
FT                                location in transfected HEK293T cells;
FT                                loss of chloride conductance).
FT                                {ECO:0000269|PubMed:26720466}.
FT                                /FTId=VAR_075346.
FT   VARIANT      41     41       L -> P (in VMD2 and ARB; no effect on
FT                                subcellular location in transfected
FT                                MDCK.2 cells; possible decrease in
FT                                protein stability; reduced chloride
FT                                conductance; dbSNP:rs121918288).
FT                                {ECO:0000269|PubMed:14517959,
FT                                ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_017371.
FT   VARIANT      47     47       R -> H (in VMD2; dbSNP:rs28940278).
FT                                /FTId=VAR_017372.
FT   VARIANT      58     58       Q -> L (in VMD2; dbSNP:rs281865529).
FT                                /FTId=VAR_000839.
FT   VARIANT      67     67       L -> V.
FT                                /FTId=VAR_000840.
FT   VARIANT      73     73       I -> N (in VMD2).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010472.
FT   VARIANT      80     80       F -> L (in VMD2; dbSNP:rs281865221).
FT                                /FTId=VAR_017373.
FT   VARIANT      82     82       L -> V (in VMD2; dbSNP:rs281865530).
FT                                {ECO:0000269|PubMed:10394929,
FT                                ECO:0000269|PubMed:19357557}.
FT                                /FTId=VAR_010473.
FT   VARIANT      85     85       Y -> H (in VMD2; decreased chloride and
FT                                bicarbonate conductance;
FT                                dbSNP:rs28940274).
FT                                {ECO:0000269|PubMed:18400985,
FT                                ECO:0000269|PubMed:21330666,
FT                                ECO:0000269|PubMed:9662395}.
FT                                /FTId=VAR_000841.
FT   VARIANT      86     86       V -> M (in ADVIRC; dbSNP:rs121918289).
FT                                {ECO:0000269|PubMed:15452077}.
FT                                /FTId=VAR_058274.
FT   VARIANT      89     89       V -> A (in VMD2).
FT                                {ECO:0000269|PubMed:11449320}.
FT                                /FTId=VAR_017374.
FT   VARIANT      91     91       T -> I (in VMD2; dbSNP:rs281865223).
FT                                /FTId=VAR_017375.
FT   VARIANT      92     92       R -> C (in VMD2; loss of cloride and
FT                                bicarbonate conductance;
FT                                dbSNP:rs281865224).
FT                                {ECO:0000269|PubMed:10394929,
FT                                ECO:0000269|PubMed:18400985}.
FT                                /FTId=VAR_010474.
FT   VARIANT      92     92       R -> H (in VMD2; dbSNP:rs281865225).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010475.
FT   VARIANT      92     92       R -> S (in VMD2; dbSNP:rs281865224).
FT                                /FTId=VAR_000842.
FT   VARIANT      93     93       W -> C (in VMD2; no effect on subcellular
FT                                location in transfected HEK293T cells;
FT                                loss of cloride and bicarbonate
FT                                conductance; dbSNP:rs28940273).
FT                                {ECO:0000269|PubMed:10331951,
FT                                ECO:0000269|PubMed:18400985,
FT                                ECO:0000269|PubMed:26720466,
FT                                ECO:0000269|PubMed:9662395}.
FT                                /FTId=VAR_000843.
FT   VARIANT      96     96       Q -> H (in VMD2; dbSNP:rs281865226).
FT                                {ECO:0000269|PubMed:10394929}.
FT                                /FTId=VAR_010476.
FT   VARIANT      99     99       N -> K (in VMD2; dbSNP:rs281865227).
FT                                /FTId=VAR_000844.
FT   VARIANT     100    100       L -> R (in VMD2; dbSNP:rs281865228).
FT                                /FTId=VAR_000845.
FT   VARIANT     101    101       P -> T (in VMD2; dbSNP:rs281865229).
FT                                /FTId=VAR_017376.
FT   VARIANT     102    102       W -> R (in VMD2; dbSNP:rs281865230).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_017377.
FT   VARIANT     104    104       D -> E (in VMD2; dbSNP:rs281865232).
FT                                /FTId=VAR_000846.
FT   VARIANT     104    104       D -> H (in VMD2; dbSNP:rs281865231).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_017378.
FT   VARIANT     105    105       R -> C (in age-related macular
FT                                degeneration; dbSNP:rs281865273).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025731.
FT   VARIANT     113    113       F -> L (in VMD2).
FT                                {ECO:0000269|PubMed:15176385}.
FT                                /FTId=VAR_025732.
FT   VARIANT     119    119       E -> Q (in a sporadic case of concentric
FT                                annular macular dystrophy;
FT                                dbSNP:rs1805142).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010477.
FT   VARIANT     133    133       N -> K (in VMD2; dbSNP:rs281865233).
FT                                /FTId=VAR_017379.
FT   VARIANT     135    135       G -> S (in VMD2; dbSNP:rs281865234).
FT                                {ECO:0000269|PubMed:10394929}.
FT                                /FTId=VAR_010478.
FT   VARIANT     140    140       L -> R (in VMD2; dbSNP:rs281865235).
FT                                /FTId=VAR_017380.
FT   VARIANT     140    140       L -> V (in RP50 and ARB; possible
FT                                decrease in protein stability; causes
FT                                protein mislocalization to the cytoplasm
FT                                and reduction of channel activity;
FT                                dbSNP:rs267606678).
FT                                {ECO:0000269|PubMed:19853238,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_063169.
FT   VARIANT     141    141       R -> H (in VMD2 and ARB; no effect on
FT                                subcellular location in induced
FT                                pluripotent stem cell-derived retinal
FT                                pigment epithelial cells; loss of cell
FT                                membrane localization in transfected
FT                                MDCK.2 cells; possible decrease in
FT                                protein stability; reduced chloride
FT                                conductance; dbSNP:rs121918284).
FT                                {ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:21330666,
FT                                ECO:0000269|PubMed:26200502}.
FT                                /FTId=VAR_000847.
FT   VARIANT     146    146       A -> K (in VMD2; sporadic; requires 2
FT                                nucleotide substitutions;
FT                                dbSNP:rs1800995).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010479.
FT   VARIANT     152    152       P -> A (in ARB; no effect on protein
FT                                stability; loss of cell membrane
FT                                localization in transfected MDCK.2 cells;
FT                                reduced whole-cell conductance).
FT                                {ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_043493.
FT   VARIANT     195    195       A -> V (in ARB and VMD2; no effect on
FT                                subcellular location in transfected
FT                                MDCK.2 and HEK293T cells; possible
FT                                decrease in protein stability; reduced
FT                                chloride conductance; dbSNP:rs200277476).
FT                                {ECO:0000269|PubMed:21330666,
FT                                ECO:0000269|PubMed:26720466}.
FT                                /FTId=VAR_017381.
FT   VARIANT     201    201       I -> T (in VMD2; dbSNP:rs199529046).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025733.
FT   VARIANT     202    202       R -> W (in ARB; possible decrease in
FT                                protein stability; loss of cell membrane
FT                                localization in transfected MDCK.2 cells;
FT                                reduced chloride conductance;
FT                                dbSNP:rs765998048).
FT                                {ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_075347.
FT   VARIANT     205    205       I -> T (in RP50; reduced channel
FT                                activity; dbSNP:rs267606680).
FT                                {ECO:0000269|PubMed:19853238}.
FT                                /FTId=VAR_063170.
FT   VARIANT     207    207       L -> I (in VMD2; dbSNP:rs74653691).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025734.
FT   VARIANT     209    209       S -> N (in VMD2; dbSNP:rs281865237).
FT                                /FTId=VAR_000848.
FT   VARIANT     216    216       T -> I (in a sporadic case of age-related
FT                                macular degeneration; dbSNP:rs281865275).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010480.
FT   VARIANT     218    218       R -> C (in VMD2; dbSNP:rs281865238).
FT                                {ECO:0000269|PubMed:10331951,
FT                                ECO:0000269|PubMed:10394929,
FT                                ECO:0000269|PubMed:11241846,
FT                                ECO:0000269|PubMed:18766995}.
FT                                /FTId=VAR_000849.
FT   VARIANT     218    218       R -> H (in VMD2; dbSNP:rs281865239).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010481.
FT   VARIANT     218    218       R -> Q (in VMD2).
FT                                /FTId=VAR_000850.
FT   VARIANT     218    218       R -> S (in VMD2; dbSNP:rs281865238).
FT                                {ECO:0000269|PubMed:10394929}.
FT                                /FTId=VAR_000851.
FT   VARIANT     221    221       C -> W (in VMD2; dbSNP:rs281865240).
FT                                {ECO:0000269|PubMed:10682987}.
FT                                /FTId=VAR_025735.
FT   VARIANT     222    222       G -> V (in a family affected by Leber
FT                                congenital amaurosis/VMD2;
FT                                dbSNP:rs281865241).
FT                                {ECO:0000269|PubMed:10766140}.
FT                                /FTId=VAR_025736.
FT   VARIANT     224    224       L -> M (in VMD2; dbSNP:rs281865242).
FT                                /FTId=VAR_000852.
FT   VARIANT     224    224       L -> P (in VMD2; dbSNP:rs281865243).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025737.
FT   VARIANT     227    227       Y -> C (in RP50; dbSNP:rs267606677).
FT                                {ECO:0000269|PubMed:19853238}.
FT                                /FTId=VAR_000853.
FT   VARIANT     227    227       Y -> N (in VMD2; dbSNP:rs28941469).
FT                                {ECO:0000269|PubMed:19357557,
FT                                ECO:0000269|PubMed:9662395}.
FT                                /FTId=VAR_000854.
FT   VARIANT     228    228       D -> N (in RP50; causes protein
FT                                mislocalization to the cytoplasm;
FT                                dbSNP:rs267606676).
FT                                {ECO:0000269|PubMed:19853238}.
FT                                /FTId=VAR_063171.
FT   VARIANT     231    231       S -> R (in VMD2; dbSNP:rs281865244).
FT                                /FTId=VAR_000855.
FT   VARIANT     235    235       V -> L (in VMD2; dbSNP:rs281865245).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010482.
FT   VARIANT     235    235       V -> M (in VMD2; dbSNP:rs281865245).
FT                                /FTId=VAR_000856.
FT   VARIANT     236    236       Y -> C (in ADVIRC; dbSNP:rs121918291).
FT                                {ECO:0000269|PubMed:15452077}.
FT                                /FTId=VAR_058275.
FT   VARIANT     237    237       T -> R (in VMD2; dbSNP:rs281865246).
FT                                {ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_000857.
FT   VARIANT     239    239       V -> M (in ADVIRC; dbSNP:rs121918290).
FT                                {ECO:0000269|PubMed:15452077}.
FT                                /FTId=VAR_058276.
FT   VARIANT     241    241       T -> N (in VMD2; dbSNP:rs281865247).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_025738.
FT   VARIANT     242    242       V -> M (in VMD2; late-onset of visual
FT                                disturbance).
FT                                {ECO:0000269|PubMed:18766995}.
FT                                /FTId=VAR_058277.
FT   VARIANT     243    243       A -> T (in VMD2; dbSNP:rs28940570).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025739.
FT   VARIANT     243    243       A -> V (in VMD2; dbSNP:rs28940570).
FT                                {ECO:0000269|PubMed:19357557}.
FT                                /FTId=VAR_000858.
FT   VARIANT     275    275       V -> I (in age-related macular
FT                                degeneration; dbSNP:rs281865276).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025740.
FT   VARIANT     276    276       F -> L (in VMD2; dbSNP:rs281865248).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025741.
FT   VARIANT     293    293       Q -> K (in VMD2; dbSNP:rs281865250).
FT                                {ECO:0000269|PubMed:10394929}.
FT                                /FTId=VAR_010483.
FT   VARIANT     294    294       L -> V (in VMD2; dbSNP:rs281865251).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_025742.
FT   VARIANT     295    295       I -> T (in VMD2; dbSNP:rs281865253).
FT                                {ECO:0000269|PubMed:12187431}.
FT                                /FTId=VAR_025743.
FT   VARIANT     295    295       Missing (in VMD2).
FT                                /FTId=VAR_000859.
FT   VARIANT     296    296       N -> H (in VMD2; dbSNP:rs281865254).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025744.
FT   VARIANT     296    296       N -> S (in VMD2; dbSNP:rs281865255).
FT                                {ECO:0000269|PubMed:11241846}.
FT                                /FTId=VAR_010484.
FT   VARIANT     297    297       P -> A (in VMD2; dbSNP:rs1805143).
FT                                /FTId=VAR_000860.
FT   VARIANT     297    297       P -> S (in VMD2; dbSNP:rs1805143).
FT                                {ECO:0000269|PubMed:10453731,
FT                                ECO:0000269|PubMed:13129869}.
FT                                /FTId=VAR_010485.
FT   VARIANT     298    298       F -> S (in VMD2; dbSNP:rs281865257).
FT                                {ECO:0000269|PubMed:14517959}.
FT                                /FTId=VAR_025745.
FT   VARIANT     299    299       G -> A (in VMD2).
FT                                {ECO:0000269|PubMed:19357557}.
FT                                /FTId=VAR_058313.
FT   VARIANT     299    299       G -> E (in VMD2; dbSNP:rs28941468).
FT                                {ECO:0000269|PubMed:9662395}.
FT                                /FTId=VAR_000861.
FT   VARIANT     300    300       E -> D (in VMD2; dbSNP:rs1805144).
FT                                {ECO:0000269|PubMed:10331951,
FT                                ECO:0000269|PubMed:10453731,
FT                                ECO:0000269|PubMed:13129869}.
FT                                /FTId=VAR_010486.
FT   VARIANT     300    300       E -> K (in VMD2; dbSNP:rs281865258).
FT                                /FTId=VAR_000862.
FT   VARIANT     301    301       D -> E (in VMD2; dbSNP:rs281865261).
FT                                {ECO:0000269|PubMed:10331951}.
FT                                /FTId=VAR_000863.
FT   VARIANT     301    301       D -> N (in VMD2; dbSNP:rs281865259).
FT                                /FTId=VAR_000864.
FT   VARIANT     302    304       Missing (in VMD2).
FT                                {ECO:0000269|PubMed:19357557}.
FT                                /FTId=VAR_058278.
FT   VARIANT     302    302       D -> G (in VMD2; dbSNP:rs281865263).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025746.
FT   VARIANT     302    302       D -> H (in VMD2; dbSNP:rs281865262).
FT                                {ECO:0000269|PubMed:12324875}.
FT                                /FTId=VAR_025747.
FT   VARIANT     302    302       D -> V (in VMD2; dbSNP:rs281865263).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025748.
FT   VARIANT     303    303       D -> E (in VMD2; dbSNP:rs281865264).
FT                                {ECO:0000269|PubMed:12324875}.
FT                                /FTId=VAR_025749.
FT   VARIANT     305    305       F -> S (in VMD2; dbSNP:rs281865265).
FT                                /FTId=VAR_000865.
FT   VARIANT     306    306       E -> D (in VMD2; dbSNP:rs281865267).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025750.
FT   VARIANT     306    306       E -> G (in VMD2; dbSNP:rs281865266).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025751.
FT   VARIANT     307    307       T -> A (in VMD2; dbSNP:rs281865268).
FT                                {ECO:0000269|PubMed:10798642}.
FT                                /FTId=VAR_025752.
FT   VARIANT     307    307       T -> I (in VMD2; dbSNP:rs281865269).
FT                                {ECO:0000269|PubMed:10331951}.
FT                                /FTId=VAR_010487.
FT   VARIANT     308    308       N -> S (in VMD2; dbSNP:rs281865270).
FT                                {ECO:0000269|PubMed:12324875}.
FT                                /FTId=VAR_025753.
FT   VARIANT     310    310       I -> T (in VMD2; dbSNP:rs281865271).
FT                                /FTId=VAR_000866.
FT   VARIANT     311    311       V -> G (in VMD2).
FT                                /FTId=VAR_000867.
FT   VARIANT     312    312       D -> N (in VMD2 and ARB; no effect on
FT                                protein stability; loss of cell membrane
FT                                localization in transfected MDCK.2 cells;
FT                                reduced chloride conductance;
FT                                dbSNP:rs281865277).
FT                                {ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:19853238,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_000868.
FT   VARIANT     317    317       V -> M (in ARB; no effect on protein
FT                                stability; loss of cell membrane
FT                                localization in transfected MDCK.2 cells;
FT                                reduced chloride conductance;
FT                                dbSNP:rs121918287).
FT                                {ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_043494.
FT   VARIANT     325    325       M -> T (in ARB; possible decrease in
FT                                protein stability; loss of cell membrane
FT                                localization in transfected MDCK.2 cells;
FT                                reduced chloride conductance;
FT                                dbSNP:rs368387447).
FT                                {ECO:0000269|PubMed:18179881,
FT                                ECO:0000269|PubMed:21330666}.
FT                                /FTId=VAR_043495.
FT   VARIANT     357    357       A -> V (in dbSNP:rs17854138).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_043496.
FT   VARIANT     525    525       E -> A (in dbSNP:rs200582915).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010488.
FT   VARIANT     557    557       E -> K (in dbSNP:rs147192139).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010489.
FT   VARIANT     561    561       T -> A (in dbSNP:rs281865283).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010490.
FT   VARIANT     567    567       L -> F (in a sporadic case of age-related
FT                                macular degeneration; unknown
FT                                pathological significance;
FT                                dbSNP:rs148060787).
FT                                {ECO:0000269|PubMed:10453731}.
FT                                /FTId=VAR_010491.
FT   VARIANT     578    578       E -> V (in dbSNP:rs1800010).
FT                                /FTId=VAR_009278.
SQ   SEQUENCE   585 AA;  67684 MW;  D0629AAF65BA1ACD CRC64;
     MTITYTSQVA NARLGSFSRL LLCWRGSIYK LLYGEFLIFL LCYYIIRFIY RLALTEEQQL
     MFEKLTLYCD SYIQLIPISF VLGFYVTLVV TRWWNQYENL PWPDRLMSLV SGFVEGKDEQ
     GRLLRRTLIR YANLGNVLIL RSVSTAVYKR FPSAQHLVQA GFMTPAEHKQ LEKLSLPHNM
     FWVPWVWFAN LSMKAWLGGR IRDPILLQSL LNEMNTLRTQ CGHLYAYDWI SIPLVYTQVV
     TVAVYSFFLT CLVGRQFLNP AKAYPGHELD LVVPVFTFLQ FFFYVGWLKV AEQLINPFGE
     DDDDFETNWI VDRNLQVSLL AVDEMHQDLP RMEPDMYWNK PEPQPPYTAA SAQFRRASFM
     GSTFNISLNK EEMEFQPNQE DEEDAHAGII GRFLGLQSHD HHPPRANSRT KLLWPKRESL
     LHEGLPKNHK AAKQNVRGQE DNKAWKLKAV DAFKSAPLYQ RPGYYSAPQT PLSPTPMFFP
     LEPSAPSKLH SVTGIDTKDK SLKTVSSGAK KSFELLSESD GALMEHPEVS QVRRKTVEFN
     LTDMPEIPEN HLKEPLEQSP TNIHTTLKDH MDPYWALENR DEAHS
//
ID   GLRA1_DANRE             Reviewed;         444 AA.
AC   O93430;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-NOV-2017, entry version 136.
DE   RecName: Full=Glycine receptor subunit alphaZ1;
DE   Flags: Precursor;
GN   Name=glra1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10188956; DOI=10.1016/S0306-4522(98)00430-8;
RA   David-Watine B., Goblet C., de Saint Jan D., Fucile S., Devignot V.,
RA   Bregestovski P., Korn H.;
RT   "Cloning, expression and electrophysiological characterization of
RT   glycine receptor alpha subunit from zebrafish.";
RL   Neuroscience 90:303-317(1999).
RN   [2] {ECO:0000244|PDB:3JAD, ECO:0000244|PDB:3JAE, ECO:0000244|PDB:3JAF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.80 ANGSTROMS) OF 34-434 IN
RP   COMPLEXES WITH GLYCINE; IVERMECTINE AND STRYCHNINE, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, DOMAIN, DISULFIDE
RP   BONDS, AND GLYCOSYLATION AT ASN-62.
RX   PubMed=26344198; DOI=10.1038/nature14853;
RA   Du J., Lu W., Wu S., Cheng Y., Gouaux E.;
RT   "Glycine receptor mechanism elucidated by electron cryo-microscopy.";
RL   Nature 526:224-229(2015).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine
CC       (PubMed:10188956, PubMed:26344198). Plays an important role in the
CC       down-regulation of neuronal excitability. Contributes to the
CC       generation of inhibitory postsynaptic currents. Channel activity
CC       is potentiated by ethanol (By similarity).
CC       {ECO:0000250|UniProtKB:P23415, ECO:0000269|PubMed:10188956,
CC       ECO:0000269|PubMed:26344198}.
CC   -!- ENZYME REGULATION: Activated by glycine and taurine. Inhibited by
CC       strychnine (PubMed:10188956, PubMed:26344198). Allosterically
CC       activated by ivermectin (PubMed:26344198). Inhibited by
CC       picrotoxinin (PubMed:26344198). Strychnine binding locks the
CC       channel in a closed conformation and prevents channel opening in
CC       response to extracellular glycine (PubMed:26344198). Can also be
CC       activated by GABA and inhibited by bicuculline, but this requires
CC       heterologous expression in human cells (PubMed:10188956).
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}.
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:26344198). Heteropentamer
CC       composed of glra1 and glrb (By similarity). Both homopentamers and
CC       heteropentamers form functional ion channels (By similarity).
CC       {ECO:0000250|UniProtKB:P23415, ECO:0000269|PubMed:26344198}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q64018}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q64018}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q64018}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q64018}. Cell membrane
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:26344198}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain.
CC       {ECO:0000269|PubMed:10188956}.
CC   -!- DOMAIN: The channel pore is formed by pentameric assembly of the
CC       second transmembrane domain from all five subunits. Channel
CC       opening is effected by an outward rotation of the transmembrane
CC       domains that increases the diameter of the pore.
CC       {ECO:0000269|PubMed:26344198}.
CC   -!- MISCELLANEOUS: Highly sensitive to activation by taurine despite
CC       the presence of Val in position 135. In mammals, Val-135 causes a
CC       drastic loss of taurine efficacy. {ECO:0000269|PubMed:10188956}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA1 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ005812; CAA06711.1; -; mRNA.
DR   RefSeq; NP_571477.1; NM_131402.1.
DR   UniGene; Dr.75842; -.
DR   PDB; 3JAD; EM; 3.90 A; A/B/C/D/E=34-434.
DR   PDB; 3JAE; EM; 3.90 A; A/B/C/D/E=34-434.
DR   PDB; 3JAF; EM; 3.80 A; A/B/C/D/E=34-434.
DR   PDBsum; 3JAD; -.
DR   PDBsum; 3JAE; -.
DR   PDBsum; 3JAF; -.
DR   ProteinModelPortal; O93430; -.
DR   SMR; O93430; -.
DR   DIP; DIP-61772N; -.
DR   STRING; 7955.ENSDARP00000066196; -.
DR   iPTMnet; O93430; -.
DR   PaxDb; O93430; -.
DR   PRIDE; O93430; -.
DR   Ensembl; ENSDART00000005499; ENSDARP00000003268; ENSDARG00000012019.
DR   GeneID; 30676; -.
DR   KEGG; dre:30676; -.
DR   CTD; 2741; -.
DR   ZFIN; ZDB-GENE-991117-1; glra1.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O93430; -.
DR   KO; K05193; -.
DR   Reactome; R-DRE-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:O93430; -.
DR   Proteomes; UP000000437; Chromosome 14.
DR   Bgee; ENSDARG00000012019; -.
DR   ExpressionAtlas; O93430; baseline.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:ZFIN.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:ZFIN.
DR   GO; GO:0016594; F:glycine binding; IDA:ZFIN.
DR   GO; GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; ISS:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IMP:ZFIN.
DR   GO; GO:0006811; P:ion transport; IDA:ZFIN.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:ZFIN.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:ZFIN.
DR   GO; GO:0043200; P:response to amino acid; IDA:ZFIN.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008128; Glycine_rcpt_A1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01674; GLYRALPHA1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Metal-binding; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    444       Glycine receptor subunit alphaZ1.
FT                                /FTId=PRO_0000000415.
FT   TOPO_DOM     25    246       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    247    268       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    269    273       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    274    294       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    295    305       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    306    326       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    327    412       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    413    433       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    434    444       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   REGION      226    231       Strychnine-binding.
FT                                {ECO:0000269|PubMed:26344198}.
FT   METAL       216    216       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       218    218       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       239    239       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   SITE        285    285       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:26344198}.
FT   CARBOHYD     62     62       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:26344198}.
FT   DISULFID    162    176       {ECO:0000250|UniProtKB:P23415}.
FT   DISULFID    222    233       {ECO:0000269|PubMed:26344198}.
SQ   SEQUENCE   444 AA;  50766 MW;  77F6FC8C14E80581 CRC64;
     MFALGIYLWE TIVFFSLAAS QQAAARKAAS PMPPSEFLDK LMGKVSGYDA RIRPNFKGPP
     VNVTCNIFIN SFGSIAETTM DYRVNIFLRQ QWNDPRLAYS EYPDDSLDLD PSMLDSIWKP
     DLFFANEKGA NFHEVTTDNK LLRISKNGNV LYSIRITLVL ACPMDLKNFP MDVQTCIMQL
     ESFGYTMNDL IFEWDEKGAV QVADGLTLPQ FILKEEKDLR YCTKHYNTGK FTCIEARFHL
     ERQMGYYLIQ MYIPSLLIVI LSWVSFWINM DAAPARVGLG ITTVLTMTTQ SSGSRASLPK
     VSYVKAIDIW MAVCLLFVFS ALLEYAAVNF IARQHKELLR FQRRRRHLKE DEAGDGRFSF
     AAYGMGPACL QAKDGMAIKG NNNNAPTSTN PPEKTVEEMR KLFISRAKRI DTVSRVAFPL
     VFLIFNIFYW ITYKIIRSED IHKQ
//
ID   CLIC3_HUMAN             Reviewed;         236 AA.
AC   O95833; Q5SPZ7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Chloride intracellular channel protein 3;
GN   Name=CLIC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-236, SUBCELLULAR LOCATION, FUNCTION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9880541; DOI=10.1074/jbc.274.3.1621;
RA   Qian Z., Okuhara D., Abe M.K., Rosner M.R.;
RT   "Molecular cloning and characterization of a mitogen-activated protein
RT   kinase-associated intracellular chloride channel.";
RL   J. Biol. Chem. 274:1621-1627(1999).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17027078; DOI=10.1016/j.placenta.2006.08.002;
RA   Money T.T., King R.G., Wong M.H., Stevenson J.L., Kalionis B.,
RA   Erwich J.J.H.M., Huisman M.A., Timmer A., Hiden U., Desoye G.,
RA   Gude N.M.;
RT   "Expression and cellular localisation of chloride intracellular
RT   channel 3 in human placenta and fetal membranes.";
RL   Placenta 28:429-436(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49 AND SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1-230, AND DISULFIDE BOND.
RX   PubMed=20146363; DOI=10.1002/prot.22675;
RA   Littler D.R., Brown L.J., Breit S.N., Perrakis A., Curmi P.M.;
RT   "Structure of human CLIC3 at 2 A resolution.";
RL   Proteins 78:1594-1600(2010).
CC   -!- FUNCTION: Can insert into membranes and form chloride ion
CC       channels. May participate in cellular growth control.
CC       {ECO:0000269|PubMed:9880541}.
CC   -!- SUBUNIT: Associated with the C-terminal of ERK7.
CC   -!- INTERACTION:
CC       Q5JST6:EFHC2; NbExp=3; IntAct=EBI-10192241, EBI-2349927;
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-10192241, EBI-752420;
CC       Q9UN37:VPS4A; NbExp=4; IntAct=EBI-10192241, EBI-1171942;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Membrane; Single-pass membrane
CC       protein. Cytoplasm. Note=Predominantly nuclear. Some protein was
CC       found in the cytoplasm. Exists both as soluble cytoplasmic protein
CC       and as membrane protein with probably a single transmembrane
CC       domain (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in placenta (at protein level).
CC       Widely expressed. High expression is found in placenta followed by
CC       lung and heart. Low expression in skeletal muscle, kidney and
CC       pancreas. {ECO:0000269|PubMed:17027078,
CC       ECO:0000269|PubMed:9880541}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD16450.1; Type=Frameshift; Positions=28; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL807752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88329.1; -; Genomic_DNA.
DR   EMBL; BC007012; AAH07012.2; -; mRNA.
DR   EMBL; AF102166; AAD16450.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS7021.1; -.
DR   RefSeq; NP_004660.2; NM_004669.2.
DR   RefSeq; XP_016870771.1; XM_017015282.1.
DR   UniGene; Hs.64746; -.
DR   PDB; 3FY7; X-ray; 1.95 A; A/B=1-230.
DR   PDB; 3KJY; X-ray; 1.95 A; A/B=1-230.
DR   PDBsum; 3FY7; -.
DR   PDBsum; 3KJY; -.
DR   ProteinModelPortal; O95833; -.
DR   SMR; O95833; -.
DR   BioGrid; 114489; 21.
DR   IntAct; O95833; 17.
DR   STRING; 9606.ENSP00000419378; -.
DR   TCDB; 1.A.12.1.7; the intracellular chloride channel (clic) family.
DR   iPTMnet; O95833; -.
DR   PhosphoSitePlus; O95833; -.
DR   BioMuta; CLIC3; -.
DR   MaxQB; O95833; -.
DR   PaxDb; O95833; -.
DR   PeptideAtlas; O95833; -.
DR   PRIDE; O95833; -.
DR   DNASU; 9022; -.
DR   Ensembl; ENST00000494426; ENSP00000419378; ENSG00000169583.
DR   GeneID; 9022; -.
DR   KEGG; hsa:9022; -.
DR   UCSC; uc004ckj.2; human.
DR   CTD; 9022; -.
DR   DisGeNET; 9022; -.
DR   EuPathDB; HostDB:ENSG00000169583.12; -.
DR   GeneCards; CLIC3; -.
DR   HGNC; HGNC:2064; CLIC3.
DR   HPA; HPA005963; -.
DR   MIM; 606533; gene.
DR   neXtProt; NX_O95833; -.
DR   OpenTargets; ENSG00000169583; -.
DR   PharmGKB; PA26590; -.
DR   eggNOG; ENOG410INGX; Eukaryota.
DR   eggNOG; ENOG41128FW; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000231548; -.
DR   HOVERGEN; HBG050994; -.
DR   InParanoid; O95833; -.
DR   KO; K05023; -.
DR   OMA; QDDALYQ; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; O95833; -.
DR   TreeFam; TF315438; -.
DR   EvolutionaryTrace; O95833; -.
DR   GeneWiki; CLIC3; -.
DR   GenomeRNAi; 9022; -.
DR   PRO; PR:O95833; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000169583; -.
DR   CleanEx; HS_CLIC3; -.
DR   Genevisible; O95833; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006821; P:chloride transport; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030261; CLIC-3.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF3; PTHR43920:SF3; 1.
DR   Pfam; PF13417; GST_N_3; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS50404; GST_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Disulfide bond; Ion channel; Ion transport; Membrane;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    236       Chloride intracellular channel protein 3.
FT                                /FTId=PRO_0000144207.
FT   TRANSMEM     24     44       Helical. {ECO:0000255}.
FT   DOMAIN       12     90       GST N-terminal.
FT   DOMAIN       91    235       GST C-terminal.
FT   REGION        1     88       Required for insertion into the membrane.
FT                                {ECO:0000250}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   DISULFID     22     25       In soluble form.
FT                                {ECO:0000269|PubMed:20146363}.
FT   VARIANT      38     38       P -> H (in dbSNP:rs2292923).
FT                                /FTId=VAR_020424.
FT   STRAND        6     12       {ECO:0000244|PDB:3FY7}.
FT   STRAND       16     19       {ECO:0000244|PDB:3FY7}.
FT   HELIX        23     35       {ECO:0000244|PDB:3FY7}.
FT   STRAND       40     44       {ECO:0000244|PDB:3FY7}.
FT   STRAND       64     67       {ECO:0000244|PDB:3FY7}.
FT   STRAND       70     72       {ECO:0000244|PDB:3FY7}.
FT   HELIX        75     85       {ECO:0000244|PDB:3FY7}.
FT   TURN         88     90       {ECO:0000244|PDB:3FY7}.
FT   HELIX        99    103       {ECO:0000244|PDB:3FY7}.
FT   TURN        104    107       {ECO:0000244|PDB:3FY7}.
FT   HELIX       108    117       {ECO:0000244|PDB:3FY7}.
FT   HELIX       121    123       {ECO:0000244|PDB:3FY7}.
FT   HELIX       124    143       {ECO:0000244|PDB:3FY7}.
FT   HELIX       147    152       {ECO:0000244|PDB:3FY7}.
FT   STRAND      162    168       {ECO:0000244|PDB:3FY7}.
FT   HELIX       171    191       {ECO:0000244|PDB:3FY7}.
FT   HELIX       200    210       {ECO:0000244|PDB:3FY7}.
FT   HELIX       213    216       {ECO:0000244|PDB:3FY7}.
FT   HELIX       222    229       {ECO:0000244|PDB:3FY7}.
SQ   SEQUENCE   236 AA;  26648 MW;  CA20E66195950886 CRC64;
     MAETKLQLFV KASEDGESVG HCPSCQRLFM VLLLKGVPFT LTTVDTRRSP DVLKDFAPGS
     QLPILLYDSD AKTDTLQIED FLEETLGPPD FPSLAPRYRE SNTAGNDVFH KFSAFIKNPV
     PAQDEALYQQ LLRALARLDS YLRAPLEHEL AGEPQLRESR RRFLDGDRLT LADCSLLPKL
     HIVDTVCAHF RQAPIPAELR GVRRYLDSAM QEKEFKYTCP HSAEILAAYR PAVHPR
//
ID   CLCNX_USTMA             Reviewed;        1131 AA.
AC   P0C197; A0A0D1DXR2; Q4P8S3;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 1.
DT   05-JUL-2017, entry version 61.
DE   RecName: Full=Probable chloride channel protein UM03490-D;
GN   ORFNames=UMAG_11084;
OS   Ustilago maydis (strain 521 / FGSC 9021) (Corn smut fungus).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Ustilaginomycotina;
OC   Ustilaginomycetes; Ustilaginales; Ustilaginaceae; Ustilago.
OX   NCBI_TaxID=237631;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=521 / FGSC 9021;
RX   PubMed=17080091; DOI=10.1038/nature05248;
RA   Kaemper J., Kahmann R., Boelker M., Ma L.-J., Brefort T.,
RA   Saville B.J., Banuett F., Kronstad J.W., Gold S.E., Mueller O.,
RA   Perlin M.H., Woesten H.A.B., de Vries R., Ruiz-Herrera J.,
RA   Reynaga-Pena C.G., Snetselaar K., McCann M., Perez-Martin J.,
RA   Feldbruegge M., Basse C.W., Steinberg G., Ibeas J.I., Holloman W.,
RA   Guzman P., Farman M.L., Stajich J.E., Sentandreu R.,
RA   Gonzalez-Prieto J.M., Kennell J.C., Molina L., Schirawski J.,
RA   Mendoza-Mendoza A., Greilinger D., Muench K., Roessel N., Scherer M.,
RA   Vranes M., Ladendorf O., Vincon V., Fuchs U., Sandrock B., Meng S.,
RA   Ho E.C.H., Cahill M.J., Boyce K.J., Klose J., Klosterman S.J.,
RA   Deelstra H.J., Ortiz-Castellanos L., Li W., Sanchez-Alonso P.,
RA   Schreier P.H., Haeuser-Hahn I., Vaupel M., Koopmann E., Friedrich G.,
RA   Voss H., Schlueter T., Margolis J., Platt D., Swimmer C., Gnirke A.,
RA   Chen F., Vysotskaia V., Mannhaupt G., Gueldener U.,
RA   Muensterkoetter M., Haase D., Oesterheld M., Mewes H.-W.,
RA   Mauceli E.W., DeCaprio D., Wade C.M., Butler J., Young S.K.,
RA   Jaffe D.B., Calvo S.E., Nusbaum C., Galagan J.E., Birren B.W.;
RT   "Insights from the genome of the biotrophic fungal plant pathogen
RT   Ustilago maydis.";
RL   Nature 444:97-101(2006).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=521 / FGSC 9021;
RA   Gueldener U., Muensterkoetter M., Walter M.C., Mannhaupt G.,
RA   Kahmann R.;
RL   Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Voltage-gated chloride channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CM003148; KIS68396.1; -; Genomic_DNA.
DR   RefSeq; XP_011390091.1; XM_011391789.1.
DR   ProteinModelPortal; P0C197; -.
DR   STRING; 5270.UM03490P0; -.
DR   PRIDE; P0C197; -.
DR   EnsemblFungi; KIS68396; KIS68396; UMAG_11084.
DR   GeneID; 23567013; -.
DR   KEGG; uma:UMAG_11084; -.
DR   EuPathDB; FungiDB:UMAG_11084; -.
DR   InParanoid; P0C197; -.
DR   KO; K05012; -.
DR   OrthoDB; EOG092C14Y0; -.
DR   Proteomes; UP000000561; Chromosome 9.
DR   Proteomes; UP000000561; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 1.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 1.
PE   3: Inferred from homology;
KW   Chloride; Chloride channel; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1131       Probable chloride channel protein
FT                                UM03490-D.
FT                                /FTId=PRO_0000232936.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical. {ECO:0000255}.
FT   TRANSMEM    305    325       Helical. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical. {ECO:0000255}.
FT   TRANSMEM    380    397       Helical. {ECO:0000255}.
FT   TRANSMEM    414    434       Helical. {ECO:0000255}.
FT   TRANSMEM    485    505       Helical. {ECO:0000255}.
FT   TRANSMEM    518    538       Helical. {ECO:0000255}.
FT   TRANSMEM    577    597       Helical. {ECO:0000255}.
FT   TRANSMEM    603    623       Helical. {ECO:0000255}.
FT   TRANSMEM    643    663       Helical. {ECO:0000255}.
FT   TRANSMEM    680    702       Helical. {ECO:0000255}.
FT   DOMAIN      944   1000       CBS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
SQ   SEQUENCE   1131 AA;  120695 MW;  4EC300BA7D7413E6 CRC64;
     MNASPHSKPS AALAPSPTAA FFPSTSRVYT SKAATVVDDD EALDEIRRYE SFSTVDWVVD
     NTRERNRLAR ERQAASAHFV SSSSNAHLGN ADAAWGHIGF GRGGVPPRWW SRGPWGRRAW
     LVWGIVKSAS SAFTDSGVIV LVGILIGLNM GVISLATEWA SDLKQGYCSS GWWLNQKFCC
     WEMMDQAGPG GAPLPAAAKA LATATVTVTA SIGAAAAATD SAPILPATPA ATPTAAIRAV
     AQEAYNLTIR AIPDHQLWSR SAQDVIQDGF GTGLRLLSRA EGAASGAGDL SETCTDWVRW
     SKWSFPAWII YMLFAGLLSF ICAHLVKSFA PYAAGSGISE IKCILAGFVI NGYLGFWTLA
     IKSLTLPLAI ASGLSVGKEG PAVHVACCIG NVVASFFRSF NRSQAKMREL LTASSAAGVA
     VAFGSPIGGV LFSLEEMAYN FPASTMWRSF LCALAATVTL SFMNPFRTGK LVLFQVSYDR
     DWHYFEIMFY ILIGIFGGLY GAFVIKYNLQ VQSFRRSYLV KHGVSEVVVL ATLTAFVGYA
     NKFLRIDMTE SLEILFRECE GGGDYDNLCQ SWAQWRMVNS LLLATVLRTA LVIVSYGCKV
     PAGIFVPSMA IGATFGRMVG ILVKALYNAF PHWSLFSACQ PDVPCITPGT YAFLGAAAAL
     AGVTRITVAV VVIMFELTGA LTYILPTMIV VGITKGVADW FSRGGIAEQM IKFSGYPFLD
     KDDHNFGIPV ADVMRVCPQV LFASGMKLSE LEGKLADGSY KGFPLVLAKH DATLLGYVGK
     VELRYAIGKA RRARALDGDT LCLFSVGPNA LDRADGVESS AHGAQQQQPD LLSVASLPTT
     AAADRAVRED MLSRFSGATG AGSASGLGST SATGVASQRR HESESLIGQL DVEDDRSSAP
     SYRSRVDAGD NMSSSSDDDA VVGNAGGGVD GESDLDKLEL GGWIDPTPLI VQPGMPLETV
     MDMFKNLGPR VILVVEYGRL SGLVTVKDVL KRIAMQEKAE AAARTAAAAG LPMSGSANSF
     TGEGAGAGGG ELEALLKEAY EWAQEKWALI SPRIERISAR RASASRGGAP GSQAGQARYS
     HLRESTEDRY DDSDAVAEDM PMHSTRQTSA TKNTRSEHHQ FVLGAQDDDD E
//
ID   CFTR_HUMAN              Reviewed;        1480 AA.
AC   P13569; Q20BG8; Q20BH2; Q2I0A1; Q2I102;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 3.
DT   22-NOV-2017, entry version 232.
DE   RecName: Full=Cystic fibrosis transmembrane conductance regulator;
DE            Short=CFTR;
DE   AltName: Full=ATP-binding cassette sub-family C member 7;
DE   AltName: Full=Channel conductance-controlling ATPase;
DE            EC=3.6.3.49 {ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:8910473};
DE   AltName: Full=cAMP-dependent chloride channel;
GN   Name=CFTR; Synonyms=ABCC7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-470.
RX   PubMed=2475911; DOI=10.1126/science.2475911;
RA   Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R.,
RA   Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.-L.,
RA   Drumm M.L., Iannuzzi M.C., Collins F.S., Tsui L.-C.;
RT   "Identification of the cystic fibrosis gene: cloning and
RT   characterization of complementary DNA.";
RL   Science 245:1066-1073(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-470.
RX   PubMed=1710598; DOI=10.1016/0888-7543(91)90503-7;
RA   Zielenski J., Rozmahel R., Bozon D., Kerem B., Grzelczak Z.,
RA   Riordan J.R., Rommens J., Tsui L.-C.;
RT   "Genomic DNA sequence of the cystic fibrosis transmembrane conductance
RT   regulator (CFTR) gene.";
RL   Genomics 10:214-228(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-470 AND TRP-1453.
RA   Stacy R., Subramanian S., Deodato C., Burkhardt P., Song Y.,
RA   Paddock M., Chang J., Zhou Y., Haugen E., Waring D., Chapman P.,
RA   Hayden H., Levy R., Wu Z., Rouse G., James R., Phelps K., Olson M.V.,
RA   Kaul R.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   PHOSPHORYLATION AT SER-660; SER-686; SER-700; SER-737; SER-768;
RP   SER-790; SER-795 AND SER-813.
RX   PubMed=1377674;
RA   Picciotto M.R., Cohn J.A., Bertuzzi G., Greenguard P., Nairn A.C.;
RT   "Phosphorylation of the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   J. Biol. Chem. 267:12742-12752(1992).
RN   [7]
RP   GLYCOSYLATION AT ASN-894 AND ASN-900, AND TOPOLOGY.
RX   PubMed=7518437;
RA   Chang X.-B., Hou Y.-X., Jensen T.J., Riordan J.R.;
RT   "Mapping of cystic fibrosis transmembrane conductance regulator
RT   membrane topology by glycosylation site insertion.";
RL   J. Biol. Chem. 269:18572-18575(1994).
RN   [8]
RP   PHOSPHORYLATION AT SER-660; SER-700; SER-712; SER-737; SER-753;
RP   SER-768; SER-795 AND SER-813.
RX   PubMed=9385646; DOI=10.1002/pro.5560061117;
RA   Neville D.C.A., Rozanas C.R., Rice E.M., Gruis D.B., Verkman A.S.,
RA   Townsend R.R.;
RT   "Evidence for phosphorylation of serine 753 in CFTR using a novel
RT   metal-ion affinity resin and matrix-assisted laser desorption mass
RT   spectrometry.";
RL   Protein Sci. 6:2436-2445(1997).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=10766763; DOI=10.1074/jbc.M910165199;
RA   Pagani F., Buratti E., Stuani C., Romano M., Zuccato E., Niksic M.,
RA   Giglio L., Faraguna D., Baralle F.E.;
RT   "Splicing factors induce cystic fibrosis transmembrane regulator exon
RT   9 skipping through a nonevolutionary conserved intronic element.";
RL   J. Biol. Chem. 275:21041-21047(2000).
RN   [10]
RP   DOMAIN, FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=10792060; DOI=10.1073/pnas.100588797;
RA   Ostedgaard L.S., Baldursson O., Vermeer D.W., Welsh M.J.,
RA   Robertson A.D.;
RT   "A functional R domain from cystic fibrosis transmembrane conductance
RT   regulator is predominantly unstructured in solution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5657-5662(2000).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=11524016; DOI=10.1021/bi0108195;
RA   Ramjeesingh M., Li C., Kogan I., Wang Y., Huan L.J., Bear C.E.;
RT   "A monomer is the minimum functional unit required for channel and
RT   ATPase activity of the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   Biochemistry 40:10700-10706(2001).
RN   [12]
RP   INTERACTION WITH GOPC, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11707463; DOI=10.1074/jbc.M110177200;
RA   Cheng J., Moyer B.D., Milewski M., Loffing J., Ikeda M., Mickle J.E.,
RA   Cutting G.R., Li M., Stanton B.A., Guggino W.B.;
RT   "A Golgi-associated PDZ domain protein modulates cystic fibrosis
RT   transmembrane regulator plasma membrane expression.";
RL   J. Biol. Chem. 277:3520-3529(2002).
RN   [13]
RP   INTERACTION WITH SLC4A7 AND SLC9A3R1, AND FUNCTION.
RX   PubMed=12403779; DOI=10.1074/jbc.M201862200;
RA   Park M., Ko S.B.H., Choi J.Y., Muallem G., Thomas P.J., Pushkin A.,
RA   Lee M.-S., Kim J.Y., Lee M.G., Muallem S., Kurtz I.;
RT   "The cystic fibrosis transmembrane conductance regulator interacts
RT   with and regulates the activity of the HCO3- salvage transporter human
RT   Na+-HCO3-cotransport isoform 3.";
RL   J. Biol. Chem. 277:50503-50509(2002).
RN   [14]
RP   PHOSPHORYLATION BY AMPK, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12519745; DOI=10.1152/ajpcell.00227.2002;
RA   Hallows K.R., Kobinger G.P., Wilson J.M., Witters L.A., Foskett J.K.;
RT   "Physiological modulation of CFTR activity by AMP-activated protein
RT   kinase in polarized T84 cells.";
RL   Am. J. Physiol. 284:C1297-C1308(2003).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15010471; DOI=10.1074/jbc.M313323200;
RA   Shcheynikov N., Kim K.H., Kim K.M., Dorwart M.R., Ko S.B., Goto H.,
RA   Naruse S., Thomas P.J., Muallem S.;
RT   "Dynamic control of cystic fibrosis transmembrane conductance
RT   regulator Cl(-)/HCO3(-) selectivity by external Cl(-).";
RL   J. Biol. Chem. 279:21857-21865(2004).
RN   [16]
RP   INTERACTION WITH MYO6, AND SUBCELLULAR LOCATION.
RX   PubMed=15247260; DOI=10.1074/jbc.M403141200;
RA   Swiatecka-Urban A., Boyd C., Coutermarsh B., Karlson K.H., Barnaby R.,
RA   Aschenbrenner L., Langford G.M., Hasson T., Stanton B.A.;
RT   "Myosin VI regulates endocytosis of the cystic fibrosis transmembrane
RT   conductance regulator.";
RL   J. Biol. Chem. 279:38025-38031(2004).
RN   [17]
RP   REVIEW.
RX   PubMed=1378801;
RA   McIntosh I., Cutting G.R.;
RT   "Cystic fibrosis transmembrane conductance regulator and the etiology
RT   and pathogenesis of cystic fibrosis.";
RL   FASEB J. 6:2775-2782(1992).
RN   [18]
RP   ALTERNATIVE SPLICING (ISOFORM 3).
RX   PubMed=12913074; DOI=10.1093/hmg/ddg215;
RA   Aznarez I., Chan E.M., Zielenski J., Blencowe B.J., Tsui L.-C.;
RT   "Characterization of disease-associated mutations affecting an exonic
RT   splicing enhancer and two cryptic splice sites in exon 13 of the
RT   cystic fibrosis transmembrane conductance regulator gene.";
RL   Hum. Mol. Genet. 12:2031-2040(2003).
RN   [19]
RP   CHANNEL GATING REGULATION, PHOSPHORYLATION, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12588899; DOI=10.1113/jphysiol.2002.035790;
RA   Chappe V., Hinkson D.A., Zhu T., Chang X.B., Riordan J.R.,
RA   Hanrahan J.W.;
RT   "Phosphorylation of protein kinase C sites in NBD1 and the R domain
RT   control CFTR channel activation by PKA.";
RL   J. Physiol. (Lond.) 548:39-52(2003).
RN   [20]
RP   FUNCTION.
RX   PubMed=14668433; DOI=10.1073/pnas.2634339100;
RA   Coakley R.D., Grubb B.R., Paradiso A.M., Gatzy J.T., Johnson L.G.,
RA   Kreda S.M., O'Neal W.K., Boucher R.C.;
RT   "Abnormal surface liquid pH regulation by cultured cystic fibrosis
RT   bronchial epithelium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:16083-16088(2003).
RN   [21]
RP   CATALYTIC ACTIVITY, AND DOMAIN.
RX   PubMed=15284228; DOI=10.1074/jbc.M407666200;
RA   Kidd J.F., Ramjeesingh M., Stratford F., Huan L.J., Bear C.E.;
RT   "A heteromeric complex of the two nucleotide binding domains of cystic
RT   fibrosis transmembrane conductance regulator (CFTR) mediates ATPase
RT   activity.";
RL   J. Biol. Chem. 279:41664-41669(2004).
RN   [22]
RP   FUNCTION.
RX   PubMed=16645176; DOI=10.1164/rccm.200506-987OC;
RA   Blouquit S., Regnier A., Dannhoffer L., Fermanian C., Naline E.,
RA   Boucher R., Chinet T.;
RT   "Ion and fluid transport properties of small airways in cystic
RT   fibrosis.";
RL   Am. J. Respir. Crit. Care Med. 174:299-305(2006).
RN   [23]
RP   DOMAIN, PHOSPHORYLATION, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17036051; DOI=10.1038/sj.emboj.7601373;
RA   Mense M., Vergani P., White D.M., Altberg G., Nairn A.C., Gadsby D.C.;
RT   "In vivo phosphorylation of CFTR promotes formation of a nucleotide-
RT   binding domain heterodimer.";
RL   EMBO J. 25:4728-4739(2006).
RN   [24]
RP   IDENTIFICATION IN A COMPLEX WITH RAB11A AND MYO5B, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=17462998; DOI=10.1074/jbc.M608531200;
RA   Swiatecka-Urban A., Talebian L., Kanno E., Moreau-Marquis S.,
RA   Coutermarsh B., Hansen K., Karlson K.H., Barnaby R., Cheney R.E.,
RA   Langford G.M., Fukuda M., Stanton B.A.;
RT   "Myosin Vb is required for trafficking of the cystic fibrosis
RT   transmembrane conductance regulator in Rab11a-specific apical
RT   recycling endosomes in polarized human airway epithelial cells.";
RL   J. Biol. Chem. 282:23725-23736(2007).
RN   [25]
RP   FUNCTION.
RX   PubMed=17434346; DOI=10.1016/j.jcf.2007.03.001;
RA   Lu C., Jiang C., Pribanic S., Rotin D.;
RT   "CFTR stabilizes ENaC at the plasma membrane.";
RL   J. Cyst. Fibros. 6:419-422(2007).
RN   [26]
RP   DOMAIN.
RX   PubMed=17660831; DOI=10.1038/nsmb1278;
RA   Baker J.M., Hudson R.P., Kanelis V., Choy W.Y., Thibodeau P.H.,
RA   Thomas P.J., Forman-Kay J.D.;
RT   "CFTR regulatory region interacts with NBD1 predominantly via multiple
RT   transient helices.";
RL   Nat. Struct. Mol. Biol. 14:738-745(2007).
RN   [27]
RP   UBIQUITINATION, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=19398555; DOI=10.1074/jbc.M109.001685;
RA   Bomberger J.M., Barnaby R.L., Stanton B.A.;
RT   "The deubiquitinating enzyme USP10 regulates the post-endocytic
RT   sorting of cystic fibrosis transmembrane conductance regulator in
RT   airway epithelial cells.";
RL   J. Biol. Chem. 284:18778-18789(2009).
RN   [28]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19019741; DOI=10.1016/j.jcf.2008.10.004;
RA   Tang L., Fatehi M., Linsdell P.;
RT   "Mechanism of direct bicarbonate transport by the CFTR anion
RT   channel.";
RL   J. Cyst. Fibros. 8:115-121(2009).
RN   [29]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19621064; DOI=10.1371/journal.pbio.1000155;
RA   Zhang L., Button B., Gabriel S.E., Burkett S., Yan Y.,
RA   Skiadopoulos M.H., Dang Y.L., Vogel L.N., McKay T., Mengos A.,
RA   Boucher R.C., Collins P.L., Pickles R.J.;
RT   "CFTR delivery to 25% of surface epithelial cells restores normal
RT   rates of mucus transport to human cystic fibrosis airway epithelium.";
RL   PLoS Biol. 7:E1000155-E1000155(2009).
RN   [30]
RP   INTERACTION WITH CSE1L.
RX   PubMed=20933420; DOI=10.1016/j.cub.2010.09.012;
RA   Bagnat M., Navis A., Herbstreith S., Brand-Arzamendi K., Curado S.,
RA   Gabriel S., Mostov K., Huisken J., Stainier D.Y.;
RT   "Cse1l is a negative regulator of CFTR-dependent fluid secretion.";
RL   Curr. Biol. 20:1840-1845(2010).
RN   [31]
RP   SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT CF PHE-508 DEL,
RP   MUTAGENESIS OF ASN-894 AND ASN-900, AND GLYCOSYLATION AT ASN-894 AND
RP   ASN-900.
RX   PubMed=20008117; DOI=10.1152/ajplung.00016.2009;
RA   Cholon D.M., O'Neal W.K., Randell S.H., Riordan J.R., Gentzsch M.;
RT   "Modulation of endocytic trafficking and apical stability of CFTR in
RT   primary human airway epithelial cultures.";
RL   Am. J. Physiol. 298:L304-L314(2010).
RN   [32]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19923167; DOI=10.1093/humrep/dep406;
RA   Li C.Y., Jiang L.Y., Chen W.Y., Li K., Sheng H.Q., Ni Y., Lu J.X.,
RA   Xu W.X., Zhang S.Y., Shi Q.X.;
RT   "CFTR is essential for sperm fertilizing capacity and is correlated
RT   with sperm quality in humans.";
RL   Hum. Reprod. 25:317-327(2010).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [34]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ANO1.
RX   PubMed=22178883; DOI=10.1159/000335765;
RA   Ousingsawat J., Kongsuphol P., Schreiber R., Kunzelmann K.;
RT   "CFTR and TMEM16A are separate but functionally related Cl-channels.";
RL   Cell. Physiol. Biochem. 28:715-724(2011).
RN   [35]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22207244; DOI=10.1007/s00418-011-0904-1;
RA   Enuka Y., Hanukoglu I., Edelheit O., Vaknine H., Hanukoglu A.;
RT   "Epithelial sodium channels (ENaC) are uniformly distributed on motile
RT   cilia in the oviduct and the respiratory airways.";
RL   Histochem. Cell Biol. 137:339-353(2012).
RN   [36]
RP   INTERACTION WITH SLC26A8.
RX   PubMed=22121115; DOI=10.1093/hmg/ddr558;
RA   Rode B., Dirami T., Bakouh N., Rizk-Rabin M., Norez C., Lhuillier P.,
RA   Lores P., Jollivet M., Melin P., Zvetkova I., Bienvenu T., Becq F.,
RA   Planelles G., Edelman A., Gacon G., Toure A.;
RT   "The testis anion transporter TAT1 (SLC26A8) physically and
RT   functionally interacts with the cystic fibrosis transmembrane
RT   conductance regulator channel: a potential role during sperm
RT   capacitation.";
RL   Hum. Mol. Genet. 21:1287-1298(2012).
RN   [37]
RP   PHOSPHORYLATION AT SER-660; SER-686; SER-700; SER-712; THR-717;
RP   SER-737; SER-795; SER-1444 AND SER-1456, UBIQUITINATION AT LYS-688,
RP   PALMITOYLATION AT CYS-524 AND CYS-1395, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22119790; DOI=10.1093/protein/gzr054;
RA   McClure M., Delucas L.J., Wilson L., Ray M., Rowe S.M., Wu X., Dai Q.,
RA   Hong J.S., Sorscher E.J., Kappes J.C., Barnes S.;
RT   "Purification of CFTR for mass spectrometry analysis: identification
RT   of palmitoylation and other post-translational modifications.";
RL   Protein Eng. Des. Sel. 25:7-14(2012).
RN   [38]
RP   UBIQUITINATION BY RNF185.
RX   PubMed=24019521; DOI=10.1074/jbc.M113.470500;
RA   El Khouri E., Le Pavec G., Toledano M.B., Delaunay-Moisan A.;
RT   "RNF185 is a novel E3 ligase of endoplasmic reticulum-associated
RT   degradation (ERAD) that targets cystic fibrosis transmembrane
RT   conductance regulator (CFTR).";
RL   J. Biol. Chem. 288:31177-31191(2013).
RN   [39]
RP   FUNCTION, CHARACTERIZATION OF CF VARIANT PHE-508 DEL, SUBCELLULAR
RP   LOCATION, PHOSPHORYLATION AT SER-660; SER-670; SER-700; SER-712;
RP   SER-737; SER-753; SER-768; SER-795 AND SER-813, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=25330774; DOI=10.1002/pmic.201400218;
RA   Pasyk S., Molinski S., Ahmadi S., Ramjeesingh M., Huan L.J., Chin S.,
RA   Du K., Yeger H., Taylor P., Moran M.F., Bear C.E.;
RT   "The major cystic fibrosis causing mutation exhibits defective
RT   propensity for phosphorylation.";
RL   Proteomics 15:447-461(2015).
RN   [40]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=26627831; DOI=10.1074/jbc.M115.704809;
RA   Ehrhardt A., Chung W.J., Pyle L.C., Wang W., Nowotarski K.,
RA   Mulvihill C.M., Ramjeesingh M., Hong J., Velu S.E., Lewis H.A.,
RA   Atwell S., Aller S., Bear C.E., Lukacs G.L., Kirk K.L., Sorscher E.J.;
RT   "Channel gating regulation by the cystic fibrosis transmembrane
RT   conductance regulator (CFTR) first cytosolic loop.";
RL   J. Biol. Chem. 291:1854-1865(2016).
RN   [41]
RP   FUNCTION.
RX   PubMed=26823428; DOI=10.1126/science.aad5589;
RA   Shah V.S., Meyerholz D.K., Tang X.X., Reznikov L., Abou Alaiwa M.,
RA   Ernst S.E., Karp P.H., Wohlford-Lenane C.L., Heilmann K.P.,
RA   Leidinger M.R., Allen P.D., Zabner J., McCray P.B. Jr.,
RA   Ostedgaard L.S., Stoltz D.A., Randak C.O., Welsh M.J.;
RT   "Airway acidification initiates host defense abnormalities in cystic
RT   fibrosis mice.";
RL   Science 351:503-507(2016).
RN   [42]
RP   FUNCTION.
RX   PubMed=27941075; DOI=10.1152/ajplung.00375.2016;
RA   Rauh R., Hoerner C., Korbmacher C.;
RT   "deltabetagamma-ENaC is inhibited by CFTR but stimulated by cAMP in
RT   Xenopus laevis oocytes.";
RL   Am. J. Physiol. 312:L277-L287(2017).
RN   [43]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28130590; DOI=10.1007/s00418-016-1535-3;
RA   Hanukoglu I., Boggula V.R., Vaknine H., Sharma S., Kleyman T.,
RA   Hanukoglu A.;
RT   "Expression of epithelial sodium channel (ENaC) and CFTR in the human
RT   epidermis and epidermal appendages.";
RL   Histochem. Cell Biol. 147:733-748(2017).
RN   [44]
RP   FUNCTION.
RX   PubMed=27714810; DOI=10.1002/jcp.25634;
RA   Puga Molina L.C., Pinto N.A., Torres Rodriguez P., Romarowski A.,
RA   Vicens Sanchez A., Visconti P.E., Darszon A., Trevino C.L.,
RA   Buffone M.G.;
RT   "Essential role of CFTR in PKA-dependent phosphorylation,
RT   alkalinization, and hyperpolarization during human sperm
RT   capacitation.";
RL   J. Cell. Physiol. 232:1404-1414(2017).
RN   [45]
RP   3D-STRUCTURE MODELING OF 425-638.
RX   PubMed=9517543;
RX   DOI=10.1002/(SICI)1097-0134(19980215)30:3<275::AID-PROT7>3.3.CO;2-L;
RA   Hoedemaeker F.J., Davidson A.R., Rose D.R.;
RT   "A model for the nucleotide-binding domains of ABC transporters based
RT   on the large domain of aspartate aminotransferase.";
RL   Proteins 30:275-286(1998).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1476-1480 IN COMPLEX WITH
RP   SLC9A3R1.
RX   PubMed=11304524; DOI=10.1074/jbc.C100154200;
RA   Karthikeyan S., Leung T., Ladias J.A.A.;
RT   "Structural basis of the Na+/H+ exchanger regulatory factor PDZ1
RT   interaction with the carboxyl-terminal region of the cystic fibrosis
RT   transmembrane conductance regulator.";
RL   J. Biol. Chem. 276:19683-19686(2001).
RN   [47] {ECO:0000244|PDB:2LOB}
RP   STRUCTURE BY NMR OF 1473-1480 IN COMPLEX WITH GOPC.
RX   PubMed=16331976; DOI=10.1021/bi0516475;
RA   Piserchio A., Fellows A., Madden D.R., Mierke D.F.;
RT   "Association of the cystic fibrosis transmembrane regulator with CAL:
RT   structural features and molecular dynamics.";
RL   Biochemistry 44:16158-16166(2005).
RN   [48] {ECO:0000244|PDB:1XMI, ECO:0000244|PDB:1XMJ}
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 389-678 OF WILD-TYPE AND
RP   VARIANT CF PHE-508 DEL IN COMPLEX WITH ATP, AND CHARACTERIZATION OF
RP   VARIANT CF PHE-508 DEL.
RX   PubMed=15528182; DOI=10.1074/jbc.M410968200;
RA   Lewis H.A., Zhao X., Wang C., Sauder J.M., Rooney I., Noland B.W.,
RA   Lorimer D., Kearins M.C., Conners K., Condon B., Maloney P.C.,
RA   Guggino W.B., Hunt J.F., Emtage S.;
RT   "Impact of the deltaF508 mutation in first nucleotide-binding domain
RT   of human cystic fibrosis transmembrane conductance regulator on domain
RT   folding and structure.";
RL   J. Biol. Chem. 280:1346-1353(2005).
RN   [49] {ECO:0000244|PDB:3GD7}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1193-1435 AND 1458-1470 IN
RP   COMPLEX WITH ATP ANALOG.
RA   Atwell S., Antonysamy S., Guggino W.B., Conners K., Emtage S.,
RA   Gheyi T., Hunt J.F., Lewis H.A., Lu F., Sauder J.M., Weber P.C.,
RA   Wetmore D., Zhao X.;
RT   "Crystal structure of human NBD2 complexed with N6-phenylethyl-ATP (P-
RT   ATP).";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [50] {ECO:0000244|PDB:2BBO, ECO:0000244|PDB:2BBS, ECO:0000244|PDB:2BBT}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 389-677 IN COMPLEX WITH ATP.
RX   PubMed=19944699; DOI=10.1016/j.jmb.2009.11.051;
RA   Lewis H.A., Wang C., Zhao X., Hamuro Y., Conners K., Kearins M.C.,
RA   Lu F., Sauder J.M., Molnar K.S., Coales S.J., Maloney P.C.,
RA   Guggino W.B., Wetmore D.R., Weber P.C., Hunt J.F.;
RT   "Structure and dynamics of NBD1 from CFTR characterized using
RT   crystallography and hydrogen/deuterium exchange mass spectrometry.";
RL   J. Mol. Biol. 396:406-430(2010).
RN   [51] {ECO:0000244|PDB:2PZE, ECO:0000244|PDB:2PZF, ECO:0000244|PDB:2PZG}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 387-646 IN COMPLEX WITH ATP,
RP   AND CHARACTERIZATION OF VARIANT CF PHE-508 DEL.
RX   PubMed=20150177; DOI=10.1093/protein/gzq004;
RA   Atwell S., Brouillette C.G., Conners K., Emtage S., Gheyi T.,
RA   Guggino W.B., Hendle J., Hunt J.F., Lewis H.A., Lu F.,
RA   Protasevich I.I., Rodgers L.A., Romero R., Wasserman S.R., Weber P.C.,
RA   Wetmore D., Zhang F.F., Zhao X.;
RT   "Structures of a minimal human CFTR first nucleotide-binding domain as
RT   a monomer, head-to-tail homodimer, and pathogenic mutant.";
RL   Protein Eng. Des. Sel. 23:375-384(2010).
RN   [52]
RP   STRUCTURE BY ELECTRON MICROSCOPY (9 ANGSTROMS).
RX   PubMed=21931164; DOI=10.1074/jbc.M111.292268;
RA   Rosenberg M.F., O'Ryan L.P., Hughes G., Zhao Z., Aleksandrov L.A.,
RA   Riordan J.R., Ford R.C.;
RT   "The cystic fibrosis transmembrane conductance regulator (CFTR):
RT   three-dimensional structure and localization of a channel gate.";
RL   J. Biol. Chem. 286:42647-42654(2011).
RN   [53] {ECO:0000244|PDB:4WZ6}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 389-678.
RX   PubMed=26444971; DOI=10.1002/pro.2821;
RA   Hall J.D., Wang H., Byrnes L.J., Shanker S., Wang K., Efremov I.V.,
RA   Chong P.A., Forman-Kay J.D., Aulabaugh A.E.;
RT   "Binding screen for cystic fibrosis transmembrane conductance
RT   regulator correctors finds new chemical matter and yields insights
RT   into cystic fibrosis therapeutic strategy.";
RL   Protein Sci. 25:360-373(2016).
RN   [54] {ECO:0000244|PDB:5UAK}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.87 ANGSTROMS), AND TOPOLOGY.
RA   Liu F., Zhang Z., Chen J.;
RT   "Structure of human cystic fibrosis transmembrane conductance
RT   regulator (CFTR).";
RL   Submitted (DEC-2016) to the PDB data bank.
RN   [55]
RP   REVIEW ON VARIANTS.
RX   PubMed=1284534; DOI=10.1002/humu.1380010304;
RA   Tsui L.-C.;
RT   "Mutations and sequence variations detected in the cystic fibrosis
RT   transmembrane conductance regulator (CFTR) gene: a report from the
RT   Cystic Fibrosis Genetic Analysis Consortium.";
RL   Hum. Mutat. 1:197-203(1992).
RN   [56]
RP   CHARACTERIZATION OF VARIANT CF TRP-334; ILE-507 DEL; PHE-508 DEL;
RP   ASP-551 AND ILE-549, MUTAGENESIS OF LYS-464; PHE-508 AND LYS-1250, AND
RP   GLYCOSYLATION.
RX   PubMed=1699669; DOI=10.1016/0092-8674(90)90148-8;
RA   Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W.,
RA   White G.A., O'Riordan C.R., Smith A.E.;
RT   "Defective intracellular transport and processing of CFTR is the
RT   molecular basis of most cystic fibrosis.";
RL   Cell 63:827-834(1990).
RN   [57]
RP   VARIANTS CF.
RX   PubMed=1695717; DOI=10.1038/346366a0;
RA   Cutting G.R., Kasch L.M., Rosenstein B.J., Zielenski J., Tsui L.-C.,
RA   Antonarakis S.E., Kazazian H.H. Jr.;
RT   "A cluster of cystic fibrosis mutations in the first nucleotide-
RT   binding fold of the cystic fibrosis conductance regulator protein.";
RL   Nature 346:366-369(1990).
RN   [58]
RP   VARIANTS CF.
RX   PubMed=2236053; DOI=10.1073/pnas.87.21.8447;
RA   Kerem B.-S., Zielenski J., Markiewicz D., Bozon D., Gazit E.,
RA   Yahav J., Kennedy D., Riordan J.R., Collins F.S., Rommens J.M.,
RA   Tsui L.-C.;
RT   "Identification of mutations in regions corresponding to the two
RT   putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8447-8451(1990).
RN   [59]
RP   VARIANTS CF.
RX   PubMed=1710600; DOI=10.1016/0888-7543(91)90510-L;
RA   White M.B., Krueger L.J., Holsclaw D.S. Jr., Gerrard B.C., Stewart C.,
RA   Quittell L., Dolganov G., Baranov V., Ivaschenko T., Kapronov N.I.,
RA   Sebastio G., Castiglione O., Dean M.;
RT   "Detection of three rare frameshift mutations in the cystic fibrosis
RT   gene in an African-American (CF444delA), an Italian (CF2522insC), and
RT   a Soviet (CF3821delT).";
RL   Genomics 10:266-269(1991).
RN   [60]
RP   CHARACTERIZATION OF CF VARIANTS ILE-507 DEL; PHE-508 DEL; ILE-549;
RP   ARG-549; ASP-551; THR-559; ASN-572; LYS-1303 AND ASP-1349, FUNCTION,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF PHE-508.
RX   PubMed=1712898; DOI=10.1128/MCB.11.8.3886;
RA   Gregory R.J., Rich D.P., Cheng S.H., Souza D.W., Paul S.,
RA   Manavalan P., Anderson M.P., Welsh M.J., Smith A.E.;
RT   "Maturation and function of cystic fibrosis transmembrane conductance
RT   regulator variants bearing mutations in putative nucleotide-binding
RT   domains 1 and 2.";
RL   Mol. Cell. Biol. 11:3886-3893(1991).
RN   [61]
RP   VARIANTS CF PHE-520 AND HIS-1291.
RX   PubMed=1284466; DOI=10.1093/hmg/1.1.11;
RA   Jones C.T., McIntosh I., Keston M., Ferguson A., Brock D.J.H.;
RT   "Three novel mutations in the cystic fibrosis gene detected by
RT   chemical cleavage: analysis of variant splicing and a nonsense
RT   mutation.";
RL   Hum. Mol. Genet. 1:11-17(1992).
RN   [62]
RP   VARIANT CF MET-1283.
RX   PubMed=1284468; DOI=10.1093/hmg/1.2.123;
RA   Cheadle J.P., Meredith A.L., Al-Jader L.N.;
RT   "A new missense mutation (R1283M) in exon 20 of the cystic fibrosis
RT   transmembrane conductance regulator gene.";
RL   Hum. Mol. Genet. 1:123-125(1992).
RN   [63]
RP   VARIANT CF PRO-1255.
RX   PubMed=1284530; DOI=10.1093/hmg/1.6.441;
RA   Lissens W., Bonduelle M., Malfroot A., Dab I., Liebaers I.;
RT   "A serine to proline substitution (S1255P) in the second nucleotide
RT   binding fold of the cystic fibrosis gene.";
RL   Hum. Mol. Genet. 1:441-442(1992).
RN   [64]
RP   VARIANTS CF LYS-92 AND CYS-117.
RX   PubMed=1284529; DOI=10.1093/hmg/1.6.439;
RA   Shackleton S., Beards F., Harris A.;
RT   "Detection of novel and rare mutations in exon 4 of the cystic
RT   fibrosis gene by SSCP.";
RL   Hum. Mol. Genet. 1:439-440(1992).
RN   [65]
RP   CHARACTERIZATION OF VARIANT CF PHE-508 DEL AND ASP-551, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=1284548; DOI=10.1038/ng0892-321;
RA   Kartner N., Augustinas O., Jensen T.J., Naismith A.L., Riordan J.R.;
RT   "Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.";
RL   Nat. Genet. 1:321-327(1992).
RN   [66]
RP   VARIANT CF LYS-1101.
RX   PubMed=7680525;
RA   Zielenski J., Fugiwara T.M., Markiewicz D., Paradis A.J.,
RA   Anacleto A.I., Richards B., Schwartz R.H., Klinger K.W., Tsui L.-C.,
RA   Morgan K.;
RT   "Identification of the M1101K mutation in the cystic fibrosis
RT   transmembrane conductance regulator (CFTR) gene and complete detection
RT   of cystic fibrosis mutations in the Hutterite population.";
RL   Am. J. Hum. Genet. 52:609-615(1993).
RN   [67]
RP   VARIANTS CF VAL-1052; ARG-1061; LEU-1066; GLN-1070; ARG-1085 AND
RP   ARG-1101.
RX   PubMed=7683628; DOI=10.1006/geno.1993.1183;
RA   Mercier B., Lissens W., Novelli G., Kalaydjieva L., De Arce M.,
RA   Kapranov N., Klain N.C., Lenoir G., Chauveau P., Lenaerts C.,
RA   Rault G., Cashman S., Sangiuolo F., Audrezet M.-P., Dallapiccola B.,
RA   Guillermit H., Bonduelle M., Liebaers I., Quere I., Verlingue C.,
RA   Ferec C.;
RT   "Identification of eight novel mutations in a collaborative analysis
RT   of a part of the second transmembrane domain of the CFTR gene.";
RL   Genomics 16:296-297(1993).
RN   [68]
RP   VARIANT CF LEU-693.
RX   PubMed=8406518;
RA   Audrezet M.P., Novelli G., Mercier B., Sangiuolo F., Maceratesi P.,
RA   Ferec C., Dallapiccola B.;
RT   "Identification of three novel cystic fibrosis mutations in a sample
RT   of Italian cystic fibrosis patients.";
RL   Hum. Hered. 43:295-300(1993).
RN   [69]
RP   VARIANT CF LYS-92.
RX   PubMed=7683954; DOI=10.1093/hmg/2.1.79;
RA   Nunes V., Chillon M., Doerk T., Tuemmler B., Casals T., Estivill X.;
RT   "A new missense mutation (E92K) in the first transmembrane domain of
RT   the CFTR gene causes a benign cystic fibrosis phenotype.";
RL   Hum. Mol. Genet. 2:79-80(1993).
RN   [70]
RP   VARIANT CF SER-205.
RX   PubMed=7505694; DOI=10.1093/hmg/2.10.1741;
RA   Chillon M., Casals T., Nunes V., Gimenez J., Ruiz E.P., Estivill X.;
RT   "Identification of a new missense mutation (P205S) in the first
RT   transmembrane domain of the CFTR gene associated with a mild cystic
RT   fibrosis phenotype.";
RL   Hum. Mol. Genet. 2:1741-1742(1993).
RN   [71]
RP   VARIANTS CF.
RX   PubMed=7504969; DOI=10.1002/humu.1380020511;
RA   Gasparini P., Marigo C., Bisceglia G., Nicolis E., Zelante L.,
RA   Bombieri C., Borgo G., Pignatti P.F., Cabrini G.;
RT   "Screening of 62 mutations in a cohort of cystic fibrosis patients
RT   from north eastern Italy: their incidence and clinical features of
RT   defined genotypes.";
RL   Hum. Mutat. 2:389-394(1993).
RN   [72]
RP   VARIANTS CYS-31 AND ILE-1220, AND VARIANTS CF LEU-912; TYR-949;
RP   PRO-1065 AND PRO-1071.
RX   PubMed=7522211; DOI=10.1006/geno.1994.1290;
RA   Ghaneb N., Costes B., Girodon E., Martin J., Fanen P., Goossens M.;
RT   "Identification of eight mutations and three sequence variations in
RT   the cystic fibrosis transmembrane conductance regulator (CFTR) gene.";
RL   Genomics 21:434-436(1994).
RN   [73]
RP   VARIANT CF PRO-346.
RX   PubMed=7513296; DOI=10.1007/BF00202817;
RA   Boteva K., Papageorgiou E., Georgiou C., Angastiniotis M.,
RA   Middleton L.T., Constantinou-Deltas C.D.;
RT   "Novel cystic fibrosis mutation associated with mild disease in
RT   Cypriot patients.";
RL   Hum. Genet. 93:529-532(1994).
RN   [74]
RP   VARIANTS CF TYR-199; SER-619; ARG-1005 AND ARG-1291.
RX   PubMed=7525450; DOI=10.1007/BF00211022;
RA   Doerk T., Mekus F., Schmidt K., Bosshammer J., Fislage R., Heuer T.,
RA   Dziadek V., Neumann T., Kaelin N., Wulbrand U., Wulf B.,
RA   von der Hardt H., Maass G., Tuemmler B.;
RT   "Detection of more than 50 different CFTR mutations in a large group
RT   of German cystic fibrosis patients.";
RL   Hum. Genet. 94:533-542(1994).
RN   [75]
RP   VARIANT CF GLU-1249.
RX   PubMed=7520022; DOI=10.1159/000154223;
RA   Greil I., Wagner K., Rosenkranz W.;
RT   "A new missense mutation G1249E in exon 20 of the cystic fibrosis
RT   transmembrane conductance regulator (CFTR) gene.";
RL   Hum. Hered. 44:238-240(1994).
RN   [76]
RP   VARIANT CF GLU-1397.
RX   PubMed=7524913; DOI=10.1093/hmg/3.6.999;
RA   Petreska L., Koceva S., Gordova-Muratovska A., Nestorov R.,
RA   Efremov G.D.;
RT   "Identification of two new mutations (711 +3A-->G and V1397E) in CF
RT   chromosomes of Albanian and Macedonian origin.";
RL   Hum. Mol. Genet. 3:999-1000(1994).
RN   [77]
RP   VARIANT CF CYS-109.
RX   PubMed=7524909; DOI=10.1093/hmg/3.6.1001;
RA   Schaedel C., Kristoffersson A.-C., Kornfaelt R., Holmberg L.;
RT   "A novel cystic fibrosis mutation, Y109C, in the first transmembrane
RT   domain of CFTR.";
RL   Hum. Mol. Genet. 3:1001-1002(1994).
RN   [78]
RP   VARIANT CF THR-120.
RX   PubMed=7517264; DOI=10.1002/humu.1380030308;
RA   Chillon M., Casals T., Gimenez J., Nunes V., Estivill X.;
RT   "Analysis of the CFTR gene in the Spanish population: SSCP-screening
RT   for 60 known mutations and identification of four new mutations (Q30X,
RT   A120T, 1812-1 G-->A, and 3667del4).";
RL   Hum. Mutat. 3:223-230(1994).
RN   [79]
RP   VARIANT CF LEU-87.
RX   PubMed=8081395; DOI=10.1002/humu.1380030412;
RA   Bienvenu T., Petitpretz P., Beldjord C., Kaplan J.C.;
RT   "A missense mutation (F87L) in exon 3 of the cystic fibrosis
RT   transmembrane conductance regulator gene.";
RL   Hum. Mutat. 3:395-396(1994).
RN   [80]
RP   VARIANTS CBAVD ARG-149; LYS-193; GLY-258 AND GLY-800.
RX   PubMed=7529962;
RA   Mercier B., Verlingue C., Lissens W., Silber S.J., Novelli G.,
RA   Bonduelle M., Audrezet M.-P., Ferec C.;
RT   "Is congenital bilateral absence of vas deferens a primary form of
RT   cystic fibrosis? Analyses of the CFTR gene in 67 patients.";
RL   Am. J. Hum. Genet. 56:272-277(1995).
RN   [81]
RP   VARIANTS CBAVD.
RX   PubMed=7539342;
RA   Jezequel P., Dorval I., Fergelot P., Chauvel B., Le Treut A.,
RA   Le Gall J.-Y., Le Lannou D., Blayau M.;
RT   "Structural analysis of CFTR gene in congenital bilateral absence of
RT   vas deferens.";
RL   Clin. Chem. 41:833-835(1995).
RN   [82]
RP   VARIANT CF SER-551.
RX   PubMed=7606851;
RA   Orozco L., Lezana J.L., Villarreal M.T., Chavez M., Carnevale A.;
RT   "Mild cystic fibrosis disease in three Mexican delta-F508/G551S
RT   compound heterozygous siblings.";
RL   Clin. Genet. 47:96-98(1995).
RN   [83]
RP   VARIANTS CF GLY-57; LYS-193 AND GLY-579.
RX   PubMed=7544319; DOI=10.1007/BF00210414;
RA   Brancolini V., Cremonesi L., Belloni E., Pappalardo E., Bordoni R.,
RA   Seia M., Russo S., Padoan R., Giunta A., Ferrari M.;
RT   "Search for mutations in pancreatic sufficient cystic fibrosis Italian
RT   patients: detection of 90% of molecular defects and identification of
RT   three novel mutations.";
RL   Hum. Genet. 96:312-318(1995).
RN   [84]
RP   VARIANT CF TRP-206.
RX   PubMed=8522333; DOI=10.1007/BF00210305;
RA   Desgeorges M., Rodier M., Piot M., Demaille J., Claustres M.;
RT   "Four adult patients with the missense mutation L206W and a mild
RT   cystic fibrosis phenotype.";
RL   Hum. Genet. 96:717-720(1995).
RN   [85]
RP   VARIANTS CF LEU-31 AND ARG-1098.
RX   PubMed=7537150; DOI=10.1002/humu.1380050106;
RA   Zielenski J., Markiewicz D., Chen H.S., Schappert K.T., Seller A.,
RA   Durie P., Corey M., Tsui L.-C.;
RT   "Identification of six mutations (R31L, 441delA, 681delC, 1461ins4,
RT   W1089R, E1104X) in the cystic fibrosis transmembrane conductance
RT   regulator (CFTR) gene.";
RL   Hum. Mutat. 5:43-47(1995).
RN   [86]
RP   VARIANT CF ASN-572.
RX   PubMed=7541273; DOI=10.1002/humu.1380050304;
RA   Verlingue C., Kapranov N.I., Mercier B., Ginter E.K., Petrova N.V.,
RA   Audrezet M.P., Ferec C.;
RT   "Complete screening of mutations in the coding sequence of the CFTR
RT   gene in a sample of CF patients from Russia: identification of three
RT   novel alleles.";
RL   Hum. Mutat. 5:205-209(1995).
RN   [87]
RP   VARIANT CF ARG-98.
RX   PubMed=7581407; DOI=10.1002/humu.1380060216;
RA   Romey M.-C., Desgeorges M., Ray P., Godard P., Demaille J.,
RA   Claustres M.;
RT   "Novel missense mutation in the first transmembrane segment of the
RT   CFTR gene (Q98R) identified in a male adult.";
RL   Hum. Mutat. 6:190-191(1995).
RN   [88]
RP   VARIANT CF ILE-338.
RX   PubMed=7543567; DOI=10.1016/S0022-3476(95)70310-1;
RA   Leoni G.B., Pitzalis S., Podda R., Zanda M., Silvetti M., Caocci L.,
RA   Cao A., Rosatelli M.C.;
RT   "A specific cystic fibrosis mutation (T338I) associated with the
RT   phenotype of isolated hypotonic dehydration.";
RL   J. Pediatr. 127:281-283(1995).
RN   [89]
RP   VARIANTS CF PHE-42; LEU-117; ARG-139 AND GLU-1006.
RX   PubMed=7541510; DOI=10.1016/S0890-8508(95)80038-7;
RA   Ferec C., Novelli G., Verlingue C., Quere I., Dallapiccola B.,
RA   Audrezet M.P., Mercier B.;
RT   "Identification of six novel CFTR mutations in a sample of Italian
RT   cystic fibrosis patients.";
RL   Mol. Cell. Probes 9:135-137(1995).
RN   [90]
RP   VARIANT CF SER-665.
RX   PubMed=8800923;
RA   Messaoud T., Verlingue C., Denamur E., Pascaud O., Quere I.,
RA   Fattoum S., Elion J., Ferec C.;
RT   "Distribution of CFTR mutations in cystic fibrosis patients of
RT   Tunisian origin: identification of two novel mutations.";
RL   Eur. J. Hum. Genet. 4:20-24(1996).
RN   [91]
RP   VARIANT CF ARG-314.
RX   PubMed=8829633;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:2<151::AID-HUMU10>3.0.CO;2-1;
RA   Nasr S.Z., Strong T.V., Mansoura M.K., Dawson D.C., Collins F.S.;
RT   "Novel missense mutation (G314R) in a cystic fibrosis patient with
RT   hepatic failure.";
RL   Hum. Mutat. 7:151-154(1996).
RN   [92]
RP   VARIANT CF CYS-569.
RX   PubMed=8723693;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:4<375::AID-HUMU17>3.3.CO;2-K;
RA   Petreska L., Plaseska D., Koseva S., Stavljenic-Rukavina A.,
RA   Efremov G.D.;
RT   "A novel mutation in exon 12 (Y569C) of the CFTR gene identified in a
RT   patient of Croatian origin.";
RL   Hum. Mutat. 7:374-375(1996).
RN   [93]
RP   VARIANT CF ARG-1061.
RX   PubMed=8723695;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:4<376::AID-HUMU18>3.3.CO;2-E;
RA   Bienvenu T., Chertkoff L., Beldjord C., Segal E., Carniglia L.,
RA   Barreiro C., Kaplan J.-C.;
RT   "Identification of three novel mutations in the cystic fibrosis
RT   transmembrane conductance regulator gene in Argentinian CF patients.";
RL   Hum. Mutat. 7:376-377(1996).
RN   [94]
RP   VARIANT CF LEU-562.
RX   PubMed=8956039;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:4<340::AID-HUMU7>3.3.CO;2-K;
RA   Hughes D.J., Hill A.J.M., Macek M. Jr., Redmond A.O., Nevin N.C.,
RA   Graham C.A.;
RT   "Mutation characterization of CFTR gene in 206 Northern Irish CF
RT   families: thirty mutations, including two novel, account for
RT   approximately 94% of CF chromosomes.";
RL   Hum. Mutat. 8:340-347(1996).
RN   [95]
RP   CHARACTERIZATION OF VARIANT CF ASP-551, CATALYTIC ACTIVITY, FUNCTION,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=8910473; DOI=10.1074/jbc.271.45.28463;
RA   Li C., Ramjeesingh M., Wang W., Garami E., Hewryk M., Lee D.,
RA   Rommens J.M., Galley K., Bear C.E.;
RT   "ATPase activity of the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   J. Biol. Chem. 271:28463-28468(1996).
RN   [96]
RP   VARIANT CBAVD TYR-50.
RX   PubMed=9067761;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:2<183::AID-HUMU13>3.0.CO;2-Z;
RA   Zielenski J., Patrizio P., Markiewicz D., Asch R.H., Tsui L.-C.;
RT   "Identification of two mutations (S50Y and 4173delC) in the CFTR gene
RT   from patients with congenital bilateral absence of vas deferens
RT   (CBAVD).";
RL   Hum. Mutat. 9:183-184(1997).
RN   [97]
RP   VARIANT CF MET-1140 DEL.
RX   PubMed=9101301;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<368::AID-HUMU13>3.3.CO;2-F;
RA   Clavel C., Pennaforte F., Pigeon F., Verlingue C., Birembaut P.,
RA   Ferec C.;
RT   "Identification of four novel mutations in the cystic fibrosis
RT   transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA,
RT   and delta M1140.";
RL   Hum. Mutat. 9:368-369(1997).
RN   [98]
RP   VARIANT CF ASP-141.
RX   PubMed=9222768;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:1<86::AID-HUMU15>3.0.CO;2-W;
RA   Gouya L., Pascaud O., Munck A., Elion J., Denamur E.;
RT   "Novel mutation (A141D) in exon 4 of the CFTR gene identified in an
RT   Algerian patient.";
RL   Hum. Mutat. 10:86-87(1997).
RN   [99]
RP   VARIANT CF CYS-1066.
RX   PubMed=9375855;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:5<387::AID-HUMU9>3.3.CO;2-V;
RA   Casals T., Pacheco P., Barreto C., Gimenez J., Ramos M.D., Pereira S.,
RA   Pinheiro J.A., Cobos N., Curvelo A., Vazquez C., Rocha H.,
RA   Seculi J.L., Perez E., Dapena J., Carrilho E., Duarte A.,
RA   Palacio A.M., Nunes V., Lavinha J., Estivill X.;
RT   "Missense mutation R1066C in the second transmembrane domain of CFTR
RT   causes a severe cystic fibrosis phenotype: study of 19 heterozygous
RT   and 2 homozygous patients.";
RL   Hum. Mutat. 10:387-392(1997).
RN   [100]
RP   VARIANTS CF GLU-85; HIS-117; TYR-287; GLU-455; ASP-551; PRO-1070 AND
RP   LYS-1303.
RX   PubMed=9401006;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:6<436::AID-HUMU4>3.0.CO;2-B;
RA   Shrimpton A.E., Borowitz D., Swender P.;
RT   "Cystic fibrosis mutation frequencies in upstate New York.";
RL   Hum. Mutat. 10:436-442(1997).
RN   [101]
RP   VARIANT CF PHE-311 DEL.
RX   PubMed=9443874; DOI=10.1086/301681;
RA   Friedman K.J., Leigh M.W., Czarnecki P., Feldman G.L.;
RT   "Cystic fibrosis transmembrane-conductance regulator mutations among
RT   African Americans.";
RL   Am. J. Hum. Genet. 62:195-196(1998).
RN   [102]
RP   CHARACTERIZATION OF VARIANTS CF VAL-1137; MET-1140 DEL AND HIS-1152,
RP   MUTAGENESIS OF MET-1137; ILE-1139 AND ASP-1154, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=9804160; DOI=10.1016/S0014-5793(98)01042-4;
RA   Vankeerberghen A., Wei L., Teng H., Jaspers M., Cassiman J.J.,
RA   Nilius B., Cuppens H.;
RT   "Characterization of mutations located in exon 18 of the CFTR gene.";
RL   FEBS Lett. 437:1-4(1998).
RN   [103]
RP   VARIANTS CF LEU-1013 AND ILE-1028.
RX   PubMed=9521595; DOI=10.1007/s004390050683;
RA   Onay T., Topaloglu O., Zielenski J., Gokgoz N., Kayserili H.,
RA   Camcioglu Y., Cokugras H., Akcakaya N., Apak M., Tsui L.-C.,
RA   Kirdar B.;
RT   "Analysis of the CFTR gene in Turkish cystic fibrosis patients:
RT   identification of three novel mutations (3172delAC, P1013L and
RT   M1028I).";
RL   Hum. Genet. 102:224-230(1998).
RN   [104]
RP   VARIANTS CF, AND VARIANTS CYS-31; GLN-75; VAL-506 AND CYS-668.
RX   PubMed=9921909; DOI=10.1007/s004390050897;
RA   Bombieri C., Benetazzo M., Saccomani A., Belpinati F., Gile L.S.,
RA   Luisetti M., Pignatti P.F.;
RT   "Complete mutational screening of the CFTR gene in 120 patients with
RT   pulmonary disease.";
RL   Hum. Genet. 103:718-722(1998).
RN   [105]
RP   CHARACTERIZATION OF VARIANTS CF PHE-601; SER-610; THR-613; GLY-614;
RP   THR-618; SER-619; GLN-620; PRO-620; ARG-628; PRO-633 AND SER-665,
RP   CHARACTERIZATION OF VARIANT OLIGOSPERMIA ASP-622, CHARACTERIZATION OF
RP   VARIANTS CBAVD GLY-792 AND GLY-800, AND CHARACTERIZATION OF VARIANT
RP   THORACIC SARCOIDOSIS LYS-828.
RX   PubMed=9736778; DOI=10.1093/hmg/7.11.1761;
RA   Vankeerberghen A., Wei L., Jaspers M., Cassiman J.-J., Nilius B.,
RA   Cuppens H.;
RT   "Characterization of 19 disease-associated missense mutations in the
RT   regulatory domain of the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   Hum. Mol. Genet. 7:1761-1769(1998).
RN   [106]
RP   VARIANTS CF SER-560 AND ASP-569.
RX   PubMed=9482579;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:2<152::AID-HUMU8>3.0.CO;2-L;
RA   Malone G., Haworth A., Schwarz M.J., Cuppens H., Super M.;
RT   "Detection of five novel mutations of the cystic fibrosis
RT   transmembrane regulator (CFTR) gene in Pakistani patients with cystic
RT   fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C).";
RL   Hum. Mutat. 11:152-157(1998).
RN   [107]
RP   VARIANTS CF PHE-13 AND ILE-338.
RX   PubMed=9554753;
RA   Leoni G.B., Pitzalis S., Tonelli R., Cao A.;
RT   "Identification of a novel mutation (S13F) in the CFTR gene in a CF
RT   patient of Sardinian origin.";
RL   Hum. Mutat. 11:337-337(1998).
RN   [108]
RP   VARIANTS CF PRO-117 AND ASP-192 DEL.
RX   PubMed=9452048;
RA   Feldmann D., Sardet A., Cougoureux E., Plouvier E., Fontaine J.-L.,
RA   Tournier G., Aymard P.;
RT   "Identification of three novel mutations in the CFTR gene, R117P,
RT   deltaD192, and 3121+1G-->A in four French patients.";
RL   Hum. Mutat. Suppl. 1:S78-S80(1998).
RN   [109]
RP   VARIANT CF ARG-1065.
RX   PubMed=9452054;
RA   Casals T., Ramos M.D., Gimenez J., Nadal M., Nunes V., Estivill X.;
RT   "Paternal origin of a de novo novel CFTR mutation (L1065R) causing
RT   cystic fibrosis.";
RL   Hum. Mutat. Suppl. 1:S99-S102(1998).
RN   [110]
RP   VARIANT CF ASN-LYS-370 INS.
RX   PubMed=9452073;
RA   Shackleton S., Harris A.;
RT   "A 2-amino acid insertion mutation (1243insACAAAA) in exon 7 of the
RT   CFTR gene.";
RL   Hum. Mutat. Suppl. 1:S156-S157(1998).
RN   [111]
RP   VARIANT CBAVD GLY-513, AND VARIANT MET-470.
RX   PubMed=10651488;
RA   Bienvenu T., Bousquet S., Vidaud D., Hubert D., Francoual C.,
RA   Beldjord C., Kaplan J.-C.;
RT   "A novel missense mutation D513G in exon 10 of the cystic fibrosis
RT   transmembrane conductance regulator (CFTR) gene identified in a French
RT   CBAVD patient.";
RL   Hum. Mutat. 12:213-214(1998).
RN   [112]
RP   VARIANTS CBAVD LEU-111; LYS-244; VAL-544 AND VAL-1364.
RA   de Meeus A., Guittard C., Desgeorges M., Carles S., Demaille J.,
RA   Claustres M.;
RT   "Genetic findings in congenital bilateral aplasia of vas deferens
RT   patients and identification of six novel mutations.";
RL   Hum. Mutat. 12:480-480(1998).
RN   [113]
RP   VARIANT CF GLY-579.
RX   PubMed=10094564;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:2<173::AID-HUMU20>3.0.CO;2-3;
RA   Picci L., Cameran M., Olante P., Zacchello F., Scarpa M.;
RT   "Identification of a D579G homozygote cystic fibrosis patient with
RT   pancreatic sufficiency and minor lung involvement.";
RL   Hum. Mutat. 13:173-173(1999).
RN   [114]
RP   VARIANT CF LEU-693.
RX   PubMed=12167682; DOI=10.1056/NEJMoa011899;
RA   Groman J.D., Meyer M.E., Wilmott R.W., Zeitlin P.L., Cutting G.R.;
RT   "Variant cystic fibrosis phenotypes in the absence of CFTR
RT   mutations.";
RL   N. Engl. J. Med. 347:401-407(2002).
RN   [115]
RP   CHARACTERIZATION OF VARIANT CF TYR-287 AND PHE-508 DEL, SUBCELLULAR
RP   LOCATION, FUNCTION, AND GLYCOSYLATION.
RX   PubMed=12529365; DOI=10.1074/jbc.M212843200;
RA   Silvis M.R., Picciano J.A., Bertrand C., Weixel K., Bridges R.J.,
RA   Bradbury N.A.;
RT   "A mutation in the cystic fibrosis transmembrane conductance regulator
RT   generates a novel internalization sequence and enhances endocytic
RT   rates.";
RL   J. Biol. Chem. 278:11554-11560(2003).
RN   [116]
RP   CHARACTERIZATION OF VARIANT CF PHE-508 DEL, SUBCELLULAR LOCATION,
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15716351; DOI=10.1091/mbc.E04-11-1010;
RA   Kreda S.M., Mall M., Mengos A., Rochelle L., Yankaskas J.,
RA   Riordan J.R., Boucher R.C.;
RT   "Characterization of wild-type and deltaF508 cystic fibrosis
RT   transmembrane regulator in human respiratory epithelia.";
RL   Mol. Biol. Cell 16:2154-2167(2005).
RN   [117]
RP   CHARACTERIZATION OF CF VARIANT LYS-1303, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=17182731; DOI=10.1152/ajpcell.00064.2006;
RA   Suaud L., Yan W., Carattino M.D., Robay A., Kleyman T.R.,
RA   Rubenstein R.C.;
RT   "Regulatory interactions of N1303K-CFTR and ENaC in Xenopus oocytes:
RT   evidence that chloride transport is not necessary for inhibition of
RT   ENaC.";
RL   Am. J. Physiol. 292:C1553-C1561(2007).
RN   [118]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-470.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [119]
RP   CHARACTERIZATION OF VARIANT CF HIS-117, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26846474; DOI=10.1113/JP271723;
RA   Yu Y.C., Sohma Y., Hwang T.C.;
RT   "On the mechanism of gating defects caused by the R117H mutation in
RT   cystic fibrosis transmembrane conductance regulator.";
RL   J. Physiol. (Lond.) 594:3227-3244(2016).
RN   [120]
RP   CHARACTERIZATION OF VARIANT CF PHE-508 DEL, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ILE-539.
RX   PubMed=28001373; DOI=10.1021/acs.biochem.6b00853;
RA   Zhang Z., Baksh M.M., Finn M.G., Heidary D.K., Richards C.I.;
RT   "Direct measurement of trafficking of the cystic fibrosis
RT   transmembrane conductance regulator to the cell surface and binding to
RT   a chemical chaperone.";
RL   Biochemistry 56:240-249(2017).
RN   [121]
RP   CHARACTERIZATION OF VARIANTS CF PHE-508 DEL AND ASP-551, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=28087700; DOI=10.1074/jbc.M116.751537;
RA   Meng X., Wang Y., Wang X., Wrennall J.A., Rimington T.L., Li H.,
RA   Cai Z., Ford R.C., Sheppard D.N.;
RT   "Two small molecules restore stability to a sub-population of the
RT   cystic fibrosis transmembrane conductance regulator with the
RT   predominant disease-causing mutation.";
RL   J. Biol. Chem. 292:3706-3719(2017).
CC   -!- FUNCTION: Epithelial ion channel that plays an important role in
CC       the regulation of epithelial ion and water transport and fluid
CC       homeostasis (PubMed:26823428). Mediates the transport of chloride
CC       ions across the cell membrane (PubMed:10792060, PubMed:11524016,
CC       PubMed:11707463, PubMed:12519745, PubMed:15010471,
CC       PubMed:12588899, PubMed:17036051, PubMed:19398555,
CC       PubMed:19621064, PubMed:22178883, PubMed:25330774, PubMed:1712898,
CC       PubMed:8910473, PubMed:9804160, PubMed:12529365, PubMed:17182731,
CC       PubMed:26846474, PubMed:28087700). Channel activity is coupled to
CC       ATP hydrolysis (PubMed:8910473). The ion channel is also permeable
CC       to HCO(3-); selectivity depends on the extracellular chloride
CC       concentration (PubMed:15010471, PubMed:19019741). Exerts its
CC       function also by modulating the activity of other ion channels and
CC       transporters (PubMed:12403779, PubMed:22178883, PubMed:22121115,
CC       PubMed:27941075). Plays an important role in airway fluid
CC       homeostasis (PubMed:16645176, PubMed:19621064, PubMed:26823428).
CC       Contributes to the regulation of the pH and the ion content of the
CC       airway surface fluid layer and thereby plays an important role in
CC       defense against pathogens (PubMed:14668433, PubMed:16645176,
CC       PubMed:26823428). Modulates the activity of the epithelial sodium
CC       channel (ENaC) complex, in part by regulating the cell surface
CC       expression of the ENaC complex (PubMed:17434346, PubMed:27941075,
CC       PubMed:17182731). Inhibits the activity of the ENaC channel
CC       containing subunits SCNN1A, SCNN1B and SCNN1G (PubMed:17182731).
CC       Inhibits the activity of the ENaC channel containing subunits
CC       SCNN1D, SCNN1B and SCNN1G, but not of the ENaC channel containing
CC       subunits SCNN1A, SCNN1B and SCNN1G (PubMed:27941075). May regulate
CC       bicarbonate secretion and salvage in epithelial cells by
CC       regulating the transporter SLC4A7 (PubMed:12403779). Can inhibit
CC       the chloride channel activity of ANO1 (PubMed:22178883). Plays a
CC       role in the chloride and bicarbonate homeostasis during sperm
CC       epididymal maturation and capacitation (PubMed:19923167,
CC       PubMed:27714810). {ECO:0000269|PubMed:10792060,
CC       ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:12403779, ECO:0000269|PubMed:12519745,
CC       ECO:0000269|PubMed:12529365, ECO:0000269|PubMed:12588899,
CC       ECO:0000269|PubMed:14668433, ECO:0000269|PubMed:15010471,
CC       ECO:0000269|PubMed:16645176, ECO:0000269|PubMed:17036051,
CC       ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731,
CC       ECO:0000269|PubMed:19019741, ECO:0000269|PubMed:19398555,
CC       ECO:0000269|PubMed:19621064, ECO:0000269|PubMed:22178883,
CC       ECO:0000269|PubMed:25330774, ECO:0000269|PubMed:26627831,
CC       ECO:0000269|PubMed:26823428, ECO:0000269|PubMed:26846474,
CC       ECO:0000269|PubMed:27714810, ECO:0000269|PubMed:27941075,
CC       ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:8910473,
CC       ECO:0000269|PubMed:9804160, ECO:0000305|PubMed:19923167}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:15284228,
CC       ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:8910473}.
CC   -!- SUBUNIT: Monomer; does not require oligomerization for channel
CC       activity (PubMed:11524016). May form oligomers in the membrane
CC       (PubMed:11524016). Interacts with SLC26A3, SLC26A6 and SHANK2 (By
CC       similarity). Interacts with SLC9A3R1 and MYO6 (PubMed:12403779,
CC       PubMed:15247260, PubMed:11304524). Interacts (via C-terminus) with
CC       GOPC (via PDZ domain); this promotes CFTR internalization and
CC       thereby decreases channel activity (PubMed:11707463,
CC       PubMed:16331976). Interacts with SLC4A7 through SLC9A3R1
CC       (PubMed:12403779). Found in a complex with MYO5B and RAB11A
CC       (PubMed:17462998). Interacts with ANO1 (PubMed:22178883).
CC       Interacts with SLC26A8 (PubMed:22121115). Interacts with AHCYL1;
CC       the interaction increases CFTR activity (By similarity). Interacts
CC       with CSE1L (PubMed:20933420). {ECO:0000250|UniProtKB:P26361,
CC       ECO:0000250|UniProtKB:P34158, ECO:0000269|PubMed:11304524,
CC       ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:12403779, ECO:0000269|PubMed:15247260,
CC       ECO:0000269|PubMed:16331976, ECO:0000269|PubMed:17462998,
CC       ECO:0000269|PubMed:20933420, ECO:0000269|PubMed:22121115,
CC       ECO:0000269|PubMed:22178883}.
CC   -!- INTERACTION:
CC       P51572:BCAP31; NbExp=3; IntAct=EBI-349854, EBI-77683;
CC       P27824:CANX; NbExp=3; IntAct=EBI-349854, EBI-355947;
CC       Q9BUN8:DERL1; NbExp=2; IntAct=EBI-349854, EBI-398977;
CC       Q9H8Y8:GORASP2; NbExp=3; IntAct=EBI-349854, EBI-739467;
CC       P19120:HSPA8 (xeno); NbExp=2; IntAct=EBI-349854, EBI-907802;
CC       O15554:KCNN4; NbExp=5; IntAct=EBI-349854, EBI-2924473;
CC       P05787:KRT8; NbExp=7; IntAct=EBI-349854, EBI-297852;
CC       Q9HBW0:LPAR2; NbExp=4; IntAct=EBI-349854, EBI-765995;
CC       Q5T2W1:PDZK1; NbExp=2; IntAct=EBI-349854, EBI-349819;
CC       Q99942:RNF5; NbExp=3; IntAct=EBI-349854, EBI-348482;
CC       Q9QX74:Shank2 (xeno); NbExp=2; IntAct=EBI-349854, EBI-397902;
CC       Q96RN1:SLC26A8; NbExp=2; IntAct=EBI-349854, EBI-1792052;
CC       O14745:SLC9A3R1; NbExp=5; IntAct=EBI-349854, EBI-349787;
CC       Q15599:SLC9A3R2; NbExp=7; IntAct=EBI-349854, EBI-1149760;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12529365,
CC       ECO:0000269|PubMed:1284548, ECO:0000269|PubMed:15247260,
CC       ECO:0000269|PubMed:15716351, ECO:0000269|PubMed:17462998,
CC       ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:19621064,
CC       ECO:0000269|PubMed:20008117, ECO:0000269|PubMed:22207244,
CC       ECO:0000269|PubMed:28130590}; Multi-pass membrane protein
CC       {ECO:0000269|Ref.54}. Early endosome membrane
CC       {ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:20008117}; Multi-
CC       pass membrane protein {ECO:0000269|Ref.54}. Cell membrane
CC       {ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:11524016,
CC       ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:12588899,
CC       ECO:0000269|PubMed:15010471, ECO:0000269|PubMed:17036051,
CC       ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731,
CC       ECO:0000269|PubMed:19019741, ECO:0000269|PubMed:19398555,
CC       ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:25330774,
CC       ECO:0000269|PubMed:26846474, ECO:0000269|PubMed:28001373,
CC       ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:28130590,
CC       ECO:0000269|PubMed:9804160, ECO:0000305|PubMed:8910473}; Multi-
CC       pass membrane protein {ECO:0000269|Ref.54}. Recycling endosome
CC       membrane {ECO:0000305|PubMed:17462998}; Multi-pass membrane
CC       protein {ECO:0000269|Ref.54}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:25330774}; Multi-
CC       pass membrane protein {ECO:0000269|Ref.54}. Note=The channel is
CC       internalized from the cell surface into an endosomal recycling
CC       compartment, from where it is recycled to the cell membrane
CC       (PubMed:17462998, PubMed:19398555, PubMed:20008117). In the
CC       oviduct and bronchus, detected on the apical side of epithelial
CC       cells, but not associated with cilia (PubMed:22207244).
CC       {ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:20008117,
CC       ECO:0000269|PubMed:22207244, ECO:0000305|PubMed:17462998}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P13569-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13569-2; Sequence=VSP_022123;
CC         Note=Exon skipping favored by a high number of TG repeats and a
CC         low number of T repeats at the intron-exon boundary. Causes
CC         congenital bilateral absence of the vas deferens (CBAVD).;
CC       Name=3;
CC         IsoId=P13569-3; Sequence=VSP_022124, VSP_022125;
CC         Note=Alternative acceptor site favored by mutation in an exonic
CC         splicing enhancer (ESE). Causes cystic fibrosis (CF).;
CC   -!- TISSUE SPECIFICITY: Expressed in the respiratory airway, including
CC       bronchial epithelium, and in the female reproductive tract,
CC       including oviduct (at protein level) (PubMed:22207244,
CC       PubMed:15716351). Detected in pancreatic intercalated ducts in the
CC       exocrine tissue, on epithelial cells in intralobular striated
CC       ducts in sublingual salivary glands, on apical membranes of crypt
CC       cells throughout the small and large intestine, and on the
CC       reabsorptive duct in eccrine sweat glands (PubMed:1284548,
CC       PubMed:28130590). Detected on the equatorial segment of the sperm
CC       head (at protein level) (PubMed:19923167). Detected in nasal and
CC       bronchial superficial epithelium (PubMed:15716351). Expressed by
CC       the central cells on the sebaceous glands, dermal adipocytes and,
CC       at lower levels, by epithelial cells (PubMed:28130590).
CC       {ECO:0000269|PubMed:1284548, ECO:0000269|PubMed:15716351,
CC       ECO:0000269|PubMed:19923167, ECO:0000269|PubMed:22207244,
CC       ECO:0000269|PubMed:28130590}.
CC   -!- DOMAIN: Binds and hydrolyzes ATP via the two cytoplasmic ABC
CC       transporter nucleotide-binding domains (PubMed:15284228). The two
CC       ATP-binding domains interact with each other, forming a head-to-
CC       tail dimer (PubMed:17036051). Normal ATPase activity requires
CC       interaction between the two domains (PubMed:15284228). The first
CC       ABC transporter nucleotide-binding domain has no ATPase activity
CC       by itself (By similarity). {ECO:0000250|UniProtKB:P26361,
CC       ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:17036051}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interactions with GOPC and
CC       with the SLC4A7, SLC9A3R1/EBP50 complex.
CC       {ECO:0000269|PubMed:11304524, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:16331976}.
CC   -!- DOMAIN: The R region is intrinsically disordered (PubMed:10792060,
CC       PubMed:17660831). It mediates channel activation when it is
CC       phosphorylated, but not in the absence of phosphorylation
CC       (PubMed:10792060). {ECO:0000269|PubMed:10792060,
CC       ECO:0000269|PubMed:17660831}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12529365,
CC       ECO:0000269|PubMed:1699669, ECO:0000269|PubMed:20008117}.
CC   -!- PTM: Phosphorylated; cAMP treatment promotes phosphorylation and
CC       activates the channel (PubMed:12588899, PubMed:17036051,
CC       PubMed:8910473). Dephosphorylation decreases the ATPase activity
CC       (in vitro) (PubMed:8910473). Phosphorylation at PKA sites
CC       activates the channel (PubMed:10792060, PubMed:12519745,
CC       PubMed:12588899, PubMed:25330774). Phosphorylation at PKC sites
CC       enhances the response to phosphorylation by PKA (PubMed:12588899).
CC       Phosphorylated by AMPK; this inhibits channel activity
CC       (PubMed:12519745). {ECO:0000269|PubMed:10792060,
CC       ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12588899,
CC       ECO:0000269|PubMed:1377674, ECO:0000269|PubMed:17036051,
CC       ECO:0000269|PubMed:22119790, ECO:0000269|PubMed:25330774,
CC       ECO:0000269|PubMed:8910473, ECO:0000269|PubMed:9385646}.
CC   -!- PTM: Ubiquitinated, leading to its degradation in the lysosome
CC       (PubMed:19398555). Deubiquitination by USP10 in early endosomes
CC       enhances its endocytic recycling to the cell membrane
CC       (PubMed:19398555). Ubiquitinated by RNF185 during ER stress
CC       (PubMed:24019521). {ECO:0000269|PubMed:19398555,
CC       ECO:0000269|PubMed:22119790, ECO:0000269|PubMed:24019521}.
CC   -!- DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized
CC       disorder of the exocrine glands which impairs clearance of
CC       secretions in a variety of organs. It is characterized by the
CC       triad of chronic bronchopulmonary disease (with recurrent
CC       respiratory infections), pancreatic insufficiency (which leads to
CC       malabsorption and growth retardation) and elevated sweat
CC       electrolytes. It is the most common genetic disease in Caucasians,
CC       with a prevalence of about 1 in 2'000 live births. Inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:10094564,
CC       ECO:0000269|PubMed:12167682, ECO:0000269|PubMed:12529365,
CC       ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468,
CC       ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530,
CC       ECO:0000269|PubMed:1284548, ECO:0000269|PubMed:15528182,
CC       ECO:0000269|PubMed:15716351, ECO:0000269|PubMed:1695717,
CC       ECO:0000269|PubMed:1699669, ECO:0000269|PubMed:1710600,
CC       ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731,
CC       ECO:0000269|PubMed:20008117, ECO:0000269|PubMed:20150177,
CC       ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:25330774,
CC       ECO:0000269|PubMed:26846474, ECO:0000269|PubMed:28001373,
CC       ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:7504969,
CC       ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296,
CC       ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022,
CC       ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909,
CC       ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450,
CC       ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273,
CC       ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567,
CC       ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407,
CC       ECO:0000269|PubMed:7606851, ECO:0000269|PubMed:7680525,
CC       ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954,
CC       ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8406518,
CC       ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693,
CC       ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923,
CC       ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8910473,
CC       ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301,
CC       ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855,
CC       ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874,
CC       ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054,
CC       ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579,
CC       ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753,
CC       ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9804160,
CC       ECO:0000269|PubMed:9921909}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Congenital bilateral absence of the vas deferens (CBAVD)
CC       [MIM:277180]: Important cause of sterility in men and could
CC       represent an incomplete form of cystic fibrosis, as the majority
CC       of men suffering from cystic fibrosis lack the vas deferens.
CC       {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962,
CC       ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761,
CC       ECO:0000269|PubMed:9736778, ECO:0000269|Ref.112}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC
CC       family. CFTR transporter (TC 3.A.1.202) subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=CFTR; Note=Cystic fibrosis mutation db;
CC       URL="http://www.genet.sickkids.on.ca/app";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CFTR entry;
CC       URL="https://en.wikipedia.org/wiki/Cystic_fibrosis_transmembrane_conductance_regulator";
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=P13569";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28668; AAA35680.1; -; mRNA.
DR   EMBL; M55131; AAC13657.1; -; Genomic_DNA.
DR   EMBL; M55106; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55107; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55108; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55110; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55111; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55112; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55113; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55114; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55115; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55116; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55117; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55118; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55119; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55120; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55121; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55122; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55123; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55124; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55125; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55126; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55127; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55128; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55129; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; M55130; AAC13657.1; JOINED; Genomic_DNA.
DR   EMBL; DQ354388; ABC79050.1; -; Genomic_DNA.
DR   EMBL; DQ354389; ABC79052.1; -; Genomic_DNA.
DR   EMBL; DQ354390; ABC79054.1; -; Genomic_DNA.
DR   EMBL; DQ354391; ABC79056.1; -; Genomic_DNA.
DR   EMBL; DQ356258; ABC87055.1; -; Genomic_DNA.
DR   EMBL; DQ356259; ABC87057.1; -; Genomic_DNA.
DR   EMBL; DQ356261; ABC87061.1; -; Genomic_DNA.
DR   EMBL; DQ356262; ABC87063.1; -; Genomic_DNA.
DR   EMBL; DQ356263; ABC87065.1; -; Genomic_DNA.
DR   EMBL; DQ356264; ABC87067.1; -; Genomic_DNA.
DR   EMBL; DQ388128; ABD72183.1; -; Genomic_DNA.
DR   EMBL; DQ388129; ABD72185.1; -; Genomic_DNA.
DR   EMBL; DQ388131; ABD72189.1; -; Genomic_DNA.
DR   EMBL; DQ388132; ABD72191.1; -; Genomic_DNA.
DR   EMBL; DQ388133; ABD72193.1; -; Genomic_DNA.
DR   EMBL; DQ388134; ABD72195.1; -; Genomic_DNA.
DR   EMBL; DQ388135; ABD72197.1; -; Genomic_DNA.
DR   EMBL; DQ388138; ABD72203.1; -; Genomic_DNA.
DR   EMBL; DQ388139; ABD72205.1; -; Genomic_DNA.
DR   EMBL; DQ388140; ABD72207.1; -; Genomic_DNA.
DR   EMBL; DQ388141; ABD72209.1; -; Genomic_DNA.
DR   EMBL; DQ388142; ABD72211.1; -; Genomic_DNA.
DR   EMBL; DQ388143; ABD72213.1; -; Genomic_DNA.
DR   EMBL; DQ388145; ABD72217.1; -; Genomic_DNA.
DR   EMBL; AC000061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236947; EAL24353.1; -; Genomic_DNA.
DR   EMBL; M65196; AAA51979.1; -; Genomic_DNA.
DR   EMBL; M65197; AAA51980.1; -; Genomic_DNA.
DR   CCDS; CCDS5773.1; -. [P13569-1]
DR   PIR; A39069; DVHUCF.
DR   RefSeq; NP_000483.3; NM_000492.3. [P13569-1]
DR   UniGene; Hs.489786; -.
DR   UniGene; Hs.621460; -.
DR   UniGene; Hs.661104; -.
DR   PDB; 1NBD; Model; -; A=425-638.
DR   PDB; 1XMI; X-ray; 2.25 A; A/B/C/D/E=389-678.
DR   PDB; 1XMJ; X-ray; 2.30 A; A=389-677.
DR   PDB; 2BBO; X-ray; 2.55 A; A=389-678.
DR   PDB; 2BBS; X-ray; 2.05 A; A/B=389-677.
DR   PDB; 2BBT; X-ray; 2.30 A; A/B=389-678.
DR   PDB; 2LOB; NMR; -; B=1473-1480.
DR   PDB; 2PZE; X-ray; 1.70 A; A/B=387-646.
DR   PDB; 2PZF; X-ray; 2.00 A; A/B=387-646.
DR   PDB; 2PZG; X-ray; 1.80 A; A/B=375-646.
DR   PDB; 3GD7; X-ray; 2.70 A; A/B/C/D=1193-1427.
DR   PDB; 3ISW; X-ray; 2.80 A; C=5-20.
DR   PDB; 4WZ6; X-ray; 2.05 A; A=389-678.
DR   PDB; 5D2D; X-ray; 2.10 A; C=747-774.
DR   PDB; 5D3E; X-ray; 2.75 A; C/G/K=762-801.
DR   PDB; 5D3F; X-ray; 2.74 A; C=747-774.
DR   PDB; 5UAK; EM; 3.87 A; A=1-1480.
DR   PDBsum; 1NBD; -.
DR   PDBsum; 1XMI; -.
DR   PDBsum; 1XMJ; -.
DR   PDBsum; 2BBO; -.
DR   PDBsum; 2BBS; -.
DR   PDBsum; 2BBT; -.
DR   PDBsum; 2LOB; -.
DR   PDBsum; 2PZE; -.
DR   PDBsum; 2PZF; -.
DR   PDBsum; 2PZG; -.
DR   PDBsum; 3GD7; -.
DR   PDBsum; 3ISW; -.
DR   PDBsum; 4WZ6; -.
DR   PDBsum; 5D2D; -.
DR   PDBsum; 5D3E; -.
DR   PDBsum; 5D3F; -.
DR   PDBsum; 5UAK; -.
DR   DisProt; DP00012; -.
DR   ProteinModelPortal; P13569; -.
DR   SMR; P13569; -.
DR   BioGrid; 107506; 275.
DR   CORUM; P13569; -.
DR   DIP; DIP-32788N; -.
DR   IntAct; P13569; 142.
DR   MINT; MINT-148539; -.
DR   STRING; 9606.ENSP00000003084; -.
DR   BindingDB; P13569; -.
DR   ChEMBL; CHEMBL4051; -.
DR   DrugBank; DB00887; Bumetanide.
DR   DrugBank; DB04941; Crofelemer.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB08820; Ivacaftor.
DR   DrugBank; DB09280; Lumacaftor.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   DrugBank; DB04522; Phosphonoserine.
DR   GuidetoPHARMACOLOGY; 707; -.
DR   MoonProt; P13569; -.
DR   TCDB; 3.A.1.202.1; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; P13569; -.
DR   PhosphoSitePlus; P13569; -.
DR   SwissPalm; P13569; -.
DR   BioMuta; CFTR; -.
DR   DMDM; 147744553; -.
DR   PaxDb; P13569; -.
DR   PeptideAtlas; P13569; -.
DR   PRIDE; P13569; -.
DR   DNASU; 1080; -.
DR   Ensembl; ENST00000003084; ENSP00000003084; ENSG00000001626. [P13569-1]
DR   GeneID; 1080; -.
DR   KEGG; hsa:1080; -.
DR   UCSC; uc003vjd.4; human. [P13569-1]
DR   CTD; 1080; -.
DR   DisGeNET; 1080; -.
DR   EuPathDB; HostDB:ENSG00000001626.14; -.
DR   GeneCards; CFTR; -.
DR   GeneReviews; CFTR; -.
DR   HGNC; HGNC:1884; CFTR.
DR   HPA; CAB001951; -.
DR   HPA; HPA021939; -.
DR   MalaCards; CFTR; -.
DR   MIM; 219700; phenotype.
DR   MIM; 277180; phenotype.
DR   MIM; 602421; gene.
DR   neXtProt; NX_P13569; -.
DR   OpenTargets; ENSG00000001626; -.
DR   Orphanet; 48; Congenital bilateral absence of vas deferens.
DR   Orphanet; 586; Cystic fibrosis.
DR   Orphanet; 676; Hereditary chronic pancreatitis.
DR   Orphanet; 60033; Idiopathic bronchiectasis.
DR   Orphanet; 399805; Male infertility with azoospermia or oligozoospermia due to single gene mutation.
DR   PharmGKB; PA109; -.
DR   eggNOG; KOG0054; Eukaryota.
DR   eggNOG; COG1132; LUCA.
DR   GeneTree; ENSGT00900000140905; -.
DR   HOVERGEN; HBG004169; -.
DR   InParanoid; P13569; -.
DR   KO; K05031; -.
DR   OMA; LAHFVWI; -.
DR   OrthoDB; EOG091G00K4; -.
DR   PhylomeDB; P13569; -.
DR   TreeFam; TF105200; -.
DR   BioCyc; MetaCyc:HS00075-MONOMER; -.
DR   BRENDA; 3.6.3.49; 2681.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5627083; RHO GTPases regulate CFTR trafficking.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SIGNOR; P13569; -.
DR   EvolutionaryTrace; P13569; -.
DR   GenomeRNAi; 1080; -.
DR   PRO; PR:P13569; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000001626; -.
DR   CleanEx; HS_CFTR; -.
DR   ExpressionAtlas; P13569; baseline and differential.
DR   Genevisible; P13569; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:GO_Central.
DR   GO; GO:0043225; F:ATPase-coupled anion transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0019869; F:chloride channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0017081; F:chloride channel regulator activity; TAS:Reactome.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0005260; F:intracellular ATPase-gated chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; IDA:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030301; P:cholesterol transport; IEA:Ensembl.
DR   GO; GO:0051454; P:intracellular pH elevation; ISS:UniProtKB.
DR   GO; GO:0060081; P:membrane hyperpolarization; ISS:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0050891; P:multicellular organismal water homeostasis; IMP:UniProtKB.
DR   GO; GO:1902161; P:positive regulation of cyclic nucleotide-gated ion channel activity; IMP:UniProtKB.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:1902943; P:positive regulation of voltage-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0048240; P:sperm capacitation; ISS:UniProtKB.
DR   GO; GO:0035377; P:transepithelial water transport; IMP:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; IEA:Ensembl.
DR   Gene3D; 1.20.1560.10; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR009147; CFTR/ABCC7.
DR   InterPro; IPR025837; CFTR_reg_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24223:SF19; PTHR24223:SF19; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   Pfam; PF14396; CFTR_R; 1.
DR   PRINTS; PR01851; CYSFIBREGLTR.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 2.
DR   TIGRFAMs; TIGR01271; CFTR_protein; 1.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Hydrolase; Ion channel;
KW   Ion transport; Isopeptide bond; Lipoprotein; Membrane;
KW   Nucleotide-binding; Palmitate; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   CHAIN         1   1480       Cystic fibrosis transmembrane conductance
FT                                regulator.
FT                                /FTId=PRO_0000093419.
FT   TOPO_DOM      1     77       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     78     98       Helical; Name=1. {ECO:0000269|Ref.54}.
FT   TOPO_DOM     99    122       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM    123    146       Helical; Name=2. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    147    195       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   TRANSMEM    196    216       Helical; Name=3. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    217    222       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM    223    243       Helical; Name=4. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    244    298       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   TRANSMEM    299    319       Helical; Name=5. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    320    339       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM    340    358       Helical; Name=6. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    359    858       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   TRANSMEM    859    879       Helical; Name=7. {ECO:0000269|Ref.54}.
FT   TOPO_DOM    880    918       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM    919    939       Discontinuously helical; Name=8.
FT                                {ECO:0000269|Ref.54}.
FT   TOPO_DOM    940    990       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   TRANSMEM    991   1011       Helical; Name=9. {ECO:0000269|Ref.54}.
FT   TOPO_DOM   1012   1013       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM   1014   1034       Helical; Name=10. {ECO:0000269|Ref.54}.
FT   TOPO_DOM   1035   1095       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   TRANSMEM   1096   1116       Helical; Name=11. {ECO:0000269|Ref.54}.
FT   TOPO_DOM   1117   1130       Extracellular. {ECO:0000269|Ref.54}.
FT   TRANSMEM   1131   1151       Helical; Name=12. {ECO:0000269|Ref.54}.
FT   TOPO_DOM   1152   1480       Cytoplasmic. {ECO:0000269|Ref.54}.
FT   DOMAIN       81    365       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      423    646       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      859   1155       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1210   1443       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     458    465       ATP 1. {ECO:0000244|PDB:1XMI,
FT                                ECO:0000244|PDB:1XMJ,
FT                                ECO:0000244|PDB:2BBO,
FT                                ECO:0000244|PDB:2BBS,
FT                                ECO:0000244|PDB:2BBT,
FT                                ECO:0000255|PROSITE-ProRule:PRU00434,
FT                                ECO:0000269|PubMed:15528182}.
FT   NP_BIND    1244   1251       ATP 2. {ECO:0000244|PDB:3GD7,
FT                                ECO:0000255|PROSITE-ProRule:PRU00434}.
FT   REGION      654    831       Intrinsically disordered R region.
FT                                {ECO:0000269|PubMed:10792060}.
FT   MOTIF      1478   1480       PDZ-binding.
FT                                {ECO:0000269|PubMed:11707463,
FT                                ECO:0000269|PubMed:16331976}.
FT   BINDING     401    401       ATP 1. {ECO:0000244|PDB:1XMI,
FT                                ECO:0000244|PDB:1XMJ,
FT                                ECO:0000244|PDB:2BBO,
FT                                ECO:0000244|PDB:2BBS,
FT                                ECO:0000244|PDB:2BBT,
FT                                ECO:0000244|PDB:2PZE,
FT                                ECO:0000244|PDB:2PZF,
FT                                ECO:0000244|PDB:2PZG,
FT                                ECO:0000269|PubMed:15528182,
FT                                ECO:0000269|PubMed:20150177}.
FT   BINDING     434    434       ATP 1. {ECO:0000244|PDB:2PZE,
FT                                ECO:0000244|PDB:2PZF,
FT                                ECO:0000244|PDB:2PZG,
FT                                ECO:0000269|PubMed:20150177}.
FT   BINDING     493    493       ATP 1. {ECO:0000244|PDB:1XMI,
FT                                ECO:0000244|PDB:2BBO,
FT                                ECO:0000244|PDB:2BBS,
FT                                ECO:0000269|PubMed:15528182}.
FT   BINDING    1219   1219       ATP 2. {ECO:0000244|PDB:3GD7}.
FT   MOD_RES     549    549       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     660    660       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:22119790,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     670    670       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:25330774}.
FT   MOD_RES     686    686       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:22119790}.
FT   MOD_RES     700    700       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:22119790,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     712    712       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:22119790,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     717    717       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22119790}.
FT   MOD_RES     737    737       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:22119790,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     753    753       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     768    768       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     790    790       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:1377674}.
FT   MOD_RES     795    795       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:22119790,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES     813    813       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:1377674,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:9385646}.
FT   MOD_RES    1444   1444       Phosphoserine.
FT                                {ECO:0000269|PubMed:22119790}.
FT   MOD_RES    1456   1456       Phosphoserine.
FT                                {ECO:0000269|PubMed:22119790}.
FT   LIPID       524    524       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:22119790}.
FT   LIPID      1395   1395       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:22119790}.
FT   CARBOHYD    894    894       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:7518437,
FT                                ECO:0000305|PubMed:20008117}.
FT   CARBOHYD    900    900       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:7518437,
FT                                ECO:0000305|PubMed:20008117}.
FT   CROSSLNK    688    688       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:22119790}.
FT   VAR_SEQ     404    464       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_022123.
FT   VAR_SEQ     589    605       SCVCKLMANKTRILVTS -> RRRCSCLLDRNKKTIF (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_022124.
FT   VAR_SEQ     606   1480       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_022125.
FT   VARIANT      13     13       S -> F (in CF; dbSNP:rs397508635).
FT                                {ECO:0000269|PubMed:9554753}.
FT                                /FTId=VAR_000101.
FT   VARIANT      31     31       R -> C (in dbSNP:rs1800073).
FT                                {ECO:0000269|PubMed:7522211,
FT                                ECO:0000269|PubMed:9921909}.
FT                                /FTId=VAR_000102.
FT   VARIANT      31     31       R -> L (in CF; dbSNP:rs149353983).
FT                                {ECO:0000269|PubMed:7537150}.
FT                                /FTId=VAR_000103.
FT   VARIANT      42     42       S -> F (in CF; dbSNP:rs143456784).
FT                                {ECO:0000269|PubMed:7541510}.
FT                                /FTId=VAR_000104.
FT   VARIANT      44     44       D -> G (in CF; dbSNP:rs1800074).
FT                                /FTId=VAR_000105.
FT   VARIANT      44     44       D -> V (in dbSNP:rs1800074).
FT                                /FTId=VAR_000106.
FT   VARIANT      50     50       S -> Y (in CBAVD; dbSNP:rs397508220).
FT                                {ECO:0000269|PubMed:9067761}.
FT                                /FTId=VAR_000107.
FT   VARIANT      57     57       W -> G (in CF; dbSNP:rs397508272).
FT                                {ECO:0000269|PubMed:7544319}.
FT                                /FTId=VAR_000108.
FT   VARIANT      67     67       P -> L (in CF; dbSNP:rs368505753).
FT                                /FTId=VAR_000109.
FT   VARIANT      74     74       R -> W (in CF; dbSNP:rs115545701).
FT                                /FTId=VAR_000110.
FT   VARIANT      75     75       R -> Q (in dbSNP:rs1800076).
FT                                {ECO:0000269|PubMed:9921909}.
FT                                /FTId=VAR_000111.
FT   VARIANT      85     85       G -> E (in CF; dbSNP:rs75961395).
FT                                {ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000112.
FT   VARIANT      87     87       F -> L (in CF; dbSNP:rs397508403).
FT                                {ECO:0000269|PubMed:8081395}.
FT                                /FTId=VAR_000113.
FT   VARIANT      91     91       G -> R (in CF; dbSNP:rs121908750).
FT                                /FTId=VAR_000114.
FT   VARIANT      92     92       E -> K (in CF; dbSNP:rs121908751).
FT                                {ECO:0000269|PubMed:1284529,
FT                                ECO:0000269|PubMed:7683954}.
FT                                /FTId=VAR_000115.
FT   VARIANT      98     98       Q -> R (in CF; dbSNP:rs397508464).
FT                                {ECO:0000269|PubMed:7581407}.
FT                                /FTId=VAR_000116.
FT   VARIANT     105    105       I -> S (in CF).
FT                                /FTId=VAR_000117.
FT   VARIANT     109    109       Y -> C (in CF; dbSNP:rs121909031).
FT                                {ECO:0000269|PubMed:7524909}.
FT                                /FTId=VAR_000118.
FT   VARIANT     110    110       D -> H (in CF; dbSNP:rs113993958).
FT                                /FTId=VAR_000119.
FT   VARIANT     111    111       P -> L (in CBAVD; dbSNP:rs140502196).
FT                                {ECO:0000269|Ref.112}.
FT                                /FTId=VAR_000120.
FT   VARIANT     117    117       R -> C (in CF; dbSNP:rs77834169).
FT                                {ECO:0000269|PubMed:1284529}.
FT                                /FTId=VAR_000121.
FT   VARIANT     117    117       R -> H (in CF and CBAVD; decreases single
FT                                channel conductance; promotes rapid
FT                                return to the closed state of the
FT                                channel; dbSNP:rs78655421).
FT                                {ECO:0000269|PubMed:26846474,
FT                                ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000122.
FT   VARIANT     117    117       R -> L (in CF; dbSNP:rs78655421).
FT                                {ECO:0000269|PubMed:7541510}.
FT                                /FTId=VAR_000123.
FT   VARIANT     117    117       R -> P (in CF; dbSNP:rs78655421).
FT                                {ECO:0000269|PubMed:9452048}.
FT                                /FTId=VAR_000124.
FT   VARIANT     120    120       A -> T (in CF; dbSNP:rs201958172).
FT                                {ECO:0000269|PubMed:7517264}.
FT                                /FTId=VAR_000125.
FT   VARIANT     138    138       L -> P (in dbSNP:rs1800078).
FT                                /FTId=VAR_009895.
FT   VARIANT     139    139       H -> R (in CF; dbSNP:rs76371115).
FT                                {ECO:0000269|PubMed:7541510}.
FT                                /FTId=VAR_000126.
FT   VARIANT     141    141       A -> D (in CF; dbSNP:rs397508700).
FT                                {ECO:0000269|PubMed:9222768}.
FT                                /FTId=VAR_000127.
FT   VARIANT     148    148       I -> T (in CF; dbSNP:rs35516286).
FT                                /FTId=VAR_000128.
FT   VARIANT     149    149       G -> R (in CBAVD; dbSNP:rs397508718).
FT                                {ECO:0000269|PubMed:7529962}.
FT                                /FTId=VAR_000129.
FT   VARIANT     170    170       R -> H (in dbSNP:rs1800079).
FT                                /FTId=VAR_009896.
FT   VARIANT     178    178       G -> R (in CF; dbSNP:rs80282562).
FT                                /FTId=VAR_000130.
FT   VARIANT     182    182       S -> G (in dbSNP:rs1800080).
FT                                /FTId=VAR_009897.
FT   VARIANT     192    192       Missing (in CF).
FT                                {ECO:0000269|PubMed:9452048}.
FT                                /FTId=VAR_000131.
FT   VARIANT     193    193       E -> K (in CBAVD and CF;
FT                                dbSNP:rs397508759).
FT                                {ECO:0000269|PubMed:7529962,
FT                                ECO:0000269|PubMed:7544319}.
FT                                /FTId=VAR_000132.
FT   VARIANT     199    199       H -> Q (in CF; dbSNP:rs397508765).
FT                                /FTId=VAR_000133.
FT   VARIANT     199    199       H -> Y (in CF; dbSNP:rs121908802).
FT                                {ECO:0000269|PubMed:7525450}.
FT                                /FTId=VAR_000134.
FT   VARIANT     205    205       P -> S (in CF; dbSNP:rs121908803).
FT                                {ECO:0000269|PubMed:7505694}.
FT                                /FTId=VAR_000135.
FT   VARIANT     206    206       L -> W (in CF; dbSNP:rs121908752).
FT                                {ECO:0000269|PubMed:8522333}.
FT                                /FTId=VAR_000136.
FT   VARIANT     225    225       C -> R (in CF; dbSNP:rs397508780).
FT                                /FTId=VAR_000137.
FT   VARIANT     244    244       M -> K (in CBAVD; dbSNP:rs397508790).
FT                                {ECO:0000269|Ref.112}.
FT                                /FTId=VAR_000138.
FT   VARIANT     258    258       R -> G (in CBAVD; dbSNP:rs191456345).
FT                                {ECO:0000269|PubMed:7529962}.
FT                                /FTId=VAR_000139.
FT   VARIANT     287    287       N -> Y (in CF; decreased presence at the
FT                                cell membrane due to increased
FT                                internalization from the apical cell
FT                                membrane; no effect on single channel
FT                                gating and conductance;
FT                                dbSNP:rs397508804).
FT                                {ECO:0000269|PubMed:12529365,
FT                                ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000140.
FT   VARIANT     297    297       R -> Q (in CF; dbSNP:rs143486492).
FT                                /FTId=VAR_000141.
FT   VARIANT     301    301       Y -> C (in CF; dbSNP:rs150691494).
FT                                /FTId=VAR_000142.
FT   VARIANT     307    307       S -> N (in CF; dbSNP:rs397508817).
FT                                /FTId=VAR_000143.
FT   VARIANT     311    311       F -> L (in CF; dbSNP:rs121909016).
FT                                /FTId=VAR_000144.
FT   VARIANT     311    311       Missing (in CF).
FT                                {ECO:0000269|PubMed:9443874}.
FT                                /FTId=VAR_000145.
FT   VARIANT     314    314       G -> E (in CF; dbSNP:rs75763344).
FT                                /FTId=VAR_000146.
FT   VARIANT     314    314       G -> R (in CF; dbSNP:rs397508819).
FT                                {ECO:0000269|PubMed:8829633}.
FT                                /FTId=VAR_000147.
FT   VARIANT     322    322       V -> M (in dbSNP:rs1800085).
FT                                /FTId=VAR_009898.
FT   VARIANT     334    334       R -> W (in CF; mild; does not prevent
FT                                maturation of glycans;
FT                                dbSNP:rs121909011).
FT                                {ECO:0000269|PubMed:1699669}.
FT                                /FTId=VAR_000148.
FT   VARIANT     336    336       I -> K (in CF; dbSNP:rs397508139).
FT                                /FTId=VAR_000150.
FT   VARIANT     338    338       T -> I (in CF; mild; isolated hypotonic
FT                                dehydration; dbSNP:rs77409459).
FT                                {ECO:0000269|PubMed:7543567,
FT                                ECO:0000269|PubMed:9554753}.
FT                                /FTId=VAR_000151.
FT   VARIANT     346    346       L -> P (in CF; dominant mutation but mild
FT                                phenotype; dbSNP:rs397508146).
FT                                {ECO:0000269|PubMed:7513296}.
FT                                /FTId=VAR_000152.
FT   VARIANT     347    347       R -> H (in CF; dbSNP:rs77932196).
FT                                /FTId=VAR_000153.
FT   VARIANT     347    347       R -> L (in CF; dbSNP:rs77932196).
FT                                /FTId=VAR_000154.
FT   VARIANT     347    347       R -> P (in CF; MILD; dbSNP:rs77932196).
FT                                /FTId=VAR_000155.
FT   VARIANT     351    351       T -> S (in dbSNP:rs1800086).
FT                                /FTId=VAR_009899.
FT   VARIANT     352    352       R -> Q (in CF; dbSNP:rs121908753).
FT                                /FTId=VAR_000156.
FT   VARIANT     353    353       Q -> H (in dbSNP:rs1800087).
FT                                /FTId=VAR_009900.
FT   VARIANT     359    360       QT -> KK (in CF; dbSNP:rs397508152).
FT                                /FTId=VAR_000158.
FT   VARIANT     359    359       Q -> K (in CF; dbSNP:rs76879328).
FT                                /FTId=VAR_000157.
FT   VARIANT     370    370       K -> KNK (in CF).
FT                                {ECO:0000269|PubMed:9452073}.
FT                                /FTId=VAR_000159.
FT   VARIANT     455    455       A -> E (in CF; dbSNP:rs74551128).
FT                                {ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000160.
FT   VARIANT     456    456       V -> F (in CF; dbSNP:rs397508195).
FT                                /FTId=VAR_000161.
FT   VARIANT     458    458       G -> V (in CF; dbSNP:rs121909009).
FT                                /FTId=VAR_000162.
FT   VARIANT     467    467       L -> F (in dbSNP:rs1800089).
FT                                /FTId=VAR_000163.
FT   VARIANT     470    470       V -> M (in dbSNP:rs213950).
FT                                {ECO:0000269|PubMed:10651488,
FT                                ECO:0000269|PubMed:1710598,
FT                                ECO:0000269|PubMed:18987736,
FT                                ECO:0000269|PubMed:2475911,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_000164.
FT   VARIANT     480    480       G -> C (in CF; dbSNP:rs79282516).
FT                                /FTId=VAR_000165.
FT   VARIANT     492    492       S -> F (in CF; dbSNP:rs121909017).
FT                                /FTId=VAR_000166.
FT   VARIANT     504    504       E -> Q (in CF; dbSNP:rs397508223).
FT                                /FTId=VAR_000167.
FT   VARIANT     506    506       I -> M (in dbSNP:rs1800092).
FT                                /FTId=VAR_009901.
FT   VARIANT     506    506       I -> V (in dbSNP:rs1800091).
FT                                {ECO:0000269|PubMed:9921909}.
FT                                /FTId=VAR_000168.
FT   VARIANT     507    507       I -> V (in dbSNP:rs1800091).
FT                                /FTId=VAR_000169.
FT   VARIANT     507    507       Missing (in CF; impaired maturation of
FT                                glycan chains).
FT                                {ECO:0000269|PubMed:1699669,
FT                                ECO:0000269|PubMed:1710600}.
FT                                /FTId=VAR_000170.
FT   VARIANT     508    508       F -> C (in dbSNP:rs1800093).
FT                                /FTId=VAR_000172.
FT   VARIANT     508    508       Missing (in CF and CBAVD; most common
FT                                mutation; impairs protein folding and
FT                                stability; causes local changes to the
FT                                surface that mediates interactions
FT                                between domains; decreases frequency of
FT                                channel opening in vitro; decreases
FT                                presence at the cell membrane due to
FT                                retention in intracellular compartments;
FT                                impairs recycling to the cell membrane
FT                                after endocytosis).
FT                                {ECO:0000269|PubMed:12529365,
FT                                ECO:0000269|PubMed:1284548,
FT                                ECO:0000269|PubMed:15528182,
FT                                ECO:0000269|PubMed:15716351,
FT                                ECO:0000269|PubMed:1699669,
FT                                ECO:0000269|PubMed:1710600,
FT                                ECO:0000269|PubMed:20008117,
FT                                ECO:0000269|PubMed:20150177,
FT                                ECO:0000269|PubMed:25330774,
FT                                ECO:0000269|PubMed:28001373,
FT                                ECO:0000269|PubMed:28087700}.
FT                                /FTId=VAR_000171.
FT   VARIANT     513    513       D -> G (in CBAVD; dbSNP:rs397508225).
FT                                {ECO:0000269|PubMed:10651488}.
FT                                /FTId=VAR_000173.
FT   VARIANT     520    520       V -> F (in CF; dbSNP:rs77646904).
FT                                {ECO:0000269|PubMed:1284466}.
FT                                /FTId=VAR_000174.
FT   VARIANT     532    532       K -> E (in dbSNP:rs35032490).
FT                                /FTId=VAR_048150.
FT   VARIANT     544    544       G -> V (in CBAVD; dbSNP:rs397508241).
FT                                {ECO:0000269|Ref.112}.
FT                                /FTId=VAR_000175.
FT   VARIANT     549    549       S -> I (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs121908755).
FT                                {ECO:0000269|PubMed:1699669,
FT                                ECO:0000269|PubMed:1712898}.
FT                                /FTId=VAR_000177.
FT   VARIANT     549    549       S -> N (in CF; dbSNP:rs121908755).
FT                                /FTId=VAR_000176.
FT   VARIANT     549    549       S -> R (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs121909005).
FT                                {ECO:0000269|PubMed:1712898}.
FT                                /FTId=VAR_000178.
FT   VARIANT     551    551       G -> D (in CF; decreases frequency of
FT                                channel opening in vitro; decreases
FT                                channel activity and ATPase activity; no
FT                                effect on trafficking to the cell
FT                                membrane; no effect on protein stability;
FT                                no effect on maturation of glycans;
FT                                dbSNP:rs75527207).
FT                                {ECO:0000269|PubMed:1284548,
FT                                ECO:0000269|PubMed:1699669,
FT                                ECO:0000269|PubMed:1712898,
FT                                ECO:0000269|PubMed:28087700,
FT                                ECO:0000269|PubMed:8910473,
FT                                ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000179.
FT   VARIANT     551    551       G -> S (in CF; dbSNP:rs121909013).
FT                                {ECO:0000269|PubMed:7606851}.
FT                                /FTId=VAR_000180.
FT   VARIANT     553    553       R -> Q (in CF; dbSNP:rs121909044).
FT                                /FTId=VAR_000181.
FT   VARIANT     558    558       L -> S (in CF; dbSNP:rs193922504).
FT                                /FTId=VAR_000182.
FT   VARIANT     559    559       A -> T (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs75549581).
FT                                {ECO:0000269|PubMed:1712898}.
FT                                /FTId=VAR_000183.
FT   VARIANT     560    560       R -> K (in CF; dbSNP:rs80055610).
FT                                /FTId=VAR_000184.
FT   VARIANT     560    560       R -> S (in CF; dbSNP:rs397508267).
FT                                {ECO:0000269|PubMed:9482579}.
FT                                /FTId=VAR_000185.
FT   VARIANT     560    560       R -> T (in CF; dbSNP:rs80055610).
FT                                /FTId=VAR_000186.
FT   VARIANT     562    562       V -> I (in dbSNP:rs1800097).
FT                                /FTId=VAR_000187.
FT   VARIANT     562    562       V -> L (in CF; dbSNP:rs1800097).
FT                                {ECO:0000269|PubMed:8956039}.
FT                                /FTId=VAR_000188.
FT   VARIANT     563    563       Y -> N (in CF; dbSNP:rs121909006).
FT                                /FTId=VAR_000189.
FT   VARIANT     569    569       Y -> C (in CF; dbSNP:rs397508277).
FT                                {ECO:0000269|PubMed:8723693}.
FT                                /FTId=VAR_000190.
FT   VARIANT     569    569       Y -> D (in CF; dbSNP:rs397508276).
FT                                {ECO:0000269|PubMed:9482579}.
FT                                /FTId=VAR_000191.
FT   VARIANT     569    569       Y -> H (in CF; dbSNP:rs397508276).
FT                                /FTId=VAR_000192.
FT   VARIANT     571    571       L -> S (in CF; dbSNP:rs397508280).
FT                                /FTId=VAR_000193.
FT   VARIANT     572    572       D -> N (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508282).
FT                                {ECO:0000269|PubMed:1712898,
FT                                ECO:0000269|PubMed:7541273}.
FT                                /FTId=VAR_000194.
FT   VARIANT     574    574       P -> H (in CF; dbSNP:rs121908758).
FT                                /FTId=VAR_000195.
FT   VARIANT     576    576       G -> A (in dbSNP:rs1800098).
FT                                /FTId=VAR_000196.
FT   VARIANT     579    579       D -> G (in CF; dbSNP:rs397508288).
FT                                {ECO:0000269|PubMed:10094564,
FT                                ECO:0000269|PubMed:7544319}.
FT                                /FTId=VAR_000197.
FT   VARIANT     601    601       I -> F (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508306).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000198.
FT   VARIANT     605    605       S -> F (in dbSNP:rs766874).
FT                                /FTId=VAR_048151.
FT   VARIANT     610    610       L -> S (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508311).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000199.
FT   VARIANT     613    613       A -> T (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs201978662).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000200.
FT   VARIANT     614    614       D -> G (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs201124247).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000201.
FT   VARIANT     618    618       I -> T (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs139468767).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000202.
FT   VARIANT     619    619       L -> S (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508313).
FT                                {ECO:0000269|PubMed:7525450,
FT                                ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000203.
FT   VARIANT     620    620       H -> P (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508314).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000204.
FT   VARIANT     620    620       H -> Q (in CF; no effect on glycan
FT                                maturation but strongly increased channel
FT                                activity; dbSNP:rs397508315).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000205.
FT   VARIANT     622    622       G -> D (in oligospermia; no effect on
FT                                glycan maturation but decreased channel
FT                                activity; dbSNP:rs121908759).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000206.
FT   VARIANT     628    628       G -> R (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508316).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000207.
FT   VARIANT     633    633       L -> P (in CF; impaired maturation of
FT                                glycan chains; dbSNP:rs397508318).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000208.
FT   VARIANT     648    648       D -> V (in CF; dbSNP:rs121909033).
FT                                /FTId=VAR_000209.
FT   VARIANT     651    651       D -> N (in CF; dbSNP:rs780526529).
FT                                /FTId=VAR_000210.
FT   VARIANT     654    654       S -> G (in dbSNP:rs1800099).
FT                                /FTId=VAR_009902.
FT   VARIANT     665    665       T -> S (in CF; no effect on glycan
FT                                maturation and channel activity).
FT                                {ECO:0000269|PubMed:8800923,
FT                                ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000211.
FT   VARIANT     668    668       R -> C (in dbSNP:rs1800100).
FT                                {ECO:0000269|PubMed:9921909}.
FT                                /FTId=VAR_000212.
FT   VARIANT     693    693       F -> L (in CF; unknown pathological
FT                                significance; dbSNP:rs145540754 and
FT                                dbSNP:rs397508338).
FT                                {ECO:0000269|PubMed:12167682,
FT                                ECO:0000269|PubMed:8406518}.
FT                                /FTId=VAR_000213.
FT   VARIANT     754    754       V -> M (in CF; dbSNP:rs150157202).
FT                                /FTId=VAR_000214.
FT   VARIANT     766    766       R -> M (in CBAVD; dbSNP:rs397508363).
FT                                /FTId=VAR_000215.
FT   VARIANT     792    792       R -> G (in CBAVD; no effect on glycan
FT                                maturation but decreased channel
FT                                activity; dbSNP:rs145449046).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000216.
FT   VARIANT     800    800       A -> G (in CBAVD; no effect on glycan
FT                                maturation but strongly increased channel
FT                                activity; dbSNP:rs397508373).
FT                                {ECO:0000269|PubMed:7529962,
FT                                ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000217.
FT   VARIANT     807    807       I -> M (in CBAVD; dbSNP:rs1800103).
FT                                /FTId=VAR_000218.
FT   VARIANT     822    822       E -> K (in CF; dbSNP:rs397508378).
FT                                /FTId=VAR_000219.
FT   VARIANT     826    826       E -> K (in thoracic sarcoidosis; no
FT                                effect on glycan maturation and channel
FT                                activity; dbSNP:rs397508381).
FT                                {ECO:0000269|PubMed:9736778}.
FT                                /FTId=VAR_000220.
FT   VARIANT     866    866       C -> Y (in CF; dbSNP:rs193922506).
FT                                /FTId=VAR_000221.
FT   VARIANT     903    903       Y -> H (in dbSNP:rs1800106).
FT                                /FTId=VAR_009903.
FT   VARIANT     909    909       S -> I (in dbSNP:rs1800107).
FT                                /FTId=VAR_009904.
FT   VARIANT     912    912       S -> L (in dbSNP:rs121909034).
FT                                {ECO:0000269|PubMed:7522211}.
FT                                /FTId=VAR_000222.
FT   VARIANT     913    913       Y -> C (in CF; dbSNP:rs121909008).
FT                                /FTId=VAR_000223.
FT   VARIANT     917    917       Y -> C (in CF; dbSNP:rs397508428).
FT                                /FTId=VAR_000224.
FT   VARIANT     949    949       H -> Y (in CF; dbSNP:rs121909035).
FT                                {ECO:0000269|PubMed:7522211}.
FT                                /FTId=VAR_000225.
FT   VARIANT     952    952       M -> I (in CF; dbSNP:rs151048781).
FT                                /FTId=VAR_000226.
FT   VARIANT     967    967       L -> S (in dbSNP:rs1800110).
FT                                /FTId=VAR_009905.
FT   VARIANT     997    997       L -> F (in CF; dbSNP:rs1800111).
FT                                /FTId=VAR_000227.
FT   VARIANT    1005   1005       I -> R (in CF; dbSNP:rs397508479).
FT                                {ECO:0000269|PubMed:7525450}.
FT                                /FTId=VAR_000228.
FT   VARIANT    1006   1006       A -> E (in CF; dbSNP:rs397508480).
FT                                {ECO:0000269|PubMed:7541510}.
FT                                /FTId=VAR_000229.
FT   VARIANT    1013   1013       P -> L (in CF; dbSNP:rs193922516).
FT                                {ECO:0000269|PubMed:9521595}.
FT                                /FTId=VAR_000230.
FT   VARIANT    1028   1028       M -> I (in CF; dbSNP:rs200553511).
FT                                {ECO:0000269|PubMed:9521595}.
FT                                /FTId=VAR_000231.
FT   VARIANT    1052   1052       F -> V (in CF; dbSNP:rs150212784).
FT                                {ECO:0000269|PubMed:7683628}.
FT                                /FTId=VAR_000232.
FT   VARIANT    1061   1061       G -> R (in CF; dbSNP:rs142394380).
FT                                {ECO:0000269|PubMed:7683628,
FT                                ECO:0000269|PubMed:8723695}.
FT                                /FTId=VAR_000233.
FT   VARIANT    1065   1065       L -> P (in CF; dbSNP:rs121909036).
FT                                {ECO:0000269|PubMed:7522211}.
FT                                /FTId=VAR_000234.
FT   VARIANT    1065   1065       L -> R (in CF; dbSNP:rs121909036).
FT                                {ECO:0000269|PubMed:9452054}.
FT                                /FTId=VAR_000235.
FT   VARIANT    1066   1066       R -> C (in CF; dbSNP:rs78194216).
FT                                {ECO:0000269|PubMed:9375855}.
FT                                /FTId=VAR_000236.
FT   VARIANT    1066   1066       R -> H (in CF; dbSNP:rs121909019).
FT                                /FTId=VAR_000237.
FT   VARIANT    1066   1066       R -> L (in CF; dbSNP:rs121909019).
FT                                {ECO:0000269|PubMed:7683628}.
FT                                /FTId=VAR_000238.
FT   VARIANT    1067   1067       A -> T (in CF; dbSNP:rs121909020).
FT                                /FTId=VAR_000239.
FT   VARIANT    1067   1067       A -> V (in dbSNP:rs1800114).
FT                                /FTId=VAR_000240.
FT   VARIANT    1070   1070       R -> P (in CF; dbSNP:rs78769542).
FT                                {ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000242.
FT   VARIANT    1070   1070       R -> Q (in CF; dbSNP:rs78769542).
FT                                {ECO:0000269|PubMed:7683628}.
FT                                /FTId=VAR_000241.
FT   VARIANT    1070   1070       R -> W (in CBAVD; dbSNP:rs202179988).
FT                                /FTId=VAR_011564.
FT   VARIANT    1071   1071       Q -> P (in CF; dbSNP:rs121909037).
FT                                {ECO:0000269|PubMed:7522211}.
FT                                /FTId=VAR_000243.
FT   VARIANT    1072   1072       P -> L (in CF).
FT                                /FTId=VAR_000244.
FT   VARIANT    1077   1077       L -> P (in CF; dbSNP:rs139304906).
FT                                /FTId=VAR_000245.
FT   VARIANT    1085   1085       H -> R (in CF; dbSNP:rs79635528).
FT                                {ECO:0000269|PubMed:7683628}.
FT                                /FTId=VAR_000246.
FT   VARIANT    1098   1098       W -> R (in CF; dbSNP:rs397508531).
FT                                {ECO:0000269|PubMed:7537150}.
FT                                /FTId=VAR_000247.
FT   VARIANT    1101   1101       M -> K (in CF; dbSNP:rs36210737).
FT                                {ECO:0000269|PubMed:7680525}.
FT                                /FTId=VAR_000248.
FT   VARIANT    1101   1101       M -> R (in CF; dbSNP:rs36210737).
FT                                {ECO:0000269|PubMed:7683628}.
FT                                /FTId=VAR_011565.
FT   VARIANT    1137   1137       M -> V (in CF; decreases channel
FT                                activity; no visible effect on protein
FT                                maturation; dbSNP:rs397508553).
FT                                {ECO:0000269|PubMed:9804160}.
FT                                /FTId=VAR_000249.
FT   VARIANT    1140   1140       Missing (in CF; abolishes channel
FT                                activity; no visible effect on protein
FT                                maturation). {ECO:0000269|PubMed:9101301,
FT                                ECO:0000269|PubMed:9804160}.
FT                                /FTId=VAR_000250.
FT   VARIANT    1152   1152       D -> H (in CF; decreases channel
FT                                activity; no visible effect on protein
FT                                maturation; dbSNP:rs75541969).
FT                                {ECO:0000269|PubMed:9804160}.
FT                                /FTId=VAR_000251.
FT   VARIANT    1162   1162       R -> L (in dbSNP:rs1800120).
FT                                /FTId=VAR_000252.
FT   VARIANT    1220   1220       T -> I (in dbSNP:rs1800123).
FT                                {ECO:0000269|PubMed:7522211}.
FT                                /FTId=VAR_000253.
FT   VARIANT    1234   1234       I -> V (in CF; dbSNP:rs75389940).
FT                                /FTId=VAR_000254.
FT   VARIANT    1235   1235       S -> R (in CF; dbSNP:rs34911792).
FT                                /FTId=VAR_000255.
FT   VARIANT    1244   1244       G -> E (in CF; dbSNP:rs267606723).
FT                                /FTId=VAR_000256.
FT   VARIANT    1249   1249       G -> E (in CF; dbSNP:rs121909040).
FT                                {ECO:0000269|PubMed:7520022}.
FT                                /FTId=VAR_000257.
FT   VARIANT    1251   1251       S -> N (in CF; dbSNP:rs74503330).
FT                                /FTId=VAR_000258.
FT   VARIANT    1255   1255       S -> P (in CF; dbSNP:rs121909041).
FT                                {ECO:0000269|PubMed:1284530}.
FT                                /FTId=VAR_000259.
FT   VARIANT    1270   1270       D -> N (in CF; dbSNP:rs11971167).
FT                                /FTId=VAR_000260.
FT   VARIANT    1282   1282       W -> R (in CF; dbSNP:rs397508616).
FT                                /FTId=VAR_000261.
FT   VARIANT    1283   1283       R -> M (in CF; dbSNP:rs77902683).
FT                                {ECO:0000269|PubMed:1284468}.
FT                                /FTId=VAR_000262.
FT   VARIANT    1286   1286       F -> S (in CF; dbSNP:rs121909028).
FT                                /FTId=VAR_000263.
FT   VARIANT    1291   1291       Q -> H (in CF; dbSNP:rs121909015).
FT                                {ECO:0000269|PubMed:1284466}.
FT                                /FTId=VAR_000264.
FT   VARIANT    1291   1291       Q -> R (in CF; dbSNP:rs397508621).
FT                                {ECO:0000269|PubMed:7525450}.
FT                                /FTId=VAR_000265.
FT   VARIANT    1303   1303       N -> H (in CF; dbSNP:rs121909042).
FT                                /FTId=VAR_000266.
FT   VARIANT    1303   1303       N -> K (in CF; impaired maturation of
FT                                glycan chains; has low in vitro channel
FT                                activity at low temperature;
FT                                dbSNP:rs80034486).
FT                                {ECO:0000269|PubMed:1712898,
FT                                ECO:0000269|PubMed:17182731,
FT                                ECO:0000269|PubMed:9401006}.
FT                                /FTId=VAR_000267.
FT   VARIANT    1349   1349       G -> D (in CF; no effect on maturation of
FT                                glycan chains; dbSNP:rs193922525).
FT                                {ECO:0000269|PubMed:1712898}.
FT                                /FTId=VAR_000268.
FT   VARIANT    1364   1364       A -> V (in CBAVD; dbSNP:rs397508670).
FT                                {ECO:0000269|Ref.112}.
FT                                /FTId=VAR_000269.
FT   VARIANT    1397   1397       V -> E (in CF; dbSNP:rs397508691).
FT                                {ECO:0000269|PubMed:7524913}.
FT                                /FTId=VAR_000270.
FT   VARIANT    1453   1453       R -> W (in dbSNP:rs4148725).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_048152.
FT   MUTAGEN     464    464       K->M: Impaired maturation of glycan
FT                                chains indicating impaired trafficking
FT                                from the endoplasmic reticulum to the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:1699669}.
FT   MUTAGEN     508    508       F->R: Impaired maturation of glycan
FT                                chains indicating impaired trafficking
FT                                from the endoplasmic reticulum to the
FT                                cell membrane.
FT                                {ECO:0000269|PubMed:1699669,
FT                                ECO:0000269|PubMed:1712898}.
FT   MUTAGEN     539    539       I->T: Enhances trafficking from the
FT                                endoplasmic reticulum to the cell
FT                                membrane. {ECO:0000269|PubMed:28001373}.
FT   MUTAGEN     894    894       N->D: Abolishes N-glycosylation, enhances
FT                                endocytosis and impairs subsequent
FT                                recycling to the cell surface; when
FT                                associated with D-900.
FT                                {ECO:0000269|PubMed:20008117}.
FT   MUTAGEN     900    900       N->D: Abolishes N-glycosylation, enhances
FT                                endocytosis and impairs subsequent
FT                                recycling to the cell surface; when
FT                                associated with D-894.
FT                                {ECO:0000269|PubMed:20008117}.
FT   MUTAGEN    1137   1137       M->R: Abolishes channel activity. Impairs
FT                                protein maturation, suggesting the
FT                                protein is retained in the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:9804160}.
FT   MUTAGEN    1139   1139       I->V: Decreases channel activity, no
FT                                visible effect on protein maturation.
FT                                {ECO:0000269|PubMed:9804160}.
FT   MUTAGEN    1154   1154       D->G: Decreases channel activity, no
FT                                visible effect on protein maturation.
FT                                {ECO:0000269|PubMed:9804160}.
FT   MUTAGEN    1250   1250       K->M: No effect on maturation of glycans,
FT                                suggesting that trafficking to the plasma
FT                                membrane is not altered.
FT                                {ECO:0000269|PubMed:1699669}.
FT   CONFLICT    620    620       H -> N (in Ref. 1; AAA35680).
FT                                {ECO:0000305}.
FT   CONFLICT    833    833       F -> L (in Ref. 1; AAA35680).
FT                                {ECO:0000305}.
FT   STRAND       11     19       {ECO:0000244|PDB:3ISW}.
FT   STRAND      390    399       {ECO:0000244|PDB:2PZE}.
FT   HELIX       403    411       {ECO:0000244|PDB:2BBS}.
FT   HELIX       414    417       {ECO:0000244|PDB:2BBT}.
FT   HELIX       433    436       {ECO:0000244|PDB:1XMI}.
FT   STRAND      440    449       {ECO:0000244|PDB:2PZE}.
FT   STRAND      453    457       {ECO:0000244|PDB:2PZE}.
FT   HELIX       464    471       {ECO:0000244|PDB:2PZE}.
FT   STRAND      478    484       {ECO:0000244|PDB:2PZE}.
FT   STRAND      488    491       {ECO:0000244|PDB:2PZE}.
FT   STRAND      499    501       {ECO:0000244|PDB:2PZG}.
FT   HELIX       502    507       {ECO:0000244|PDB:2PZE}.
FT   HELIX       514    523       {ECO:0000244|PDB:2PZE}.
FT   HELIX       527    530       {ECO:0000244|PDB:2PZE}.
FT   STRAND      533    535       {ECO:0000244|PDB:2PZF}.
FT   HELIX       536    538       {ECO:0000244|PDB:2PZE}.
FT   STRAND      540    542       {ECO:0000244|PDB:1XMJ}.
FT   HELIX       550    563       {ECO:0000244|PDB:2PZE}.
FT   STRAND      567    573       {ECO:0000244|PDB:2PZE}.
FT   TURN        574    577       {ECO:0000244|PDB:2PZE}.
FT   HELIX       580    589       {ECO:0000244|PDB:2PZE}.
FT   HELIX       590    594       {ECO:0000244|PDB:2PZE}.
FT   TURN        595    597       {ECO:0000244|PDB:2PZE}.
FT   STRAND      598    603       {ECO:0000244|PDB:2PZE}.
FT   HELIX       607    612       {ECO:0000244|PDB:2PZE}.
FT   STRAND      614    620       {ECO:0000244|PDB:2PZE}.
FT   STRAND      623    628       {ECO:0000244|PDB:2PZE}.
FT   HELIX       630    634       {ECO:0000244|PDB:2PZE}.
FT   HELIX       640    644       {ECO:0000244|PDB:2PZE}.
FT   HELIX       650    652       {ECO:0000244|PDB:2BBS}.
FT   HELIX       655    669       {ECO:0000244|PDB:2BBS}.
FT   STRAND     1204   1207       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1210   1223       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1226   1234       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1239   1245       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1250   1258       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1261   1271       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1279   1284       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1286   1290       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1297   1299       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1300   1304       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1312   1321       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1325   1328       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1334   1336       {ECO:0000244|PDB:3GD7}.
FT   TURN       1341   1345       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1348   1361       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1366   1371       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1372   1375       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1378   1389       {ECO:0000244|PDB:3GD7}.
FT   TURN       1390   1394       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1397   1400       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1402   1404       {ECO:0000244|PDB:3GD7}.
FT   HELIX      1405   1407       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1412   1417       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1420   1426       {ECO:0000244|PDB:3GD7}.
FT   STRAND     1478   1480       {ECO:0000244|PDB:2LOB}.
SQ   SEQUENCE   1480 AA;  168142 MW;  8D082AA2E768C065 CRC64;
     MQRSPLEKAS VVSKLFFSWT RPILRKGYRQ RLELSDIYQI PSVDSADNLS EKLEREWDRE
     LASKKNPKLI NALRRCFFWR FMFYGIFLYL GEVTKAVQPL LLGRIIASYD PDNKEERSIA
     IYLGIGLCLL FIVRTLLLHP AIFGLHHIGM QMRIAMFSLI YKKTLKLSSR VLDKISIGQL
     VSLLSNNLNK FDEGLALAHF VWIAPLQVAL LMGLIWELLQ ASAFCGLGFL IVLALFQAGL
     GRMMMKYRDQ RAGKISERLV ITSEMIENIQ SVKAYCWEEA MEKMIENLRQ TELKLTRKAA
     YVRYFNSSAF FFSGFFVVFL SVLPYALIKG IILRKIFTTI SFCIVLRMAV TRQFPWAVQT
     WYDSLGAINK IQDFLQKQEY KTLEYNLTTT EVVMENVTAF WEEGFGELFE KAKQNNNNRK
     TSNGDDSLFF SNFSLLGTPV LKDINFKIER GQLLAVAGST GAGKTSLLMV IMGELEPSEG
     KIKHSGRISF CSQFSWIMPG TIKENIIFGV SYDEYRYRSV IKACQLEEDI SKFAEKDNIV
     LGEGGITLSG GQRARISLAR AVYKDADLYL LDSPFGYLDV LTEKEIFESC VCKLMANKTR
     ILVTSKMEHL KKADKILILH EGSSYFYGTF SELQNLQPDF SSKLMGCDSF DQFSAERRNS
     ILTETLHRFS LEGDAPVSWT ETKKQSFKQT GEFGEKRKNS ILNPINSIRK FSIVQKTPLQ
     MNGIEEDSDE PLERRLSLVP DSEQGEAILP RISVISTGPT LQARRRQSVL NLMTHSVNQG
     QNIHRKTTAS TRKVSLAPQA NLTELDIYSR RLSQETGLEI SEEINEEDLK ECFFDDMESI
     PAVTTWNTYL RYITVHKSLI FVLIWCLVIF LAEVAASLVV LWLLGNTPLQ DKGNSTHSRN
     NSYAVIITST SSYYVFYIYV GVADTLLAMG FFRGLPLVHT LITVSKILHH KMLHSVLQAP
     MSTLNTLKAG GILNRFSKDI AILDDLLPLT IFDFIQLLLI VIGAIAVVAV LQPYIFVATV
     PVIVAFIMLR AYFLQTSQQL KQLESEGRSP IFTHLVTSLK GLWTLRAFGR QPYFETLFHK
     ALNLHTANWF LYLSTLRWFQ MRIEMIFVIF FIAVTFISIL TTGEGEGRVG IILTLAMNIM
     STLQWAVNSS IDVDSLMRSV SRVFKFIDMP TEGKPTKSTK PYKNGQLSKV MIIENSHVKK
     DDIWPSGGQM TVKDLTAKYT EGGNAILENI SFSISPGQRV GLLGRTGSGK STLLSAFLRL
     LNTEGEIQID GVSWDSITLQ QWRKAFGVIP QKVFIFSGTF RKNLDPYEQW SDQEIWKVAD
     EVGLRSVIEQ FPGKLDFVLV DGGCVLSHGH KQLMCLARSV LSKAKILLLD EPSAHLDPVT
     YQIIRRTLKQ AFADCTVILC EHRIEAMLEC QQFLVIEENK VRQYDSIQKL LNERSLFRQA
     ISPSDRVKLF PHRNSSKCKS KPQIAALKEE TEEEVQDTRL
//
ID   GBRB1_RAT               Reviewed;         474 AA.
AC   P15431;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-NOV-2017, entry version 158.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-1;
DE   AltName: Full=GABA(A) receptor subunit beta-1;
DE   Flags: Precursor;
GN   Name=Gabrb1; Synonyms=Gabrb-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2548852;
RA   Ymer S., Schofield P.R., Draguhn A., Werner P., Koehler M.,
RA   Seeburg P.H.;
RT   "GABAA receptor beta subunit heterogeneity: functional expression of
RT   cloned cDNAs.";
RL   EMBO J. 8:1665-1670(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=1977069; DOI=10.1016/0169-328X(90)90017-8;
RA   Malherbe P., Draguhn A., Multhaup G., Beyreuther K., Mohler H.;
RT   "GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs
RT   displays potentiation by benzodiazepine receptor ligands.";
RL   Brain Res. Mol. Brain Res. 8:199-208(1990).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18281286; DOI=10.1074/jbc.M709993200;
RA   Saras A., Gisselmann G., Vogt-Eisele A.K., Erlkamp K.S., Kletke O.,
RA   Pusch H., Hatt H.;
RT   "Histamine action on vertebrate GABAA receptors: direct channel gating
RT   and potentiation of GABA responses.";
RL   J. Biol. Chem. 283:10470-10475(2008).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel. {ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:1977069}.
CC   -!- SUBUNIT: Binds UBQLN1. Interacts with KCTD8, KCTD12 and KCTD16;
CC       this interaction determines the pharmacology and kinetics of the
CC       receptor response, the KCTD proteins markedly accelerating the
CC       GABA-B response, although to different extents (By similarity).
CC       Heteropentamer, formed by a combination of alpha, beta, gamma,
CC       delta and rho chains. {ECO:0000250, ECO:0000269|PubMed:18281286}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:18281286}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:18281286}. Cell membrane
CC       {ECO:0000269|PubMed:18281286}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18281286}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15466; CAA33493.1; -; mRNA.
DR   PIR; S04464; B60039.
DR   RefSeq; NP_037088.1; NM_012956.1.
DR   UniGene; Rn.207157; -.
DR   ProteinModelPortal; P15431; -.
DR   SMR; P15431; -.
DR   IntAct; P15431; 2.
DR   MINT; MINT-219840; -.
DR   STRING; 10116.ENSRNOP00000003170; -.
DR   ChEMBL; CHEMBL1907607; -.
DR   TCDB; 1.A.9.5.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P15431; -.
DR   PhosphoSitePlus; P15431; -.
DR   PRIDE; P15431; -.
DR   Ensembl; ENSRNOT00000003170; ENSRNOP00000003170; ENSRNOG00000002327.
DR   GeneID; 25450; -.
DR   KEGG; rno:25450; -.
DR   UCSC; RGD:2649; rat.
DR   CTD; 2560; -.
DR   RGD; 2649; Gabrb1.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P15431; -.
DR   KO; K05181; -.
DR   OMA; NAGYWIF; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P15431; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-RNO-977441; GABA A receptor activation.
DR   PRO; PR:P15431; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002327; -.
DR   Genevisible; P15431; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:1902711; C:GABA-A receptor complex; IMP:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043235; C:receptor complex; IDA:RGD.
DR   GO; GO:0005253; F:anion channel activity; IDA:RGD.
DR   GO; GO:0050811; F:GABA receptor binding; IPI:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:RGD.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; ISS:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IMP:UniProtKB.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:0021954; P:central nervous system neuron development; IEP:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; TAS:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IMP:UniProtKB.
DR   GO; GO:0042698; P:ovulation cycle; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IDA:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    474       Gamma-aminobutyric acid receptor subunit
FT                                beta-1.
FT                                /FTId=PRO_0000000458.
FT   TOPO_DOM     26    245       Extracellular. {ECO:0000305}.
FT   TRANSMEM    246    267       Helical. {ECO:0000305}.
FT   TRANSMEM    271    293       Helical. {ECO:0000305}.
FT   TRANSMEM    305    327       Helical. {ECO:0000305}.
FT   TOPO_DOM    328    451       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    452    473       Helical. {ECO:0000305}.
FT   REGION      120    122       Agonist binding. {ECO:0000250}.
FT   REGION      180    182       Agonist binding. {ECO:0000250}.
FT   REGION      290    311       Allosteric effector binding.
FT                                {ECO:0000250}.
FT   BINDING     225    225       Agonist. {ECO:0000250}.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    175       {ECO:0000250}.
FT   CONFLICT    420    420       R -> Q (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       R -> P (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   474 AA;  54072 MW;  986277FDBD66377A CRC64;
     MWTVQNRESL GLLSFPVMVA MVCCAHSSNE PSNMSYVKET VDRLLKGYDI RLRPDFGGPP
     VDVGMRIDVA SIDMVSEVNM DYTLTMYFQQ SWKDKRLSYS GIPLNLTLDN RVADQLWVPD
     TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
     SYGYTTDDIE FYWNGGEGAV TGVNKIELPQ FSIVDYKMVS KKVEFTTGAY PRLSLSFRLK
     RNIGYFILQT YMPSTLITIL SWVSFWINYD ASAARVALGI TTVLTMTTIS THLRETLPKI
     PYVKAIDIYL MGCFVFVFLA LLEYAFVNYI FFGKGPQKKG ASKQDQSANE KNKLEMNKVQ
     VDAHGNILLS TLEIRNETSG SEVLTGVSDP KATMYSYDSA SIQYRKPLSS REGFGRGLDR
     HGVPGKGRIR RRASQLKVKI PDLTDVNSID KWSRMFFPIT FSLFNVVYWL YYVH
//
ID   GBRG2_HUMAN             Reviewed;         467 AA.
AC   P18507; F5HB82; Q6GRL6; Q6PCC3; Q9UDB3; Q9UN15;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 192.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit gamma-2;
DE   AltName: Full=GABA(A) receptor subunit gamma-2;
DE   Flags: Precursor;
GN   Name=GABRG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=2538761; DOI=10.1038/338582a0;
RA   Pritchett D.B., Sontheimer H., Shivers B.D., Ymer S., Kettenmann H.,
RA   Schofield P.R., Seeburg P.H.;
RT   "Importance of a novel GABAA receptor subunit for benzodiazepine
RT   pharmacology.";
RL   Nature 338:582-585(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11328646; DOI=10.3109/10425170009033988;
RA   Jiang S., Yu J., Wang J., Tan Z., Xue H., Feng G., He L., Yang H.;
RT   "Complete genomic sequence of 195 Kb of human DNA containing the gene
RT   GABRG2.";
RL   DNA Seq. 11:373-382(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ARG-357.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 357-443 (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=8382267; DOI=10.1111/j.1471-4159.1993.tb03243.x;
RA   Khan Z.U., Fernando L.P., Escriba P., Busquets X., Mallet J.,
RA   Miralles C.P., Filla M., De Blas A.L.;
RT   "Antibodies to the human gamma 2 subunit of the gamma-aminobutyric
RT   acidA/benzodiazepine receptor.";
RL   J. Neurochem. 60:961-971(1993).
RN   [6]
RP   INTERACTION WITH GABARAP.
RX   PubMed=9892355; DOI=10.1038/16264;
RA   Wang H., Bedford F.K., Brandon N.J., Moss S.J., Olsen R.W.;
RT   "GABA(A)-receptor-associated protein links GABA(A) receptors and the
RT   cytoskeleton.";
RL   Nature 397:69-72(1999).
RN   [7]
RP   VARIANT GEFS+3 MET-328.
RX   PubMed=11326274; DOI=10.1038/88254;
RA   Baulac S., Huberfeld G., Gourfinkel-An I., Mitropoulou G.,
RA   Beranger A., Prud'homme J.-F., Baulac M., Brice A., Bruzzone R.,
RA   LeGuern E.;
RT   "First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a
RT   mutation in the gamma2-subunit gene.";
RL   Nat. Genet. 28:46-48(2001).
RN   [8]
RP   VARIANT ECA2/FEB8 GLN-82.
RX   PubMed=11326275; DOI=10.1038/88259;
RA   Wallace R.H., Marini C., Petrou S., Harkin L.A., Bowser D.N.,
RA   Panchal R.G., Williams D.A., Sutherland G.R., Mulley J.C.,
RA   Scheffer I.E., Berkovic S.F.;
RT   "Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy
RT   and febrile seizures.";
RL   Nat. Genet. 28:49-52(2001).
RN   [9]
RP   VARIANT FEB8 GLY-177.
RX   PubMed=16924025; DOI=10.1212/01.wnl.0000230145.73496.a2;
RA   Audenaert D., Schwartz E., Claeys K.G., Claes L., Deprez L., Suls A.,
RA   Van Dyck T., Lagae L., Van Broeckhoven C., Macdonald R.L.,
RA   De Jonghe P.;
RT   "A novel GABRG2 mutation associated with febrile seizures.";
RL   Neurology 67:687-690(2006).
RN   [10]
RP   VARIANT SER-79.
RX   PubMed=20485450; DOI=10.1038/jhg.2010.47;
RA   Shi X., Huang M.C., Ishii A., Yoshida S., Okada M., Morita K.,
RA   Nagafuji H., Yasumoto S., Kaneko S., Kojima T., Hirose S.;
RT   "Mutational analysis of GABRG2 in a Japanese cohort with childhood
RT   epilepsies.";
RL   J. Hum. Genet. 55:375-378(2010).
RN   [11]
RP   VARIANT SER-83, AND CHARACTERIZATION VARIANT SER-83.
RX   PubMed=21714819; DOI=10.1111/j.1460-9568.2011.07767.x;
RA   Lachance-Touchette P., Brown P., Meloche C., Kinirons P., Lapointe L.,
RA   Lacasse H., Lortie A., Carmant L., Bedford F., Bowie D., Cossette P.;
RT   "Novel alpha1 and gamma2 GABAA receptor subunit mutations in families
RT   with idiopathic generalized epilepsy.";
RL   Eur. J. Neurosci. 34:237-249(2011).
RN   [12]
RP   VARIANT GEFS+3 GLN-323.
RX   PubMed=23708187; DOI=10.1038/ng.2646;
RA   Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J.,
RA   Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S.,
RA   Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S.,
RA   Mackay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z.,
RA   Zelnick N., Lerman-Sagie T., Lev D., Moeller R.S., Gill D.,
RA   Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F.,
RA   Scheffer I.E., Mefford H.C.;
RT   "Targeted resequencing in epileptic encephalopathies identifies de
RT   novo mutations in CHD2 and SYNGAP1.";
RL   Nat. Genet. 45:825-830(2013).
RN   [13]
RP   VARIANT CYS-274.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel. {ECO:0000269|PubMed:2538761}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta,
CC       gamma, delta and rho chains (PubMed:2538761). Interacts with
CC       GABARAP (PubMed:9892355). Interacts with KIF21B (By similarity).
CC       {ECO:0000250|UniProtKB:P18508, ECO:0000269|PubMed:2538761,
CC       ECO:0000269|PubMed:9892355}.
CC   -!- INTERACTION:
CC       O95166:GABARAP; NbExp=3; IntAct=EBI-15096952, EBI-712001;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:2538761}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:2538761}. Cell membrane
CC       {ECO:0000269|PubMed:2538761}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:2538761}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P22723}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:P18508}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P18507-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P18507-2; Sequence=VSP_041124;
CC       Name=3;
CC         IsoId=P18507-3; Sequence=VSP_047323, VSP_041124;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Palmitoylated by ZDHHC3/GODZ; which may affect presynaptic
CC       clustering and/or cell surface stability. {ECO:0000250}.
CC   -!- DISEASE: Epilepsy, childhood absence 2 (ECA2) [MIM:607681]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Some
CC       individuals manifest febrile seizures. Absence seizures may either
CC       remit or persist into adulthood. {ECO:0000269|PubMed:11326275}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Febrile seizures, familial, 8 (FEB8) [MIM:611277]:
CC       Seizures associated with febrile episodes in childhood without any
CC       evidence of intracranial infection or defined pathologic or
CC       traumatic cause. It is a common condition, affecting 2-5% of
CC       children aged 3 months to 5 years. The majority are simple febrile
CC       seizures (generally defined as generalized onset, single seizures
CC       with a duration of less than 30 minutes). Complex febrile seizures
CC       are characterized by focal onset, duration greater than 30
CC       minutes, and/or more than one seizure in a 24 hour period. The
CC       likelihood of developing epilepsy following simple febrile
CC       seizures is low. Complex febrile seizures are associated with a
CC       moderately increased incidence of epilepsy.
CC       {ECO:0000269|PubMed:16924025}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Generalized epilepsy with febrile seizures plus 3
CC       (GEFS+3) [MIM:611277]: A rare autosomal dominant, familial
CC       condition with incomplete penetrance and large intrafamilial
CC       variability. Patients display febrile seizures persisting
CC       sometimes beyond the age of 6 years and/or a variety of afebrile
CC       seizure types. This disease combines febrile seizures, generalized
CC       seizures often precipitated by fever at age 6 years or more, and
CC       partial seizures, with a variable degree of severity.
CC       {ECO:0000269|PubMed:11326274, ECO:0000269|PubMed:23708187}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: This subunit carries the benzodiazepine binding
CC       site.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRG2 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15376; CAA33437.1; -; mRNA.
DR   EMBL; AF165124; AAD50273.1; -; Genomic_DNA.
DR   EMBL; AC008611; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091984; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC059389; AAH59389.1; -; mRNA.
DR   EMBL; BC069348; AAH69348.1; -; mRNA.
DR   EMBL; BC074795; AAH74795.1; -; mRNA.
DR   CCDS; CCDS4358.1; -. [P18507-1]
DR   CCDS; CCDS4359.1; -. [P18507-2]
DR   CCDS; CCDS47333.1; -. [P18507-3]
DR   PIR; S03905; S03905.
DR   RefSeq; NP_000807.2; NM_000816.3. [P18507-1]
DR   RefSeq; NP_944493.2; NM_198903.2. [P18507-3]
DR   RefSeq; NP_944494.1; NM_198904.2. [P18507-2]
DR   UniGene; Hs.7195; -.
DR   ProteinModelPortal; P18507; -.
DR   BioGrid; 108840; 15.
DR   CORUM; P18507; -.
DR   IntAct; P18507; 1.
DR   BindingDB; P18507; -.
DR   ChEMBL; CHEMBL2111392; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   TCDB; 1.A.9.5.4; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P18507; -.
DR   PhosphoSitePlus; P18507; -.
DR   SwissPalm; P18507; -.
DR   BioMuta; GABRG2; -.
DR   DMDM; 116242488; -.
DR   EPD; P18507; -.
DR   PeptideAtlas; P18507; -.
DR   PRIDE; P18507; -.
DR   TopDownProteomics; P18507-2; -. [P18507-2]
DR   Ensembl; ENST00000414552; ENSP00000410732; ENSG00000113327. [P18507-3]
DR   Ensembl; ENST00000639111; ENSP00000492125; ENSG00000113327. [P18507-2]
DR   Ensembl; ENST00000639213; ENSP00000491909; ENSG00000113327. [P18507-1]
DR   GeneID; 2566; -.
DR   KEGG; hsa:2566; -.
DR   UCSC; uc003lyy.5; human. [P18507-1]
DR   CTD; 2566; -.
DR   DisGeNET; 2566; -.
DR   EuPathDB; HostDB:ENSG00000113327.14; -.
DR   GeneCards; GABRG2; -.
DR   HGNC; HGNC:4087; GABRG2.
DR   MalaCards; GABRG2; -.
DR   MIM; 137164; gene.
DR   MIM; 604233; phenotype.
DR   MIM; 607681; phenotype.
DR   MIM; 611277; phenotype.
DR   neXtProt; NX_P18507; -.
DR   OpenTargets; ENSG00000113327; -.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   Orphanet; 33069; Dravet syndrome.
DR   Orphanet; 36387; Generalized epilepsy with febrile seizures-plus.
DR   PharmGKB; PA28501; -.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P18507; -.
DR   KO; K05186; -.
DR   OMA; SATIQMN; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P18507; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   ChiTaRS; GABRG2; human.
DR   GeneWiki; GABRG2; -.
DR   GenomeRNAi; 2566; -.
DR   PRO; PR:P18507; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113327; -.
DR   CleanEx; HS_GABRG2; -.
DR   ExpressionAtlas; P18507; baseline and differential.
DR   Genevisible; P18507; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032590; C:dendrite membrane; ISS:BHF-UCL.
DR   GO; GO:1902711; C:GABA-A receptor complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc.
DR   GO; GO:0005254; F:chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; ISS:UniProtKB.
DR   GO; GO:0030534; P:adult behavior; IEA:Ensembl.
DR   GO; GO:0071420; P:cellular response to histamine; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR005439; GABBAg2_rcpt.
DR   InterPro; IPR005437; GABBAg_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01620; GABAARGAMMA.
DR   PRINTS; PR01622; GABAARGAMMA2.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Chloride; Chloride channel; Complete proteome; Cytoplasmic vesicle;
KW   Disease mutation; Disulfide bond; Epilepsy; Glycoprotein; Ion channel;
KW   Ion transport; Lipoprotein; Membrane; Palmitate;
KW   Postsynaptic cell membrane; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     39       {ECO:0000255}.
FT   CHAIN        40    467       Gamma-aminobutyric acid receptor subunit
FT                                gamma-2.
FT                                /FTId=PRO_0000000477.
FT   TOPO_DOM     40    273       Extracellular. {ECO:0000305}.
FT   TRANSMEM    274    296       Helical. {ECO:0000305}.
FT   TRANSMEM    300    322       Helical. {ECO:0000305}.
FT   TRANSMEM    334    356       Helical. {ECO:0000305}.
FT   TOPO_DOM    357    443       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    444    466       Helical. {ECO:0000305}.
FT   REGION      425    442       Interaction with GABARAP. {ECO:0000255}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    129    129       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    247    247       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    190    204       {ECO:0000250}.
FT   VAR_SEQ     211    211       Y -> WSRSIAQAGMCSGVISAHYSLRFWGSTDPPTLASRV
FT                                AGISD (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047323.
FT   VAR_SEQ     376    376       P -> PLLRMFSFK (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041124.
FT   VARIANT      79     79       N -> S (found in a patient with
FT                                generalized tonic-clonic seizures;
FT                                dbSNP:rs112894280).
FT                                {ECO:0000269|PubMed:20485450}.
FT                                /FTId=VAR_065226.
FT   VARIANT      82     82       R -> Q (in ECA2 and FEB8; abolishes in
FT                                vitro sensitivity to diazepam;
FT                                dbSNP:rs121909673).
FT                                {ECO:0000269|PubMed:11326275}.
FT                                /FTId=VAR_014265.
FT   VARIANT      83     83       P -> S (found in a patient with
FT                                idiopathic generalized epilepsy; unknown
FT                                pathological significance; the currents
FT                                elicited by mutant receptors are
FT                                indistinguishable from wild-type; no
FT                                difference in sensitivity of the mutant
FT                                receptors to the allosteric regulators
FT                                zinc and benzodiazepine diazepam compared
FT                                to wild-type; dbSNP:rs587777365).
FT                                {ECO:0000269|PubMed:21714819}.
FT                                /FTId=VAR_071813.
FT   VARIANT     177    177       R -> G (in FEB8; dbSNP:rs267606837).
FT                                {ECO:0000269|PubMed:16924025}.
FT                                /FTId=VAR_038602.
FT   VARIANT     274    274       Y -> C (probable disease-associated
FT                                mutation found in a patient with
FT                                generalized epilepsy with myoclonic
FT                                atonic seizures, cognitive impairment and
FT                                behavioral disorder).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078226.
FT   VARIANT     323    323       R -> Q (in GEFS+3; dbSNP:rs397514737).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_078620.
FT   VARIANT     328    328       K -> M (in GEFS+3; dbSNP:rs121909672).
FT                                {ECO:0000269|PubMed:11326274}.
FT                                /FTId=VAR_014266.
FT   VARIANT     357    357       H -> R (in dbSNP:rs17855003).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_065163.
FT   CONFLICT    120    120       T -> M (in Ref. 1; CAA33437).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       T -> S (in Ref. 1; CAA33437).
FT                                {ECO:0000305}.
FT   CONFLICT    384    385       Missing (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    399    399       E -> D (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    438    439       IA -> RI (in Ref. 5; no nucleotide
FT                                entry). {ECO:0000305}.
SQ   SEQUENCE   467 AA;  54162 MW;  7450DFE1157C9224 CRC64;
     MSSPNIWSTG SSVYSTPVFS QKMTVWILLL LSLYPGFTSQ KSDDDYEDYA SNKTWVLTPK
     VPEGDVTVIL NNLLEGYDNK LRPDIGVKPT LIHTDMYVNS IGPVNAINME YTIDIFFAQT
     WYDRRLKFNS TIKVLRLNSN MVGKIWIPDT FFRNSKKADA HWITTPNRML RIWNDGRVLY
     TLRLTIDAEC QLQLHNFPMD EHSCPLEFSS YGYPREEIVY QWKRSSVEVG DTRSWRLYQF
     SFVGLRNTTE VVKTTSGDYV VMSVYFDLSR RMGYFTIQTY IPCTLIVVLS WVSFWINKDA
     VPARTSLGIT TVLTMTTLST IARKSLPKVS YVTAMDLFVS VCFIFVFSAL VEYGTLHYFV
     SNRKPSKDKD KKKKNPAPTI DIRPRSATIQ MNNATHLQER DEEYGYECLD GKDCASFFCC
     FEDCRTGAWR HGRIHIRIAK MDSYARIFFP TAFCLFNLVY WVSYLYL
//
ID   GLRA1_HUMAN             Reviewed;         457 AA.
AC   P23415; B2R6T3; Q14C77; Q6DJV9;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 192.
DE   RecName: Full=Glycine receptor subunit alpha-1;
DE   AltName: Full=Glycine receptor 48 kDa subunit;
DE   AltName: Full=Glycine receptor strychnine-binding subunit;
DE   Flags: Precursor;
GN   Name=GLRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, SUBCELLULAR
RP   LOCATION, AND ENZYME REGULATION.
RX   PubMed=2155780;
RA   Grenningloh G., Schmieden V., Schofield P.R., Seeburg P.H.,
RA   Siddique T., Mohandas T.K., Becker C.-M., Betz H.;
RT   "Alpha subunit variants of the human glycine receptor: primary
RT   structures, functional expression and chromosomal localization of the
RT   corresponding genes.";
RL   EMBO J. 9:771-776(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ALA-80.
RX   PubMed=7920629; DOI=10.1038/ng0694-131;
RA   Ryan S.G., Buckwalter M.S., Lynch J.W., Handford C.A., Segura L.,
RA   Shiang R., Wasmuth J.J., Camper S.A., Schofield P., O'Connell P.;
RT   "A missense mutation in the gene encoding the alpha 1 subunit of the
RT   inhibitory glycine receptor in the spasmodic mouse.";
RL   Nat. Genet. 7:131-135(1994).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH GLRB.
RX   PubMed=14551753; DOI=10.1007/s00249-003-0286-y;
RA   Mohammadi B., Krampfl K., Cetinkaya C., Moschref H., Grosskreutz J.,
RA   Dengler R., Bufler J.;
RT   "Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta
RT   glycine receptor channels.";
RL   Eur. Biophys. J. 32:529-536(2003).
RN   [7]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   HIS-137; GLU-220; ASP-222 AND HIS-243.
RX   PubMed=16144831; DOI=10.1074/jbc.M508303200;
RA   Miller P.S., Da Silva H.M., Smart T.G.;
RT   "Molecular basis for zinc potentiation at strychnine-sensitive glycine
RT   receptors.";
RL   J. Biol. Chem. 280:37877-37884(2005).
RN   [8]
RP   DISULFIDE BONDS.
RX   PubMed=19861413; DOI=10.1074/jbc.M109.043448;
RA   Vogel N., Kluck C.J., Melzer N., Schwarzinger S., Breitinger U.,
RA   Seeber S., Becker C.M.;
RT   "Mapping of disulfide bonds within the amino-terminal extracellular
RT   domain of the inhibitory glycine receptor.";
RL   J. Biol. Chem. 284:36128-36136(2009).
RN   [9]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, INTERACTION WITH
RP   GLRB, AND SUBUNIT STOICHIOMETRY.
RX   PubMed=22715885; DOI=10.1021/bi300063m;
RA   Yang Z., Taran E., Webb T.I., Lynch J.W.;
RT   "Stoichiometry and subunit arrangement of alpha1beta glycine receptors
RT   as determined by atomic force microscopy.";
RL   Biochemistry 51:5229-5231(2012).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH GLRB, AND SUBUNIT
RP   STOICHIOMETRY.
RX   PubMed=22973015; DOI=10.1523/JNEUROSCI.2050-12.2012;
RA   Durisic N., Godin A.G., Wever C.M., Heyes C.D., Lakadamyali M.,
RA   Dent J.A.;
RT   "Stoichiometry of the human glycine receptor revealed by direct
RT   subunit counting.";
RL   J. Neurosci. 32:12915-12920(2012).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25973519; DOI=10.1111/acer.12735;
RA   Horani S., Stater E.P., Corringer P.J., Trudell J.R., Harris R.A.,
RA   Howard R.J.;
RT   "Ethanol modulation is quantitatively determined by the transmembrane
RT   domain of human alpha1 glycine receptors.";
RL   Alcohol. Clin. Exp. Res. 39:962-968(2015).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=25445488; DOI=10.1016/j.neuropharm.2014.10.026;
RA   Zhang Y., Dixon C.L., Keramidas A., Lynch J.W.;
RT   "Functional reconstitution of glycinergic synapses incorporating
RT   defined glycine receptor subunit combinations.";
RL   Neuropharmacology 89:391-397(2015).
RN   [13]
RP   STRUCTURE BY NMR OF 277-304.
RX   PubMed=12667090; DOI=10.1021/bi026767g;
RA   Yushmanov V.E., Mandal P.K., Liu Z., Tang P., Xu Y.;
RT   "NMR structure and backbone dynamics of the extended second
RT   transmembrane domain of the human neuronal glycine receptor alpha1
RT   subunit.";
RL   Biochemistry 42:3989-3995(2003).
RN   [14]
RP   STRUCTURE BY NMR OF 278-337.
RX   PubMed=15952785; DOI=10.1021/bi050256n;
RA   Ma D., Liu Z., Li L., Tang P., Xu Y.;
RT   "Structure and dynamics of the second and third transmembrane domains
RT   of human glycine receptor.";
RL   Biochemistry 44:8790-8800(2005).
RN   [15]
RP   STRUCTURE BY NMR OF 244-453, ELECTRON MICROSCOPY, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, AND DOMAIN.
RX   PubMed=23994010; DOI=10.1016/j.str.2013.07.014;
RA   Mowrey D.D., Cui T., Jia Y., Ma D., Makhov A.M., Zhang P., Tang P.,
RA   Xu Y.;
RT   "Open-channel structures of the human glycine receptor alpha1 full-
RT   length transmembrane domain.";
RL   Structure 21:1897-1904(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 246-338 AND 418-446,
RP   FUNCTION, ENZYME REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY,
RP   CHARACTERIZATION OF VARIANTS HKPX1 GLU-254; THR-278; GLN-299 AND
RP   MET-308, AND MUTAGENESIS OF GLY-282 AND LYS-304.
RX   PubMed=25730860; DOI=10.1073/pnas.1417864112;
RA   Moraga-Cid G., Sauguet L., Huon C., Malherbe L., Girard-Blanc C.,
RA   Petres S., Murail S., Taly A., Baaden M., Delarue M., Corringer P.J.;
RT   "Allosteric and hyperekplexic mutant phenotypes investigated on an
RT   alpha1 glycine receptor transmembrane structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:2865-2870(2015).
RN   [17]
RP   VARIANTS HKPX1 LEU-299 AND GLN-299.
RX   PubMed=8298642; DOI=10.1038/ng1293-351;
RA   Shiang R., Ryan S.G., Zhu Y.-Z., Hahn A.F., O'Connell P.,
RA   Wasmuth J.J.;
RT   "Mutations in the alpha 1 subunit of the inhibitory glycine receptor
RT   cause the dominant neurologic disorder, hyperekplexia.";
RL   Nat. Genet. 5:351-357(1993).
RN   [18]
RP   VARIANT HKPX1 CYS-307.
RA   Shiang R., Ryan S.G., Zhu Y.-Z., O'Connell P., Wasmuth J.J.;
RT   "Mutational and haplotype analysis of the aplha1 subunit of the
RT   glycine receptor in hyperekplexia patients.";
RL   Am. J. Hum. Genet. 55:A242-A242(1994).
RN   [19]
RP   CHARACTERIZATION OF VARIANTS HKPX1 LEU-299 AND GLN-299, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=7925268;
RA   Langosch D., Laube B., Runstroem N., Schmieden V., Bormann J.,
RA   Betz H.;
RT   "Decreased agonist affinity and chloride conductance of mutant glycine
RT   receptors associated with human hereditary hyperekplexia.";
RL   EMBO J. 13:4223-4228(1994).
RN   [20]
RP   VARIANT HKPX1 LEU-299.
RX   PubMed=7981700; DOI=10.1093/hmg/3.7.1201;
RA   Schorderet D.F., Pescia G., Bernasconi A., Regli F.;
RT   "An additional family with Startle disease and a G1192A mutation at
RT   the alpha 1 subunit of the inhibitory glycine receptor gene.";
RL   Hum. Mol. Genet. 3:1201-1201(1994).
RN   [21]
RP   VARIANT HKPX1 ASN-272.
RX   PubMed=7881416; DOI=10.1093/hmg/3.12.2175;
RA   Rees M.I., Andrew M., Jawad S., Owen M.J.;
RT   "Evidence for recessive as well as dominant forms of startle disease
RT   (hyperekplexia) caused by mutations in the alpha 1 subunit of the
RT   inhibitory glycine receptor.";
RL   Hum. Mol. Genet. 3:2175-2179(1994).
RN   [22]
RP   VARIANT HKPX1 CYS-307.
RX   PubMed=7611730; DOI=10.1002/ana.410380115;
RA   Shiang R., Ryan S.G., Zhu Y.-Z., Fielder T.J., Allen R.J., Fryer A.,
RA   Yamashita S., O'Connell P., Wasmuth J.J.;
RT   "Mutational analysis of familial and sporadic hyperekplexia.";
RL   Ann. Neurol. 38:85-91(1995).
RN   [23]
RP   VARIANT HKPX1 HIS-294.
RX   PubMed=8571969;
RA   Milani N., Dalpra L., del Prete A., Zanini R., Larizza L.;
RT   "A novel mutation (Gln266-->His) in the alpha 1 subunit of the
RT   inhibitory glycine-receptor gene (GLRA1) in hereditary
RT   hyperekplexia.";
RL   Am. J. Hum. Genet. 58:420-422(1996).
RN   [24]
RP   VARIANT HKPX1 GLU-304.
RX   PubMed=8733061; DOI=10.1136/jmg.33.5.435;
RA   Elmslie F.V., Hutchings S.M., Spencer V., Curtis A., Covanis T.,
RA   Gardiner R.M., Rees M.;
RT   "Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel
RT   mutation in a family cosegregating for hyperekplexia and spastic
RT   paraparesis.";
RL   J. Med. Genet. 33:435-436(1996).
RN   [25]
RP   CHARACTERIZATION OF VARIANTS HKPX1 ASN-272; LEU-299; GLN-299; GLU-304
RP   AND CYS-307, FUNCTION, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=9009272; DOI=10.1093/emboj/16.1.110;
RA   Lynch J.W., Rajendra S., Pierce K.D., Handford C.A., Barry P.H.,
RA   Schofield P.R.;
RT   "Identification of intracellular and extracellular domains mediating
RT   signal transduction in the inhibitory glycine receptor chloride
RT   channel.";
RL   EMBO J. 16:110-120(1997).
RN   [26]
RP   VARIANT HKPX1 GLU-304.
RX   PubMed=9067762;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:2<185::AID-HUMU14>3.0.CO;2-Z;
RA   Seri M., Bolino A., Galietta L.J.V., Lerone M., Silengo M., Romeo G.;
RT   "Startle disease in an Italian family by mutation (K276E): the alpha-
RT   subunit of the inhibiting glycine receptor.";
RL   Hum. Mutat. 9:185-187(1997).
RN   [27]
RP   VARIANTS HKPX1 HIS-280 AND HIS-428.
RX   PubMed=10514101;
RX   DOI=10.1002/1531-8249(199910)46:4<634::AID-ANA12>3.0.CO;2-9;
RA   Vergouwe M.N., Tijssen M.A., Peters A.C., Wielaard R., Frants R.R.;
RT   "Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene
RT   mutations.";
RL   Ann. Neurol. 46:634-638(1999).
RN   [28]
RP   VARIANT HKPX1 THR-278.
RX   PubMed=9920650;
RA   Saul B., Kuner T., Sobetzko D., Brune W., Hanefeld F., Meinck H.-M.,
RA   Becker C.-M.;
RT   "Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia
RT   defines an intracellular determinant of glycine receptor channel
RT   gating.";
RL   J. Neurosci. 19:869-877(1999).
RN   [29]
RP   VARIANTS HKPX1 TRP-93; CYS-100; TRP-246; GLU-254; SER-258; PRO-319 AND
RP   ALA-424, CHARACTERIZATION OF VARIANTS HKPX1 TRP-93; CYS-100; TRP-246;
RP   GLU-254; SER-258; HIS-280; MET-308; PRO-319; ALA-424 AND HIS-450,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24108130; DOI=10.1074/jbc.M113.509240;
RA   Bode A., Wood S.E., Mullins J.G., Keramidas A., Cushion T.D.,
RA   Thomas R.H., Pickrell W.O., Drew C.J., Masri A., Jones E.A.,
RA   Vassallo G., Born A.P., Alehan F., Aharoni S., Bannasch G.,
RA   Bartsch M., Kara B., Krause A., Karam E.G., Matta S., Jain V.,
RA   Mandel H., Freilinger M., Graham G.E., Hobson E., Chatfield S.,
RA   Vincent-Delorme C., Rahme J.E., Afawi Z., Berkovic S.F., Howell O.W.,
RA   Vanbellinghen J.F., Rees M.I., Chung S.K., Lynch J.W.;
RT   "New hyperekplexia mutations provide insight into glycine receptor
RT   assembly, trafficking, and activation mechanisms.";
RL   J. Biol. Chem. 288:33745-33759(2013).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels
CC       (PubMed:23994010, PubMed:25730860). Channel opening is triggered
CC       by extracellular glycine (PubMed:2155780, PubMed:7920629,
CC       PubMed:14551753, PubMed:16144831, PubMed:22715885,
CC       PubMed:22973015, PubMed:25973519, PubMed:9009272). Channel opening
CC       is also triggered by taurine and beta-alanine (PubMed:16144831,
CC       PubMed:9009272). Channel characteristics depend on the subunit
CC       composition; heteropentameric channels are activated by lower
CC       glycine levels and display faster desensitization
CC       (PubMed:14551753). Plays an important role in the down-regulation
CC       of neuronal excitability (PubMed:8298642, PubMed:9009272).
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (PubMed:25445488). Channel activity is potentiated by ethanol
CC       (PubMed:25973519). Potentiation of channel activity by
CC       intoxicating levels of ethanol contribute to the sedative effects
CC       of ethanol (By similarity). {ECO:0000250|UniProtKB:Q64018,
CC       ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:25973519, ECO:0000269|PubMed:7920629,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:9009272,
CC       ECO:0000305|PubMed:8298642}.
CC   -!- ENZYME REGULATION: Channel activity is potentiated by nanomolar
CC       concentrations of Zn(2+); half-maximal activation is observed with
CC       37 nM Zn(2+) (PubMed:16144831). Inhibited by higher Zn(2+) levels;
CC       haf-maximal inhibition occurs at 20 uM Zn(2+) (PubMed:16144831).
CC       Inhibited by strychnine (PubMed:2155780, PubMed:16144831,
CC       PubMed:25445488). Inhibited by lindane (PubMed:25445488).
CC       Inhibited by picrotoxin (PubMed:22715885, PubMed:23994010,
CC       PubMed:25730860). Strychnine binding locks the channel in a closed
CC       conformation and prevents channel opening in response to
CC       extracellular glycine (By similarity).
CC       {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:23994010, ECO:0000269|PubMed:25445488,
CC       ECO:0000269|PubMed:25730860}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=A concentration of about 0.02 mM glycine results in half-
CC         maximal channel conductance for homopentamers. A concentration
CC         of 0.018 mM glycine results in half-maximal channel conductance
CC         for homopentamers upon heterologous expression in cultured human
CC         embryonic kidney cells (PubMed:9009272). A concentration of
CC         0.027 mM glycine results in half-maximal channel conductance for
CC         homopentamers upon heterologous expression in cultured human
CC         embryonic kidney cells (PubMed:7920629).
CC         {ECO:0000269|PubMed:7920629, ECO:0000269|PubMed:9009272};
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:22715885,
CC       PubMed:22973015, PubMed:23994010, PubMed:25730860). Interacts with
CC       GLRB to form heteropentameric channels; this is probably the
CC       predominant form in vivo (PubMed:22715885, PubMed:22973015,
CC       PubMed:25445488). Heteropentamer composed of two GLRA1 and three
CC       GLRB (PubMed:22715885). Heteropentamer composed of three GLRA1 and
CC       two GLRB (PubMed:22973015). Both homopentamers and heteropentamers
CC       form functional ion channels, but their characteristics are subtly
CC       different (PubMed:14551753, PubMed:22715885, PubMed:22973015,
CC       PubMed:25445488, PubMed:23994010, PubMed:25730860).
CC       {ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q64018}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q64018}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q64018}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q64018}. Cell membrane
CC       {ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:24108130,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:25973519, ECO:0000269|PubMed:7920629,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:9009272}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25730860, ECO:0000305|PubMed:2155780}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P23415-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P23415-2; Sequence=VSP_021142;
CC   -!- DOMAIN: The channel pore is formed by pentameric assembly of the
CC       second transmembrane domain from all five subunits. In the absence
CC       of the extracellular domain, the channel is in a constitutively
CC       open conformation (PubMed:23994010). Channel opening is effected
CC       by an outward rotation of the transmembrane domains that increases
CC       the diameter of the pore (By similarity).
CC       {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:23994010}.
CC   -!- DISEASE: Hyperekplexia 1 (HKPX1) [MIM:149400]: A neurologic
CC       disorder characterized by muscular rigidity of central nervous
CC       system origin, particularly in the neonatal period, and by an
CC       exaggerated startle response to unexpected acoustic or tactile
CC       stimuli. {ECO:0000269|PubMed:10514101,
CC       ECO:0000269|PubMed:24108130, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:7611730, ECO:0000269|PubMed:7881416,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:7981700,
CC       ECO:0000269|PubMed:8298642, ECO:0000269|PubMed:8571969,
CC       ECO:0000269|PubMed:8733061, ECO:0000269|PubMed:9009272,
CC       ECO:0000269|PubMed:9067762, ECO:0000269|PubMed:9920650,
CC       ECO:0000269|Ref.18}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:2155780}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA1 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52009; CAA36258.1; -; mRNA.
DR   EMBL; AK312702; BAG35580.1; -; mRNA.
DR   EMBL; CH471062; EAW61657.1; -; Genomic_DNA.
DR   EMBL; BC074980; AAH74980.1; -; mRNA.
DR   EMBL; BC114947; AAI14948.1; -; mRNA.
DR   CCDS; CCDS4320.1; -. [P23415-2]
DR   CCDS; CCDS54942.1; -. [P23415-1]
DR   PIR; S12382; S12382.
DR   RefSeq; NP_000162.2; NM_000171.3. [P23415-2]
DR   RefSeq; NP_001139512.1; NM_001146040.1. [P23415-1]
DR   UniGene; Hs.121490; -.
DR   PDB; 1MOT; NMR; -; A=277-304.
DR   PDB; 1VRY; NMR; -; A=278-337.
DR   PDB; 2M6B; NMR; -; A=244-453.
DR   PDB; 2M6I; NMR; -; A/B/C/D/E=244-453.
DR   PDB; 4X5T; X-ray; 3.50 A; A/B/C/D/E=246-338, A/B/C/D/E=418-446.
DR   PDBsum; 1MOT; -.
DR   PDBsum; 1VRY; -.
DR   PDBsum; 2M6B; -.
DR   PDBsum; 2M6I; -.
DR   PDBsum; 4X5T; -.
DR   ProteinModelPortal; P23415; -.
DR   SMR; P23415; -.
DR   DIP; DIP-48768N; -.
DR   IntAct; P23415; 2.
DR   STRING; 9606.ENSP00000411593; -.
DR   BindingDB; P23415; -.
DR   ChEMBL; CHEMBL5845; -.
DR   DrugBank; DB03929; D-Serine.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB05417; GW 468816.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00431; Lindane.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   GuidetoPHARMACOLOGY; 423; -.
DR   TCDB; 1.A.9.3.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P23415; -.
DR   PhosphoSitePlus; P23415; -.
DR   BioMuta; GLRA1; -.
DR   DMDM; 116242495; -.
DR   EPD; P23415; -.
DR   PaxDb; P23415; -.
DR   PeptideAtlas; P23415; -.
DR   PRIDE; P23415; -.
DR   Ensembl; ENST00000274576; ENSP00000274576; ENSG00000145888. [P23415-2]
DR   Ensembl; ENST00000455880; ENSP00000411593; ENSG00000145888. [P23415-1]
DR   GeneID; 2741; -.
DR   KEGG; hsa:2741; -.
DR   UCSC; uc003lur.4; human. [P23415-1]
DR   CTD; 2741; -.
DR   DisGeNET; 2741; -.
DR   EuPathDB; HostDB:ENSG00000145888.10; -.
DR   GeneCards; GLRA1; -.
DR   GeneReviews; GLRA1; -.
DR   HGNC; HGNC:4326; GLRA1.
DR   HPA; HPA016502; -.
DR   MalaCards; GLRA1; -.
DR   MIM; 138491; gene.
DR   MIM; 149400; phenotype.
DR   neXtProt; NX_P23415; -.
DR   OpenTargets; ENSG00000145888; -.
DR   Orphanet; 3197; Hereditary hyperekplexia.
DR   PharmGKB; PA28727; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P23415; -.
DR   KO; K05193; -.
DR   OMA; FNFAYGM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P23415; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   EvolutionaryTrace; P23415; -.
DR   GeneWiki; Glycine_receptor,_alpha_1; -.
DR   GenomeRNAi; 2741; -.
DR   PRO; PR:P23415; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000145888; -.
DR   CleanEx; HS_GLRA1; -.
DR   ExpressionAtlas; P23415; baseline and differential.
DR   Genevisible; P23415; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0060077; C:inhibitory synapse; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030977; F:taurine binding; IDA:UniProtKB.
DR   GO; GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IMP:UniProtKB.
DR   GO; GO:0007340; P:acrosome reaction; IEA:Ensembl.
DR   GO; GO:0001508; P:action potential; IEA:Ensembl.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; IDA:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0051970; P:negative regulation of transmission of nerve impulse; IMP:UniProtKB.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; IMP:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0097305; P:response to alcohol; ISS:UniProtKB.
DR   GO; GO:0060013; P:righting reflex; IEA:Ensembl.
DR   GO; GO:0001964; P:startle response; IMP:UniProtKB.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:Ensembl.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008128; Glycine_rcpt_A1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01674; GLYRALPHA1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chloride; Chloride channel; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Metal-binding;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport; Zinc.
FT   SIGNAL        1     28       {ECO:0000250|UniProtKB:P07727,
FT                                ECO:0000255}.
FT   CHAIN        29    457       Glycine receptor subunit alpha-1.
FT                                /FTId=PRO_0000000412.
FT   TOPO_DOM     29    250       Extracellular. {ECO:0000305}.
FT   TRANSMEM    251    272       Helical; Name=1.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    273    277       Cytoplasmic.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TRANSMEM    278    298       Helical; Name=2.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    299    309       Extracellular.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TRANSMEM    310    330       Helical; Name=3.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    331    425       Cytoplasmic.
FT                                {ECO:0000269|PubMed:23994010}.
FT   TRANSMEM    426    446       Helical; Name=4.
FT                                {ECO:0000269|PubMed:23994010}.
FT   TOPO_DOM    447    457       Extracellular. {ECO:0000305}.
FT   REGION      230    235       Strychnine-binding.
FT                                {ECO:0000250|UniProtKB:O93430}.
FT   METAL       220    220       Zinc. {ECO:0000305|PubMed:16144831}.
FT   METAL       222    222       Zinc. {ECO:0000305|PubMed:16144831}.
FT   METAL       243    243       Zinc. {ECO:0000305|PubMed:16144831}.
FT   SITE        289    289       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   DISULFID    166    180       {ECO:0000269|PubMed:19861413}.
FT   DISULFID    226    237       {ECO:0000269|PubMed:19861413}.
FT   VAR_SEQ     354    361       Missing (in isoform b).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2155780}.
FT                                /FTId=VSP_021142.
FT   VARIANT      93     93       R -> W (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with S-258;
FT                                dbSNP:rs199547699).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075418.
FT   VARIANT     100    100       R -> C (in HKPX1; abolishes expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075419.
FT   VARIANT     246    246       R -> W (in HKPX1; abolishes expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs751659671).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075420.
FT   VARIANT     254    254       Q -> E (in HKPX1; strongly increases
FT                                sensitivity to extracellular glycine;
FT                                high leak currents in the absence of
FT                                glycine due to spontaneous channel
FT                                opening). {ECO:0000269|PubMed:24108130,
FT                                ECO:0000269|PubMed:25730860}.
FT                                /FTId=VAR_075421.
FT   VARIANT     258    258       P -> S (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with W-93).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075422.
FT   VARIANT     272    272       I -> N (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918409).
FT                                {ECO:0000269|PubMed:7881416,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000296.
FT   VARIANT     278    278       P -> T (in HKPX1; requires much higher
FT                                glycine levels for channel activation and
FT                                displays an increased rate of
FT                                desensitization; dbSNP:rs121918413).
FT                                {ECO:0000269|PubMed:25730860,
FT                                ECO:0000269|PubMed:9920650}.
FT                                /FTId=VAR_010112.
FT   VARIANT     280    280       R -> H (in HKPX1; dbSNP:rs281864918).
FT                                {ECO:0000269|PubMed:10514101}.
FT                                /FTId=VAR_010113.
FT   VARIANT     294    294       Q -> H (in HKPX1; dbSNP:rs121918411).
FT                                {ECO:0000269|PubMed:8571969}.
FT                                /FTId=VAR_000297.
FT   VARIANT     299    299       R -> L (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918408).
FT                                {ECO:0000269|PubMed:7925268,
FT                                ECO:0000269|PubMed:7981700,
FT                                ECO:0000269|PubMed:8298642,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000298.
FT   VARIANT     299    299       R -> Q (in HKPX1; decreases unitary
FT                                channel conductance and requires much
FT                                higher glycine concentrations for
FT                                activation; dbSNP:rs121918408).
FT                                {ECO:0000269|PubMed:25730860,
FT                                ECO:0000269|PubMed:7925268,
FT                                ECO:0000269|PubMed:8298642,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000299.
FT   VARIANT     304    304       K -> E (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918412).
FT                                {ECO:0000269|PubMed:8733061,
FT                                ECO:0000269|PubMed:9009272,
FT                                ECO:0000269|PubMed:9067762}.
FT                                /FTId=VAR_000300.
FT   VARIANT     307    307       Y -> C (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918410).
FT                                {ECO:0000269|PubMed:7611730,
FT                                ECO:0000269|PubMed:9009272,
FT                                ECO:0000269|Ref.18}.
FT                                /FTId=VAR_000301.
FT   VARIANT     308    308       V -> M (in HKPX1; high leak currents in
FT                                the absence of glycine due to spontaneous
FT                                channel opening).
FT                                {ECO:0000269|PubMed:24108130,
FT                                ECO:0000269|PubMed:25730860}.
FT                                /FTId=VAR_075423.
FT   VARIANT     319    319       L -> P (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with A-424).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075424.
FT   VARIANT     424    424       D -> A (in HKPX1; abolishes expression at
FT                                the cell membrane; compound heterozygote
FT                                with P-319).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075425.
FT   VARIANT     428    428       R -> H (in HKPX1; dbSNP:rs281864919).
FT                                {ECO:0000269|PubMed:10514101}.
FT                                /FTId=VAR_010114.
FT   VARIANT     450    450       R -> H (in HKPX1; displays leak currents
FT                                in the absence of glycine due to
FT                                spontaneous channel opening;
FT                                dbSNP:rs200130685).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075426.
FT   MUTAGEN      80     80       A->S: The mutant channel requires much
FT                                higher glycine concentrations for
FT                                activation. {ECO:0000269|PubMed:7920629}.
FT   MUTAGEN     137    137       H->F: Abolishes sensitivity of channel
FT                                activity to potentiation or inhibition by
FT                                Zn(2+); when associated with K-222.
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     137    137       H->N: Strongly decreases sensitivity to
FT                                inhibition by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     220    220       E->A: Abolishes potentiation of channel
FT                                activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     222    222       D->A: Abolishes potentiation of channel
FT                                activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     222    222       D->K: Abolishes sensitivity of channel
FT                                activity to potentiation or inhibition by
FT                                Zn(2+); when associated with F-137.
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     243    243       H->A: Strongly decreases potentiation of
FT                                channel activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     282    282       G->A: Increased single-channel
FT                                conductance. No effect on glycine
FT                                sensitivity, but decreased rate of
FT                                activation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   MUTAGEN     304    304       K->C: Decreases channel conductance; the
FT                                mutant channel requires much higher
FT                                glycine concentrations for activation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   CONFLICT     12     14       WET -> SGA (in Ref. 1; CAA36258).
FT                                {ECO:0000305}.
FT   CONFLICT     33     33       P -> T (in Ref. 1; CAA36258).
FT                                {ECO:0000305}.
FT   TURN        246    248       {ECO:0000244|PDB:2M6B}.
FT   HELIX       249    254       {ECO:0000244|PDB:4X5T}.
FT   HELIX       256    267       {ECO:0000244|PDB:4X5T}.
FT   TURN        274    276       {ECO:0000244|PDB:2M6B}.
FT   HELIX       278    280       {ECO:0000244|PDB:4X5T}.
FT   HELIX       281    284       {ECO:0000244|PDB:4X5T}.
FT   HELIX       286    289       {ECO:0000244|PDB:4X5T}.
FT   HELIX       291    297       {ECO:0000244|PDB:4X5T}.
FT   HELIX       299    301       {ECO:0000244|PDB:4X5T}.
FT   TURN        310    312       {ECO:0000244|PDB:4X5T}.
FT   HELIX       316    323       {ECO:0000244|PDB:4X5T}.
FT   HELIX       325    335       {ECO:0000244|PDB:4X5T}.
FT   HELIX       416    419       {ECO:0000244|PDB:2M6B}.
FT   HELIX       420    423       {ECO:0000244|PDB:4X5T}.
FT   TURN        424    426       {ECO:0000244|PDB:4X5T}.
FT   HELIX       427    446       {ECO:0000244|PDB:4X5T}.
FT   TURN        449    453       {ECO:0000244|PDB:2M6B}.
SQ   SEQUENCE   457 AA;  52624 MW;  5ED80AF62B06A3AA CRC64;
     MYSFNTLRLY LWETIVFFSL AASKEAEAAR SAPKPMSPSD FLDKLMGRTS GYDARIRPNF
     KGPPVNVSCN IFINSFGSIA ETTMDYRVNI FLRQQWNDPR LAYNEYPDDS LDLDPSMLDS
     IWKPDLFFAN EKGAHFHEIT TDNKLLRISR NGNVLYSIRI TLTLACPMDL KNFPMDVQTC
     IMQLESFGYT MNDLIFEWQE QGAVQVADGL TLPQFILKEE KDLRYCTKHY NTGKFTCIEA
     RFHLERQMGY YLIQMYIPSL LIVILSWISF WINMDAAPAR VGLGITTVLT MTTQSSGSRA
     SLPKVSYVKA IDIWMAVCLL FVFSALLEYA AVNFVSRQHK ELLRFRRKRR HHKSPMLNLF
     QEDEAGEGRF NFSAYGMGPA CLQAKDGISV KGANNSNTTN PPPAPSKSPE EMRKLFIQRA
     KKIDKISRIG FPMAFLIFNM FYWIIYKIVR REDVHNQ
//
ID   GBRR1_HUMAN             Reviewed;         479 AA.
AC   P24046; A1L401; B4DJK8; B4DQT5; B7ZBQ7; Q9BX06;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   20-DEC-2017, entry version 169.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit rho-1;
DE   AltName: Full=GABA(A) receptor subunit rho-1;
DE   AltName: Full=GABA(C) receptor;
DE   Flags: Precursor;
GN   Name=GABRR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=1849271; DOI=10.1073/pnas.88.7.2673;
RA   Cutting G.R., Lu L., O'Hara B.F., Kasch L.M., Montrose-Rafizadeh C.,
RA   Donovan D.M., Shimada S., Antonarakis S.E., Guggino W.B., Uhl G.R.,
RA   Kazazian H.H. Jr.;
RT   "Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA
RT   receptor subunit highly expressed in the retina.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2673-2677(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   VAL-26.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel. Rho-1 GABA receptor could play a role in retinal
CC       neurotransmission.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho. Interacts
CC       with SQSTM1 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P24046-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24046-2; Sequence=VSP_036363;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P24046-3; Sequence=VSP_046665;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the retina and in a lesser
CC       extent in brain, lung and thymus.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRR1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52509.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAI30345.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M62400; AAA52509.1; ALT_INIT; mRNA.
DR   EMBL; AK296124; BAG58870.1; -; mRNA.
DR   EMBL; AK298948; BAG61047.1; -; mRNA.
DR   EMBL; AL353659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353135; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC130344; AAI30345.1; ALT_INIT; mRNA.
DR   CCDS; CCDS5019.2; -. [P24046-1]
DR   CCDS; CCDS59028.1; -. [P24046-3]
DR   CCDS; CCDS59029.1; -. [P24046-2]
DR   PIR; A38627; A38627.
DR   RefSeq; NP_001243632.1; NM_001256703.1. [P24046-2]
DR   RefSeq; NP_001243633.1; NM_001256704.1. [P24046-3]
DR   RefSeq; NP_001254511.1; NM_001267582.1. [P24046-3]
DR   RefSeq; NP_002033.2; NM_002042.4. [P24046-1]
DR   RefSeq; XP_016866178.1; XM_017010689.1. [P24046-3]
DR   UniGene; Hs.99927; -.
DR   ProteinModelPortal; P24046; -.
DR   SMR; P24046; -.
DR   BioGrid; 108843; 12.
DR   IntAct; P24046; 1.
DR   STRING; 9606.ENSP00000412673; -.
DR   BindingDB; P24046; -.
DR   ChEMBL; CHEMBL3561; -.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00466; Picrotoxin.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB00897; Triazolam.
DR   TCDB; 1.A.9.5.5; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P24046; -.
DR   PhosphoSitePlus; P24046; -.
DR   BioMuta; GABRR1; -.
DR   DMDM; 223590210; -.
DR   EPD; P24046; -.
DR   MaxQB; P24046; -.
DR   PaxDb; P24046; -.
DR   PeptideAtlas; P24046; -.
DR   PRIDE; P24046; -.
DR   DNASU; 2569; -.
DR   Ensembl; ENST00000369451; ENSP00000358463; ENSG00000146276. [P24046-3]
DR   Ensembl; ENST00000435811; ENSP00000394687; ENSG00000146276. [P24046-2]
DR   Ensembl; ENST00000454853; ENSP00000412673; ENSG00000146276. [P24046-1]
DR   Ensembl; ENST00000611484; ENSP00000478846; ENSG00000146276. [P24046-3]
DR   Ensembl; ENST00000621627; ENSP00000481986; ENSG00000146276. [P24046-3]
DR   GeneID; 2569; -.
DR   KEGG; hsa:2569; -.
DR   UCSC; uc003pna.3; human. [P24046-1]
DR   CTD; 2569; -.
DR   DisGeNET; 2569; -.
DR   EuPathDB; HostDB:ENSG00000146276.11; -.
DR   GeneCards; GABRR1; -.
DR   HGNC; HGNC:4090; GABRR1.
DR   MIM; 137161; gene.
DR   neXtProt; NX_P24046; -.
DR   OpenTargets; ENSG00000146276; -.
DR   PharmGKB; PA28505; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P24046; -.
DR   KO; K05190; -.
DR   OMA; CNMDLSR; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P24046; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-977442; GABA A (rho) receptor activation.
DR   SignaLink; P24046; -.
DR   GeneWiki; GABRR1; -.
DR   GenomeRNAi; 2569; -.
DR   PRO; PR:P24046; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146276; -.
DR   CleanEx; HS_GABRR1; -.
DR   ExpressionAtlas; P24046; baseline and differential.
DR   Genevisible; P24046; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:ProtInc.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008058; GABAAa_rho1_rcpt.
DR   InterPro; IPR008057; GABAAa_rho_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01670; GABAARRHO.
DR   PRINTS; PR01671; GABAARRHO1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    479       Gamma-aminobutyric acid receptor subunit
FT                                rho-1.
FT                                /FTId=PRO_0000000485.
FT   TOPO_DOM     22    281       Extracellular. {ECO:0000305}.
FT   TRANSMEM    282    305       Helical. {ECO:0000305}.
FT   TRANSMEM    309    331       Helical. {ECO:0000305}.
FT   TRANSMEM    343    365       Helical. {ECO:0000305}.
FT   TOPO_DOM    366    457       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    458    479       Helical. {ECO:0000305}.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    198    212       {ECO:0000250}.
FT   VAR_SEQ       1     87       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046665.
FT   VAR_SEQ      41     57       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036363.
FT   VARIANT      26     26       M -> V (in dbSNP:rs12200969).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_054426.
FT   VARIANT      27     27       H -> R (in dbSNP:rs1186902).
FT                                /FTId=VAR_024361.
FT   CONFLICT     40     40       G -> GS (in Ref. 4; AAI30345).
FT                                {ECO:0000305}.
FT   CONFLICT    424    425       MV -> VM (in Ref. 2; BAG61047).
FT                                {ECO:0000305}.
SQ   SEQUENCE   479 AA;  55883 MW;  C0C1985F16C18231 CRC64;
     MLAVPNMRFG IFLLWWGWVL ATESRMHWPG REVHEMSKKG RPQRQRREVH EDAHKQVSPI
     LRRSPDITKS PLTKSEQLLR IDDHDFSMRP GFGGPAIPVG VDVQVESLDS ISEVDMDFTM
     TLYLRHYWKD ERLSFPSTNN LSMTFDGRLV KKIWVPDMFF VHSKRSFIHD TTTDNVMLRV
     QPDGKVLYSL RVTVTAMCNM DFSRFPLDTQ TCSLEIESYA YTEDDLMLYW KKGNDSLKTD
     ERISLSQFLI QEFHTTTKLA FYSSTGWYNR LYINFTLRRH IFFFLLQTYF PATLMVMLSW
     VSFWIDRRAV PARVPLGITT VLTMSTIITG VNASMPRVSY IKAVDIYLWV SFVFVFLSVL
     EYAAVNYLTT VQERKEQKLR EKLPCTSGLP PPRTAMLDGN YSDGEVNDLD NYMPENGEKP
     DRMMVQLTLA SERSSPQRKS QRSSYVSMRI DTHAIDKYSR IIFPAAYILF NLIYWSIFS
//
ID   GBRB_DROME              Reviewed;         606 AA.
AC   P25123; P92138; Q24561; Q26302; Q7JPX8; Q8IQB5; Q8IQB6; Q961R4;
AC   Q9TX51; Q9VSV0;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   14-MAY-2014, sequence version 4.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor subunit beta;
DE   AltName: Full=Protein cyclodiene resistance;
DE   Flags: Precursor;
GN   Name=Rdl; ORFNames=CG10537;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C), AND RNA EDITING OF POSITION
RP   283.
RC   TISSUE=Embryo;
RX   PubMed=1651498; DOI=10.1073/pnas.88.16.7209;
RA   ffrench-Constant R.H., Mortlock D.P., Shaffer C.D., Macintyre R.J.,
RA   Roush R.T.;
RT   "Molecular cloning and transformation of cyclodiene resistance in
RT   Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor
RT   locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7209-7213(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND RNA EDITING OF POSITIONS
RP   122; 283 AND 360.
RC   TISSUE=Head;
RX   PubMed=8016117; DOI=10.1073/pnas.91.13.6069;
RA   Chen R., Belelli D., Reyes A., Lambert J.J., Peters J.A., Lan N.C.;
RT   "Cloning and functional expression of a Drosophila gamma-aminobutyric
RT   acid receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6069-6073(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D), AND RNA EDITING OF
RP   POSITION 283.
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 70-113 (ISOFORMS A/D).
RX   PubMed=7684073; DOI=10.1111/j.1471-4159.1993.tb03523.x;
RA   ffrench-Constant R.H., Rocheleau T.A.;
RT   "Drosophila gamma-aminobutyric acid receptor gene Rdl shows extensive
RT   alternative splicing.";
RL   J. Neurochem. 60:2323-2326(1993).
RN   [7]
RP   RNA EDITING.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=F;
CC         IsoId=P25123-2; Sequence=Displayed;
CC       Name=C;
CC         IsoId=P25123-1; Sequence=VSP_054455, VSP_054456;
CC       Name=D;
CC         IsoId=P25123-3; Sequence=VSP_054456, VSP_054457, VSP_054458;
CC   -!- RNA EDITING: Modified_positions=122 {ECO:0000269|PubMed:12907802,
CC       ECO:0000269|PubMed:8016117}, 283 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:1651498,
CC       ECO:0000269|PubMed:8016117}, 294 {ECO:0000269|PubMed:12907802},
CC       360 {ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:8016117};
CC       Note=Partially edited.;
CC   -!- MISCELLANEOUS: Resistance is thought to be due to insensitivity of
CC       the cyclodiene/picrotoxinin binding site on the GABA(A) receptor-
CC       chloride ionophore complex.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA28557.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA28558.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAK92842.1; Type=Frameshift; Positions=448; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69057; AAA28556.1; -; mRNA.
DR   EMBL; M69057; AAA28557.1; ALT_INIT; mRNA.
DR   EMBL; M69057; AAA28558.1; ALT_INIT; mRNA.
DR   EMBL; U02042; AAA19249.1; -; mRNA.
DR   EMBL; AE014296; AAF50311.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11988.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11989.2; -; Genomic_DNA.
DR   EMBL; AY051418; AAK92842.1; ALT_FRAME; mRNA.
DR   EMBL; S61113; AAB26669.1; -; mRNA.
DR   PIR; A41145; A41145.
DR   RefSeq; NP_001261616.1; NM_001274687.1. [P25123-2]
DR   RefSeq; NP_523991.2; NM_079267.4. [P25123-2]
DR   RefSeq; NP_729461.1; NM_168321.3. [P25123-1]
DR   RefSeq; NP_729462.2; NM_168322.3. [P25123-3]
DR   UniGene; Dm.2698; -.
DR   ProteinModelPortal; P25123; -.
DR   SMR; P25123; -.
DR   BioGrid; 64454; 6.
DR   STRING; 7227.FBpp0305970; -.
DR   PaxDb; P25123; -.
DR   PRIDE; P25123; -.
DR   EnsemblMetazoa; FBtr0076534; FBpp0076261; FBgn0004244. [P25123-2]
DR   EnsemblMetazoa; FBtr0076536; FBpp0076263; FBgn0004244. [P25123-1]
DR   EnsemblMetazoa; FBtr0309054; FBpp0301075; FBgn0004244. [P25123-3]
DR   EnsemblMetazoa; FBtr0333835; FBpp0305969; FBgn0004244. [P25123-2]
DR   GeneID; 39054; -.
DR   KEGG; dme:Dmel_CG10537; -.
DR   CTD; 39054; -.
DR   FlyBase; FBgn0004244; Rdl.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   InParanoid; P25123; -.
DR   KO; K05181; -.
DR   OrthoDB; EOG091G0805; -.
DR   GenomeRNAi; 39054; -.
DR   PRO; PR:P25123; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0004244; -.
DR   ExpressionAtlas; P25123; differential.
DR   Genevisible; P25123; DM.
DR   GO; GO:0030424; C:axon; IDA:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:FlyBase.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IDA:UniProtKB.
DR   GO; GO:0002121; P:inter-male aggressive behavior; IMP:FlyBase.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IMP:FlyBase.
DR   GO; GO:0042749; P:regulation of circadian sleep/wake cycle; IMP:FlyBase.
DR   GO; GO:0090328; P:regulation of olfactory learning; IMP:FlyBase.
DR   GO; GO:0042493; P:response to drug; IMP:FlyBase.
DR   GO; GO:0009612; P:response to mechanical stimulus; IGI:FlyBase.
DR   GO; GO:0030431; P:sleep; IMP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 3.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; RNA editing;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     44       {ECO:0000255}.
FT   CHAIN        45    606       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000000452.
FT   TOPO_DOM     45    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    291       Helical. {ECO:0000255}.
FT   TRANSMEM    297    316       Helical. {ECO:0000255}.
FT   TRANSMEM    333    356       Helical. {ECO:0000255}.
FT   TOPO_DOM    357    568       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    569    590       Helical. {ECO:0000255}.
FT   COMPBIAS    499    535       Gly-rich.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    185    199       {ECO:0000250}.
FT   VAR_SEQ      97    101       LSEVK -> VSEVL (in isoform C).
FT                                {ECO:0000303|PubMed:1651498}.
FT                                /FTId=VSP_054455.
FT   VAR_SEQ     216    248       KWNEGPNSVGVSSEVSLPQFKVLGHRQRAMEIS -> FWRD
FT                                GLSSVGMSSEVELPQFRVLGHRQRATEIN (in isoform
FT                                C and isoform D).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1651498}.
FT                                /FTId=VSP_054456.
FT   VAR_SEQ     448    476       Missing (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_054457.
FT   VAR_SEQ     552    552       K -> KKV (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_054458.
FT   VARIANT     122    122       R -> G (in RNA edited version).
FT   VARIANT     283    283       I -> V (in RNA edited version).
FT   VARIANT     294    294       N -> D (in RNA edited version).
FT   VARIANT     360    360       M -> V (in RNA edited version).
FT   CONFLICT     38     38       H -> N (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
FT   CONFLICT     68     68       V -> I (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       G -> R (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
SQ   SEQUENCE   606 AA;  65656 MW;  25BDDCB03DAD54F8 CRC64;
     MSDSKMDKLA RMAPLPRTPL LTIWLAINMA LIAQETGHKR IHTVQAATGG GSMLGDVNIS
     AILDSFSVSY DKRVRPNYGG PPVEVGVTMY VLSISSLSEV KMDFTLDFYF RQFWTDPRLA
     YRKRPGVETL SVGSEFIKNI WVPDTFFVNE KQSYFHIATT SNEFIRVHHS GSITRSIRLT
     ITASCPMNLQ YFPMDRQLCH IEIESFGYTM RDIRYKWNEG PNSVGVSSEV SLPQFKVLGH
     RQRAMEISLT TGNYSRLACE IQFVRSMGYY LIQIYIPSGL IVIISWVSFW LNRNATPARV
     ALGVTTVLTM TTLMSSTNAA LPKISYVKSI DVYLGTCFVM VFASLLEYAT VGYMAKRIQM
     RKQRFMAIQK IAEQKKQQLD GANQQQANPN PNANVGGPGG VGVGPGGPGG PGGGVNVGVG
     MGMGPEHGHG HGHHAHSHGH PHAPKQTVSN RPIGFSNIQQ NVGTRGCSIV GPLFQEVRFK
     VHDPKAHSKG GTLENTVNGG RGGPQSHGPG PGQGGGPPGG GGGGGGGGGP PEGGGDPEAA
     VPAHLLHPGK VKKDINKLLG ITPSDIDKYS RIVFPVCFVC FNLMYWIIYL HVSDVVADDL
     VLLGEE
//
ID   GBRB_LYMST              Reviewed;         499 AA.
AC   P26714;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   25-OCT-2017, entry version 100.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor;
DE   Flags: Precursor;
OS   Lymnaea stagnalis (Great pond snail) (Helix stagnalis).
OC   Eukaryota; Metazoa; Lophotrochozoa; Mollusca; Gastropoda;
OC   Heterobranchia; Euthyneura; Panpulmonata; Hygrophila; Lymnaeoidea;
OC   Lymnaeidae; Lymnaea.
OX   NCBI_TaxID=6523;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1655414;
RA   Harvey R.J., Vreugdenhil E., Zaman S.H., Bhandal N.S.,
RA   Usherwood P.N.R., Barnard E.A., Darlison M.G.;
RT   "Sequence of a functional invertebrate GABAA receptor subunit which
RT   can form a chimeric receptor with a vertebrate alpha subunit.";
RL   EMBO J. 10:3239-3245(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 201-334.
RX   PubMed=2164988; DOI=10.1042/bst0180438;
RA   Harvey R.J., Vreugdenhil E., Barnard E.A., Darlison M.G.;
RT   "Cloning of genomic and cDNA sequences encoding an invertebrate gamma-
RT   aminobutyric acid A receptor subunit.";
RL   Biochem. Soc. Trans. 18:438-439(1990).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA/benzodiazepine receptor and
CC       opening an integral chloride channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58638; CAA41495.1; -; mRNA.
DR   PIR; S17785; S17785.
DR   ProteinModelPortal; P26714; -.
DR   SMR; P26714; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    499       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000000467.
FT   TOPO_DOM     24    251       Extracellular. {ECO:0000305}.
FT   TRANSMEM    252    273       Helical. {ECO:0000305}.
FT   TRANSMEM    278    299       Helical. {ECO:0000305}.
FT   TRANSMEM    311    333       Helical. {ECO:0000305}.
FT   TOPO_DOM    334    475       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    476    499       Helical. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    152    152       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    167    181       {ECO:0000250}.
FT   CONFLICT    232    232       S -> L (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  57082 MW;  F81C9F2A850D62F4 CRC64;
     MWGIIVPFFS ASLMCSLVAV VRCQQDTDHF ANVTNTIDSL LKGYDIRLRP SFGGAPLEIG
     IEVILASFDS ISEVDMDYTI TMYLNQYWRD ERLQFIFNES LDLGENRSVT TMTLTGAFAE
     KIWVPDTFLA NDKNSFLHDI TEKNKMVRLY GNGSLVYGMR FTTTLACMMD LHNYPLDHQE
     CTVEIESYGY TMDDIVLYWL NDRGAVTGVE DVSLPQFSIT NYATINKIEE LSTGDYQRLS
     LIFQLQRNIG YFIFQTYLPS ILIVMLSWVS FWINHEATSA RVALGITTVL TMTTISNGVR
     SSLPRISYVK AIDIYLVMCF VFVFAALLEY AAVNYTYWGA RAKRKAKRLR ERATSVRKRV
     DDGDQMNNTN MDTVELKEVH MVPTSVGVTN SQSFNLDLDD GSGDDTGFRV VPPIPRSFTH
     SHATTHGYIP TNVVRRRSSS HVPPRRRRLL SHFRQKAKSI KVKIPRVQDV NTIDKYARLM
     FPLLFIIFNT SYWSVYLLT
//
ID   GBRB3_HUMAN             Reviewed;         473 AA.
AC   P28472; B7Z2W1; B7Z825; F5H3D2; H7BYV8; Q14352; Q96FM5;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   20-DEC-2017, entry version 184.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-3;
DE   AltName: Full=GABA(A) receptor subunit beta-3;
DE   Flags: Precursor;
GN   Name=GABRB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1664410; DOI=10.1016/0888-7543(91)90034-C;
RA   Wagstaff J., Chaillet J.R., Lalande M.;
RT   "The GABAA receptor beta 3 subunit gene: characterization of a human
RT   cDNA from chromosome 15q11q13 and mapping to a region of conserved
RT   synteny on mouse chromosome 7.";
RL   Genomics 11:1071-1078(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-173.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80 (ISOFORMS 1 AND 2).
RC   TISSUE=Fibroblast;
RX   PubMed=8382702;
RA   Kirkness E.F., Fraser C.M.;
RT   "A strong promoter element is located between alternative exons of a
RT   gene encoding the human gamma-aminobutyric acid-type A receptor beta 3
RT   subunit (GABRB3).";
RL   J. Biol. Chem. 268:4420-4428(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-153 AND 183-227.
RX   PubMed=1714232;
RA   Wagstaff J., Knoll J.H.M., Fleming J., Kirkness E.F.,
RA   Martin-Gallardo A., Greenberg F., Graham J.M. Jr., Menninger J.,
RA   Ward D., Venter J.C., Lalande M.;
RT   "Localization of the gene encoding the GABAA receptor beta 3 subunit
RT   to the Angelman/Prader-Willi region of human chromosome 15.";
RL   Am. J. Hum. Genet. 49:330-337(1991).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18281286; DOI=10.1074/jbc.M709993200;
RA   Saras A., Gisselmann G., Vogt-Eisele A.K., Erlkamp K.S., Kletke O.,
RA   Pusch H., Hatt H.;
RT   "Histamine action on vertebrate GABAA receptors: direct channel gating
RT   and potentiation of GABA responses.";
RL   J. Biol. Chem. 283:10470-10475(2008).
RN   [9]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=22243422; DOI=10.1021/bi201772m;
RA   Chiara D.C., Dostalova Z., Jayakar S.S., Zhou X., Miller K.W.,
RA   Cohen J.B.;
RT   "Mapping general anesthetic binding site(s) in human alpha1beta3
RT   gamma-aminobutyric acid type A receptors with [^3H]TDBzl-etomidate, a
RT   photoreactive etomidate analogue.";
RL   Biochemistry 51:836-847(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.97 ANGSTROMS) OF 26-473 IN COMPLEX WITH THE
RP   AGONIST BENZAMIDINE, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY,
RP   SUBUNIT, GLYCOSYLATION AT ASN-33; ASN-105 AND ASN-174, AND DISULFIDE
RP   BOND.
RX   PubMed=24909990; DOI=10.1038/nature13293;
RA   Miller P.S., Aricescu A.R.;
RT   "Crystal structure of a human GABAA receptor.";
RL   Nature 512:270-275(2014).
RN   [11]
RP   VARIANT HIS-217, AND CHARACTERIZATION OF VARIANT HIS-217.
RX   PubMed=12189488; DOI=10.1007/s00439-002-0766-7;
RA   Buhr A., Bianchi M.T., Baur R., Courtet P., Pignay V., Boulenger J.P.,
RA   Gallati S., Hinkle D.J., Macdonald R.L., Sigel E.;
RT   "Functional characterization of the new human GABA(A) receptor
RT   mutation beta3(R192H).";
RL   Hum. Genet. 111:154-160(2002).
RN   [12]
RP   VARIANT ECA5 ARG-32, CHARACTERIZATION OF VARIANT ECA5 ARG-32, VARIANTS
RP   ECA5 SER-11 AND PHE-15 (ISOFORM 2), CHARACTERIZATION OF VARIANTS ECA5
RP   SER-11 AND PHE-15 (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=18514161; DOI=10.1016/j.ajhg.2008.04.020;
RA   Tanaka M., Olsen R.W., Medina M.T., Schwartz E., Alonso M.E.,
RA   Duron R.M., Castro-Ortega R., Martinez-Juarez I.E.,
RA   Pascual-Castroviejo I., Machado-Salas J., Silva R., Bailey J.N.,
RA   Bai D., Ochoa A., Jara-Prado A., Pineda G., Macdonald R.L.,
RA   Delgado-Escueta A.V.;
RT   "Hyperglycosylation and reduced GABA currents of mutated GABRB3
RT   polypeptide in remitting childhood absence epilepsy.";
RL   Am. J. Hum. Genet. 82:1249-1261(2008).
RN   [13]
RP   CHARACTERIZATION OF VARIANT ECA5 ARG-32, FUNCTION, SUBCELLULAR
RP   LOCATION, AND SUBUNIT.
RX   PubMed=22303015; DOI=10.1074/jbc.M111.332528;
RA   Gurba K.N., Hernandez C.C., Hu N., Macdonald R.L.;
RT   "GABRB3 mutation, G32R, associated with childhood absence epilepsy
RT   alters alpha1beta3gamma2L gamma-aminobutyric acid type A (GABAA)
RT   receptor expression and channel gating.";
RL   J. Biol. Chem. 287:12083-12097(2012).
RN   [14]
RP   INVOLVEMENT IN EIEE43, AND VARIANT EIEE43 ASN-120.
RX   PubMed=23934111; DOI=10.1038/nature12439;
RG   Epi4K Consortium;
RG   Epilepsy Phenome/Genome Project;
RA   Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D.,
RA   Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y.,
RA   Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R.,
RA   Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C.,
RA   Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A.,
RA   Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B.,
RA   Alldredge B.K., Bautista J.F., Berkovic S.F., Boro A., Cascino G.D.,
RA   Consalvo D., Crumrine P., Devinsky O., Dlugos D., Epstein M.P.,
RA   Fiol M., Fountain N.B., French J., Friedman D., Geller E.B.,
RA   Glauser T., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S.,
RA   Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R.,
RA   Kuzniecky R., Lowenstein D.H., McGuire S.M., Motika P.V.,
RA   Novotny E.J., Ottman R., Paolicchi J.M., Parent J.M., Park K.,
RA   Poduri A., Scheffer I.E., Shellhaas R.A., Sherr E.H., Shih J.J.,
RA   Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A.,
RA   Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P.,
RA   Winawer M.R.;
RT   "De novo mutations in epileptic encephalopathies.";
RL   Nature 501:217-221(2013).
RN   [15]
RP   VARIANT EIEE43 HIS-138 INS.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C.,
RA   Patry L., Massicotte C., Ambalavanan A., Spiegelman D., Diallo O.,
RA   Henrion E., Dionne-Laporte A., Fougerat A., Pshezhetsky A.V.,
RA   Venkateswaran S., Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
RN   [16]
RP   INVOLVEMENT IN EIEE43, AND VARIANTS EIEE43 ASN-120; MET-157; PHE-182;
RP   LYS-249; GLN-256; HIS-293 AND THR-305.
RX   PubMed=27476654; DOI=10.1016/j.ajhg.2016.06.003;
RG   Epi4K Consortium;
RT   "De novo mutations in SLC1A2 and CACNA1A are important causes of
RT   epileptic encephalopathies.";
RL   Am. J. Hum. Genet. 99:287-298(2016).
RN   [17]
RP   CHARACTERIZATION OF VARIANT EIEE43 ASN-120, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26950270; DOI=10.1002/ana.24631;
RA   Janve V.S., Hernandez C.C., Verdier K.M., Hu N., Macdonald R.L.;
RT   "Epileptic encephalopathy de novo GABRB mutations impair GABAA
RT   receptor function.";
RL   Ann. Neurol. 0:0-0(2016).
RN   [18]
RP   VARIANT EIEE43 ILE-287.
RX   PubMed=26993267; DOI=10.1136/jmedgenet-2015-103263;
RA   Trump N., McTague A., Brittain H., Papandreou A., Meyer E., Ngoh A.,
RA   Palmer R., Morrogh D., Boustred C., Hurst J.A., Jenkins L.,
RA   Kurian M.A., Scott R.H.;
RT   "Improving diagnosis and broadening the phenotypes in early-onset
RT   seizure and severe developmental delay disorders through gene panel
RT   analysis.";
RL   J. Med. Genet. 53:310-317(2016).
RN   [19]
RP   VARIANT GLN-232.
RX   PubMed=28544625; DOI=10.1002/ajmg.a.38282;
RA   Le S.V., Le P.H.T., Le T.K.V., Kieu Huynh T.T., Hang Do T.T.;
RT   "A mutation in GABRB3 associated with Dravet syndrome.";
RL   Am. J. Med. Genet. A 173:2126-2131(2017).
RN   [20]
RP   VARIANTS EIEE43 PHE-124 AND PHE-254.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel. {ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422,
CC       ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990,
CC       ECO:0000269|PubMed:26950270}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta,
CC       gamma, delta and rho chains (PubMed:22243422, PubMed:18281286,
CC       PubMed:18514161, PubMed:24909990). Can form functional
CC       homopentamers (in vitro) (PubMed:22303015). Interacts with UBQLN1
CC       (By similarity). May interact with KIF21B (By similarity).
CC       {ECO:0000250|UniProtKB:P63079, ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422,
CC       ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-6258252, EBI-6258252;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24909990}. Cell membrane
CC       {ECO:0000269|PubMed:18281286, ECO:0000269|PubMed:18514161,
CC       ECO:0000269|PubMed:22243422, ECO:0000269|PubMed:22303015,
CC       ECO:0000269|PubMed:24909990, ECO:0000269|PubMed:26950270}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:24909990}. Cytoplasmic
CC       vesicle membrane {ECO:0000250|UniProtKB:P63079}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Isoforms differ in their signal region.;
CC       Name=1;
CC         IsoId=P28472-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28472-2; Sequence=VSP_000088;
CC         Note=Variant in position: 11:P->S (in ECA5, the mutant protein
CC         is hyperglycosylated and has reduced mean current densities
CC         compared to wild-type, dbSNP:rs25409). Variant in position:
CC         15:S->F (in ECA5, the mutant protein is hyperglycosylated and
CC         has reduced mean current densities compared to wild-type).
CC         {ECO:0000269|PubMed:18514161};
CC       Name=3;
CC         IsoId=P28472-3; Sequence=VSP_046126;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P28472-4; Sequence=VSP_046676;
CC   -!- POLYMORPHISM: GABRB3 variants may be associated with insomnia, a
CC       condition of inability to initiate or maintain sleep [MIM:137192].
CC   -!- DISEASE: Epilepsy, childhood absence 5 (ECA5) [MIM:612269]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Absence
CC       seizures may either remit or persist into adulthood.
CC       {ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22303015}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 43 (EIEE43)
CC       [MIM:617113]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE43
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:23934111,
CC       ECO:0000269|PubMed:25356899, ECO:0000269|PubMed:26950270,
CC       ECO:0000269|PubMed:26993267, ECO:0000269|PubMed:27476654,
CC       ECO:0000269|PubMed:27864847}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M82919; AAA52511.1; -; mRNA.
DR   EMBL; AK295167; BAH11997.1; -; mRNA.
DR   EMBL; AK302822; BAH13811.1; -; mRNA.
DR   EMBL; AC009878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC145167; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC145196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EU606048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471151; EAW57655.1; -; Genomic_DNA.
DR   EMBL; BC010641; AAH10641.1; -; mRNA.
DR   EMBL; L04311; AAA52508.1; -; Genomic_DNA.
DR   EMBL; L04311; AAA52507.1; -; Genomic_DNA.
DR   CCDS; CCDS10018.1; -. [P28472-2]
DR   CCDS; CCDS10019.1; -. [P28472-1]
DR   CCDS; CCDS53920.1; -. [P28472-4]
DR   CCDS; CCDS53921.1; -. [P28472-3]
DR   PIR; A55275; A55275.
DR   PIR; B45468; B45468.
DR   RefSeq; NP_000805.1; NM_000814.5. [P28472-1]
DR   RefSeq; NP_001178249.1; NM_001191320.1. [P28472-4]
DR   RefSeq; NP_001178250.1; NM_001191321.2. [P28472-3]
DR   RefSeq; NP_001265560.1; NM_001278631.1. [P28472-4]
DR   RefSeq; NP_068712.1; NM_021912.4. [P28472-2]
DR   UniGene; Hs.302352; -.
DR   UniGene; Hs.727263; -.
DR   PDB; 4COF; X-ray; 2.97 A; A/B/C/D/E=26-332, A/B/C/D/E=447-473.
DR   PDB; 5O8F; X-ray; 3.20 A; A/B/C/D/E=26-246.
DR   PDBsum; 4COF; -.
DR   PDBsum; 5O8F; -.
DR   ProteinModelPortal; P28472; -.
DR   SMR; P28472; -.
DR   BioGrid; 108836; 10.
DR   DIP; DIP-61029N; -.
DR   IntAct; P28472; 1.
DR   STRING; 9606.ENSP00000299267; -.
DR   BindingDB; P28472; -.
DR   ChEMBL; CHEMBL1847; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB06716; Fospropofol.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB00592; Piperazine.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   GuidetoPHARMACOLOGY; 412; -.
DR   TCDB; 1.A.9.5.4; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P28472; -.
DR   PhosphoSitePlus; P28472; -.
DR   BioMuta; GABRB3; -.
DR   DMDM; 120773; -.
DR   MaxQB; P28472; -.
DR   PaxDb; P28472; -.
DR   PeptideAtlas; P28472; -.
DR   PRIDE; P28472; -.
DR   DNASU; 2562; -.
DR   Ensembl; ENST00000299267; ENSP00000299267; ENSG00000166206. [P28472-2]
DR   Ensembl; ENST00000311550; ENSP00000308725; ENSG00000166206. [P28472-1]
DR   Ensembl; ENST00000400188; ENSP00000383049; ENSG00000166206. [P28472-3]
DR   Ensembl; ENST00000545868; ENSP00000439169; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000622697; ENSP00000481004; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000628124; ENSP00000486819; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000636466; ENSP00000489768; ENSG00000166206. [P28472-4]
DR   GeneID; 2562; -.
DR   KEGG; hsa:2562; -.
DR   UCSC; uc001zaz.5; human. [P28472-1]
DR   CTD; 2562; -.
DR   DisGeNET; 2562; -.
DR   EuPathDB; HostDB:ENSG00000166206.13; -.
DR   GeneCards; GABRB3; -.
DR   GeneReviews; GABRB3; -.
DR   HGNC; HGNC:4083; GABRB3.
DR   MalaCards; GABRB3; -.
DR   MIM; 137192; gene+phenotype.
DR   MIM; 612269; phenotype.
DR   MIM; 617113; phenotype.
DR   neXtProt; NX_P28472; -.
DR   OpenTargets; ENSG00000166206; -.
DR   Orphanet; 106; Autism.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   PharmGKB; PA28497; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P28472; -.
DR   KO; K05181; -.
DR   PhylomeDB; P28472; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   SignaLink; P28472; -.
DR   ChiTaRS; GABRB3; human.
DR   GeneWiki; GABRB3; -.
DR   GenomeRNAi; 2562; -.
DR   PRO; PR:P28472; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166206; -.
DR   CleanEx; HS_GABRB3; -.
DR   ExpressionAtlas; P28472; baseline and differential.
DR   Genevisible; P28472; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1902711; C:GABA-A receptor complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IMP:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:GO_Central.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0060119; P:inner ear receptor cell development; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Epilepsy;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    473       Gamma-aminobutyric acid receptor subunit
FT                                beta-3.
FT                                /FTId=PRO_0000000462.
FT   TOPO_DOM     26    245       Extracellular.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    246    267       Helical.
FT   TOPO_DOM    268    270       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    271    293       Helical.
FT   TOPO_DOM    294    304       Extracellular.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    305    327       Helical.
FT   TOPO_DOM    328    450       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    451    472       Helical.
FT   REGION      120    122       Agonist binding.
FT   REGION      180    182       Agonist binding.
FT   REGION      290    311       Allosteric effector binding.
FT   BINDING     225    225       Agonist.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   DISULFID    161    175       {ECO:0000269|PubMed:24909990}.
FT   VAR_SEQ       1     85       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046676.
FT   VAR_SEQ       1     26       MWGLAGGRLFGIFSAPVLVAVVCCAQ -> MCSGLLELLLP
FT                                IWLSWTLGTRGSEPR (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000088.
FT   VAR_SEQ       3     80       GLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDK
FT                                LLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNM ->
FT                                ATYQTEE (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046126.
FT   VARIANT      32     32       G -> R (in ECA5; the mutant protein is
FT                                hyperglycosylated and has reduced mean
FT                                current densities compared to wild-type;
FT                                dbSNP:rs71651682).
FT                                {ECO:0000269|PubMed:18514161,
FT                                ECO:0000269|PubMed:22303015}.
FT                                /FTId=VAR_047957.
FT   VARIANT     120    120       D -> N (in EIEE43; no effect on
FT                                localization to the plasma membrane;
FT                                decreased GABA-gated chloride ion channel
FT                                activity; decreased single channel open
FT                                probability; dbSNP:rs886037938).
FT                                {ECO:0000269|PubMed:23934111,
FT                                ECO:0000269|PubMed:26950270,
FT                                ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077076.
FT   VARIANT     124    124       L -> F (in EIEE43; dbSNP:rs1057519550).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078223.
FT   VARIANT     138    138       N -> NH (in EIEE43).
FT                                {ECO:0000269|PubMed:25356899}.
FT                                /FTId=VAR_078619.
FT   VARIANT     157    157       T -> M (in EIEE43; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077077.
FT   VARIANT     173    173       Q -> L (in dbSNP:rs17850679).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_047958.
FT   VARIANT     182    182       Y -> F (in EIEE43; dbSNP:rs886037939).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077078.
FT   VARIANT     217    217       R -> H (found in a subject suffering from
FT                                insomnia; functional analysis reveals a
FT                                slower rate of the fast phase of
FT                                desensitization compared with
FT                                alpha1beta3gamma2S GABA(A) receptors;
FT                                current deactivation is faster in the
FT                                mutated receptors; dbSNP:rs121913125).
FT                                {ECO:0000269|PubMed:12189488}.
FT                                /FTId=VAR_047959.
FT   VARIANT     232    232       R -> Q (found in patients with Dravet
FT                                syndrome; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:28544625}.
FT                                /FTId=VAR_079429.
FT   VARIANT     249    249       Q -> K (in EIEE43; dbSNP:rs886037940).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077079.
FT   VARIANT     254    254       S -> F (in EIEE43; dbSNP:rs1057519549).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078224.
FT   VARIANT     256    256       L -> Q (in EIEE43).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077080.
FT   VARIANT     287    287       T -> I (in EIEE43).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078719.
FT   VARIANT     293    293       L -> H (in EIEE43; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077081.
FT   VARIANT     305    305       A -> T (in EIEE43; dbSNP:rs886037941).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077082.
FT   CONFLICT     97     97       L -> H (in Ref. 2; BAH13811).
FT                                {ECO:0000305}.
FT   CONFLICT    193    193       W -> R (in Ref. 2; BAH11997).
FT                                {ECO:0000305}.
FT   HELIX        34     45       {ECO:0000244|PDB:4COF}.
FT   TURN         54     57       {ECO:0000244|PDB:4COF}.
FT   STRAND       61     76       {ECO:0000244|PDB:4COF}.
FT   TURN         77     80       {ECO:0000244|PDB:4COF}.
FT   STRAND       81     93       {ECO:0000244|PDB:4COF}.
FT   HELIX        95     97       {ECO:0000244|PDB:4COF}.
FT   STRAND      106    108       {ECO:0000244|PDB:4COF}.
FT   HELIX       110    115       {ECO:0000244|PDB:4COF}.
FT   STRAND      121    123       {ECO:0000244|PDB:4COF}.
FT   STRAND      126    131       {ECO:0000244|PDB:4COF}.
FT   STRAND      134    136       {ECO:0000244|PDB:4COF}.
FT   STRAND      138    143       {ECO:0000244|PDB:4COF}.
FT   STRAND      147    160       {ECO:0000244|PDB:4COF}.
FT   TURN        166    169       {ECO:0000244|PDB:4COF}.
FT   STRAND      172    183       {ECO:0000244|PDB:4COF}.
FT   TURN        186    188       {ECO:0000244|PDB:4COF}.
FT   STRAND      189    193       {ECO:0000244|PDB:4COF}.
FT   HELIX       196    198       {ECO:0000244|PDB:4COF}.
FT   STRAND      199    201       {ECO:0000244|PDB:4COF}.
FT   HELIX       203    205       {ECO:0000244|PDB:4COF}.
FT   STRAND      209    225       {ECO:0000244|PDB:4COF}.
FT   STRAND      228    241       {ECO:0000244|PDB:4COF}.
FT   HELIX       244    249       {ECO:0000244|PDB:4COF}.
FT   HELIX       251    262       {ECO:0000244|PDB:4COF}.
FT   HELIX       263    266       {ECO:0000244|PDB:4COF}.
FT   HELIX       272    295       {ECO:0000244|PDB:4COF}.
FT   HELIX       305    330       {ECO:0000244|PDB:4COF}.
FT   HELIX       447    471       {ECO:0000244|PDB:4COF}.
SQ   SEQUENCE   473 AA;  54116 MW;  D63597F7FBC69E71 CRC64;
     MWGLAGGRLF GIFSAPVLVA VVCCAQSVND PGNMSFVKET VDKLLKGYDI RLRPDFGGPP
     VCVGMNIDIA SIDMVSEVNM DYTLTMYFQQ YWRDKRLAYS GIPLNLTLDN RVADQLWVPD
     TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
     SYGYTTDDIE FYWRGGDKAV TGVERIELPQ FSIVEHRLVS RNVVFATGAY PRLSLSFRLK
     RNIGYFILQT YMPSILITIL SWVSFWINYD ASAARVALGI TTVLTMTTIN THLRETLPKI
     PYVKAIDMYL MGCFVFVFLA LLEYAFVNYI FFGRGPQRQK KLAEKTAKAK NDRSKSESNR
     VDAHGNILLT SLEVHNEMNE VSGGIGDTRN SAISFDNSGI QYRKQSMPRE GHGRFLGDRS
     LPHKKTHLRR RSSQLKIKIP DLTDVNAIDR WSRIVFPFTF SLFNLVYWLY YVN
//
ID   GBRA6_RAT               Reviewed;         453 AA.
AC   P30191;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-6;
DE   AltName: Full=GABA(A) receptor subunit alpha-6;
DE   Flags: Precursor;
GN   Name=Gabra6; Synonyms=Gabra-6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=2166916; DOI=10.1038/346648a0;
RA   Lueddens H., Pritchett D., Khler M., Killisch I., Keinaenen K.,
RA   Monyer H., Sprengel R., Seeburg P.H.;
RT   "Cerebellar GABAA receptor selective for a behavioural alcohol
RT   antagonist.";
RL   Nature 346:648-651(1990).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-403, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Binds UBQLN1 (By similarity). Generally pentameric. There
CC       are five types of GABA(A) receptor chains: alpha, beta, gamma,
CC       delta, and rho. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Only found in cerebellar granule cells.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L08495; AAC42034.1; -; Genomic_DNA.
DR   EMBL; X55742; CAA39273.1; -; Genomic_DNA.
DR   PIR; S11087; S11087.
DR   RefSeq; NP_068613.1; NM_021841.1.
DR   UniGene; Rn.29890; -.
DR   ProteinModelPortal; P30191; -.
DR   SMR; P30191; -.
DR   STRING; 10116.ENSRNOP00000004877; -.
DR   BindingDB; P30191; -.
DR   ChEMBL; CHEMBL293; -.
DR   iPTMnet; P30191; -.
DR   PhosphoSitePlus; P30191; -.
DR   PaxDb; P30191; -.
DR   PRIDE; P30191; -.
DR   GeneID; 29708; -.
DR   KEGG; rno:29708; -.
DR   UCSC; RGD:61861; rat.
DR   CTD; 2559; -.
DR   RGD; 61861; Gabra6.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P30191; -.
DR   KO; K05175; -.
DR   PhylomeDB; P30191; -.
DR   PRO; PR:P30191; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; IDA:RGD.
DR   GO; GO:0005254; F:chloride channel activity; TAS:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0005237; F:inhibitory extracellular ligand-gated ion channel activity; IMP:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:0051291; P:protein heterooligomerization; IPI:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; IMP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005436; GABBAa6_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01619; GABAARALPHA6.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    453       Gamma-aminobutyric acid receptor subunit
FT                                alpha-6.
FT                                /FTId=PRO_0000000449.
FT   TOPO_DOM     20    242       Extracellular. {ECO:0000305}.
FT   TRANSMEM    243    264       Helical. {ECO:0000305}.
FT   TRANSMEM    269    290       Helical. {ECO:0000305}.
FT   TRANSMEM    301    324       Helical. {ECO:0000305}.
FT   TOPO_DOM    325    419       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    420    441       Helical. {ECO:0000305}.
FT   MOD_RES     375    375       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16305}.
FT   MOD_RES     403    403       Phosphothreonine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD     31     31       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    156    170       {ECO:0000250}.
SQ   SEQUENCE   453 AA;  51184 MW;  77EF2636A8B116F2 CRC64;
     MLLLLPWLFS LLWIENAQAQ LEDEGNFYSE NVSRILDNLL EGYDNRLRPG FGGAVTEVKT
     DIYVTSFGPV SDVEMEYTMD VFFRQTWTDE RLKFKGPAEI LSLNNLMVSK IWTPDTFFRN
     GKKSIAHNMT TPNKLFRLMH NGTILYTMRL TINADCPMRL VNFPMDGHAC PLKFGSYAYP
     KSEIIYTWKK GPLYSVEVPE ESSSLLQYDL IGQTVSSETI KSNTGEYVIM TVYFHLQRKM
     GYFMIQIYTP CIMTVILSQV SFWINKESVP ARTVFGITTV LTMTTLSISA RHSLPKVSYA
     TAMDWFIAVC FAFVFSALIE FAAVNYFTNL QSQKAERQAQ TAAKPPVAKS KTTESLEAEI
     VVHSDSKYHL KKRISSLTLP IVPSSEASKV LSRTPILPST PVTPPLLLPA IGGTSKIDQY
     SRILFPVAFA GFNLVYWIVY LSKDTMEVSS TVE
//
ID   BEST5_CAEEL             Reviewed;         453 AA.
AC   P34319;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   20-DEC-2017, entry version 117.
DE   RecName: Full=Bestrophin homolog 5;
GN   Name=best-5; ORFNames=C07A9.8;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z29094; CAA82342.2; -; Genomic_DNA.
DR   PIR; S40708; S40708.
DR   RefSeq; NP_499142.2; NM_066741.3.
DR   UniGene; Cel.10863; -.
DR   ProteinModelPortal; P34319; -.
DR   SMR; P34319; -.
DR   STRING; 6239.C07A9.8; -.
DR   EPD; P34319; -.
DR   PaxDb; P34319; -.
DR   EnsemblMetazoa; C07A9.8; C07A9.8; WBGene00007404.
DR   GeneID; 176367; -.
DR   KEGG; cel:CELE_C07A9.8; -.
DR   UCSC; C07A9.8; c. elegans.
DR   CTD; 176367; -.
DR   WormBase; C07A9.8; CE33596; WBGene00007404; best-5.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; P34319; -.
DR   KO; K22204; -.
DR   OMA; QIRRNII; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; P34319; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:P34319; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00007404; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    453       Bestrophin homolog 5.
FT                                /FTId=PRO_0000143126.
FT   TRANSMEM     78     98       Helical. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TRANSMEM    275    295       Helical. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical. {ECO:0000255}.
SQ   SEQUENCE   453 AA;  52830 MW;  D8DB9F1742C5DEEC CRC64;
     MTNNNDPKCV VIEEPDDVPV KPPKIFDFTD WPFEIPDIFK RKELSYNYNY DLATSKSLMI
     VRMIFKWRGS LWQAVYKELI VWICAYSLVS VIYRFALTRS QKDIFERFGE YCDARMGYLP
     LNFVLGFFCN IIIRRWLKLY TSLGNIDNIA LFVSAYVRGT DDRARQIRRN IIRYCVISQC
     LVFRDIHVGV RRRFPTLEAV AQAGIMLPHE LEKFNSIKSR YQKYWVSFNW ALELLNVAKT
     EKSIDGDNAR NAIAQEISKF RSALTTVSMY DWVPIPLMYP QLVNMAVHTY FFLCIFTRQF
     FISADAHNKT EVDLYIPFMT IIEFIFYMGW LKVAMELLNP FGEDADDFDC NLLIDRNLAI
     GLTSVDDAYD QLPEVKPDVF TGGSVKPLDS DDTRSLKYHF GSAAQMEEIS YLKKEENKMI
     AAGKKPNKLK LWVKSVRRKR FETSATQPSF PIP
//
ID   BST18_CAEEL             Reviewed;         456 AA.
AC   P34577;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2002, sequence version 2.
DT   20-DEC-2017, entry version 107.
DE   RecName: Full=Bestrophin homolog 18;
GN   Name=best-18; ORFNames=T20G5.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z30423; CAA83005.2; -; Genomic_DNA.
DR   PIR; S42371; S42371.
DR   RefSeq; NP_001255067.1; NM_001268138.1.
DR   UniGene; Cel.35993; -.
DR   ProteinModelPortal; P34577; -.
DR   SMR; P34577; -.
DR   STRING; 6239.T20G5.4a; -.
DR   PaxDb; P34577; -.
DR   EnsemblMetazoa; T20G5.4a; T20G5.4a; WBGene00011868.
DR   GeneID; 176436; -.
DR   KEGG; cel:CELE_T20G5.4; -.
DR   UCSC; T20G5.4; c. elegans.
DR   CTD; 176436; -.
DR   WormBase; T20G5.4a; CE28844; WBGene00011868; best-18.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; P34577; -.
DR   KO; K22204; -.
DR   OMA; FIDNIAC; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; P34577; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:P34577; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00011868; -.
DR   ExpressionAtlas; P34577; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    456       Bestrophin homolog 18.
FT                                /FTId=PRO_0000143133.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TRANSMEM     83    103       Helical. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical. {ECO:0000255}.
SQ   SEQUENCE   456 AA;  53137 MW;  EDE22B541307F3C8 CRC64;
     MTVSYNQSVA TSRPWTFLAL IFRWRGSVWS AIWIQYSVWL GLYFLVSAIY RFILSAYQQQ
     IFVRLVDYVN SRMSYVPLDW MLGFFIAGVL RRFWYLYDII GFIDNIACST ATYIRGDSER
     AKQYRRNIIR YCELTQVLIF RDLSMKARKR FPTLDTVAAA GFMMPHEKAN FDLIQYNYNK
     YFLPFNWAWA LVYNARKEGL IEGDYYVTVI SEDIKKFRTG LAWVCNYDWV PLPIIYPTIV
     CLAVHMYFFV GILARQYVKG SEIDPDMIDL VFPFMTSIQF VFYMGWLKVG EGLLNPWGED
     PDDFETNMLI DRNLAMGLKI VDEGYDKTPR LEKDAFWDDT WVPLYSEASA HEKRYHQRQG
     SLAHIKIGRS VSQVRMVPRD GRRASIVKER IVNVKPGSGI GDILRPSSLL NLMKHASSSR
     SLERQRSPGS FRMETLTPGS PTNTPIEPID KIDKKK
//
ID   CLCN1_HUMAN             Reviewed;         988 AA.
AC   P35523; A4D2H5; Q2M202;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   22-NOV-2017, entry version 174.
DE   RecName: Full=Chloride channel protein 1;
DE            Short=ClC-1;
DE   AltName: Full=Chloride channel protein, skeletal muscle;
GN   Name=CLCN1; Synonyms=CLC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT MCAD LEU-480,
RP   VARIANT GLN-300, CHARACTERIZATION OF VARIANTS MCAD GLU-230 AND
RP   LEU-480, CHARACTERIZATION OF VARIANT GLN-300, AND FUNCTION.
RX   PubMed=8112288;
RA   Steinmeyer K., Lorenz C., Pusch M., Koch M.C., Jentsch T.J.;
RT   "Multimeric structure of ClC-1 chloride channel revealed by mutations
RT   in dominant myotonia congenita (Thomsen).";
RL   EMBO J. 13:737-743(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TRP-118.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 171-988, AND VARIANT MCAR CYS-413.
RX   PubMed=1379744; DOI=10.1126/science.1379744;
RA   Koch M.C., Steinmeyer K., Lorenz C., Ricker K., Wolf F., Otto M.,
RA   Zoll B., Lehmann-Horn F., Grzeschik K.-H., Jentsch T.J.;
RT   "The skeletal muscle chloride channel in dominant and recessive human
RT   myotonia.";
RL   Science 257:797-800(1992).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT MCAD
RP   GLU-230.
RX   PubMed=7981750; DOI=10.1038/ng0493-305;
RA   George A.L. Jr., Crackower M.A., Abdalla J.A., Hudson A.J.,
RA   Ebers G.C.;
RT   "Molecular basis of Thomsen's disease (autosomal dominant myotonia
RT   congenita).";
RL   Nat. Genet. 3:305-310(1993).
RN   [6]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT MCAD GLU-230.
RX   PubMed=9122265; DOI=10.1073/pnas.94.6.2729;
RA   Fahlke C., Beck C.L., George A.L. Jr.;
RT   "A mutation in autosomal dominant myotonia congenita affects pore
RT   properties of the muscle chloride channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:2729-2734(1997).
RN   [7]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT MYOTONIA LEVIOR ARG-552.
RX   PubMed=12456816; DOI=10.1113/jphysiol.2002.027037;
RA   Ryan A., Ruedel R., Kuchenbecker M., Fahlke C.;
RT   "A novel alteration of muscle chloride channel gating in myotonia
RT   levior.";
RL   J. Physiol. (Lond.) 545:345-354(2002).
RN   [8]
RP   VARIANT MCAR SER-496, CHARACTERIZATION OF VARIANT MCAR SER-496, AND
RP   FUNCTION.
RX   PubMed=7951242; DOI=10.1093/hmg/3.6.941;
RA   Lorenz C., Meyer-Kleine C., Steinmeyer K., Koch M.C., Jentsch T.J.;
RT   "Genomic organization of the human muscle chloride channel ClC-1 and
RT   analysis of novel mutations leading to Becker-type myotonia.";
RL   Hum. Mol. Genet. 3:941-946(1994).
RN   [9]
RP   VARIANT MCAR GLY-136.
RX   PubMed=7981681; DOI=10.1093/hmg/3.7.1123;
RA   Heine R., George A.L. Jr., Pika U., Deymeer F., Ruedel R.,
RA   Lehmann-Horn F.;
RT   "Proof of a non-functional muscle chloride channel in recessive
RT   myotonia congenita (Becker) by detection of a 4 base pair deletion.";
RL   Hum. Mol. Genet. 3:1123-1128(1994).
RN   [10]
RP   VARIANTS MCAR LEU-167 AND GLN-338, AND VARIANT GLN-300.
RX   PubMed=7874130;
RA   George A.L. Jr., Sloan-Brown K., Fenichel G.M., Mitchell G.A.,
RA   Spiegel R., Pascuzzi R.M.;
RT   "Nonsense and missense mutations of the muscle chloride channel gene
RT   in patients with myotonia congenita.";
RL   Hum. Mol. Genet. 3:2071-2072(1994).
RN   [11]
RP   VARIANTS MCAR AND MCAD.
RX   PubMed=8533761;
RA   Meyer-Kleine C., Steinmeyer K., Ricker K., Jentsch T.J., Koch M.C.;
RT   "Spectrum of mutations in the major human skeletal muscle chloride
RT   channel gene (CLCN1) leading to myotonia.";
RL   Am. J. Hum. Genet. 57:1325-1334(1995).
RN   [12]
RP   VARIANT MCAD MET-290, VARIANT MYOTONIA LEVIOR ARG-552, AND VARIANT
RP   TRP-118.
RX   PubMed=7581380; DOI=10.1093/hmg/4.8.1397;
RA   Lehmann-Horn F., Mailaender V., Heine R., George A.L. Jr.;
RT   "Myotonia levior is a chloride channel disorder.";
RL   Hum. Mol. Genet. 4:1397-1402(1995).
RN   [13]
RP   VARIANT MCAD MET-290, VARIANT MCAR LYS-291, CHARACTERIZATION OF
RP   VARIANTS MCAD MET-290; GLN-317 AND LEU-480, CHARACTERIZATION OF
RP   VARIANT MCAR LYS-291, CHARACTERIZATION OF VARIANT MYOTONIA LEVIOR
RP   ARG-552, AND MUTAGENESIS OF ILE-290 AND GLU-291.
RX   PubMed=8845168; DOI=10.1016/0896-6273(95)90023-3;
RA   Pusch M., Steinmeyer K., Koch M.C., Jentsch T.J.;
RT   "Mutations in dominant human myotonia congenita drastically alter the
RT   voltage dependence of the CIC-1 chloride channel.";
RL   Neuron 15:1455-1463(1995).
RN   [14]
RP   VARIANTS MCAR CYS-150; ARG-200; CYS-261 AND VAL-415.
RX   PubMed=8571958;
RA   Mailaender V., Heine R., Deymeer F., Lehmann-Horn F.;
RT   "Novel muscle chloride channel mutations and their effects on
RT   heterozygous carriers.";
RL   Am. J. Hum. Genet. 58:317-324(1996).
RN   [15]
RP   VARIANTS MCAD/MCAR LEU-236; GLU-285; ALA-286; SER-307; VAL-485 AND
RP   ASN-556, CHARACTERIZATION OF VARIANTS MCAD/MCAR LEU-236; GLU-285;
RP   ALA-286; SER-307 AND ASN-556, AND FUNCTION.
RX   PubMed=9736777; DOI=10.1093/hmg/7.11.1753;
RA   Kubisch C., Schmidt-Rose T., Fontaine B., Bretag A.H., Jentsch T.J.;
RT   "ClC-1 chloride channel mutations in myotonia congenita: variable
RT   penetrance of mutations shifting the voltage dependence.";
RL   Hum. Mol. Genet. 7:1753-1760(1998).
RN   [16]
RP   VARIANTS MCAR ILE-563 AND LEU-708.
RX   PubMed=10215406;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:4<331::AID-HUMU13>3.3.CO;2-S;
RA   Sangiuolo F., Botta A., Mesoraca A., Servidei S., Merlini L.,
RA   Fratta G., Novelli G., Dallapiccola B.;
RT   "Identification of five new mutations and three novel polymorphisms in
RT   the muscle chloride channel gene (CLCN1) in 20 Italian patients with
RT   dominant and recessive myotonia congenita.";
RL   Hum. Mutat. 11:331-331(1998).
RN   [17]
RP   VARIANTS MCAD/MCAR VAL-161; THR-313 AND ASN-556.
RX   PubMed=9566422; DOI=10.1212/WNL.50.4.1176;
RA   Plassart-Schiess E., Gervais A., Eymard B., Lagueny A., Pouget J.,
RA   Warter J.-M., Fardeau M., Jentsch T.J., Fontaine B.;
RT   "Novel muscle chloride channel (CLCN1) mutations in myotonia congenita
RT   with various modes of inheritance including incomplete dominance and
RT   penetrance.";
RL   Neurology 50:1176-1179(1998).
RN   [18]
RP   VARIANT MCAR ARG-499, CHARACTERIZATION OF VARIANT MCAR ARG-499, AND
RP   MUTAGENESIS OF ARG-496; GLY-499 AND GLU-500.
RX   PubMed=10644771; DOI=10.1074/jbc.275.4.2999;
RA   Zhang J., Sanguinetti M.C., Kwiecinski H., Ptacek L.J.;
RT   "Mechanism of inverted activation of ClC-1 channels caused by a novel
RT   myotonia congenita mutation.";
RL   J. Biol. Chem. 275:2999-3005(2000).
RN   [19]
RP   VARIANT MCAR LEU-932.
RX   PubMed=11113225; DOI=10.1212/WNL.55.11.1697;
RA   Nagamitsu S., Matsuura T., Khajavi M., Armstrong R., Gooch C.,
RA   Harati Y., Ashizawa T.;
RT   "A 'dystrophic' variant of autosomal recessive myotonia congenita
RT   caused by novel mutations in the CLCN1 gene.";
RL   Neurology 55:1697-1703(2000).
RN   [20]
RP   VARIANTS MCAD VAL-128; LYS-193; SER-307 AND LEU-480, VARIANT MCAR
RP   GLU-285, AND VARIANTS THR-437 AND ASN-614.
RX   PubMed=12661046; DOI=10.1002/mus.10347;
RA   Colding-Joergensen E., DunOe M., Schwartz M., Vissing J.;
RT   "Decrement of compound muscle action potential is related to mutation
RT   type in myotonia congenita.";
RL   Muscle Nerve 27:449-455(2003).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-548.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [22]
RP   VARIANT MCAR SER-190.
RX   PubMed=19697366; DOI=10.1002/mus.21525;
RA   Shalata A., Furman H., Adir V., Adir N., Hujeirat Y., Shalev S.A.,
RA   Borochowitz Z.U.;
RT   "Myotonia congenita in a large consanguineous Arab family: insight
RT   into the clinical spectrum of carriers and double heterozygotes of a
RT   novel mutation in the chloride channel CLCN1 gene.";
RL   Muscle Nerve 41:464-469(2010).
RN   [23]
RP   VARIANTS MCAR ARG-164; ARG-197; ILE-533; LEU-536; SER-845 AND GLU-947,
RP   CHARACTERIZATION OF VARIANTS MCAR ARG-164; SER-190; ARG-197 AND
RP   SER-845, AND FUNCTION.
RX   PubMed=22521272; DOI=10.1016/j.jns.2012.03.024;
RA   Ulzi G., Lecchi M., Sansone V., Redaelli E., Corti E., Saccomanno D.,
RA   Pagliarani S., Corti S., Magri F., Raimondi M., D'Angelo G.,
RA   Modoni A., Bresolin N., Meola G., Wanke E., Comi G.P., Lucchiari S.;
RT   "Myotonia congenita: novel mutations in CLCN1 gene and functional
RT   characterizations in Italian patients.";
RL   J. Neurol. Sci. 318:65-71(2012).
RN   [24]
RP   VARIANTS MCAR LEU-167; ARG-277; TYR-277 AND THR-527, AND
RP   CHARACTERIZATION OF VARIANTS MCAR ARG-277 AND TYR-277.
RX   PubMed=22641783; DOI=10.1113/jphysiol.2012.232785;
RA   Weinberger S., Wojciechowski D., Sternberg D., Lehmann-Horn F.,
RA   Jurkat-Rott K., Becher T., Begemann B., Fahlke C., Fischer M.;
RT   "Disease-causing mutations C277R and C277Y modify gating of human ClC-
RT   1 chloride channels in myotonia congenita.";
RL   J. Physiol. (Lond.) 590:3449-3464(2012).
RN   [25]
RP   VARIANTS MCAD PRO-198 AND LEU-484, CHARACTERIZATION OF VARIANTS MCAD
RP   PRO-198 AND LEU-484, VARIANTS MCAR PRO-628 AND GLY-640, AND
RP   CHARACTERIZATION OF VARIANTS MCAR PRO-628 AND GLY-640.
RX   PubMed=26096614; DOI=10.1113/JP270358;
RA   Imbrici P., Maggi L., Mangiatordi G.F., Dinardo M.M., Altamura C.,
RA   Brugnoni R., Alberga D., Pinter G.L., Ricci G., Siciliano G.,
RA   Micheli R., Annicchiarico G., Lattanzi G., Nicolotti O., Morandi L.,
RA   Bernasconi P., Desaphy J.F., Mantegazza R., Camerino D.C.;
RT   "ClC-1 mutations in myotonia congenita patients: insights into
RT   molecular gating mechanisms and genotype-phenotype correlation.";
RL   J. Physiol. (Lond.) 593:4181-4199(2015).
RN   [26]
RP   VARIANTS MCAR ALA-82; SER-190; VAL-270 AND TRP-453, CHARACTERIZATION
RP   OF VARIANTS MCAR ALA-82; SER-190; VAL-270 AND TRP-453, AND FUNCTION.
RX   PubMed=26007199; DOI=10.1007/s12017-015-8356-8;
RA   Portaro S., Altamura C., Licata N., Camerino G.M., Imbrici P.,
RA   Musumeci O., Rodolico C., Conte Camerino D., Toscano A., Desaphy J.F.;
RT   "Clinical, molecular, and functional characterization of CLCN1
RT   mutations in three families with recessive myotonia congenita.";
RL   NeuroMolecular Med. 17:285-296(2015).
RN   [27]
RP   VARIANTS MCAR ARG-43; LEU-70; ASP-137; HIS-160; SER-496 AND GLU-855,
RP   CHARACTERIZATION OF VARIANTS MCAR ARG-43; LEU-70; ASP-137 AND HIS-160,
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26502825; DOI=10.1038/srep15382;
RA   Ronstedt K., Sternberg D., Detro-Dassen S., Gramkow T., Begemann B.,
RA   Becher T., Kilian P., Grieschat M., Machtens J.P., Schmalzing G.,
RA   Fischer M., Fahlke C.;
RT   "Impaired surface membrane insertion of homo- and heterodimeric human
RT   muscle chloride channels carrying amino-terminal myotonia-causing
RT   mutations.";
RL   Sci. Rep. 5:15382-15382(2015).
RN   [28]
RP   VARIANTS MCAR CYS-105; LEU-167 AND PRO-412, VARIANT ARG-154,
RP   CHARACTERIZATION OF VARIANTS MCAR CYS-105; LEU-167 AND PRO-412,
RP   CHARACTERIZATION OF VARIANT ARG-154, AND FUNCTION.
RX   PubMed=26510092; DOI=10.1002/humu.22916;
RA   Vindas-Smith R., Fiore M., Vasquez M., Cuenca P., Del Valle G.,
RA   Lagostena L., Gaitan-Penas H., Estevez R., Pusch M., Morales F.;
RT   "Identification and functional characterization of CLCN1 mutations
RT   found in nondystrophic myotonia patients.";
RL   Hum. Mutat. 37:74-83(2016).
RN   [29]
RP   VARIANT MCAD LYS-950.
RX   PubMed=27653901; DOI=10.1016/j.jns.2016.08.030;
RA   Kato H., Kokunai Y., Dalle C., Kubota T., Madokoro Y., Yuasa H.,
RA   Uchida Y., Ikeda T., Mochizuki H., Nicole S., Fontaine B.,
RA   Takahashi M.P., Mitake S.;
RT   "A case of non-dystrophic myotonia with concomitant mutations in the
RT   SCN4A and CLCN1 genes.";
RL   J. Neurol. Sci. 369:254-258(2016).
RN   [30]
RP   VARIANT MCAD HIS-480, AND CHARACTERIZATION OF VARIANT MCAD HIS-480.
RX   PubMed=27666773; DOI=10.1016/j.nmd.2016.08.016;
RA   Mori Y., Yamashita S., Kato M., Masuda T., Takamatsu K., Kumamoto T.,
RA   Sasaki R., Ando Y.;
RT   "Thomsen disease with ptosis and abnormal MR findings.";
RL   Neuromuscul. Disord. 26:805-808(2016).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. {ECO:0000269|PubMed:12456816,
CC       ECO:0000269|PubMed:22521272, ECO:0000269|PubMed:26007199,
CC       ECO:0000269|PubMed:26502825, ECO:0000269|PubMed:26510092,
CC       ECO:0000269|PubMed:7951242, ECO:0000269|PubMed:8112288,
CC       ECO:0000269|PubMed:9122265, ECO:0000269|PubMed:9736777}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:26502825}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=7; IntAct=EBI-10206780, EBI-743771;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-10206780, EBI-10175124;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26502825};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscles.
CC   -!- DISEASE: Myotonia congenita, autosomal dominant (MCAD)
CC       [MIM:160800]: A non-dystrophic skeletal muscle disorder
CC       characterized by muscle stiffness and an inability of the muscle
CC       to relax after voluntary contraction. Most patients have symptom
CC       onset in the legs, which later progresses to the arms, neck, and
CC       facial muscles. Many patients show marked hypertrophy of the lower
CC       limb muscles. The autosomal dominant form (Thomsen disease) is
CC       less common and less severe than the autosomal recessive one
CC       (Becker disease). A milder form of autosomal dominant myotonia is
CC       characterized by isolated myotonia without muscle weakness,
CC       hypotrophy, or hypertrophy (myotonia levior).
CC       {ECO:0000269|PubMed:12661046, ECO:0000269|PubMed:26096614,
CC       ECO:0000269|PubMed:27653901, ECO:0000269|PubMed:27666773,
CC       ECO:0000269|PubMed:7581380, ECO:0000269|PubMed:7981750,
CC       ECO:0000269|PubMed:8112288, ECO:0000269|PubMed:8533761,
CC       ECO:0000269|PubMed:8845168, ECO:0000269|PubMed:9122265,
CC       ECO:0000269|PubMed:9566422, ECO:0000269|PubMed:9736777}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myotonia congenita, autosomal recessive (MCAR)
CC       [MIM:255700]: A non-dystrophic skeletal muscle disorder
CC       characterized by muscle stiffness and an inability of the muscle
CC       to relax after voluntary contraction. Most patients have symptom
CC       onset in the legs, which later progresses to the arms, neck, and
CC       facial muscles. Many patients show marked hypertrophy of the lower
CC       limb muscles. The autosomal recessive form (Becker disease) is
CC       more severe than the autosomal dominant one (Thomsen disease).
CC       {ECO:0000269|PubMed:10215406, ECO:0000269|PubMed:10644771,
CC       ECO:0000269|PubMed:11113225, ECO:0000269|PubMed:12661046,
CC       ECO:0000269|PubMed:1379744, ECO:0000269|PubMed:19697366,
CC       ECO:0000269|PubMed:22521272, ECO:0000269|PubMed:22641783,
CC       ECO:0000269|PubMed:26007199, ECO:0000269|PubMed:26096614,
CC       ECO:0000269|PubMed:26502825, ECO:0000269|PubMed:26510092,
CC       ECO:0000269|PubMed:7874130, ECO:0000269|PubMed:7951242,
CC       ECO:0000269|PubMed:7981681, ECO:0000269|PubMed:8533761,
CC       ECO:0000269|PubMed:8571958, ECO:0000269|PubMed:8845168,
CC       ECO:0000269|PubMed:9566422, ECO:0000269|PubMed:9736777}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: The CLC channel family contains both chloride
CC       channels and proton-coupled anion transporters that exchange
CC       chloride or another anion for protons. The absence of conserved
CC       gating glutamate residues is typical for family members that
CC       function as channels.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClC-1/CLCN1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z25587; CAA80996.1; -; Genomic_DNA.
DR   EMBL; Z25884; CAA81103.1; -; mRNA.
DR   EMBL; CH236959; EAL23786.1; -; Genomic_DNA.
DR   EMBL; BC112156; AAI12157.1; -; mRNA.
DR   EMBL; BC113495; AAI13496.1; -; mRNA.
DR   EMBL; M97820; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L08261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L08262; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L08263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L08264; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L08265; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z25753; CAB56792.1; -; Genomic_DNA.
DR   EMBL; Z25754; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25755; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25756; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25757; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25758; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25759; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25760; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25761; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25762; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25763; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25764; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25765; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25766; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25767; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25752; CAB56792.1; JOINED; Genomic_DNA.
DR   EMBL; Z25768; CAB56814.1; -; Genomic_DNA.
DR   EMBL; Z25872; CAB56814.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS5881.1; -.
DR   PIR; S37078; S37078.
DR   RefSeq; NP_000074.2; NM_000083.2.
DR   UniGene; Hs.121483; -.
DR   ProteinModelPortal; P35523; -.
DR   BioGrid; 107594; 10.
DR   IntAct; P35523; 3.
DR   STRING; 9606.ENSP00000339867; -.
DR   BindingDB; P35523; -.
DR   TCDB; 2.A.49.2.1; the chloride carrier/channel (clc) family.
DR   iPTMnet; P35523; -.
DR   PhosphoSitePlus; P35523; -.
DR   BioMuta; CLCN1; -.
DR   DMDM; 311033468; -.
DR   EPD; P35523; -.
DR   PaxDb; P35523; -.
DR   PeptideAtlas; P35523; -.
DR   PRIDE; P35523; -.
DR   DNASU; 1180; -.
DR   Ensembl; ENST00000343257; ENSP00000339867; ENSG00000188037.
DR   GeneID; 1180; -.
DR   KEGG; hsa:1180; -.
DR   UCSC; uc003wcr.2; human.
DR   CTD; 1180; -.
DR   DisGeNET; 1180; -.
DR   EuPathDB; HostDB:ENSG00000188037.10; -.
DR   GeneCards; CLCN1; -.
DR   GeneReviews; CLCN1; -.
DR   HGNC; HGNC:2019; CLCN1.
DR   MalaCards; CLCN1; -.
DR   MIM; 118425; gene.
DR   MIM; 160800; phenotype.
DR   MIM; 255700; phenotype.
DR   neXtProt; NX_P35523; -.
DR   OpenTargets; ENSG00000188037; -.
DR   Orphanet; 614; Thomsen and Becker disease.
DR   PharmGKB; PA26546; -.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000231297; -.
DR   HOVERGEN; HBG005332; -.
DR   InParanoid; P35523; -.
DR   KO; K05010; -.
DR   OMA; SFTFPPG; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; P35523; -.
DR   TreeFam; TF352264; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; CLCN1; human.
DR   GeneWiki; CLCN1; -.
DR   GenomeRNAi; 1180; -.
DR   PRO; PR:P35523; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000188037; -.
DR   CleanEx; HS_CLCN1; -.
DR   ExpressionAtlas; P35523; baseline and differential.
DR   Genevisible; P35523; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IMP:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0019227; P:neuronal action potential propagation; IEA:Ensembl.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002243; Cl_channel-1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01112; CLCHANNEL1.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disease mutation; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    988       Chloride channel protein 1.
FT                                /FTId=PRO_0000094429.
FT   TOPO_DOM      1    114       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    115    152       Helical. {ECO:0000250}.
FT   TRANSMEM    159    182       Helical. {ECO:0000250}.
FT   INTRAMEM    191    198       Helical. {ECO:0000250}.
FT   TRANSMEM    207    225       Helical. {ECO:0000250}.
FT   TRANSMEM    232    250       Helical. {ECO:0000250}.
FT   INTRAMEM    266    278       Helical. {ECO:0000250}.
FT   INTRAMEM    282    290       Helical. {ECO:0000250}.
FT   TRANSMEM    302    321       Helical. {ECO:0000250}.
FT   TRANSMEM    348    376       Helical. {ECO:0000250}.
FT   TRANSMEM    385    404       Helical. {ECO:0000250}.
FT   TRANSMEM    454    474       Helical. {ECO:0000250}.
FT   TRANSMEM    482    505       Helical. {ECO:0000250}.
FT   INTRAMEM    522    536       Helical. {ECO:0000250}.
FT   INTRAMEM    537    538       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   INTRAMEM    539    550       Helical. {ECO:0000250}.
FT   INTRAMEM    551    555       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   TRANSMEM    556    573       Helical. {ECO:0000250}.
FT   TOPO_DOM    574    988       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      609    668       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      821    876       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOTIF       188    192       Selectivity filter part_1. {ECO:0000250}.
FT   MOTIF       230    234       Selectivity filter part_2. {ECO:0000250}.
FT   MOTIF       482    486       Selectivity filter part_3. {ECO:0000250}.
FT   BINDING     189    189       Chloride. {ECO:0000250}.
FT   BINDING     484    484       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     578    578       Chloride. {ECO:0000250}.
FT   MOD_RES     886    886       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64347}.
FT   VARIANT      43     43       Q -> R (in MCAR; decreased chloride
FT                                transport; decreased localization to the
FT                                plasma membrane; dominant negative effect
FT                                on chloride transport and localization to
FT                                the plasma membrane; no significant
FT                                effect on chloride channel activity; no
FT                                effect on homodimerization).
FT                                {ECO:0000269|PubMed:26502825}.
FT                                /FTId=VAR_075588.
FT   VARIANT      70     70       S -> L (in MCAR; unknown pathological
FT                                significance; no effect on chloride
FT                                transport; dbSNP:rs769312894).
FT                                {ECO:0000269|PubMed:26502825}.
FT                                /FTId=VAR_075589.
FT   VARIANT      82     82       T -> A (in MCAR; unknown pathological
FT                                significance; no effect on chloride
FT                                transport; dbSNP:rs772100356).
FT                                {ECO:0000269|PubMed:26007199}.
FT                                /FTId=VAR_075590.
FT   VARIANT     105    105       R -> C (in MCAR; no effect on chloride
FT                                transport; dbSNP:rs201509501).
FT                                {ECO:0000269|PubMed:26510092}.
FT                                /FTId=VAR_001582.
FT   VARIANT     118    118       G -> W (in dbSNP:rs10282312).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7581380}.
FT                                /FTId=VAR_001583.
FT   VARIANT     128    128       M -> V (in MCAD; dbSNP:rs80356699).
FT                                {ECO:0000269|PubMed:12661046}.
FT                                /FTId=VAR_075591.
FT   VARIANT     136    136       D -> G (in MCAR).
FT                                {ECO:0000269|PubMed:7981681}.
FT                                /FTId=VAR_001584.
FT   VARIANT     137    137       Y -> D (in MCAR; reduced chloride
FT                                transport; decreased localization to the
FT                                plasma membrane; no significant effect on
FT                                chloride channel activity;
FT                                dbSNP:rs748639603).
FT                                {ECO:0000269|PubMed:26502825}.
FT                                /FTId=VAR_075592.
FT   VARIANT     150    150       Y -> C (in MCAR).
FT                                {ECO:0000269|PubMed:8571958}.
FT                                /FTId=VAR_001585.
FT   VARIANT     154    154       Q -> R (polymorphism; no effect on
FT                                chloride transport; dbSNP:rs111482384).
FT                                {ECO:0000269|PubMed:26510092}.
FT                                /FTId=VAR_075593.
FT   VARIANT     160    160       Q -> H (in MCAR; reduced chloride
FT                                transport; decreased localization to the
FT                                plasma membrane; no significant effect on
FT                                chloride channel activity;
FT                                dbSNP:rs771532474).
FT                                {ECO:0000269|PubMed:26502825}.
FT                                /FTId=VAR_075594.
FT   VARIANT     161    161       F -> V (in MCAD and MCAR).
FT                                {ECO:0000269|PubMed:9566422}.
FT                                /FTId=VAR_001586.
FT   VARIANT     164    164       W -> R (in MCAR; altered chloride channel
FT                                activity). {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075595.
FT   VARIANT     165    165       V -> G (in MCAR).
FT                                /FTId=VAR_001587.
FT   VARIANT     167    167       F -> L (in MCAR; no effect on chloride
FT                                transport; dbSNP:rs149729531).
FT                                {ECO:0000269|PubMed:22641783,
FT                                ECO:0000269|PubMed:26510092,
FT                                ECO:0000269|PubMed:7874130}.
FT                                /FTId=VAR_001588.
FT   VARIANT     190    190       G -> S (in MCAR; loss of chloride channel
FT                                activity; dbSNP:rs797045032).
FT                                {ECO:0000269|PubMed:19697366,
FT                                ECO:0000269|PubMed:22521272,
FT                                ECO:0000269|PubMed:26007199}.
FT                                /FTId=VAR_075596.
FT   VARIANT     193    193       E -> K (in MCAD; dbSNP:rs80356686).
FT                                {ECO:0000269|PubMed:12661046}.
FT                                /FTId=VAR_075597.
FT   VARIANT     197    197       I -> R (in MCAR; changed chloride channel
FT                                activity). {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075598.
FT   VARIANT     198    198       L -> P (in MCAD; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed gating of the channel).
FT                                {ECO:0000269|PubMed:26096614}.
FT                                /FTId=VAR_075599.
FT   VARIANT     200    200       G -> R (in MCAD and MCAR).
FT                                {ECO:0000269|PubMed:8571958}.
FT                                /FTId=VAR_001589.
FT   VARIANT     230    230       G -> E (in MCAD and MCAR; changed ion
FT                                selectivity; loss of chloride transport;
FT                                mild dominant effect; dbSNP:rs80356700).
FT                                {ECO:0000269|PubMed:7981750,
FT                                ECO:0000269|PubMed:8112288,
FT                                ECO:0000269|PubMed:9122265}.
FT                                /FTId=VAR_001590.
FT   VARIANT     236    236       V -> L (in MCAR; loss of chloride
FT                                transport; changed calcium channel
FT                                activity; changed gating of the channel).
FT                                {ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001591.
FT   VARIANT     261    261       Y -> C (in MCAR; dbSNP:rs200621976).
FT                                {ECO:0000269|PubMed:8571958}.
FT                                /FTId=VAR_001592.
FT   VARIANT     270    270       G -> V (in MCAR; decreased chloride
FT                                channel activity).
FT                                {ECO:0000269|PubMed:26007199}.
FT                                /FTId=VAR_075600.
FT   VARIANT     277    277       C -> R (in MCAR; reduced chloride
FT                                transport; no effect on protein
FT                                abundance; dbSNP:rs757109632).
FT                                {ECO:0000269|PubMed:22641783}.
FT                                /FTId=VAR_075601.
FT   VARIANT     277    277       C -> Y (in MCAR; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed gating of the channel;
FT                                no effect on protein abundance).
FT                                {ECO:0000269|PubMed:22641783}.
FT                                /FTId=VAR_075602.
FT   VARIANT     285    285       G -> E (in MCAR; loss of chloride channel
FT                                activity; dbSNP:rs150885084).
FT                                {ECO:0000269|PubMed:12661046,
FT                                ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001593.
FT   VARIANT     286    286       V -> A (in MCAD; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed gating of the channel;
FT                                dominant negative effect;
FT                                dbSNP:rs80356689).
FT                                {ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001594.
FT   VARIANT     290    290       I -> M (in MCAD; reduced chloride
FT                                transport; changed chloride channel
FT                                activity; changed gating of the channel;
FT                                dominant negative effect;
FT                                dbSNP:rs80356690).
FT                                {ECO:0000269|PubMed:7581380,
FT                                ECO:0000269|PubMed:8845168}.
FT                                /FTId=VAR_001595.
FT   VARIANT     291    291       E -> K (in MCAR; loss of calcium channel
FT                                activity; no dominant negative effect;
FT                                dbSNP:rs121912805).
FT                                {ECO:0000269|PubMed:8533761,
FT                                ECO:0000269|PubMed:8845168}.
FT                                /FTId=VAR_001596.
FT   VARIANT     300    300       R -> Q (polymorphism; no effect on
FT                                chloride transport; dbSNP:rs118066140).
FT                                {ECO:0000269|PubMed:7874130,
FT                                ECO:0000269|PubMed:8112288}.
FT                                /FTId=VAR_001597.
FT   VARIANT     307    307       F -> S (in MCAD; reduced chloride
FT                                transport; changed chloride channel
FT                                activity; changed gating of the channel;
FT                                dominant negative effect;
FT                                dbSNP:rs80356701).
FT                                {ECO:0000269|PubMed:12661046,
FT                                ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001598.
FT   VARIANT     313    313       A -> T (in MCAD and MCAR;
FT                                dbSNP:rs80356692).
FT                                {ECO:0000269|PubMed:9566422}.
FT                                /FTId=VAR_001599.
FT   VARIANT     317    317       R -> Q (in MCAD; reduced chloride
FT                                transport; changed chloride channel
FT                                activity; changed gating of the channel;
FT                                dbSNP:rs80356702).
FT                                {ECO:0000269|PubMed:8533761,
FT                                ECO:0000269|PubMed:8845168}.
FT                                /FTId=VAR_001600.
FT   VARIANT     327    327       V -> I (in MCAR; dbSNP:rs774396430).
FT                                /FTId=VAR_001601.
FT   VARIANT     329    329       I -> T (in MCAR).
FT                                /FTId=VAR_001602.
FT   VARIANT     338    338       R -> Q (in MCAD and MCAR;
FT                                dbSNP:rs80356703).
FT                                {ECO:0000269|PubMed:7874130}.
FT                                /FTId=VAR_001603.
FT   VARIANT     412    412       Q -> P (in MCAR; loss of chloride
FT                                transport; decreased localization to the
FT                                plasma membrane; loss of
FT                                homodimerization; might be degraded).
FT                                {ECO:0000269|PubMed:26510092}.
FT                                /FTId=VAR_075603.
FT   VARIANT     413    413       F -> C (in MCAR; dbSNP:rs121912799).
FT                                {ECO:0000269|PubMed:1379744}.
FT                                /FTId=VAR_001604.
FT   VARIANT     415    415       A -> V (in MCAR).
FT                                {ECO:0000269|PubMed:8571958}.
FT                                /FTId=VAR_001605.
FT   VARIANT     437    437       A -> T (polymorphism; dbSNP:rs41276054).
FT                                {ECO:0000269|PubMed:12661046}.
FT                                /FTId=VAR_001606.
FT   VARIANT     453    453       R -> W (in MCAR; unknown pathological
FT                                significance; no effect on chloride
FT                                channel activity; dbSNP:rs376026619).
FT                                {ECO:0000269|PubMed:26007199}.
FT                                /FTId=VAR_075604.
FT   VARIANT     480    480       P -> H (in MCAD; decreased protein
FT                                abundance).
FT                                {ECO:0000269|PubMed:27666773}.
FT                                /FTId=VAR_077244.
FT   VARIANT     480    480       P -> L (in MCAD; loss of chloride
FT                                transport; changed chloride channel
FT                                activity; changed gating of the channel;
FT                                dominant effect; dbSNP:rs80356694).
FT                                {ECO:0000269|PubMed:12661046,
FT                                ECO:0000269|PubMed:8112288,
FT                                ECO:0000269|PubMed:8845168}.
FT                                /FTId=VAR_001607.
FT   VARIANT     482    482       G -> R (in MCAR; dbSNP:rs746125212).
FT                                /FTId=VAR_001608.
FT   VARIANT     484    484       F -> L (in MCAD; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed channel gating; no
FT                                dominant negative effect).
FT                                {ECO:0000269|PubMed:26096614}.
FT                                /FTId=VAR_075605.
FT   VARIANT     485    485       M -> V (in MCAR; dbSNP:rs146457619).
FT                                {ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001609.
FT   VARIANT     496    496       R -> S (in MCAR; loss of chloride channel
FT                                activity; recessive; dbSNP:rs121912801).
FT                                {ECO:0000269|PubMed:26502825,
FT                                ECO:0000269|PubMed:7951242}.
FT                                /FTId=VAR_001610.
FT   VARIANT     499    499       G -> R (in MCAR; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed channel gating;
FT                                dbSNP:rs121912807).
FT                                {ECO:0000269|PubMed:10644771}.
FT                                /FTId=VAR_075606.
FT   VARIANT     527    527       I -> T (in MCAR; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22641783}.
FT                                /FTId=VAR_075607.
FT   VARIANT     533    533       T -> I (in MCAR; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075608.
FT   VARIANT     536    536       V -> L (in MCAR; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075609.
FT   VARIANT     548    548       E -> K (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs546411827).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036300.
FT   VARIANT     552    552       Q -> R (in MCAD and MCAR; also found in
FT                                myotonia levior; reduced chloride
FT                                transport; changed calcium channel
FT                                activity; changed channel gating; weak
FT                                dominant negative effect;
FT                                dbSNP:rs80356696).
FT                                {ECO:0000269|PubMed:12456816,
FT                                ECO:0000269|PubMed:7581380,
FT                                ECO:0000269|PubMed:8845168}.
FT                                /FTId=VAR_001611.
FT   VARIANT     556    556       I -> N (in MCAD and MCAR; mild form;
FT                                reduced chloride transport; changed
FT                                chloride channel activity; changed gating
FT                                of the channel; partial dominant negative
FT                                effect; dbSNP:rs80356697).
FT                                {ECO:0000269|PubMed:9566422,
FT                                ECO:0000269|PubMed:9736777}.
FT                                /FTId=VAR_001612.
FT   VARIANT     563    563       V -> I (in MCAR).
FT                                {ECO:0000269|PubMed:10215406}.
FT                                /FTId=VAR_001613.
FT   VARIANT     614    614       K -> N (polymorphism; dbSNP:rs140205115).
FT                                {ECO:0000269|PubMed:12661046}.
FT                                /FTId=VAR_075610.
FT   VARIANT     628    628       L -> P (in MCAR; unknown pathological
FT                                significance; no effect on calcium
FT                                channel activity).
FT                                {ECO:0000269|PubMed:26096614}.
FT                                /FTId=VAR_075611.
FT   VARIANT     640    640       V -> G (in MCAR; reduced calcium channel
FT                                activity). {ECO:0000269|PubMed:26096614}.
FT                                /FTId=VAR_075612.
FT   VARIANT     708    708       F -> L (in MCAR).
FT                                {ECO:0000269|PubMed:10215406}.
FT                                /FTId=VAR_001614.
FT   VARIANT     727    727       P -> L (in dbSNP:rs13438232).
FT                                /FTId=VAR_047779.
FT   VARIANT     845    845       G -> S (in MCAR; unknown pathological
FT                                significance; no effect on chloride
FT                                channel activity; dbSNP:rs755433272).
FT                                {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075613.
FT   VARIANT     855    855       G -> E (in MCAR; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26502825}.
FT                                /FTId=VAR_075614.
FT   VARIANT     932    932       P -> L (in MCAR; unknown pathological
FT                                significance; dbSNP:rs80356706).
FT                                {ECO:0000269|PubMed:11113225}.
FT                                /FTId=VAR_075615.
FT   VARIANT     947    947       V -> E (in MCAR; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22521272}.
FT                                /FTId=VAR_075616.
FT   VARIANT     950    950       E -> K (in MCAD; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27653901}.
FT                                /FTId=VAR_079520.
FT   MUTAGEN     290    290       I->C,E,F,G,K,L,Q,T,V,Y: Changed chloride
FT                                channel activity; changed gating of the
FT                                channel. {ECO:0000269|PubMed:8845168}.
FT   MUTAGEN     291    291       E->D: No effect on calcium channel
FT                                activity. {ECO:0000269|PubMed:8845168}.
FT   MUTAGEN     291    291       E->L: Loss of calcium channel activity.
FT                                {ECO:0000269|PubMed:8845168}.
FT   MUTAGEN     496    496       R->K: Changed gating of the channel.
FT                                {ECO:0000269|PubMed:10644771}.
FT   MUTAGEN     499    499       G->K,E: Changed gating of the channel.
FT                                {ECO:0000269|PubMed:10644771}.
FT   MUTAGEN     499    499       G->Q: No effect on gating of the channel.
FT                                {ECO:0000269|PubMed:10644771}.
FT   MUTAGEN     500    500       E->Q: No effect on channel function.
FT                                {ECO:0000269|PubMed:10644771}.
FT   CONFLICT    697    697       L -> P (in Ref. 1; CAA80996/CAA81103).
FT                                {ECO:0000305}.
SQ   SEQUENCE   988 AA;  108626 MW;  CA838BCD2AF3CA68 CRC64;
     MEQSRSQQRG GEQSWWGSDP QYQYMPFEHC TSYGLPSENG GLQHRLRKDA GPRHNVHPTQ
     IYGHHKEQFS DREQDIGMPK KTGSSSTVDS KDEDHYSKCQ DCIHRLGQVV RRKLGEDGIF
     LVLLGLLMAL VSWSMDYVSA KSLQAYKWSY AQMQPSLPLQ FLVWVTFPLV LILFSALFCH
     LISPQAVGSG IPEMKTILRG VVLKEYLTMK AFVAKVVALT AGLGSGIPVG KEGPFVHIAS
     ICAAVLSKFM SVFCGVYEQP YYYSDILTVG CAVGVGCCFG TPLGGVLFSI EVTSTYFAVR
     NYWRGFFAAT FSAFVFRVLA VWNKDAVTIT ALFRTNFRMD FPFDLKELPA FAAIGICCGL
     LGAVFVYLHR QVMLGVRKHK ALSQFLAKHR LLYPGIVTFV IASFTFPPGM GQFMAGELMP
     REAISTLFDN NTWVKHAGDP ESLGQSAVWI HPRVNVVIII FLFFVMKFWM SIVATTMPIP
     CGGFMPVFVL GAAFGRLVGE IMAMLFPDGI LFDDIIYKIL PGGYAVIGAA ALTGAVSHTV
     STAVICFELT GQIAHILPMM VAVILANMVA QSLQPSLYDS IIQVKKLPYL PDLGWNQLSK
     YTIFVEDIMV RDVKFVSASY TYGELRTLLQ TTTVKTLPLV DSKDSMILLG SVERSELQAL
     LQRHLCPERR LRAAQEMARK LSELPYDGKA RLAGEGLPGA PPGRPESFAF VDEDEDEDLS
     GKSELPPSLA LHPSTTAPLS PEEPNGPLPG HKQQPEAPEP AGQRPSIFQS LLHCLLGRAR
     PTKKKTTQDS TDLVDNMSPE EIEAWEQEQL SQPVCFDSCC IDQSPFQLVE QTTLHKTHTL
     FSLLGLHLAY VTSMGKLRGV LALEELQKAI EGHTKSGVQL RPPLASFRNT TSTRKSTGAP
     PSSAENWNLP EDRPGATGTG DVIAASPETP VPSPSPEPPL SLAPGKVEGE LEELELVESP
     GLEEELADIL QGPSLRSTDE EDEDELIL
//
ID   GLRB_MOUSE              Reviewed;         496 AA.
AC   P48168; Q5U5X3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Glycine receptor subunit beta;
DE   AltName: Full=Glycine receptor 58 kDa subunit;
DE   Flags: Precursor;
GN   Name=Glrb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DISEASE, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7920630; DOI=10.1038/ng0694-136;
RA   Kingsmore S.F., Giros B., Suh D., Bieniarz M., Caron M.G.,
RA   Seldin M.F.;
RT   "Glycine receptor beta-subunit gene mutation in spastic mouse
RT   associated with LINE-1 element insertion.";
RL   Nat. Genet. 7:136-141(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANTS SPASTIC, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=BALB/cJ, and C57BL/6J; TISSUE=Brain, and Liver;
RX   PubMed=7946325; DOI=10.1016/0896-6273(94)90265-8;
RA   Muelhardt C., Fischer M., Gass P., Simon-Chazottes D., Guenet J.-L.,
RA   Kuhse J., Betz H., Becker C.M.;
RT   "The spastic mouse: aberrant splicing of glycine receptor beta subunit
RT   mRNA caused by intronic insertion of L1 element.";
RL   Neuron 13:1003-1015(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Hippocampus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DISEASE, AND FUNCTION.
RX   PubMed=12809985; DOI=10.1016/S0304-3940(03)00499-3;
RA   von Wegerer J., Becker K., Glockenhammer D., Becker C.M.,
RA   Zeilhofer H.U., Swandulla D.;
RT   "Spinal inhibitory synaptic transmission in the glycine receptor mouse
RT   mutant spastic.";
RL   Neurosci. Lett. 345:45-48(2003).
RN   [7]
RP   DISEASE, AND FUNCTION.
RX   PubMed=16672662; DOI=10.1523/JNEUROSCI.3991-05.2006;
RA   Graham B.A., Schofield P.R., Sah P., Margrie T.W., Callister R.J.;
RT   "Distinct physiological mechanisms underlie altered glycinergic
RT   synaptic transmission in the murine mutants spastic, spasmodic, and
RT   oscillator.";
RL   J. Neurosci. 26:4880-4890(2006).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19723286; DOI=10.1111/j.1460-9568.2009.06903.x;
RA   Eichler S.A., Foerstera B., Smolinsky B., Juettner R., Lehmann T.N.,
RA   Faehling M., Schwarz G., Legendre P., Meier J.C.;
RT   "Splice-specific roles of glycine receptor alpha3 in the
RT   hippocampus.";
RL   Eur. J. Neurosci. 30:1077-1091(2009).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22592841; DOI=10.1002/cne.23139;
RA   Weltzien F., Puller C., O'Sullivan G.A., Paarmann I., Betz H.;
RT   "Distribution of the glycine receptor beta-subunit in the mouse CNS as
RT   revealed by a novel monoclonal antibody.";
RL   J. Comp. Neurol. 520:3962-3981(2012).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       GLRB does not form ligand-gated ion channels by itself, but is
CC       part of heteromeric ligand-gated chloride channels. Channel
CC       opening is triggered by extracellular glycine (PubMed:12809985).
CC       Heteropentameric channels composed of GLRB and GLRA1 are activated
CC       by lower glycine levels than homopentameric GLRA1. Plays an
CC       important role in the down-regulation of neuronal excitability.
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (PubMed:12809985, PubMed:16672662). {ECO:0000250|UniProtKB:P48167,
CC       ECO:0000269|PubMed:12809985, ECO:0000269|PubMed:16672662}.
CC   -!- SUBUNIT: Heteropentamer composed of GLRB and GLRA1. Heteropentamer
CC       composed of GLRB and GLRA2. Heteropentamer composed of GLRB and
CC       GLRA3. Heteropentamer composed of two GLRA1 and three GLRB
CC       subunits. Heteropentamer composed of three GLRA1 and two GLRB
CC       subunits. Interacts with GPHN. {ECO:0000250|UniProtKB:P48167}.
CC   -!- INTERACTION:
CC       Q03555:Gphn (xeno); NbExp=4; IntAct=EBI-7069198, EBI-349317;
CC       Q8BUV3:Gphn; NbExp=4; IntAct=EBI-7069198, EBI-771218;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:22592841}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:P48167}. Cell junction, synapse
CC       {ECO:0000269|PubMed:19723286, ECO:0000269|PubMed:22592841}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:19723286}. Cell membrane
CC       {ECO:0000269|PubMed:12809985}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23415}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P48167}. Note=Retained in the cytoplasm
CC       upon heterologous expression by itself. Coexpression with GPHN
CC       promotes expression at the cell membrane. Coexpression with GLRA1,
CC       GLRA2 or GLRA3 promotes expression at the cell membrane.
CC       {ECO:0000250|UniProtKB:P20781}.
CC   -!- TISSUE SPECIFICITY: Detected in spinal cord, brain and brain stem,
CC       especially in the periolivary region, spinal nuclei, trigeminal
CC       nucleus, medulla oblongata, pons and midbrain. Detected in the
CC       inner plexiform layer of the retina (at protein level)
CC       (PubMed:22592841). High levels of expression in cortex,
CC       hippocampus, thalamus and cerebellum (PubMed:7920630). Detected in
CC       spinal cord (PubMed:7946325). {ECO:0000269|PubMed:22592841,
CC       ECO:0000269|PubMed:7920630, ECO:0000269|PubMed:7946325}.
CC   -!- DISEASE: Note=Defects in Glrb cause the spastic condition which is
CC       characterized by muscle rigidity, tremors, myoclonic jerks,
CC       pronounced startle reaction, abnormal gait and impaired righting
CC       ability (PubMed:7920630). Neurons from the ventral horn of the
CC       spinal cord display reduced inhibitory postsynaptic currents
CC       (PubMed:12809985). Likewise, hypoglossal neurons display a
CC       dramatic reduction in the frequency and amplitude of postsynaptic
CC       inhibitory currents (PubMed:16672662).
CC       {ECO:0000269|PubMed:12809985, ECO:0000269|PubMed:16672662,
CC       ECO:0000269|PubMed:7920630}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRB sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09399; AAA61874.1; -; mRNA.
DR   EMBL; X81202; CAA57076.1; -; mRNA.
DR   EMBL; X81201; CAA57075.1; -; Genomic_DNA.
DR   EMBL; L32594; AAA65966.1; -; Genomic_DNA.
DR   EMBL; AK083251; BAC38831.1; -; mRNA.
DR   EMBL; CH466547; EDL15445.1; -; Genomic_DNA.
DR   EMBL; BC037605; AAH37605.1; -; mRNA.
DR   CCDS; CCDS17424.1; -.
DR   PIR; S46459; S46459.
DR   RefSeq; NP_001268898.1; NM_001281969.2.
DR   RefSeq; NP_001332884.1; NM_001345955.1.
DR   RefSeq; NP_001332885.1; NM_001345956.1.
DR   RefSeq; NP_001332886.1; NM_001345957.1.
DR   RefSeq; NP_001332887.1; NM_001345958.1.
DR   RefSeq; NP_001332888.1; NM_001345959.1.
DR   RefSeq; NP_001332925.1; NM_001345996.1.
DR   RefSeq; NP_034428.2; NM_010298.6.
DR   UniGene; Mm.275639; -.
DR   ProteinModelPortal; P48168; -.
DR   SMR; P48168; -.
DR   IntAct; P48168; 5.
DR   MINT; MINT-4787310; -.
DR   STRING; 10090.ENSMUSP00000029654; -.
DR   iPTMnet; P48168; -.
DR   PhosphoSitePlus; P48168; -.
DR   PaxDb; P48168; -.
DR   PRIDE; P48168; -.
DR   Ensembl; ENSMUST00000029654; ENSMUSP00000029654; ENSMUSG00000028020.
DR   GeneID; 14658; -.
DR   KEGG; mmu:14658; -.
DR   UCSC; uc008pog.2; mouse.
DR   CTD; 2743; -.
DR   MGI; MGI:95751; Glrb.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P48168; -.
DR   KO; K05196; -.
DR   OMA; PRLKLPN; -.
DR   OrthoDB; EOG091G0805; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-MMU-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P48168; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000028020; -.
DR   CleanEx; MM_GLRB; -.
DR   ExpressionAtlas; P48168; baseline and differential.
DR   Genevisible; P48168; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; ISA:MGI.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:MGI.
DR   GO; GO:0016935; C:glycine-gated chloride channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008144; F:drug binding; IPI:MGI.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IMP:MGI.
DR   GO; GO:0016933; F:extracellular-glycine-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IMP:MGI.
DR   GO; GO:0007340; P:acrosome reaction; IMP:MGI.
DR   GO; GO:0007628; P:adult walking behavior; IMP:MGI.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; IGI:MGI.
DR   GO; GO:0006811; P:ion transport; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0050905; P:neuromuscular process; IMP:MGI.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0043200; P:response to amino acid; IBA:GO_Central.
DR   GO; GO:0060013; P:righting reflex; IMP:MGI.
DR   GO; GO:0001964; P:startle response; ISS:UniProtKB.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IMP:MGI.
DR   GO; GO:0007601; P:visual perception; IMP:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008060; Glycine_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF29; PTHR18945:SF29; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01677; GLYRBETA.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Cytoplasm; Disease mutation;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    496       Glycine receptor subunit beta.
FT                                /FTId=PRO_0000000424.
FT   TOPO_DOM     23    268       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    269    290       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    291    295       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    296    316       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    317    327       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    328    348       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    349    474       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    475    495       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   REGION      247    253       Strychnine-binding.
FT                                {ECO:0000250|UniProtKB:O93430}.
FT   SITE        307    307       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   MOD_RES     391    391       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P20781}.
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    242    242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    183    197       {ECO:0000250|UniProtKB:P23415}.
FT   DISULFID    243    255       {ECO:0000250|UniProtKB:P23415}.
FT   VARIANT      74     83       NFKGIPVDVV -> TTMLDIQPMI (in spastic 1).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT      84    496       Missing (in spastic 1).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT     143    151       LFFANEKSA -> VSMSWIYNR (in spastic 2).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT     152    496       Missing (in spastic 2).
FT                                {ECO:0000269|PubMed:7946325}.
FT   CONFLICT    365    365       A -> R (in Ref. 1; AAA61874).
FT                                {ECO:0000305}.
SQ   SEQUENCE   496 AA;  55951 MW;  554840A6DE9DE7BE CRC64;
     MKFSLAISFF ILMSLLFEDA CAKEKSSKKG KGKKKQYLCP SQQSPEDLAR VPPNSTSNIL
     NRLLVSYDPR IRPNFKGIPV DVVVNIFINS FGSIQETTMD YRVNIFLRQK WNDPRLKLPS
     DFRGSDALTV DPTMYKCLWK PDLFFANEKS ANFHDVTQEN ILLFIFRDGD VLVSMRLSIT
     LSCPLDLTLF PMDTQRCKMQ LESFGYTTDD LRFIWQSGDP VQLEKIALPQ FDIKKEDIEY
     GNCTKYYKGT GYYTCVEVIF TLRRQVGFYM MGVYAPTLLI VVLSWLSFWI NPDASAARVP
     LGIFSVLSLA SECTTLAAEL PKVSYVKALD VWLIACLLFG FASLVEYAVV QVMLNNPKRV
     EAEKARIAKA EQADGKGGNA AKKNTVNGTG TPVHISTLQV GETRCKKVCT SKSDLRSNDF
     SIVGSLPRDF ELSNYDCYGK PIEVNNGLGK PQAKNKKPPP AKPVIPTAAK RIDLYARALF
     PFCFLFFNVI YWSIYL
//
ID   GBRA4_HUMAN             Reviewed;         554 AA.
AC   P48169; Q8IYR7;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   20-DEC-2017, entry version 169.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-4;
DE   AltName: Full=GABA(A) receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=GABRA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Brain cortex;
RX   PubMed=8719416; DOI=10.1016/0922-4106(95)90072-1;
RA   Yang W., Drewe J.A., Lan N.C.;
RT   "Cloning and characterization of the human GABAA receptor alpha 4
RT   subunit: identification of a unique diazepam-insensitive binding
RT   site.";
RL   Eur. J. Pharmacol. 291:319-325(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RX   PubMed=7607683; DOI=10.1016/0888-7543(95)80178-O;
RA   McLean P.J., Farb D.H., Russek S.J.;
RT   "Mapping of the alpha 4 subunit gene (GABRA4) to human chromosome 4
RT   defines an alpha 2-alpha 4-beta 1-gamma 1 gene cluster: further
RT   evidence that modern GABAA receptor gene clusters are derived from an
RT   ancestral cluster.";
RL   Genomics 26:580-586(1995).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-516.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- INDUCTION: The alpha4 beta2 gamma 2L receptor is not repressed by
CC       diazepam. {ECO:0000269|PubMed:8719416}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA4 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U30461; AAB52519.1; -; mRNA.
DR   EMBL; AK090780; BAG52228.1; -; mRNA.
DR   EMBL; AC107383; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW93029.1; -; Genomic_DNA.
DR   EMBL; BC035055; AAH35055.1; -; mRNA.
DR   EMBL; U20166; AAA74743.1; -; Genomic_DNA.
DR   CCDS; CCDS3473.1; -.
DR   PIR; G01928; G01928.
DR   RefSeq; NP_000800.2; NM_000809.3.
DR   RefSeq; NP_001191195.1; NM_001204266.1.
DR   RefSeq; NP_001191196.1; NM_001204267.1.
DR   UniGene; Hs.248112; -.
DR   ProteinModelPortal; P48169; -.
DR   SMR; P48169; -.
DR   BioGrid; 108831; 3.
DR   IntAct; P48169; 1.
DR   STRING; 9606.ENSP00000264318; -.
DR   BindingDB; P48169; -.
DR   ChEMBL; CHEMBL2472; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; P48169; -.
DR   PhosphoSitePlus; P48169; -.
DR   BioMuta; GABRA4; -.
DR   DMDM; 206729865; -.
DR   PaxDb; P48169; -.
DR   PeptideAtlas; P48169; -.
DR   PRIDE; P48169; -.
DR   TopDownProteomics; P48169; -.
DR   DNASU; 2557; -.
DR   Ensembl; ENST00000264318; ENSP00000264318; ENSG00000109158.
DR   GeneID; 2557; -.
DR   KEGG; hsa:2557; -.
DR   CTD; 2557; -.
DR   DisGeNET; 2557; -.
DR   EuPathDB; HostDB:ENSG00000109158.10; -.
DR   GeneCards; GABRA4; -.
DR   HGNC; HGNC:4078; GABRA4.
DR   MIM; 137141; gene.
DR   neXtProt; NX_P48169; -.
DR   OpenTargets; ENSG00000109158; -.
DR   PharmGKB; PA28492; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P48169; -.
DR   KO; K05175; -.
DR   OMA; PNPFSHA; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P48169; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; GABRA4; -.
DR   GenomeRNAi; 2557; -.
DR   PRO; PR:P48169; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109158; -.
DR   CleanEx; HS_GABRA4; -.
DR   ExpressionAtlas; P48169; baseline and differential.
DR   Genevisible; P48169; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:2001023; P:regulation of response to drug; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005434; GABBAa4_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01617; GABAARALPHA4.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36    554       Gamma-aminobutyric acid receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000441.
FT   TOPO_DOM     36    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    280       Helical. {ECO:0000305}.
FT   TRANSMEM    285    306       Helical. {ECO:0000305}.
FT   TRANSMEM    318    340       Helical. {ECO:0000305}.
FT   TOPO_DOM    341    523       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    524    543       Helical. {ECO:0000305}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    172    186       {ECO:0000250}.
FT   VARIANT      19     19       A -> T (in dbSNP:rs16859837).
FT                                /FTId=VAR_046552.
FT   VARIANT      26     26       L -> M (in dbSNP:rs2229940).
FT                                /FTId=VAR_046553.
FT   VARIANT     516    516       S -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036032.
FT   CONFLICT    316    316       A -> L (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       N -> D (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
FT   CONFLICT    463    463       Y -> H (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
SQ   SEQUENCE   554 AA;  61623 MW;  B159F9934FB02390 CRC64;
     MVSAKKVPAI ALSAGVSFAL LRFLCLAVCL NESPGQNQKE EKLCTENFTR ILDSLLDGYD
     NRLRPGFGGP VTEVKTDIYV TSFGPVSDVE MEYTMDVFFR QTWIDKRLKY DGPIEILRLN
     NMMVTKVWTP DTFFRNGKKS VSHNMTAPNK LFRIMRNGTI LYTMRLTISA ECPMRLVDFP
     MDGHACPLKF GSYAYPKSEM IYTWTKGPEK SVEVPKESSS LVQYDLIGQT VSSETIKSIT
     GEYIVMTVYF HLRRKMGYFM IQTYIPCIMT VILSQVSFWI NKESVPARTV FGITTVLTMT
     TLSISARHSL PKVSYATAMD WFIAVCFAFV FSALIEFAAV NYFTNIQMEK AKRKTSKPPQ
     EVPAAPVQRE KHPEAPLQNT NANLNMRKRT NALVHSESDV GNRTEVGNHS SKSSTVVQES
     SKGTPRSYLA SSPNPFSRAN AAETISAARA LPSASPTSIR TGYMPRKASV GSASTRHVFG
     SRLQRIKTTV NTIGATGKLS ATPPPSAPPP SGSGTSKIDK YARILFPVTF GAFNMVYWVV
     YLSKDTMEKS ESLM
//
ID   CLCN2_HUMAN             Reviewed;         898 AA.
AC   P51788; B4DQT9; B4DZ58; E9PBD9; E9PCD2; O14864; Q6IPA9; Q8WU13;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 2.
DT   27-SEP-2017, entry version 167.
DE   RecName: Full=Chloride channel protein 2;
DE            Short=ClC-2;
GN   Name=CLCN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-668.
RC   TISSUE=Placenta;
RX   PubMed=7795595; DOI=10.1093/hmg/4.3.407;
RA   Cid L.P., Montrose-Rafizadeh C., Smith D.I., Guggino W.B.,
RA   Cutting G.R.;
RT   "Cloning of a putative human voltage-gated chloride channel (ClC-2)
RT   cDNA widely expressed in human tissues.";
RL   Hum. Mol. Genet. 4:407-413(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lens epithelium;
RA   Rae J.L., Shepard A.R.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), AND VARIANT
RP   SER-668.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RC   TISSUE=Aortic endothelium, and Vascular smooth muscle;
RX   PubMed=10198195; DOI=10.1006/jmcc.1998.0901;
RA   Lamb F.S., Clayton G.H., Liu B.-X., Smith R.L., Barna T.J.,
RA   Schutte B.C.;
RT   "Expression of CLCN voltage-gated chloride channel genes in human
RT   blood vessels.";
RL   J. Mol. Cell. Cardiol. 31:657-666(1999).
RN   [7]
RP   FUNCTION.
RX   PubMed=19153159; DOI=10.1113/jphysiol.2008.167353;
RA   Niemeyer M.I., Cid L.P., Yusef Y.R., Briones R., Sepulveda F.V.;
RT   "Voltage-dependent and -independent titration of specific residues
RT   accounts for complex gating of a ClC chloride channel by extracellular
RT   protons.";
RL   J. Physiol. (Lond.) 587:1387-1400(2009).
RN   [8]
RP   POSSIBLE INVOLVEMENT IN JAE2, AND VARIANT JAE2 GLU-715.
RX   PubMed=12612585; DOI=10.1038/ng1121;
RA   Haug K., Warnstedt M., Alekov A.K., Sander T., Ramirez A., Poser B.,
RA   Maljevic S., Hebeisen S., Kubisch C., Rebstock J., Horvath S.,
RA   Hallmann K., Dullinger J.S., Rau B., Haverkamp F., Beyenburg S.,
RA   Schulz H., Janz D., Giese B., Mueller-Newen G., Propping P.,
RA   Elger C.E., Fahlke C., Lerche H., Heils A.;
RT   "Mutations in CLCN2 encoding a voltage-gated chloride channel are
RT   associated with idiopathic generalized epilepsies.";
RL   Nat. Genet. 33:527-532(2003).
RN   [9]
RP   ERRATUM, AND RETRACTION.
RX   PubMed=19710717; DOI=10.1038/ng0909-1043;
RA   Haug K., Warnstedt M., Alekov A.K., Sander T., Ramirez A., Poser B.,
RA   Maljevic S., Hebeisen S., Kubisch C., Rebstock J., Horvath S.,
RA   Hallmann K., Dullinger J.S., Rau B., Haverkamp F., Beyenburg S.,
RA   Schulz H., Janz D., Giese B., Mueller-Newen G., Propping P.,
RA   Elger C.E., Fahlke C., Lerche H.;
RL   Nat. Genet. 41:1043-1043(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-712, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   VARIANTS ARG-48; HIS-68; ALA-199; GLN-646; SER-668; TRP-725 AND
RP   HIS-747, AND CHARACTERIZATION OF VARIANTS ARG-48; HIS-68; ALA-199;
RP   GLN-646; TRP-725 AND HIS-747.
RX   PubMed=17762171; DOI=10.1159/000107528;
RA   Paul J., Jeyaraj S., Huber S.M., Seebohm G., Boehmer C., Lang F.,
RA   Kremsner P.G., Kun J.F.J.;
RT   "Alterations in the cytoplasmic domain of CLCN2 result in altered
RT   gating kinetics.";
RL   Cell. Physiol. Biochem. 20:441-454(2007).
RN   [13]
RP   VARIANT LEU-719.
RX   PubMed=19200853; DOI=10.1016/j.brainresbull.2009.01.008;
RA   Combi R., Grioni D., Contri M., Redaelli S., Redaelli F., Bassi M.T.,
RA   Barisani D., Lavitrano M.L., Tredici G., Tenchini M.L., Bertolini M.,
RA   Dalpra L.;
RT   "Clinical and genetic familial study of a large cohort of Italian
RT   children with idiopathic epilepsy.";
RL   Brain Res. Bull. 79:89-96(2009).
RN   [14]
RP   VARIANT JAE2 GLU-715, AND POSSIBLE INVOLVEMENT IN JAE2.
RX   PubMed=19710712; DOI=10.1038/ng0909-954;
RA   Kleefuss-Lie A., Friedl W., Cichon S., Haug K., Warnstedt M.,
RA   Alekov A., Sander T., Ramirez A., Poser B., Maljevic S., Hebeisen S.,
RA   Kubisch C., Rebstock J., Horvath S., Hallmann K., Dullinger J.S.,
RA   Rau B., Haverkamp F., Beyenburg S., Schulz H., Janz D., Giese B.,
RA   Muller-Newen G., Propping P., Elger C.E., Fahlke C., Lerche H.;
RT   "CLCN2 variants in idiopathic generalized epilepsy.";
RL   Nat. Genet. 41:954-955(2009).
RN   [15]
RP   INVOLVEMENT IN EJM8, INVOLVEMENT IN EIG11, VARIANT EJM8 GLN-235,
RP   VARIANT EIG11 GLN-577, VARIANT CYS-644, CHARACTERIZATION OF VARIANT
RP   EJM8 GLN-235, CHARACTERIZATION OF VARIANT EIG11 GLN-577,
RP   CHARACTERIZATION OF VARIANT CYS-644, AND FUNCTION.
RX   PubMed=19191339; DOI=10.1002/humu.20876;
RA   Saint-Martin C., Gauvain G., Teodorescu G., Gourfinkel-An I.,
RA   Fedirko E., Weber Y.G., Maljevic S., Ernst J.-P., Garcia-Olivares J.,
RA   Fahlke C., Nabbout R., LeGuern E., Lerche H., Christophe Poncer J.,
RA   Depienne C.;
RT   "Two novel CLCN2 mutations accelerating chloride channel deactivation
RT   are associated with idiopathic generalized epilepsy.";
RL   Hum. Mutat. 30:397-405(2009).
RN   [16]
RP   VARIANTS LKPAT 144-LEU-ILE-145 DEL AND VAL-500, AND CHARACTERIZATION
RP   OF VARIANTS LKPAT 144-LEU-ILE-145 DEL AND VAL-500.
RX   PubMed=23707145; DOI=10.1016/S1474-4422(13)70053-X;
RA   Depienne C., Bugiani M., Dupuits C., Galanaud D., Touitou V.,
RA   Postma N., van Berkel C., Polder E., Tollard E., Darios F., Brice A.,
RA   de Die-Smulders C.E., Vles J.S., Vanderver A., Uziel G.,
RA   Yalcinkaya C., Frints S.G., Kalscheuer V.M., Klooster J.,
RA   Kamermans M., Abbink T.E., Wolf N.I., Sedel F., van der Knaap M.S.;
RT   "Brain white matter oedema due to ClC-2 chloride channel deficiency:
RT   an observational analytical study.";
RL   Lancet Neurol. 12:659-668(2013).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. {ECO:0000269|PubMed:19153159,
CC       ECO:0000269|PubMed:19191339}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P35525}; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P51788-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51788-2; Sequence=VSP_007831, VSP_007832, VSP_036455;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P51788-3; Sequence=VSP_036456;
CC       Name=4;
CC         IsoId=P51788-4; Sequence=VSP_045457;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P51788-5; Sequence=VSP_045458;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Moderately expressed
CC       in aortic and coronary vascular smooth muscle cells and expressed
CC       at a low level in aortic endothelial cells.
CC       {ECO:0000269|PubMed:10198195}.
CC   -!- PTM: Phosphorylated. Activated by dephosphorylation.
CC       {ECO:0000250|UniProtKB:P35525}.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 11 (EIG11) [MIM:607628]:
CC       A disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain.
CC       {ECO:0000269|PubMed:19191339}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Juvenile absence epilepsy 2 (JAE2) [MIM:607628]: A
CC       subtype of idiopathic generalized epilepsy characterized by onset
CC       occurring around puberty, absence seizures, generalized tonic-
CC       clonic seizures (GTCS), GTCS on awakening, and myoclonic seizures.
CC       {ECO:0000269|PubMed:12612585, ECO:0000269|PubMed:19710712}.
CC       Note=Disease susceptibility may be associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Juvenile myoclonic epilepsy 8 (EJM8) [MIM:607628]: A
CC       subtype of idiopathic generalized epilepsy. Patients have afebrile
CC       seizures only, with onset in adolescence (rather than in
CC       childhood) and myoclonic jerks which usually occur after awakening
CC       and are triggered by sleep deprivation and fatigue.
CC       {ECO:0000269|PubMed:19191339}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Leukoencephalopathy with ataxia (LKPAT) [MIM:615651]: An
CC       autosomal recessive neurologic disorder with a characteristic
CC       pattern of white matter abnormalities on brain MRI. Affected
CC       individuals have prominent signal abnormalities and decreased
CC       apparent diffusion coefficient values in the posterior limbs of
CC       the internal capsules, middle cerebral peduncles, pyramidal tracts
CC       in the pons, and middle cerebellar peduncles, suggesting myelin
CC       microvacuolation. Clinical features include ataxia and unstable
CC       gait. More variable abnormalities may include visual field
CC       defects, headaches, and learning disabilities.
CC       {ECO:0000269|PubMed:23707145}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The CLC channel family contains both chloride
CC       channels and proton-coupled anion transporters that exchange
CC       chloride or another anion for protons. The absence of conserved
CC       gating glutamate residues is typical for family members that
CC       function as channels (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClC-2/CLCN2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH21578.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S77770; AAB34722.2; -; mRNA.
DR   EMBL; AF026004; AAB88807.1; -; mRNA.
DR   EMBL; AK298952; BAG61051.1; -; mRNA.
DR   EMBL; AK302759; BAG63970.1; -; mRNA.
DR   EMBL; AC078797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021578; AAH21578.1; ALT_SEQ; mRNA.
DR   EMBL; BC072004; AAH72004.1; -; mRNA.
DR   CCDS; CCDS3263.1; -. [P51788-1]
DR   CCDS; CCDS54690.1; -. [P51788-4]
DR   CCDS; CCDS54691.1; -. [P51788-3]
DR   CCDS; CCDS54692.1; -. [P51788-5]
DR   RefSeq; NP_001164558.1; NM_001171087.2. [P51788-3]
DR   RefSeq; NP_001164559.1; NM_001171088.2. [P51788-4]
DR   RefSeq; NP_001164560.1; NM_001171089.2. [P51788-5]
DR   RefSeq; NP_004357.3; NM_004366.5. [P51788-1]
DR   UniGene; Hs.436847; -.
DR   ProteinModelPortal; P51788; -.
DR   BioGrid; 107595; 19.
DR   IntAct; P51788; 31.
DR   STRING; 9606.ENSP00000265593; -.
DR   ChEMBL; CHEMBL1628478; -.
DR   DrugBank; DB01046; Lubiprostone.
DR   GuidetoPHARMACOLOGY; 699; -.
DR   TCDB; 2.A.49.2.12; the chloride carrier/channel (clc) family.
DR   iPTMnet; P51788; -.
DR   PhosphoSitePlus; P51788; -.
DR   BioMuta; CLCN2; -.
DR   DMDM; 288558807; -.
DR   MaxQB; P51788; -.
DR   PaxDb; P51788; -.
DR   PeptideAtlas; P51788; -.
DR   PRIDE; P51788; -.
DR   Ensembl; ENST00000265593; ENSP00000265593; ENSG00000114859. [P51788-1]
DR   Ensembl; ENST00000344937; ENSP00000345056; ENSG00000114859. [P51788-3]
DR   Ensembl; ENST00000434054; ENSP00000400425; ENSG00000114859. [P51788-4]
DR   Ensembl; ENST00000457512; ENSP00000391928; ENSG00000114859. [P51788-5]
DR   GeneID; 1181; -.
DR   KEGG; hsa:1181; -.
DR   UCSC; uc003foi.4; human. [P51788-1]
DR   CTD; 1181; -.
DR   DisGeNET; 1181; -.
DR   EuPathDB; HostDB:ENSG00000114859.14; -.
DR   GeneCards; CLCN2; -.
DR   HGNC; HGNC:2020; CLCN2.
DR   HPA; CAB009397; -.
DR   HPA; HPA014545; -.
DR   HPA; HPA024108; -.
DR   MalaCards; CLCN2; -.
DR   MIM; 600570; gene.
DR   MIM; 607628; phenotype.
DR   MIM; 615651; phenotype.
DR   neXtProt; NX_P51788; -.
DR   OpenTargets; ENSG00000114859; -.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   Orphanet; 363540; Leukoencephalopathy with mild cerebellar ataxia and white matter edema.
DR   PharmGKB; PA26547; -.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000231297; -.
DR   HOVERGEN; HBG005332; -.
DR   InParanoid; P51788; -.
DR   KO; K05011; -.
DR   OMA; YEQTLMY; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; P51788; -.
DR   TreeFam; TF300522; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; CLCN2; human.
DR   GeneWiki; CLCN2; -.
DR   GenomeRNAi; 1181; -.
DR   PRO; PR:P51788; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114859; -.
DR   CleanEx; HS_CLCN2; -.
DR   ExpressionAtlas; P51788; baseline and differential.
DR   Genevisible; P51788; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:0060689; P:cell differentiation involved in salivary gland development; IEA:Ensembl.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR002244; Cl-channel-2.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01113; CLCHANNEL2.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; CBS domain; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Disease mutation;
KW   Epilepsy; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    898       Chloride channel protein 2.
FT                                /FTId=PRO_0000094433.
FT   TOPO_DOM      2     87       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     88    121       Helical. {ECO:0000250}.
FT   TRANSMEM    130    155       Helical. {ECO:0000250}.
FT   INTRAMEM    164    171       Helical. {ECO:0000255}.
FT   TRANSMEM    180    198       Helical. {ECO:0000250}.
FT   TRANSMEM    205    223       Helical. {ECO:0000250}.
FT   INTRAMEM    239    251       Helical. {ECO:0000250}.
FT   INTRAMEM    255    263       Helical. {ECO:0000250}.
FT   TRANSMEM    275    295       Helical. {ECO:0000250}.
FT   TRANSMEM    321    349       Helical. {ECO:0000250}.
FT   TRANSMEM    358    377       Helical. {ECO:0000250}.
FT   TRANSMEM    429    449       Helical. {ECO:0000250}.
FT   TRANSMEM    457    480       Helical. {ECO:0000250}.
FT   INTRAMEM    497    511       Helical. {ECO:0000250}.
FT   INTRAMEM    512    513       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   INTRAMEM    514    525       Helical. {ECO:0000250}.
FT   INTRAMEM    526    530       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   TRANSMEM    531    548       Helical. {ECO:0000250}.
FT   TOPO_DOM    549    898       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      584    642       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      790    850       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOTIF       161    165       Selectivity filter part_1. {ECO:0000250}.
FT   MOTIF       203    207       Selectivity filter part_2. {ECO:0000250}.
FT   MOTIF       457    461       Selectivity filter part_3. {ECO:0000250}.
FT   COMPBIAS      2      6       Poly-Ala.
FT   BINDING     162    162       Chloride. {ECO:0000250}.
FT   BINDING     459    459       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     553    553       Chloride. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      20     20       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9R0A1}.
FT   MOD_RES     712    712       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     758    758       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35525}.
FT   VAR_SEQ       1    359       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007831.
FT   VAR_SEQ      74    117       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045457.
FT   VAR_SEQ     443    485       FWMSALATTIPVPCGAFMPVFVIGAAFGRLVGESMAAWFPD
FT                                GI -> HLGVWWVKAWLPGSQMEFIRTAAPTGLCLGATLWS
FT                                GQLRWQER (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007832.
FT   VAR_SEQ     466    482       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036456.
FT   VAR_SEQ     486    898       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036455.
FT   VAR_SEQ     806    834       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045458.
FT   VARIANT      48     48       P -> R (polymorphism; reduces channel
FT                                activity; dbSNP:rs115661422).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057886.
FT   VARIANT      68     68       R -> H (polymorphism; reduces channel
FT                                activity; dbSNP:rs61729156).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057887.
FT   VARIANT     144    145       Missing (in LKPAT; loss of function
FT                                mutation; the mutant protein is
FT                                restricted to the endoplasmic reticulum
FT                                and hardly reached the plasma membrane;
FT                                lower amounts of the mutant protein
FT                                compared to wild-type).
FT                                {ECO:0000269|PubMed:23707145}.
FT                                /FTId=VAR_070976.
FT   VARIANT     199    199       G -> A (polymorphism; no effect;
FT                                dbSNP:rs863225248).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057888.
FT   VARIANT     235    235       R -> Q (in EJM8; associated with disease
FT                                susceptibility; the mutant channel has
FT                                accelerated deactivation rates compared
FT                                to wild-type, but normal activation and
FT                                peak current; dbSNP:rs71318369).
FT                                {ECO:0000269|PubMed:19191339}.
FT                                /FTId=VAR_057889.
FT   VARIANT     500    500       A -> V (in LKPAT; loss of function
FT                                mutation; the mutant protein is
FT                                restricted to the endoplasmic reticulum
FT                                and hardly reaches the plasma membrane;
FT                                lower amounts of the mutant protein
FT                                compared to wild-type;
FT                                dbSNP:rs587777111).
FT                                {ECO:0000269|PubMed:23707145}.
FT                                /FTId=VAR_070977.
FT   VARIANT     577    577       R -> Q (in EIG11; associated with disease
FT                                susceptibility; the mutant channel has
FT                                accelerated deactivation rates compared
FT                                to wild-type, but normal activation and
FT                                peak current; dbSNP:rs137852682).
FT                                {ECO:0000269|PubMed:19191339}.
FT                                /FTId=VAR_057890.
FT   VARIANT     644    644       R -> C (polymorphism; no effect;
FT                                dbSNP:rs148545588).
FT                                {ECO:0000269|PubMed:19191339}.
FT                                /FTId=VAR_057891.
FT   VARIANT     646    646       R -> Q (polymorphism; reduces channel
FT                                activity; dbSNP:rs115961753).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057892.
FT   VARIANT     668    668       T -> S (in dbSNP:rs9820367).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17762171,
FT                                ECO:0000269|PubMed:7795595}.
FT                                /FTId=VAR_054550.
FT   VARIANT     715    715       G -> E (in JAE2; unknown pathological
FT                                significance; dbSNP:rs137852681).
FT                                {ECO:0000269|PubMed:12612585,
FT                                ECO:0000269|PubMed:19710712}.
FT                                /FTId=VAR_015989.
FT   VARIANT     718    718       E -> D (in dbSNP:rs2228292).
FT                                /FTId=VAR_054551.
FT   VARIANT     719    719       S -> L (found in a patient with childhood
FT                                absence epilepsy; unknown pathological
FT                                significance; dbSNP:rs138573287).
FT                                {ECO:0000269|PubMed:19200853}.
FT                                /FTId=VAR_058426.
FT   VARIANT     725    725       R -> W (polymorphism; slightly faster
FT                                channel activation; dbSNP:rs114702742).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057893.
FT   VARIANT     747    747       R -> H (polymorphism; slightly faster
FT                                channel activation; dbSNP:rs144164281).
FT                                {ECO:0000269|PubMed:17762171}.
FT                                /FTId=VAR_057894.
FT   CONFLICT     17     17       Y -> H (in Ref. 1; AAB34722).
FT                                {ECO:0000305}.
FT   CONFLICT    537    537       A -> V (in Ref. 5; AAH21578).
FT                                {ECO:0000305}.
SQ   SEQUENCE   898 AA;  98535 MW;  5F20FA8713C0C74E CRC64;
     MAAAAAEEGM EPRALQYEQT LMYGRYTQDL GAFAKEEAAR IRLGGPEPWK GPPSSRAAPE
     LLEYGRSRCA RCRVCSVRCH KFLVSRVGED WIFLVLLGLL MALVSWVMDY AIAACLQAQQ
     WMSRGLNTSI LLQYLAWVTY PVVLITFSAG FTQILAPQAV GSGIPEMKTI LRGVVLKEYL
     TLKTFIAKVI GLTCALGSGM PLGKEGPFVH IASMCAALLS KFLSLFGGIY ENESRNTEML
     AAACAVGVGC CFAAPIGGVL FSIEVTSTFF AVRNYWRGFF AATFSAFIFR VLAVWNRDEE
     TITALFKTRF RLDFPFDLQE LPAFAVIGIA SGFGGALFVY LNRKIVQVMR KQKTINRFLM
     RKRLLFPALV TLLISTLTFP PGFGQFMAGQ LSQKETLVTL FDNRTWVRQG LVEELEPPST
     SQAWNPPRAN VFLTLVIFIL MKFWMSALAT TIPVPCGAFM PVFVIGAAFG RLVGESMAAW
     FPDGIHTDSS TYRIVPGGYA VVGAAALAGA VTHTVSTAVI VFELTGQIAH ILPVMIAVIL
     ANAVAQSLQP SLYDSIIRIK KLPYLPELGW GRHQQYRVRV EDIMVRDVPH VALSCTFRDL
     RLALHRTKGR MLALVESPES MILLGSIERS QVVALLGAQL SPARRRQHMQ ERRATQTSPL
     SDQEGPPTPE ASVCFQVNTE DSAFPAARGE THKPLKPALK RGPSVTRNLG ESPTGSAESA
     GIALRSLFCG SPPPEAASEK LESCEKRKLK RVRISLASDA DLEGEMSPEE ILEWEEQQLD
     EPVNFSDCKI DPAPFQLVER TSLHKTHTIF SLLGVDHAYV TSIGRLIGIV TLKELRKAIE
     GSVTAQGVKV RPPLASFRDS ATSSSDTETT EVHALWGPHS RHGLPREGSP SDSDDKCQ
//
ID   CLCKA_HUMAN             Reviewed;         687 AA.
AC   P51800; B4DPD3; E7EPH6; Q5T5P8; Q5T5Q4; Q7Z6D1; Q86VT1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   20-DEC-2017, entry version 163.
DE   RecName: Full=Chloride channel protein ClC-Ka;
DE            Short=Chloride channel Ka;
DE   AltName: Full=ClC-K1;
GN   Name=CLCNKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=8041726; DOI=10.1073/pnas.91.15.6943;
RA   Kieferle S., Fong P., Bens M., Vandewalle A., Jentsch T.;
RT   "Two highly homologous members of the ClC chloride channel family in
RT   both rat and human kidney.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6943-6947(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   THR-447.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS
RP   GLY-83; GLN-357 AND THR-447.
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   VARIANTS ILE-67 AND PHE-315.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 153-203.
RA   Schutte B.C., Malik M.I., Fingert J., Barna T.J., Stone E., Lamb F.S.;
RT   "Refined chromosomal localization of six human CLCN chloride ion
RT   channel genes.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=11734858; DOI=10.1038/35107099;
RA   Estevez R., Boettger T., Stein V., Birkenhaeger R., Otto E.,
RA   Hildebrandt F., Jentsch T.J.;
RT   "Barttin is a Cl- channel beta-subunit crucial for renal Cl-
RT   reabsorption and inner ear K+ secretion.";
RL   Nature 414:558-561(2001).
RN   [8]
RP   INVOLVEMENT IN BARTS4B.
RX   PubMed=18310267; DOI=10.1136/jmg.2007.052944;
RA   Nozu K., Inagaki T., Fu X.J., Nozu Y., Kaito H., Kanda K., Sekine T.,
RA   Igarashi T., Nakanishi K., Yoshikawa N., Iijima K., Matsuo M.;
RT   "Molecular analysis of digenic inheritance in Bartter syndrome with
RT   sensorineural deafness.";
RL   J. Med. Genet. 45:182-186(2008).
RN   [9]
RP   ENZYME REGULATION, CALCIUM-BINDING SITES, AND MUTAGENESIS OF GLU-259;
RP   GLU-261; ASP-278 AND GLU-281.
RX   PubMed=23148261; DOI=10.1085/jgp.201210878;
RA   Gradogna A., Fenollar-Ferrer C., Forrest L.R., Pusch M.;
RT   "Dissecting a regulatory calcium-binding site of CLC-K kidney chloride
RT   channels.";
RL   J. Gen. Physiol. 140:681-696(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 533-687, AND SUBUNIT.
RX   PubMed=17562318; DOI=10.1016/j.str.2007.04.013;
RA   Markovic S., Dutzler R.;
RT   "The structure of the cytoplasmic domain of the chloride channel ClC-
RT   Ka reveals a conserved interaction interface.";
RL   Structure 15:715-725(2007).
RN   [11]
RP   VARIANT BARTS4B CYS-80.
RX   PubMed=15044642; DOI=10.1056/NEJMoa032843;
RA   Schlingmann K.P., Konrad M., Jeck N., Waldegger P., Reinalter S.C.,
RA   Holder M., Seyberth H.W., Waldegger S.;
RT   "Salt wasting and deafness resulting from mutations in two chloride
RT   channels.";
RL   N. Engl. J. Med. 350:1314-1319(2004).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. May be important in urinary
CC       concentrating mechanisms.
CC   -!- ENZYME REGULATION: Activated by extracellular calcium and
CC       inhibited by extracellular protons. {ECO:0000305|PubMed:23148261}.
CC   -!- SUBUNIT: Homodimer (PubMed:17562318). Interacts with BSND. Forms
CC       heteromers with BSND in the thin ascending limb of Henle (By
CC       similarity). {ECO:0000250|UniProtKB:Q9WUB7,
CC       ECO:0000269|PubMed:17562318}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-12538872, EBI-12538872;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51800-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51800-2; Sequence=VSP_044700;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P51800-3; Sequence=VSP_045795;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the kidney. All
CC       nephron segments expressing BSND also express CLCNK proteins.
CC       {ECO:0000269|PubMed:11734858}.
CC   -!- DISEASE: Bartter syndrome 4B, neonatal, with sensorineural
CC       deafness (BARTS4B) [MIM:613090]: A digenic form of Bartter
CC       syndrome, an autosomal recessive disorder characterized by
CC       impaired salt reabsorption in the thick ascending loop of Henle
CC       with pronounced salt wasting, hypokalemic metabolic alkalosis, and
CC       varying degrees of hypercalciuria. BARTS4B is associated with
CC       sensorineural deafness. {ECO:0000269|PubMed:15044642,
CC       ECO:0000269|PubMed:18310267}. Note=The disease is caused by
CC       mutations affecting distinct genetic loci, including the gene
CC       represented in this entry. Loss-of-function of both CLCNKA and
CC       CLCNKB results in the disease phenotype (PubMed:18310267).
CC       {ECO:0000269|PubMed:18310267}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       CLCNKA subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z30643; CAA83120.1; -; mRNA.
DR   EMBL; AK298285; BAG60545.1; -; mRNA.
DR   EMBL; AK225550; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL355994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC048282; AAH48282.1; -; mRNA.
DR   EMBL; BC053869; AAH53869.1; -; mRNA.
DR   EMBL; U93878; AAB65148.1; -; Genomic_DNA.
DR   CCDS; CCDS167.1; -. [P51800-1]
DR   CCDS; CCDS41269.1; -. [P51800-3]
DR   CCDS; CCDS57973.1; -. [P51800-2]
DR   PIR; C57713; C57713.
DR   RefSeq; NP_001036169.1; NM_001042704.1. [P51800-3]
DR   RefSeq; NP_001244068.1; NM_001257139.1. [P51800-2]
DR   RefSeq; NP_004061.3; NM_004070.3. [P51800-1]
DR   UniGene; Hs.591533; -.
DR   PDB; 2PFI; X-ray; 1.60 A; A/B=533-687.
DR   PDBsum; 2PFI; -.
DR   ProteinModelPortal; P51800; -.
DR   SMR; P51800; -.
DR   BioGrid; 107601; 1.
DR   DIP; DIP-29432N; -.
DR   IntAct; P51800; 14.
DR   STRING; 9606.ENSP00000332771; -.
DR   DrugBank; DB04552; Niflumic Acid.
DR   GuidetoPHARMACOLOGY; 700; -.
DR   iPTMnet; P51800; -.
DR   PhosphoSitePlus; P51800; -.
DR   BioMuta; CLCNKA; -.
DR   DMDM; 1705857; -.
DR   PaxDb; P51800; -.
DR   PeptideAtlas; P51800; -.
DR   PRIDE; P51800; -.
DR   Ensembl; ENST00000331433; ENSP00000332771; ENSG00000186510. [P51800-1]
DR   Ensembl; ENST00000375692; ENSP00000364844; ENSG00000186510. [P51800-3]
DR   Ensembl; ENST00000439316; ENSP00000414445; ENSG00000186510. [P51800-2]
DR   GeneID; 1187; -.
DR   KEGG; hsa:1187; -.
DR   UCSC; uc001axu.4; human. [P51800-1]
DR   CTD; 1187; -.
DR   DisGeNET; 1187; -.
DR   EuPathDB; HostDB:ENSG00000186510.11; -.
DR   GeneCards; CLCNKA; -.
DR   HGNC; HGNC:2026; CLCNKA.
DR   HPA; HPA057717; -.
DR   MalaCards; CLCNKA; -.
DR   MIM; 602024; gene.
DR   MIM; 613090; phenotype.
DR   neXtProt; NX_P51800; -.
DR   OpenTargets; ENSG00000186510; -.
DR   Orphanet; 89938; Infantile Bartter syndrome with sensorineural deafness.
DR   PharmGKB; PA26553; -.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000231297; -.
DR   HOVERGEN; HBG005332; -.
DR   InParanoid; P51800; -.
DR   KO; K05017; -.
DR   OMA; PCPHIRR; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; P51800; -.
DR   TreeFam; TF300522; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   EvolutionaryTrace; P51800; -.
DR   GeneWiki; CLCNKA; -.
DR   GenomeRNAi; 1187; -.
DR   PRO; PR:P51800; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000186510; -.
DR   CleanEx; HS_CLCNKA; -.
DR   Genevisible; P51800; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002250; Cl_channel-K.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01119; CLCHANNELKDY.
DR   SMART; SM00116; CBS; 1.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Bartter syndrome; Calcium;
KW   CBS domain; Chloride; Chloride channel; Complete proteome; Deafness;
KW   Disease mutation; Ion channel; Ion transport; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    687       Chloride channel protein ClC-Ka.
FT                                /FTId=PRO_0000094455.
FT   TRANSMEM     52     72       Helical. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    329    349       Helical. {ECO:0000255}.
FT   TRANSMEM    396    416       Helical. {ECO:0000255}.
FT   TRANSMEM    417    437       Helical. {ECO:0000255}.
FT   TRANSMEM    452    472       Helical. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   TOPO_DOM    507    687       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      551    609       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      626    684       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   METAL       259    259       Calcium. {ECO:0000305|PubMed:23148261}.
FT   METAL       261    261       Calcium. {ECO:0000305|PubMed:23148261}.
FT   METAL       278    278       Calcium. {ECO:0000305|PubMed:23148261}.
FT   METAL       281    281       Calcium. {ECO:0000305|PubMed:23148261}.
FT   VAR_SEQ      77    119       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044700.
FT   VAR_SEQ     615    615       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_045795.
FT   VARIANT       8      8       R -> H (in dbSNP:rs9442189).
FT                                /FTId=VAR_048695.
FT   VARIANT      45     45       R -> H (in dbSNP:rs35932996).
FT                                /FTId=VAR_033768.
FT   VARIANT      67     67       M -> I (in dbSNP:rs17855678).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030784.
FT   VARIANT      80     80       W -> C (in BARTS4B; a patient also
FT                                carrying a mutation in CLCNKB;
FT                                dbSNP:rs121909137).
FT                                {ECO:0000269|PubMed:15044642}.
FT                                /FTId=VAR_063074.
FT   VARIANT      83     83       R -> G (in dbSNP:rs10927887).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_019787.
FT   VARIANT     315    315       Y -> F (in dbSNP:rs12126269).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_019788.
FT   VARIANT     357    357       H -> Q (in dbSNP:rs79751787).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_068971.
FT   VARIANT     447    447       A -> T (in dbSNP:rs1805152).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014465.
FT   VARIANT     534    534       R -> W (in dbSNP:rs12140223).
FT                                /FTId=VAR_059209.
FT   VARIANT     683    683       P -> L (in dbSNP:rs12746751).
FT                                /FTId=VAR_061095.
FT   MUTAGEN     259    259       E->N: Calcium insensitive.
FT                                {ECO:0000269|PubMed:23148261}.
FT   MUTAGEN     261    261       E->Q: Calcium insensitive.
FT                                {ECO:0000269|PubMed:23148261}.
FT   MUTAGEN     278    278       D->N: Calcium insensitive.
FT                                {ECO:0000269|PubMed:23148261}.
FT   MUTAGEN     281    281       E->D: Calcium insensitive.
FT                                {ECO:0000269|PubMed:23148261}.
FT   CONFLICT     28     28       I -> V (in Ref. 2; BAG60545).
FT                                {ECO:0000305}.
FT   CONFLICT    451    451       G -> D (in Ref. 2; BAG60545).
FT                                {ECO:0000305}.
FT   HELIX       547    550       {ECO:0000244|PDB:2PFI}.
FT   HELIX       564    572       {ECO:0000244|PDB:2PFI}.
FT   STRAND      577    583       {ECO:0000244|PDB:2PFI}.
FT   TURN        585    587       {ECO:0000244|PDB:2PFI}.
FT   STRAND      589    595       {ECO:0000244|PDB:2PFI}.
FT   HELIX       596    604       {ECO:0000244|PDB:2PFI}.
FT   HELIX       618    623       {ECO:0000244|PDB:2PFI}.
FT   HELIX       641    650       {ECO:0000244|PDB:2PFI}.
FT   STRAND      654    660       {ECO:0000244|PDB:2PFI}.
FT   STRAND      663    669       {ECO:0000244|PDB:2PFI}.
FT   HELIX       670    681       {ECO:0000244|PDB:2PFI}.
SQ   SEQUENCE   687 AA;  75285 MW;  E97C6928470A4460 CRC64;
     MEELVGLREG FSGDPVTLQE LWGPCPHIRR AIQGGLEWLK QKVFRLGEDW YFLMTLGVLM
     ALVSYAMNFA IGCVVRAHQW LYREIGDSHL LRYLSWTVYP VALVSFSSGF SQSITPSSGG
     SGIPELKTML AGVILEDYLD IKNFGAKVVG LSCTLATGST LFLGKVGPFV HLSVMIAAYL
     GRVRTTTIGE PENKSKQNEM LVAAAAVGVA TVFAAPFSGV LFSIEVMSSH FSVRDYWRGF
     FAATCGAFIF RLLAVFNSEQ ETITSLYKTS FRVDVPFDLP EIFFFVALGG ICGVLSCAYL
     FCQRTFLSFI KTNRYSSKLL ATSKPVYSAL ATLLLASITY PPGVGHFLAS RLSMKQHLDS
     LFDNHSWALM TQNSSPPWPE ELDPQHLWWE WYHPRFTIFG TLAFFLVMKF WMLILATTIP
     MPAGYFMPIF ILGAAIGRLL GEALAVAFPE GIVTGGVTNP IMPGGYALAG AAAFSGAVTH
     TISTALLAFE LTGQIVHALP VLMAVLAANA IAQSCQPSFY DGTIIVKKLP YLPRILGRNI
     GSHHVRVEHF MNHSITTLAK DTPLEEVVKV VTSTDVTEYP LVESTESQIL VGIVQRAQLV
     QALQAEPPSR APGHQQCLQD ILARGCPTEP VTLTLFSETT LHQAQNLFKL LNLQSLFVTS
     RGRAVGCVSW VEMKKAISNL TNPPAPK
//
ID   CLCKB_HUMAN             Reviewed;         687 AA.
AC   P51801; B3KUY3; Q5T5Q7; Q5T5Q8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 3.
DT   20-DEC-2017, entry version 165.
DE   RecName: Full=Chloride channel protein ClC-Kb;
DE            Short=Chloride channel Kb;
DE   AltName: Full=ClC-K2;
GN   Name=CLCNKB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LEU-27; GLY-214;
RP   VAL-287; THR-562 AND GLU-578.
RC   TISSUE=Kidney;
RX   PubMed=8041726; DOI=10.1073/pnas.91.15.6943;
RA   Kieferle S., Fong P., Bens M., Vandewalle A., Jentsch T.;
RT   "Two highly homologous members of the ClC chloride channel family in
RT   both rat and human kidney.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6943-6947(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LEU-27; GLY-214;
RP   VAL-287; THR-562 AND GLU-578.
RC   TISSUE=Kidney;
RX   PubMed=8544406; DOI=10.1038/ki.1995.439;
RA   Takeuchi Y., Uchida S., Marumo F., Sasaki S.;
RT   "Cloning, tissue distribution, and intrarenal localization of ClC
RT   chloride channels in human kidney.";
RL   Kidney Int. 48:1497-1503(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-287.
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 153-203.
RA   Schutte B.C., Malik M.I., Fingert J., Barna T.J., Stone E., Lamb F.S.;
RT   "Refined chromosomal localization of six human CLCN chloride ion
RT   channel genes.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTIONAL CHARACTERIZATION, AND TISSUE SPECIFICITY.
RX   PubMed=11734858; DOI=10.1038/35107099;
RA   Estevez R., Boettger T., Stein V., Birkenhaeger R., Otto E.,
RA   Hildebrandt F., Jentsch T.J.;
RT   "Barttin is a Cl- channel beta-subunit crucial for renal Cl-
RT   reabsorption and inner ear K+ secretion.";
RL   Nature 414:558-561(2001).
RN   [7]
RP   INVOLVEMENT IN BARTS4B.
RX   PubMed=15044642; DOI=10.1056/NEJMoa032843;
RA   Schlingmann K.P., Konrad M., Jeck N., Waldegger P., Reinalter S.C.,
RA   Holder M., Seyberth H.W., Waldegger S.;
RT   "Salt wasting and deafness resulting from mutations in two chloride
RT   channels.";
RL   N. Engl. J. Med. 350:1314-1319(2004).
RN   [8]
RP   INVOLVEMENT IN BARTS4B.
RX   PubMed=18310267; DOI=10.1136/jmg.2007.052944;
RA   Nozu K., Inagaki T., Fu X.J., Nozu Y., Kaito H., Kanda K., Sekine T.,
RA   Igarashi T., Nakanishi K., Yoshikawa N., Iijima K., Matsuo M.;
RT   "Molecular analysis of digenic inheritance in Bartter syndrome with
RT   sensorineural deafness.";
RL   J. Med. Genet. 45:182-186(2008).
RN   [9]
RP   VARIANTS BARTS3 LEU-124; THR-204; ASP-349; HIS-432 AND CYS-438.
RX   PubMed=9326936; DOI=10.1038/ng1097-171;
RA   Simon D.B., Bindra R.S., Mansfield T.A., Nelson-Williams C.,
RA   Mendonca E., Stone R., Schurman S., Nayir A., Alpay H., Bakkaloglu A.,
RA   Rodriguez-Soriano J., Morales J.M., Sanjad S.A., Taylor C.M., Pilz D.,
RA   Brem A., Trachtman H., Griswold W., Richard G.A., John E.,
RA   Lifton R.P.;
RT   "Mutations in the chloride channel gene, CLCNKB, cause Bartter's
RT   syndrome type III.";
RL   Nat. Genet. 17:171-178(1997).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. May be important in urinary
CC       concentrating mechanisms. {ECO:0000269|PubMed:11734858}.
CC   -!- SUBUNIT: Interacts with BSND. Forms heteromers with BSND in the
CC       thick ascending limb of Henle and more distal segments (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51801-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51801-2; Sequence=VSP_045965, VSP_045966, VSP_045967;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the kidney.
CC       {ECO:0000269|PubMed:11734858}.
CC   -!- DISEASE: Bartter syndrome 3 (BARTS3) [MIM:607364]: A form of
CC       Bartter syndrome, an autosomal recessive disorder characterized by
CC       impaired salt reabsorption in the thick ascending loop of Henle
CC       with pronounced salt wasting, hypokalemic metabolic alkalosis, and
CC       varying degrees of hypercalciuria. {ECO:0000269|PubMed:9326936}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Bartter syndrome 4B, neonatal, with sensorineural
CC       deafness (BARTS4B) [MIM:613090]: A digenic form of Bartter
CC       syndrome, an autosomal recessive disorder characterized by
CC       impaired salt reabsorption in the thick ascending loop of Henle
CC       with pronounced salt wasting, hypokalemic metabolic alkalosis, and
CC       varying degrees of hypercalciuria. BARTS4B is associated with
CC       sensorineural deafness. {ECO:0000269|PubMed:15044642,
CC       ECO:0000269|PubMed:18310267}. Note=The disease is caused by
CC       mutations affecting distinct genetic loci, including the gene
CC       represented in this entry. Loss-of-function of both CLCNKA and
CC       CLCNKB results in the disease phenotype (PubMed:18310267).
CC       {ECO:0000269|PubMed:18310267}.
CC   -!- MISCELLANEOUS: Compared with CLCNKA/BSND, CLCNKB/BSND is more
CC       sensitive to pH and less responsive to Ca(2+).
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       CLCNKB subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z30644; CAA83121.1; -; mRNA.
DR   EMBL; S80315; AAB35898.1; -; mRNA.
DR   EMBL; AK098217; BAG53595.1; -; mRNA.
DR   EMBL; AL355994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U93879; AAB65149.1; -; Genomic_DNA.
DR   CCDS; CCDS168.1; -. [P51801-1]
DR   CCDS; CCDS57974.1; -. [P51801-2]
DR   PIR; D57713; D57713.
DR   RefSeq; NP_000076.2; NM_000085.4. [P51801-1]
DR   RefSeq; NP_001159417.2; NM_001165945.2. [P51801-2]
DR   UniGene; Hs.352243; -.
DR   ProteinModelPortal; P51801; -.
DR   SMR; P51801; -.
DR   IntAct; P51801; 1.
DR   MINT; MINT-7969230; -.
DR   STRING; 9606.ENSP00000364831; -.
DR   GuidetoPHARMACOLOGY; 701; -.
DR   iPTMnet; P51801; -.
DR   PhosphoSitePlus; P51801; -.
DR   BioMuta; CLCNKB; -.
DR   DMDM; 288558843; -.
DR   PaxDb; P51801; -.
DR   PeptideAtlas; P51801; -.
DR   PRIDE; P51801; -.
DR   Ensembl; ENST00000375667; ENSP00000364819; ENSG00000184908. [P51801-2]
DR   Ensembl; ENST00000375679; ENSP00000364831; ENSG00000184908. [P51801-1]
DR   GeneID; 1188; -.
DR   KEGG; hsa:1188; -.
DR   UCSC; uc001axx.6; human. [P51801-1]
DR   CTD; 1188; -.
DR   DisGeNET; 1188; -.
DR   EuPathDB; HostDB:ENSG00000184908.17; -.
DR   GeneCards; CLCNKB; -.
DR   H-InvDB; HIX0020336; -.
DR   HGNC; HGNC:2027; CLCNKB.
DR   HPA; HPA057717; -.
DR   MalaCards; CLCNKB; -.
DR   MIM; 602023; gene.
DR   MIM; 607364; phenotype.
DR   MIM; 613090; phenotype.
DR   neXtProt; NX_P51801; -.
DR   OpenTargets; ENSG00000184908; -.
DR   Orphanet; 93605; Classic Bartter syndrome.
DR   Orphanet; 358; Gitelman syndrome.
DR   Orphanet; 89938; Infantile Bartter syndrome with sensorineural deafness.
DR   PharmGKB; PA26554; -.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000231297; -.
DR   HOVERGEN; HBG005332; -.
DR   InParanoid; P51801; -.
DR   KO; K05018; -.
DR   OMA; LAFEMTG; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; P51801; -.
DR   TreeFam; TF300522; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; CLCNKB; human.
DR   GeneWiki; CLCNKB; -.
DR   GenomeRNAi; 1188; -.
DR   PRO; PR:P51801; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000184908; -.
DR   CleanEx; HS_CLCNKB; -.
DR   ExpressionAtlas; P51801; baseline and differential.
DR   Genevisible; P51801; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007588; P:excretion; TAS:ProtInc.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002250; Cl_channel-K.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01119; CLCHANNELKDY.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Bartter syndrome; Calcium; CBS domain;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Deafness; Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    687       Chloride channel protein ClC-Kb.
FT                                /FTId=PRO_0000094459.
FT   TOPO_DOM      1     50       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     51     71       Helical. {ECO:0000255}.
FT   TRANSMEM     94    114       Helical. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    325    345       Helical. {ECO:0000255}.
FT   TRANSMEM    396    416       Helical. {ECO:0000255}.
FT   TRANSMEM    417    437       Helical. {ECO:0000255}.
FT   TRANSMEM    452    472       Helical. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   DOMAIN      551    609       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      626    684       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   METAL       259    259       Calcium. {ECO:0000250}.
FT   METAL       261    261       Calcium. {ECO:0000250}.
FT   METAL       278    278       Calcium. {ECO:0000250}.
FT   METAL       281    281       Calcium. {ECO:0000250}.
FT   CARBOHYD    679    679       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     49       MEEFVGLREGSSGNPVTLQELWGPCPRIRRGIRGGLEWLKQ
FT                                KLFRLGED -> MPCPPLLSVPVRAAGEQDRWVREEVTWGG
FT                                GPTVTGGWGWRAHLRSVSPP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045965.
FT   VAR_SEQ      50    218       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045966.
FT   VAR_SEQ     616    616       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045967.
FT   VARIANT       4      4       F -> L (in dbSNP:rs34851419).
FT                                /FTId=VAR_033770.
FT   VARIANT      27     27       R -> L (in dbSNP:rs2015352).
FT                                {ECO:0000269|PubMed:8041726,
FT                                ECO:0000269|PubMed:8544406}.
FT                                /FTId=VAR_046797.
FT   VARIANT      88     88       S -> R (in dbSNP:rs5256).
FT                                /FTId=VAR_014466.
FT   VARIANT     104    104       V -> I (in dbSNP:rs35530360).
FT                                /FTId=VAR_033771.
FT   VARIANT     124    124       P -> L (in BARTS3; dbSNP:rs121909131).
FT                                {ECO:0000269|PubMed:9326936}.
FT                                /FTId=VAR_001624.
FT   VARIANT     143    143       N -> H (in dbSNP:rs5259).
FT                                /FTId=VAR_014467.
FT   VARIANT     204    204       A -> T (in BARTS3; dbSNP:rs121909132).
FT                                {ECO:0000269|PubMed:9326936}.
FT                                /FTId=VAR_001625.
FT   VARIANT     214    214       A -> G (in dbSNP:rs1889789).
FT                                {ECO:0000269|PubMed:8041726,
FT                                ECO:0000269|PubMed:8544406}.
FT                                /FTId=VAR_033772.
FT   VARIANT     287    287       A -> V (in dbSNP:rs7367494).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:8041726,
FT                                ECO:0000269|PubMed:8544406}.
FT                                /FTId=VAR_069104.
FT   VARIANT     334    334       V -> L (in dbSNP:rs5251).
FT                                /FTId=VAR_014468.
FT   VARIANT     349    349       A -> D (in BARTS3; dbSNP:rs121909134).
FT                                {ECO:0000269|PubMed:9326936}.
FT                                /FTId=VAR_001626.
FT   VARIANT     395    395       R -> W (in dbSNP:rs34255952).
FT                                /FTId=VAR_046799.
FT   VARIANT     419    419       I -> V (in dbSNP:rs6650119).
FT                                /FTId=VAR_033773.
FT   VARIANT     432    432       Y -> H (in BARTS3; dbSNP:rs121909135).
FT                                {ECO:0000269|PubMed:9326936}.
FT                                /FTId=VAR_001627.
FT   VARIANT     438    438       R -> C (in BARTS3; dbSNP:rs121909133).
FT                                {ECO:0000269|PubMed:9326936}.
FT                                /FTId=VAR_001628.
FT   VARIANT     481    481       T -> S (in dbSNP:rs12140311).
FT                                /FTId=VAR_046800.
FT   VARIANT     562    562       M -> T (in dbSNP:rs5253).
FT                                {ECO:0000269|PubMed:8041726,
FT                                ECO:0000269|PubMed:8544406}.
FT                                /FTId=VAR_014469.
FT   VARIANT     578    578       K -> E (in dbSNP:rs2275166).
FT                                {ECO:0000269|PubMed:8041726,
FT                                ECO:0000269|PubMed:8544406}.
FT                                /FTId=VAR_024409.
FT   VARIANT     660    660       S -> L (in dbSNP:rs5255).
FT                                /FTId=VAR_046801.
FT   CONFLICT    609    609       S -> P (in Ref. 3; BAG53595).
FT                                {ECO:0000305}.
SQ   SEQUENCE   687 AA;  75446 MW;  4D28BC19DDD5D412 CRC64;
     MEEFVGLREG SSGNPVTLQE LWGPCPRIRR GIRGGLEWLK QKLFRLGEDW YFLMTLGVLM
     ALVSCAMDLA VESVVRAHQW LYREIGDSHL LRYLSWTVYP VALVSFSSGF SQSITPSSGG
     SGIPEVKTML AGVVLEDYLD IKNFGAKVVG LSCTLACGST LFLGKVGPFV HLSVMMAAYL
     GRVRTTTIGE PENKSKQNEM LVAAAAVGVA TVFAAPFSGV LFSIEVMSSH FSVWDYWRGF
     FAATCGAFMF RLLAVFNSEQ ETITSLYKTS FRVDVPFDLP EIFFFVALGG LCGILGSAYL
     FCQRIFFGFI RNNRFSSKLL ATSKPVYSAL ATLVLASITY PPSAGRFLAS RLSMKQHLDS
     LFDNHSWALM TQNSSPPWPE ELDPQHLWWE WYHPRFTIFG TLAFFLVMKF WMLILATTIP
     MPAGYFMPIF VYGAAIGRLF GETLSFIFPE GIVAGGITNP IMPGGYALAG AAAFSGAVTH
     TISTALLAFE VTGQIVHALP VLMAVLAANA IAQSCQPSFY DGTVIVKKLP YLPRILGRNI
     GSHRVRVEHF MNHSITTLAK DMPLEEVVKV VTSTDVAKYP LVESTESQIL VGIVRRAQLV
     QALKAEPPSW APGHQQCLQD ILAAGCPTEP VTLKLSPETS LHEAHNLFEL LNLHSLFVTS
     RGRAVGCVSW VEMKKAISNL TNPPAPK
//
ID   CLD17_HUMAN             Reviewed;         224 AA.
AC   P56750; Q3MJB5; Q6UY37;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 1.
DT   27-SEP-2017, entry version 127.
DE   RecName: Full=Claudin-17;
GN   Name=CLDN17; ORFNames=UNQ758/PRO1489;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Keen T.J., Inglehearn C.F.;
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH OCLN.
RX   PubMed=20375010; DOI=10.1074/jbc.M110.104836;
RA   Harris H.J., Davis C., Mullins J.G., Hu K., Goodall M., Farquhar M.J.,
RA   Mee C.J., McCaffrey K., Young S., Drummer H., Balfe P.,
RA   McKeating J.A.;
RT   "Claudin association with CD81 defines hepatitis C virus entry.";
RL   J. Biol. Chem. 285:21092-21102(2010).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   LYS-65.
RX   PubMed=22402829; DOI=10.1007/s00018-012-0949-x;
RA   Krug S.M., Guenzel D., Conrad M.P., Rosenthal R., Fromm A.,
RA   Amasheh S., Schulzke J.D., Fromm M.;
RT   "Claudin-17 forms tight junction channels with distinct anion
RT   selectivity.";
RL   Cell. Mol. Life Sci. 69:2765-2778(2012).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF ARG-31; GLU-44; ARG-45; GLU-48; ARG-56;
RP   ARG-59; ARG-61; LYS-65; SER-68; TYR-149 AND HIS-154.
RX   PubMed=26194246; DOI=10.1007/s00018-015-1987-y;
RA   Conrad M.P., Piontek J., Guenzel D., Fromm M., Krug S.M.;
RT   "Molecular basis of claudin-17 anion selectivity.";
RL   Cell. Mol. Life Sci. 73:185-200(2016).
CC   -!- FUNCTION: Channel-forming tight junction protein with selectivity
CC       for anions, including chloride and bicarbonate, and for solutes
CC       smaller than 9 Angstrom in diameter. In the kidney proximal
CC       tubule, may be involved in quantitative reabsorption of filtered
CC       anions. Does not affect water permeability.
CC       {ECO:0000269|PubMed:22402829}.
CC   -!- SUBUNIT: Interacts with OCLN (PubMed:20375010).
CC       {ECO:0000269|PubMed:20375010}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000269|PubMed:22402829}. Cell membrane
CC       {ECO:0000269|PubMed:20375010}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: In the kidney, expressed in the proximal
CC       tubule and in the Henle's loop. In the distal convoluted tubule,
CC       not expressed in all tubules. Not detected in the collecting duct
CC       (at protein level). {ECO:0000269|PubMed:22402829}.
CC   -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ88461.1; Type=Frameshift; Positions=31; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ250712; CAB60616.1; -; Genomic_DNA.
DR   EMBL; AY358094; AAQ88461.1; ALT_FRAME; mRNA.
DR   EMBL; AP001707; BAA95566.1; -; Genomic_DNA.
DR   EMBL; BC101503; AAI01504.1; -; mRNA.
DR   EMBL; BC101505; AAI01506.1; -; mRNA.
DR   CCDS; CCDS13586.1; -.
DR   RefSeq; NP_036263.1; NM_012131.2.
DR   UniGene; Hs.258589; -.
DR   ProteinModelPortal; P56750; -.
DR   SMR; P56750; -.
DR   BioGrid; 117667; 2.
DR   STRING; 9606.ENSP00000286808; -.
DR   TCDB; 1.H.1.1.13; the claudin tight junction (claudin1) family.
DR   iPTMnet; P56750; -.
DR   PhosphoSitePlus; P56750; -.
DR   BioMuta; CLDN17; -.
DR   DMDM; 6685309; -.
DR   PaxDb; P56750; -.
DR   PeptideAtlas; P56750; -.
DR   PRIDE; P56750; -.
DR   Ensembl; ENST00000286808; ENSP00000286808; ENSG00000156282.
DR   GeneID; 26285; -.
DR   KEGG; hsa:26285; -.
DR   UCSC; uc011acv.3; human.
DR   CTD; 26285; -.
DR   DisGeNET; 26285; -.
DR   EuPathDB; HostDB:ENSG00000156282.4; -.
DR   GeneCards; CLDN17; -.
DR   HGNC; HGNC:2038; CLDN17.
DR   HPA; HPA045903; -.
DR   MIM; 617005; gene.
DR   neXtProt; NX_P56750; -.
DR   OpenTargets; ENSG00000156282; -.
DR   PharmGKB; PA26564; -.
DR   eggNOG; ENOG410IJK4; Eukaryota.
DR   eggNOG; ENOG410YQQY; LUCA.
DR   GeneTree; ENSGT00760000118928; -.
DR   HOGENOM; HOG000220937; -.
DR   HOVERGEN; HBG000643; -.
DR   InParanoid; P56750; -.
DR   KO; K06087; -.
DR   OMA; ARALMCV; -.
DR   OrthoDB; EOG091G0MX2; -.
DR   PhylomeDB; P56750; -.
DR   TreeFam; TF331936; -.
DR   Reactome; R-HSA-420029; Tight junction interactions.
DR   GeneWiki; CLDN17; -.
DR   GenomeRNAi; 26285; -.
DR   PRO; PR:P56750; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000156282; -.
DR   CleanEx; HS_CLDN17; -.
DR   Genevisible; P56750; HS.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB.
DR   InterPro; IPR006187; Claudin.
DR   InterPro; IPR017974; Claudin_CS.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   PANTHER; PTHR12002; PTHR12002; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PROSITE; PS01346; CLAUDIN; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Tight junction; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    224       Claudin-17.
FT                                /FTId=PRO_0000144777.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TOPO_DOM     29     81       Extracellular. {ECO:0000255}.
FT   TRANSMEM     82    102       Helical. {ECO:0000255}.
FT   TOPO_DOM    103    124       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    125    145       Helical. {ECO:0000255}.
FT   TOPO_DOM    146    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical. {ECO:0000255}.
FT   TOPO_DOM    186    224       Cytoplasmic. {ECO:0000255}.
FT   VARIANT      82     82       A -> T (in dbSNP:rs35531957).
FT                                /FTId=VAR_033774.
FT   MUTAGEN      31     31       R->E: Decreased transepithelial
FT                                resistance and anion selectivity. Higher
FT                                permeability to chloride, sodium and also
FT                                to larger anions, including pyruvate,
FT                                nitrate, and thiocyanate.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      44     44       E->A: Decreased transepithelial
FT                                resistance and anion selectivity.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      45     45       R->A: Decreased transepithelial
FT                                resistance, no effect on anion
FT                                selectivity.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      48     48       E->K,Q: Decreased transepithelial
FT                                resistance and anion selectivity. Higher
FT                                permeability to chloride, sodium and also
FT                                to larger anions, including pyruvate,
FT                                nitrate, and thiocyanate.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      56     56       R->A: No effect on transepithelial
FT                                resistance, nor on anion selectivity.
FT                                Elevated permeabilities not only for
FT                                chloride, but also for sodium and the
FT                                larger anions, including pyruvate,
FT                                nitrate and thiocyanate.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      56     56       R->T: Decreased anion selectivity.
FT                                Increased permeabilities not only for
FT                                chloride, but also for sodium and
FT                                thiocyanate. No effect on transepithelial
FT                                resistance.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      59     59       R->A: No effect on transepithelial
FT                                resistance, nor on anion selectivity.
FT                                Increased permeability for thiocyanate.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      61     61       R->A: Decreased anion selectivity. No
FT                                effect on transepithelial resistance.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      65     65       K->A: Reduced channel formation ability.
FT                                Increased transepithelial resistance.
FT                                Loss of anion selectivity in favor of
FT                                cation selectivity.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      65     65       K->E: No effect on channel formation
FT                                ability. Loss of anion selectivity in
FT                                favor of cation selectivity. No effect on
FT                                transepithelial resistance.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      65     65       K->R: Strongly reduced channel formation
FT                                ability. Increased transepithelial
FT                                resistance. Loss of anion selectivity in
FT                                favor of cation selectivity.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN      68     68       S->E: Increased transepithelial
FT                                resistance. Loss of anion selectivity in
FT                                favor of cation (sodium) selectivity.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN     149    149       Y->A: Increased transepithelial
FT                                resistance. No effect on localization to
FT                                cell-cell junctions.
FT                                {ECO:0000269|PubMed:22402829}.
FT   MUTAGEN     154    154       H->A: Loss of anion selectivity. Strongly
FT                                increased permeabilities not only for
FT                                chloride, but also for sodium and the
FT                                larger anions, including pyruvate,
FT                                nitrate and thiocyanate. No effect on
FT                                localization to cell-cell junctions.
FT                                {ECO:0000269|PubMed:22402829}.
SQ   SEQUENCE   224 AA;  24603 MW;  1833ED3178B7F63A CRC64;
     MAFYPLQIAG LVLGFLGMVG TLATTLLPQW RVSAFVGSNI IVFERLWEGL WMNCIRQARV
     RLQCKFYSSL LALPPALETA RALMCVAVAL SLIALLIGIC GMKQVQCTGS NERAKAYLLG
     TSGVLFILTG IFVLIPVSWT ANIIIRDFYN PAIHIGQKRE LGAALFLGWA SAAVLFIGGG
     LLCGFCCCNR KKQGYRYPVP GYRVPHTDKR RNTTMLSKTS TSYV
//
ID   CLCB_SHIFL              Reviewed;         418 AA.
AC   P59638;
DT   23-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 1.
DT   05-JUL-2017, entry version 93.
DE   RecName: Full=Voltage-gated ClC-type chloride channel ClcB;
GN   Name=clcB; OrderedLocusNames=SF1613, S1745;
OS   Shigella flexneri.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=623;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=301 / Serotype 2a;
RX   PubMed=12384590; DOI=10.1093/nar/gkf566;
RA   Jin Q., Yuan Z., Xu J., Wang Y., Shen Y., Lu W., Wang J., Liu H.,
RA   Yang J., Yang F., Zhang X., Zhang J., Yang G., Wu H., Qu D., Dong J.,
RA   Sun L., Xue Y., Zhao A., Gao Y., Zhu J., Kan B., Ding K., Chen S.,
RA   Cheng H., Yao Z., He B., Chen R., Ma D., Qiang B., Wen Y., Hou Y.,
RA   Yu J.;
RT   "Genome sequence of Shigella flexneri 2a: insights into pathogenicity
RT   through comparison with genomes of Escherichia coli K12 and O157.";
RL   Nucleic Acids Res. 30:4432-4441(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700930 / 2457T / Serotype 2a;
RX   PubMed=12704152; DOI=10.1128/IAI.71.5.2775-2786.2003;
RA   Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W.,
RA   Fournier G., Mayhew G.F., Plunkett G. III, Rose D.J., Darling A.,
RA   Mau B., Perna N.T., Payne S.M., Runyen-Janecky L.J., Zhou S.,
RA   Schwartz D.C., Blattner F.R.;
RT   "Complete genome sequence and comparative genomics of Shigella
RT   flexneri serotype 2a strain 2457T.";
RL   Infect. Immun. 71:2775-2786(2003).
CC   -!- FUNCTION: Probably acts as an electrical shunt for an outwardly-
CC       directed proton pump that is linked to amino acid decarboxylation,
CC       as part of the extreme acid resistance (XAR) response.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClcB subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN43197.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAP17085.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005674; AAN43197.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AE014073; AAP17085.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; NP_707490.3; NC_004337.2.
DR   ProteinModelPortal; P59638; -.
DR   PaxDb; P59638; -.
DR   EnsemblBacteria; AAN43197; AAN43197; SF1613.
DR   EnsemblBacteria; AAP17085; AAP17085; S1745.
DR   GeneID; 1024819; -.
DR   KEGG; sfl:SF1613; -.
DR   KEGG; sft:NCTC1_01750; -.
DR   KEGG; sfx:S1745; -.
DR   PATRIC; fig|198214.7.peg.1906; -.
DR   eggNOG; ENOG4105CMQ; Bacteria.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000230177; -.
DR   KO; K03281; -.
DR   Proteomes; UP000001006; Chromosome.
DR   Proteomes; UP000002673; Chromosome.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   GO; GO:0010447; P:response to acidic pH; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   HAMAP; MF_01203; CLC_ClcB; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR023790; Cl-channel_volt-gated_ClcB.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    418       Voltage-gated ClC-type chloride channel
FT                                ClcB.
FT                                /FTId=PRO_0000094490.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      5     25       Helical. {ECO:0000255}.
FT   TOPO_DOM     26     53       Periplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75    145       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TOPO_DOM    167    172       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   TOPO_DOM    194    221       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical. {ECO:0000255}.
FT   TOPO_DOM    243    257       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical. {ECO:0000255}.
FT   TOPO_DOM    279    290       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TOPO_DOM    312    315       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    316    336       Helical. {ECO:0000255}.
FT   TOPO_DOM    337    351       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical. {ECO:0000255}.
FT   TOPO_DOM    373    379       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TOPO_DOM    401    418       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   418 AA;  44277 MW;  BEED5EA651D470CA CRC64;
     MFRRLLIATV VGILAVFAVA GFRHAMLLLE WLFLNNDSGS LVNAATNLSS WRRLLTPALG
     GLAAGLLLMG WQKFTQQRPH APTDYMEALQ TDGQFDYAAS LVKSLASLLV VTSGSAIGRE
     GAMILLAALA ASCFAQRFTP RQEWKLWIAC GAAAGMAAAY RAPLAGSLFI AEVLFGTMML
     ASLGPVIISA IVAWLVSNLI NHSDALLYNV QLSVTVQARD YALIISTGVL AGLCGPLLLT
     LMNACHRGFV SLKLAPPWQL ALGGLIVGLL SLFTPAVWGN GYSTVQSFLT APPLLMIIAG
     IFLCKLCAVL ASSGSGAPGG VFTPTLFIGL AIGMLYGRSL GLWFPDGEEI TLLLGLTGMA
     TLLAATTHAP IMSTLMICEM TGEYQLLPGL LIACVIASVI SRTLHRDSIY RQHTAQHS
//
ID   GLUCB_HAECO             Reviewed;         432 AA.
AC   P91730;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   25-OCT-2017, entry version 81.
DE   RecName: Full=Glutamate-gated chloride channel subunit beta;
DE            Short=Glu-Cl subunit beta;
DE   AltName: Full=Avermectin-sensitive glutamate-gated chloride channel subunit;
DE   AltName: Full=HG4;
DE   Flags: Precursor;
OS   Haemonchus contortus (Barber pole worm).
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Strongylida; Trichostrongyloidea; Haemonchidae; Haemonchinae;
OC   Haemonchus.
OX   NCBI_TaxID=6289;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9879896; DOI=10.1016/S0166-6851(98)00148-0;
RA   Delany N.S., Laughton D.L., Wolstenholme A.J.;
RT   "Cloning and localisation of an avermectin receptor-related subunit
RT   from Haemonchus contortus.";
RL   Mol. Biochem. Parasitol. 97:177-187(1998).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit; channel
CC       properties may be modulated by the formation of heteromeric
CC       channels. Glutamate binding triggers a rapidly reversible current,
CC       while the anti-helmintic drug ivermectin triggers a permanently
CC       open channel configuration. {ECO:0000250|UniProtKB:G5EBR3}.
CC   -!- SUBUNIT: Pentamer (By similarity). {ECO:0000250|UniProtKB:G5EBR3}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q94900}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q94900}.
CC   -!- TISSUE SPECIFICITY: Expressed in motor neuron commissures at the
CC       anterior portion of the worms. {ECO:0000269|PubMed:9879896}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y09796; CAA70929.1; -; mRNA.
DR   ProteinModelPortal; P91730; -.
DR   ChEMBL; CHEMBL2363050; -.
DR   TCDB; 1.A.9.4.3; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR015680; Glu_Cl_Channel.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF504; PTHR18945:SF504; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    432       Glutamate-gated chloride channel subunit
FT                                beta.
FT                                /FTId=PRO_0000255717.
FT   TOPO_DOM     19    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    250    272       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    273    277       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    278    299       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    300    306       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    307    327       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    328    402       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    403    426       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    427    432       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      69     69       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      88     88       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     155    155       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     184    184       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    219    219       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    164    178       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    226    237       {ECO:0000250|UniProtKB:G5EBR3}.
SQ   SEQUENCE   432 AA;  49626 MW;  AE6E7342FA8C883B CRC64;
     MSQYMMVAVA AVVAVAGSSQ ISRRSTGGTQ EQEILNELLS NYDMRVRPPP SNYSDPMGPV
     TVRVNIMIRM LSKIDVVNME YSMQLTFREQ WLDSRLAYAH LGYHNPPKFL TVPHIKSNLW
     IPDTFFPTEK AAHRHLIDTD NMFLRIHPDG KVLYSSRISI TSSCHMQLQL YPLDLQFCDF
     DLVSYAHTMK DIVYEWDPLA PVQLKPGVGS DLPNFQLTNI TTNDDCTSHT NTGSYACLRM
     QLTLKRQFSY YLVQLYGPTT MIVIVSWVSF WIDMHSTAGR VALGVTTLLT MTTMQAAINA
     KLPPVSYVKV VDVWLGACQT FVFGALLEYA FVSYQDSQRQ TEQAKSRAAR KAQKRRAKME
     LVEREQYQPP CTCHLYQDYE PSFRDRLRRY FTKPDYLPAK IDYYARFCVP LGFLAFNAIY
     WTSCLVMVSR LV
//
ID   CLCA_ARATH              Reviewed;         775 AA.
AC   P92941; O64990; Q93YS0;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   20-DEC-2017, entry version 130.
DE   RecName: Full=Chloride channel protein CLC-a;
DE            Short=AtCLC-a;
DE   AltName: Full=CBS domain-containing protein CBSCLC5;
GN   Name=CLC-A; Synonyms=CBSCLC5; OrderedLocusNames=At5g40890;
GN   ORFNames=MHK7.12;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=8969232; DOI=10.1074/jbc.271.52.33632;
RA   Hechenberger M., Schwappach B., Fischer W.N., Frommer W.B.,
RA   Jentsch T.J., Steinmeyer K.;
RT   "A family of putative chloride channels from Arabidopsis and
RT   functional complementation of a yeast strain with a CLC gene
RT   disruption.";
RL   J. Biol. Chem. 271:33632-33638(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=cv. Wassilewskija;
RX   PubMed=10758477; DOI=10.1046/j.1365-313x.2000.00680.x;
RA   Geelen D., Lurin C., Bouchez D., Frachisse J.-M., Lelievre F.,
RA   Courtial B., Barbier-Brygoo H., Maurel C.;
RT   "Disruption of putative anion channel gene AtCLC-a in Arabidopsis
RT   suggests a role in the regulation of nitrate content.";
RL   Plant J. 21:259-267(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9679202; DOI=10.1093/dnares/5.2.131;
RA   Kaneko T., Kotani H., Nakamura Y., Sato S., Asamizu E., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence
RT   features of the regions of 1,381,565 bp covered by twenty one
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:131-145(1998).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19376835; DOI=10.1104/pp.109.138677;
RA   Reiland S., Messerli G., Baerenfaller K., Gerrits B., Endler A.,
RA   Grossmann J., Gruissem W., Baginsky S.;
RT   "Large-scale Arabidopsis phosphoproteome profiling reveals novel
RT   chloroplast kinase substrates and phosphorylation networks.";
RL   Plant Physiol. 150:889-903(2009).
RN   [8]
RP   INTERACTION WITH PP2A5.
RX   PubMed=27676158; DOI=10.1111/pce.12837;
RA   Hu R., Zhu Y., Wei J., Chen J., Shi H., Shen G., Zhang H.;
RT   "Overexpression of PP2A-C5 that encodes the catalytic subunit 5 of
RT   protein phosphatase 2A in Arabidopsis confers better root and shoot
RT   development under salt conditions.";
RL   Plant Cell Environ. 40:150-164(2017).
CC   -!- FUNCTION: Voltage-gated chloride channel that could play a role in
CC       the regulation of nitrate content. {ECO:0000269|PubMed:10758477}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with PP2A5
CC       (PubMed:27676158). {ECO:0000250, ECO:0000269|PubMed:27676158}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=P92941-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Broadly expressed in the plant.
CC   -!- INDUCTION: In shoots and roots by nitrate treatment.
CC       {ECO:0000269|PubMed:10758477}.
CC   -!- DISRUPTION PHENOTYPE: Loss-of-function mutation clca-1 leads to an
CC       altered nitrate content and hypersensitivity to chlorate.
CC       {ECO:0000269|PubMed:10758477}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z71445; CAA96057.1; -; mRNA.
DR   EMBL; AF044313; AAC05742.1; -; mRNA.
DR   EMBL; AB011477; BAB11351.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED94612.1; -; Genomic_DNA.
DR   EMBL; AY059791; AAL24139.1; -; mRNA.
DR   EMBL; AY150506; AAN13022.1; -; mRNA.
DR   PIR; T52107; T52107.
DR   RefSeq; NP_198905.1; NM_123454.3. [P92941-1]
DR   UniGene; At.25457; -.
DR   ProteinModelPortal; P92941; -.
DR   BioGrid; 19341; 5.
DR   IntAct; P92941; 5.
DR   STRING; 3702.AT5G40890.1; -.
DR   iPTMnet; P92941; -.
DR   PaxDb; P92941; -.
DR   PRIDE; P92941; -.
DR   EnsemblPlants; AT5G40890.1; AT5G40890.1; AT5G40890. [P92941-1]
DR   GeneID; 834090; -.
DR   Gramene; AT5G40890.1; AT5G40890.1; AT5G40890. [P92941-1]
DR   KEGG; ath:AT5G40890; -.
DR   Araport; AT5G40890; -.
DR   TAIR; locus:2164466; AT5G40890.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000231081; -.
DR   InParanoid; P92941; -.
DR   KO; K05016; -.
DR   OMA; CCCRWCC; -.
DR   OrthoDB; EOG093602TR; -.
DR   PhylomeDB; P92941; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   PRO; PR:P92941; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; P92941; baseline and differential.
DR   Genevisible; P92941; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; TAS:TAIR.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IBA:GO_Central.
DR   GO; GO:0015112; F:nitrate transmembrane transporter activity; IDA:TAIR.
DR   GO; GO:0009671; F:nitrate:proton symporter activity; IBA:GO_Central.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IDA:TAIR.
DR   GO; GO:0015706; P:nitrate transport; IDA:TAIR.
DR   GO; GO:0010167; P:response to nitrate; IMP:TAIR.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002251; Cl_channel_pln.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01120; CLCHANNELPLT.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; CBS domain; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    775       Chloride channel protein CLC-a.
FT                                /FTId=PRO_0000094465.
FT   TRANSMEM     88    108       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    131    151       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    248    268       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    278    298       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    453    473       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    478    498       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    510    530       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    531    551       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    730    750       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      595    658       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      703    768       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   CONFLICT    330    330       D -> H (in Ref. 1; CAA96057).
FT                                {ECO:0000305}.
FT   CONFLICT    506    506       Q -> L (in Ref. 5; AAL24139).
FT                                {ECO:0000305}.
SQ   SEQUENCE   775 AA;  85406 MW;  A352FB24583E714E CRC64;
     MDEDGNLQIS NSNYNGEEEG EDPENNTLNQ PLLKRHRTLS STPLALVGAK VSHIESLDYE
     INENDLFKHD WRSRSKAQVF QYIFLKWTLA CLVGLFTGLI ATLINLAVEN IAGYKLLAVG
     YYIAQDRFWT GLMVFTGANL GLTLVATVLV VYFAPTAAGP GIPEIKAYLN GIDTPNMFGF
     TTMMVKIVGS IGAVAAGLDL GKEGPLVHIG SCIASLLGQG GPDNHRIKWR WLRYFNNDRD
     RRDLITCGSA SGVCAAFRSP VGGVLFALEE VATWWRSALL WRTFFSTAVV VVVLRAFIEI
     CNSGKCGLFG SGGLIMFDVS HVEVRYHAAD IIPVTLIGVF GGILGSLYNH LLHKVLRLYN
     LINQKGKIHK VLLSLGVSLF TSVCLFGLPF LAECKPCDPS IDEICPTNGR SGNFKQFNCP
     NGYYNDLSTL LLTTNDDAVR NIFSSNTPNE FGMVSLWIFF GLYCILGLIT FGIATPSGLF
     LPIILMGSAY GRMLGTAMGS YTNIDQGLYA VLGAASLMAG SMRMTVSLCV IFLELTNNLL
     LLPITMFVLL IAKTVGDSFN LSIYEIILHL KGLPFLEANP EPWMRNLTVG ELNDAKPPVV
     TLNGVEKVAN IVDVLRNTTH NAFPVLDGAD QNTGTELHGL ILRAHLVKVL KKRWFLNEKR
     RTEEWEVREK FTPVELAERE DNFDDVAITS SEMQLYVDLH PLTNTTPYTV VQSMSVAKAL
     VLFRSVGLRH LLVVPKIQAS GMSPVIGILT RQDLRAYNIL QAFPHLDKHK SGKAR
//
ID   CLCB_ARATH              Reviewed;         780 AA.
AC   P92942;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   27-SEP-2017, entry version 129.
DE   RecName: Full=Chloride channel protein CLC-b;
DE            Short=AtCLC-b;
DE   AltName: Full=CBS domain-containing protein CBSCLC7;
GN   Name=CLC-B; Synonyms=CBSCLC7; OrderedLocusNames=At3g27170;
GN   ORFNames=MYF5.4;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=8969232; DOI=10.1074/jbc.271.52.33632;
RA   Hechenberger M., Schwappach B., Fischer W.N., Frommer W.B.,
RA   Jentsch T.J., Steinmeyer K.;
RT   "A family of putative chloride channels from Arabidopsis and
RT   functional complementation of a yeast strain with a CLC gene
RT   disruption.";
RL   J. Biol. Chem. 271:33632-33638(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10907853; DOI=10.1093/dnares/7.3.217;
RA   Kaneko T., Katoh T., Sato S., Nakamura Y., Asamizu E., Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 3. II.
RT   Sequence features of the 4,251,695 bp regions covered by 90 P1, TAC
RT   and BAC clones.";
RL   DNA Res. 7:217-221(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
RN   [6]
RP   INTERACTION WITH PP2A5.
RX   PubMed=27676158; DOI=10.1111/pce.12837;
RA   Hu R., Zhu Y., Wei J., Chen J., Shi H., Shen G., Zhang H.;
RT   "Overexpression of PP2A-C5 that encodes the catalytic subunit 5 of
RT   protein phosphatase 2A in Arabidopsis confers better root and shoot
RT   development under salt conditions.";
RL   Plant Cell Environ. 40:150-164(2017).
CC   -!- FUNCTION: Voltage-gated chloride channel.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with PP2A5
CC       (PubMed:27676158). {ECO:0000250, ECO:0000269|PubMed:27676158}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Broadly expressed in the plant.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z71446; CAA96058.1; -; mRNA.
DR   EMBL; AP001312; BAB01934.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE77275.1; -; Genomic_DNA.
DR   EMBL; AY062518; AAL32596.1; -; mRNA.
DR   RefSeq; NP_189353.1; NM_113631.4.
DR   UniGene; At.15; -.
DR   UniGene; At.37101; -.
DR   ProteinModelPortal; P92942; -.
DR   BioGrid; 7666; 18.
DR   STRING; 3702.AT3G27170.1; -.
DR   iPTMnet; P92942; -.
DR   PaxDb; P92942; -.
DR   EnsemblPlants; AT3G27170.1; AT3G27170.1; AT3G27170.
DR   GeneID; 822336; -.
DR   Gramene; AT3G27170.1; AT3G27170.1; AT3G27170.
DR   KEGG; ath:AT3G27170; -.
DR   Araport; AT3G27170; -.
DR   TAIR; locus:2095123; AT3G27170.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000231081; -.
DR   InParanoid; P92942; -.
DR   KO; K05016; -.
DR   OMA; IQASGMC; -.
DR   OrthoDB; EOG093602TR; -.
DR   PhylomeDB; P92942; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   PRO; PR:P92942; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; P92942; baseline and differential.
DR   Genevisible; P92942; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:TAIR.
DR   GO; GO:0009671; F:nitrate:proton symporter activity; IDA:TAIR.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002251; Cl_channel_pln.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01120; CLCHANNELPLT.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    780       Chloride channel protein CLC-b.
FT                                /FTId=PRO_0000094466.
FT   TRANSMEM     87    107       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    130    150       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    247    267       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    277    297       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    327    347       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    452    472       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    477    497       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    509    529       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    530    550       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    735    755       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      594    663       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      708    770       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
SQ   SEQUENCE   780 AA;  85458 MW;  0E9FB0FBF52AEAA5 CRC64;
     MVEEDLNQIG GNSNYNGEGG DPESNTLNQP LVKANRTLSS TPLALVGAKV SHIESLDYEI
     NENDLFKHDW RKRSKAQVLQ YVFLKWTLAC LVGLFTGLIA TLINLAVENI AGYKLLAVGH
     FLTQERYVTG LMVLVGANLG LTLVASVLCV CFAPTAAGPG IPEIKAYLNG VDTPNMFGAT
     TMIVKIVGSI GAVAAGLDLG KEGPLVHIGS CIASLLGQGG TDNHRIKWRW LRYFNNDRDR
     RDLITCGSAA GVCAAFRSPV GGVLFALEEV ATWWRSALLW RTFFSTAVVV VVLREFIEIC
     NSGKCGLFGK GGLIMFDVSH VTYTYHVTDI IPVMLIGVIG GILGSLYNHL LHKVLRLYNL
     INEKGKIHKV LLSLTVSLFT SVCLYGLPFL AKCKPCDPSI DEICPTNGRS GNFKQFHCPK
     GYYNDLATLL LTTNDDAVRN LFSSNTPNEF GMGSLWIFFV LYCILGLFTF GIATPSGLFL
     PIILMGAAYG RMLGAAMGSY TSIDQGLYAV LGAAALMAGS MRMTVSLCVI FLELTNNLLL
     LPITMIVLLI AKTVGDSFNP SIYDIILHLK GLPFLEANPE PWMRNLTVGE LGDAKPPVVT
     LQGVEKVSNI VDVLKNTTHN AFPVLDEAEV PQVGLATGAT ELHGLILRAH LVKVLKKRWF
     LTEKRRTEEW EVREKFPWDE LAEREDNFDD VAITSAEMEM YVDLHPLTNT TPYTVMENMS
     VAKALVLFRQ VGLRHLLIVP KIQASGMCPV VGILTRQDLR AYNILQAFPL LEKSKGGKTH
//
ID   CLCD_ARATH              Reviewed;         792 AA.
AC   P92943; O81491;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   25-OCT-2017, entry version 128.
DE   RecName: Full=Chloride channel protein CLC-d;
DE            Short=AtCLC-d;
DE   AltName: Full=CBS domain-containing protein CBSCLC2;
GN   Name=CLC-D; Synonyms=CBSCLC2; OrderedLocusNames=At5g26240;
GN   ORFNames=F9D12.10, T19G15.90;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND MUTAGENESIS.
RC   STRAIN=cv. Columbia;
RX   PubMed=8969232; DOI=10.1074/jbc.271.52.33632;
RA   Hechenberger M., Schwappach B., Fischer W.N., Frommer W.B.,
RA   Jentsch T.J., Steinmeyer K.;
RT   "A family of putative chloride channels from Arabidopsis and
RT   functional complementation of a yeast strain with a CLC gene
RT   disruption.";
RL   J. Biol. Chem. 271:33632-33638(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
CC   -!- FUNCTION: Voltage-gated chloride channel.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Broadly expressed in the plant, but
CC       predominantly in the silique.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC26247.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z71450; CAA96065.1; -; mRNA.
DR   EMBL; AC005965; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF077407; AAC26247.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002688; AED93540.1; -; Genomic_DNA.
DR   PIR; T01843; T01843.
DR   RefSeq; NP_001330038.1; NM_001343969.1.
DR   RefSeq; NP_197996.1; NM_122525.3.
DR   UniGene; At.25560; -.
DR   ProteinModelPortal; P92943; -.
DR   BioGrid; 17968; 1.
DR   STRING; 3702.AT5G26240.1; -.
DR   iPTMnet; P92943; -.
DR   PaxDb; P92943; -.
DR   PRIDE; P92943; -.
DR   EnsemblPlants; AT5G26240.1; AT5G26240.1; AT5G26240.
DR   GeneID; 832693; -.
DR   Gramene; AT5G26240.1; AT5G26240.1; AT5G26240.
DR   KEGG; ath:AT5G26240; -.
DR   Araport; AT5G26240; -.
DR   TAIR; locus:2179724; AT5G26240.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000231081; -.
DR   InParanoid; P92943; -.
DR   KO; K05016; -.
DR   OMA; YFCALVA; -.
DR   OrthoDB; EOG093602TR; -.
DR   PhylomeDB; P92943; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   PRO; PR:P92943; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; P92943; baseline and differential.
DR   Genevisible; P92943; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:TAIR.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   GO; GO:0009826; P:unidimensional cell growth; IMP:TAIR.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002251; Cl_channel_pln.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01120; CLCHANNELPLT.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    792       Chloride channel protein CLC-d.
FT                                /FTId=PRO_0000094468.
FT   TRANSMEM     78     98       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    119    139       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    195    215       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    361    381       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    474    494       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    508    528       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    529    549       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    731    751       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      592    652       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      704    761       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MUTAGEN     180    180       I->R: Abolishes the activity.
FT                                {ECO:0000269|PubMed:8969232}.
FT   MUTAGEN     187    187       L->R: Abolishes the activity.
FT                                {ECO:0000269|PubMed:8969232}.
FT   MUTAGEN     471    471       P->L: Abolishes the activity.
FT                                {ECO:0000269|PubMed:8969232}.
FT   CONFLICT    775    775       E -> D (in Ref. 1; CAA96065).
FT                                {ECO:0000305}.
SQ   SEQUENCE   792 AA;  87062 MW;  45B136A2A8CCE85A CRC64;
     MLSNHLQNGI ESDNLLWSRV PESDDTSTDD ITLLNSHRDG DGGVNSLDYE VIENYAYREE
     QAHRGKLYVG YYVAVKWFFS LLIGIGTGLA AVFINLSVEN FAGWKFALTF AIIQKSYFAG
     FIVYLLINLV LVFSSAYIIT QFAPAAAGSG IPEIKGYLNG IDIPGTLLFR TLIGKIFGSI
     GSVGGGLALG KEGPLVHTGA CIASLLGQGG STKYHLNSRW PQLFKSDRDR RDLVTCGCAA
     GVAAAFRAPV GGVLFALEEV TSWWRSQLMW RVFFTSAIVA VVVRTAMGWC KSGICGHFGG
     GGFIIWDVSD GQDDYYFKEL LPMAVIGVIG GLLGALFNQL TLYMTSWRRN SLHKKGNRVK
     IIEACIISCI TSAISFGLPL LRKCSPCPES VPDSGIECPR PPGMYGNYVN FFCKTDNEYN
     DLATIFFNTQ DDAIRNLFSA KTMREFSAQS LLTFLAMFYT LAVVTFGTAV PAGQFVPGIM
     IGSTYGRLVG MFVVRFYKKL NIEEGTYALL GAASFLGGSM RMTVSLCVIM VEITNNLKLL
     PLIMLVLLIS KAVGDAFNEG LYEVQARLKG IPLLESRPKY HMRQMIAKEA CQSQKVISLP
     RVIRVADVAS ILGSNKHNGF PVIDHTRSGE TLVIGLVLRS HLLVLLQSKV DFQHSPLPCD
     PSARNIRHSF SEFAKPVSSK GLCIEDIHLT SDDLEMYIDL APFLNPSPYV VPEDMSLTKV
     YNLFRQLGLR HLFVVPRPSR VIGLITRKDL LIEENGESSA VELQQSTSVR GRYSETATRM
     DAARPLLDDL LG
//
ID   GBRB3_DROME             Reviewed;         496 AA.
AC   Q08832; A4V4J6; Q9TX49; Q9VXL8;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   22-NOV-2017, entry version 156.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-like;
DE   AltName: Full=GABA(A) receptor;
DE   Flags: Precursor;
GN   Name=Lcch3; ORFNames=CG17336;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Canton-S; TISSUE=Pupae;
RX   PubMed=7685594; DOI=10.1006/bbrc.1993.1648;
RA   Henderson J.E., Soderlund D.M., Knipple D.C.;
RT   "Characterization of a putative gamma-aminobutyric acid (GABA)
RT   receptor beta subunit gene from Drosophila melanogaster.";
RL   Biochem. Biophys. Res. Commun. 193:474-482(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 284-340.
RC   STRAIN=Canton-S;
RX   PubMed=8025558; DOI=10.1016/0965-1748(94)90029-9;
RA   Henderson J.E., Knipple D.C., Soderlund D.M.;
RT   "PCR-based homology probing reveals a family of GABA receptor-like
RT   genes in Drosophila melanogaster.";
RL   Insect Biochem. Mol. Biol. 24:363-371(1994).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH GRD.
RX   PubMed=15148245; DOI=10.1038/sj.bjp.0705818;
RA   Gisselmann G., Plonka J., Pusch H., Hatt H.;
RT   "Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric
RT   GABA-gated cation channels.";
RL   Br. J. Pharmacol. 142:409-413(2004).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. Combines with the ligand-gated ion channel
CC       subunit GRD to form cation-selective GABA-gated ion channels when
CC       coexpressed in Xenopus laevis oocytes.
CC       {ECO:0000269|PubMed:15148245}.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho. Interacts
CC       with Grd (alpha chain). {ECO:0000269|PubMed:15148245}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L17436; AAA28559.1; -; mRNA.
DR   EMBL; S62717; AAB27090.1; -; mRNA.
DR   EMBL; AE014298; AAS65370.1; -; Genomic_DNA.
DR   EMBL; AY060660; AAL28208.1; -; mRNA.
DR   PIR; JN0603; JN0603.
DR   RefSeq; NP_996469.1; NM_206746.2.
DR   UniGene; Dm.6661; -.
DR   ProteinModelPortal; Q08832; -.
DR   SMR; Q08832; -.
DR   STRING; 7227.FBpp0089263; -.
DR   TCDB; 1.A.9.5.6; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q08832; -.
DR   PRIDE; Q08832; -.
DR   EnsemblMetazoa; FBtr0074129; FBpp0089263; FBgn0010240.
DR   GeneID; 32554; -.
DR   KEGG; dme:Dmel_CG17336; -.
DR   CTD; 32554; -.
DR   FlyBase; FBgn0010240; Lcch3.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   InParanoid; Q08832; -.
DR   KO; K05181; -.
DR   OMA; SMPREGH; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q08832; -.
DR   Reactome; R-DME-977441; GABA A receptor activation.
DR   ChiTaRS; Lcch3; fly.
DR   GenomeRNAi; 32554; -.
DR   PRO; PR:Q08832; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0010240; -.
DR   Genevisible; Q08832; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       Or 27. {ECO:0000255}.
FT   CHAIN        21    496       Gamma-aminobutyric acid receptor subunit
FT                                beta-like.
FT                                /FTId=PRO_0000000454.
FT   TOPO_DOM     21    258       Extracellular. {ECO:0000255}.
FT   TRANSMEM    259    280       Helical. {ECO:0000255}.
FT   TRANSMEM    285    306       Helical. {ECO:0000255}.
FT   TRANSMEM    318    342       Helical. {ECO:0000255}.
FT   TOPO_DOM    343    472       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    473    494       Helical. {ECO:0000255}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    189    189       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    176    190       {ECO:0000250}.
FT   CONFLICT     12     12       G -> S (in Ref. 1; AAA28559/AAB27090).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       V -> C (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   496 AA;  56597 MW;  62C9A9E97E8DF681 CRC64;
     MTCFTRVGVS CGLFFFLLGA QLQLIRCIRK DVLAGRLENV TQTISNILQG YDIRLRPNFG
     GEPLHVGMDL TIASFDAISE VNMDYTITMY LNQYWRDERL AFNIFGQYFD DENDDGISDV
     LTLSGDFAEK IWVPDTFFAN DKNSFLHDVT ERNKLVRLGG DGAVTYGMRF TTTLACMMDL
     HYYPLDSQNC TVEIESYGYT VSDVVMYWKP TPVRGVEDAE LPQFTIIGYE TNDRKERLAT
     GVYQRLSLSF KLQRNIGYFV FQTYLPSILI VMLSWVSFWI NHEATSARVA LGITTVLTMT
     TISTGVRSSL PRISYVKAID IYLVMCFVFV FAALLEYAAV NYTYWGKRAK KKIKKVKECC
     PGKIGKSERS ETCSTTEDII ELQDVRMSPI PSLRRGTYNA TLDSIGTETM NLGKFPPSFR
     ITRNYGTGHS QLRRRAQRGI STRPRMLHAL KRGASAIKAT IPKIKDVNII DKYSRMIFPI
     SFLAFNLGYW LFYILE
//
ID   GLRB4_CAEEL             Reviewed;         473 AA.
AC   Q09453;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   25-OCT-2017, entry version 127.
DE   RecName: Full=Glycine receptor subunit beta-type 4;
DE   Flags: Precursor;
GN   Name=ggr-1; Synonyms=gbr-4; ORFNames=C09G5.1/C09G5.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine. Contributes
CC       to the generation of inhibitory postsynaptic currents.
CC       {ECO:0000250|UniProtKB:P48168}.
CC   -!- SUBUNIT: Pentamer. {ECO:0000250|UniProtKB:P48167}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:P48168}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:P48167}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P48168}. Cell membrane
CC       {ECO:0000250|UniProtKB:P48168}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23415}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z46791; CAA86760.2; -; Genomic_DNA.
DR   PIR; T19145; T19145.
DR   RefSeq; NP_496306.2; NM_063905.3.
DR   UniGene; Cel.25057; -.
DR   ProteinModelPortal; Q09453; -.
DR   STRING; 6239.C09G5.1; -.
DR   PaxDb; Q09453; -.
DR   EnsemblMetazoa; C09G5.1; C09G5.1; WBGene00001586.
DR   GeneID; 191636; -.
DR   KEGG; cel:CELE_C09G5.1; -.
DR   UCSC; C09G5.1; c. elegans.
DR   CTD; 191636; -.
DR   WormBase; C09G5.1; CE36915; WBGene00001586; ggr-1.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   InParanoid; Q09453; -.
DR   KO; K05273; -.
DR   OMA; EITHHII; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q09453; -.
DR   PRO; PR:Q09453; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00001586; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    473       Glycine receptor subunit beta-type 4.
FT                                /FTId=PRO_0000000426.
FT   TOPO_DOM     20    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    250    271       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    272    276       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    277    297       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    298    308       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    309    329       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    330    439       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    440    460       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    461    473       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    166    180       {ECO:0000250|UniProtKB:P23415}.
SQ   SEQUENCE   473 AA;  55540 MW;  0290671D994F7307 CRC64;
     MHSLFLKILI YSLMQCVLGQ AEFWDYDENV TQIEEDFKID DVTRILKRVG NYNRNAYPLL
     DQDLATHVDI QMYIEGMSSF HAQSMDFQVD IYFQEKWVDH RLQHNNTKRI LVKDPKLFGL
     LWHPDLYFAN ARTASFHDVT QPNFLVWIYP NGTVWYDCRI SLTVLCMQDL ARYPLDSQNC
     GLRILSYAYD EEQLIIRWNG GNPVEVNRGI RMPDMHLKHI KFYTKRDKYA TGIWSSAVAE
     FHVDREITHH IIQSYIPTSL IVIISWFSFW LDVEAVPGRV SLSITTLLTL ATQSSAARMA
     LPQASDVKAI DVWMGTCMAF VFSAMIEFTV VNYCVRRKVR TKIKPRGLSE QVHDMVAQYR
     EKKDKFNNGN CEISYEMALQ PNEDNATVQR NFEKKEVREM NQASLFVRRS LLPTSKRKTI
     EDRINRVEEN RKNAQKIDRY SRALFPLAFI IFNIFYWIYY LKYAGSNSPE LLL
//
ID   TTYH1_XENTR             Reviewed;         449 AA.
AC   Q0V9V9;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   10-MAY-2017, entry version 51.
DE   RecName: Full=Protein tweety homolog 1;
GN   Name=ttyh1;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable chloride channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q0V9V9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q0V9V9-2; Sequence=VSP_029767;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC121375; AAI21376.1; -; mRNA.
DR   RefSeq; NP_001072899.1; NM_001079431.1. [Q0V9V9-2]
DR   RefSeq; XP_012822220.1; XM_012966766.2. [Q0V9V9-1]
DR   UniGene; Str.53985; -.
DR   GeneID; 780361; -.
DR   KEGG; xtr:780361; -.
DR   CTD; 57348; -.
DR   Xenbase; XB-GENE-940450; ttyh1.
DR   HOGENOM; HOG000070449; -.
DR   HOVERGEN; HBG108621; -.
DR   InParanoid; Q0V9V9; -.
DR   Proteomes; UP000008143; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    449       Protein tweety homolog 1.
FT                                /FTId=PRO_0000312245.
FT   TOPO_DOM      1     43       Extracellular. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     65     86       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    108    212       Extracellular. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    234    238       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    260    388       Extracellular. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    410    449       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     438    449       ESKRFVQWQSSI -> ARREMLHVTGRPHLPSFYSYSSSCD
FT                                SHSSLRVSAPPISNAPVSQYMNQSALSSGNPRFENIPLIDR
FT                                QSPPPSYSPSMRTSFISATQEETDTPCRTDVAF (in
FT                                isoform 2). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_029767.
SQ   SEQUENCE   449 AA;  50958 MW;  BCC923C1F3B739B0 CRC64;
     MSSSHGYRAS WWTYILHQVP HTNFQFEVVD NQFAPQEWPY QQALLFLASI AGLCLAISLI
     LICVYLIRFC CCSSQEDDDS KSHRVCCVTW SCVAAVIICC AGIGIGFYGN SETNDGVYQV
     TYSLMNANHT LTSINLLISD TVELLSSVVR SDLTQLEEIF SKRTEFLVMI RNTRRQVESV
     AQQLAEISFW KGPEPNPNAL AEQVNFIEDY RWLAYILLLL LDLIICLFTL LGLAKQIKWL
     VIVMTVVSFF VLLLSWGSMG LEMATAVGLS DFCSDPDAYV MNQTQAITNI NPDILQYYIS
     CNQDVTNPFR QRLTMSQRAL SNIHSQLHGL EREAVPQFPT AEKNLLVVQG MLNTTEGNFH
     HLVALLNCRG LHKDYVDALK GLCYDGMEGI LFLLLFSFLS ALSFTAAICS LPRAWKRFQN
     RDLDYDDMDE DDPFNPQESK RFVQWQSSI
//
ID   GLUCB_CAEEL             Reviewed;         434 AA.
AC   Q17328; O02524;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 132.
DE   RecName: Full=Glutamate-gated chloride channel subunit beta;
DE            Short=Glu-Cl subunit beta;
DE   AltName: Full=Avermectin-sensitive glutamate-gated chloride channel subunit;
DE   Flags: Precursor;
GN   Name=glc-2; ORFNames=F25F8.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT,
RP   AND INTERACTION WITH GLC-1.
RC   STRAIN=Bristol N2;
RX   PubMed=7935817; DOI=10.1038/371707a0;
RA   Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S.,
RA   Van der Ploeg L.H.T., Schaeffer J.M., Arena J.P.;
RT   "Cloning of an avermectin-sensitive glutamate-gated chloride channel
RT   from Caenorhabditis elegans.";
RL   Nature 371:707-711(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit; channel
CC       properties depend on the subunit composition. Glutamate binding
CC       triggers a rapidly reversible current in heteromeric channels
CC       formed by glc-1 and glc-2, while the anti-helmintic drug
CC       ivermectin and other avermectins trigger a permanently open
CC       channel configuration. Channels containing only glc-2 are
CC       activated by glutamate, but not by ivermectin (in vitro). The
CC       heteromeric channel formed by glc-1 and glc-2 is also activated by
CC       ibotenate, and it is blocked by picrotoxin and flufenamic acid
CC       (PubMed:7935817). {ECO:0000269|PubMed:7935817}.
CC   -!- SUBUNIT: Pentamer (By similarity). Homooligomer that can form
CC       functional heterooligomers with glc-1 (PubMed:7935817).
CC       {ECO:0000250|UniProtKB:G5EBR3, ECO:0000269|PubMed:7935817}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q94900}. Cell membrane
CC       {ECO:0000255, ECO:0000269|PubMed:7935817}; Multi-pass membrane
CC       protein {ECO:0000255, ECO:0000269|PubMed:7935817}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14525; AAA50786.1; -; mRNA.
DR   EMBL; FO080262; CCD62432.1; -; Genomic_DNA.
DR   PIR; S50865; S50865.
DR   RefSeq; NP_491470.1; NM_059069.3.
DR   UniGene; Cel.19753; -.
DR   ProteinModelPortal; Q17328; -.
DR   SMR; Q17328; -.
DR   BioGrid; 37565; 1.
DR   DIP; DIP-27494N; -.
DR   MINT; MINT-1047253; -.
DR   STRING; 6239.F25F8.2; -.
DR   iPTMnet; Q17328; -.
DR   PaxDb; Q17328; -.
DR   EnsemblMetazoa; F25F8.2; F25F8.2; WBGene00001592.
DR   GeneID; 172103; -.
DR   KEGG; cel:CELE_F25F8.2; -.
DR   UCSC; F25F8.2; c. elegans.
DR   CTD; 172103; -.
DR   WormBase; F25F8.2; CE09636; WBGene00001592; glc-2.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   InParanoid; Q17328; -.
DR   KO; K05273; -.
DR   OMA; ENMFLRI; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q17328; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:Q17328; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00001592; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008068; F:extracellular-glutamate-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR015680; Glu_Cl_Channel.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF504; PTHR18945:SF504; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    434       Glutamate-gated chloride channel subunit
FT                                beta.
FT                                /FTId=PRO_0000255716.
FT   TOPO_DOM     23    246       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    247    269       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    270    274       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    275    296       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    297    303       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    304    324       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    325    398       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    399    422       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    423    434       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      66     66       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      85     85       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     152    152       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     181    181       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    216    216       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    175       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    223    234       {ECO:0000250|UniProtKB:G5EBR3}.
SQ   SEQUENCE   434 AA;  49893 MW;  754B973359834F75 CRC64;
     MTTPSSFSIL LLLLLMPVVT NGEYSMQSEQ EILNALLKNY DMRVRPPPAN SSTEGAVNVR
     VNIMIRMLSK IDVVNMEYSI QLTFREQWID PRLAYENLGF YNPPAFLTVP HVKKSLWIPD
     TFFPTEKAAH RHLIDMENMF LRIYPDGKIL YSSRISLTSS CPMRLQLYPL DYQSCNFDLV
     SYAHTMNDIM YEWDPSTPVQ LKPGVGSDLP NFILKNYTTN ADCTSHTNTG SYGCLRMQLL
     FKRQFSYYLV QLYAPTTMIV IVSWVSFWID LHSTAGRVAL GVTTLLTMTT MQSAINAKLP
     PVSYVKVVDV WLGACQTFVF GALLEYAFVS YQDSVRQNDR SREKAARKAQ RRREKLEMVD
     AEVYQPPCTC HTFEARETFR DKVRRYFTKP DYLPAKIDFY ARFVVPLAFL AFNVIYWVSC
     LIMSANASTP ESLV
//
ID   BEST1_CAEEL             Reviewed;         450 AA.
AC   Q17528;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 92.
DE   RecName: Full=Bestrophin homolog 1;
GN   Name=best-1; ORFNames=B0564.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z73422; CAA97765.1; -; Genomic_DNA.
DR   PIR; T18781; T18781.
DR   RefSeq; NP_502523.1; NM_070122.5.
DR   UniGene; Cel.13630; -.
DR   ProteinModelPortal; Q17528; -.
DR   SMR; Q17528; -.
DR   STRING; 6239.B0564.3.1; -.
DR   PaxDb; Q17528; -.
DR   EnsemblMetazoa; B0564.3.1; B0564.3.1; WBGene00007203.
DR   EnsemblMetazoa; B0564.3.2; B0564.3.2; WBGene00007203.
DR   GeneID; 178264; -.
DR   KEGG; cel:CELE_B0564.3; -.
DR   UCSC; B0564.3.1; c. elegans.
DR   CTD; 178264; -.
DR   WormBase; B0564.3; CE05177; WBGene00007203; best-1.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; Q17528; -.
DR   KO; K22204; -.
DR   OMA; NIMRYCE; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; Q17528; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q17528; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00007203; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    450       Bestrophin homolog 1.
FT                                /FTId=PRO_0000143124.
FT   TRANSMEM     28     48       Helical. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TRANSMEM    275    295       Helical. {ECO:0000255}.
SQ   SEQUENCE   450 AA;  53276 MW;  A0FED9A476166AD7 CRC64;
     MTINYHKEIM TSHPWTFFLL LFKWKGSIWK AVYMETIIFL ICYGIISVIY KTAMGESSQR
     TFESLVRYFD KRLSYIPLEF VLGFFVTTVV NRWTKLYQTI GFIDNVGLMA NCYIRGATEK
     ARIYRRNIMR YCELVQILVF RDMSMRTRRR FPTMETVVAA GFMNKHELEL YNSYDTKYNS
     KLGTKYWIPA NWALCMTYKA RKDGYIESDY FKAQMEGEIR TWRTNIEWVC NYDWVPLPLM
     YPQLVCLAVN LYFLVSIIAR QLVIEKHKMV DEVDVYFPVM TFLQFIFYMG WLKVIDVMLN
     PFGEDDDDFE TNALIDRNIT MGLMIADNPM STPELRKDPF YDEVDVPLLY SEESSNIPNH
     HYHGSVSEVR LEQKGNAPVM MMPHSQSAAN LRRMMSFKSV DEDEKDINAF SMSHDDARMR
     NWREVSLDSS FLADLNENKE WKIPTNPQKF
//
ID   ACC2_CAEEL              Reviewed;         445 AA.
AC   Q18812;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 142.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-2 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-2 {ECO:0000312|WormBase:C53D6.3};
GN   ORFNames=C53D6.3 {ECO:0000312|WormBase:C53D6.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Acetylcholine-gated chloride channel subunit. Currents
CC       in channels are triggered in response to acetylcholine. Channel
CC       properties may be modulated by the formation of homomeric and
CC       heteromeric channels. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Homopentamer (in vitro). May interact with either acc-3
CC       or acc-4; the interactions do not result in significant
CC       heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in RIA, RIG, PHA and AIZ
CC       glutamatergic neurons, URX and RIH cholinergic neurons, and in
CC       male-specific MCM neurons. {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284604; CAA94228.1; -; Genomic_DNA.
DR   PIR; T20190; T20190.
DR   RefSeq; NP_501567.1; NM_069166.1.
DR   UniGene; Cel.13246; -.
DR   ProteinModelPortal; Q18812; -.
DR   SMR; Q18812; -.
DR   STRING; 6239.C53D6.3; -.
DR   PaxDb; Q18812; -.
DR   EnsemblMetazoa; C53D6.3; C53D6.3; WBGene00008280.
DR   GeneID; 183758; -.
DR   KEGG; cel:CELE_C53D6.3; -.
DR   UCSC; C53D6.3; c. elegans.
DR   CTD; 183758; -.
DR   WormBase; C53D6.3; CE05488; WBGene00008280; acc-2.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q18812; -.
DR   OMA; IYITETW; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PhylomeDB; Q18812; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00008280; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    445       Acetylcholine-gated chloride channel
FT                                subunit acc-2. {ECO:0000305}.
FT                                /FTId=PRO_5004186831.
FT   TOPO_DOM     27    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TOPO_DOM    280    286       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    287    307       Helical. {ECO:0000255}.
FT   TOPO_DOM    308    326       Extracellular. {ECO:0000305}.
FT   TRANSMEM    327    347       Helical. {ECO:0000255}.
FT   TOPO_DOM    348    407       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    408    428       Helical. {ECO:0000255}.
FT   TOPO_DOM    429    445       Extracellular. {ECO:0000305}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    162    162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    218    218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    177    191       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   445 AA;  51686 MW;  3F60AE853A50F4FC CRC64;
     MIFTLLSTLP VLIITTELDY SELVHSAELV SSSSYIHHKT NKKPDNCTRD TDIIDRLLNG
     TGYNKFRIPQ EEGMTVVVEI WIQAITSIDE LTNDFDMDIY ITETWLDPAL NFQTMTPCKG
     NLSLNHQVLD RLWTPNSCFI NSKVAQIHNS PFRSVFLMLF PNGTVMVNYR VRVKGPCSLD
     LSNFPLDLQK CSLIYESFNY NRQEVEMRWS DAEHPVFNLS KIMLPDFDLF EIQTERRQEP
     YPAGMWDELH VTIIFERRFI WYFMQAYLPT YLTIFISWIS FSLGSRAIPA RTMLGVNSLL
     AIVFSFGNIM RNLPRVSYIK GIDVWMLVSM TFIFCSLLEL AIVGFMVRDE TVAKKKQQKK
     ISGNISREES PHGIISERRF MFPPGCSESS KSLSSCTSGW TPERIDSISS VMFPFSFFVF
     NIIYWFYYIH RKEIIKQNLI NRVDG
//
ID   CFTR_DANRE              Reviewed;        1485 AA.
AC   Q1LX78; B7ZVN9;
DT   12-APR-2017, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 1.
DT   22-NOV-2017, entry version 104.
DE   RecName: Full=Cystic fibrosis transmembrane conductance regulator {ECO:0000255|RuleBase:RU362037};
DE            EC=3.6.3.49 {ECO:0000255|RuleBase:RU362037, ECO:0000269|PubMed:27912062};
DE   AltName: Full=ATP-binding cassette sub-family C member 7 {ECO:0000255|RuleBase:RU362037};
DE   AltName: Full=Channel conductance-controlling ATPase {ECO:0000255|RuleBase:RU362037};
DE   AltName: Full=cAMP-dependent chloride channel {ECO:0000255|RuleBase:RU362037};
GN   Name=cftr {ECO:0000312|ZFIN:ZDB-GENE-050517-20};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955 {ECO:0000312|Ensembl:ENSDARP00000060242};
RN   [1] {ECO:0000312|Ensembl:ENSDARP00000060242, ECO:0000312|Proteomes:UP000000437}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen {ECO:0000312|Ensembl:ENSDARP00000060242,
RC   ECO:0000312|Proteomes:UP000000437};
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C.,
RA   Muffato M., Collins J.E., Humphray S., McLaren K., Matthews L.,
RA   McLaren S., Sealy I., Caccamo M., Churcher C., Scott C., Barrett J.C.,
RA   Koch R., Rauch G.J., White S., Chow W., Kilian B., Quintais L.T.,
RA   Guerra-Assuncao J.A., Zhou Y., Gu Y., Yen J., Vogel J.H., Eyre T.,
RA   Redmond S., Banerjee R., Chi J., Fu B., Langley E., Maguire S.F.,
RA   Laird G.K., Lloyd D., Kenyon E., Donaldson S., Sehra H.,
RA   Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Eliott D., Threadgold G.,
RA   Harden G., Ware D., Mortimer B., Kerry G., Heath P., Phillimore B.,
RA   Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S., Pelan S.,
RA   Griffiths G., Smith M., Glithero R., Howden P., Barker N., Stevens C.,
RA   Harley J., Holt K., Panagiotidis G., Lovell J., Beasley H.,
RA   Henderson C., Gordon D., Auger K., Wright D., Collins J., Raisen C.,
RA   Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J.,
RA   Babbage A., Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S.,
RA   Wray P., Ellington A., Matthews N., Ellwood M., Woodmansey R.,
RA   Clark G., Cooper J., Tromans A., Grafham D., Skuce C., Pandian R.,
RA   Andrews R., Harrison E., Kimberley A., Garnett J., Fosker N., Hall R.,
RA   Garner P., Kelly D., Bird C., Palmer S., Gehring I., Berger A.,
RA   Dooley C.M., Ersan-Urun Z., Eser C., Geiger H., Geisler M.,
RA   Karotki L., Kirn A., Konantz J., Konantz M., Oberlander M.,
RA   Rudolph-Geiger S., Teucke M., Osoegawa K., Zhu B., Rapp A., Widaa S.,
RA   Langford C., Yang F., Carter N.P., Harrow J., Ning Z., Herrero J.,
RA   Searle S.M., Enright A., Geisler R., Plasterk R.H., Lee C.,
RA   Westerfield M., de Jong P.J., Zon L.I., Postlethwait J.H.,
RA   Nusslein-Volhard C., Hubbard T.J., Roest Crollius H., Rogers J.,
RA   Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the
RT   human genome.";
RL   Nature 496:498-503(2013).
RN   [2] {ECO:0000312|EMBL:AAI71654.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (NOV-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20933420; DOI=10.1016/j.cub.2010.09.012;
RA   Bagnat M., Navis A., Herbstreith S., Brand-Arzamendi K., Curado S.,
RA   Gabriel S., Mostov K., Huisken J., Stainier D.Y.;
RT   "Cse1l is a negative regulator of CFTR-dependent fluid secretion.";
RL   Curr. Biol. 20:1840-1845(2010).
RN   [4]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=20732993; DOI=10.1128/IAI.00302-10;
RA   Phennicie R.T., Sullivan M.J., Singer J.T., Yoder J.A., Kim C.H.;
RT   "Specific resistance to Pseudomonas aeruginosa infection in zebrafish
RT   is mediated by the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   Infect. Immun. 78:4542-4550(2010).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 205-SER-PRO-206.
RX   PubMed=23487313; DOI=10.1242/dev.091819;
RA   Navis A., Marjoram L., Bagnat M.;
RT   "Cftr controls lumen expansion and function of Kupffer's vesicle in
RT   zebrafish.";
RL   Development 140:1703-1712(2013).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=26432887; DOI=10.1242/bio.014076;
RA   Roxo-Rosa M., Jacinto R., Sampaio P., Lopes S.S.;
RT   "The zebrafish Kupffer's vesicle as a model system for the molecular
RT   mechanisms by which the lack of Polycystin-2 leads to stimulation of
RT   CFTR.";
RL   Biol. Open 4:1356-1366(2015).
RN   [7]
RP   DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL
RP   STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=25592226; DOI=10.1016/j.ydbio.2014.12.034;
RA   Navis A., Bagnat M.;
RT   "Loss of cftr function leads to pancreatic destruction in larval
RT   zebrafish.";
RL   Dev. Biol. 399:237-248(2015).
RN   [8]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.73 ANGSTROMS), CATALYTIC ACTIVITY,
RP   TOPOLOGY, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=27912062; DOI=10.1016/j.cell.2016.11.014;
RA   Zhang Z., Chen J.;
RT   "Atomic structure of the cystic fibrosis transmembrane conductance
RT   regulator.";
RL   Cell 167:1586-1597(2016).
CC   -!- FUNCTION: Epithelial ion channel that plays an important role in
CC       the regulation of epithelial ion and water transport and fluid
CC       homeostasis (PubMed:20933420, PubMed:23487313, PubMed:25592226).
CC       Mediates the transport of chloride ions across the cell membrane
CC       (By similarity). Channel activity is coupled to ATP hydrolysis.
CC       The ion channel is also permeable to HCO(3-); selectivity depends
CC       on the extracellular chloride concentration. Exerts its function
CC       also by modulating the activity of other ion channels and
CC       transporters. Contributes to the regulation of the pH and the ion
CC       content of the epithelial fluid layer (By similarity). Required
CC       for normal fluid homeostasis in the gut (PubMed:20933420).
CC       Required for normal volume expansion of Kupffer's vesicle during
CC       embryonic development and for normal establishment of left-right
CC       body patterning (PubMed:23487313, PubMed:26432887). Required for
CC       normal resistance to infection by P.aeruginosa strain PA14 and
CC       strain SMC573 (PubMed:20732993). {ECO:0000250|UniProtKB:P13569,
CC       ECO:0000269|PubMed:20732993, ECO:0000269|PubMed:20933420,
CC       ECO:0000269|PubMed:23487313, ECO:0000269|PubMed:26432887,
CC       ECO:0000305|PubMed:25592226}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000255|RuleBase:RU362037, ECO:0000269|PubMed:27912062}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.22 mM for ATP {ECO:0000269|PubMed:27912062};
CC   -!- SUBUNIT: Monomer; does not require oligomerization for channel
CC       activity (By similarity). Interacts with cse1l; this interaction
CC       may downregulate cftr activity (PubMed:20933420).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000269|PubMed:20933420}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:20933420, ECO:0000269|PubMed:23487313,
CC       ECO:0000269|PubMed:25592226}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27912062}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:P13569}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:27912062}. Cell membrane
CC       {ECO:0000269|PubMed:23487313, ECO:0000305|PubMed:27912062}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:27912062}. Recycling
CC       endosome membrane {ECO:0000250|UniProtKB:P13569}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:27912062}. Endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P13569}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:27912062}. Note=The channel
CC       is internalized from the cell surface into an endosomal recycling
CC       compartment, from where it is recycled to the cell membrane.
CC       {ECO:0000250|UniProtKB:P13569}.
CC   -!- TISSUE SPECIFICITY: Detected in gut epithelium (at protein level)
CC       (PubMed:20933420). Detected in kidney, spleen, intestine and liver
CC       (PubMed:20732993). Detected in pancreatic duct epithelium at 5 dpf
CC       and throughout adult life (PubMed:25592226).
CC       {ECO:0000269|PubMed:20732993, ECO:0000269|PubMed:25592226}.
CC   -!- DEVELOPMENTAL STAGE: First detected in developing pancreatic duct
CC       at 3 dpf (PubMed:25592226). Detected on Kupffer's vesicle during
CC       embryonic development (PubMed:23487313, PubMed:26432887). Detected
CC       on neural floorplate, brain and pronephric duct primordia in
CC       embryos at the 10 somite stage (PubMed:26432887).
CC       {ECO:0000269|PubMed:23487313, ECO:0000269|PubMed:25592226,
CC       ECO:0000269|PubMed:26432887}.
CC   -!- DOMAIN: Binds and hydrolyzes ATP via the two cytoplasmic ABC
CC       transporter nucleotide-binding domains. The two ATP-binding
CC       domains interact with each other, forming a head-to-tail dimer.
CC       Normal ATPase activity requires interaction between the two
CC       domains. The first ABC transporter nucleotide-binding domain has
CC       no ATPase activity by itself. {ECO:0000250|UniProtKB:P13569,
CC       ECO:0000250|UniProtKB:P26361}.
CC   -!- DOMAIN: The R region is intrinsically disordered. It mediates
CC       channel activation when it is phosphorylated, but not in the
CC       absence of phosphorylation. {ECO:0000250|UniProtKB:P13569}.
CC   -!- PTM: Phosphorylated; this activates the channel (PubMed:27912062).
CC       Dephosphorylation strongly decreases ATPase activity
CC       (PubMed:27912062). Phosphorylation at PKA sites activates the
CC       channel. Phosphorylation at PKC sites enhances the response to
CC       phosphorylation by PKA (By similarity).
CC       {ECO:0000250|UniProtKB:P13569, ECO:0000269|PubMed:27912062}.
CC   -!- DISRUPTION PHENOTYPE: Considerable lethality around 10 dpf
CC       (PubMed:25592226). No effect on initial pancreas development, but
CC       at 16 dpf mutants display loss of pancreatic acinar tissue
CC       (PubMed:25592226). At 22 dpf, most pancreatic acinar tissue has
CC       disappeared and has been replaced by fibrotic tissue that
CC       surrounds dilated, mucus-filled ducts (PubMed:25592226).
CC       Morpholino knockdown of the protein in 48 hpf embryos leads to
CC       impaired resistance to P.aeruginosa strain PA14 and strain SMC573,
CC       as shown by the increased bacterial burden, but there is no effect
CC       on resistance to E.tarda, B.cenocepacia, S.aureus MZ100, E.coli
CC       XL-10 and H.influenzae Hib EAGAN (PubMed:20732993). Morpholino
CC       knockdown of the protein causes an importanr reduction of the
CC       volume of Kupffer's vesicle during embryonic development
CC       (PubMed:26432887). {ECO:0000269|PubMed:20732993,
CC       ECO:0000269|PubMed:25592226, ECO:0000269|PubMed:26432887}.
CC   -!- MISCELLANEOUS: Mutations that lead to the production of a severely
CC       truncated protein that ends before the start of the fourth
CC       transmembrane domain disrupt normal left-right body patterning
CC       during embryogenesis and abolish lumen expansion of Kupffer's
CC       vesicle. {ECO:0000269|PubMed:23487313}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC
CC       family. CFTR transporter (TC 3.A.1.202) subfamily.
CC       {ECO:0000255|RuleBase:RU362037}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX470130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC171654; AAI71654.1; -; mRNA.
DR   RefSeq; NP_001038348.1; NM_001044883.1.
DR   UniGene; Dr.74099; -.
DR   PDB; 5UAR; EM; 3.73 A; A=1-1485.
DR   PDB; 5W81; EM; 3.37 A; A=1-1485.
DR   PDBsum; 5UAR; -.
DR   PDBsum; 5W81; -.
DR   ProteinModelPortal; Q1LX78; -.
DR   SMR; Q1LX78; -.
DR   STRING; 7955.ENSDARP00000060242; -.
DR   PaxDb; Q1LX78; -.
DR   Ensembl; ENSDART00000060243; ENSDARP00000060242; ENSDARG00000041107.
DR   GeneID; 559080; -.
DR   KEGG; dre:559080; -.
DR   CTD; 1080; -.
DR   ZFIN; ZDB-GENE-050517-20; cftr.
DR   eggNOG; KOG0054; Eukaryota.
DR   eggNOG; COG1132; LUCA.
DR   GeneTree; ENSGT00900000140905; -.
DR   HOVERGEN; HBG004169; -.
DR   InParanoid; Q1LX78; -.
DR   KO; K05031; -.
DR   PhylomeDB; Q1LX78; -.
DR   TreeFam; TF105200; -.
DR   Reactome; R-DRE-382556; ABC-family proteins mediated transport.
DR   Reactome; R-DRE-5627083; RHO GTPases regulate CFTR trafficking.
DR   Reactome; R-DRE-5689880; Ub-specific processing proteases.
DR   Reactome; R-DRE-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-DRE-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:Q1LX78; -.
DR   Proteomes; UP000000437; Chromosome 18.
DR   Bgee; ENSDARG00000041107; -.
DR   ExpressionAtlas; Q1LX78; baseline.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ZFIN.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:GO_Central.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0005260; F:intracellular ATPase-gated chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:ZFIN.
DR   GO; GO:0070121; P:Kupffer's vesicle development; IMP:ZFIN.
DR   GO; GO:0050891; P:multicellular organismal water homeostasis; ISS:UniProtKB.
DR   GO; GO:0031016; P:pancreas development; IMP:ZFIN.
DR   GO; GO:0090022; P:regulation of neutrophil chemotaxis; IMP:ZFIN.
DR   GO; GO:0002679; P:respiratory burst involved in defense response; IMP:ZFIN.
DR   GO; GO:0035377; P:transepithelial water transport; ISS:UniProtKB.
DR   Gene3D; 1.20.1560.10; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR009147; CFTR/ABCC7.
DR   InterPro; IPR025837; CFTR_reg_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24223:SF19; PTHR24223:SF19; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   Pfam; PF14396; CFTR_R; 1.
DR   PRINTS; PR01851; CYSFIBREGLTR.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 3.
DR   TIGRFAMs; TIGR01271; CFTR_protein; 1.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Endoplasmic reticulum; Endosome; Glycoprotein;
KW   Hydrolase; Ion channel; Ion transport; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1485       Cystic fibrosis transmembrane conductance
FT                                regulator.
FT                                /FTId=PRO_0000439670.
FT   TOPO_DOM      1     78       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM     79     99       Helical; Name=1.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    100    123       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    124    149       Helical; Name=2.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    150    195       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    196    216       Helical; Name=3.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    217    224       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    225    245       Helical; Name=4.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    246    299       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    300    320       Helical; Name=5.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    321    340       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    341    363       Helical; Name=6.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    364    856       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    857    877       Helical; Name=7.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    878    924       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    925    946       Discontinuously helical; Name=8.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM    947    996       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM    997   1019       Helical; Name=9.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM   1020   1021       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM   1022   1042       Helical; Name=10.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM   1043   1103       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM   1104   1124       Helical; Name=11.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM   1125   1138       Extracellular.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TRANSMEM   1139   1159       Helical; Name=12.
FT                                {ECO:0000269|PubMed:27912062}.
FT   TOPO_DOM   1160   1485       Cytoplasmic.
FT                                {ECO:0000269|PubMed:27912062}.
FT   DOMAIN       83    353       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      424    645       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      860   1163       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1211   1444       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     457    464       ATP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND    1245   1252       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   REGION      653    826       Intrinsically disordered R region.
FT                                {ECO:0000250|UniProtKB:P13569}.
FT   MOTIF      1483   1485       PDZ-binding.
FT                                {ECO:0000250|UniProtKB:P13569}.
FT   BINDING     402    402       ATP 1. {ECO:0000250|UniProtKB:P13569}.
FT   BINDING     492    492       ATP 1. {ECO:0000250|UniProtKB:P13569}.
FT   BINDING    1220   1220       ATP 2. {ECO:0000250|UniProtKB:P13569}.
FT   CARBOHYD    897    897       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    903    903       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   MUTAGEN     205    206       Missing: In pd1048; abolishes trafficking
FT                                to the cell membrane and leads to severe
FT                                reduction of the size of the Kupffer's
FT                                vesicle. {ECO:0000269|PubMed:23487313}.
FT   CONFLICT    658    658       C -> S (in Ref. 2; AAI71654).
FT                                {ECO:0000305}.
FT   STRAND        7      9       {ECO:0000244|PDB:5W81}.
FT   HELIX        11     16       {ECO:0000244|PDB:5W81}.
FT   HELIX        18     20       {ECO:0000244|PDB:5W81}.
FT   HELIX        21     29       {ECO:0000244|PDB:5W81}.
FT   TURN         34     36       {ECO:0000244|PDB:5W81}.
FT   HELIX        46     62       {ECO:0000244|PDB:5W81}.
FT   HELIX        70     97       {ECO:0000244|PDB:5W81}.
FT   HELIX        99    108       {ECO:0000244|PDB:5W81}.
FT   STRAND      114    116       {ECO:0000244|PDB:5W81}.
FT   HELIX       120    165       {ECO:0000244|PDB:5W81}.
FT   HELIX       170    173       {ECO:0000244|PDB:5W81}.
FT   HELIX       178    194       {ECO:0000244|PDB:5W81}.
FT   HELIX       196    199       {ECO:0000244|PDB:5W81}.
FT   HELIX       201    216       {ECO:0000244|PDB:5W81}.
FT   HELIX       222    268       {ECO:0000244|PDB:5W81}.
FT   HELIX       270    276       {ECO:0000244|PDB:5W81}.
FT   HELIX       280    328       {ECO:0000244|PDB:5W81}.
FT   HELIX       336    352       {ECO:0000244|PDB:5W81}.
FT   HELIX       354    376       {ECO:0000244|PDB:5W81}.
FT   STRAND      394    400       {ECO:0000244|PDB:5W81}.
FT   TURN        402    404       {ECO:0000244|PDB:5W81}.
FT   STRAND      439    446       {ECO:0000244|PDB:5W81}.
FT   STRAND      452    456       {ECO:0000244|PDB:5W81}.
FT   HELIX       463    471       {ECO:0000244|PDB:5W81}.
FT   STRAND      477    482       {ECO:0000244|PDB:5W81}.
FT   STRAND      487    490       {ECO:0000244|PDB:5W81}.
FT   HELIX       501    506       {ECO:0000244|PDB:5W81}.
FT   HELIX       514    522       {ECO:0000244|PDB:5W81}.
FT   HELIX       526    530       {ECO:0000244|PDB:5W81}.
FT   STRAND      532    536       {ECO:0000244|PDB:5W81}.
FT   STRAND      544    547       {ECO:0000244|PDB:5W81}.
FT   HELIX       549    562       {ECO:0000244|PDB:5W81}.
FT   STRAND      566    570       {ECO:0000244|PDB:5W81}.
FT   STRAND      575    577       {ECO:0000244|PDB:5W81}.
FT   HELIX       579    588       {ECO:0000244|PDB:5W81}.
FT   HELIX       589    593       {ECO:0000244|PDB:5W81}.
FT   STRAND      597    602       {ECO:0000244|PDB:5W81}.
FT   HELIX       606    611       {ECO:0000244|PDB:5W81}.
FT   STRAND      612    619       {ECO:0000244|PDB:5W81}.
FT   STRAND      622    627       {ECO:0000244|PDB:5W81}.
FT   HELIX       629    634       {ECO:0000244|PDB:5W81}.
FT   STRAND      635    637       {ECO:0000244|PDB:5W81}.
FT   HELIX       845    853       {ECO:0000244|PDB:5W81}.
FT   HELIX       855    885       {ECO:0000244|PDB:5W81}.
FT   HELIX       922    934       {ECO:0000244|PDB:5W81}.
FT   HELIX       939    965       {ECO:0000244|PDB:5W81}.
FT   HELIX       969    974       {ECO:0000244|PDB:5W81}.
FT   HELIX       977    993       {ECO:0000244|PDB:5W81}.
FT   HELIX       995   1018       {ECO:0000244|PDB:5W81}.
FT   HELIX      1023   1055       {ECO:0000244|PDB:5W81}.
FT   HELIX      1057   1068       {ECO:0000244|PDB:5W81}.
FT   HELIX      1070   1075       {ECO:0000244|PDB:5W81}.
FT   HELIX      1079   1125       {ECO:0000244|PDB:5W81}.
FT   HELIX      1138   1147       {ECO:0000244|PDB:5W81}.
FT   TURN       1148   1150       {ECO:0000244|PDB:5W81}.
FT   HELIX      1151   1165       {ECO:0000244|PDB:5W81}.
FT   HELIX      1167   1175       {ECO:0000244|PDB:5W81}.
FT   STRAND     1211   1221       {ECO:0000244|PDB:5W81}.
FT   STRAND     1227   1235       {ECO:0000244|PDB:5W81}.
FT   STRAND     1240   1245       {ECO:0000244|PDB:5W81}.
FT   HELIX      1251   1258       {ECO:0000244|PDB:5W81}.
FT   STRAND     1262   1264       {ECO:0000244|PDB:5W81}.
FT   TURN       1275   1277       {ECO:0000244|PDB:5W81}.
FT   HELIX      1280   1285       {ECO:0000244|PDB:5W81}.
FT   STRAND     1287   1290       {ECO:0000244|PDB:5W81}.
FT   HELIX      1301   1305       {ECO:0000244|PDB:5W81}.
FT   HELIX      1313   1322       {ECO:0000244|PDB:5W81}.
FT   HELIX      1326   1330       {ECO:0000244|PDB:5W81}.
FT   STRAND     1332   1334       {ECO:0000244|PDB:5W81}.
FT   STRAND     1342   1347       {ECO:0000244|PDB:5W81}.
FT   HELIX      1349   1363       {ECO:0000244|PDB:5W81}.
FT   STRAND     1366   1371       {ECO:0000244|PDB:5W81}.
FT   HELIX      1379   1392       {ECO:0000244|PDB:5W81}.
FT   STRAND     1393   1395       {ECO:0000244|PDB:5W81}.
FT   STRAND     1397   1401       {ECO:0000244|PDB:5W81}.
FT   HELIX      1408   1410       {ECO:0000244|PDB:5W81}.
FT   STRAND     1411   1417       {ECO:0000244|PDB:5W81}.
FT   STRAND     1419   1427       {ECO:0000244|PDB:5W81}.
FT   HELIX      1428   1434       {ECO:0000244|PDB:5W81}.
FT   STRAND     1437   1439       {ECO:0000244|PDB:5W81}.
FT   TURN       1440   1442       {ECO:0000244|PDB:5W81}.
FT   HELIX      1447   1450       {ECO:0000244|PDB:5W81}.
FT   HELIX      1453   1456       {ECO:0000244|PDB:5W81}.
SQ   SEQUENCE   1485 AA;  168400 MW;  62601EBC307A3B8A CRC64;
     MQRSPVEDAN CLSRYFFWWT NPIMRKGFKE KLRPSDVYQA PSQDAADILA ERLEKEWDRE
     VASGKKKPSL LRAMARCYIK PFLLFGFLLY IGEATKTVQP QLLGRIIASF DPAHEPERAN
     GYFLAFGLGL LFTARFLLLQ PAMFGLHHLG MQIRIALFSI IYKKTLKLSS RVLDKISTGQ
     LVSLMSANLG KFDQSLGMAH FIWISPLQCI LCTGLIWELI DVNSFCALAA ISLLGVLQAF
     LSHKMGPYKA QKVLLTNKRL ALTSEIMENL HSVKAYGWEE IMETLIKNIR QDEVKLTRKI
     GSLRYFYSSA YFFSAIFVIV AAVVPHALSR GINLRRIFTT LSYCMVLRMT VTRQLPGSIQ
     MWYDTMRLIW KIEEFLSKEE YKLMEYDLSI TELELQDVTA SWDEGPGELL ERIKQENKAN
     GHHNGDAGLF FTNLYVAPVL KDISLKLKKG EMLAVTGSMG SGKSSLLMTI LGELVPSSGK
     IRHSGRISYS SQTAWIMPGT IRDNILFGLT YDEYRYKSVV KACQLEEDLA ALPEKDKTPM
     AEGGLNLSGG QKARVALARA VYRDADLYLL DAPFTHLDIA TEKEIFDKCL CKLMASKTRI
     LVTNKIEHLK RADKILLLHN GESFFYGTFP ELQSERPDFS SLLLGLEAYD NISAERRCSI
     LTETLHRVSV DESAGMQPER SAFRQVPPTK PMYIDERKAS VIVNPLGVAR KASFIQVPEE
     EVRRTLPDRK FSLVPENELV DESFMGSDVY HNHGVHMAGQ RRQSVLAFMT NAQGQGRREH
     LQSSFRRRLS VVPQSELASE LDIYTRRLSD STYDMTGILE EENIEACLTD EIDEIEETFE
     TTKWNTYVRY VSNNKSLLYV LIFILFIAAI EIAGSVAGIF LITDELWREE HQRSEPNMTK
     HSNASSSGQT YAITVTPTSS YYILYIYVAT SESLLAMGFF RGLPFVHTTI TISKKLHQKM
     LHAVLSAPMS VLNTMKTGRI MNRFTKDMAT IDDMLPLLMF DFVQLTVVVV GCILVVSIVR
     PYIFLAATPL AIIFIVMRKY FLRTGQQLKQ LETEARSPIF SHLIMSLKGL WTIRAFERQA
     YFEALFHKTL NTHTATWFLY LSTLRWFLFR ADILFVFFFT LAAWIAVGTN QDKPGEIGII
     ICLAMLILGT FQWCVATSIA VDGMMRSVDR VFKFIDLPSE TPKPDKGKDS DLIIENVDAQ
     ADSSWPHRGQ IEVRNLTVKY TEAGHAVLKN LSFSAEGRQR VGILGRTGSG KSSLFNALLK
     LVYTDGEISI DGVNWNKMPL QKWRKAFGVV PQKVFIFTGP LRMNLDPYGC HSDEELWRVA
     EEVGLKTVIE QFPDKLDFQL EYGGYVLSNG HKQLICLARS ILSGARILLL DEPSAHLDPV
     TIKVLKKTLR QSFSTCTILL SEHKVEPLLE CQSFLMMDKG QVKTYDSIQK LLNETSHLKQ
     AISPAERLKL FPRRNSSMRT PQSKLSSVTQ TLQEEAEDNI QDTRL
//
ID   CLCD_DICDI              Reviewed;        1000 AA.
AC   Q1ZXJ0;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 1.
DT   07-JUN-2017, entry version 67.
DE   RecName: Full=Chloride channel protein D;
GN   Name=clcD; ORFNames=DDB_G0278639;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17659086; DOI=10.1186/gb-2007-8-7-r144;
RA   Sawai S., Guan X.-J., Kuspa A., Cox E.C.;
RT   "High-throughput analysis of spatio-temporal dynamics in
RT   Dictyostelium.";
RL   Genome Biol. 8:R144.1-R144.15(2007).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). Required for normal aggregation. {ECO:0000250,
CC       ECO:0000269|PubMed:17659086}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Cells display slow oscillators with delayed
CC       aggregation. {ECO:0000269|PubMed:17659086}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000023; EAS66897.1; -; Genomic_DNA.
DR   RefSeq; XP_001134581.3; XM_001134581.2.
DR   ProteinModelPortal; Q1ZXJ0; -.
DR   STRING; 44689.DDB0233313; -.
DR   PaxDb; Q1ZXJ0; -.
DR   PRIDE; Q1ZXJ0; -.
DR   EnsemblProtists; EAS66897; EAS66897; DDB_G0278639.
DR   GeneID; 8621440; -.
DR   KEGG; ddi:DDB_G0278639; -.
DR   dictyBase; DDB_G0278639; clcD.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q1ZXJ0; -.
DR   OMA; KYHSASM; -.
DR   PhylomeDB; Q1ZXJ0; -.
DR   PRO; PR:Q1ZXJ0; -.
DR   Proteomes; UP000002195; Chromosome 3.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0030587; P:sorocarp development; IMP:dictyBase.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1000       Chloride channel protein D.
FT                                /FTId=PRO_0000328046.
FT   TOPO_DOM      1    256       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical. {ECO:0000255}.
FT   TRANSMEM    416    436       Helical. {ECO:0000255}.
FT   TRANSMEM    442    462       Helical. {ECO:0000255}.
FT   TRANSMEM    493    513       Helical. {ECO:0000255}.
FT   TRANSMEM    534    554       Helical. {ECO:0000255}.
FT   TRANSMEM    678    698       Helical. {ECO:0000255}.
FT   TRANSMEM    710    730       Helical. {ECO:0000255}.
FT   TRANSMEM    733    753       Helical. {ECO:0000255}.
FT   TRANSMEM    772    792       Helical. {ECO:0000255}.
FT   DOMAIN      824    881       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      926    984       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   COMPBIAS     38     57       Poly-Asn.
SQ   SEQUENCE   1000 AA;  112657 MW;  4860E16E1F153FBE CRC64;
     MSSGNPFDNG NPNDGNKSPS IDELYSPSES LARDGDDNNN NNNNNNNNNN NNNNNNNSSV
     SEKKKSKKKV RIQEEERLTE SYDDDGDDEE RRAYIENEEG EEEETEDGII LQPIVRDHST
     YRPKNLYGSS DDIREGDSFG AKVSKTFGKT NKKIKQKIGE SNKKIETRVK HSNKAIEEGW
     KTIAQTTMKP VDNIREQHHR RAEQHEVAER AVWFKDKLQI QKYECLDYVT IYNKAHRNEL
     YKNFSKLASD HEVLRWIVSL FMGIFIGVIA YFSHACVSNI TKYKFKFVEA VLELDLFLAF
     LTYFLLNTLL ATCSSLLAVY YEPTAAGSGI PEVKGYLNGT KIPHTLKMKT LWTKFLSMVL
     AVSSGLQAGS EGPMIHIGAI VGNGFSQAQS KEFGFKIPFL RSFRNDKDKR DFVTSGAGAG
     VAAAFSAPLG GTLFSLEEVS SFWSIALTWR AFFCCMVATY TMNVLQSNSG SLTGLIIFNT
     GIGDKESYNW FEIIPFLLIG VLGGLGGALF TWINVKVTEF RREKINKIKS LRVLEVFLII
     GLSTCIQFFL PLFFSCQNTA PFIPSVGNST LTDVTLTNGA FYNSTIINGT FYNSTIANGT
     IYNSKFYNSS IYNSTITNGT GVSYDPAETL KELSEFKRFN CKEGWYNPMA TLIFASYEES
     ITNLLKVNSN NVTNTERLGL WPMFLFCIFY LFFAAYTAGC AVATGTLVPM LVIGASYGRF
     VGLVVYHILG DKVSIDPGIY AVMGAAAFMG GVSRLTISLT VILIEITDRL KYLLPLMLTV
     MTAKWVADAL IHPLFDLLMQ MKYIPYLELD QSKEMKLMMC KHIMAKKPVY LAEKDTLGNL
     RVLKETRHNG FPVVNNDEEK LVKGLILRTQ LLMILERISD VYIPNSEAIY SHIEYTTKLT
     WKLPSVNDFN FDPADYSQEI DLSDVMNLTV ITVNVEFAVS EAFQLFRTMG LRHMPVVNEN
     NKLKGIITKK DLLEKTCEQR YRELNHMKLG IDQLIHVGDE
//
ID   TTYH1_CAEEL             Reviewed;         519 AA.
AC   Q20332; Q7JM69; Q8MQ53; Q9U3F6;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 104.
DE   RecName: Full=Protein tweety homolog 1;
GN   Name=ttyh-1; ORFNames=F42E11.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=15888633; DOI=10.1093/glycob/cwi075;
RA   Fan X., She Y.-M., Bagshaw R.D., Callahan J.W., Schachter H.,
RA   Mahuran D.J.;
RT   "Identification of the hydrophobic glycoproteins of Caenorhabditis
RT   elegans.";
RL   Glycobiology 15:952-964(2005).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-163 AND ASN-176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Probable chloride channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a;
CC         IsoId=Q20332-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=Q20332-2; Sequence=VSP_029773, VSP_029774;
CC         Note=No experimental confirmation available.;
CC       Name=c;
CC         IsoId=Q20332-3; Sequence=VSP_029775;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z66562; CAB60289.1; -; Genomic_DNA.
DR   EMBL; Z66562; CAA91464.1; -; Genomic_DNA.
DR   EMBL; Z66562; CAD44123.1; -; Genomic_DNA.
DR   PIR; T22091; T22091.
DR   RefSeq; NP_509903.1; NM_077502.4. [Q20332-1]
DR   RefSeq; NP_509904.1; NM_077503.4. [Q20332-2]
DR   RefSeq; NP_741904.1; NM_171973.5. [Q20332-3]
DR   UniGene; Cel.7681; -.
DR   ProteinModelPortal; Q20332; -.
DR   BioGrid; 46237; 1.
DR   DIP; DIP-27409N; -.
DR   MINT; MINT-1065744; -.
DR   iPTMnet; Q20332; -.
DR   EPD; Q20332; -.
DR   PaxDb; Q20332; -.
DR   PeptideAtlas; Q20332; -.
DR   EnsemblMetazoa; F42E11.2a; F42E11.2a; WBGene00009632. [Q20332-1]
DR   GeneID; 181328; -.
DR   KEGG; cel:CELE_F42E11.2; -.
DR   UCSC; F42E11.2c; c. elegans. [Q20332-1]
DR   CTD; 181328; -.
DR   WormBase; F42E11.2a; CE03309; WBGene00009632; ttyh-1. [Q20332-1]
DR   WormBase; F42E11.2b; CE23715; WBGene00009632; ttyh-1. [Q20332-2]
DR   WormBase; F42E11.2c; CE31512; WBGene00009632; ttyh-1. [Q20332-3]
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   HOGENOM; HOG000021075; -.
DR   InParanoid; Q20332; -.
DR   OMA; YVEYYRW; -.
DR   OrthoDB; EOG091G074H; -.
DR   PRO; PR:Q20332; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00009632; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    519       Protein tweety homolog 1.
FT                                /FTId=PRO_0000312255.
FT   TOPO_DOM      1     42       Extracellular. {ECO:0000255}.
FT   TRANSMEM     43     63       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     64     82       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     83    103       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    104    217       Extracellular. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    239    245       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    246    266       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    267    395       Extracellular. {ECO:0000255}.
FT   TRANSMEM    396    416       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    417    519       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    142    142       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    348    348       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    389    389       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      96    110       FMLGVCLFANEHVNR -> DKLFAFVIIMPIARV (in
FT                                isoform b). {ECO:0000305}.
FT                                /FTId=VSP_029773.
FT   VAR_SEQ     111    519       Missing (in isoform b). {ECO:0000305}.
FT                                /FTId=VSP_029774.
FT   VAR_SEQ     464    497       Missing (in isoform c). {ECO:0000305}.
FT                                /FTId=VSP_029775.
SQ   SEQUENCE   519 AA;  58259 MW;  48BC0372A73F81EA CRC64;
     MTFASFLINF YSVIPRLNFK FHWTNDVFNL EWSSEYFQAL ALVACLGAAV SLLLLVTIII
     VWICQACHKN ETTGKTRRRV RRLSTVLFII SVLCFFMLGV CLFANEHVNR GMSISINSII
     NTKKSYQIST AQISQFQEAA LNTTVHLKNL EDTVHVESKK TKNATIVQQI DQILTNITDE
     IDIIAKNGKL FQAKHGDDIG KLEKIRKVLS LYESERWAFL VILLSITMVV LFTGVVAFCK
     QSKKGAVVFS AIGFFIFVVV WLLISISLPL TIALADFCRD GDQVTRKNLG NLYETVQFYN
     TCVPVTTHDN LPLPVARHVA LLNNIPANKS QLDRLMEVAF NSSAAIVNSS SAVGDDITKM
     LKLAGAVSSS SSCYVFHDDV VNFYYGTCNQ SVAGMSIYML SILLLGVFLF ILLIVVSKTW
     NLFSRLPNEY TEVDEDDPFF PRGVNDSTIP VDIYGTHVYN PRTRDRTEPS TNTTSGTADE
     PNAPLWSQNV TVPLVSNSMS RQPFMSDHPY NNYEDRYNM
//
ID   ACC1_CAEEL              Reviewed;         466 AA.
AC   Q21005;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   20-DEC-2017, entry version 150.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-1 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-1 {ECO:0000312|WormBase:F58G6.4a};
GN   ORFNames=F58G6.4 {ECO:0000312|WormBase:F58G6.4a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Acetylcholine-gated chloride channel subunit. Forms
CC       functional homopentameric (in vitro) and functional
CC       heteropentameric ion channels with acc-3 and acc-4 ion channel
CC       subunits. Currents in channels are triggered in response to
CC       acetylcholine, but not in response to GABA, glutamate, glycine,
CC       histamine or dopamine. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Homopentamer (in vitro). Forms heteropentamers composed
CC       of acc-1 and acc-4 or acc-1 and acc-3. Both homopentamers and
CC       heteropentamers form functional ion channels.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in a subset of cholinergic motor
CC       neurons including cholinergic motor neurons in the ventral cord,
CC       the retrovesicular ganglion and in head neurons such as the SMD,
CC       RMD motor neurons, the AVA and AVE command interneurons and the
CC       SAA neurons. Also expressed in a small number of glutamatergic
CC       neurons including the pharyngeal neurons MI and M3, the PLM
CC       neurons and a pair of neurons in the lateral ganglion.
CC       {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284604; CAA92466.2; -; Genomic_DNA.
DR   PIR; T22947; T22947.
DR   RefSeq; NP_501715.1; NM_069314.4.
DR   UniGene; Cel.7828; -.
DR   ProteinModelPortal; Q21005; -.
DR   STRING; 6239.F58G6.4; -.
DR   PaxDb; Q21005; -.
DR   EnsemblMetazoa; F58G6.4a; F58G6.4a; WBGene00010275.
DR   GeneID; 177799; -.
DR   UCSC; F58G6.4; c. elegans.
DR   CTD; 177799; -.
DR   WormBase; F58G6.4a; CE28039; WBGene00010275; acc-1.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q21005; -.
DR   OMA; MELEQPY; -.
DR   PhylomeDB; Q21005; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00010275; -.
DR   ExpressionAtlas; Q21005; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    466       Acetylcholine-gated chloride channel
FT                                subunit acc-1. {ECO:0000305}.
FT                                /FTId=PRO_5004199465.
FT   TOPO_DOM     25    242       Extracellular. {ECO:0000305}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   TOPO_DOM    264    272       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    273    290       Helical. {ECO:0000255}.
FT   TOPO_DOM    291    304       Extracellular. {ECO:0000305}.
FT   TRANSMEM    305    325       Helical. {ECO:0000255}.
FT   TOPO_DOM    326    427       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    428    448       Helical. {ECO:0000255}.
FT   TOPO_DOM    449    466       Extracellular. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    211    211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    158    172       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   466 AA;  54967 MW;  2D6B40994889C80D CRC64;
     MSHPGWIMVS FLTELLSQSS KGIAQSLDNC ANDTEIINAL LKDSYNKHYI PSHPTHVRVD
     MWVQEVTSVS ELTQDFEIDL YINEFWEDPA LVYEDMNPCK RNISFDDKVL QRLWLPNTCF
     INSKSAAIHE SPFKNVFLMV FSNGTLWTNY RMKLTGPCDM KLKRFPFDKQ KCYLTFESFN
     YNTGEVRMQW NQPYPVILLK RIELPDFKLV NFSVIAVEQM YPAGWWDELT VAFVFERRYG
     WYVLQGYIPT MVTIVISWIS FYLGPRAIPA RTMLGVNSLL AMTFQFGNII RNLPRVSYVK
     AIDVWMLSGM LFIFLSLLEL AVVGFMSRNE GLPPKVKKRK RQEDDDEGFS WKSMQTSPHL
     ELRQFWVDKR VNSLRNDSAV PPVEDYAPME LEQPYQNITK RREKRKWMSG LRKKWRAMRE
     LRPETVDFYS AIFFPTAYML FNISYWSFYL TSLSEYFDED VNIDQP
//
ID   BST15_CAEEL             Reviewed;         525 AA.
AC   Q21973;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   20-DEC-2017, entry version 106.
DE   RecName: Full=Bestrophin homolog 15;
DE   AltName: Full=Bestrophin-1;
DE            Short=ceBest1;
GN   Name=best-15; ORFNames=R13.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBUNIT.
RX   PubMed=11904445; DOI=10.1073/pnas.052692999;
RA   Sun H., Tsunenari T., Yau K.-W., Nathans J.;
RT   "The vitelliform macular dystrophy protein defines a new family of
RT   chloride channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:4008-4013(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000269|PubMed:11904445}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000269|PubMed:11904445}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY515708; AAR99658.1; -; mRNA.
DR   EMBL; Z73105; CAA97442.2; -; Genomic_DNA.
DR   PIR; T24210; T24210.
DR   RefSeq; NP_502007.2; NM_069606.6.
DR   UniGene; Cel.12470; -.
DR   ProteinModelPortal; Q21973; -.
DR   SMR; Q21973; -.
DR   STRING; 6239.R13.3; -.
DR   TCDB; 1.A.46.1.3; the anion channel-forming bestrophin (bestrophin) family.
DR   PaxDb; Q21973; -.
DR   PeptideAtlas; Q21973; -.
DR   EnsemblMetazoa; R13.3; R13.3; WBGene00011258.
DR   GeneID; 177975; -.
DR   KEGG; cel:CELE_R13.3; -.
DR   UCSC; R13.3; c. elegans.
DR   CTD; 177975; -.
DR   WormBase; R13.3; CE32919; WBGene00011258; best-15.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; Q21973; -.
DR   KO; K22204; -.
DR   OMA; WNDIFAN; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; Q21973; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q21973; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00011258; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    525       Bestrophin homolog 15.
FT                                /FTId=PRO_0000143123.
FT   TRANSMEM     36     56       Helical. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical. {ECO:0000255}.
FT   TRANSMEM    273    293       Helical. {ECO:0000255}.
SQ   SEQUENCE   525 AA;  60485 MW;  9E0A90D9523C3229 CRC64;
     MTVNYNLDVS SASIFSFLRL QLRWKGSIWK YLLKELFMFI IAFITVSSVY RSNLIIGEKT
     RKIWDNFAAL FDQNMDFIPL TFMLGFFVTI IVRRWNDIFA NLGWVENTAI TVANYIRGTD
     DRTRMIRRNV IRYMVLAQVL VFRDCSIQVR KRFPTMESIV SAGFMLEHEK EALDNVQCGK
     LQKYFVPIQW STGLLVDARA EGKIAADLLM NEIGKHIIEF RKMLALLSNY DWVPIPLAYP
     QVVFLAVRSY FFMALIARQS VLLDGKEPEQ PSILYPTVPF VMSILQFIFV VGWMKVAESM
     INPLGEDDDD FECNYLLDRN LMIGLCIVDD NYNRTPSVEK DAFWCADVEP LYSVETAMIP
     KNPQIGSAAN YDVKVDEEEV MMMPHMDDVD LFDFESTNNL IPRKTFSVIS IQRPFGSRAS
     LASRKRSMMF DQLRGRIAKK QHRSNMFQNS VSQASLHYFE SQAPSEINLS TLEMTAPKRK
     SSTGKLGSMN VAEEQHKLSA EVLPIVIEED EERSKMLEKD KNKNA
//
ID   BST17_CAEEL             Reviewed;         501 AA.
AC   Q22566;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   20-DEC-2017, entry version 103.
DE   RecName: Full=Bestrophin homolog 17;
GN   Name=best-17; ORFNames=T19C3.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO081735; CCD73733.1; -; Genomic_DNA.
DR   RefSeq; NP_497218.2; NM_064817.2.
DR   UniGene; Cel.27730; -.
DR   ProteinModelPortal; Q22566; -.
DR   SMR; Q22566; -.
DR   STRING; 6239.T19C3.1; -.
DR   iPTMnet; Q22566; -.
DR   EPD; Q22566; -.
DR   PaxDb; Q22566; -.
DR   PeptideAtlas; Q22566; -.
DR   EnsemblMetazoa; T19C3.1; T19C3.1; WBGene00020559.
DR   GeneID; 188585; -.
DR   KEGG; cel:CELE_T19C3.1; -.
DR   UCSC; T19C3.1; c. elegans.
DR   CTD; 188585; -.
DR   WormBase; T19C3.1; CE30182; WBGene00020559; best-17.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; Q22566; -.
DR   KO; K22204; -.
DR   OMA; FERWRSA; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; Q22566; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q22566; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00020559; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    501       Bestrophin homolog 17.
FT                                /FTId=PRO_0000143132.
FT   TRANSMEM     50     70       Helical. {ECO:0000255}.
FT   TRANSMEM     97    115       Helical. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
SQ   SEQUENCE   501 AA;  57931 MW;  1C56C4C70707FC62 CRC64;
     MYIANYFIQI HRFLCFSQIL NEMTVSYQLD VSSGNPLLFL RLLGRWRGSI WKSVVGDLFV
     WLLFYYAIYF AYRYAFSKQL QTVFEEISIH TDDRMKYLPL TFMLGFFVTT VFERWRSALN
     VMPFIESVAL SVAVLLPGKG REDRLTRRAI IRYVVLHQIL VFRDISMRVR RRFPTLKYVV
     DAGFMRQEEL DVLESVNQES SQTYWVPINW ANSLALVAHQ QKLIDQPTAF NNVIFAIKEF
     RVAMETLIKF DAIPIPIAYP QVVFLAVRVY FAICLVSRQF LISDMKSKTQ MDWPVPIMTV
     LEFIFVIGWM KVAEVLLNPL GEDDDDFEVN SIIDNNISRG MAIVDTTHGY HPDLVDDVFS
     DPNYLPAYSE NSQIPRNLTG SAAKVELAAP TDEVKIVRVN PEDAPPTSER GSMFTRRNAY
     SLRNRKISIA SNNLESPSQE RKFNLSMPAG MLNKSTQPDR PTMETVSEEH EPSHFYRGDR
     VHSSDSVIPS FRRSFFQIKA F
//
ID   BST22_CAEEL             Reviewed;         499 AA.
AC   Q23369;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Bestrophin homolog 22;
GN   Name=best-22; ORFNames=ZC518.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Forms chloride channels. {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z68753; CAA92989.1; -; Genomic_DNA.
DR   PIR; T27630; T27630.
DR   RefSeq; NP_502353.1; NM_069952.6.
DR   UniGene; Cel.11621; -.
DR   ProteinModelPortal; Q23369; -.
DR   SMR; Q23369; -.
DR   STRING; 6239.ZC518.1a; -.
DR   PaxDb; Q23369; -.
DR   EnsemblMetazoa; ZC518.1a; ZC518.1a; WBGene00013921.
DR   GeneID; 191197; -.
DR   UCSC; ZC518.1a; c. elegans.
DR   CTD; 191197; -.
DR   WormBase; ZC518.1a; CE06601; WBGene00013921; best-22.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   InParanoid; Q23369; -.
DR   PhylomeDB; Q23369; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q23369; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00013921; -.
DR   ExpressionAtlas; Q23369; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    499       Bestrophin homolog 22.
FT                                /FTId=PRO_0000143134.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TRANSMEM     77     97       Helical. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical. {ECO:0000255}.
SQ   SEQUENCE   499 AA;  57229 MW;  4E87725437A5C9DF CRC64;
     MTISYTLDVS QTNLQSFFSL LLRWRGSVWK AVFGQLAVWT AVFLLISCIY RYMLSPSQQD
     VFEQLIRYFD NKLDANIPLT FLLGFFVSFV VARWGSILNG IGWIDDASLL FATYIRGADE
     ETRVIRRNLV RYLVLSQALV LRDISMQVRK RFPTMDTLAA SGLMTHEEMD ILDHIKDPYS
     RYWTSIQWSL NLVYECQKKG KVDSYYLMNK IVDEIGKFRH GLASLLKYDW VPVPLVYPQV
     IFLAVRIYFM ICLIGRQFIV TGPNPSGIDL WLPITTMVQF LVYMGWMKVA EALLNPLGED
     DDDLECNYII DKNLITGLSI VDTMWKHDDT GYSMVEEHMA KTPAQKKDEF WGIDKIAPLY
     SMESAERSVH PLVGSASKIN LVKNKKEIVM TPHKNKLSEL DPSEQKTYLR RVNVSDHNAK
     HAKQRGLERA NSPDKCLSKM RSRSNGKFRT SANGSQNGVD LWTRAGDIEM NVATSNPNQV
     HPHSIAVFPP EEQQTTSRH
//
ID   GBRAL_DROME             Reviewed;         686 AA.
AC   Q24352; Q9TX50; Q9VVL3;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 136.
DE   RecName: Full=Gamma-aminobutyric acid receptor alpha-like;
DE   AltName: Full=GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila;
DE            Short=GRD;
DE   Flags: Precursor;
GN   Name=Grd; ORFNames=CG7446;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Berlin; TISSUE=Head, and Salivary gland;
RX   PubMed=8189252;
RA   Harvey R.J., Schmitt B., Hermans-Borgmeyer I., Gundelfinger E.D.,
RA   Betz H., Darlison M.G.;
RT   "Sequence of a Drosophila ligand-gated ion-channel polypeptide with an
RT   unusual amino-terminal extracellular domain.";
RL   J. Neurochem. 62:2480-2483(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH LCCH3.
RX   PubMed=15148245; DOI=10.1038/sj.bjp.0705818;
RA   Gisselmann G., Plonka J., Pusch H., Hatt H.;
RT   "Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric
RT   GABA-gated cation channels.";
RL   Br. J. Pharmacol. 142:409-413(2004).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. May combine with the ligand-gated ion channel
CC       subunit Lcch3 to form cation-selective GABA-gated ion channels.
CC       {ECO:0000269|PubMed:15148245}.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho. Interacts
CC       with Lcch3 (beta chain). {ECO:0000269|PubMed:15148245}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X78349; CAA55144.1; -; mRNA.
DR   EMBL; AE014296; AAF49298.2; -; Genomic_DNA.
DR   PIR; S60749; S60749.
DR   RefSeq; NP_524131.1; NM_079407.3.
DR   UniGene; Dm.2530; -.
DR   ProteinModelPortal; Q24352; -.
DR   SMR; Q24352; -.
DR   STRING; 7227.FBpp0074905; -.
DR   TCDB; 1.A.9.5.6; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q24352; -.
DR   PRIDE; Q24352; -.
DR   EnsemblMetazoa; FBtr0075139; FBpp0074905; FBgn0001134.
DR   GeneID; 39984; -.
DR   KEGG; dme:Dmel_CG7446; -.
DR   CTD; 39984; -.
DR   FlyBase; FBgn0001134; Grd.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   InParanoid; Q24352; -.
DR   KO; K05175; -.
DR   OMA; HPSEYSM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q24352; -.
DR   Reactome; R-DME-977441; GABA A receptor activation.
DR   GenomeRNAi; 39984; -.
DR   PRO; PR:Q24352; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0001134; -.
DR   Genevisible; Q24352; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005261; F:cation channel activity; IDA:UniProtKB.
DR   GO; GO:0016933; F:extracellular-glycine-gated ion channel activity; ISS:FlyBase.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; TAS:FlyBase.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:1904456; P:negative regulation of neuronal action potential; IMP:FlyBase.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:FlyBase.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IGI:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     58       {ECO:0000255}.
FT   CHAIN        59    686       Gamma-aminobutyric acid receptor alpha-
FT                                like.
FT                                /FTId=PRO_0000000451.
FT   TOPO_DOM     97    393       Extracellular. {ECO:0000255}.
FT   TRANSMEM    394    414       Helical. {ECO:0000255}.
FT   TRANSMEM    424    441       Helical. {ECO:0000255}.
FT   TRANSMEM    456    476       Helical. {ECO:0000255}.
FT   TOPO_DOM    477    650       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    651    671       Helical. {ECO:0000255}.
FT   COMPBIAS    589    609       Ala-rich.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    233    247       {ECO:0000250}.
SQ   SEQUENCE   686 AA;  76558 MW;  E2BD771B7E3BAC7A CRC64;
     MCTMPATRDA SGSGDASTDL IAARSLSSHQ GQRSNLRIFK LLISCCLLML CIYPNAWPWS
     IGPGSGPFSV SADSIKGRGD THRLGEMGTS LSSSLPSSWL TQSNNHANIS ELLDNLLRGY
     DNSIRPDFGG PPATIEVDIM VRSMGPISEV DMTYSMDCYF RQSWVDKRLA FEGAQDTLAL
     SVSMLARIWK PDTYFYNGKQ SYLHTITTPN KFVRIYQNGR VLYSSRLTIK AGCPMNLADF
     PMDIQKCPLK FGSFGYTTSD VIYRWNKERP PVAIAEDMKL SQFDLVDCPA GNLTDIVYKA
     AAPRPQRRPF NNKDPPRPTS KVMTTFAGPA AKNQHVRGTG LKLDKGAFGT GRDATGGSGS
     TTGLSGTITL ETNHPSEYSM LMVNFHLQRH MGNFLIQVYG PCCLLVVLSW VSFWLNREAT
     ADRVSLGITT VLTMTFLGLE ARTDLPKVSY PTALDFFVFL SFGFIFATIL QFAVVHYYTK
     YGSGECYFII EELDSESGES ETEPLTSDFR GSTESKIYEV IPLSMCAISM PPPPTRLGML
     TSRNRRPRNR RHGLWSMKLL GLFDWRRRRK PPRADSDEDE DDEQTQLRAN EAPTTSAAAA
     AAQAAAQAAR ISPPTGGRRR MSYYRREEME ARRKGKRTPQ YNSVSKIDRA SRIVFPLLFI
     LINVFYWYGY LSRSSRILAN TPDAST
//
ID   TTYH1_BOVIN             Reviewed;         450 AA.
AC   Q2KJ98;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 1.
DT   10-MAY-2017, entry version 59.
DE   RecName: Full=Protein tweety homolog 1;
GN   Name=TTYH1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Hypothalamus;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable chloride channel. May be involved in cell
CC       adhesion (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC105448; AAI05449.1; -; mRNA.
DR   RefSeq; NP_001070483.1; NM_001077015.1.
DR   UniGene; Bt.7619; -.
DR   STRING; 9913.ENSBTAP00000004515; -.
DR   PaxDb; Q2KJ98; -.
DR   PRIDE; Q2KJ98; -.
DR   GeneID; 767943; -.
DR   KEGG; bta:767943; -.
DR   CTD; 57348; -.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   HOGENOM; HOG000070449; -.
DR   HOVERGEN; HBG108621; -.
DR   InParanoid; Q2KJ98; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    450       Protein tweety homolog 1.
FT                                /FTId=PRO_0000312238.
FT   TOPO_DOM      1     43       Extracellular. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     65     88       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     89    109       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    110    214       Extracellular. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    236    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    262    390       Extracellular. {ECO:0000255}.
FT   TRANSMEM    391    411       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    412    450       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    428    433       Poly-Asp.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3A9}.
FT   CARBOHYD    130    130       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    284    284       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   450 AA;  49230 MW;  6841F75BC2D06407 CRC64;
     MGAPPGYRPS AWVHLLHQLP RADFQLRPVP SAFAPQEREY QQALLLVAAL AGLGLGLSLI
     FIAVYLIRFC CCRPPEPPGA KSPPPGGGCV TWNCIAALLV GCAGIGVGFY GNSETSDGVS
     QLSSALLHAN HTLTAIDHLV LEMVERLNEA VRTELTTLEE VLTQRTELVA AARGARRQAE
     TVAQQLQGLA FWRGVPLSPL QVAEDVSFVE EYRWLAYVLL LLLELLVCLF TLLGLARQSK
     WLVIVMTVMS LLVLVLSWGS MGLEAATAVG LSDFCSSPDS YILNLTQEET GLGSDILNYY
     FLCNQAVSNP FQQRLTLSQR ALANIHSQLQ GLEREAVPQF PSAQKPVLSL EETLNVTEGN
     FHQLVALLHC RGLHKDYGSA LRGLCEDTLE GLLFLLLFSL LSAGALATVL CSLPRAWALF
     PPSDDYEDTD DDDPFNPQES KRFVQWQSSI
//
ID   TTYH3_DANRE             Reviewed;         560 AA.
AC   Q32LT7;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 1.
DT   10-MAY-2017, entry version 62.
DE   RecName: Full=Protein tweety homolog 3;
GN   Name=ttyh3; ORFNames=zgc:123242;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable large-conductance Ca(2+)-activated chloride
CC       channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC109434; AAI09435.1; -; mRNA.
DR   RefSeq; NP_001032464.1; NM_001037387.2.
DR   UniGene; Dr.151742; -.
DR   STRING; 7955.ENSDARP00000108518; -.
DR   PaxDb; Q32LT7; -.
DR   GeneID; 798421; -.
DR   KEGG; dre:798421; -.
DR   CTD; 798421; -.
DR   ZFIN; ZDB-GENE-051120-105; ttyh3b.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   HOGENOM; HOG000070449; -.
DR   HOVERGEN; HBG108621; -.
DR   InParanoid; Q32LT7; -.
DR   PhylomeDB; Q32LT7; -.
DR   PRO; PR:Q32LT7; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    560       Protein tweety homolog 3.
FT                                /FTId=PRO_0000312253.
FT   TOPO_DOM      1     43       Extracellular. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     65     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    109    212       Extracellular. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    234    238       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    260    387       Extracellular. {ECO:0000255}.
FT   TRANSMEM    388    408       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    409    560       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    127    127       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   560 AA;  62192 MW;  288ABB92E40D04F6 CRC64;
     MAAVVNYSPP WWVNLFHRLP HFNLQFQQTS SDFRPDDSDY QKAVLLLGAA ALVCLALDLL
     FLLFYSFWLC CCRRKNHDSP NADCCCTAWC VIIATLVCSA GIAVGFYGNG ETCDGVTRLT
     YSLRHANQTV AGIDKLVSES TSSLNETLME GLVQLETVYS KQTDYLSIVQ KLQGQLDELI
     NLMLGVPFWS SNDLSLDHLA SITEQYDWYR WLGYLGLLLF DVIICLLVLV GLIRNSRSIL
     IGVCFLGVLT LVISWASLGL EFSFAVGASD FCVSPDSYIT KVTRENAVIN QDILQYYLKC
     SMGQTNPFQQ KLSGSHKALV EMQDDVSELL RSAIRDFPKT KSNLEEMQGV LNSTEVSLHH
     LTALVDCRSL HMDYVQALTG LCYDGVEGLI YLVLFSFVTA LMFSSIVCSV PHTWQSKRSE
     EEDGDETSAT LGSRAPHDNL YRVHMPSLYS CGSSTYGNEA SLPAAAHTVS NAPVTEYMSQ
     NANFQTPRCE NTPLIGRESP PPSYTSSMRA KYLATSRPDQ PRPTESQNGL EPNMRPDLTS
     RSAPNSRPNS AIHRPHSAIH
//
ID   ANO6_HUMAN              Reviewed;         910 AA.
AC   Q4KMQ2; A6NNM6; B9EGG0; E7ENK4; E9PB30; E9PCT2; Q8N3Q2;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   25-OCT-2017, entry version 119.
DE   RecName: Full=Anoctamin-6;
DE   AltName: Full=Small-conductance calcium-activated nonselective cation channel;
DE            Short=SCAN channel;
DE   AltName: Full=Transmembrane protein 16F;
GN   Name=ANO6; Synonyms=TMEM16F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 772-910 (ISOFORM 1/2).
RC   TISSUE=Adipose tissue;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=15067359;
RA   Katoh M., Katoh M.;
RT   "Identification and characterization of TMEM16E and TMEM16F genes in
RT   silico.";
RL   Int. J. Oncol. 24:1345-1349(2004).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-493.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20056604; DOI=10.1074/jbc.M109.065367;
RA   Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M.,
RA   Martins J.R., Kunzelmann K.;
RT   "Expression and function of epithelial anoctamins.";
RL   J. Biol. Chem. 285:7838-7845(2010).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INVOLVEMENT IN SCOTT SYNDROME.
RX   PubMed=21107324; DOI=10.1038/nature09583;
RA   Suzuki J., Umeda M., Sims P.J., Nagata S.;
RT   "Calcium-dependent phospholipid scrambling by TMEM16F.";
RL   Nature 468:834-838(2010).
RN   [8]
RP   REVIEW.
RX   PubMed=21642943; DOI=10.1038/aps.2011.48;
RA   Duran C., Hartzell H.C.;
RT   "Physiological roles and diseases of Tmem16/Anoctamin proteins: are
RT   they all chloride channels?";
RL   Acta Pharmacol. Sin. 32:685-692(2011).
RN   [9]
RP   REVIEW.
RX   PubMed=21607626; DOI=10.1007/s00424-011-0975-9;
RA   Kunzelmann K., Tian Y., Martins J.R., Faria D., Kongsuphol P.,
RA   Ousingsawat J., Thevenod F., Roussa E., Rock J., Schreiber R.;
RT   "Anoctamins.";
RL   Pflugers Arch. 462:195-208(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=22006324; DOI=10.1073/pnas.1108094108;
RA   Martins J.R., Faria D., Kongsuphol P., Reisch B., Schreiber R.,
RA   Kunzelmann K.;
RT   "Anoctamin 6 is an essential component of the outwardly rectifying
RT   chloride channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:18168-18172(2011).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22075693; DOI=10.1152/ajpcell.00140.2011;
RA   Duran C., Qu Z., Osunkoya A.O., Cui Y., Hartzell H.C.;
RT   "ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular
RT   proteins.";
RL   Am. J. Physiol. 302:C482-C493(2012).
RN   [12]
RP   REVIEW.
RX   PubMed=22302790; DOI=10.1113/expphysiol.2011.058214;
RA   Winpenny J.P., Gray M.A.;
RT   "The anoctamin (TMEM16) gene family: calcium-activated chloride
RT   channels come of age.";
RL   Exp. Physiol. 97:175-176(2012).
RN   [13]
RP   REVIEW, AND ABSENCE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL ACTIVITY.
RX   PubMed=21984732; DOI=10.1113/expphysiol.2011.058198;
RA   Scudieri P., Sondo E., Ferrera L., Galietta L.J.;
RT   "The anoctamin family: TMEM16A and TMEM16B as calcium-activated
RT   chloride channels.";
RL   Exp. Physiol. 97:177-183(2012).
RN   [14]
RP   REVIEW, AND FUNCTION.
RX   PubMed=21908539; DOI=10.1113/expphysiol.2011.058206;
RA   Kunzelmann K., Schreiber R., Kmit A., Jantarajit W., Martins J.R.,
RA   Faria D., Kongsuphol P., Ousingsawat J., Tian Y.;
RT   "Expression and function of epithelial anoctamins.";
RL   Exp. Physiol. 97:184-192(2012).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22946059; DOI=10.1242/jcs.109553;
RA   Tian Y., Schreiber R., Kunzelmann K.;
RT   "Anoctamins are a family of Ca2+ activated Cl- channels.";
RL   J. Cell Sci. 125:4991-4998(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Small-conductance calcium-activated nonselective cation
CC       (SCAN) channel which acts as a regulator of phospholipid
CC       scrambling in platelets and osteoblasts. Phospholipid scrambling
CC       results in surface exposure of phosphatidylserine which in
CC       platelets is essential to trigger the clotting system whereas in
CC       osteoblasts is essential for the deposition of hydroxyapatite
CC       during bone mineralization. Has calcium-dependent phospholipid
CC       scramblase activity; scrambles phosphatidylserine,
CC       phosphatidylcholine and galactosylceramide (By similarity). Can
CC       generate outwardly rectifying chloride channel currents in airway
CC       epithelial cells and Jurkat T lymphocytes.
CC       {ECO:0000250|UniProtKB:Q6P9J9, ECO:0000269|PubMed:20056604,
CC       ECO:0000269|PubMed:21107324, ECO:0000269|PubMed:21908539,
CC       ECO:0000269|PubMed:22006324, ECO:0000269|PubMed:22946059}.
CC   -!- ENZYME REGULATION: Exhibits synergistic gating by Ca(2+) and
CC       voltage. Inhibited by some non-specific cation channel blockers
CC       such as: ruthenium red, 2-aminoethyl diphenylborinate (2APB),
CC       gadolinium and cadmium ions (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20056604,
CC       ECO:0000269|PubMed:21107324, ECO:0000269|PubMed:22075693,
CC       ECO:0000269|PubMed:22946059}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:20056604, ECO:0000269|PubMed:21107324,
CC       ECO:0000269|PubMed:22075693, ECO:0000269|PubMed:22946059}.
CC       Note=Shows an intracellular localization according to
CC       PubMed:22075693.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q4KMQ2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4KMQ2-2; Sequence=VSP_042893;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q4KMQ2-3; Sequence=VSP_046819;
CC         Note=Gene prediction based on EST data.;
CC       Name=4;
CC         IsoId=Q4KMQ2-4; Sequence=VSP_046820;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed in embryonic stem cell, fetal liver,
CC       retina, chronic myologenous leukemia and intestinal cancer.
CC       {ECO:0000269|PubMed:15067359}.
CC   -!- DISEASE: Scott syndrome (SCTS) [MIM:262890]: A mild bleeding
CC       disorder due to impaired surface exposure of procoagulant
CC       phosphatidylserine (PS) on platelets and other blood cells,
CC       following activation with Ca(2+)-elevating agents.
CC       {ECO:0000269|PubMed:21107324}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The term 'anoctamin' was coined because these
CC       channels are anion selective and have eight (OCT) transmembrane
CC       segments. There is some dissatisfaction in the field with the Ano
CC       nomenclature because it is not certain that all the members of
CC       this family are anion channels or have the 8-transmembrane
CC       topology.
CC   -!- SIMILARITY: Belongs to the anoctamin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC009248; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009778; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC063924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC098410; AAH98410.1; -; mRNA.
DR   EMBL; BC136445; AAI36446.1; -; mRNA.
DR   EMBL; AL833405; CAD38638.1; -; mRNA.
DR   CCDS; CCDS31782.1; -. [Q4KMQ2-1]
DR   CCDS; CCDS44865.1; -. [Q4KMQ2-4]
DR   CCDS; CCDS44866.1; -. [Q4KMQ2-3]
DR   CCDS; CCDS55819.1; -. [Q4KMQ2-2]
DR   RefSeq; NP_001020527.2; NM_001025356.2. [Q4KMQ2-1]
DR   RefSeq; NP_001136150.1; NM_001142678.1. [Q4KMQ2-3]
DR   RefSeq; NP_001136151.1; NM_001142679.1. [Q4KMQ2-4]
DR   RefSeq; NP_001191732.1; NM_001204803.1. [Q4KMQ2-2]
DR   UniGene; Hs.505339; -.
DR   ProteinModelPortal; Q4KMQ2; -.
DR   BioGrid; 128218; 33.
DR   IntAct; Q4KMQ2; 6.
DR   MINT; MINT-5001391; -.
DR   STRING; 9606.ENSP00000409126; -.
DR   TCDB; 1.A.17.1.4; the calcium-dependent chloride channel (ca-clc) family.
DR   iPTMnet; Q4KMQ2; -.
DR   PhosphoSitePlus; Q4KMQ2; -.
DR   SwissPalm; Q4KMQ2; -.
DR   BioMuta; ANO6; -.
DR   DMDM; 116242820; -.
DR   EPD; Q4KMQ2; -.
DR   MaxQB; Q4KMQ2; -.
DR   PaxDb; Q4KMQ2; -.
DR   PeptideAtlas; Q4KMQ2; -.
DR   PRIDE; Q4KMQ2; -.
DR   Ensembl; ENST00000320560; ENSP00000320087; ENSG00000177119. [Q4KMQ2-1]
DR   Ensembl; ENST00000423947; ENSP00000409126; ENSG00000177119. [Q4KMQ2-2]
DR   Ensembl; ENST00000425752; ENSP00000391417; ENSG00000177119. [Q4KMQ2-4]
DR   Ensembl; ENST00000441606; ENSP00000413137; ENSG00000177119. [Q4KMQ2-3]
DR   GeneID; 196527; -.
DR   KEGG; hsa:196527; -.
DR   UCSC; uc001roo.4; human. [Q4KMQ2-1]
DR   CTD; 196527; -.
DR   DisGeNET; 196527; -.
DR   EuPathDB; HostDB:ENSG00000177119.15; -.
DR   GeneCards; ANO6; -.
DR   H-InvDB; HIX0010565; -.
DR   HGNC; HGNC:25240; ANO6.
DR   HPA; HPA038958; -.
DR   MalaCards; ANO6; -.
DR   MIM; 262890; phenotype.
DR   MIM; 608663; gene.
DR   neXtProt; NX_Q4KMQ2; -.
DR   OpenTargets; ENSG00000177119; -.
DR   Orphanet; 806; Scott syndrome.
DR   PharmGKB; PA164715690; -.
DR   eggNOG; KOG2514; Eukaryota.
DR   eggNOG; ENOG410XS4S; LUCA.
DR   GeneTree; ENSGT00760000119015; -.
DR   HOGENOM; HOG000006509; -.
DR   HOVERGEN; HBG069519; -.
DR   InParanoid; Q4KMQ2; -.
DR   KO; K19500; -.
DR   OMA; KHNIYYW; -.
DR   OrthoDB; EOG091G01JF; -.
DR   PhylomeDB; Q4KMQ2; -.
DR   TreeFam; TF314265; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; ANO6; human.
DR   GenomeRNAi; 196527; -.
DR   PRO; PR:Q4KMQ2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177119; -.
DR   CleanEx; HS_ANO6; -.
DR   ExpressionAtlas; Q4KMQ2; baseline and differential.
DR   Genevisible; Q4KMQ2; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0017128; F:phospholipid scramblase activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0002543; P:activation of blood coagulation via clotting cascade; IMP:UniProtKB.
DR   GO; GO:0032060; P:bleb assembly; IMP:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; ISS:UniProtKB.
DR   GO; GO:0035630; P:bone mineralization involved in bone maturation; IEA:Ensembl.
DR   GO; GO:0061591; P:calcium activated galactosylceramide scrambling; IEA:Ensembl.
DR   GO; GO:0061590; P:calcium activated phosphatidylcholine scrambling; IEA:Ensembl.
DR   GO; GO:0061589; P:calcium activated phosphatidylserine scrambling; IEA:Ensembl.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IGI:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IGI:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IMP:UniProtKB.
DR   GO; GO:0002407; P:dendritic cell chemotaxis; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0045794; P:negative regulation of cell volume; IMP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0097045; P:phosphatidylserine exposure on blood platelet; IMP:UniProtKB.
DR   GO; GO:0017121; P:phospholipid scrambling; IMP:UniProtKB.
DR   GO; GO:0046931; P:pore complex assembly; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:UniProtKB.
DR   GO; GO:2000353; P:positive regulation of endothelial cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0034767; P:positive regulation of ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IMP:UniProtKB.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; ISS:UniProtKB.
DR   GO; GO:1902304; P:positive regulation of potassium ion export; ISS:BHF-UCL.
DR   GO; GO:0035590; P:purinergic nucleotide receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IGI:UniProtKB.
DR   InterPro; IPR032394; Anoct_dimer.
DR   InterPro; IPR007632; Anoctamin.
DR   InterPro; IPR031295; Anoctamin-6.
DR   PANTHER; PTHR12308; PTHR12308; 1.
DR   PANTHER; PTHR12308:SF21; PTHR12308:SF21; 1.
DR   Pfam; PF16178; Anoct_dimer; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Lipid transport; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    910       Anoctamin-6.
FT                                /FTId=PRO_0000191757.
FT   TOPO_DOM      1    294       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    295    315       Helical. {ECO:0000255}.
FT   TOPO_DOM    316    375       Extracellular. {ECO:0000255}.
FT   TRANSMEM    376    396       Helical. {ECO:0000255}.
FT   TOPO_DOM    397    454       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    455    475       Helical. {ECO:0000255}.
FT   TOPO_DOM    476    513       Extracellular. {ECO:0000255}.
FT   TRANSMEM    514    534       Helical. {ECO:0000255}.
FT   TOPO_DOM    535    551       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    552    572       Helical. {ECO:0000255}.
FT   TOPO_DOM    573    669       Extracellular. {ECO:0000255}.
FT   TRANSMEM    670    690       Helical. {ECO:0000255}.
FT   TOPO_DOM    691    725       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    726    746       Helical. {ECO:0000255}.
FT   TOPO_DOM    747    824       Extracellular. {ECO:0000255}.
FT   TRANSMEM    825    845       Helical. {ECO:0000255}.
FT   TOPO_DOM    846    910       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    329    329       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    361    361       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    493    493       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    777    777       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    790    790       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    802    802       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     23       MKKMSRNVLLQMEEEEDDDDGDI -> MFCAA (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_046819.
FT   VAR_SEQ      23     23       I -> IGDVPASRRPFLTPHTHLPSSL (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042893.
FT   VAR_SEQ     843    910       HVIYSVKFFISYAIPDVSKRTKSKIQREKYLTQKLLHENHL
FT                                KDMTKNMGVIAERMIEAVDNNLRPKSE -> YLALLPRLGH
FT                                SGMILAHCNLRLPVDCCMCYRFVDEIRLLEQLTSDFIDSLY
FT                                YIFSISIISIFFSVTFFFLLLSLGPTPCFSVSNFLS (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_046820.
FT   VARIANT     128    128       A -> T (in dbSNP:rs2162321).
FT                                /FTId=VAR_028109.
FT   CONFLICT    837    837       F -> L (in Ref. 2; AAH98410).
FT                                {ECO:0000305}.
SQ   SEQUENCE   910 AA;  106165 MW;  8F7F1CB78FAAEB78 CRC64;
     MKKMSRNVLL QMEEEEDDDD GDIVLENLGQ TIVPDLGSLE SQHDFRTPEF EEFNGKPDSL
     FFNDGQRRID FVLVYEDESR KETNKKGTNE KQRRKRQAYE SNLICHGLQL EATRSVLDDK
     LVFVKVHAPW EVLCTYAEIM HIKLPLKPND LKNRSSAFGT LNWFTKVLSV DESIIKPEQE
     FFTAPFEKNR MNDFYIVDRD AFFNPATRSR IVYFILSRVK YQVINNVSKF GINRLVNSGI
     YKAAFPLHDC KFRRQSEDPS CPNERYLLYR EWAHPRSIYK KQPLDLIRKY YGEKIGIYFA
     WLGYYTQMLL LAAVVGVACF LYGYLNQDNC TWSKEVCHPD IGGKIIMCPQ CDRLCPFWKL
     NITCESSKKL CIFDSFGTLV FAVFMGVWVT LFLEFWKRRQ AELEYEWDTV ELQQEEQARP
     EYEARCTHVV INEITQEEER IPFTAWGKCI RITLCASAVF FWILLIIASV IGIIVYRLSV
     FIVFSAKLPK NINGTDPIQK YLTPQTATSI TASIISFIII MILNTIYEKV AIMITNFELP
     RTQTDYENSL TMKMFLFQFV NYYSSCFYIA FFKGKFVGYP GDPVYWLGKY RNEECDPGGC
     LLELTTQLTI IMGGKAIWNN IQEVLLPWIM NLIGRFHRVS GSEKITPRWE QDYHLQPMGK
     LGLFYEYLEM IIQFGFVTLF VASFPLAPLL ALVNNILEIR VDAWKLTTQF RRLVPEKAQD
     IGAWQPIMQG IAILAVVTNA MIIAFTSDMI PRLVYYWSFS VPPYGDHTSY TMEGYINNTL
     SIFKVADFKN KSKGNPYSDL GNHTTCRYRD FRYPPGHPQE YKHNIYYWHV IAAKLAFIIV
     MEHVIYSVKF FISYAIPDVS KRTKSKIQRE KYLTQKLLHE NHLKDMTKNM GVIAERMIEA
     VDNNLRPKSE
//
ID   CLCE_DICDI              Reviewed;         994 AA.
AC   Q54LQ4;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   10-MAY-2017, entry version 68.
DE   RecName: Full=Chloride channel protein E;
GN   Name=clcE; ORFNames=DDB_G0286491;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000086; EAL64196.1; -; Genomic_DNA.
DR   RefSeq; XP_637702.1; XM_632610.1.
DR   ProteinModelPortal; Q54LQ4; -.
DR   SMR; Q54LQ4; -.
DR   STRING; 44689.DDB0233306; -.
DR   PaxDb; Q54LQ4; -.
DR   PRIDE; Q54LQ4; -.
DR   EnsemblProtists; EAL64196; EAL64196; DDB_G0286491.
DR   GeneID; 8625644; -.
DR   KEGG; ddi:DDB_G0286491; -.
DR   dictyBase; DDB_G0286491; clcE.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q54LQ4; -.
DR   OMA; CCISFIS; -.
DR   PhylomeDB; Q54LQ4; -.
DR   Reactome; R-DDI-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q54LQ4; -.
DR   Proteomes; UP000002195; Chromosome 4.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    994       Chloride channel protein E.
FT                                /FTId=PRO_0000328047.
FT   TOPO_DOM      1    163       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TRANSMEM    300    320       Helical. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   TRANSMEM    410    430       Helical. {ECO:0000255}.
FT   TRANSMEM    449    469       Helical. {ECO:0000255}.
FT   TRANSMEM    505    525       Helical. {ECO:0000255}.
FT   TRANSMEM    527    547       Helical. {ECO:0000255}.
FT   TRANSMEM    554    574       Helical. {ECO:0000255}.
FT   DOMAIN      644    705       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      944    994       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   COMPBIAS     21     30       Poly-Asn.
FT   COMPBIAS    717    764       Poly-Asn.
FT   COMPBIAS    889    899       Poly-Thr.
SQ   SEQUENCE   994 AA;  110302 MW;  9DE0EE43EFB7896C CRC64;
     MTRKENEESE SLSSSSSPID NSNNNNNNNN HSIFNPIGHI QNAFNNIDLN PLNVDFKGHT
     DKVVNFFQHG TGDLNDRMQG VVSKLRSNEY RKKMHSVLTK IKDTKEYKST SNTDYDVIFE
     SVDMYSNLQQ DPTMDKDEID VVTDLSSYKK KFTHWLGKER ISTLLFIPTL GILIALMGIL
     CDFLLMELGT LRDFVTSRHN SHVIPTDGTT PTPNSSIADK YDLVEGIVFV GYSVFFALIS
     VCCISFISPY AVGSGIPEMK SIMSGINLSR VLGFKTLVSK IVGMVCASAA GLTIGRTGPF
     MHASAIISQM LMNLKVFGAI KKNQIVRYQM LICALTSGVV ANFGAPIGGL LFAIEVTATT
     AVMGNLWKGF LCATTTAIIF FLSRSTFSKG NFHSVYEFEF VPKEYGVADL ITFVGIGIIT
     GLIGAFFVFI YEKLVRFRLR YPILKQSRII LVLVVSLFSA IITYSAGPLC RVSLPTAMKQ
     FLGQNEPKPF LFEQDQTPYY KYLNLLVFIV VKLILTAFNI VLPIPGGAIT PFIVTGAALG
     RLFGEILKDH FDSQAIEPAG FAAIASAGLV SGTIRNISPS IFVLELTGQL SLLVPILICS
     ITSTAVGNFF NRPLFDTALK IQGLPFLSNY RSSKVYTMTA KQVMKKNINY LSMTSTVIEM
     KNFLDTFKYT FIPIVDSKEN MLLVGIVERS SMIYMLDIHI ENIEQKIDEF KSKYFVNNNN
     NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NSNNSENLEI ENTGAILNTN
     SNNNNSDEED YDRKDNDKIS LIKPNQDESS SNSNGGSSSD FEEILNTQNT NINKNDNEDL
     IKEIEDENSS LGEKPIIEHD DEDDDEEEGD GIPLVSMKDQ QPVLRNRHTT TTTTTTTTTP
     ITENIYVNDA FEISINDLKN GGQSVWGKHI LGDIIHSGET ALLMDLAPSQ VPDLTPLNKV
     FHLFTMLGLG FTYVTSLGKL VGVITKNSLM EQDL
//
ID   Y305_METJA              Reviewed;         395 AA.
AC   Q57753;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-JUN-2017, entry version 100.
DE   RecName: Full=Uncharacterized protein MJ0305;
GN   OrderedLocusNames=MJ0305;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L77117; AAB98292.1; -; Genomic_DNA.
DR   PIR; B64338; B64338.
DR   ProteinModelPortal; Q57753; -.
DR   STRING; 243232.MJ_0305; -.
DR   TCDB; 2.A.49.4.1; the chloride carrier/channel (clc) family.
DR   EnsemblBacteria; AAB98292; AAB98292; MJ_0305.
DR   KEGG; mja:MJ_0305; -.
DR   eggNOG; arCOG02569; Archaea.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q57753; -.
DR   KO; K03281; -.
DR   OMA; PMISGSG; -.
DR   OrthoDB; POG093Z067D; -.
DR   PhylomeDB; Q57753; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    395       Uncharacterized protein MJ0305.
FT                                /FTId=PRO_0000094500.
FT   TRANSMEM     19     39       Helical. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical. {ECO:0000255}.
FT   TRANSMEM    279    299       Helical. {ECO:0000255}.
FT   TRANSMEM    311    331       Helical. {ECO:0000255}.
FT   TRANSMEM    359    379       Helical. {ECO:0000255}.
SQ   SEQUENCE   395 AA;  42618 MW;  9CDC65D6201CF7C0 CRC64;
     MPMNIVNMFG KYIKIIKWIG IASLIGIVGG LSSVIIAIII EYFPEKHNVL LIPIVFFIAG
     LFVDYIYELK GSGIDRVLKA LNTNEKLTWI RGLLKVLLAG AVIAVGGSAG KEGPCVQSSA
     SFADELYRLL KLKNRELVII TGIAGGLGGA FSAPLGTAIL ACEIIEHENF NYINLIPPII
     ASVVGYLIFY LITGRKHLFN ITLSYTINIH DFLLFILGAF FCSLIAHCYI KTYRKISSTF
     DNLKIPYCIK TLIGGILVAV ISYFIPEVMG MGLTLTKELF IMEFSLVFLV LLLIGKILAT
     SFTVGSGTPG GLVFPSMCIG AISGIIFGSL IGDCSAPYIV LGIATTLSAT TNAPLGGAVL
     CTEIFGFDFA VPASIGAVIG YQMTKLETIF KYIRF
//
ID   CLIC1_BOVIN             Reviewed;         241 AA.
AC   Q5E9B7;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   25-OCT-2017, entry version 98.
DE   RecName: Full=Chloride intracellular channel protein 1;
GN   Name=CLIC1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16305752; DOI=10.1186/1471-2164-6-166;
RA   Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L.,
RA   Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.;
RT   "Characterization of 954 bovine full-CDS cDNA sequences.";
RL   BMC Genomics 6:166-166(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Crossbred X Angus; TISSUE=Ileum;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Can insert into membranes and form chloride ion
CC       channels. Channel activity depends on the pH. Membrane insertion
CC       seems to be redox-regulated and may occur only under oxydizing
CC       conditions (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Homodimer (in vitro). Interacts with TRAPPC2.
CC       Dimerization requires a conformation change that leads to the
CC       exposure of a large hydrophobic surface. In vivo, this may lead to
CC       membrane insertion (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus membrane
CC       {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.
CC       Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Single-pass
CC       membrane protein {ECO:0000250}. Note=Mostly in the nucleus
CC       including in the nuclear membrane. Small amount in the cytoplasm
CC       and the plasma membrane. Exists both as soluble cytoplasmic
CC       protein and as membrane protein with probably a single
CC       transmembrane domain (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT021003; AAX09020.1; -; mRNA.
DR   EMBL; BC102103; AAI02104.1; -; mRNA.
DR   RefSeq; NP_001015608.1; NM_001015608.1.
DR   UniGene; Bt.49164; -.
DR   ProteinModelPortal; Q5E9B7; -.
DR   SMR; Q5E9B7; -.
DR   STRING; 9913.ENSBTAP00000017995; -.
DR   PaxDb; Q5E9B7; -.
DR   PeptideAtlas; Q5E9B7; -.
DR   PRIDE; Q5E9B7; -.
DR   Ensembl; ENSBTAT00000017995; ENSBTAP00000017995; ENSBTAG00000013533.
DR   GeneID; 515646; -.
DR   KEGG; bta:515646; -.
DR   CTD; 1192; -.
DR   eggNOG; ENOG410INGZ; Eukaryota.
DR   eggNOG; ENOG410ZZZX; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000231548; -.
DR   HOVERGEN; HBG050994; -.
DR   InParanoid; Q5E9B7; -.
DR   KO; K05021; -.
DR   OMA; LWRYLNA; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   TreeFam; TF315438; -.
DR   Proteomes; UP000009136; Chromosome 23.
DR   Bgee; ENSBTAG00000013533; -.
DR   GO; GO:0072562; C:blood microparticle; IEA:Ensembl.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045296; F:cadherin binding; IEA:Ensembl.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0070527; P:platelet aggregation; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:InterPro.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030259; CLIC-1.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF2; PTHR43920:SF2; 1.
DR   Pfam; PF13409; GST_N_2; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Cytoplasm; Disulfide bond; Ion channel;
KW   Ion transport; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:O00299}.
FT   CHAIN         2    241       Chloride intracellular channel protein 1.
FT                                /FTId=PRO_0000236248.
FT   TRANSMEM     26     46       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN       93    233       GST C-terminal.
FT   REGION        2     90       Required for insertion into the membrane.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES      13     13       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES     119    119       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES     131    131       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O00299}.
FT   MOD_RES     233    233       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9Z1Q5}.
FT   DISULFID     24     59       {ECO:0000250}.
SQ   SEQUENCE   241 AA;  26992 MW;  7443E31C9A88100D CRC64;
     MAEEQPQVEL FVKAGSDGAK IGNCPFSQRL FMVLWLKGVT FNVTTVDTKR RTETVQKLCP
     GGQLPFLLYG TEVHTDTNKI EEFLEAVLCP PRYPKLAALN PESNTAGLDI FAKFSAYIKN
     SNPALNDNLE KGLLKALKVL DNYLTSPLPD EVDETSAEDE GISQRKFLDG NELTLADCNL
     LPKLHIVQVV CKKYRGFSIP DVFRGVHRYL RNAYAREEFA STCPDDEEIE LAYEQVAKAL
     K
//
ID   ANO1_HUMAN              Reviewed;         986 AA.
AC   Q5XXA6; A8KAM3; Q8IYY8; Q8N7V3;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   25-OCT-2017, entry version 114.
DE   RecName: Full=Anoctamin-1;
DE   AltName: Full=Discovered on gastrointestinal stromal tumors protein 1;
DE   AltName: Full=Oral cancer overexpressed protein 2;
DE   AltName: Full=Transmembrane protein 16A;
DE   AltName: Full=Tumor-amplified and overexpressed sequence 2;
GN   Name=ANO1; Synonyms=DOG1, ORAOV2, TAOS2, TMEM16A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=16906560; DOI=10.1002/gcc.20371;
RA   Huang X., Godfrey T.E., Gooding W.E., McCarty K.S. Jr., Gollin S.M.;
RT   "Comprehensive genome and transcriptome analysis of the 11q13 amplicon
RT   in human oral cancer and synteny to the 7F5 amplicon in murine oral
RT   carcinoma.";
RL   Genes Chromosomes Cancer 45:1058-1069(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION, AND TOPOLOGY.
RX   PubMed=12739008;
RA   Katoh M., Katoh M.;
RT   "FLJ10261 gene, located within the CCND1-EMS1 locus on human
RT   chromosome 11q13, encodes the eight-transmembrane protein homologous
RT   to C12orf3, C11orf25 and FLJ34272 gene products.";
RL   Int. J. Oncol. 22:1375-1381(2003).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15215166; DOI=10.1016/S0002-9440(10)63279-8;
RA   West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S.,
RA   Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R.,
RA   Goldblum J.R., Brown P.O., Heinrich M.C., van de Rijn M.;
RT   "The novel marker, DOG1, is expressed ubiquitously in gastrointestinal
RT   stromal tumors irrespective of KIT or PDGFRA mutation status.";
RL   Am. J. Pathol. 165:107-113(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16261155; DOI=10.1038/sj.onc.1209203;
RA   Carles A., Millon R., Cromer A., Ganguli G., Lemaire F., Young J.,
RA   Wasylyk C., Muller D., Schultz I., Rabouel Y., Dembele D., Zhao C.,
RA   Marchal P., Ducray C., Bracco L., Abecassis J., Poch O., Wasylyk B.;
RT   "Head and neck squamous cell carcinoma transcriptome analysis by
RT   comprehensive validated differential display.";
RL   Oncogene 25:1821-1831(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20056604; DOI=10.1074/jbc.M109.065367;
RA   Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M.,
RA   Martins J.R., Kunzelmann K.;
RT   "Expression and function of epithelial anoctamins.";
RL   J. Biol. Chem. 285:7838-7845(2010).
RN   [8]
RP   REVIEW.
RX   PubMed=21186280; DOI=10.1152/physiol.00030.2010;
RA   Ferrera L., Caputo A., Galietta L.J.;
RT   "TMEM16A protein: a new identity for Ca(2+)-dependent Cl? channels.";
RL   Physiology (Bethesda) 25:357-363(2010).
RN   [9]
RP   REVIEW.
RX   PubMed=21642943; DOI=10.1038/aps.2011.48;
RA   Duran C., Hartzell H.C.;
RT   "Physiological roles and diseases of Tmem16/Anoctamin proteins: are
RT   they all chloride channels?";
RL   Acta Pharmacol. Sin. 32:685-692(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CFTR, AND ENZYME
RP   REGULATION.
RX   PubMed=22178883; DOI=10.1159/000335765;
RA   Ousingsawat J., Kongsuphol P., Schreiber R., Kunzelmann K.;
RT   "CFTR and TMEM16A are separate but functionally related Cl-channels.";
RL   Cell. Physiol. Biochem. 28:715-724(2011).
RN   [12]
RP   SUBUNIT.
RX   PubMed=21056985; DOI=10.1074/jbc.M110.174847;
RA   Sheridan J.T., Worthington E.N., Yu K., Gabriel S.E., Hartzell H.C.,
RA   Tarran R.;
RT   "Characterization of the oligomeric structure of the Ca(2+)-activated
RT   Cl- channel Ano1/TMEM16A.";
RL   J. Biol. Chem. 286:1381-1388(2011).
RN   [13]
RP   REVIEW.
RX   PubMed=21607626; DOI=10.1007/s00424-011-0975-9;
RA   Kunzelmann K., Tian Y., Martins J.R., Faria D., Kongsuphol P.,
RA   Ousingsawat J., Thevenod F., Roussa E., Rock J., Schreiber R.;
RT   "Anoctamins.";
RL   Pflugers Arch. 462:195-208(2011).
RN   [14]
RP   REVIEW.
RX   PubMed=22302790; DOI=10.1113/expphysiol.2011.058214;
RA   Winpenny J.P., Gray M.A.;
RT   "The anoctamin (TMEM16) gene family: calcium-activated chloride
RT   channels come of age.";
RL   Exp. Physiol. 97:175-176(2012).
RN   [15]
RP   REVIEW, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21984732; DOI=10.1113/expphysiol.2011.058198;
RA   Scudieri P., Sondo E., Ferrera L., Galietta L.J.;
RT   "The anoctamin family: TMEM16A and TMEM16B as calcium-activated
RT   chloride channels.";
RL   Exp. Physiol. 97:177-183(2012).
RN   [16]
RP   REVIEW.
RX   PubMed=21908539; DOI=10.1113/expphysiol.2011.058206;
RA   Kunzelmann K., Schreiber R., Kmit A., Jantarajit W., Martins J.R.,
RA   Faria D., Kongsuphol P., Ousingsawat J., Tian Y.;
RT   "Expression and function of epithelial anoctamins.";
RL   Exp. Physiol. 97:184-192(2012).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22946059; DOI=10.1242/jcs.109553;
RA   Tian Y., Schreiber R., Kunzelmann K.;
RT   "Anoctamins are a family of Ca2+ activated Cl- channels.";
RL   J. Cell Sci. 125:4991-4998(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107 AND SER-196, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Calcium-activated chloride channel (CaCC) which plays a
CC       role in transepithelial anion transport and smooth muscle
CC       contraction. Required for the normal functioning of the
CC       interstitial cells of Cajal (ICCs) which generate electrical
CC       pacemaker activity in gastrointestinal smooth muscles. Acts as a
CC       major contributor to basal and stimulated chloride conductance in
CC       airway epithelial cells and plays an important role in tracheal
CC       cartilage development. {ECO:0000269|PubMed:20056604,
CC       ECO:0000269|PubMed:21984732, ECO:0000269|PubMed:22178883,
CC       ECO:0000269|PubMed:22946059}.
CC   -!- ENZYME REGULATION: ATP and calmodulin are essential for its
CC       activation. Channel activity is inhibited by CFTR protein and by
CC       chloride inhibitors such as niflumic acid (NFA) and 4,4'-
CC       diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS).
CC       {ECO:0000269|PubMed:22178883}.
CC   -!- SUBUNIT: Homodimer (PubMed:21056985). Interacts with CFTR
CC       (PubMed:22178883). Interacts with TRPV4 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BHY3, ECO:0000269|PubMed:21056985,
CC       ECO:0000269|PubMed:22178883}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15215166,
CC       ECO:0000269|PubMed:20056604, ECO:0000269|PubMed:21984732,
CC       ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:22946059}; Multi-
CC       pass membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000269|PubMed:16261155}. Note=Cytoplasmic localization seen
CC       in neoplastic cells of head and neck squamous cell carcinoma
CC       (HNSCC) tumors. {ECO:0000269|PubMed:16261155}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5XXA6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5XXA6-2; Sequence=VSP_025665, VSP_025668, VSP_025669;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q5XXA6-3; Sequence=VSP_025666, VSP_025667, VSP_025668,
CC                                  VSP_025669, VSP_025670, VSP_025671;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed with higher levels in liver,
CC       skeletal muscle and gastrointestinal muscles.
CC       {ECO:0000269|PubMed:15215166, ECO:0000269|PubMed:16906560}.
CC   -!- DOMAIN: The region spanning the fifth and sixth transmembrane
CC       domains probably forms the pore-forming region. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The term 'anoctamin' was coined because these
CC       channels are anion selective and have eight (OCT) transmembrane
CC       segments. There is some dissatisfaction in the field with the Ano
CC       nomenclature because it is not certain that all the members of
CC       this family are anion channels or have the 8-transmembrane
CC       topology.
CC   -!- SIMILARITY: Belongs to the anoctamin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY728143; AAU82085.1; -; mRNA.
DR   EMBL; AK097619; BAC05123.1; -; mRNA.
DR   EMBL; AK293088; BAF85777.1; -; mRNA.
DR   EMBL; BC033036; AAH33036.2; -; mRNA.
DR   CCDS; CCDS44663.1; -. [Q5XXA6-1]
DR   RefSeq; NP_060513.5; NM_018043.5. [Q5XXA6-1]
DR   RefSeq; XP_006718668.1; XM_006718605.2. [Q5XXA6-2]
DR   RefSeq; XP_011543433.1; XM_011545131.2. [Q5XXA6-3]
DR   UniGene; Hs.503074; -.
DR   ProteinModelPortal; Q5XXA6; -.
DR   BioGrid; 120417; 1.
DR   IntAct; Q5XXA6; 1.
DR   STRING; 9606.ENSP00000347454; -.
DR   BindingDB; Q5XXA6; -.
DR   ChEMBL; CHEMBL2046267; -.
DR   DrugBank; DB04941; Crofelemer.
DR   GuidetoPHARMACOLOGY; 708; -.
DR   TCDB; 1.A.17.1.1; the calcium-dependent chloride channel (ca-clc) family.
DR   iPTMnet; Q5XXA6; -.
DR   PhosphoSitePlus; Q5XXA6; -.
DR   BioMuta; ANO1; -.
DR   DMDM; 74708278; -.
DR   EPD; Q5XXA6; -.
DR   MaxQB; Q5XXA6; -.
DR   PaxDb; Q5XXA6; -.
DR   PeptideAtlas; Q5XXA6; -.
DR   PRIDE; Q5XXA6; -.
DR   Ensembl; ENST00000316296; ENSP00000319477; ENSG00000131620. [Q5XXA6-3]
DR   Ensembl; ENST00000355303; ENSP00000347454; ENSG00000131620. [Q5XXA6-1]
DR   Ensembl; ENST00000530676; ENSP00000435797; ENSG00000131620. [Q5XXA6-2]
DR   GeneID; 55107; -.
DR   KEGG; hsa:55107; -.
DR   UCSC; uc001opj.4; human. [Q5XXA6-1]
DR   CTD; 55107; -.
DR   DisGeNET; 55107; -.
DR   EuPathDB; HostDB:ENSG00000131620.17; -.
DR   GeneCards; ANO1; -.
DR   HGNC; HGNC:21625; ANO1.
DR   HPA; HPA032148; -.
DR   MIM; 610108; gene.
DR   neXtProt; NX_Q5XXA6; -.
DR   OpenTargets; ENSG00000131620; -.
DR   PharmGKB; PA164715378; -.
DR   eggNOG; KOG2514; Eukaryota.
DR   eggNOG; ENOG410XS4S; LUCA.
DR   GeneTree; ENSGT00760000119015; -.
DR   HOGENOM; HOG000006509; -.
DR   HOVERGEN; HBG069519; -.
DR   InParanoid; Q5XXA6; -.
DR   KO; K19496; -.
DR   OMA; DPDAECK; -.
DR   OrthoDB; EOG091G01JF; -.
DR   PhylomeDB; Q5XXA6; -.
DR   TreeFam; TF314265; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; ANO1; human.
DR   GeneWiki; ANO1; -.
DR   GenomeRNAi; 55107; -.
DR   PRO; PR:Q5XXA6; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000131620; -.
DR   CleanEx; HS_ANO1; -.
DR   ExpressionAtlas; Q5XXA6; baseline and differential.
DR   Genevisible; Q5XXA6; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0015111; F:iodide transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IMP:UniProtKB.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0015705; P:iodide transport; IMP:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   InterPro; IPR032394; Anoct_dimer.
DR   InterPro; IPR007632; Anoctamin.
DR   InterPro; IPR031287; Anoctamin-1.
DR   PANTHER; PTHR12308; PTHR12308; 1.
DR   PANTHER; PTHR12308:SF13; PTHR12308:SF13; 1.
DR   Pfam; PF16178; Anoct_dimer; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Cytoplasm; Developmental protein;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    986       Anoctamin-1.
FT                                /FTId=PRO_0000288435.
FT   TOPO_DOM      1    333       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical. {ECO:0000255}.
FT   TOPO_DOM    355    402       Extracellular. {ECO:0000255}.
FT   TRANSMEM    403    423       Helical. {ECO:0000255}.
FT   TOPO_DOM    424    519       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    520    540       Helical. {ECO:0000255}.
FT   TOPO_DOM    541    565       Extracellular. {ECO:0000255}.
FT   TRANSMEM    566    586       Helical. {ECO:0000255}.
FT   TOPO_DOM    587    606       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    607    627       Helical. {ECO:0000255}.
FT   TOPO_DOM    628    731       Extracellular. {ECO:0000255}.
FT   TRANSMEM    732    752       Helical. {ECO:0000255}.
FT   TOPO_DOM    753    791       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    792    812       Helical. {ECO:0000255}.
FT   TOPO_DOM    813    882       Extracellular. {ECO:0000255}.
FT   TRANSMEM    883    903       Helical. {ECO:0000255}.
FT   TOPO_DOM    904    986       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     107    107       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    832    832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    116       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025665.
FT   VAR_SEQ       1     28       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025666.
FT   VAR_SEQ      29     36       GYLPSEGT -> MLTRPSQV (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025667.
FT   VAR_SEQ     448    451       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025668.
FT   VAR_SEQ     476    501       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025669.
FT   VAR_SEQ     651    700       CAPGGCLMELCIQLSIIMLGKQLIQNNLFEIGIPKMKKLIR
FT                                YLKLKQQSP -> VTEILFISGSPFCLAYDLSTPCTWEKQL
FT                                QHICSAKSSRFLSFLLETFLFP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025670.
FT   VAR_SEQ     701    986       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025671.
FT   VARIANT     608    608       F -> S (in dbSNP:rs2186797).
FT                                /FTId=VAR_032417.
FT   VARIANT     983    983       G -> R (in dbSNP:rs3740722).
FT                                /FTId=VAR_032418.
FT   CONFLICT    202    202       T -> A (in Ref. 2; BAF85777).
FT                                {ECO:0000305}.
FT   CONFLICT    801    801       N -> D (in Ref. 3; AAH33036).
FT                                {ECO:0000305}.
FT   CONFLICT    948    948       W -> C (in Ref. 3; AAH33036).
FT                                {ECO:0000305}.
SQ   SEQUENCE   986 AA;  114078 MW;  E30A02F91EF36FC2 CRC64;
     MRVNEKYSTL PAEDRSVHII NICAIEDIGY LPSEGTLLNS LSVDPDAECK YGLYFRDGRR
     KVDYILVYHH KRPSGNRTLV RRVQHSDTPS GARSVKQDHP LPGKGASLDA GSGEPPMDYH
     EDDKRFRREE YEGNLLEAGL ELERDEDTKI HGVGFVKIHA PWNVLCREAE FLKLKMPTKK
     MYHINETRGL LKKINSVLQK ITDPIQPKVA EHRPQTMKRL SYPFSREKQH LFDLSDKDSF
     FDSKTRSTIV YEILKRTTCT KAKYSMGITS LLANGVYAAA YPLHDGDYNG ENVEFNDRKL
     LYEEWARYGV FYKYQPIDLV RKYFGEKIGL YFAWLGVYTQ MLIPASIVGI IVFLYGCATM
     DENIPSMEMC DQRHNITMCP LCDKTCSYWK MSSACATARA SHLFDNPATV FFSVFMALWA
     ATFMEHWKRK QMRLNYRWDL TGFEEEEEAV KDHPRAEYEA RVLEKSLKKE SRNKEKRRHI
     PEESTNKWKQ RVKTAMAGVK LTDKVKLTWR DRFPAYLTNL VSIIFMIAVT FAIVLGVIIY
     RISMAAALAM NSSPSVRSNI RVTVTATAVI INLVVIILLD EVYGCIARWL TKIEVPKTEK
     SFEERLIFKA FLLKFVNSYT PIFYVAFFKG RFVGRPGDYV YIFRSFRMEE CAPGGCLMEL
     CIQLSIIMLG KQLIQNNLFE IGIPKMKKLI RYLKLKQQSP PDHEECVKRK QRYEVDYNLE
     PFAGLTPEYM EMIIQFGFVT LFVASFPLAP LFALLNNIIE IRLDAKKFVT ELRRPVAVRA
     KDIGIWYNIL RGIGKLAVII NAFVISFTSD FIPRLVYLYM YSKNGTMHGF VNHTLSSFNV
     SDFQNGTAPN DPLDLGYEVQ ICRYKDYREP PWSENKYDIS KDFWAVLAAR LAFVIVFQNL
     VMFMSDFVDW VIPDIPKDIS QQIHKEKVLM VELFMREEQD KQQLLETWME KERQKDEPPC
     NHHNTKACPD SLGSPAPSHA YHGGVL
//
ID   CLCN1_MOUSE             Reviewed;         994 AA.
AC   Q64347; Q8BZ41; Q9QVY5;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   07-JUN-2017, entry version 141.
DE   RecName: Full=Chloride channel protein 1;
DE            Short=ClC-1;
DE   AltName: Full=Chloride channel protein, skeletal muscle;
GN   Name=Clcn1; Synonyms=Clc1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=9321463; DOI=10.1007/s003359900553;
RA   Schnuelle V., Antropova O., Gronemeier M., Wedemeyer N., Jockusch H.,
RA   Bartsch J.W.;
RT   "The mouse Clc1/myotonia gene: ETn insertion, a variable AATC repeat,
RT   and PCR diagnosis of alleles.";
RL   Mamm. Genome 8:718-725(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-467.
RX   PubMed=1659665; DOI=10.1038/354304a0;
RA   Steinmeyer K., Klocke R., Ortland C., Gronemeier M., Jockusch H.,
RA   Gruender S., Jentsch T.J.;
RT   "Inactivation of muscle chloride channel by transposon insertion in
RT   myotonic mice.";
RL   Nature 354:304-308(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 543-563; 740-760 AND 941-961, AND
RP   MUTAGENESIS OF ILE-553.
RC   STRAIN=C57BL/6 X CBA/CaJ, and SWR/J;
RX   PubMed=8119941;
RA   Gronemeier M., Condie A., Prosser J., Steinmeyer K., Jentsch T.J.,
RA   Jockusch H.;
RT   "Nonsense and missense mutations in the muscular chloride channel gene
RT   Clc-1 of myotonic mice.";
RL   J. Biol. Chem. 269:5963-5967(1994).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-892, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. {ECO:0000250|UniProtKB:P35523}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P35523}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P35523}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscles.
CC   -!- MISCELLANEOUS: The CLC channel family contains both chloride
CC       channels and proton-coupled anion transporters that exchange
CC       chloride or another anion for protons. The absence of conserved
CC       gating glutamate residues is typical for family members that
CC       function as channels (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClC-1/CLCN1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z95127; CAB08359.1; -; Genomic_DNA.
DR   EMBL; Z95128; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95129; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95130; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95131; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95132; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95133; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95134; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95135; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95136; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95137; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95138; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95139; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95140; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95141; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95142; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95143; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95144; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95145; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95146; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95147; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95148; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; Z95149; CAB08359.1; JOINED; Genomic_DNA.
DR   EMBL; AK036735; BAC29557.1; -; mRNA.
DR   EMBL; CH466533; EDL13488.1; -; Genomic_DNA.
DR   EMBL; BC114336; AAI14337.1; -; mRNA.
DR   EMBL; X62895; CAA44684.1; -; mRNA.
DR   EMBL; X62896; CAA44685.1; -; mRNA.
DR   EMBL; X62897; CAA44686.1; -; mRNA.
DR   CCDS; CCDS39471.1; -.
DR   PIR; I48773; I48773.
DR   RefSeq; NP_038519.1; NM_013491.2.
DR   UniGene; Mm.386757; -.
DR   ProteinModelPortal; Q64347; -.
DR   STRING; 10090.ENSMUSP00000031894; -.
DR   iPTMnet; Q64347; -.
DR   PhosphoSitePlus; Q64347; -.
DR   PaxDb; Q64347; -.
DR   PRIDE; Q64347; -.
DR   Ensembl; ENSMUST00000031894; ENSMUSP00000031894; ENSMUSG00000029862.
DR   GeneID; 12723; -.
DR   KEGG; mmu:12723; -.
DR   UCSC; uc009bqs.1; mouse.
DR   CTD; 1180; -.
DR   MGI; MGI:88417; Clcn1.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   HOGENOM; HOG000231297; -.
DR   HOVERGEN; HBG005332; -.
DR   InParanoid; Q64347; -.
DR   KO; K05010; -.
DR   OMA; SFTFPPG; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; Q64347; -.
DR   TreeFam; TF352264; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q64347; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; ENSMUSG00000029862; -.
DR   CleanEx; MM_CLCN1; -.
DR   ExpressionAtlas; Q64347; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IMP:MGI.
DR   GO; GO:0006936; P:muscle contraction; ISS:UniProtKB.
DR   GO; GO:0019227; P:neuronal action potential propagation; IMP:MGI.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002243; Cl_channel-1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01112; CLCHANNEL1.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   1: Evidence at protein level;
KW   CBS domain; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    994       Chloride channel protein 1.
FT                                /FTId=PRO_0000094430.
FT   TOPO_DOM      1    114       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    115    152       Helical. {ECO:0000250}.
FT   TRANSMEM    159    182       Helical. {ECO:0000250}.
FT   INTRAMEM    191    198       Helical. {ECO:0000250}.
FT   TRANSMEM    207    225       Helical. {ECO:0000250}.
FT   TRANSMEM    232    250       Helical. {ECO:0000250}.
FT   INTRAMEM    266    278       Helical. {ECO:0000250}.
FT   INTRAMEM    282    290       Helical. {ECO:0000250}.
FT   TRANSMEM    302    321       Helical. {ECO:0000250}.
FT   TRANSMEM    348    376       Helical. {ECO:0000250}.
FT   TRANSMEM    385    404       Helical. {ECO:0000250}.
FT   TRANSMEM    454    474       Helical. {ECO:0000250}.
FT   TRANSMEM    482    505       Helical. {ECO:0000250}.
FT   INTRAMEM    522    536       Helical. {ECO:0000250}.
FT   INTRAMEM    537    538       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   INTRAMEM    539    550       Helical. {ECO:0000250}.
FT   INTRAMEM    551    555       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   TRANSMEM    556    573       Helical. {ECO:0000250}.
FT   TOPO_DOM    574    994       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      609    668       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      827    882       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOTIF       188    192       Selectivity filter part_1. {ECO:0000250}.
FT   MOTIF       230    234       Selectivity filter part_2. {ECO:0000250}.
FT   MOTIF       482    486       Selectivity filter part_3. {ECO:0000250}.
FT   BINDING     189    189       Chloride. {ECO:0000250}.
FT   BINDING     578    578       Chloride. {ECO:0000250}.
FT   MOD_RES     892    892       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MUTAGEN     553    553       I->T: Causes myotonia.
FT                                {ECO:0000269|PubMed:8119941}.
FT   CONFLICT     65     65       Q -> H (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT     72     72       K -> Q (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT     76     78       GGM -> RGI (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT     82     83       MG -> TD (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT     88     88       M -> V (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    243    243       A -> T (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    483    484       GF -> VN (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    585    585       K -> E (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    620    620       C -> S (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    631    631       A -> T (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    746    746       N -> H (in Ref. 6; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    864    864       R -> T (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    877    877       E -> K (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    912    912       G -> S (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    918    919       DG -> GE (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    924    924       G -> E (in Ref. 1; CAB08359).
FT                                {ECO:0000305}.
FT   CONFLICT    944    944       A -> V (in Ref. 6; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   994 AA;  109794 MW;  3C523C4325B279BF CRC64;
     MERSQSQRHG GEQSWWGSAP QYQYMPFEHC TSYGLPSENG GLQHRPRKDM GPRHNAHPTQ
     IYGHQKEQYS YKAQDGGMPK KMGSSSTMDS LDEDHYSKCQ DCVHRLGRVL RRKLGEDWIF
     LVLLGLLMAL VSWCMDYVSA KSLQAYKWTY AQMKPSLPLQ YLAWVTFPLI LILFSALFCQ
     LISPQAVGSG IPEMKTILRG VVLKEYLTLK AFVAKVVALT AGLGSGIPVG KEGPFVHIAS
     ICAAVLSKFM SMFSGVYEQP YYYTDILTVG CAVGVGCCFG TPLGGVLFSI EVTSTYFAVR
     NYWRGFFAAT FSAFVFRVLA VWNKDAVTIT ALFRTNFRMD FPFDLKELPA FAVIGICCGF
     LGAVFVYLHR QVMLGVRKHK CLSQFLAKHR LLYPGIVTFV IASLTFPPGM GQFMAGELMP
     REAISTLFDN NTWVKHIGDP QSLGQSAVWL HPQVNVIIII LLFFVMKFWM SIVATTMPIP
     CGGFMPVFVL GAAFGRLVGE IMAMLFPEGI LFDDIIYKIL PGGYAVIGAA ALTGAVSHTV
     STAVICFELT GQIAHILPMM VAVILANMVA QSLQPSLYDS IIQVKKLPYL PDLGWNQLSK
     FTIFVEDIMV RDVKFVSASC TYGELRNLLQ ATTVKTLPLV DSKDSMILLG SVERSELQSL
     LQRHLCAERR LKAAQDMARK LSELPYNGKA QLAGDWHPGG RPESFAFVDE DEDEDLSRKM
     ELPLTPAPPP PSPPPPPSQF PIAPSNPEEP NGPLPSHKQP PEASDSADQR SSTFQRLLHC
     LLGKAHSKKK KITQDSTDLV DNMSPEEIEA WEREQLSQPV CFDCCCIDQS PFQLVEQTTL
     HKTHTLFSLL GLHLAYVTSM GKLRGVLALE ELQKAIEGHT KSGVQLRPPL ASFRNTTSIR
     KTPGGPPPPA EGWNVPEDGD GAPGREVMVP TMPETPVPPP SPEAPSCLAP ARAEGELEEL
     EMVGSLEPEE ELADILHGPS LRSTDEEDED ELIL
//
ID   TTYH3_XENLA             Reviewed;         522 AA.
AC   Q6GPA5;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 45.
DE   RecName: Full=Protein tweety homolog 3;
GN   Name=ttyh3;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable large-conductance Ca(2+)-activated chloride
CC       channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC073236; AAH73236.1; -; mRNA.
DR   RefSeq; NP_001085713.1; NM_001092244.1.
DR   UniGene; Xl.72740; -.
DR   GeneID; 444139; -.
DR   KEGG; xla:444139; -.
DR   CTD; 444139; -.
DR   Xenbase; XB-GENE-941475; ttyh3.
DR   HOVERGEN; HBG108621; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    522       Protein tweety homolog 3.
FT                                /FTId=PRO_0000312254.
FT   TOPO_DOM      1     43       Extracellular. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     65     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    109    211       Extracellular. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    233    238       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    260    386       Extracellular. {ECO:0000255}.
FT   TRANSMEM    387    407       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    408    522       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    127    127       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    351    351       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   522 AA;  58981 MW;  F53029D8859159F1 CRC64;
     MAAAISYTPP WWVNLLHRLP HLNLQWESLN GDFRPEDPDY QQSLMLLACV ALSCLALDLL
     FLLFYSFWFC CRHRKTEENT NADCCCTVWC VIVATLVCSA GIAVGFYGNG ETSDGIHRVT
     YSIRHVNRTM AGIHDRVSDT TTSLNQTVEP CLQNLEVMFT KQTDYLRIVQ RLQSLLYTLV
     QQTSEIPFWK NHYLLDEFAA QVDLFDWYRW LGYLGLLLFH VFICLLVLFG LIRNSKGTLI
     CVCFLGMMAL IISWASMGLE LAVAVGSSDF CVNPDTFVSK MVEEKSVLRA DILNYYLVCN
     TGSPNPFQQM LSSGHKALVE MQDDVRDLLR SAVKEYPNSK DYLVCIQGVL NSTEINLQHL
     TALVDCRGLH LDYVQSLTGF CYDGVEGLIY LVLFSFVTAL MFSSIVCSVP HTWQQRRANY
     EEGDEETTTP GTRQTHDNLY RVHMPSLYSC GSSYGSETSI PAAAHTVSNA PVTEYMSQNA
     NFQNPRCENT PLIGRESPPP SYTSSMRAKY LATNRPETDP VH
//
ID   CLCC_DICDI              Reviewed;         757 AA.
AC   Q75JF3; Q552G7;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-JUN-2017, entry version 82.
DE   RecName: Full=Chloride channel protein C;
GN   Name=clcC; ORFNames=DDB_G0276229;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A.,
RA   Bankier A.T., Dear P.H., Lehmann R., Baumgart C., Parra G.,
RA   Abril J.F., Guigo R., Kumpf K., Tunggal B., Cox E.C., Quail M.A.,
RA   Platzer M., Rosenthal A., Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels may
CC       have several functions including the regulation of cell volume,
CC       membrane potential stabilization and signal transduction (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000014; EAL69414.1; -; Genomic_DNA.
DR   RefSeq; XP_643243.1; XM_638151.1.
DR   ProteinModelPortal; Q75JF3; -.
DR   STRING; 44689.DDB0233304; -.
DR   PaxDb; Q75JF3; -.
DR   EnsemblProtists; EAL69414; EAL69414; DDB_G0276229.
DR   GeneID; 8620286; -.
DR   KEGG; ddi:DDB_G0276229; -.
DR   dictyBase; DDB_G0276229; clcC.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   InParanoid; Q75JF3; -.
DR   KO; K05016; -.
DR   OMA; QDERECM; -.
DR   PhylomeDB; Q75JF3; -.
DR   PRO; PR:Q75JF3; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 2.
PE   3: Inferred from homology;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    757       Chloride channel protein C.
FT                                /FTId=PRO_0000328045.
FT   TOPO_DOM      1     96       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TRANSMEM    141    161       Helical. {ECO:0000255}.
FT   TRANSMEM    196    216       Helical. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical. {ECO:0000255}.
FT   TRANSMEM    378    398       Helical. {ECO:0000255}.
FT   TRANSMEM    462    482       Helical. {ECO:0000255}.
FT   TRANSMEM    484    504       Helical. {ECO:0000255}.
FT   TRANSMEM    506    526       Helical. {ECO:0000255}.
FT   TRANSMEM    535    555       Helical. {ECO:0000255}.
FT   DOMAIN      600    667       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      710    757       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
SQ   SEQUENCE   757 AA;  85415 MW;  5C353B22B2A75C0D CRC64;
     MGSSLNKPLS DRVEDINNQS SMIYDPWRHR GDVNSTYHSS SSVTHRRRNH RLSPLEKQKM
     KNIQSLNFSV NDNLLQREEY EKTTKGLHLK KTFGKWIICL FLGVIVGCIA YVIKMVVQLL
     QGLKFHYTNH YVSNGLQGEA FLTFLGINLL FVFLSCLMVI VAGPLASSSG IPEVKGILNG
     VKVREALGFR ALLGKIVSLV LSFSSGLFVG PEGPMIHIGS AVGAAISQFK SSTMGFYPSL
     FLSYRNDRDK RDFISIGAAT GLAAAFGAPI GGVLFSIEEV SSFWSRQLTW RTFFTCVIAA
     FTTNFLLQGI GSSPDMHDTG LLTFGFSRLY LFRYSELLCF CFLGLIGGLL GAFFVFLNIH
     LNKWRKEKLK QNPYLRLFEA LFVSVVTSVV CYYASFIFDC RYQSNIVIET SVCEDQSNTE
     MVQFFCPDGM YSELGSLLFG NPDQALRRLY SRTNNMFTLP PLLVFTLISL FFSIWSSGLW
     VAGGLFVPMM MVGAGFGRLF GQTISMWFTN IDSSIYALVG SAAMMAGYCR MTVCIVVIMV
     ELTEGTQYLV PIILAVMISK WVGDFFNESV YEHLMEQKSI PFLQSKPPHS TNNIRISDVM
     SKNVVVLPEV CQVRLLVNIL NSNNHNAFPV INSGPYDNQR LYRGIILRDH ILVLLFYRVF
     YRGTGEEIYL DENFDFDKFT TETSKSPPPL SEMNFDQFEL DSFIDLRPYM NSSGVTIHNT
     FSFVEAYKLF RNMGLRHLPV IDINNEVVGM VTRNDLF
//
ID   CLIC6_RAT               Reviewed;         612 AA.
AC   Q811Q2;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   22-NOV-2017, entry version 113.
DE   RecName: Full=Chloride intracellular channel protein 6;
GN   Name=Clic6; Synonyms=Clic6b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH DRD2; DRD3 AND DRD4.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=14499480; DOI=10.1016/S0169-328X(03)00283-3;
RA   Griffon N., Jeanneteau F., Prieur F., Diaz J., Sokoloff P.;
RT   "CLIC6, a member of the intracellular chloride channel family,
RT   interacts with dopamine D(2)-like receptors.";
RL   Brain Res. Mol. Brain Res. 117:47-57(2003).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-264; SER-303;
RP   SER-321 AND SER-368, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May insert into membranes and form chloride ion
CC       channels. May play a critical role in water-secreting cells,
CC       possibly through the regulation of chloride ion transport (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with dopamine receptors DRD2, DRD3 and DRD4.
CC       {ECO:0000269|PubMed:14499480}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000305|PubMed:14499480}; Single-pass membrane protein
CC       {ECO:0000305|PubMed:14499480}. Note=Predominantly cytoplasmic.
CC       Upon chloride ion efflux from the cell, it is translocated to the
CC       plasma membrane (By similarity). Colocalizes with DRD3 at the
CC       plasma membrane. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Predominanlty expressed in brain, pituitary
CC       and stomach. In adult brain, it is restricted to the choroid
CC       plexus, the striatal proliferative subventricular zone and the
CC       cerebellum where it colocalizes with the D(3)R in the Purkinje
CC       cells of the lobules IX and X. {ECO:0000269|PubMed:14499480}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY191249; AAO38057.1; -; mRNA.
DR   RefSeq; NP_788267.1; NM_176078.2.
DR   UniGene; Rn.214050; -.
DR   ProteinModelPortal; Q811Q2; -.
DR   SMR; Q811Q2; -.
DR   STRING; 10116.ENSRNOP00000033206; -.
DR   iPTMnet; Q811Q2; -.
DR   PhosphoSitePlus; Q811Q2; -.
DR   PaxDb; Q811Q2; -.
DR   PRIDE; Q811Q2; -.
DR   GeneID; 304081; -.
DR   KEGG; rno:304081; -.
DR   UCSC; RGD:727938; rat.
DR   CTD; 54102; -.
DR   RGD; 727938; Clic6.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   HOGENOM; HOG000013008; -.
DR   HOVERGEN; HBG050996; -.
DR   InParanoid; Q811Q2; -.
DR   KO; K05026; -.
DR   PhylomeDB; Q811Q2; -.
DR   PRO; PR:Q811Q2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0031749; F:D2 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0031750; F:D3 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0031751; F:D4 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:RGD.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    612       Chloride intracellular channel protein 6.
FT                                /FTId=PRO_0000144220.
FT   TRANSMEM    397    417       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN      464    612       GST C-terminal.
FT   COMPBIAS    134    370       Glu-rich.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     264    264       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     321    321       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
SQ   SEQUENCE   612 AA;  64687 MW;  E9868AB4BDEF58D0 CRC64;
     MAEATEPKEV SSGSQGQPEG AVIEGPGEPG AADLEGREAS EGAAEAPRDL GEGAEAMASG
     KEEGGCGQDG EIGEVQAQDP RPGPGTETPG TSGAPGEAEA AECDSEGALI PQSGGGAKRQ
     QVQGTSSGLD AQGEAPEVPE DARREPEDPK ASEAGEEAES GQEALGGSAP ESQINPEVQG
     PVGDNMDTEA PAGEPQGSEG EPQGGGESSP QPQDEAIEIA AAEVGGHEPG ELAGASAADA
     KGEGETLRKD GFEEAAPEEA RVDSGENGFE EAAPEEARVD SGENRDQGRL QEETGEEEAR
     PESGLKGPCE EAIQEKAPDG SLDGEEAKST GHEESQVELS NHLAEETSAQ GGEELGRVNG
     RRENGPASEE GDLGQEHDIT LFVKAGSDGE SIGNCPFSQR LFMILWLKGV IFNVTTVDLK
     RKPADLQNLA PGTNPPFMTF DGEVKTDVNK IEEFLEEKLV PPRYPKLGTQ HPESNSAGND
     VFAKFSAFIK NTKKDANDIY EKNLLRALKK LDSYLNSPLP DEIDAYSTED VTVSQRKFLD
     GDELTLADCN LLPKLHIIKI VAKKYRGFEF PSEMTGIWRY LNNAYARDEF TNTCPADQEI
     EHAYSDAAKR MK
//
ID   ERIC_PSESM              Reviewed;         452 AA.
AC   Q87WD2;
DT   14-MAY-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   07-JUN-2017, entry version 87.
DE   RecName: Full=Chloride/fluoride channel protein;
GN   Name=eriC; OrderedLocusNames=PSPTO_4619;
OS   Pseudomonas syringae pv. tomato (strain ATCC BAA-871 / DC3000).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=223283;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-871 / DC3000;
RX   PubMed=12928499; DOI=10.1073/pnas.1731982100;
RA   Buell C.R., Joardar V., Lindeberg M., Selengut J., Paulsen I.T.,
RA   Gwinn M.L., Dodson R.J., DeBoy R.T., Durkin A.S., Kolonay J.F.,
RA   Madupu R., Daugherty S.C., Brinkac L.M., Beanan M.J., Haft D.H.,
RA   Nelson W.C., Davidsen T.M., Zafar N., Zhou L., Liu J., Yuan Q.,
RA   Khouri H.M., Fedorova N.B., Tran B., Russell D., Berry K.J.,
RA   Utterback T.R., Van Aken S.E., Feldblyum T.V., D'Ascenzo M.,
RA   Deng W.-L., Ramos A.R., Alfano J.R., Cartinhour S., Chatterjee A.K.,
RA   Delaney T.P., Lazarowitz S.G., Martin G.B., Schneider D.J., Tang X.,
RA   Bender C.L., White O., Fraser C.M., Collmer A.;
RT   "The complete genome sequence of the Arabidopsis and tomato pathogen
RT   Pseudomonas syringae pv. tomato DC3000.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10181-10186(2003).
RN   [2]
RP   FUNCTION IN TRANSPORT, INDUCTION, AND GENE NAME.
RC   STRAIN=ATCC BAA-871 / DC3000;
RX   PubMed=22194412; DOI=10.1126/science.1215063;
RA   Baker J.L., Sudarsan N., Weinberg Z., Roth A., Stockbridge R.B.,
RA   Breaker R.R.;
RT   "Widespread genetic switches and toxicity resistance proteins for
RT   fluoride.";
RL   Science 335:233-235(2012).
CC   -!- FUNCTION: Transports chloride and fluoride with similar
CC       efficiency. {ECO:0000269|PubMed:22194412}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- INDUCTION: By fluoride, via a fluoride-responsive riboswitch.
CC       {ECO:0000269|PubMed:22194412}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE016853; AAO58065.1; -; Genomic_DNA.
DR   RefSeq; NP_794370.1; NC_004578.1.
DR   RefSeq; WP_011105086.1; NC_004578.1.
DR   ProteinModelPortal; Q87WD2; -.
DR   STRING; 223283.PSPTO_4619; -.
DR   EnsemblBacteria; AAO58065; AAO58065; PSPTO_4619.
DR   GeneID; 1186302; -.
DR   KEGG; pst:PSPTO_4619; -.
DR   PATRIC; fig|223283.9.peg.4732; -.
DR   eggNOG; ENOG4107R4J; Bacteria.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000151535; -.
DR   OMA; NPYYRVL; -.
DR   OrthoDB; POG091H0JVQ; -.
DR   PhylomeDB; Q87WD2; -.
DR   Proteomes; UP000002515; Chromosome.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    452       Chloride/fluoride channel protein.
FT                                /FTId=PRO_0000428836.
FT   TRANSMEM     23     43       Helical. {ECO:0000255}.
FT   TRANSMEM     57     77       Helical. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TRANSMEM    160    180       Helical. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TRANSMEM    315    337       Helical. {ECO:0000255}.
FT   TRANSMEM    344    364       Helical. {ECO:0000255}.
FT   TRANSMEM    386    408       Helical. {ECO:0000255}.
SQ   SEQUENCE   452 AA;  48306 MW;  F9583A01AEFC8E9C CRC64;
     MAGQMSKFRR PEQLDLLPYI AKWLALAGLV ALLAGSASAL FLLSLDHATQ WRETHPWVIW
     LLPVAGFAVG LAYHLIGKPV DAGNNLIIDE IHDPKKIVPL RMVPMVLIGT VVSHLFGASV
     GREGTAVQMG GALADQLTHV FRLRREDRRV ILMAGISAGF ASVFGTPLAG ALFGLEVLAI
     GRMRYDALFP CVVAAIVADQ VGQAWGVVHT HYVIGEVVPV QLWSVMAVVA AGIVFGLTGL
     LFATATHKLG AFVKRLITYS PLRPFAGGLL IAVAVWALGS NHYIDVDKYI GLGIPSIVQS
     FQMPMAPWDW LGKMVFTVVS LGTGFKGGEV TPLFYIGATL GNALAPLLHL PFGMLAGIGF
     VAVFAGAANT PLATIVMAME LFGPEIAPLA AIACIASYLV SGHTGIYHAQ RVGHSKHHRP
     LPEEIRLSDI KQFHAQSESA SERKVTLAGE EK
//
ID   BEST2_MOUSE             Reviewed;         508 AA.
AC   Q8BGM5; Q6H1U9; Q8VCM0;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   30-AUG-2017, entry version 107.
DE   RecName: Full=Bestrophin-2;
DE   AltName: Full=Vitelliform macular dystrophy 2-like protein 1;
GN   Name=Best2; Synonyms=Vmd2l1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Colon;
RX   PubMed=15218265; DOI=10.1159/000078016;
RA   Kraemer F., Stoehr H., Weber B.H.F.;
RT   "Cloning and characterization of the murine Vmd2 RFP-TM gene family.";
RL   Cytogenet. Genome Res. 105:107-114(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=18400985; DOI=10.1152/ajpcell.00398.2007;
RA   Qu Z., Hartzell H.C.;
RT   "Bestrophin Cl- channels are highly permeable to HCO3-.";
RL   Am. J. Physiol. 294:C1371-C1377(2008).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to
CC       bicarbonate. {ECO:0000269|PubMed:18400985}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Mainly confined to the retinal pigment
CC       epithelium and colon.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH19528.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH31186.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH36157.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH36163.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY450428; AAS09923.1; -; mRNA.
DR   EMBL; BC019528; AAH19528.1; ALT_INIT; mRNA.
DR   EMBL; BC031186; AAH31186.1; ALT_INIT; mRNA.
DR   EMBL; BC036157; AAH36157.2; ALT_INIT; mRNA.
DR   EMBL; BC036163; AAH36163.2; ALT_INIT; mRNA.
DR   CCDS; CCDS52621.1; -.
DR   RefSeq; NP_001123666.1; NM_001130194.1.
DR   RefSeq; XP_006530883.1; XM_006530820.1.
DR   UniGene; Mm.215154; -.
DR   ProteinModelPortal; Q8BGM5; -.
DR   SMR; Q8BGM5; -.
DR   STRING; 10090.ENSMUSP00000053408; -.
DR   PhosphoSitePlus; Q8BGM5; -.
DR   PaxDb; Q8BGM5; -.
DR   PRIDE; Q8BGM5; -.
DR   GeneID; 212989; -.
DR   KEGG; mmu:212989; -.
DR   UCSC; uc009mov.1; mouse.
DR   CTD; 54831; -.
DR   MGI; MGI:2387588; Best2.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   HOGENOM; HOG000115678; -.
DR   HOVERGEN; HBG044928; -.
DR   InParanoid; Q8BGM5; -.
DR   KO; K13879; -.
DR   PhylomeDB; Q8BGM5; -.
DR   TreeFam; TF315803; -.
DR   PRO; PR:Q8BGM5; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_BEST2; -.
DR   GO; GO:0034707; C:chloride channel complex; IDA:BHF-UCL.
DR   GO; GO:0005929; C:cilium; IDA:HGNC.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IDA:MGI.
DR   GO; GO:1902476; P:chloride transmembrane transport; IMP:BHF-UCL.
DR   GO; GO:0006821; P:chloride transport; IDA:MGI.
DR   GO; GO:0051899; P:membrane depolarization; IDA:HGNC.
DR   GO; GO:0007608; P:sensory perception of smell; IEP:HGNC.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    508       Bestrophin-2.
FT                                /FTId=PRO_0000143119.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     70       Extracellular. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TOPO_DOM     92    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       {ECO:0000255}.
FT   TOPO_DOM    250    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    508       Cytoplasmic. {ECO:0000255}.
FT   CONFLICT    462    462       P -> S (in Ref. 1; AAS09923).
FT                                {ECO:0000305}.
SQ   SEQUENCE   508 AA;  57023 MW;  8730B806F0576B3D CRC64;
     MTVTYTARVA NARFGGFSQL LLLWRGSIYK LLWRELLCFL GLYMALSAAY RFLLAEEQKR
     YFEKLVIYCD QYASLIPVSF VLGFYVTLVV HRWWNQYLCM PLPDALMCIV AGTVHGRDDR
     GRLYRRTLMR YAGLSAVLIL RSVSTAVFKR FPTIDHVVEA GFMTREERKK FENLNSSYNK
     YWVPCVWFSS LAAQARREGR IRDNSALKLL LEELNVFRSK CGMLFHYDWI SIPLVYTQVV
     TIAVYSYFLA CLIGRQFLDP AQGYKDHTLD LCVPIFTLLQ FFFYAGWLKV AEQLINPFGE
     DDDDFETNFL IDRNFQVSML AVDEMYDDLA MLEKDLYWDA AEARAPYTAA TAFLLQQPSF
     QGSTFDIALA KEDMQFQRLD GVDGPLGEVH GDFLQRLLPA GAGSVGPLGR RLSLLRRKNS
     CVSEASTAAS CGCAGAADGG GVECGCGDPL LDPSLREPEL EPPACPEPPA PIPGPTPEPF
     TTVSIPGPRA PAPPWLPSPI GEEEESPA
//
ID   ANO1_MOUSE              Reviewed;         960 AA.
AC   Q8BHY3; Q6P5C6; Q8BI26; Q99JK1;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   25-OCT-2017, entry version 118.
DE   RecName: Full=Anoctamin-1;
DE   AltName: Full=Transmembrane protein 16A;
GN   Name=Ano1; Synonyms=Tmem16a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   PORE-FORMING REGION, KNOCKDOWN, AND MUTAGENESIS OF ARG-621; CYS-625;
RP   CYS-630; CYS-635; LYS-645 AND LYS-668.
RX   PubMed=18724360; DOI=10.1038/nature07313;
RA   Yang Y.D., Cho H., Koo J.Y., Tak M.H., Cho Y., Shim W.-S., Park S.P.,
RA   Lee J., Lee B., Kim B.-M., Raouf R., Shin Y.K., Oh U.;
RT   "TMEM16A confers receptor-activated calcium-dependent chloride
RT   conductance.";
RL   Nature 455:1210-1215(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Head, Kidney, and Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J, and Czech II; TISSUE=Eye, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=18585372; DOI=10.1016/j.ydbio.2008.06.009;
RA   Rock J.R., Futtner C.R., Harfe B.D.;
RT   "The transmembrane protein TMEM16A is required for normal development
RT   of the murine trachea.";
RL   Dev. Biol. 321:141-149(2008).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=18729231; DOI=10.1002/dvdy.21676;
RA   Rock J.R., Harfe B.D.;
RT   "Expression of TMEM16 paralogs during murine embryogenesis.";
RL   Dev. Dyn. 237:2566-2574(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Lung, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=20056604; DOI=10.1074/jbc.M109.065367;
RA   Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M.,
RA   Martins J.R., Kunzelmann K.;
RT   "Expression and function of epithelial anoctamins.";
RL   J. Biol. Chem. 285:7838-7845(2010).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22075693; DOI=10.1152/ajpcell.00140.2011;
RA   Duran C., Qu Z., Osunkoya A.O., Cui Y., Hartzell H.C.;
RT   "ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular
RT   proteins.";
RL   Am. J. Physiol. 302:C482-C493(2012).
RN   [9]
RP   MUTAGENESIS OF LYS-588.
RX   PubMed=23021219; DOI=10.1016/j.cell.2012.07.036;
RA   Yang H., Kim A., David T., Palmer D., Jin T., Tien J., Huang F.,
RA   Cheng T., Coughlin S.R., Jan Y.N., Jan L.Y.;
RT   "TMEM16F forms a Ca(2+)-activated cation channel required for lipid
RT   scrambling in platelets during blood coagulation.";
RL   Cell 151:111-122(2012).
RN   [10]
RP   REVIEW.
RX   PubMed=22302790; DOI=10.1113/expphysiol.2011.058214;
RA   Winpenny J.P., Gray M.A.;
RT   "The anoctamin (TMEM16) gene family: calcium-activated chloride
RT   channels come of age.";
RL   Exp. Physiol. 97:175-176(2012).
RN   [11]
RP   REVIEW, AND FUNCTION.
RX   PubMed=21908539; DOI=10.1113/expphysiol.2011.058206;
RA   Kunzelmann K., Schreiber R., Kmit A., Jantarajit W., Martins J.R.,
RA   Faria D., Kongsuphol P., Ousingsawat J., Tian Y.;
RT   "Expression and function of epithelial anoctamins.";
RL   Exp. Physiol. 97:184-192(2012).
RN   [12]
RP   REVIEW, AND FUNCTION.
RX   PubMed=22002868; DOI=10.1113/expphysiol.2011.058248;
RA   Sanders K.M., Zhu M.H., Britton F., Koh S.D., Ward S.M.;
RT   "Anoctamins and gastrointestinal smooth muscle excitability.";
RL   Exp. Physiol. 97:200-206(2012).
RN   [13]
RP   INTERACTION WITH TRPV4.
RX   PubMed=24509911; DOI=10.1096/fj.13-243436;
RA   Takayama Y., Shibasaki K., Suzuki Y., Yamanaka A., Tominaga M.;
RT   "Modulation of water efflux through functional interaction between
RT   TRPV4 and TMEM16A/anoctamin 1.";
RL   FASEB J. 28:2238-2248(2014).
CC   -!- FUNCTION: Calcium-activated chloride channel (CaCC) which plays an
CC       important role in transepithelial anion transport and smooth
CC       muscle contraction. Required for the normal functioning of the
CC       interstitial cells of Cajal (ICCs) which generate electrical
CC       pacemaker activity in gastrointestinal smooth muscles. Acts as a
CC       major contributor to basal and stimulated chloride conductance in
CC       airway epithelial cells and plays an important role in tracheal
CC       cartilage development. {ECO:0000269|PubMed:18585372,
CC       ECO:0000269|PubMed:18724360, ECO:0000269|PubMed:21908539,
CC       ECO:0000269|PubMed:22002868, ECO:0000269|PubMed:22075693}.
CC   -!- ENZYME REGULATION: ATP and calmodulin are essential for its
CC       activation. Channel activity is inhibited by CFTR protein and by
CC       chloride inhibitors such as niflumic acid (NFA) and 4,4'-
CC       diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with CFTR (By similarity). Interacts
CC       with TRPV4 (PubMed:24509911). {ECO:0000250|UniProtKB:Q5XXA6,
CC       ECO:0000269|PubMed:24509911}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18585372,
CC       ECO:0000269|PubMed:22075693}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q5XXA6}.
CC       Note=Cytoplasmic localization seen in neoplastic cells of head and
CC       neck squamous cell carcinoma (HNSCC) tumors.
CC       {ECO:0000250|UniProtKB:Q5XXA6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8BHY3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8BHY3-2; Sequence=VSP_025672;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pulmonary bronchiole
CC       epithelial cells, pancreatic and submandibular gland acinar cells,
CC       kidney proximal tubule, all retinal cell layers, most sensory
CC       cells of dorsal root ganglia, Leydig cells and spermatocytes (at
CC       protein level). Expressed at high levels in the thyroid gland and
CC       gastrointestinal muscles. {ECO:0000269|PubMed:18585372,
CC       ECO:0000269|PubMed:18724360, ECO:0000269|PubMed:20056604}.
CC   -!- DEVELOPMENTAL STAGE: In the developing respiratory system,
CC       expressed in epithelium of trachea and lung at E12.5 and E14.5 but
CC       not detected in distal epithelial tips. Expressed in the
CC       mesenchyme adjacent to the proximal conducting airway epithelium
CC       at E14.5 but not at E16.5. Epithelial expression persists at
CC       E16.5. At E18.5, high levels detected only in epithelial cells of
CC       terminal sacules. In the developing gastrointestinal tract,
CC       expressed in the esophageal mesenchyme and epithelium of posterior
CC       stomach and intestine. In the developing skeleton, expressed in
CC       the perichondria of the neural arch of developing vertebrae at
CC       E14.5 and E16.5. In developing skin, expression is restricted to
CC       basal layers of the epidermis at E16.5.
CC       {ECO:0000269|PubMed:18729231}.
CC   -!- DOMAIN: The region spanning the fifth and sixth transmembrane
CC       domains probably forms the pore-forming region.
CC   -!- DISRUPTION PHENOTYPE: Mice display severe tracheomalacia with gaps
CC       in the tracheal cartilage rings along the entire length of the
CC       trachea. 90% of mutants die within the first nine days of
CC       postnatal life and no mutants survive longer than 30 days
CC       postpartum. Knockdown of Ano1 reduces calcium-activated chloride
CC       currents and saliva production. {ECO:0000269|PubMed:18585372}.
CC   -!- MISCELLANEOUS: The term 'anoctamin' was coined because these
CC       channels are anion selective and have eight (OCT) transmembrane
CC       segments. There is some dissatisfaction in the field with the Ano
CC       nomenclature because it is not certain that all the members of
CC       this family are anion channels or have the 8-transmembrane
CC       topology.
CC   -!- SIMILARITY: Belongs to the anoctamin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH06062.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC26230.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC26398.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC35051.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK028991; BAC26230.1; ALT_INIT; mRNA.
DR   EMBL; AK029329; BAC26398.1; ALT_INIT; mRNA.
DR   EMBL; AK052589; BAC35051.1; ALT_SEQ; mRNA.
DR   EMBL; BC006062; AAH06062.1; ALT_INIT; mRNA.
DR   EMBL; BC062959; AAH62959.1; -; mRNA.
DR   RefSeq; NP_001229278.1; NM_001242349.1.
DR   RefSeq; NP_848757.4; NM_178642.5.
DR   UniGene; Mm.26700; -.
DR   PDB; 5NL2; EM; 6.60 A; A/B=1-960.
DR   PDBsum; 5NL2; -.
DR   ProteinModelPortal; Q8BHY3; -.
DR   SMR; Q8BHY3; -.
DR   IntAct; Q8BHY3; 1.
DR   STRING; 10090.ENSMUSP00000113899; -.
DR   TCDB; 1.A.17.1.25; the calcium-dependent chloride channel (ca-clc) family.
DR   iPTMnet; Q8BHY3; -.
DR   PhosphoSitePlus; Q8BHY3; -.
DR   PaxDb; Q8BHY3; -.
DR   PRIDE; Q8BHY3; -.
DR   Ensembl; ENSMUST00000033393; ENSMUSP00000033393; ENSMUSG00000031075. [Q8BHY3-2]
DR   GeneID; 101772; -.
DR   KEGG; mmu:101772; -.
DR   CTD; 55107; -.
DR   MGI; MGI:2142149; Ano1.
DR   eggNOG; KOG2514; Eukaryota.
DR   eggNOG; ENOG410XS4S; LUCA.
DR   GeneTree; ENSGT00760000119015; -.
DR   HOGENOM; HOG000006509; -.
DR   HOVERGEN; HBG069519; -.
DR   InParanoid; Q8BHY3; -.
DR   KO; K19496; -.
DR   PhylomeDB; Q8BHY3; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q8BHY3; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000031075; -.
DR   ExpressionAtlas; Q8BHY3; baseline and differential.
DR   Genevisible; Q8BHY3; MM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:MGI.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; ISO:MGI.
DR   GO; GO:0005254; F:chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0015111; F:iodide transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:MGI.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0006812; P:cation transport; ISO:MGI.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IMP:UniProtKB.
DR   GO; GO:0015705; P:iodide transport; ISO:MGI.
DR   GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0060438; P:trachea development; IMP:UniProtKB.
DR   InterPro; IPR032394; Anoct_dimer.
DR   InterPro; IPR007632; Anoctamin.
DR   InterPro; IPR031287; Anoctamin-1.
DR   PANTHER; PTHR12308; PTHR12308; 1.
DR   PANTHER; PTHR12308:SF13; PTHR12308:SF13; 1.
DR   Pfam; PF16178; Anoct_dimer; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Cytoplasm; Developmental protein;
KW   Glycoprotein; Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    960       Anoctamin-1.
FT                                /FTId=PRO_0000288436.
FT   TOPO_DOM      1    333       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical. {ECO:0000255}.
FT   TOPO_DOM    355    402       Extracellular. {ECO:0000255}.
FT   TRANSMEM    403    423       Helical. {ECO:0000255}.
FT   TOPO_DOM    424    493       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    494    514       Helical. {ECO:0000255}.
FT   TOPO_DOM    515    539       Extracellular. {ECO:0000255}.
FT   TRANSMEM    540    560       Helical. {ECO:0000255}.
FT   TOPO_DOM    561    581       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    582    602       Helical. {ECO:0000255}.
FT   TOPO_DOM    603    705       Extracellular. {ECO:0000255}.
FT   TRANSMEM    706    726       Helical. {ECO:0000255}.
FT   TOPO_DOM    727    765       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    766    786       Helical. {ECO:0000255}.
FT   TOPO_DOM    787    856       Extracellular. {ECO:0000255}.
FT   TRANSMEM    857    877       Helical. {ECO:0000255}.
FT   TOPO_DOM    878    960       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5XXA6}.
FT   CARBOHYD    806    806       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     448    451       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025672.
FT   MUTAGEN     588    588       K->Q: Decreased permeability to chloride
FT                                ions. {ECO:0000269|PubMed:23021219}.
FT   MUTAGEN     621    621       R->E: Reduced anion permeability and
FT                                increased cation permeability.
FT                                {ECO:0000269|PubMed:18724360}.
FT   MUTAGEN     625    625       C->A: No effect of cysteine-modifying
FT                                agent MTSET on ion permeability in
FT                                contrast to wild-type where MTSET blocks
FT                                current. {ECO:0000269|PubMed:18724360}.
FT   MUTAGEN     630    630       C->A: No effect of cysteine-modifying
FT                                agent MTSET on ion permeability in
FT                                contrast to wild-type where MTSET blocks
FT                                current. {ECO:0000269|PubMed:18724360}.
FT   MUTAGEN     635    635       C->A: No effect of cysteine-modifying
FT                                agent MTSET on ion permeability in
FT                                contrast to wild-type where MTSET blocks
FT                                current. {ECO:0000269|PubMed:18724360}.
FT   MUTAGEN     645    645       K->E: Reduced anion permeability and
FT                                increased cation permeability.
FT                                {ECO:0000269|PubMed:18724360}.
FT   MUTAGEN     668    668       K->E: Reduced anion permeability and
FT                                increased cation permeability.
FT                                {ECO:0000269|PubMed:18724360}.
SQ   SEQUENCE   960 AA;  110916 MW;  BFD0112FD310CE88 CRC64;
     MRVPEKYSTL PAEDRSVHIV NICAIEDLGY LPSEGTLLNS LSVDPDAECK YGLYFRDGKR
     KVDYILVYHH KRASGSRTLA RRGLQNDMVL GTRSVRQDQP LPGKGSPVDA GSPEVPMDYH
     EDDKRFRREE YEGNLLEAGL ELENDEDTKI HGVGFVKIHA PWHVLCREAE FLKLKMPTKK
     VYHISETRGL LKTINSVLQK ITDPIQPKVA EHRPQTTKRL SYPFSREKQH LFDLTDRDSF
     FDSKTRSTIV YEILKRTTCT KAKYSMGITS LLANGVYSAA YPLHDGDYEG DNVEFNDRKL
     LYEEWASYGV FYKYQPIDLV RKYFGEKVGL YFAWLGAYTQ MLIPASIVGV IVFLYGCATV
     DENIPSMEMC DQRYNITMCP LCDKTCSYWK MSSACATARA SHLFDNPATV FFSVFMALWA
     ATFMEHWKRK QMRLNYRWDL TGFEEEEEAV KDHPRAEYEA RVLEKSLRKE SRNKETDKVK
     LTWRDRFPAY FTNLVSIIFM IAVTFAIVLG VIIYRISTAA ALAMNSSPSV RSNIRVTVTA
     TAVIINLVVI ILLDEVYGCI ARWLTKIEVP KTEKSFEERL TFKAFLLKFV NSYTPIFYVA
     FFKGRFVGRP GDYVYIFRSF RMEECAPGGC LMELCIQLSI IMLGKQLIQN NLFEIGIPKM
     KKFIRYLKLR RQSPSDREEY VKRKQRYEVD FNLEPFAGLT PEYMEMIIQF GFVTLFVASF
     PLAPLFALLN NIIEIRLDAK KFVTELRRPV AIRAKDIGIW YNILRGVGKL AVIINAFVIS
     FTSDFIPRLV YLYMYSQNGT MHGFVNHTLS SFNVSDFQNG TAPNDPLDLG YEVQICRYKD
     YREPPWSEHK YDISKDFWAV LAARLAFVIV FQNLVMFMSD FVDWVIPDIP KDISQQIHKE
     KVLMVELFMR EEQGKQQLLD TWMEKEKPRD VPCNNHSPTT HPEAGDGSPV PSYEYHGDAL
//
ID   ANO2_MOUSE              Reviewed;        1002 AA.
AC   Q8CFW1; C4N788; Q8C8N6;
DT   04-NOV-2008, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 2.
DT   25-OCT-2017, entry version 103.
DE   RecName: Full=Anoctamin-2 {ECO:0000250|UniProtKB:Q9NQ90};
DE   AltName: Full=Transmembrane protein 16B {ECO:0000312|EMBL:AAH33409.1};
GN   Name=Ano2 {ECO:0000250|UniProtKB:Q9NQ90};
GN   Synonyms=Tmem16b {ECO:0000312|EMBL:AAH33409.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, GLYCOSYLATION, SUBCELLULAR
RP   LOCATION, SUBUNIT, INTERACTION WITH DLG4, MUTAGENESIS OF
RP   1000-THR--ASN-1002, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Retina;
RX   PubMed=19474308; DOI=10.1523/JNEUROSCI.5546-08.2009;
RA   Stoehr H., Heisig J.B., Benz P.M., Schoeberl S., Milenkovic V.M.,
RA   Strauss O., Aartsen W.M., Wijnholds J., Weber B.H.F., Schulz H.L.;
RT   "TMEM16B, a novel protein with calcium-dependent chloride channel
RT   activity, associates with a presynaptic protein complex in
RT   photoreceptor terminals.";
RL   J. Neurosci. 29:6809-6818(2009).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAC32073.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-543.
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC32073.1};
RC   TISSUE=Retina {ECO:0000312|EMBL:BAC32073.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH33409.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 59-1002.
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH33409.1};
RC   TISSUE=Eye {ECO:0000312|EMBL:AAH33409.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   DEVELOPMENTAL STAGE.
RX   PubMed=18729231; DOI=10.1002/dvdy.21676;
RA   Rock J.R., Harfe B.D.;
RT   "Expression of TMEM16 paralogs during murine embryogenesis.";
RL   Dev. Dyn. 237:2566-2574(2008).
RN   [5]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=19475416; DOI=10.1007/s00424-009-0684-9;
RA   Pifferi S., Dibattista M., Menini A.;
RT   "TMEM16B induces chloride currents activated by calcium in mammalian
RT   cells.";
RL   Pflugers Arch. 458:1023-1038(2009).
RN   [6]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=19561302; DOI=10.1073/pnas.0903304106;
RA   Stephan A.B., Shum E.Y., Hirsh S., Cygnar K.D., Reisert J., Zhao H.;
RT   "ANO2 is the cilial calcium-activated chloride channel that may
RT   mediate olfactory amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:11776-11781(2009).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=20056604; DOI=10.1074/jbc.M109.065367;
RA   Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M.,
RA   Martins J.R., Kunzelmann K.;
RT   "Expression and function of epithelial anoctamins.";
RL   J. Biol. Chem. 285:7838-7845(2010).
RN   [8]
RP   FUNCTION.
RX   PubMed=22075693; DOI=10.1152/ajpcell.00140.2011;
RA   Duran C., Qu Z., Osunkoya A.O., Cui Y., Hartzell H.C.;
RT   "ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular
RT   proteins.";
RL   Am. J. Physiol. 302:C482-C493(2012).
RN   [9]
RP   REVIEW.
RX   PubMed=22302790; DOI=10.1113/expphysiol.2011.058214;
RA   Winpenny J.P., Gray M.A.;
RT   "The anoctamin (TMEM16) gene family: calcium-activated chloride
RT   channels come of age.";
RL   Exp. Physiol. 97:175-176(2012).
RN   [10]
RP   REVIEW, AND FUNCTION.
RX   PubMed=21890523; DOI=10.1113/expphysiol.2011.058230;
RA   Pifferi S., Cenedese V., Menini A.;
RT   "Anoctamin 2/TMEM16B: a calcium-activated chloride channel in
RT   olfactory transduction.";
RL   Exp. Physiol. 97:193-199(2012).
CC   -!- FUNCTION: Calcium-activated chloride channel (CaCC) which may play
CC       a role in olfactory signal transduction. Odorant molecules bind to
CC       odor-sensing receptors (OSRs), leading to an increase in calcium
CC       entry that activates CaCC current which amplifies the
CC       depolarization of the OSR cells, ANO2 seems to be the underlying
CC       chloride channel involved in this process. May mediate light
CC       perception amplification in retina. {ECO:0000269|PubMed:19474308,
CC       ECO:0000269|PubMed:19475416, ECO:0000269|PubMed:19561302,
CC       ECO:0000269|PubMed:21890523, ECO:0000269|PubMed:22075693}.
CC   -!- ENZYME REGULATION: Channel activity is repressed by chloride
CC       inhibitors; strongly by niflumic acid (NFA), partially by
CC       flufenamic acid (FFA), and only slightly by meclofenamic acid
CC       (MFA), 5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), 4-
CC       acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate (SITS), and
CC       4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS).
CC       {ECO:0000269|PubMed:19475416}.
CC   -!- SUBUNIT: Component of a presynaptic protein complex recruited to
CC       specialized plasma membrane domains of photoreceptors. Interacts
CC       with DLG4 by its C-terminal region. {ECO:0000269|PubMed:19474308}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19474308,
CC       ECO:0000269|PubMed:19561302}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19474308, ECO:0000269|PubMed:19561302}.
CC   -!- TISSUE SPECIFICITY: Expressed in retina, especially in the
CC       photoreceptor synaptic terminals, and in olfactory epithelium,
CC       particularly in sensory neurons (OSNs) and cilia (at protein
CC       level). Also observed in retinal pigment epithelium (RPE),
CC       olfactory bulb, brain, and cortex. {ECO:0000269|PubMed:19474308,
CC       ECO:0000269|PubMed:19561302, ECO:0000269|PubMed:20056604}.
CC   -!- DEVELOPMENTAL STAGE: Detected in the mantle layer of the neural
CC       tube and in the dorsal root ganglia at E14.5. In developing skin,
CC       expression is restricted to basal layers of the epidermis at
CC       E16.5. {ECO:0000269|PubMed:18729231}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:19474308}.
CC   -!- MISCELLANEOUS: The term 'anoctamin' was coined because these
CC       channels are anion selective and have eight (OCT) transmembrane
CC       segments. There is some dissatisfaction in the field with the Ano
CC       nomenclature because it is not certain that all the members of
CC       this family are anion channels or have the 8-transmembrane
CC       topology.
CC   -!- SIMILARITY: Belongs to the anoctamin family.
CC       {ECO:0000250|UniProtKB:Q9NQ90}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33409.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC32073.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ384096; ACL36051.1; -; mRNA.
DR   EMBL; AK044763; BAC32073.1; ALT_SEQ; mRNA.
DR   EMBL; BC033409; AAH33409.1; ALT_INIT; mRNA.
DR   CCDS; CCDS39643.2; -.
DR   RefSeq; NP_705817.2; NM_153589.2.
DR   RefSeq; XP_006506182.1; XM_006506119.1.
DR   UniGene; Mm.333398; -.
DR   STRING; 10090.ENSMUSP00000125303; -.
DR   iPTMnet; Q8CFW1; -.
DR   PhosphoSitePlus; Q8CFW1; -.
DR   PaxDb; Q8CFW1; -.
DR   PRIDE; Q8CFW1; -.
DR   Ensembl; ENSMUST00000160496; ENSMUSP00000125303; ENSMUSG00000038115.
DR   GeneID; 243634; -.
DR   KEGG; mmu:243634; -.
DR   UCSC; uc009duv.1; mouse.
DR   CTD; 57101; -.
DR   MGI; MGI:2387214; Ano2.
DR   eggNOG; KOG2514; Eukaryota.
DR   eggNOG; ENOG410XS4S; LUCA.
DR   GeneTree; ENSGT00760000119015; -.
DR   HOGENOM; HOG000006509; -.
DR   HOVERGEN; HBG069519; -.
DR   InParanoid; Q8CFW1; -.
DR   KO; K19497; -.
DR   OMA; DEDKLTW; -.
DR   OrthoDB; EOG091G01JF; -.
DR   TreeFam; TF314265; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   ChiTaRS; Ano2; mouse.
DR   PRO; PR:Q8CFW1; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; ENSMUSG00000038115; -.
DR   ExpressionAtlas; Q8CFW1; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0097730; C:non-motile cilium; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:MGI.
DR   GO; GO:0006821; P:chloride transport; IDA:MGI.
DR   InterPro; IPR032394; Anoct_dimer.
DR   InterPro; IPR007632; Anoctamin.
DR   InterPro; IPR031288; Anoctamin-2.
DR   PANTHER; PTHR12308; PTHR12308; 1.
DR   PANTHER; PTHR12308:SF20; PTHR12308:SF20; 1.
DR   Pfam; PF16178; Anoct_dimer; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1002       Anoctamin-2.
FT                                /FTId=PRO_0000353187.
FT   TOPO_DOM      1    364       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    365    385       Helical. {ECO:0000255}.
FT   TOPO_DOM    386    433       Extracellular. {ECO:0000255}.
FT   TRANSMEM    434    454       Helical. {ECO:0000255}.
FT   TOPO_DOM    455    536       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    537    557       Helical. {ECO:0000255}.
FT   TOPO_DOM    558    580       Extracellular. {ECO:0000255}.
FT   TRANSMEM    581    601       Helical. {ECO:0000255}.
FT   TOPO_DOM    602    621       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    622    642       Helical. {ECO:0000255}.
FT   TOPO_DOM    643    746       Extracellular. {ECO:0000255}.
FT   TRANSMEM    747    767       Helical. {ECO:0000255}.
FT   TOPO_DOM    768    799       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    800    820       Helical. {ECO:0000255}.
FT   TOPO_DOM    821    905       Extracellular. {ECO:0000255}.
FT   TRANSMEM    906    926       Helical. {ECO:0000255}.
FT   TOPO_DOM    927   1002       Cytoplasmic. {ECO:0000255}.
FT   MOTIF      1000   1002       DLG4 binding (PDZ).
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    839    839       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    847    847       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    854    854       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN    1000   1002       Missing: Impaired interaction with DLG4.
FT                                {ECO:0000269|PubMed:19474308}.
SQ   SEQUENCE   1002 AA;  114134 MW;  8514FC9CC13F78C7 CRC64;
     MAAPGLRDIP LLPGSPRRLS SRTVARGSQG PKHGQQYLKV PGHRAPGQRD NSSLHPSQVS
     RRESSRDRSV INNYLDANEP PSSEARLSRM HFHDNQRKVD YVLAYHYRKR GAHLGHGSPG
     HSLAVISNGE TGKERHGGGP GDVELGPLDA LEEERREQRD EFEHNLMAAG LELEKDLESK
     SQGSVFVRIH APWQVLAREA EFLKIKVPTK KMYEIKAGGS IAKKFSAILQ TLSSPLQPRV
     PEHSNNRMKN LSYPFSREKM YLYNIQEKDT FFDNATRSRI VHEILKRTAC SRANNTMGIN
     SLIANNIYEA AYPLHDGEYD SPGDDMNDRK LLYQEWARYG VFYKFQPIDL IRKYFGEKIG
     LYFAWLGLYT SFLIPSSVIG VIVFLYGCAT IEEDIPSKEM CDHQNAFTMC PLCDKSCDYW
     NLSSACGTAR ASHLFDNPAT VFFSIFMALW ATMFLENWKR LQMRLGYFWD LTGIEEEEER
     SQEHSRPEYE TKVREKLLKE SGKSAVQKLE ANSPEDDEDD EDKLTWKDRF PGYLMNFASI
     LFMIALTFSI VFGVIVYRIT TAAALSLNKA TRSNVRVTVT ATAVIINLVV ILILDEIYGA
     VAKWLTKIEV PKTEQTFEER LILKAFLLKF VNAYSPIFYV AFFKGRFVGR PGSYVYVFDG
     YRMEECAPGG CLMELCIQLS IIMLGKQLIQ NNIFEIGVPK LKKLFRKLKD ETEPGESDPD
     HSKRPEQWDL DHSLEPYTGL TPEYMEMIIQ FGFVTLFVAS FPLAPVFALL NNVIEVRLDA
     KKFVTELRRP DAVRTKDIGI WFDILSGIGK FSVIINAFVI AVTSDFIPRL VYQYSYSHNG
     TLHGFVNHTL SFFNVSQLKE GTQPENSQFD QEVQFCRFKD YREPPWAPNP YEFSKQYWSV
     LSARLAFVII FQNLVMFLSV LVDWMIPDIP TDISDQIKKE KSLLVDFFLK EEHEKVKLAD
     EPTQRSQGGG DRSRRSRAAS SAPSGRSQPG SIASSGSQHT NV
//
ID   S26A6_MOUSE             Reviewed;         758 AA.
AC   Q8CIW6; E9Q4D3; Q3TQD3; Q812E2; Q8CJD0; Q8K142; Q923J3;
DT   18-SEP-2013, integrated into UniProtKB/Swiss-Prot.
DT   18-SEP-2013, sequence version 2.
DT   25-OCT-2017, entry version 99.
DE   RecName: Full=Solute carrier family 26 member 6;
DE   AltName: Full=Anion exchange transporter;
DE   AltName: Full=Chloride-formate exchanger;
DE   AltName: Full=Pendrin-L1;
DE   AltName: Full=Pendrin-like protein 1;
DE   AltName: Full=Putative anion transporter-1;
DE            Short=Pat-1;
GN   Name=Slc26a6 {ECO:0000312|MGI:MGI:2159728}; Synonyms=Cfex, Pat1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=BALB/cJ;
RX   PubMed=11459928; DOI=10.1073/pnas.141241098;
RA   Knauf F., Yang C.L., Thomson R.B., Mentone S.A., Giebisch G.,
RA   Aronson P.S.;
RT   "Identification of a chloride-formate exchanger expressed on the brush
RT   border membrane of renal proximal tubule cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9425-9430(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, ENZYME
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=12217875; DOI=10.1152/ajprenal.00079.2002;
RA   Xie Q., Welch R., Mercado A., Romero M.F., Mount D.B.;
RT   "Molecular characterization of the murine Slc26a6 anion exchanger:
RT   functional comparison with Slc26a1.";
RL   Am. J. Physiol. 283:F826-F838(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ENZYME REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=BALB/cJ; TISSUE=Kidney;
RX   PubMed=15203903; DOI=10.1080/10611860410001693742;
RA   Nozawa T., Sugiura S., Hashino Y., Tsuji A., Tamai I.;
RT   "Role of anion exchange transporter PAT1 (SLC26A6) in intestinal
RT   absorption of organic anions.";
RL   J. Drug. Target. 12:97-104(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=FVB/N; TISSUE=Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11842009; DOI=10.1152/ajpgi.00338.2001;
RA   Wang Z., Petrovic S., Mann E., Soleimani M.;
RT   "Identification of an apical Cl(-)/HCO3(-) exchanger in the small
RT   intestine.";
RL   Am. J. Physiol. 282:G573-G579(2002).
RN   [9]
RP   FUNCTION, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12119287; DOI=10.1074/jbc.M202660200;
RA   Jiang Z., Grichtchenko I.I., Boron W.F., Aronson P.S.;
RT   "Specificity of anion exchange mediated by mouse Slc26a6.";
RL   J. Biol. Chem. 277:33963-33967(2002).
RN   [10]
RP   FUNCTION, INTERACTION WITH PDZK1, AND SUBCELLULAR LOCATION.
RX   PubMed=16141316; DOI=10.1073/pnas.0506578102;
RA   Thomson R.B., Wang T., Thomson B.R., Tarrats L., Girardi A.,
RA   Mentone S., Soleimani M., Kocher O., Aronson P.S.;
RT   "Role of PDZK1 in membrane expression of renal brush border ion
RT   exchangers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13331-13336(2005).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17053783; DOI=10.1038/sj.emboj.7601387;
RA   Wang Y., Soyombo A.A., Shcheynikov N., Zeng W., Dorwart M.,
RA   Marino C.R., Thomas P.J., Muallem S.;
RT   "Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct
RT   HCO3-secretion: relevance to cystic fibrosis.";
RL   EMBO J. 25:5049-5057(2006).
RN   [12]
RP   FUNCTION.
RX   PubMed=16606687; DOI=10.1085/jgp.200509392;
RA   Shcheynikov N., Wang Y., Park M., Ko S.B., Dorwart M., Naruse S.,
RA   Thomas P.J., Muallem S.;
RT   "Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and
RT   slc26a6.";
RL   J. Gen. Physiol. 127:511-524(2006).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16532010; DOI=10.1038/ng1762;
RA   Jiang Z., Asplin J.R., Evan A.P., Rajendran V.M., Velazquez H.,
RA   Nottoli T.P., Binder H.J., Aronson P.S.;
RT   "Calcium oxalate urolithiasis in mice lacking anion transporter
RT   Slc26a6.";
RL   Nat. Genet. 38:474-478(2006).
RN   [14]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17170027; DOI=10.1152/ajpgi.00354.2006;
RA   Simpson J.E., Schweinfest C.W., Shull G.E., Gawenis L.R., Walker N.M.,
RA   Boyle K.T., Soleimani M., Clarke L.L.;
RT   "PAT-1 (Slc26a6) is the predominant apical membrane Cl-/HCO3-exchanger
RT   in the upper villous epithelium of the murine duodenum.";
RL   Am. J. Physiol. 292:G1079-G1088(2007).
RN   [15]
RP   FUNCTION (ISOFORM 2), SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   THR-575.
RX   PubMed=17151144; DOI=10.1152/ajpcell.00447.2006;
RA   Hassan H.A., Mentone S., Karniski L.P., Rajendran V.M., Aronson P.S.;
RT   "Regulation of anion exchanger Slc26a6 by protein kinase C.";
RL   Am. J. Physiol. 292:C1485-C1492(2007).
RN   [16]
RP   FUNCTION.
RX   PubMed=18046080; DOI=10.1159/000111826;
RA   Petrovic S., Barone S., Wang Z., McDonough A.A., Amlal H.,
RA   Soleimani M.;
RT   "Slc26a6 (PAT1) deletion downregulates the apical Na+/H+ exchanger in
RT   the straight segment of the proximal tubule.";
RL   Am. J. Nephrol. 28:330-338(2008).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18496516; DOI=10.1038/ki.2008.184;
RA   Singh A.K., Amlal H., Haas P.J., Dringenberg U., Fussell S.,
RA   Barone S.L., Engelhardt R., Zuo J., Seidler U., Soleimani M.;
RT   "Fructose-induced hypertension: essential role of chloride and
RT   fructose absorbing transporters PAT1 and Glut5.";
RL   Kidney Int. 74:438-447(2008).
RN   [18]
RP   FUNCTION.
RX   PubMed=20150244; DOI=10.1152/ajpgi.00293.2009;
RA   Simpson J.E., Walker N.M., Supuran C.T., Soleimani M., Clarke L.L.;
RT   "Putative anion transporter-1 (Pat-1, Slc26a6) contributes to
RT   intracellular pH regulation during H+-dipeptide transport in duodenal
RT   villous epithelium.";
RL   Am. J. Physiol. 298:G683-G691(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [20]
RP   FUNCTION.
RX   PubMed=20969732; DOI=10.1111/j.1748-1716.2010.02210.x;
RA   Walker N.M., Simpson J.E., Hoover E.E., Brazill J.M.,
RA   Schweinfest C.W., Soleimani M., Clarke L.L.;
RT   "Functional activity of Pat-1 (Slc26a6) Cl(-)/HCO(3)(-) exchange in
RT   the lower villus epithelium of murine duodenum.";
RL   Acta Physiol. 201:21-31(2011).
RN   [21]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=22021714; DOI=10.1681/ASN.2011040433;
RA   Knauf F., Ko N., Jiang Z., Robertson W.G., Van Itallie C.M.,
RA   Anderson J.M., Aronson P.S.;
RT   "Net intestinal transport of oxalate reflects passive absorption and
RT   SLC26A6-mediated secretion.";
RL   J. Am. Soc. Nephrol. 22:2247-2255(2011).
RN   [22]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=22895259; DOI=10.1152/ajpcell.00151.2012;
RA   Song Y., Yamamoto A., Steward M.C., Ko S.B., Stewart A.K.,
RA   Soleimani M., Liu B.C., Kondo T., Jin C.X., Ishiguro H.;
RT   "Deletion of Slc26a6 alters the stoichiometry of apical Cl-/HCO-3
RT   exchange in mouse pancreatic duct.";
RL   Am. J. Physiol. 303:C815-C824(2012).
RN   [23]
RP   FUNCTION, INTERACTION WITH CFTR; SLC26A3 AND SLC9A3R1, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21976599; DOI=10.1095/biolreprod.111.094037;
RA   Chavez J.C., Hernandez-Gonzalez E.O., Wertheimer E., Visconti P.E.,
RA   Darszon A., Trevino C.L.;
RT   "Participation of the Cl-/HCO(3)- exchangers SLC26A3 and SLC26A6, the
RT   Cl- channel CFTR, and the regulatory factor SLC9A3R1 in mouse sperm
RT   capacitation.";
RL   Biol. Reprod. 86:1-14(2012).
RN   [24]
RP   INTERACTION WITH AHCYL1.
RX   PubMed=23542070; DOI=10.1053/j.gastro.2013.03.047;
RA   Park S., Shcheynikov N., Hong J.H., Zheng C., Suh S.H., Kawaai K.,
RA   Ando H., Mizutani A., Abe T., Kiyonari H., Seki G., Yule D.,
RA   Mikoshiba K., Muallem S.;
RT   "Irbit mediates synergy between ca(2+) and cAMP signaling pathways
RT   during epithelial transport in mice.";
RL   Gastroenterology 145:232-241(2013).
CC   -!- FUNCTION: Apical membrane anion-exchanger with wide epithelial
CC       distribution that plays a role as a component of the pH buffering
CC       system for maintaining acid-base homeostasis. Acts as a versatile
CC       DIDS-sensitive inorganic and organic anion transporter that
CC       mediates the uptake of monovalent anions like chloride,
CC       bicarbonate, formate and hydroxyl ion and divalent anions like
CC       sulfate and oxalate. Function in multiple exchange modes involving
CC       pairs of these anions, which include chloride-bicarbonate,
CC       chloride-oxalate, oxalate-formate, oxalate-sulfate and chloride-
CC       formate exchange. Apical membrane chloride-bicarbonate exchanger
CC       that mediates luminal chloride absorption and bicarbonate
CC       secretion by the small intestinal brush border membrane and
CC       contributes to intracellular pH regulation in the duodenal upper
CC       villous epithelium during proton-coupled peptide absorption,
CC       possibly by providing a bicarbonate import pathway. Its
CC       association with carbonic anhydrase CA2 forms a bicarbonate
CC       transport metabolon; hence maximizes the local concentration of
CC       bicarbonate at the transporter site. Mediates also intestinal
CC       chloride absorption and oxalate secretion, thereby preventing
CC       hyperoxaluria and calcium oxalate urolithiasis. Transepithelial
CC       oxalate secretion, chloride-formate, chloride-oxalate and
CC       chloride-bicarbonate transport activities in the duodenum are
CC       inhibited by PKC activation in a calcium-independent manner. The
CC       apical membrane chloride-bicarbonate exchanger provides also a
CC       major route for fluid and bicarbonate secretion into the proximal
CC       tubules of the kidney as well as into the proximal part of the
CC       interlobular pancreatic ductal tree, where it mediates
CC       electrogenic chloride-bicarbonate exchange with a chloride-
CC       bicarbonate stoichiometry of 1:2, and hence will dilute and
CC       alkalinize protein-rich acinar secretion. Mediates also the
CC       transcellular sulfate absorption and oxalate secretion across the
CC       apical membrane in the duodenum and the formate ion efflux at the
CC       apical brush border of cells in the proximal tubules of kidney.
CC       Plays a role in sperm capacitation by increasing intracellular pH.
CC       {ECO:0000269|PubMed:11459928, ECO:0000269|PubMed:11842009,
CC       ECO:0000269|PubMed:12119287, ECO:0000269|PubMed:12217875,
CC       ECO:0000269|PubMed:15203903, ECO:0000269|PubMed:16141316,
CC       ECO:0000269|PubMed:16532010, ECO:0000269|PubMed:16606687,
CC       ECO:0000269|PubMed:17053783, ECO:0000269|PubMed:17170027,
CC       ECO:0000269|PubMed:18046080, ECO:0000269|PubMed:18496516,
CC       ECO:0000269|PubMed:20150244, ECO:0000269|PubMed:20969732,
CC       ECO:0000269|PubMed:21976599, ECO:0000269|PubMed:22021714,
CC       ECO:0000269|PubMed:22895259}.
CC   -!- ENZYME REGULATION: Apical membrane chloride-bicarbonate exchange
CC       activity of the pancreatic duct is inhibited by DIDS (By
CC       similarity). Apical membrane chloride-formate exchange activity in
CC       the proximal tubules of the kidney and oxalate secretion in the
CC       duodenum are inhibited by 4,4'-diisothiocyanatostilbene-2,2'-
CC       disulfonic acid (DIDS - an inhibitor of several anion channels and
CC       transporters). {ECO:0000250, ECO:0000269|PubMed:11459928,
CC       ECO:0000269|PubMed:12119287, ECO:0000269|PubMed:12217875,
CC       ECO:0000269|PubMed:15203903, ECO:0000269|PubMed:22021714,
CC       ECO:0000269|PubMed:22895259}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3 mM for oxalate, PubMed:12119287
CC         {ECO:0000269|PubMed:12119287, ECO:0000269|PubMed:15203903};
CC         KM=0.314 mM for oxalate, PubMed:15203903
CC         {ECO:0000269|PubMed:12119287, ECO:0000269|PubMed:15203903};
CC         KM=3.87 mM for formate, PubMed:15203903
CC         {ECO:0000269|PubMed:12119287, ECO:0000269|PubMed:15203903};
CC   -!- SUBUNIT: Interacts (via C-terminal cytoplasmic domain) with CA2;
CC       the interaction stimulates chloride-bicarbonate exchange activity.
CC       Interacts with SLC9A3R1 (via the PDZ domains). Interacts with
CC       SLC9A3R2 (via the PDZ domains) (By similarity). Interacts (via C-
CC       terminal domain) with PDZK1 (via C-terminal PDZ domain); the
CC       interaction induces chloride and oxalate exchange transport.
CC       Interacts with CFTR, SLC26A3 and SLC9A3R1. Interacts with AHCYL1;
CC       the interaction increases SLC26A6 activity (PubMed:23542070).
CC       {ECO:0000250|UniProtKB:Q9BXS9, ECO:0000269|PubMed:16141316,
CC       ECO:0000269|PubMed:21976599, ECO:0000269|PubMed:23542070}.
CC   -!- INTERACTION:
CC       P26361:Cftr; NbExp=3; IntAct=EBI-6895517, EBI-6115317;
CC       Q9WVC8:Slc26a3; NbExp=2; IntAct=EBI-6895517, EBI-6895537;
CC       P70441:Slc9a3r1; NbExp=2; IntAct=EBI-6895517, EBI-1184085;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       membrane; Multi-pass membrane protein. Apical cell membrane;
CC       Multi-pass membrane protein. Cytoplasmic vesicle membrane; Multi-
CC       pass membrane protein. Microsome. Note=Colocalized with CA2 at the
CC       surface of the cell membrane in order to form a bicarbonate
CC       transport metabolon; colocalization is reduced in phorbol
CC       myristate acetate (PMA)-induced cells (By similarity). Localized
CC       in sperm membranes. Colocalizes with CFTR at the midpiece of sperm
CC       tail. Localizes to the apical membrane brush border of epithelial
CC       cells in the proximal tubules of kidney, of enterocytes of the
CC       small intestine and of gastric parietal cells in the stomach. May
CC       be translocated from the cytosolic surface of the cell membrane to
CC       the intracellular space by PKC in phorbol myristate acetate (PMA)-
CC       induced cells. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Slc26a6a;
CC         IsoId=Q8CIW6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Slc26a6b;
CC         IsoId=Q8CIW6-2; Sequence=VSP_047853;
CC       Name=3;
CC         IsoId=Q8CIW6-3; Sequence=VSP_047853, VSP_047854;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney (at protein level). Highly
CC       expressed in stomach, kidney, heart and small intestine, low in
CC       the lung, liver, testis, brain, skeletal muscle and colon.
CC       Expressed in spermatogenic cells. Isoform 1 is expressed in
CC       intestine, kidney, testis, brain, muscle, heart, and stomach.
CC       {ECO:0000269|PubMed:11459928, ECO:0000269|PubMed:11842009,
CC       ECO:0000269|PubMed:12217875, ECO:0000269|PubMed:17170027,
CC       ECO:0000269|PubMed:21976599}.
CC   -!- INDUCTION: Up-regulated by dietary fructose intake (at protein
CC       level). {ECO:0000269|PubMed:18496516}.
CC   -!- PTM: Phosphorylated on serine residues by PKC; the phosphorylation
CC       disrupts interaction with carbonic anhydrase CA2 and reduces
CC       bicarbonate transport activity in a phorbol myristate acetate
CC       (PMA)-induced manner. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice show an important decrease in salt
CC       absorption in the intestine and failed to develop hypertension on
CC       a high-fructose diet. Show a reduction in pancreatic duct fluid
CC       and bicarbonate secretion. Show enhanced oxalate absorption in the
CC       intestine leading to hyperoxalemia and hyperoxaluria with high
CC       incidence of calcium-oxalate stones formation.
CC       {ECO:0000269|PubMed:16532010, ECO:0000269|PubMed:17053783,
CC       ECO:0000269|PubMed:18496516}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AC168054; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAAA01111125; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAAA01200220; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY032863; AAK51131.1; -; mRNA.
DR   EMBL; AF248494; AAN07089.1; -; mRNA.
DR   EMBL; AY049076; AAL13129.1; -; mRNA.
DR   EMBL; AB099881; BAC55182.1; -; mRNA.
DR   EMBL; AK163670; BAE37450.1; -; mRNA.
DR   EMBL; AK163671; BAE37451.1; -; mRNA.
DR   EMBL; AC168054; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CAAA01111125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CAAA01200220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466560; EDL21319.1; -; Genomic_DNA.
DR   EMBL; BC028856; AAH28856.1; -; mRNA.
DR   RefSeq; NP_599252.2; NM_134420.4. [Q8CIW6-2]
DR   UniGene; Mm.45201; -.
DR   ProteinModelPortal; Q8CIW6; -.
DR   SMR; Q8CIW6; -.
DR   IntAct; Q8CIW6; 3.
DR   TCDB; 2.A.53.2.8; the sulfate permease (sulp) family.
DR   iPTMnet; Q8CIW6; -.
DR   PhosphoSitePlus; Q8CIW6; -.
DR   PeptideAtlas; Q8CIW6; -.
DR   PRIDE; Q8CIW6; -.
DR   GeneID; 171429; -.
DR   KEGG; mmu:171429; -.
DR   UCSC; uc009rrd.1; mouse. [Q8CIW6-1]
DR   CTD; 65010; -.
DR   MGI; MGI:2159728; Slc26a6.
DR   HOGENOM; HOG000006546; -.
DR   HOVERGEN; HBG000639; -.
DR   KO; K14704; -.
DR   TreeFam; TF313784; -.
DR   SABIO-RK; Q8CIW6; -.
DR   PRO; PR:Q8CIW6; -.
DR   Proteomes; UP000000589; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI.
DR   GO; GO:0031526; C:brush border membrane; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:MGI.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0097225; C:sperm midpiece; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0012506; C:vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0015301; F:anion:anion antiporter activity; IDA:UniProtKB.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015660; F:formate efflux transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0015499; F:formate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015659; F:formate uptake transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0019531; F:oxalate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:UniProtKB.
DR   GO; GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015116; F:sulfate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; IDA:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071332; P:cellular response to fructose stimulus; IDA:UniProtKB.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; ISO:MGI.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0042045; P:epithelial fluid transport; IMP:UniProtKB.
DR   GO; GO:0015724; P:formate transport; IDA:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; IMP:UniProtKB.
DR   GO; GO:0051454; P:intracellular pH elevation; IMP:UniProtKB.
DR   GO; GO:0015797; P:mannitol transport; IMP:UniProtKB.
DR   GO; GO:0019532; P:oxalate transport; IDA:UniProtKB.
DR   GO; GO:0046724; P:oxalic acid secretion; IMP:UniProtKB.
DR   GO; GO:2001150; P:positive regulation of dipeptide transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0070528; P:protein kinase C signaling; IDA:UniProtKB.
DR   GO; GO:0051453; P:regulation of intracellular pH; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0048240; P:sperm capacitation; IMP:UniProtKB.
DR   GO; GO:0008272; P:sulfate transport; IDA:UniProtKB.
DR   GO; GO:0030321; P:transepithelial chloride transport; IDA:UniProtKB.
DR   GO; GO:0070633; P:transepithelial transport; IMP:UniProtKB.
DR   Gene3D; 3.30.750.24; -; 1.
DR   InterPro; IPR018045; S04_transporter_CS.
DR   InterPro; IPR011547; SLC26A/SulP_dom.
DR   InterPro; IPR001902; SLC26A/SulP_fam.
DR   InterPro; IPR030323; SLC26A6.
DR   InterPro; IPR002645; STAS_dom.
DR   InterPro; IPR036513; STAS_dom_sf.
DR   PANTHER; PTHR11814; PTHR11814; 1.
DR   PANTHER; PTHR11814:SF113; PTHR11814:SF113; 1.
DR   Pfam; PF01740; STAS; 1.
DR   Pfam; PF00916; Sulfate_transp; 1.
DR   SUPFAM; SSF52091; SSF52091; 2.
DR   TIGRFAMs; TIGR00815; sulP; 1.
DR   PROSITE; PS01130; SLC26A; 1.
DR   PROSITE; PS50801; STAS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Anion exchange; Antiport; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Ion channel; Ion transport; Membrane;
KW   Microsome; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    758       Solute carrier family 26 member 6.
FT                                /FTId=PRO_0000423423.
FT   TOPO_DOM      1    117       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    187       Extracellular. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical. {ECO:0000255}.
FT   TOPO_DOM    209    263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    292       Extracellular. {ECO:0000255}.
FT   TRANSMEM    293    313       Helical. {ECO:0000255}.
FT   TOPO_DOM    314    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical. {ECO:0000255}.
FT   TOPO_DOM    362    380       Extracellular. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    417       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical. {ECO:0000255}.
FT   TOPO_DOM    439    485       Extracellular. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   TOPO_DOM    507    758       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      531    741       STAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00198}.
FT   MOD_RES     603    603       Phosphoserine; by PKC. {ECO:0000250}.
FT   MOD_RES     751    751       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9BXS9}.
FT   VAR_SEQ       1     23       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11459928,
FT                                ECO:0000303|PubMed:12217875,
FT                                ECO:0000303|PubMed:15203903,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_047853.
FT   VAR_SEQ     691    758       IFRDFREIEVEVYIAACYSPVVAQLEAGHFFDESITKQHVF
FT                                ASVHDAVTFALSHRKSVPKSPVLATKL -> VRDCRQARAP
FT                                QAFMLILPLASHLLATPPPNKPSPLSSPTKPCPIAASLRPA
FT                                LFVAADFP (in isoform 3).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_047854.
FT   MUTAGEN     575    575       T->A: Does not inhibit formate transport
FT                                in PMA-induced cells.
FT                                {ECO:0000269|PubMed:17151144}.
FT   CONFLICT     25     25       E -> G (in Ref. 1; AAK51131 and 3;
FT                                BAC55182). {ECO:0000305}.
FT   CONFLICT    572    572       R -> P (in Ref. 2; AAL13129/AAN07089).
FT                                {ECO:0000305}.
SQ   SEQUENCE   758 AA;  82834 MW;  1512CC3A417D037B CRC64;
     MGLPDGSDQG THQTQALLSA AQEMELQRRD YHVERPLLNQ EQLEDLGHWG PAAKTHQWRT
     WFRCSRARAH SLLLQHVPVL GWLPRYPVRE WLLGDLLSGL SVAIMQLPQG LAYALLAGLP
     PMFGLYSSFY PVFIYFLFGT SRHISVGTFA VMSVMVGSVT ESLTADKAFV QGLNATADDA
     RVQVAYTLSF LVGLFQVGLG LVHFGFVVTY LSEPLVRSYT TAASVQVLVS QLKYVFGIKL
     SSHSGPLSVI YTVLEVCAQL PETVPGTVVT AIVAGVALVL VKLLNEKLHR RLPLPIPGEL
     LTLIGATGIS YGVKLNDRFK VDVVGNITTG LIPPVAPKTE LFATLVGNAF AIAVVGFAIA
     ISLGKIFALR HGYRVDSNQE LVALGLSNLI GGFFQCFPVS CSMSRSLVQE STGGNTQVAG
     AVSSLFILLI IVKLGELFRD LPKAVLAAVI IVNLKGMMKQ FSDICSLWKA NRVDLLIWLV
     TFVATILLNL DIGLAVSIVF SLLLVVVRMQ LPHYSVLGQV PDTDIYRDVA EYSGAKEVPG
     VKVFRSSATL YFANAELYSD SLKEKCGVDV DRLITQKKKR IKKQEMKLKR MKKAKKSQKQ
     DASSKISSVS VNVNTNLEDV KSNDVEGSEA KVHQGEELQD VVSSNQEDAK APTMTSLKSL
     GLPQPGFHSL ILDLSTLSFV DTVCIKSLKN IFRDFREIEV EVYIAACYSP VVAQLEAGHF
     FDESITKQHV FASVHDAVTF ALSHRKSVPK SPVLATKL
//
ID   CLCE_ARATH              Reviewed;         710 AA.
AC   Q8GX93; O65486; Q93XN4; Q9SVX1;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   20-DEC-2017, entry version 114.
DE   RecName: Full=Chloride channel protein CLC-e;
DE            Short=AtCLC-e;
DE   AltName: Full=CBS domain-containing protein CBSCLC3;
GN   Name=CLC-E; Synonyms=CBSCLC3; OrderedLocusNames=At4g35440;
GN   ORFNames=F15J1.10, F23E12.10;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia; TISSUE=Aerial part;
RA   Vinauger-Douard M., Charon C., Lapous D., Allot M., Granier F.,
RA   Bouchez D., Barbier-Brygoo H., Ephritikhine G.;
RT   "Molecular and functional characterization of AtCLC-e, a new putative
RT   Arabidopsis anion channel.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
CC   -!- FUNCTION: Voltage-gated chloride channel.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=Q8GX93-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC42971.1; Type=Frameshift; Positions=452; Evidence={ECO:0000305};
CC       Sequence=CAA18726.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB54872.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB80260.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF366367; AAK53390.1; -; mRNA.
DR   EMBL; AL022604; CAA18726.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL117188; CAB54872.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161587; CAB80260.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE86510.1; -; Genomic_DNA.
DR   EMBL; AK118357; BAC42971.1; ALT_FRAME; mRNA.
DR   PIR; T17122; T17122.
DR   RefSeq; NP_567985.1; NM_119709.1. [Q8GX93-1]
DR   UniGene; At.2274; -.
DR   ProteinModelPortal; Q8GX93; -.
DR   SMR; Q8GX93; -.
DR   STRING; 3702.AT4G35440.2; -.
DR   TCDB; 2.A.49.6.3; the chloride carrier/channel (clc) family.
DR   PaxDb; Q8GX93; -.
DR   EnsemblPlants; AT4G35440.1; AT4G35440.1; AT4G35440. [Q8GX93-1]
DR   GeneID; 829696; -.
DR   Gramene; AT4G35440.1; AT4G35440.1; AT4G35440. [Q8GX93-1]
DR   KEGG; ath:AT4G35440; -.
DR   Araport; AT4G35440; -.
DR   eggNOG; KOG0475; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000238204; -.
DR   InParanoid; Q8GX93; -.
DR   PhylomeDB; Q8GX93; -.
DR   PRO; PR:Q8GX93; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; Q8GX93; baseline and differential.
DR   Genevisible; Q8GX93; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; CBS domain; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    710       Chloride channel protein CLC-e.
FT                                /FTId=PRO_0000094469.
FT   TRANSMEM     74     94       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    296    316       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    340    360       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    379    399       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    412    432       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    472    492       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    667    687       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      565    624       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      640    702       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   CONFLICT    297    297       Missing (in Ref. 1; AAK53390).
FT                                {ECO:0000305}.
FT   CONFLICT    453    453       Missing (in Ref. 1; AAK53390).
FT                                {ECO:0000305}.
SQ   SEQUENCE   710 AA;  75556 MW;  2C7B325F7BF112DE CRC64;
     MAATLPLCAA LRSPVSSRRF APIHKTDVPF QFNVVLSPFF GSVAIGGRIF PRLPAAKQET
     DQDEVGFDQQ PSQELAIASA CLVGVLTGVS VVLFNNCVHL LRDFSWDGIP DRGASWLREA
     PIGSNWLRVI LVPTIGGLVV SILNQLRESA GKSTGDSHSS LDRVKAVLRP FLKTVAACVT
     LGTGNSLGPE GPSVEIGASI AKGVNSLFNK SPQTGFSLLA AGSAAGISSG FNAAVAGCFF
     AVESVLWPSS STDSSTSLPN TTSMVILSAV TASVVSEIGL GSEPAFKVPD YDFRSPGELP
     LYLLLGALCG LVSLALSRCT SSMTSAVDSL NKDAGIPKAV FPVMGGLSVG IIALVYPEVL
     YWGFQNVDIL LEKRPFVKGL SADLLLQLVA VKIAATAWCR ASGLVGGYYA PSLFIGGAAG
     MAYGKFIGLA LAQNPDFNLS ILEVASPQAY GLVGMAATLA GVCQVPLTAV LLLFELTQDY
     RIVLPLLGAV GMSSWITSGQ SKRQETRETK ETRKRKSQEA VQSLTSSDDE SSTNNLCEVE
     SSLCLDDSLN QSEELPKSIF VSEAMRTRFA TVMMSTSLEE ALTRMLIEKQ SCALIVDPDN
     IFLGILTLSD IQEFSKARKE GNNRPKDIFV NDICSRSGGK CKVPWTVTPD MDLLAAQTIM
     NKHELSHVAV VSGSIDAPRI HPVGVLDREC ITLTRRALAT RMYLLNSLYL
//
ID   BEST3_HUMAN             Reviewed;         668 AA.
AC   Q8N1M1; B5MDI8; F8VVZ2; Q53YQ7; Q8N356; Q8NFT9; Q9BR80;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   27-SEP-2017, entry version 134.
DE   RecName: Full=Bestrophin-3;
DE   AltName: Full=Vitelliform macular dystrophy 2-like protein 3;
GN   Name=BEST3; Synonyms=VMD2L3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12032738; DOI=10.1038/sj.ejhg.5200796;
RA   Stoehr H., Marquardt A., Nanda I., Schmid M., Weber B.H.F.;
RT   "Three novel human VMD2-like genes are members of the evolutionary
RT   highly conserved RFP-TM family.";
RL   Eur. J. Hum. Genet. 10:281-284(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=12907679; DOI=10.1074/jbc.M306150200;
RA   Tsunenari T., Sun H., Williams J., Cahill H., Smallwood P., Yau K.-W.,
RA   Nathans J.;
RT   "Structure-function analysis of the bestrophin family of anion
RT   channels.";
RL   J. Biol. Chem. 278:41114-41125(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to
CC       bicarbonate. {ECO:0000269|PubMed:12907679}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=2;
CC         IsoId=Q8N1M1-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q8N1M1-1; Sequence=VSP_008977, VSP_008978;
CC       Name=4;
CC         IsoId=Q8N1M1-4; Sequence=VSP_008981, VSP_008982, VSP_008983;
CC       Name=5;
CC         IsoId=Q8N1M1-5; Sequence=VSP_046979, VSP_046980;
CC         Note=Gene prediction based on EST data.;
CC       Name=6;
CC         IsoId=Q8N1M1-6; Sequence=VSP_008981;
CC   -!- TISSUE SPECIFICITY: Present in skeletal muscle and weakly in
CC       brain, spinal cord, bone marrow and retina.
CC       {ECO:0000269|PubMed:12032738}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF440758; AAM76997.1; -; mRNA.
DR   EMBL; AY515706; AAR99656.1; -; mRNA.
DR   EMBL; AK096459; BAC04797.1; -; mRNA.
DR   EMBL; AC016153; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC018921; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC151138; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC006440; AAH06440.1; -; mRNA.
DR   CCDS; CCDS41810.1; -. [Q8N1M1-5]
DR   CCDS; CCDS61192.1; -. [Q8N1M1-6]
DR   CCDS; CCDS61193.1; -. [Q8N1M1-1]
DR   CCDS; CCDS73496.1; -. [Q8N1M1-4]
DR   CCDS; CCDS8992.2; -. [Q8N1M1-2]
DR   RefSeq; NP_001269542.1; NM_001282613.1. [Q8N1M1-6]
DR   RefSeq; NP_001269543.1; NM_001282614.1. [Q8N1M1-1]
DR   RefSeq; NP_001269544.1; NM_001282615.1. [Q8N1M1-4]
DR   RefSeq; NP_001269545.1; NM_001282616.1. [Q8N1M1-4]
DR   RefSeq; NP_116124.2; NM_032735.2. [Q8N1M1-2]
DR   RefSeq; NP_689652.2; NM_152439.3. [Q8N1M1-5]
DR   RefSeq; XP_011536263.1; XM_011537961.1. [Q8N1M1-6]
DR   UniGene; Hs.280782; -.
DR   ProteinModelPortal; Q8N1M1; -.
DR   SMR; Q8N1M1; -.
DR   STRING; 9606.ENSP00000332413; -.
DR   iPTMnet; Q8N1M1; -.
DR   PhosphoSitePlus; Q8N1M1; -.
DR   BioMuta; BEST3; -.
DR   DMDM; 38503351; -.
DR   EPD; Q8N1M1; -.
DR   PaxDb; Q8N1M1; -.
DR   PeptideAtlas; Q8N1M1; -.
DR   PRIDE; Q8N1M1; -.
DR   DNASU; 144453; -.
DR   Ensembl; ENST00000266661; ENSP00000266661; ENSG00000127325. [Q8N1M1-4]
DR   Ensembl; ENST00000330891; ENSP00000332413; ENSG00000127325. [Q8N1M1-2]
DR   Ensembl; ENST00000331471; ENSP00000329064; ENSG00000127325. [Q8N1M1-1]
DR   Ensembl; ENST00000488961; ENSP00000433213; ENSG00000127325. [Q8N1M1-5]
DR   Ensembl; ENST00000551160; ENSP00000449377; ENSG00000127325. [Q8N1M1-4]
DR   Ensembl; ENST00000553096; ENSP00000449548; ENSG00000127325. [Q8N1M1-6]
DR   GeneID; 144453; -.
DR   KEGG; hsa:144453; -.
DR   UCSC; uc001svd.4; human. [Q8N1M1-2]
DR   CTD; 144453; -.
DR   EuPathDB; HostDB:ENSG00000127325.18; -.
DR   GeneCards; BEST3; -.
DR   H-InvDB; HIX0010809; -.
DR   HGNC; HGNC:17105; BEST3.
DR   HPA; HPA054582; -.
DR   MIM; 607337; gene.
DR   neXtProt; NX_Q8N1M1; -.
DR   OpenTargets; ENSG00000127325; -.
DR   PharmGKB; PA162377503; -.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   HOVERGEN; HBG080894; -.
DR   InParanoid; Q8N1M1; -.
DR   KO; K13880; -.
DR   OMA; KRFLSAH; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; Q8N1M1; -.
DR   TreeFam; TF315803; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; BEST3; human.
DR   GenomeRNAi; 144453; -.
DR   PRO; PR:Q8N1M1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000127325; -.
DR   CleanEx; HS_BEST3; -.
DR   ExpressionAtlas; Q8N1M1; baseline and differential.
DR   Genevisible; Q8N1M1; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0043271; P:negative regulation of ion transport; IEA:Ensembl.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Ion channel; Ion transport;
KW   Membrane; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    668       Bestrophin-3.
FT                                /FTId=PRO_0000143121.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     70       Extracellular. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TOPO_DOM     92    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       {ECO:0000255}.
FT   TOPO_DOM    250    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    668       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ       1    162       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_046979.
FT   VAR_SEQ       1    106       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008981.
FT   VAR_SEQ     161    178       GFMTTDERKLFNHLKSPH -> ERTGMKPILPSSFEMQSF
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008982.
FT   VAR_SEQ     179    668       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008983.
FT   VAR_SEQ     239    289       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_046980.
FT   VAR_SEQ     368    398       LSGSDFPDEEWLWDYEKHGHRHSMIRRVKRF -> KQMPKN
FT                                EWKMEDIKIPLPQPQFQCAKSDPGG (in isoform 1).
FT                                {ECO:0000303|PubMed:12032738,
FT                                ECO:0000303|PubMed:12907679}.
FT                                /FTId=VSP_008977.
FT   VAR_SEQ     399    668       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:12032738,
FT                                ECO:0000303|PubMed:12907679}.
FT                                /FTId=VSP_008978.
FT   VARIANT      43     43       Y -> H (in dbSNP:rs1025016).
FT                                /FTId=VAR_048409.
FT   VARIANT     622    622       E -> G (in dbSNP:rs17106884).
FT                                /FTId=VAR_048410.
SQ   SEQUENCE   668 AA;  76107 MW;  FDCBD7154C402EA2 CRC64;
     MTVTYSSKVA NATFFGFHRL LLKWRGSIYK LLYREFIVFA VLYTAISLVY RLLLTGVQKR
     YFEKLSIYCD RYAEQIPVTF VLGFYVTLVV NRWWNQFVNL PWPDRLMFLI SSSVHGSDEH
     GRLLRRTLMR YVNLTSLLIF RSVSTAVYKR FPTMDHVVEA GFMTTDERKL FNHLKSPHLK
     YWVPFIWFGN LATKARNEGR IRDSVDLQSL MTEMNRYRSW CSLLFGYDWV GIPLVYTQVV
     TLAVYTFFFA CLIGRQFLDP TKGYAGHDLD LYIPIFTLLQ FFFYAGWLKV AEQLINPFGE
     DDDDFETNWC IDRNLQVSLL AVDEMHMSLP KMKKDIYWDD SAARPPYTLA AADYCIPSFL
     GSTVQMGLSG SDFPDEEWLW DYEKHGHRHS MIRRVKRFLS AHEHPSSPRR RSYRRQTSDS
     SMFLPRDDLS PARDLLDVPS RNPPRASPTW KKSCFPEGSP TLHFSMGELS TIRETSQTST
     LQSLTPQSSV RTSPIKMPLV PEVLITAAEA PVPTSGGYHH DSATSILSSE FTGVQPSKTE
     QQQGPMGSIL SPSEKETPPG GPSPQTVSAS AEENIFNCEE DPGDTFLKRW SLPGFLGSSH
     TSLGNLSPDP MSSQPALLID TETSSEISGI NIVAGSRVSS DMLYLMENLD TKETDIIELN
     KETEESPK
//
ID   BEST4_HUMAN             Reviewed;         473 AA.
AC   Q8NFU0; Q5JR93;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   27-SEP-2017, entry version 121.
DE   RecName: Full=Bestrophin-4;
DE   AltName: Full=Vitelliform macular dystrophy 2-like protein 2;
GN   Name=BEST4; Synonyms=VMD2L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=12032738; DOI=10.1038/sj.ejhg.5200796;
RA   Stoehr H., Marquardt A., Nanda I., Schmid M., Weber B.H.F.;
RT   "Three novel human VMD2-like genes are members of the evolutionary
RT   highly conserved RFP-TM family.";
RL   Eur. J. Hum. Genet. 10:281-284(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=12907679; DOI=10.1074/jbc.M306150200;
RA   Tsunenari T., Sun H., Williams J., Cahill H., Smallwood P., Yau K.-W.,
RA   Nathans J.;
RT   "Structure-function analysis of the bestrophin family of anion
RT   channels.";
RL   J. Biol. Chem. 278:41114-41125(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=18400985; DOI=10.1152/ajpcell.00398.2007;
RA   Qu Z., Hartzell H.C.;
RT   "Bestrophin Cl- channels are highly permeable to HCO3-.";
RL   Am. J. Physiol. 294:C1371-C1377(2008).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to
CC       bicarbonate. {ECO:0000269|PubMed:12907679,
CC       ECO:0000269|PubMed:18400985}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly found in colon and the weakly in
CC       fetal brain, spinal cord, retina, lung, trachea, testis and
CC       placenta. {ECO:0000269|PubMed:12032738}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF440757; AAM76996.1; -; mRNA.
DR   EMBL; AY515707; AAR99657.1; -; mRNA.
DR   EMBL; AL592166; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101823; AAI01824.1; -; mRNA.
DR   CCDS; CCDS514.1; -.
DR   RefSeq; NP_695006.1; NM_153274.2.
DR   RefSeq; XP_016856511.1; XM_017001022.1.
DR   RefSeq; XP_016856512.1; XM_017001023.1.
DR   UniGene; Hs.302513; -.
DR   ProteinModelPortal; Q8NFU0; -.
DR   SMR; Q8NFU0; -.
DR   IntAct; Q8NFU0; 1.
DR   MINT; MINT-7969671; -.
DR   STRING; 9606.ENSP00000361281; -.
DR   iPTMnet; Q8NFU0; -.
DR   PhosphoSitePlus; Q8NFU0; -.
DR   BioMuta; BEST4; -.
DR   DMDM; 38503352; -.
DR   PaxDb; Q8NFU0; -.
DR   PeptideAtlas; Q8NFU0; -.
DR   PRIDE; Q8NFU0; -.
DR   Ensembl; ENST00000372207; ENSP00000361281; ENSG00000142959.
DR   GeneID; 266675; -.
DR   KEGG; hsa:266675; -.
DR   UCSC; uc001cmm.4; human.
DR   CTD; 266675; -.
DR   EuPathDB; HostDB:ENSG00000142959.4; -.
DR   GeneCards; BEST4; -.
DR   HGNC; HGNC:17106; BEST4.
DR   HPA; HPA058564; -.
DR   MIM; 607336; gene.
DR   neXtProt; NX_Q8NFU0; -.
DR   OpenTargets; ENSG00000142959; -.
DR   PharmGKB; PA162377520; -.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   GeneTree; ENSGT00390000002997; -.
DR   HOGENOM; HOG000115678; -.
DR   HOVERGEN; HBG044928; -.
DR   InParanoid; Q8NFU0; -.
DR   KO; K13881; -.
DR   OMA; AEKDLYW; -.
DR   OrthoDB; EOG091G06XO; -.
DR   PhylomeDB; Q8NFU0; -.
DR   TreeFam; TF315803; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   GenomeRNAi; 266675; -.
DR   PRO; PR:Q8NFU0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142959; -.
DR   CleanEx; HS_BEST4; -.
DR   Genevisible; Q8NFU0; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    473       Bestrophin-4.
FT                                /FTId=PRO_0000143120.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     70       Extracellular. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   TOPO_DOM     92    178       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TOPO_DOM    200    228       Extracellular. {ECO:0000255}.
FT   INTRAMEM    229    249       {ECO:0000255}.
FT   TOPO_DOM    250    285       Extracellular. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical. {ECO:0000255}.
FT   TOPO_DOM    307    473       Cytoplasmic. {ECO:0000255}.
FT   VARIANT      62     62       Y -> C (in dbSNP:rs16832245).
FT                                /FTId=VAR_048411.
FT   VARIANT     217    217       Y -> S (in dbSNP:rs16832242).
FT                                /FTId=VAR_048412.
FT   VARIANT     331    331       Q -> E (in dbSNP:rs16832241).
FT                                /FTId=VAR_048413.
FT   VARIANT     402    402       R -> L (in dbSNP:rs16832239).
FT                                /FTId=VAR_048414.
SQ   SEQUENCE   473 AA;  53497 MW;  A8538303EE258D65 CRC64;
     MTVSYTLKVA EARFGGFSGL LLRWRGSIYK LLYKEFLLFG ALYAVLSITY RLLLTQEQRY
     VYAQVARYCN RSADLIPLSF VLGFYVTLVV NRWWSQYTSI PLPDQLMCVI SASVHGVDQR
     GRLLRRTLIR YANLASVLVL RSVSTRVLKR FPTMEHVVDA GFMSQEERKK FESLKSDFNK
     YWVPCVWFTN LAAQARRDGR IRDDIALCLL LEELNKYRAK CSMLFHYDWI SIPLVYTQVV
     TIAVYSFFAL SLVGRQFVEP EAGAAKPQKL LKPGQEPAPA LGDPDMYVPL TTLLQFFFYA
     GWLKVAEQII NPFGEDDDDF ETNQLIDRNL QVSLLSVDEM YQNLPPAEKD QYWDEDQPQP
     PYTVATAAES LRPSFLGSTF NLRMSDDPEQ SLQVEASPGS GRPAPAAQTP LLGRFLGVGA
     PSPAISLRNF GRVRGTPRPP HLLRFRAEEG GDPEAAARIE EESAESGDEA LEP
//
ID   CLCF_ARATH              Reviewed;         781 AA.
AC   Q8RXR2; Q9ARM3; Q9LG04;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   20-DEC-2017, entry version 115.
DE   RecName: Full=Chloride channel protein CLC-f;
DE            Short=AtCLC-f;
DE   AltName: Full=CBS domain-containing protein CBSCLC1;
GN   Name=CLC-F; Synonyms=CBSCLC1; OrderedLocusNames=At1g55620;
GN   ORFNames=F20N2.5;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=cv. Columbia;
RX   PubMed=11283350; DOI=10.1105/tpc.13.4.979;
RA   Rossberg M., Theres K., Acarkan A., Herrero R., Schmitt T.,
RA   Schumacher K., Schmitz G., Schmidt R.;
RT   "Comparative sequence analysis reveals extensive microcolinearity in
RT   the lateral suppressor regions of the tomato, Arabidopsis, and
RT   Capsella genomes.";
RL   Plant Cell 13:979-988(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=cv. Columbia; TISSUE=Aerial part;
RA   Vinauger-Douard M., Charon C., Lapous D., Allot M., Granier F.,
RA   Bouchez D., Barbier-Brygoo H., Ephritikhine G.;
RT   "Molecular and functional characterization of AtCLC-f, a putative new
RT   Arabidopsis chloride channel.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
CC   -!- FUNCTION: Voltage-gated chloride channel.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8RXR2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8RXR2-2; Sequence=VSP_009325;
CC         Note=May be due to a competing acceptor splice site. No
CC         experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF79509.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ303348; CAC36386.1; -; mRNA.
DR   EMBL; AF366368; AAK53391.1; -; mRNA.
DR   EMBL; AC002328; AAF79509.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE33274.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE33275.1; -; Genomic_DNA.
DR   EMBL; AY080722; AAL86324.1; -; mRNA.
DR   RefSeq; NP_564698.1; NM_104438.4. [Q8RXR2-1]
DR   RefSeq; NP_849813.1; NM_179482.3. [Q8RXR2-2]
DR   UniGene; At.10363; -.
DR   ProteinModelPortal; Q8RXR2; -.
DR   SMR; Q8RXR2; -.
DR   STRING; 3702.AT1G55620.2; -.
DR   PaxDb; Q8RXR2; -.
DR   EnsemblPlants; AT1G55620.1; AT1G55620.1; AT1G55620. [Q8RXR2-2]
DR   EnsemblPlants; AT1G55620.2; AT1G55620.2; AT1G55620. [Q8RXR2-1]
DR   GeneID; 842011; -.
DR   Gramene; AT1G55620.1; AT1G55620.1; AT1G55620. [Q8RXR2-2]
DR   Gramene; AT1G55620.2; AT1G55620.2; AT1G55620. [Q8RXR2-1]
DR   KEGG; ath:AT1G55620; -.
DR   Araport; AT1G55620; -.
DR   TAIR; locus:2020542; AT1G55620.
DR   eggNOG; KOG0475; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000238204; -.
DR   InParanoid; Q8RXR2; -.
DR   OMA; VVDENTC; -.
DR   OrthoDB; EOG093604B6; -.
DR   PhylomeDB; Q8RXR2; -.
DR   PRO; PR:Q8RXR2; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q8RXR2; baseline and differential.
DR   Genevisible; Q8RXR2; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0009507; C:chloroplast; IDA:TAIR.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:TAIR.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; CBS domain; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    781       Chloride channel protein CLC-f.
FT                                /FTId=PRO_0000094470.
FT   TRANSMEM    129    149       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    279    299       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    314    334       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    350    370       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    388    408       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    433    453       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    457    477       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    502    522       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    523    543       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    726    746       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      621    677       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      699    763       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   VAR_SEQ       1    196       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14593172}.
FT                                /FTId=VSP_009325.
FT   CONFLICT    643    643       E -> K (in Ref. 5; AAL86324).
FT                                {ECO:0000305}.
SQ   SEQUENCE   781 AA;  83549 MW;  BE9DEB3603D9E0D8 CRC64;
     MSSGGAGEYN EDRHLLRSTD GDEVGIGGGE GDLDVESQSP AIRSGAGGVR DLFKHIDRRF
     SLSGRRLSFK RMENIRVDRE RHNPSSSSAF SAAGEEDGGG ISNLHSVDDR NDEYGFDEEV
     LGDSAPPEWA LLLIGCLIGV AAGICVAGFN KGVHVIHEWA WAGTPNEGAA WLRLQRLADT
     WHRILLIPVT GGVIVGMMHG LLEILDQIRQ SNSSQRQGLD FLAGIYPVIK AIQAAVTLGT
     GCSLGPEGPS VDIGKSCANG FALMMENNRE RRIALTAAGA ASGIASGFNA AVAGCFFAIE
     TVLRPLRAEN SPPFTTAMII LASVISSTVS NALLGTQSAF TVPSYDLKSA AELPLYLILG
     MLCGAVSVVF SRLVTWFTKS FDFIKDKFGL PAIVCPALGG LGAGIIALKY PGILYWGFTN
     VEEILHTGKS ASAPGIWLLA QLAAAKVVAT ALCKGSGLVG GLYAPSLMIG AAVGAVFGGS
     AAEIINRAIP GNAAVAQPQA YALVGMAATL ASMCSVPLTS VLLLFELTKD YRILLPLMGA
     VGLAIWVPSV ANQGKESDSS EGRSTGRGYS SLSPSERKTE GVWRHTDNAD SLELTVIENP
     DHNSFLDEET ILEDLKVMRV MSKNYVKVSS GTTLREARNI LKESHQNCIM VVDDDDFLAG
     ILTHGDIRRY LSNNASTILD ENTCPVSSVC TKKISYRGQE RGLLTCYPDA TVGVAKELME
     ARGVKQLPVV KRGEVIHKGK RRKLLGLLHY DSIWTFLRDE MSRRRSINDR RKDKEVGTNG
     H
//
ID   BEST1_PIG               Reviewed;         428 AA.
AC   Q8WMR7;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   25-OCT-2017, entry version 70.
DE   RecName: Full=Bestrophin-1;
DE   AltName: Full=Vitelliform macular dystrophy protein 2 homolog;
DE   Flags: Fragment;
GN   Name=BEST1; Synonyms=VMD2;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Suina; Suidae;
OC   Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH PPP2CB AND PPP2R1B,
RP   PHOSPHORYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12058047; DOI=10.1074/jbc.M204269200;
RA   Marmorstein L.Y., McLaughlin P.J., Stanton J.B., Yan L., Crabb J.W.,
RA   Marmorstein A.D.;
RT   "Bestrophin interacts physically and functionally with protein
RT   phosphatase 2A.";
RL   J. Biol. Chem. 277:30591-30597(2002).
CC   -!- FUNCTION: Forms calcium-sensitive chloride channels. Permeable to
CC       bicarbonate (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Tetramer or pentamers. May interact with PPP2CB and
CC       PPP2R1B (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Basolateral cell membrane {ECO:0000250}.
CC   -!- PTM: Phosphorylated (in vitro) by PP2A.
CC       {ECO:0000269|PubMed:12058047}.
CC   -!- SIMILARITY: Belongs to the bestrophin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY064707; AAL40882.1; -; mRNA.
DR   UniGene; Ssc.15771; -.
DR   SMR; Q8WMR7; -.
DR   CORUM; Q8WMR7; -.
DR   MINT; MINT-239917; -.
DR   STRING; 9823.ENSSSCP00000025663; -.
DR   PaxDb; Q8WMR7; -.
DR   PeptideAtlas; Q8WMR7; -.
DR   PRIDE; Q8WMR7; -.
DR   eggNOG; KOG3547; Eukaryota.
DR   eggNOG; ENOG410XS3J; LUCA.
DR   HOVERGEN; HBG044928; -.
DR   InParanoid; Q8WMR7; -.
DR   Proteomes; UP000008227; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:InterPro.
DR   InterPro; IPR033041; Best1.
DR   InterPro; IPR000615; Bestrophin.
DR   InterPro; IPR021134; Bestrophin/UPF0187.
DR   PANTHER; PTHR10736; PTHR10736; 1.
DR   PANTHER; PTHR10736:SF4; PTHR10736:SF4; 1.
DR   Pfam; PF01062; Bestrophin; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN        <1    428       Bestrophin-1.
FT                                /FTId=PRO_0000143117.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     75       Extracellular. {ECO:0000255}.
FT   INTRAMEM     76     96       {ECO:0000255}.
FT   TOPO_DOM     97    117       Extracellular. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    428       Cytoplasmic. {ECO:0000255}.
FT   NON_TER       1      1
SQ   SEQUENCE   428 AA;  48499 MW;  3E6591B2BCDB6383 CRC64;
     PQHLVKAGFM TPSEHKHLEK LSLPHNSFWM PWVWFANLST KAWIGGRIRD PVLLQSLLDE
     MNTLRTQCGH LYAYDWISVP LVYTQVVTVA VYSFFLACLV GRQFLNPAKA YPGHEMDLVV
     PLFTFLQFFF YAGWLKVAEQ LINPFGEDDD DFETNWIVDR SLQVSLSAVD EMHHDLPPME
     RDMYWNDPEP HPPYTAASAQ SRRPSFFGST FNISLGKEDM EFQPEEEEEA HTGILGHFLG
     LQSSDHQPPR TNSKTKLLWP KKEGHFHEGH PKNLRGARLD SSDQEDSKAW REGGFKSAAL
     CGRPGYHSAP QTPLGHTPMV FPPEESAPLG LRRVSGIDEA AKDQSLQPAT PSIKKSFELL
     PESAEASAEP LQGSHVRRKT VEFNLADLSE APEHLKEPNL EPPMGIHAIL KDHRDPYWAL
     ENRDEAHS
//
ID   EXC4_CAEEL              Reviewed;         290 AA.
AC   Q8WQA4;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   22-NOV-2017, entry version 100.
DE   RecName: Full=Chloride intracellular channel exc-4;
DE   AltName: Full=Excretory canal abnormal protein 4;
GN   Name=exc-4; ORFNames=Y105E8A.22;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DOMAIN, AND MUTAGENESIS OF LEU-46 AND PRO-238.
RC   STRAIN=Bristol N2;
RX   PubMed=14684823; DOI=10.1126/science.1087667;
RA   Berry K.L., Buelow H.E., Hall D.H., Hobert O.;
RT   "A C. elegans CLIC-like protein required for intracellular tube
RT   formation and maintenance.";
RL   Science 302:2134-2137(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS), FUNCTION, SUBCELLULAR LOCATION,
RP   AND SUBUNIT.
RX   PubMed=17985355; DOI=10.1002/prot.21704;
RA   Littler D.R., Harrop S.J., Brown L.J., Pankhurst G.J., Mynott A.V.,
RA   Luciani P., Mandyam R.A., Mazzanti M., Tanda S., Berryman M.A.,
RA   Breit S.N., Curmi P.M.G.;
RT   "Comparison of vertebrate and invertebrate CLIC proteins: the crystal
RT   structures of Caenorhabditis elegans EXC-4 and Drosophila melanogaster
RT   DmCLIC.";
RL   Proteins 71:364-378(2008).
CC   -!- FUNCTION: May insert into membranes and form chloride ion
CC       channels. Involved in the formation of the excretory canal.
CC       Required to prevent cystic lumenal expansions in the excretory
CC       cell. Not required for formation of the initial tube, but is
CC       required for regulating the size of the tube lumen as it grows.
CC       {ECO:0000269|PubMed:17985355}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:17985355}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane {ECO:0000305}; Single-
CC       pass membrane protein {ECO:0000305}. Note=Exists both as soluble
CC       cytoplasmic protein and as membrane protein with probably a single
CC       transmembrane domain. Localizes to various tubular membranes in
CC       distinct cell types, including the lumenal membrane of the
CC       excretory tubes.
CC   -!- TISSUE SPECIFICITY: Expressed in the secretory system, hypodermis,
CC       vulva, pharyngeal muscle, rectal gland, tubular rectal epithelium
CC       cells, and tubular neuronal support cells in the head and tail.
CC       {ECO:0000269|PubMed:14684823}.
CC   -!- DOMAIN: The N-terminal part (1-55) is necessary and sufficient for
CC       translocation from the cytosol to the membrane.
CC       {ECO:0000269|PubMed:14684823}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY308063; AAQ75554.1; -; mRNA.
DR   EMBL; AL132876; CAD21669.2; -; Genomic_DNA.
DR   RefSeq; NP_740950.2; NM_170954.2.
DR   UniGene; Cel.24092; -.
DR   PDB; 2YV9; X-ray; 1.60 A; A/B=1-290.
DR   PDBsum; 2YV9; -.
DR   ProteinModelPortal; Q8WQA4; -.
DR   SMR; Q8WQA4; -.
DR   STRING; 6239.Y105E8A.22; -.
DR   EPD; Q8WQA4; -.
DR   PaxDb; Q8WQA4; -.
DR   PeptideAtlas; Q8WQA4; -.
DR   PRIDE; Q8WQA4; -.
DR   EnsemblMetazoa; Y105E8A.22; Y105E8A.22; WBGene00001365.
DR   GeneID; 173314; -.
DR   KEGG; cel:CELE_Y105E8A.22; -.
DR   UCSC; Y105E8A.22; c. elegans.
DR   CTD; 173314; -.
DR   WormBase; Y105E8A.22; CE36222; WBGene00001365; exc-4.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000021696; -.
DR   InParanoid; Q8WQA4; -.
DR   KO; K05022; -.
DR   OMA; ANGDDRD; -.
DR   OrthoDB; EOG091G0GCZ; -.
DR   PhylomeDB; Q8WQA4; -.
DR   EvolutionaryTrace; Q8WQA4; -.
DR   PRO; PR:Q8WQA4; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00001365; -.
DR   GO; GO:0043296; C:apical junction complex; IDA:WormBase.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:WormBase.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:WormBase.
DR   GO; GO:0005764; C:lysosome; IDA:WormBase.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0002064; P:epithelial cell development; IMP:WormBase.
DR   GO; GO:0035150; P:regulation of tube size; IMP:WormBase.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   SUPFAM; SSF47616; SSF47616; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Ion channel; Ion transport; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    290       Chloride intracellular channel exc-4.
FT                                /FTId=PRO_0000144221.
FT   TRANSMEM     37     57       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   MUTAGEN      46     46       L->P: Abolishes membrane localization.
FT                                {ECO:0000269|PubMed:14684823}.
FT   MUTAGEN     238    238       P->L: In n2400; induces defects in
FT                                tubular morphology of the excretory
FT                                canal. {ECO:0000269|PubMed:14684823}.
FT   HELIX         1      4       {ECO:0000244|PDB:2YV9}.
FT   HELIX        13     15       {ECO:0000244|PDB:2YV9}.
FT   STRAND       18     25       {ECO:0000244|PDB:2YV9}.
FT   HELIX        37     51       {ECO:0000244|PDB:2YV9}.
FT   STRAND       56     62       {ECO:0000244|PDB:2YV9}.
FT   HELIX        67     73       {ECO:0000244|PDB:2YV9}.
FT   STRAND       80     83       {ECO:0000244|PDB:2YV9}.
FT   HELIX        84     86       {ECO:0000244|PDB:2YV9}.
FT   STRAND       88     90       {ECO:0000244|PDB:2YV9}.
FT   HELIX        93    106       {ECO:0000244|PDB:2YV9}.
FT   HELIX       116    139       {ECO:0000244|PDB:2YV9}.
FT   TURN        140    142       {ECO:0000244|PDB:2YV9}.
FT   HELIX       149    151       {ECO:0000244|PDB:2YV9}.
FT   HELIX       154    177       {ECO:0000244|PDB:2YV9}.
FT   STRAND      180    186       {ECO:0000244|PDB:2YV9}.
FT   HELIX       189    207       {ECO:0000244|PDB:2YV9}.
FT   HELIX       218    227       {ECO:0000244|PDB:2YV9}.
FT   HELIX       231    235       {ECO:0000244|PDB:2YV9}.
FT   HELIX       240    250       {ECO:0000244|PDB:2YV9}.
FT   HELIX       257    261       {ECO:0000244|PDB:2YV9}.
FT   HELIX       272    279       {ECO:0000244|PDB:2YV9}.
FT   TURN        280    282       {ECO:0000244|PDB:2YV9}.
SQ   SEQUENCE   290 AA;  33703 MW;  59256CC9BFB165DE CRC64;
     MAEAYQIQSN GDPQSKPLLE LYVKASGIDA RRIGADLFCQ EFWMELYALY EIGVARVEVK
     TVNVNSEAFK KNFLGAQPPI MIEEEKELTY TDNREIEGRI FHLAKEFNVP LFEKDPSAEK
     RIENLYRNFK LFLRAKVEFD KGKKEPSRVE DLPAQIKVHY NRVCEQLSNI DQLLSERKSR
     YLLGNSMTEY DCELMPRLHH IRIIGLSLLG FDIPHNFTHL WAYILTAYRT AAFIESCPAD
     QDIIHHYKEQ MNLFTNQRET LQSPTKTHTI PEKVLSDIRV KGLAPDVNVH
//
ID   CLCB_ECO57              Reviewed;         418 AA.
AC   Q8X794;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   07-JUN-2017, entry version 102.
DE   RecName: Full=Voltage-gated ClC-type chloride channel ClcB;
GN   Name=clcB; OrderedLocusNames=Z2583, ECs2298;
OS   Escherichia coli O157:H7.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / EDL933 / ATCC 700927 / EHEC;
RX   PubMed=11206551; DOI=10.1038/35054089;
RA   Perna N.T., Plunkett G. III, Burland V., Mau B., Glasner J.D.,
RA   Rose D.J., Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A.,
RA   Posfai G., Hackett J., Klink S., Boutin A., Shao Y., Miller L.,
RA   Grotbeck E.J., Davis N.W., Lim A., Dimalanta E.T., Potamousis K.,
RA   Apodaca J., Anantharaman T.S., Lin J., Yen G., Schwartz D.C.,
RA   Welch R.A., Blattner F.R.;
RT   "Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.";
RL   Nature 409:529-533(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=11258796; DOI=10.1093/dnares/8.1.11;
RA   Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K.,
RA   Han C.-G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T.,
RA   Iida T., Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T.,
RA   Kuhara S., Shiba T., Hattori M., Shinagawa H.;
RT   "Complete genome sequence of enterohemorrhagic Escherichia coli
RT   O157:H7 and genomic comparison with a laboratory strain K-12.";
RL   DNA Res. 8:11-22(2001).
CC   -!- FUNCTION: Probably acts as an electrical shunt for an outwardly-
CC       directed proton pump that is linked to amino acid decarboxylation,
CC       as part of the extreme acid resistance (XAR) response.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClcB subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG56579.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB35721.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE005174; AAG56579.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BA000007; BAB35721.1; ALT_INIT; Genomic_DNA.
DR   PIR; B90916; B90916.
DR   PIR; G85764; G85764.
DR   RefSeq; NP_310325.2; NC_002695.1.
DR   ProteinModelPortal; Q8X794; -.
DR   STRING; 155864.Z2583; -.
DR   EnsemblBacteria; AAG56579; AAG56579; Z2583.
DR   EnsemblBacteria; BAB35721; BAB35721; BAB35721.
DR   GeneID; 916112; -.
DR   KEGG; ece:Z2583; -.
DR   KEGG; ecs:ECs2298; -.
DR   PATRIC; fig|386585.9.peg.2406; -.
DR   eggNOG; ENOG4105CMQ; Bacteria.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000230177; -.
DR   KO; K03281; -.
DR   Proteomes; UP000000558; Chromosome.
DR   Proteomes; UP000002519; Chromosome.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   GO; GO:0010447; P:response to acidic pH; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   HAMAP; MF_01203; CLC_ClcB; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR023790; Cl-channel_volt-gated_ClcB.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    418       Voltage-gated ClC-type chloride channel
FT                                ClcB.
FT                                /FTId=PRO_0000094487.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      5     25       Helical. {ECO:0000255}.
FT   TOPO_DOM     26     53       Periplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75    145       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TOPO_DOM    167    177       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    178    200       Helical. {ECO:0000255}.
FT   TOPO_DOM    201    221       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical. {ECO:0000255}.
FT   TOPO_DOM    243    257       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical. {ECO:0000255}.
FT   TOPO_DOM    279    290       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TOPO_DOM    312    315       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    316    336       Helical. {ECO:0000255}.
FT   TOPO_DOM    337    351       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical. {ECO:0000255}.
FT   TOPO_DOM    373    379       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TOPO_DOM    401    418       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   418 AA;  44145 MW;  B956AB3EB4C6E96D CRC64;
     MFRRLLIATV VGILAAFAVA GFRHAMLLLE WLFLNNDSGS LVNAATNLSP WRRLLTPALG
     GLAAGLLLMG WQKFTQQRPH APTDYMEALQ TDGQFDYAAS LVKSLASLLV VTSGSAIGRE
     GAMILLAALA ASCFAQRFTP RQEWKLWIAC GAAAGMAAAY RAPLAGSLFI AEVLFGTMML
     ASLGPVIISA VVALLVSNLI NHSDALLYSV QLSVTVQARD YALIISTGVL AGLCGPLLLT
     LMNACHRGFV SLKLAPPWQL ALGGLIVGLL SLFTPAVWGN GYSTVQSFLT APPLLMIIAG
     IFLCKLCAVL ASSGSGAPGG VFTPTLFIGL AIGMLYGRSL GLWFPDGEEI TLLLGLTGMA
     TLLAATTHAP IMSTLMICEM TGEYQLLPGL LIACVIASVI SRTLHRDSIY RQHTAQHS
//
ID   CLCL_RALSO              Reviewed;         429 AA.
AC   Q8XTT4;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   07-JUN-2017, entry version 93.
DE   RecName: Full=Putative chloride channel protein ClcB-like;
GN   OrderedLocusNames=RSp0020; ORFNames=RS01992;
OS   Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum).
OG   Plasmid megaplasmid Rsp.
OC   Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales;
OC   Burkholderiaceae; Ralstonia.
OX   NCBI_TaxID=267608;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=GMI1000;
RX   PubMed=11823852; DOI=10.1038/415497a;
RA   Salanoubat M., Genin S., Artiguenave F., Gouzy J., Mangenot S.,
RA   Arlat M., Billault A., Brottier P., Camus J.-C., Cattolico L.,
RA   Chandler M., Choisne N., Claudel-Renard C., Cunnac S., Demange N.,
RA   Gaspin C., Lavie M., Moisan A., Robert C., Saurin W., Schiex T.,
RA   Siguier P., Thebault P., Whalen M., Wincker P., Levy M.,
RA   Weissenbach J., Boucher C.A.;
RT   "Genome sequence of the plant pathogen Ralstonia solanacearum.";
RL   Nature 415:497-502(2002).
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClcB subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD17171.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL646053; CAD17171.1; ALT_INIT; Genomic_DNA.
DR   ProteinModelPortal; Q8XTT4; -.
DR   EnsemblBacteria; CAD17171; CAD17171; RSp0020.
DR   KEGG; rso:RSp0020; -.
DR   HOGENOM; HOG000230177; -.
DR   KO; K03281; -.
DR   OMA; GPLTMTF; -.
DR   OrthoDB; POG091H0286; -.
DR   Proteomes; UP000001436; Plasmid megaplasmid Rsp.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   GO; GO:0010447; P:response to acidic pH; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   HAMAP; MF_01203; CLC_ClcB; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR023790; Cl-channel_volt-gated_ClcB.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane; Plasmid;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    429       Putative chloride channel protein ClcB-
FT                                like.
FT                                /FTId=PRO_0000094493.
FT   TRANSMEM      1     21       Helical. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TRANSMEM    168    188       Helical. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical. {ECO:0000255}.
FT   TRANSMEM    315    335       Helical. {ECO:0000255}.
FT   TRANSMEM    354    376       Helical. {ECO:0000255}.
FT   TRANSMEM    383    405       Helical. {ECO:0000255}.
SQ   SEQUENCE   429 AA;  44195 MW;  5159534BAAE9ED79 CRC64;
     MLAIAGLIGC AGALATIAFR ECLRQLQWWL AGADQGLVAT ARALPWWARL LVPTAGGLLA
     GLTLQYGLKW IPRKGAEDYM EAIAVGDGVL SARQSLVRSA SSLCSVASGA SIGREGPMVQ
     LAAMCGSLLG RVLRHAMPVS VEHMRLLVAC GAAAGITSAY NAPIAGAVFV CEIVFGAITT
     ATLGPLLVSA VTADIIVRQF FGYGAVYAMP HFDFVSGWEV LTYLGLGLAA GMAGPLLLGL
     IDRARGAFAR TRLPQALRLA LGGLIVGALS IRVPEVWGNG YSVVNGFLHA PWLWQTVALV
     LVCKVGATAA SAGSGAVGGV FTPTLFCGAA LGLLYGTGMH ALLPGAAPVP VSYAVVGMGA
     LLAATTHAPL MSILMIFEMT LSYQVVLPLM LACITGYVTA HATGAPSVYA RALARNRDDT
     LRLPPASSP
//
ID   CLCB_SALTY              Reviewed;         417 AA.
AC   Q8ZPK5;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   27-SEP-2017, entry version 98.
DE   RecName: Full=Voltage-gated ClC-type chloride channel ClcB;
GN   Name=clcB; OrderedLocusNames=STM1490;
OS   Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Salmonella.
OX   NCBI_TaxID=99287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LT2 / SGSC1412 / ATCC 700720;
RX   PubMed=11677609; DOI=10.1038/35101614;
RA   McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P.,
RA   Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D.,
RA   Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E.,
RA   Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M.,
RA   Waterston R., Wilson R.K.;
RT   "Complete genome sequence of Salmonella enterica serovar Typhimurium
RT   LT2.";
RL   Nature 413:852-856(2001).
CC   -!- FUNCTION: Probably acts as an electrical shunt for an outwardly-
CC       directed proton pump that is linked to amino acid decarboxylation,
CC       as part of the extreme acid resistance (XAR) response.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       ClcB subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL20409.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE006468; AAL20409.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; NP_460450.3; NC_003197.2.
DR   ProteinModelPortal; Q8ZPK5; -.
DR   STRING; 99287.STM1490; -.
DR   PaxDb; Q8ZPK5; -.
DR   EnsemblBacteria; AAL20409; AAL20409; STM1490.
DR   GeneID; 1253008; -.
DR   KEGG; stm:STM1490; -.
DR   PATRIC; fig|99287.12.peg.1575; -.
DR   eggNOG; ENOG4105CMQ; Bacteria.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000230177; -.
DR   KO; K03281; -.
DR   OMA; GPLTMTF; -.
DR   Proteomes; UP000001014; Chromosome.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro.
DR   GO; GO:0010447; P:response to acidic pH; IEA:InterPro.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   HAMAP; MF_01203; CLC_ClcB; 1.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR023790; Cl-channel_volt-gated_ClcB.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
PE   3: Inferred from homology;
KW   Cell inner membrane; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN         1    417       Voltage-gated ClC-type chloride channel
FT                                ClcB.
FT                                /FTId=PRO_0000094489.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      5     25       Helical. {ECO:0000255}.
FT   TOPO_DOM     26     53       Periplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75    145       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    146    166       Helical. {ECO:0000255}.
FT   TOPO_DOM    167    172       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    173    195       Helical. {ECO:0000255}.
FT   TOPO_DOM    196    221       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    222    242       Helical. {ECO:0000255}.
FT   TOPO_DOM    243    257       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical. {ECO:0000255}.
FT   TOPO_DOM    279    287       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    288    308       Helical. {ECO:0000255}.
FT   TOPO_DOM    309    315       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    316    336       Helical. {ECO:0000255}.
FT   TOPO_DOM    337    348       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    349    371       Helical. {ECO:0000255}.
FT   TOPO_DOM    372    379       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TOPO_DOM    401    417       Cytoplasmic. {ECO:0000255}.
SQ   SEQUENCE   417 AA;  44119 MW;  A22935596CF5C16C CRC64;
     MFRRLLIATL IGILAALAVA AFRHAMQLLE WIFLSNDTGS LVNAAEGLSP WRRLITPALG
     GLAAGLLLWG WQKMNQQRPH APTDYMEALQ TDGQFDVGAS LVKSLASLLV VVSGSAIGRE
     GAMILLAALA ASSFARRFTP REEWKLWIAS GAAAGMAGAY HAPLAGSLFI AEILFGTLML
     ASLGPVVVSA VVALLTTHVL NGSDSLLYTV HLTVDLHARE YVMIVSTGLV AGLCGPLLMW
     LMTASHNSFL RLKLSPPWQL ALGGLIVGLL SLLTPTVWGN GYSVVQSFLL SPPLFSLIGG
     IFVCKILAVL ASSGSGAPGG VFTPTLFVGL SIGMFLGRIW GFWLPGSDEI AILLGLAGMA
     TLLAATTHAP IMSTLMICEM TGEYQLLPGL LIACVVASVL SRTLRHDSIY RQHAAEH
//
ID   CLCC1_XENLA             Reviewed;         508 AA.
AC   Q91892;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 50.
DE   RecName: Full=Chloride channel CLIC-like protein 1;
DE   AltName: Full=Mid-1-related chloride channel protein 1;
DE            Short=MCLC;
DE   Flags: Precursor;
GN   Name=clcc1;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=8632145;
RA   Holthuis J.C., Martens G.J.M.;
RT   "The neuroendocrine proteins secretogranin II and III are regionally
RT   conserved and coordinately expressed with proopiomelanocortin in
RT   Xenopus intermediate pituitary.";
RL   J. Neurochem. 66:2248-2256(1996).
CC   -!- FUNCTION: Seems to act as a chloride ion channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Endoplasmic reticulum {ECO:0000250}. Golgi
CC       apparatus {ECO:0000250}. Nucleus {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the chloride channel MCLC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92871; CAA63477.1; -; mRNA.
DR   RefSeq; NP_001081605.1; NM_001088136.1.
DR   UniGene; Xl.125; -.
DR   TCDB; 1.A.36.1.5; the intracellular chloride channel (icc) family.
DR   GeneID; 397947; -.
DR   KEGG; xla:397947; -.
DR   CTD; 397947; -.
DR   Xenbase; XB-GENE-1010586; clcc1.
DR   HOVERGEN; HBG060364; -.
DR   KO; K22188; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   InterPro; IPR009231; Chloride_chnl_CLIC-like.
DR   PANTHER; PTHR34093; PTHR34093; 1.
DR   Pfam; PF05934; MCLC; 1.
PE   2: Evidence at transcript level;
KW   Chloride; Chloride channel; Endoplasmic reticulum; Golgi apparatus;
KW   Ion channel; Ion transport; Membrane; Nucleus; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    508       Chloride channel CLIC-like protein 1.
FT                                /FTId=PRO_0000297685.
FT   TRANSMEM    198    218       Helical. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TRANSMEM    347    367       Helical. {ECO:0000255}.
SQ   SEQUENCE   508 AA;  57913 MW;  581C2A870B771BA7 CRC64;
     MRLFLLVALY LSPVYGDYTD EWIDPSDMLN YDAASGKMKN KPQVESTQSY YSVENTVSQD
     ATQQPAQKAN ELHQNPDMTC SAEYQEYKTK LENLKGQLEE TKRMEKSKSK SQAIFKRYLN
     KILIEAGRIG LPDESYPKAH YDAEVVFTME MLQEIQSFLN NGDWNVGALD DALSSTLVQF
     KHHNEEEWKW KFEDSFGVDV YTLFMLILCV LCLVKLIATE IWTHIGWFTQ LKRLLILSTV
     ISFGWNWMYL YKVAFAERQA ELAKLQDFDK CSQKISWSES LFDWMKGAAT FQNDPCEDYF
     KALIVSPTLM VPPTKALALT FTNFITEPLK HIGKGIGEFL NALLSEIPLF FQVPVLIFIA
     VLLLAFFYGA GTAVMNPVNL YRRLTGPERE KPLPVEPTRS NRKRFIEDVR VPPALGQLPR
     DNDVVNIPKQ QPLDDIDGSN NPPVTAPADP SDTGQVKSNN TGEPLVQEDH SIKKSIKESR
     NDERPNTESP EAKPQRPEEP VVETLRST
//
ID   CLCC_ARATH              Reviewed;         779 AA.
AC   Q96282; O04753; O04837;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   20-DEC-2017, entry version 128.
DE   RecName: Full=Chloride channel protein CLC-c;
DE            Short=AtCLC-c;
DE   AltName: Full=CBS domain-containing protein CBSCLC4;
GN   Name=CLC-C; Synonyms=CBSCLC4; OrderedLocusNames=At5g49890;
GN   ORFNames=K9P8.3;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=8969232; DOI=10.1074/jbc.271.52.33632;
RA   Hechenberger M., Schwappach B., Fischer W.N., Frommer W.B.,
RA   Jentsch T.J., Steinmeyer K.;
RT   "A family of putative chloride channels from Arabidopsis and
RT   functional complementation of a yeast strain with a CLC gene
RT   disruption.";
RL   J. Biol. Chem. 271:33632-33638(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. C24;
RA   Weigmann N., Zimmermann S., Mueller-Roeber B.;
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10718197; DOI=10.1093/dnares/7.1.31;
RA   Sato S., Nakamura Y., Kaneko T., Katoh T., Asamizu E., Kotani H.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. X. Sequence
RT   features of the regions of 3,076,755 bp covered by sixty P1 and TAC
RT   clones.";
RL   DNA Res. 7:31-63(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=19400948; DOI=10.1186/1471-2164-10-200;
RA   Kushwaha H.R., Singh A.K., Sopory S.K., Singla-Pareek S.L., Pareek A.;
RT   "Genome wide expression analysis of CBS domain containing proteins in
RT   Arabidopsis thaliana (L.) Heynh and Oryza sativa L. reveals their
RT   developmental and stress regulation.";
RL   BMC Genomics 10:200-200(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND SER-672, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=cv. Columbia;
RX   PubMed=19245862; DOI=10.1016/j.jprot.2009.02.004;
RA   Jones A.M.E., MacLean D., Studholme D.J., Serna-Sanz A.,
RA   Andreasson E., Rathjen J.P., Peck S.C.;
RT   "Phosphoproteomic analysis of nuclei-enriched fractions from
RT   Arabidopsis thaliana.";
RL   J. Proteomics 72:439-451(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND SER-672, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19376835; DOI=10.1104/pp.109.138677;
RA   Reiland S., Messerli G., Baerenfaller K., Gerrits B., Endler A.,
RA   Grossmann J., Gruissem W., Baginsky S.;
RT   "Large-scale Arabidopsis phosphoproteome profiling reveals novel
RT   chloroplast kinase substrates and phosphorylation networks.";
RL   Plant Physiol. 150:889-903(2009).
RN   [9]
RP   INTERACTION WITH PP2A5.
RX   PubMed=27676158; DOI=10.1111/pce.12837;
RA   Hu R., Zhu Y., Wei J., Chen J., Shi H., Shen G., Zhang H.;
RT   "Overexpression of PP2A-C5 that encodes the catalytic subunit 5 of
RT   protein phosphatase 2A in Arabidopsis confers better root and shoot
RT   development under salt conditions.";
RL   Plant Cell Environ. 40:150-164(2017).
CC   -!- FUNCTION: Voltage-gated chloride channel.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with PP2A5
CC       (PubMed:27676158). {ECO:0000250, ECO:0000269|PubMed:27676158}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Broadly expressed in the plant.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z71447; CAA96059.1; -; mRNA.
DR   EMBL; Y09095; CAA70310.1; -; mRNA.
DR   EMBL; AB024032; BAA97010.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED95868.1; -; Genomic_DNA.
DR   EMBL; AY120754; AAM53312.1; -; mRNA.
DR   EMBL; BT001211; AAN65098.1; -; mRNA.
DR   RefSeq; NP_199800.1; NM_124367.4.
DR   UniGene; At.16; -.
DR   ProteinModelPortal; Q96282; -.
DR   BioGrid; 20298; 8.
DR   STRING; 3702.AT5G49890.1; -.
DR   iPTMnet; Q96282; -.
DR   PaxDb; Q96282; -.
DR   EnsemblPlants; AT5G49890.1; AT5G49890.1; AT5G49890.
DR   GeneID; 835052; -.
DR   Gramene; AT5G49890.1; AT5G49890.1; AT5G49890.
DR   KEGG; ath:AT5G49890; -.
DR   Araport; AT5G49890; -.
DR   TAIR; locus:2158809; AT5G49890.
DR   eggNOG; KOG0474; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   HOGENOM; HOG000231081; -.
DR   InParanoid; Q96282; -.
DR   KO; K05016; -.
DR   OMA; KYHSASM; -.
DR   OrthoDB; EOG093602TR; -.
DR   PhylomeDB; Q96282; -.
DR   Reactome; R-ATH-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q96282; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q96282; baseline and differential.
DR   Genevisible; Q96282; AT.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0009705; C:plant-type vacuole membrane; IDA:TAIR.
DR   GO; GO:0005774; C:vacuolar membrane; IDA:TAIR.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   InterPro; IPR002251; Cl_channel_pln.
DR   Pfam; PF00571; CBS; 1.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   PRINTS; PR01120; CLCHANNELPLT.
DR   SMART; SM00116; CBS; 2.
DR   SUPFAM; SSF81340; SSF81340; 2.
DR   PROSITE; PS51371; CBS; 1.
PE   1: Evidence at protein level;
KW   CBS domain; Chloride; Chloride channel; Complete proteome;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    779       Chloride channel protein CLC-c.
FT                                /FTId=PRO_0000094467.
FT   TRANSMEM     92    112       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    215    235       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    488    508       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    520    540       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    541    561       Helical; Name=12. {ECO:0000255}.
FT   TRANSMEM    741    761       Helical; Name=13. {ECO:0000255}.
FT   DOMAIN      601    659       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN      713    777       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOD_RES      27     27       Phosphoserine.
FT                                {ECO:0000244|PubMed:19245862,
FT                                ECO:0000244|PubMed:19376835}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000244|PubMed:19245862,
FT                                ECO:0000244|PubMed:19376835}.
SQ   SEQUENCE   779 AA;  85232 MW;  1717716DB1EE5867 CRC64;
     MDDRHEGDHH DIEVEGGALH GFERKISGIL DDGSVGFRQP LLARNRKNTT SQIAIVGANT
     CPIESLDYEI FENDFFKQDW RSRKKIEILQ YTFLKWALAF LIGLATGLVG FLNNLGVENI
     AGFKLLLIGN LMLKEKYFQA FFAFAGCNLI LATAAASLCA FIAPAAAGSG IPEVKAYLNG
     IDAYSILAPS TLFVKIFGSI FGVAAGFVVG KEGPMVHTGA CIANLLGQGG SKKYRLTWKW
     LRFFKNDRDR RDLITCGAAA GVAAAFRAPV GGVLFALEEA ASWWRNALLW RTFFTTAVVA
     VVLRSLIEFC RSGRCGLFGK GGLIMFDVNS GPVLYSTPDL LAIVFLGVIG GVLGSLYNYL
     VDKVLRTYSI INEKGPRFKI MLVMAVSILS SCCAFGLPWL SQCTPCPIGI EEGKCPSVGR
     SSIYKSFQCP PNHYNDLSSL LLNTNDDAIR NLFTSRSENE FHISTLAIFF VAVYCLGIIT
     YGIAIPSGLF IPVILAGASY GRLVGRLLGP VSQLDVGLFS LLGAASFLGG TMRMTVSLCV
     ILLELTNNLL MLPLVMLVLL ISKTVADCFN RGVYDQIVTM KGLPYMEDHA EPYMRNLVAK
     DVVSGALISF SRVEKVGVIW QALKMTRHNG FPVIDEPPFT EASELCGIAL RSHLLVLLQG
     KKFSKQRTTF GSQILRSCKA RDFGKAGLGK GLKIEDLDLS EEEMEMYVDL HPITNTSPYT
     VLETLSLAKA AILFRQLGLR HLCVVPKTPG RPPIVGILTR HDFMPEHVLG LYPHIDPLK
//
ID   S26A6_HUMAN             Reviewed;         759 AA.
AC   Q9BXS9; B4DMZ1; Q548A7; Q96Q90; Q9NQU1;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 141.
DE   RecName: Full=Solute carrier family 26 member 6;
DE   AltName: Full=Anion exchange transporter;
DE   AltName: Full=Pendrin-like protein 1;
DE            Short=Pendrin-L1;
GN   Name=SLC26A6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11087667; DOI=10.1006/geno.2000.6355;
RA   Lohi H., Kujala M., Kerkelae E., Saarialho-Kere U., Kestilae M.,
RA   Kere J.;
RT   "Mapping of five new putative anion transporter genes in human and
RT   characterization of SLC26A6, a candidate gene for pancreatic anion
RT   exchanger.";
RL   Genomics 70:102-112(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND VARIANT MET-206.
RX   PubMed=11247665; DOI=10.1006/geno.2000.6445;
RA   Waldegger S., Moschen I., Ramirez A., Smith R.J.H., Ayadi H., Lang F.,
RA   Kubisch C.;
RT   "Cloning and characterization of SLC26A6, a novel member of the solute
RT   carrier 26 gene family.";
RL   Genomics 72:43-50(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12217875; DOI=10.1152/ajprenal.00079.2002;
RA   Xie Q., Welch R., Mercado A., Romero M.F., Mount D.B.;
RT   "Molecular characterization of the murine Slc26a6 anion exchanger:
RT   functional comparison with Slc26a1.";
RL   Am. J. Physiol. 283:F826-F838(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RA   Ishibashi K.;
RT   "Molecular cloning of a new putative sulfate anion transporter.";
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORMS 4; 5 AND 6), FUNCTION, ENZYME
RP   REGULATION, INTERACTION WITH SLC9A3R1 AND SLC9A3R2, SUBCELLULAR
RP   LOCATION, AND TOPOLOGY.
RX   PubMed=12444019; DOI=10.1152/ajpcell.00270.2002;
RA   Lohi H., Lamprecht G., Markovich D., Heil A., Kujala M., Seidler U.,
RA   Kere J.;
RT   "Isoforms of SLC26A6 mediate anion transport and have functional PDZ
RT   interaction domains.";
RL   Am. J. Physiol. 284:C769-C779(2003).
RN   [10]
RP   FUNCTION (ISOFORM 4), ENZYME REGULATION, INTERACTION WITH CA2,
RP   PHOSPHORYLATION AT SER-574 AND SER-603 BY PKC, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF 568-ASP--ASP-570; SER-574 AND SER-603.
RX   PubMed=15990874; DOI=10.1038/sj.emboj.7600736;
RA   Alvarez B.V., Vilas G.L., Casey J.R.;
RT   "Metabolon disruption: a mechanism that regulates bicarbonate
RT   transport.";
RL   EMBO J. 24:2499-2511(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-752, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   INDUCTION.
RX   PubMed=18655181; DOI=10.1002/jcb.21842;
RA   Saksena S., Dwivedi A., Singla A., Gill R.K., Tyagi S., Borthakur A.,
RA   Alrefai W.A., Ramaswamy K., Dudeja P.K.;
RT   "Characterization of the 5'-flanking region and regulation of
RT   expression of human anion exchanger SLC26A6.";
RL   J. Cell. Biochem. 105:454-466(2008).
RN   [13]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=20501439; DOI=10.1152/ajpgi.00251.2009;
RA   Freel R.W., Morozumi M., Hatch M.;
RT   "Parsing apical oxalate exchange in Caco-2BBe1 monolayers: siRNA
RT   knockdown of SLC26A6 reveals the role and properties of PAT-1.";
RL   Am. J. Physiol. 297:G918-G929(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616; SER-752 AND
RP   SER-755, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
CC   -!- FUNCTION: Apical membrane anion-exchanger with wide epithelial
CC       distribution that plays a role as a component of the pH buffering
CC       system for maintaining acid-base homeostasis. Acts as a versatile
CC       DIDS-sensitive inorganic and organic anion transporter that
CC       mediates the uptake of monovalent anions like chloride,
CC       bicarbonate, formate and hydroxyl ion and divalent anions like
CC       sulfate and oxalate. Function in multiple exchange modes involving
CC       pairs of these anions, which include chloride-bicarbonate,
CC       chloride-oxalate, oxalate-formate, oxalate-sulfate and chloride-
CC       formate exchange. Apical membrane chloride-bicarbonate exchanger
CC       that mediates luminal chloride absorption and bicarbonate
CC       secretion by the small intestinal brush border membrane and
CC       contributes to intracellular pH regulation in the duodenal upper
CC       villous epithelium during proton-coupled peptide absorption,
CC       possibly by providing a bicarbonate import pathway. Mediates also
CC       intestinal chloride absorption and oxalate secretion, thereby
CC       preventing hyperoxaluria and calcium oxalate urolithiasis.
CC       Transepithelial oxalate secretion, chloride-formate, chloride-
CC       oxalate and chloride-bicarbonate transport activities in the
CC       duodenum are inhibited by PKC activation in a calcium-independent
CC       manner. The apical membrane chloride-bicarbonate exchanger
CC       provides also a major route for fluid and bicarbonate secretion
CC       into the proximal tubules of the kidney as well as into the
CC       proximal part of the interlobular pancreatic ductal tree, where it
CC       mediates electrogenic chloride-bicarbonate exchange with a
CC       chloride-bicarbonate stoichiometry of 1:2, and hence will dilute
CC       and alkalinize protein-rich acinar secretion. Mediates also the
CC       transcellular sulfate absorption and oxalate secretion across the
CC       apical membrane in the duodenum and the formate ion efflux at the
CC       apical brush border of cells in the proximal tubules of kidney.
CC       Plays a role in sperm capacitation by increasing intracellular pH.
CC   -!- FUNCTION: Isoform 4: Apical membrane chloride-bicarbonate
CC       exchanger. Its association with carbonic anhydrase CA2 forms a
CC       bicarbonate transport metabolon; hence maximizes the local
CC       concentration of bicarbonate at the transporter site.
CC   -!- ENZYME REGULATION: Apical membrane chloride-formate exchange
CC       activity in the proximal tubules of the kidney and oxalate
CC       secretion in the duodenum are inhibited by 4,4'-
CC       diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor
CC       of several anion channels and transporters) (By similarity).
CC       Apical membrane chloride-bicarbonate exchange activity of the
CC       pancreatic duct is inhibited by 4,4'-diisothiocyanatostilbene-
CC       2,2'-disulfonic acid (DIDS - an inhibitor of several anion
CC       channels and transporters). Isoform 4, isoform 5 and isoform 6
CC       chloride, bicarbonate and sulfate transport activities are
CC       inhibited by DIDS. {ECO:0000250, ECO:0000269|PubMed:12444019,
CC       ECO:0000269|PubMed:15990874, ECO:0000269|PubMed:20501439}.
CC   -!- SUBUNIT: Interacts (via C-terminal domain) with PDZK1 (via C-
CC       terminal PDZ domain); the interaction induces chloride and oxalate
CC       exchange transport. Interacts with CFTR, SLC26A3 and SLC9A3R1 (By
CC       similarity). Isoform 4 interacts (via C-terminal cytoplasmic
CC       domain) with CA2; the interaction stimulates chloride-bicarbonate
CC       exchange activity. Isoform 4 and isoform 5 interact with SLC9A3R1
CC       (via the PDZ domains). Isoform 4 and isoform 5 interact with
CC       SLC9A3R2 (via the PDZ domains). Interacts with AHCYL1; the
CC       interaction increases SLC26A6 activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BXS9, ECO:0000269|PubMed:12444019,
CC       ECO:0000269|PubMed:15990874}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Membrane; Multi-pass membrane protein. Apical cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cytoplasmic vesicle membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Microsome {ECO:0000250}. Note=Localized in
CC       sperm membranes. Colocalizes with CFTR at the midpiece of sperm
CC       tail. Localizes to the apical membrane brush border of epithelial
CC       cells in the proximal tubules of kidney, of enterocytes of the
CC       small intestine and of gastric parietal cells in the stomach. May
CC       be translocated from the cytosolic surface of the cell membrane to
CC       the intracellular space by PKC in phorbol myristate acetate (PMA)-
CC       induced cells (By similarity). Colocalized with CA2 at the surface
CC       of the cell membrane in order to form a bicarbonate transport
CC       metabolon; colocalization is reduced in phorbol myristate acetate
CC       (PMA)-induced cells. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cell membrane; Multi-pass
CC       membrane protein. Apical cell membrane; Multi-pass membrane
CC       protein. Basolateral cell membrane; Multi-pass membrane protein.
CC       Note=Localizes to the apical and basolateral surfaces of tubular
CC       wall cells in kidney and in the brush border of pancreatic duct
CC       cells.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 6: Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=SLC26A6b;
CC         IsoId=Q9BXS9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXS9-2; Sequence=VSP_006169;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9BXS9-3; Sequence=VSP_040127;
CC       Name=4; Synonyms=SLC26A6a;
CC         IsoId=Q9BXS9-4; Sequence=VSP_046807, VSP_040127;
CC       Name=5; Synonyms=SLC26A6c;
CC         IsoId=Q9BXS9-5; Sequence=VSP_046807, VSP_047851, VSP_040127;
CC       Name=6; Synonyms=SLC26A6d;
CC         IsoId=Q9BXS9-6; Sequence=VSP_046807, VSP_047852;
CC       Name=7;
CC         IsoId=Q9BXS9-7; Sequence=VSP_055273, VSP_055274;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest levels in kidney and
CC       pancreas. Lower expression in heart, skeletal muscle, liver and
CC       placenta. Also found in lung and brain. Isoform 4 is ubiquitously
CC       expressed. Isoform 6 is expressed in heart, brain, placenta, lung,
CC       liver, kidney, pancreas, spleen, thymus, prostate, testis and
CC       ovary. Isoform 5 is expressed weakly in placenta, lung, liver and
CC       pancreas. {ECO:0000269|PubMed:11087667,
CC       ECO:0000269|PubMed:11247665}.
CC   -!- INDUCTION: Down-regulated by pro-inflammatory cytokine IFN gamma.
CC       {ECO:0000269|PubMed:18655181}.
CC   -!- PTM: Phosphorylated on serine residues by PKC; the phosphorylation
CC       disrupts interaction with carbonic anhydrase CA2 and reduces
CC       bicarbonate transport activity in a phorbol myristate acetate
CC       (PMA)-induced manner. {ECO:0000269|PubMed:15990874}.
CC   -!- SIMILARITY: Belongs to the SLC26A/SulP transporter (TC 2.A.53)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF279265; AAF81911.1; -; mRNA.
DR   EMBL; AF288410; AAK19153.1; -; mRNA.
DR   EMBL; AF416721; AAN07094.1; -; mRNA.
DR   EMBL; AB033288; BAB69041.1; -; mRNA.
DR   EMBL; AK297695; BAG60053.1; -; mRNA.
DR   EMBL; AC121252; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64901.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64903.1; -; Genomic_DNA.
DR   EMBL; BC017697; AAH17697.1; -; mRNA.
DR   CCDS; CCDS43087.1; -. [Q9BXS9-1]
DR   CCDS; CCDS46824.1; -. [Q9BXS9-2]
DR   CCDS; CCDS46825.1; -. [Q9BXS9-3]
DR   CCDS; CCDS63628.1; -. [Q9BXS9-7]
DR   RefSeq; NP_001035544.1; NM_001040454.1.
DR   RefSeq; NP_001268661.1; NM_001281732.1. [Q9BXS9-7]
DR   RefSeq; NP_001268662.1; NM_001281733.1.
DR   RefSeq; NP_075062.2; NM_022911.2. [Q9BXS9-1]
DR   RefSeq; NP_599025.2; NM_134263.2. [Q9BXS9-3]
DR   RefSeq; NP_602298.2; NM_134426.2. [Q9BXS9-2]
DR   UniGene; Hs.631925; -.
DR   UniGene; Hs.663208; -.
DR   ProteinModelPortal; Q9BXS9; -.
DR   SMR; Q9BXS9; -.
DR   BioGrid; 122373; 18.
DR   IntAct; Q9BXS9; 13.
DR   STRING; 9606.ENSP00000378920; -.
DR   TCDB; 2.A.53.2.7; the sulfate permease (sulp) family.
DR   iPTMnet; Q9BXS9; -.
DR   PhosphoSitePlus; Q9BXS9; -.
DR   BioMuta; SLC26A6; -.
DR   DMDM; 20140224; -.
DR   EPD; Q9BXS9; -.
DR   MaxQB; Q9BXS9; -.
DR   PaxDb; Q9BXS9; -.
DR   PeptideAtlas; Q9BXS9; -.
DR   PRIDE; Q9BXS9; -.
DR   DNASU; 65010; -.
DR   Ensembl; ENST00000383733; ENSP00000373239; ENSG00000225697. [Q9BXS9-2]
DR   Ensembl; ENST00000395550; ENSP00000378920; ENSG00000225697. [Q9BXS9-1]
DR   Ensembl; ENST00000420764; ENSP00000404684; ENSG00000225697. [Q9BXS9-3]
DR   Ensembl; ENST00000455886; ENSP00000401066; ENSG00000225697. [Q9BXS9-7]
DR   GeneID; 65010; -.
DR   KEGG; hsa:65010; -.
DR   UCSC; uc003cug.4; human. [Q9BXS9-1]
DR   CTD; 65010; -.
DR   DisGeNET; 65010; -.
DR   EuPathDB; HostDB:ENSG00000225697.10; -.
DR   GeneCards; SLC26A6; -.
DR   HGNC; HGNC:14472; SLC26A6.
DR   HPA; HPA048363; -.
DR   MIM; 610068; gene.
DR   neXtProt; NX_Q9BXS9; -.
DR   OpenTargets; ENSG00000225697; -.
DR   PharmGKB; PA37889; -.
DR   eggNOG; KOG0236; Eukaryota.
DR   eggNOG; COG0659; LUCA.
DR   GeneTree; ENSGT00760000119026; -.
DR   HOGENOM; HOG000006546; -.
DR   HOVERGEN; HBG000639; -.
DR   InParanoid; Q9BXS9; -.
DR   KO; K14704; -.
DR   OMA; SNNVEDC; -.
DR   OrthoDB; EOG091G07RT; -.
DR   PhylomeDB; Q9BXS9; -.
DR   TreeFam; TF313784; -.
DR   Reactome; R-HSA-427601; Multifunctional anion exchangers.
DR   GeneWiki; SLC26A6; -.
DR   GenomeRNAi; 65010; -.
DR   PRO; PR:Q9BXS9; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000225697; -.
DR   CleanEx; HS_SLC26A6; -.
DR   ExpressionAtlas; Q9BXS9; baseline and differential.
DR   Genevisible; Q9BXS9; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0097225; C:sperm midpiece; ISS:UniProtKB.
DR   GO; GO:0031982; C:vesicle; ISS:UniProtKB.
DR   GO; GO:0012506; C:vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0015301; F:anion:anion antiporter activity; IDA:UniProtKB.
DR   GO; GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0015108; F:chloride transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015660; F:formate efflux transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015499; F:formate transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015659; F:formate uptake transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005452; F:inorganic anion exchanger activity; TAS:Reactome.
DR   GO; GO:0019531; F:oxalate transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:UniProtKB.
DR   GO; GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0015116; F:sulfate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; IDA:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071332; P:cellular response to fructose stimulus; ISS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0042045; P:epithelial fluid transport; ISS:UniProtKB.
DR   GO; GO:0015724; P:formate transport; ISS:UniProtKB.
DR   GO; GO:0050892; P:intestinal absorption; ISS:UniProtKB.
DR   GO; GO:0051454; P:intracellular pH elevation; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0015797; P:mannitol transport; ISS:UniProtKB.
DR   GO; GO:0019532; P:oxalate transport; IMP:UniProtKB.
DR   GO; GO:0046724; P:oxalic acid secretion; ISS:UniProtKB.
DR   GO; GO:2001150; P:positive regulation of dipeptide transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0070528; P:protein kinase C signaling; IDA:UniProtKB.
DR   GO; GO:0051453; P:regulation of intracellular pH; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0048240; P:sperm capacitation; ISS:UniProtKB.
DR   GO; GO:0008272; P:sulfate transport; IMP:UniProtKB.
DR   GO; GO:0030321; P:transepithelial chloride transport; IMP:UniProtKB.
DR   GO; GO:0070633; P:transepithelial transport; ISS:UniProtKB.
DR   Gene3D; 3.30.750.24; -; 1.
DR   InterPro; IPR018045; S04_transporter_CS.
DR   InterPro; IPR011547; SLC26A/SulP_dom.
DR   InterPro; IPR001902; SLC26A/SulP_fam.
DR   InterPro; IPR030323; SLC26A6.
DR   InterPro; IPR002645; STAS_dom.
DR   InterPro; IPR036513; STAS_dom_sf.
DR   PANTHER; PTHR11814; PTHR11814; 1.
DR   PANTHER; PTHR11814:SF113; PTHR11814:SF113; 1.
DR   Pfam; PF01740; STAS; 1.
DR   Pfam; PF00916; Sulfate_transp; 1.
DR   SUPFAM; SSF52091; SSF52091; 2.
DR   TIGRFAMs; TIGR00815; sulP; 1.
DR   PROSITE; PS01130; SLC26A; 1.
DR   PROSITE; PS50801; STAS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Anion exchange; Antiport; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Ion channel; Ion transport; Membrane;
KW   Microsome; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    759       Solute carrier family 26 member 6.
FT                                /FTId=PRO_0000080171.
FT   TOPO_DOM      1    115       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    116    136       Helical. {ECO:0000255}.
FT   TOPO_DOM    137    186       Extracellular. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    293       Extracellular. {ECO:0000255}.
FT   TRANSMEM    294    314       Helical. {ECO:0000255}.
FT   TOPO_DOM    315    347       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    348    368       Helical. {ECO:0000255}.
FT   TOPO_DOM    369    379       Extracellular. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical. {ECO:0000255}.
FT   TOPO_DOM    401    416       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    417    437       Helical. {ECO:0000255}.
FT   TOPO_DOM    438    484       Extracellular. {ECO:0000255}.
FT   TRANSMEM    485    505       Helical. {ECO:0000255}.
FT   TOPO_DOM    506    759       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      530    742       STAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00198}.
FT   MOD_RES     574    574       Phosphoserine; by PKC.
FT                                {ECO:0000305|PubMed:15990874}.
FT   MOD_RES     603    603       Phosphoserine; by PKC.
FT                                {ECO:0000305|PubMed:15990874}.
FT   MOD_RES     616    616       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     752    752       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     755    755       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1     21       Missing (in isoform 4, isoform 5 and
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:11087667}.
FT                                /FTId=VSP_046807.
FT   VAR_SEQ     145    216       GTFAVMSVMVGSVTESLAPQALNDSMINETARDAARVQVAS
FT                                TLSVLVGLFQVGLGLIHFGFVVTYLSEPLVR -> ATPGPL
FT                                PLLTAPGRPTGGAGPDPLRLRGHLPVRTSCPRLYHSCSCAG
FT                                LRLTAQVCVWPPSEQPLWATVPHLL (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055273.
FT   VAR_SEQ     217    252       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055274.
FT   VAR_SEQ     264    301       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_047851.
FT   VAR_SEQ     602    631       ASPKGASVSINVNTSLEDMRSNNVEDCKMM -> GPLLSAC
FT                                LAPQ (in isoform 2). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_006169.
FT   VAR_SEQ     632    759       QVSSGDKMEDATANGQEDSKAPDGSTLKALGLPQPDFHSLI
FT                                LDLGALSFVDTVCLKSLKNIFHDFREIEVEVYMAACHSPVV
FT                                SQLEAGHFFDASITKKHLFASVHDAVTFALQHPRPVPDSPV
FT                                SVTRL -> VRLEVGKEVTAVSCRDAGSTCLMRNAMDPAAV
FT                                GSRVLRRWQEEWGGWVRYSSGSVVICHRI (in isoform
FT                                6). {ECO:0000305}.
FT                                /FTId=VSP_047852.
FT   VAR_SEQ     632    632       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:11087667,
FT                                ECO:0000303|PubMed:12217875,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040127.
FT   VARIANT     206    206       V -> M (in dbSNP:rs13324142).
FT                                {ECO:0000269|PubMed:11247665}.
FT                                /FTId=VAR_012776.
FT   MUTAGEN     568    570       DVD->NVN: Does not inhibit cell membrane
FT                                localization. Inhibits interaction with
FT                                CA2 and bicarbonate transport.
FT                                {ECO:0000269|PubMed:15990874}.
FT   MUTAGEN     574    574       S->A: Does not inhibit interaction with
FT                                CA2. Inhibits interaction with CA2 and
FT                                bicarbonate transport in PMA-induced
FT                                cells. {ECO:0000269|PubMed:15990874}.
FT   MUTAGEN     603    603       S->A: Does not inhibit interaction with
FT                                CA2. Does not inhibit interaction with
FT                                CA2 and bicarbonate transport in PMA-
FT                                induced cells.
FT                                {ECO:0000269|PubMed:15990874}.
SQ   SEQUENCE   759 AA;  82967 MW;  63CB0B756C9675C6 CRC64;
     MGLADASGPR DTQALLSATQ AMDLRRRDYH MERPLLNQEH LEELGRWGSA PRTHQWRTWL
     QCSRARAYAL LLQHLPVLVW LPRYPVRDWL LGDLLSGLSV AIMQLPQGLA YALLAGLPPV
     FGLYSSFYPV FIYFLFGTSR HISVGTFAVM SVMVGSVTES LAPQALNDSM INETARDAAR
     VQVASTLSVL VGLFQVGLGL IHFGFVVTYL SEPLVRGYTT AAAVQVFVSQ LKYVFGLHLS
     SHSGPLSLIY TVLEVCWKLP QSKVGTVVTA AVAGVVLVVV KLLNDKLQQQ LPMPIPGELL
     TLIGATGISY GMGLKHRFEV DVVGNIPAGL VPPVAPNTQL FSKLVGSAFT IAVVGFAIAI
     SLGKIFALRH GYRVDSNQEL VALGLSNLIG GIFQCFPVSC SMSRSLVQES TGGNSQVAGA
     ISSLFILLII VKLGELFHDL PKAVLAAIII VNLKGMLRQL SDMRSLWKAN RADLLIWLVT
     FTATILLNLD LGLVVAVIFS LLLVVVRTQM PHYSVLGQVP DTDIYRDVAE YSEAKEVRGV
     KVFRSSATVY FANAEFYSDA LKQRCGVDVD FLISQKKKLL KKQEQLKLKQ LQKEEKLRKQ
     AASPKGASVS INVNTSLEDM RSNNVEDCKM MQVSSGDKME DATANGQEDS KAPDGSTLKA
     LGLPQPDFHS LILDLGALSF VDTVCLKSLK NIFHDFREIE VEVYMAACHS PVVSQLEAGH
     FFDASITKKH LFASVHDAVT FALQHPRPVP DSPVSVTRL
//
ID   TTYH3_HUMAN             Reviewed;         523 AA.
AC   Q9C0H2; A4D201; B7WP98; Q6L749; Q6ZVG3; Q8TEG6;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 3.
DT   27-SEP-2017, entry version 112.
DE   RecName: Full=Protein tweety homolog 3;
DE            Short=hTTY3;
GN   Name=TTYH3; Synonyms=KIAA1691;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION, GLYCOSYLATION AT ASN-351,
RP   TOPOLOGY, AND MUTAGENESIS OF THR-128; THR-146; THR-353; ARG-367 AND
RP   HIS-370.
RX   PubMed=15010458; DOI=10.1074/jbc.M313813200;
RA   Suzuki M., Mizuno A.;
RT   "A novel human Cl(-) channel family related to Drosophila flightless
RT   locus.";
RL   J. Biol. Chem. 279:22461-22468(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 342-523 (ISOFORM 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 138-523 (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-144.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Probable large-conductance Ca(2+)-activated chloride
CC       channel. May play a role in Ca(2+) signal transduction.
CC       {ECO:0000269|PubMed:15010458}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15010458};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:15010458}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9C0H2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9C0H2-2; Sequence=VSP_029770;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9C0H2-3; Sequence=VSP_029769;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9C0H2-4; Sequence=VSP_042220;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in excitable tissues. Expressed in
CC       the brain, heart, skeletal muscle, colon, spleen, kidney and
CC       peripheral blood leukocytes. {ECO:0000269|PubMed:15010458}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15010458,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- MISCELLANEOUS: The current is completely inhibited by the addition
CC       of an anion permeability inhibitor. Addition of a Ca(2+) ionophore
CC       induces an outward-rectified current in mock-transfected cells,
CC       but it introduced an overt linear current in TTYH3-transfected
CC       cells.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB21782.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=EAL23958.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB162931; BAD20190.1; -; mRNA.
DR   EMBL; AB051478; BAB21782.2; ALT_INIT; mRNA.
DR   EMBL; AK124608; BAC85898.1; -; mRNA.
DR   EMBL; AC006028; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236953; EAL23958.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471144; EAW87266.1; -; Genomic_DNA.
DR   EMBL; BC131824; AAI31825.1; -; mRNA.
DR   EMBL; BC152447; AAI52448.1; -; mRNA.
DR   EMBL; BE263005; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074158; BAB84984.1; -; mRNA.
DR   CCDS; CCDS34588.1; -. [Q9C0H2-1]
DR   RefSeq; NP_079526.1; NM_025250.2. [Q9C0H2-1]
DR   RefSeq; XP_011513837.1; XM_011515535.2. [Q9C0H2-4]
DR   RefSeq; XP_016868145.1; XM_017012656.1. [Q9C0H2-2]
DR   UniGene; Hs.440899; -.
DR   ProteinModelPortal; Q9C0H2; -.
DR   BioGrid; 123277; 39.
DR   IntAct; Q9C0H2; 3.
DR   STRING; 9606.ENSP00000258796; -.
DR   TCDB; 1.A.48.1.4; the anion channel tweety (tweety) family.
DR   iPTMnet; Q9C0H2; -.
DR   PhosphoSitePlus; Q9C0H2; -.
DR   SwissPalm; Q9C0H2; -.
DR   BioMuta; TTYH3; -.
DR   DMDM; 162416242; -.
DR   EPD; Q9C0H2; -.
DR   MaxQB; Q9C0H2; -.
DR   PaxDb; Q9C0H2; -.
DR   PeptideAtlas; Q9C0H2; -.
DR   PRIDE; Q9C0H2; -.
DR   Ensembl; ENST00000258796; ENSP00000258796; ENSG00000136295. [Q9C0H2-1]
DR   Ensembl; ENST00000403167; ENSP00000385015; ENSG00000136295. [Q9C0H2-3]
DR   Ensembl; ENST00000407643; ENSP00000385316; ENSG00000136295. [Q9C0H2-2]
DR   GeneID; 80727; -.
DR   KEGG; hsa:80727; -.
DR   UCSC; uc003smp.4; human. [Q9C0H2-1]
DR   CTD; 80727; -.
DR   EuPathDB; HostDB:ENSG00000136295.14; -.
DR   GeneCards; TTYH3; -.
DR   HGNC; HGNC:22222; TTYH3.
DR   HPA; HPA053520; -.
DR   MIM; 608919; gene.
DR   neXtProt; NX_Q9C0H2; -.
DR   OpenTargets; ENSG00000136295; -.
DR   PharmGKB; PA134908427; -.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   HOGENOM; HOG000070449; -.
DR   HOVERGEN; HBG108621; -.
DR   InParanoid; Q9C0H2; -.
DR   OMA; LNADCCC; -.
DR   OrthoDB; EOG091G05MR; -.
DR   PhylomeDB; Q9C0H2; -.
DR   TreeFam; TF319025; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   ChiTaRS; TTYH3; human.
DR   GenomeRNAi; 80727; -.
DR   PRO; PR:Q9C0H2; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136295; -.
DR   CleanEx; HS_TTYH3; -.
DR   ExpressionAtlas; Q9C0H2; baseline and differential.
DR   Genevisible; Q9C0H2; HS.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IMP:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:FlyBase.
DR   GO; GO:0006821; P:chloride transport; IDA:FlyBase.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   CDD; cd07912; Tweety_N; 1.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    523       Protein tweety homolog 3.
FT                                /FTId=PRO_0000312251.
FT   TOPO_DOM      1     42       Extracellular. {ECO:0000255}.
FT   TRANSMEM     43     63       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     64     86       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    108    211       Extracellular. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    233    236       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    258    386       Extracellular. {ECO:0000255}.
FT   TRANSMEM    387    407       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    408    523       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6P5F7}.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6P5F7}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   CARBOHYD    126    126       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    351    351       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:15010458}.
FT   VAR_SEQ       1    208       MAGVSYAAPWWVSLLHRLPHFDLSWEATSSQFRPEDTDYQQ
FT                                ALLLLGAAALACLALDLLFLLFYSFWLCCRRRKSEEHLDAD
FT                                CCCTAWCVIIATLVCSAGIAVGFYGNGETSDGIHRATYSLR
FT                                HANRTVAGVQDRVWDTAVGLNHTAEPSLQTLERQLAGRPEP
FT                                LRAVQRLQGLLETLLGYTAAIPFWRNTAVSLEVLAEQVDLY
FT                                DWY -> MPSGVPGCWPQLPLKGPWRPTPRPRVPVPWRTPR
FT                                FAC (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029769.
FT   VAR_SEQ     210    241       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12693554}.
FT                                /FTId=VSP_029770.
FT   VAR_SEQ     501    523       YTSSMRAKYLATSQPRPDSSGSH -> RYLAALDSGSHAGW
FT                                QFKPMDSARTLW (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042220.
FT   MUTAGEN     128    128       T->A: Does not affect N-glycosylation
FT                                state. {ECO:0000269|PubMed:15010458}.
FT   MUTAGEN     146    146       T->A: Does not affect N-glycosylation
FT                                state. {ECO:0000269|PubMed:15010458}.
FT   MUTAGEN     353    353       T->A: Abolishes N-glycosylation.
FT                                {ECO:0000269|PubMed:15010458}.
FT   MUTAGEN     367    367       R->Q: Induces a stronger permeability to
FT                                cations. {ECO:0000269|PubMed:15010458}.
FT   MUTAGEN     370    370       H->D: Shows a different ion selectivity.
FT                                {ECO:0000269|PubMed:15010458}.
FT   CONFLICT    169    169       Q -> K (in Ref. 9; BAB84984).
FT                                {ECO:0000305}.
FT   CONFLICT    346    346       V -> F (in Ref. 8; BE263005).
FT                                {ECO:0000305}.
FT   CONFLICT    520    520       S -> R (in Ref. 9; BAB84984).
FT                                {ECO:0000305}.
SQ   SEQUENCE   523 AA;  57545 MW;  B398391787BA0301 CRC64;
     MAGVSYAAPW WVSLLHRLPH FDLSWEATSS QFRPEDTDYQ QALLLLGAAA LACLALDLLF
     LLFYSFWLCC RRRKSEEHLD ADCCCTAWCV IIATLVCSAG IAVGFYGNGE TSDGIHRATY
     SLRHANRTVA GVQDRVWDTA VGLNHTAEPS LQTLERQLAG RPEPLRAVQR LQGLLETLLG
     YTAAIPFWRN TAVSLEVLAE QVDLYDWYRW LGYLGLLLLD VIICLLVLVG LIRSSKGILV
     GVCLLGVLAL VISWGALGLE LAVSVGSSDF CVDPDAYVTK MVEEYSVLSG DILQYYLACS
     PRAANPFQQK LSGSHKALVE MQDVVAELLR TVPWEQPATK DPLLRVQEVL NGTEVNLQHL
     TALVDCRSLH LDYVQALTGF CYDGVEGLIY LALFSFVTAL MFSSIVCSVP HTWQQKRGPD
     EDGEEEAAPG PRQAHDSLYR VHMPSLYSCG SSYGSETSIP AAAHTVSNAP VTEYMSQNAN
     FQNPRCENTP LIGRESPPPS YTSSMRAKYL ATSQPRPDSS GSH
//
ID   GBRA4_MOUSE             Reviewed;         552 AA.
AC   Q9D6F4;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 1.
DT   20-DEC-2017, entry version 137.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-4;
DE   AltName: Full=GABA(A) receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=Gabra4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Hippocampus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK013727; BAB28975.1; -; mRNA.
DR   CCDS; CCDS39107.1; -.
DR   RefSeq; NP_034381.1; NM_010251.2.
DR   UniGene; Mm.248731; -.
DR   ProteinModelPortal; Q9D6F4; -.
DR   SMR; Q9D6F4; -.
DR   BioGrid; 199800; 1.
DR   STRING; 10090.ENSMUSP00000031121; -.
DR   ChEMBL; CHEMBL2094133; -.
DR   iPTMnet; Q9D6F4; -.
DR   PhosphoSitePlus; Q9D6F4; -.
DR   MaxQB; Q9D6F4; -.
DR   PaxDb; Q9D6F4; -.
DR   PRIDE; Q9D6F4; -.
DR   Ensembl; ENSMUST00000031121; ENSMUSP00000031121; ENSMUSG00000029211.
DR   GeneID; 14397; -.
DR   KEGG; mmu:14397; -.
DR   UCSC; uc008xqy.1; mouse.
DR   CTD; 2557; -.
DR   MGI; MGI:95616; Gabra4.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; Q9D6F4; -.
DR   KO; K05175; -.
DR   PhylomeDB; Q9D6F4; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-MMU-977441; GABA A receptor activation.
DR   PRO; PR:Q9D6F4; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000029211; -.
DR   ExpressionAtlas; Q9D6F4; baseline and differential.
DR   Genevisible; Q9D6F4; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IMP:MGI.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:2001023; P:regulation of response to drug; IMP:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005434; GABBAa4_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01617; GABAARALPHA4.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36    552       Gamma-aminobutyric acid receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000442.
FT   TOPO_DOM     36    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    280       Helical. {ECO:0000305}.
FT   TRANSMEM    285    306       Helical. {ECO:0000305}.
FT   TRANSMEM    318    340       Helical. {ECO:0000305}.
FT   TOPO_DOM    341    521       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    522    541       Helical. {ECO:0000305}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    172    186       {ECO:0000250}.
SQ   SEQUENCE   552 AA;  60878 MW;  213C16C423D7F97B CRC64;
     MVSVQKVPAI ALCSGVSLAL LHFLCLAACL NESPGQNSKD EKLCPENFTR ILDSLLDGYD
     NRLRPGFGGP VTEVKTDIYV TSFGPVSDVE MEYTMDVFFR QTWIDKRLKY DGPIEILRLN
     NMMVTKVWTP DTFFRNGKKS VSHNMTAPNK LFRIMRNGTI LYTMRLTISA ECPMRLVDFP
     MDGHACPLKF GSYAYPKSEM IYTWTKGPEK SVEVPKESSS LVQYDLIGQT VSSETIKSIT
     GEYIVMTVYF HLRRKMGYFM IQTYIPCIMT VILSQVSFWI NKESVPARTV FGITTVLTMT
     TLSISARHSL PKVSYATAMD WFIAVCFAFV FSALIEFAAV NYFTNIQMQK AKKKISKPPP
     EVPAAPVLKE KHTETSLQNT HANLNMRKRT NALVHSESDV KSRTEVGNHS SKTSAVQESS
     EATPKAHLAS SPNPFSRANA AETMSAAARG LSSAASPSPH GTLRPASLGS ASTRPAFGSR
     LGRIKTTVNT TGAAGNVSAT PPPPAPPPSG SGTSKIDKYA RILFPVTFGA FNMVYWVVYL
     SKDTMEKSES LM
//
ID   GBRE_RAT                Reviewed;         506 AA.
AC   Q9ES14; O55209;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-NOV-2017, entry version 114.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit epsilon;
DE   AltName: Full=GABA(A) receptor subunit epsilon;
DE   Flags: Precursor;
GN   Name=Gabre;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11122342; DOI=10.1046/j.1460-9568.2000.01343.x;
RA   Moragues N., Ciofi P., Lafon P., Odessa M.F., Tramu G., Garret M.;
RT   "cDNA cloning and expression of a gamma-aminobutyric acid A receptor
RT   epsilon-subunit in rat brain.";
RL   Eur. J. Neurosci. 12:4318-4330(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 123-506.
RA   Hanna M.C., Hales T.G., Kirkness E.F.;
RT   "Alternative transcripts of a gene encoding the GABA-A receptor
RT   epsilon subunit on chromosome Xq28.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel. {ECO:0000250}.
CC   -!- SUBUNIT: Generally pentameric. Associates with alpha and beta
CC       subunits (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRE sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255612; AAG17631.1; -; mRNA.
DR   EMBL; U92284; AAB93879.1; -; Genomic_DNA.
DR   UniGene; Rn.54455; -.
DR   ProteinModelPortal; Q9ES14; -.
DR   SMR; Q9ES14; -.
DR   STRING; 10116.ENSRNOP00000022431; -.
DR   ChEMBL; CHEMBL1907607; -.
DR   PaxDb; Q9ES14; -.
DR   PRIDE; Q9ES14; -.
DR   RGD; 68320; Gabre.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; Q9ES14; -.
DR   PRO; PR:Q9ES14; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:RGD.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; TAS:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:RGD.
DR   GO; GO:2001226; P:negative regulation of chloride transport; ISO:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008099; GABAAe_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01723; GABAAREPSLON.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Postsynaptic cell membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    506       Gamma-aminobutyric acid receptor subunit
FT                                epsilon.
FT                                /FTId=PRO_0000000472.
FT   TOPO_DOM     23    254       Extracellular. {ECO:0000305}.
FT   TRANSMEM    255    275       Helical. {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    345    365       Helical. {ECO:0000255}.
FT   TOPO_DOM    366    485       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    486    506       Helical. {ECO:0000255}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    196    210       {ECO:0000250}.
FT   CONFLICT    133    133       R -> C (in Ref. 2; AAB93879).
FT                                {ECO:0000305}.
FT   CONFLICT    467    467       N -> S (in Ref. 2; AAB93879).
FT                                {ECO:0000305}.
SQ   SEQUENCE   506 AA;  59219 MW;  8C2FBECF10686E57 CRC64;
     MLPKVLLMLL NMFLALQWRV GPHIKLENKP PAQDKVVFGP QPQPSGKKLP ARETELTADH
     TTERPRGKLT RASQILNTIL SNYDHKLRPS IGEKPTVVTV KVFVNSLGPI SILDMEYSID
     IIFYQTWYDE RLRYNDTFET LILHGNVVSQ LWIPDTFFRN SKRTQEYDIT IPNQMALIHK
     DGKVLYTVRM TIDARCSLHM LNFPMDSHSC PLSFSSFSYD EHEMIYKWEN FKLKIDAKNT
     WKLLEFDFTG VNNKTEIIST PVGDFMVMTF FFNVSRRFGF IVFQNYIPSS VTTMLSWVSF
     WIKIEAAAAR ASVGVSSVLT MATLGTFSRK NFPRVSYLTA LDFYIAICFV LCFCTLLEFT
     VLNFLTYNNI ERQASPKFYQ FPTNSRANAR TRARARTRAR ARARARQQQE VFVCEIVTYE
     ENAEEGYQWS PRSRRPQCPW RRCGRSYVCF RVLRKYFCMV PGCEGNNWQR GRICIHVYRL
     DNYSRVLFPI TFFFFNVVYW VICLNL
//
ID   CLIC5_HUMAN             Reviewed;         410 AA.
AC   Q9NZA1; B3KUF1; Q5T4Z0; Q8NBY3; Q96JT5; Q9BWZ0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   25-OCT-2017, entry version 163.
DE   RecName: Full=Chloride intracellular channel protein 5;
GN   Name=CLIC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10793131; DOI=10.1091/mbc.11.5.1509;
RA   Berryman M., Bretscher A.;
RT   "Identification of a novel member of the chloride intracellular
RT   channel gene family (CLIC5) that associates with the actin
RT   cytoskeleton of placental microvilli.";
RL   Mol. Biol. Cell 11:1509-1521(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH AKAP9, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=12163479; DOI=10.1074/jbc.M112277200;
RA   Shanks R.A., Larocca M.C., Berryman M., Edwards J.C., Urushidani T.,
RA   Navarre J., Goldenring J.R.;
RT   "AKAP350 at the Golgi apparatus. II. Association of AKAP350 with a
RT   novel chloride intracellular channel (CLIC) family member.";
RL   J. Biol. Chem. 277:40973-40980(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION (ISOFORM 1).
RX   PubMed=15184393; DOI=10.1074/jbc.M402835200;
RA   Berryman M., Bruno J., Price J., Edwards J.C.;
RT   "CLIC-5A functions as a chloride channel in vitro and associates with
RT   the cortical actin cytoskeleton in vitro and in vivo.";
RL   J. Biol. Chem. 279:34794-34801(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH F-ACTIN.
RX   PubMed=18028448; DOI=10.1111/j.1742-4658.2007.06145.x;
RA   Singh H., Cousin M.A., Ashley R.H.;
RT   "Functional reconstitution of mammalian 'chloride intracellular
RT   channels' CLIC1, CLIC4 and CLIC5 reveals differential regulation by
RT   cytoskeletal actin.";
RL   FEBS J. 274:6306-6316(2007).
RN   [10]
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=20335315; DOI=10.1152/ajprenal.00030.2010;
RA   Wegner B., Al-Momany A., Kulak S.C., Kozlowski K., Obeidat M.,
RA   Jahroudi N., Paes J., Berryman M., Ballermann B.J.;
RT   "CLIC5A, a component of the ezrin-podocalyxin complex in glomeruli, is
RT   a determinant of podocyte integrity.";
RL   Am. J. Physiol. 298:F1492-F1503(2010).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN DFNB103.
RX   PubMed=24781754; DOI=10.1038/ejhg.2014.83;
RA   Seco C.Z., Oonk A.M., Dominguez-Ruiz M., Draaisma J.M., Gandia M.,
RA   Oostrik J., Neveling K., Kunst H.P., Hoefsloot L.H., Del Castillo I.,
RA   Pennings R.J., Kremer H., Admiraal R.J., Schraders M.;
RT   "Progressive hearing loss and vestibular dysfunction caused by a
RT   homozygous nonsense mutation in CLIC5.";
RL   Eur. J. Hum. Genet. 23:189-194(2015).
CC   -!- FUNCTION: Required for normal hearing (PubMed:24781754). It is
CC       necessary for the formation of stereocilia in the inner ear and
CC       normal development of the organ of Corti (By similarity). Can
CC       insert into membranes and form poorly selective ion channels that
CC       may also transport chloride ions. May play a role in the
CC       regulation of transepithelial ion absorption and secretion. Is
CC       required for the development and/or maintenance of the proper
CC       glomerular endothelial cell and podocyte architecture
CC       (PubMed:15184393, PubMed:18028448, PubMed:20335315).
CC       {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393,
CC       ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315,
CC       ECO:0000269|PubMed:24781754}.
CC   -!- SUBUNIT: Component of a multimeric complex consisting of several
CC       cytoskeletal proteins, including actin, ezrin, alpha-actinin,
CC       gelsolin, and IQGAP1. Interacts with AKAP9.
CC       {ECO:0000269|PubMed:12163479, ECO:0000269|PubMed:18028448}.
CC   -!- INTERACTION:
CC       P00523:SRC (xeno); NbExp=2; IntAct=EBI-5658997, EBI-848039;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:15184393}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:15184393}. Membrane
CC       {ECO:0000269|PubMed:15184393}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:15184393}. Note=Associates with the cortical
CC       actin cytoskeleton. Exists both as soluble cytoplasmic protein and
CC       as membrane protein with probably a single transmembrane domain
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Golgi apparatus. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome. Membrane;
CC       Single-pass membrane protein. Note=Colocalized with AKAP9 at the
CC       Golgi apparatus as well as, to a lesser extent, the centrosome.
CC       Exists both as soluble cytoplasmic protein and as membrane protein
CC       with probably a single transmembrane domain (By similarity).
CC       Colocalized with podocalyxin in renal glomeruli. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2; Synonyms=CLIC5B;
CC         IsoId=Q9NZA1-1; Sequence=Displayed;
CC       Name=1; Synonyms=CLIC5A;
CC         IsoId=Q9NZA1-2; Sequence=VSP_000869, VSP_000870;
CC         Note=Ref.1 (AAF66928) sequence is in conflict in position:
CC         12:R->S. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q9NZA1-3; Sequence=VSP_044889, VSP_044890, VSP_044891;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed in both fetal and adult human
CC       tissues (PubMed:24781754). Isoform 1 is expressed in renal
CC       glomeruli endothelial cells and podocytes (at protein level).
CC       {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Deafness, autosomal recessive, 103 (DFNB103)
CC       [MIM:616042]: A form of sensorineural deafness with onset in early
CC       childhood. Hearing impairment progresses from mild to severe or
CC       even profound before the second decade, and is accompanied by
CC       vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF216941; AAF66928.1; -; mRNA.
DR   EMBL; AY032602; AAK52083.1; -; mRNA.
DR   EMBL; AK075163; BAC11444.1; -; mRNA.
DR   EMBL; AK097048; BAG53413.1; -; mRNA.
DR   EMBL; AK075144; BAC11432.1; -; mRNA.
DR   EMBL; AL050336; CAI21030.1; -; Genomic_DNA.
DR   EMBL; AL357057; CAI21030.1; JOINED; Genomic_DNA.
DR   EMBL; AL050336; CAI21031.1; -; Genomic_DNA.
DR   EMBL; AL357057; CAI21031.1; JOINED; Genomic_DNA.
DR   EMBL; AL355522; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591211; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04286.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04287.1; -; Genomic_DNA.
DR   EMBL; BC035968; AAH35968.1; -; mRNA.
DR   CCDS; CCDS47438.1; -. [Q9NZA1-1]
DR   CCDS; CCDS4914.1; -. [Q9NZA1-2]
DR   CCDS; CCDS59022.1; -. [Q9NZA1-3]
DR   RefSeq; NP_001107558.1; NM_001114086.1. [Q9NZA1-1]
DR   RefSeq; NP_001242952.1; NM_001256023.1. [Q9NZA1-3]
DR   RefSeq; NP_058625.2; NM_016929.4. [Q9NZA1-2]
DR   RefSeq; XP_016866442.1; XM_017010953.1. [Q9NZA1-1]
DR   UniGene; Hs.485489; -.
DR   UniGene; Hs.734348; -.
DR   ProteinModelPortal; Q9NZA1; -.
DR   SMR; Q9NZA1; -.
DR   BioGrid; 119781; 7.
DR   CORUM; Q9NZA1; -.
DR   IntAct; Q9NZA1; 7.
DR   MINT; MINT-4540449; -.
DR   STRING; 9606.ENSP00000185206; -.
DR   iPTMnet; Q9NZA1; -.
DR   PhosphoSitePlus; Q9NZA1; -.
DR   BioMuta; CLIC5; -.
DR   DMDM; 215274174; -.
DR   OGP; Q9NZA1; -.
DR   EPD; Q9NZA1; -.
DR   MaxQB; Q9NZA1; -.
DR   PaxDb; Q9NZA1; -.
DR   PeptideAtlas; Q9NZA1; -.
DR   PRIDE; Q9NZA1; -.
DR   DNASU; 53405; -.
DR   Ensembl; ENST00000185206; ENSP00000185206; ENSG00000112782. [Q9NZA1-1]
DR   Ensembl; ENST00000339561; ENSP00000344165; ENSG00000112782. [Q9NZA1-2]
DR   Ensembl; ENST00000544153; ENSP00000439195; ENSG00000112782. [Q9NZA1-3]
DR   GeneID; 53405; -.
DR   KEGG; hsa:53405; -.
DR   UCSC; uc003oxu.5; human. [Q9NZA1-1]
DR   CTD; 53405; -.
DR   DisGeNET; 53405; -.
DR   EuPathDB; HostDB:ENSG00000112782.15; -.
DR   GeneCards; CLIC5; -.
DR   HGNC; HGNC:13517; CLIC5.
DR   HPA; HPA074371; -.
DR   MalaCards; CLIC5; -.
DR   MIM; 607293; gene.
DR   MIM; 616042; phenotype.
DR   neXtProt; NX_Q9NZA1; -.
DR   OpenTargets; ENSG00000112782; -.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   PharmGKB; PA26592; -.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000065740; -.
DR   HOVERGEN; HBG050995; -.
DR   InParanoid; Q9NZA1; -.
DR   KO; K05025; -.
DR   OMA; ANGDDRD; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; Q9NZA1; -.
DR   TreeFam; TF315438; -.
DR   ChiTaRS; CLIC5; human.
DR   GeneWiki; CLIC5; -.
DR   GenomeRNAi; 53405; -.
DR   PRO; PR:Q9NZA1; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112782; -.
DR   CleanEx; HS_CLIC5; -.
DR   ExpressionAtlas; Q9NZA1; baseline and differential.
DR   Genevisible; Q9NZA1; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; TAS:ProtInc.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0006810; P:transport; NAS:ProtInc.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030264; CLIC-5.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF6; PTHR43920:SF6; 1.
DR   Pfam; PF13417; GST_N_3; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chloride; Chloride channel; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Deafness; Golgi apparatus; Hearing;
KW   Ion channel; Ion transport; Membrane; Non-syndromic deafness;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    410       Chloride intracellular channel protein 5.
FT                                /FTId=PRO_0000144214.
FT   TRANSMEM    193    213       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN      260    400       GST C-terminal.
FT   VAR_SEQ       1    159       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:10793131,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000869.
FT   VAR_SEQ       1     17       MNDEDYSTIYDTIQNER -> MTDSATANGDDRDPEIE
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_044889.
FT   VAR_SEQ      18    176       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_044890.
FT   VAR_SEQ     160    180       AEGLEEKEGAHMNPEIYLFVK -> MTDSATANGDDRDPEI
FT                                ELFVK (in isoform 1).
FT                                {ECO:0000303|PubMed:10793131,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000870.
FT   VAR_SEQ     356    410       IVAKKYRNYDIPAEMTGLWRYLKNAYARDEFTNTCAADSEI
FT                                ELAYADVAKRLSRS -> EQVPLKGMI (in isoform
FT                                3). {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_044891.
FT   VARIANT     114    114       T -> A (in dbSNP:rs723580).
FT                                /FTId=VAR_059208.
FT   VARIANT     257    257       P -> H (in dbSNP:rs35822882).
FT                                /FTId=VAR_047541.
FT   CONFLICT    201    201       L -> F (in Ref. 2; AAK52083).
FT                                {ECO:0000305}.
SQ   SEQUENCE   410 AA;  46503 MW;  E26D307775F8354C CRC64;
     MNDEDYSTIY DTIQNERTYE VPDQPEENES PHYDDVHEYL RPENDLYATQ LNTHEYDFVS
     VYTIKGEETS LASVQSEDRG YLLPDEIYSE LQEAHPGEPQ EDRGISMEGL YSSTQDQQLC
     AAELQENGSV MKEDLPSPSS FTIQHSKAFS TTKYSCYSDA EGLEEKEGAH MNPEIYLFVK
     AGIDGESIGN CPFSQRLFMI LWLKGVVFNV TTVDLKRKPA DLHNLAPGTH PPFLTFNGDV
     KTDVNKIEEF LEETLTPEKY PKLAAKHRES NTAGIDIFSK FSAYIKNTKQ QNNAALERGL
     TKALKKLDDY LNTPLPEEID ANTCGEDKGS RRKFLDGDEL TLADCNLLPK LHVVKIVAKK
     YRNYDIPAEM TGLWRYLKNA YARDEFTNTC AADSEIELAY ADVAKRLSRS
//
ID   ACC4_CAEEL              Reviewed;         408 AA.
AC   Q9U358;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   20-DEC-2017, entry version 126.
DE   RecName: Full=Acetylcholine-gated ion channel acc-4 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-4 {ECO:0000303|PubMed:15579462,
GN   ECO:0000312|WormBase:T27E9.9};
GN   ORFNames=T27E9.9 {ECO:0000312|WormBase:T27E9.9};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBUNIT.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Probable acetylcholine-gated chloride channel subunit
CC       (PubMed:15579462). Does not have ion channel activity alone as a
CC       homopentamer, but forms a functional heteropentameric ion channel
CC       with acc-1 (PubMed:15579462). May function with lgc-46 to regulate
CC       synaptic transmission and synaptic vesicle release in response to
CC       acetylcholine in cholinergic motor neurons (PubMed:27782882).
CC       {ECO:0000269|PubMed:15579462, ECO:0000269|PubMed:27782882}.
CC   -!- SUBUNIT: Does not form a functional homopentameric ion channel.
CC       Forms a functional heteropentameric ion channel composed of acc-1
CC       and acc-4. May interact with acc-2; the interaction does not
CC       result in significant heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell
CC       membrane {ECO:0000269|PubMed:27782882}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- TISSUE SPECIFICITY: Expressed in all cholinergic motor neurons
CC       except for ASJ and RIB neurons. Also expressed in AVF neurons.
CC       {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement. In addition, in
CC       response to induced acetylcholine release, there is prolonged and
CC       slow decay of excitory postsynaptic currents which results in
CC       increased release of synaptic vesicles during that late phase of
CC       synaptic vesicle release in cholinergic motor neurons. Knockout in
CC       an lgc-46 gain of function mutant background suppresses the slow
CC       locomotion defect in the single lgc-46 gain of function mutant.
CC       Knockout together with gain of function mutations in lgc-46 and
CC       acr-2 suppresses the convulsion defects in the double lgc-46 and
CC       acr-2 double gain of function mutant.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284603; CAB04879.2; -; Genomic_DNA.
DR   PIR; E88613; E88613.
DR   PIR; T25376; T25376.
DR   RefSeq; NP_499789.1; NM_067388.4.
DR   UniGene; Cel.8920; -.
DR   ProteinModelPortal; Q9U358; -.
DR   STRING; 6239.T27E9.9; -.
DR   PaxDb; Q9U358; -.
DR   EnsemblMetazoa; T27E9.9; T27E9.9; WBGene00012099.
DR   GeneID; 176778; -.
DR   KEGG; cel:CELE_T27E9.9; -.
DR   UCSC; T27E9.9; c. elegans.
DR   CTD; 176778; -.
DR   WormBase; T27E9.9; CE24020; WBGene00012099; acc-4.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q9U358; -.
DR   OMA; WILSSMA; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PhylomeDB; Q9U358; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00012099; -.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    408       Acetylcholine-gated ion channel acc-4.
FT                                {ECO:0000305}.
FT                                /FTId=PRO_5004333882.
FT   TOPO_DOM     18    262       Extracellular. {ECO:0000305}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    295       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    296    316       Helical. {ECO:0000255}.
FT   TOPO_DOM    317    325       Extracellular. {ECO:0000305}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    380       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    408       Extracellular. {ECO:0000305}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    178    192       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   408 AA;  46218 MW;  F2D7348DE2319081 CRC64;
     MRLIILVISI LISNAGSLLR SLEDDSNECM FNCPKRARNV SVPHTEKTCM GDDAIIAQIL
     DGYNKLDLPG GGHVVVSIEI WVQEVSKIIE ITSEFELDIY VTERWTDPSL AYSHLNPCKS
     NMSVDGATIL NKIWNPHACF VNSKLANIHE SPFKNIFLQI YSNGSIWHNY RIKLTGPCSS
     TLRTFPIDQQ RCMLFYESFT HNTDQVKMEW ITTVPPITIL KGNITLPDYV LVDFSSSSEL
     RLYPPGIFNE LIATFTFQRL YGFYILQVYV PAYISVFISW VSFTLGAEQI PSRTTVGVNS
     LLALTFQFGA VVNNLPKTSD VKAIDVWILS SMAFIFASLI ELAVVGYLSR DGQHGSIKCR
     CSWLCMNCKD WTALKIDQMS SIVFPVSFLA FNIWYWFIFL GKLLVRTI
//
ID   TTY1_DROME              Reviewed;         970 AA.
AC   Q9U6L4; O61343; Q8IQ48; Q9VRG9;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   07-JUN-2017, entry version 101.
DE   RecName: Full=Protein tweety;
DE            Short=Dttyh1;
GN   Name=tty; ORFNames=CG1693;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Canton-S;
RX   PubMed=9520435; DOI=10.1073/pnas.95.7.3731;
RA   Maleszka R., de Couet H.G., Miklos G.L.G.;
RT   "Data transferability from model organisms to human beings: insights
RT   from the functional genomics of the flightless region of Drosophila.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3731-3736(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=10731138; DOI=10.1126/science.287.5461.2222;
RA   Rubin G.M., Hong L., Brokstein P., Evans-Holm M., Frise E.,
RA   Stapleton M., Harvey D.A.;
RT   "A Drosophila complementary DNA resource.";
RL   Science 287:2222-2224(2000).
RN   [5]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=8552658; DOI=10.1073/pnas.93.1.447;
RA   Maleszka R., Hanes S.D., Hackett R.L., de Couet H.G., Miklos G.L.G.;
RT   "The Drosophila melanogaster dodo (dod) gene, conserved in humans, is
RT   functionally interchangeable with the ESS1 cell division gene of
RT   Saccharomyces cerevisiae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:447-451(1996).
CC   -!- FUNCTION: Non-essential protein that probably acts as a chloride
CC       channel. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Flies lacking tty are viable and fertile.
CC       Was named 'tweety' after the cartoon character that cannot fly.
CC       Indeed, a mutant involving a genomic region that contain tty leads
CC       to flies that cannot fly. {ECO:0000269|PubMed:8552658}.
CC   -!- SIMILARITY: Belongs to the tweety family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC28400.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF017777; AAC28400.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AE014298; AAF50831.4; -; Genomic_DNA.
DR   EMBL; AF184227; AAD55738.1; -; mRNA.
DR   PIR; T08424; T08424.
DR   RefSeq; NP_542443.4; NM_080712.7.
DR   RefSeq; NP_728415.4; NM_167744.4.
DR   UniGene; Dm.2643; -.
DR   ProteinModelPortal; Q9U6L4; -.
DR   STRING; 7227.FBpp0302935; -.
DR   TCDB; 1.A.48.1.1; the anion channel tweety (tweety) family.
DR   PaxDb; Q9U6L4; -.
DR   PRIDE; Q9U6L4; -.
DR   EnsemblMetazoa; FBtr0077224; FBpp0076919; FBgn0015558.
DR   EnsemblMetazoa; FBtr0329901; FBpp0302935; FBgn0015558.
DR   EnsemblMetazoa; FBtr0329903; FBpp0302937; FBgn0015558.
DR   GeneID; 33109; -.
DR   KEGG; dme:Dmel_CG1693; -.
DR   UCSC; CG1693-RA; d. melanogaster.
DR   CTD; 33109; -.
DR   FlyBase; FBgn0015558; tty.
DR   eggNOG; KOG4433; Eukaryota.
DR   eggNOG; ENOG410ZNTN; LUCA.
DR   GeneTree; ENSGT00390000010182; -.
DR   InParanoid; Q9U6L4; -.
DR   OMA; PNDEIYL; -.
DR   OrthoDB; EOG091G0IBL; -.
DR   PhylomeDB; Q9U6L4; -.
DR   Reactome; R-DME-2672351; Stimuli-sensing channels.
DR   GenomeRNAi; 33109; -.
DR   PRO; PR:Q9U6L4; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0015558; -.
DR   ExpressionAtlas; Q9U6L4; differential.
DR   Genevisible; Q9U6L4; DM.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; ISS:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; ISS:FlyBase.
DR   CDD; cd07912; Tweety_N; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR006990; Tweety.
DR   PANTHER; PTHR12424; PTHR12424; 1.
DR   Pfam; PF04906; Tweety; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    970       Protein tweety.
FT                                /FTId=PRO_0000312256.
FT   TOPO_DOM      1     47       Extracellular. {ECO:0000255}.
FT   TRANSMEM     48     68       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     69     89       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     90    110       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    111    219       Extracellular. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    241    246       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    247    267       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    268    395       Extracellular. {ECO:0000255}.
FT   TRANSMEM    396    416       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    417    970       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    524    535       Poly-Ala.
FT   COMPBIAS    542    758       Gln-rich.
FT   COMPBIAS    841    870       Pro-rich.
FT   COMPBIAS    876    944       Gly-rich.
FT   COMPBIAS    947    951       Poly-Asp.
FT   COMPBIAS    953    957       Poly-Pro.
FT   CARBOHYD     27     27       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     34     34       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    183    183       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    359    359       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   970 AA;  105828 MW;  625FE41A35647394 CRC64;
     MGDYHEFTDQ YKVPVIAKLL HALPHYNITF HKINSTFRPN DEIYLESLGI LGSVPAALLI
     VSLLGLLFYL MTRCCDRKPR PAHSITSLKV ALSIVTVMCC AAIGLGLYGN DDLHNGLLEV
     LTAGRKVDNL VTTIRNQTHI LENTLTNRIR PQLVELADIF DQPVSNQTAL SKLFVSLNIV
     QGNVTLATNA ASDIRRPLMG ISMTHFLTRG DQWELIRWPG TVATLALLLV LCAVLLVGVA
     RHSRCALILF SVCGLLAVTG SWLMSGLYLS SSVAVGDLCI SPADFLVSTA PRDLPTNVLL
     HYTQCEPGHT NPFTQRLRES QNSLNNARSA MATVMKISLV LFKSSGLQPK LGAVNADLNS
     SERLLTQLTA LVDCKAVHHN FLAAARGLCE GGLLGLVLML IASFIAAILL TIMVWVDSHT
     WIYIRKRNDY AQVDEPSYIS HPAPQNHQQM MNAARTLPRN HNGHFSPPVI SGSHTLQHPS
     KRQQHEMMAH AHIQQNMRAM GTHTLGRLPS HNHSPTHMTG PNNAAAVAAA ANAAANMPPT
     TQAAQQQQQQ QAQQQQQQAQ QQLGGPQPIY CHHPHQHPHP HPHQHPHSHS AAAVAAAVQH
     QHAIYHQQQA QQYGTYTTAA HHAPHHLGPG QSQIYQQIPA HLAPQLAANG NPHSIYQPLV
     AVSQGSIYVS NMATMRRQNS QGGPQIPAHQ HPPSLHQQQQ QPPPPSQQQQ QLHQLKSPQQ
     HQQQLQQHQQ QQQQQHHQQQ HHQQQHQQQQ QQHHQQQQPN ESDVVPISTA MDTAIYDRDK
     QIYKCSTLRQ GGKFDPKYKP SILNCPLPEI PKDAEQPKVE SIYEQRQQAH HQNYSKTLQR
     PPMMLPPQMK AIPPPRIGTP TSPPPPVAQP LNESNGGVPS GLQNGGAVVG GGGANANEDT
     SLPPPPLEAQ TEATKARMGA GPAANGKVLH NGGGGGSVGG GGGGAVDDDD DLPPPPPAIT
     DESNYAVTEL
//
ID   CLCN2_DROME             Reviewed;        1193 AA.
AC   Q9VGH7; A4VCL3; A8JQX8; A8JQX9; E1JIJ0; Q7YU63; Q8INJ7; Q8MRL4;
AC   Q9VGH8;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 3.
DT   30-AUG-2017, entry version 122.
DE   RecName: Full=Chloride channel protein 2;
DE            Short=ClC-2;
DE            Short=DmClC-2;
DE   AltName: Full=Chloride channel-a;
GN   Name=ClC-a; ORFNames=CG31116;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000312|EMBL:AAF54702.3}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF54702.3}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAM50193.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A), AND RNA EDITING OF
RP   POSITIONS 249; 276; 285 AND 286.
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAM50193.1};
RC   TISSUE=Head {ECO:0000269|PubMed:12537569};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAQ22442.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS F AND G).
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAQ22442.1}; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E.,
RA   George R.A., Gonzalez M., Guarin H., Kapadia B., Kronmiller B.,
RA   Li P.W., Liao G., Miranda A., Mungall C.J., Nunoo J., Pacleb J.M.,
RA   Paragas V., Park S., Patel S., Phouanenavong S., Wan K.H., Yu C.,
RA   Lewis S.E., Rubin G.M., Celniker S.E.;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305}
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=15501232; DOI=10.1016/j.ydbio.2004.08.047;
RA   Kearney J.B., Wheeler S.R., Estes P., Parente B., Crews S.T.;
RT   "Gene expression profiling of the developing Drosophila CNS midline
RT   cells.";
RL   Dev. Biol. 275:473-492(2004).
RN   [6] {ECO:0000305}
RP   RNA EDITING OF POSITIONS 249; 276; 285 AND 286.
RX   PubMed=17018572; DOI=10.1261/rna.254306;
RA   Stapleton M., Carlson J.W., Celniker S.E.;
RT   "RNA editing in Drosophila melanogaster: new targets and functional
RT   consequences.";
RL   RNA 12:1922-1932(2006).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17601953; DOI=10.1242/jeb.006361;
RA   Rose U., Derst C., Wanischeck M., Marinc C., Walther C.;
RT   "Properties and possible function of a hyperpolarisation-activated
RT   chloride current in Drosophila.";
RL   J. Exp. Biol. 210:2489-2500(2007).
CC   -!- FUNCTION: Voltage-gated chloride channel. Chloride channels have
CC       several functions including the regulation of cell volume;
CC       membrane potential stabilization, signal transduction and
CC       transepithelial transport. {ECO:0000269|PubMed:17601953}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=D {ECO:0000269|PubMed:10731132};
CC         IsoId=Q9VGH7-1; Sequence=Displayed;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=A {ECO:0000269|PubMed:10731132};
CC         IsoId=Q9VGH7-2; Sequence=VSP_052366;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=F; Synonyms=B;
CC         IsoId=Q9VGH7-3; Sequence=VSP_052367;
CC         Note=No experimental confirmation available.;
CC       Name=C {ECO:0000269|PubMed:10731132};
CC         IsoId=Q9VGH7-4; Sequence=VSP_052366, VSP_052367;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=G;
CC         IsoId=Q9VGH7-6; Sequence=VSP_035041, VSP_035042, VSP_052367;
CC         Note=No experimental confirmation available.;
CC       Name=H;
CC         IsoId=Q9VGH7-7; Sequence=VSP_035041, VSP_035042;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: At embryonic stages 13-16, expressed in a
CC       subset of the midline cells of the midline primordium and in all
CC       of the midline glia. Expressed along the Z-line of the sarcomere
CC       in larval longitudinal muscles. {ECO:0000269|PubMed:15501232,
CC       ECO:0000269|PubMed:17601953}.
CC   -!- RNA EDITING: Modified_positions=249 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:17018572}, 276 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:17018572}, 285 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:17018572}, 286 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:17018572}; Note=Partially edited. Target of
CC       Adar. {ECO:0000269|PubMed:17018572};
CC   -!- MISCELLANEOUS: The CLC channel family contains both chloride
CC       channels and proton-coupled anion transporters that exchange
CC       chloride or another anion for protons. The absence of conserved
CC       gating glutamate residues is typical for family members that
CC       function as channels.
CC   -!- SIMILARITY: Belongs to the chloride channel (TC 2.A.49) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014297; AAF54701.3; -; Genomic_DNA.
DR   EMBL; AE014297; AAF54702.3; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13532.2; -; Genomic_DNA.
DR   EMBL; AE014297; ABW08644.2; -; Genomic_DNA.
DR   EMBL; AE014297; ABW08645.1; -; Genomic_DNA.
DR   EMBL; AE014297; ACZ94889.1; -; Genomic_DNA.
DR   EMBL; AY119539; AAM50193.1; -; mRNA.
DR   EMBL; BT009973; AAQ22442.1; -; mRNA.
DR   EMBL; BT030454; ABP87896.1; -; mRNA.
DR   RefSeq; NP_001097751.2; NM_001104281.2. [Q9VGH7-6]
DR   RefSeq; NP_001097752.1; NM_001104282.3. [Q9VGH7-3]
DR   RefSeq; NP_001163592.1; NM_001170121.1. [Q9VGH7-7]
DR   RefSeq; NP_731634.2; NM_169431.3. [Q9VGH7-4]
DR   RefSeq; NP_731635.2; NM_169432.3. [Q9VGH7-2]
DR   RefSeq; NP_788639.1; NM_176462.2. [Q9VGH7-1]
DR   UniGene; Dm.10007; -.
DR   ProteinModelPortal; Q9VGH7; -.
DR   SMR; Q9VGH7; -.
DR   BioGrid; 66550; 3.
DR   IntAct; Q9VGH7; 5.
DR   MINT; MINT-7956926; -.
DR   STRING; 7227.FBpp0082002; -.
DR   PaxDb; Q9VGH7; -.
DR   PRIDE; Q9VGH7; -.
DR   EnsemblMetazoa; FBtr0082526; FBpp0082000; FBgn0051116. [Q9VGH7-2]
DR   EnsemblMetazoa; FBtr0082527; FBpp0082001; FBgn0051116. [Q9VGH7-4]
DR   EnsemblMetazoa; FBtr0082528; FBpp0082002; FBgn0051116. [Q9VGH7-1]
DR   EnsemblMetazoa; FBtr0113391; FBpp0112303; FBgn0051116. [Q9VGH7-3]
DR   EnsemblMetazoa; FBtr0300622; FBpp0289849; FBgn0051116. [Q9VGH7-6]
DR   EnsemblMetazoa; FBtr0301023; FBpp0290245; FBgn0051116. [Q9VGH7-7]
DR   GeneID; 41428; -.
DR   KEGG; dme:Dmel_CG31116; -.
DR   UCSC; CG31116-RA; d. melanogaster. [Q9VGH7-1]
DR   UCSC; CG31116-RE; d. melanogaster.
DR   UCSC; CG31116-RF; d. melanogaster.
DR   CTD; 41428; -.
DR   FlyBase; FBgn0051116; ClC-a.
DR   eggNOG; KOG0476; Eukaryota.
DR   eggNOG; COG0038; LUCA.
DR   GeneTree; ENSGT00760000119109; -.
DR   InParanoid; Q9VGH7; -.
DR   KO; K05011; -.
DR   OMA; YEQTLMY; -.
DR   OrthoDB; EOG091G01RJ; -.
DR   PhylomeDB; Q9VGH7; -.
DR   Reactome; R-DME-2672351; Stimuli-sensing channels.
DR   GenomeRNAi; 41428; -.
DR   PRO; PR:Q9VGH7; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0051116; -.
DR   ExpressionAtlas; Q9VGH7; differential.
DR   Genevisible; Q9VGH7; DM.
DR   GO; GO:0015629; C:actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:FlyBase.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:FlyBase.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0005254; F:chloride channel activity; IMP:FlyBase.
DR   GO; GO:0005247; F:voltage-gated chloride channel activity; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IMP:FlyBase.
DR   GO; GO:0006821; P:chloride transport; ISS:UniProtKB.
DR   GO; GO:0003091; P:renal water homeostasis; IMP:FlyBase.
DR   GO; GO:0003097; P:renal water transport; IMP:FlyBase.
DR   GO; GO:0030321; P:transepithelial chloride transport; IMP:FlyBase.
DR   GO; GO:0035377; P:transepithelial water transport; IMP:FlyBase.
DR   Gene3D; 1.10.3080.10; -; 1.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR014743; Cl-channel_core.
DR   InterPro; IPR001807; Cl-channel_volt-gated.
DR   Pfam; PF00654; Voltage_CLC; 1.
DR   PRINTS; PR00762; CLCHANNEL.
DR   SUPFAM; SSF81340; SSF81340; 1.
DR   PROSITE; PS51371; CBS; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; CBS domain; Chloride; Chloride channel;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Repeat; RNA editing; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1193       Chloride channel protein 2.
FT                                /FTId=PRO_0000282953.
FT   TOPO_DOM      1    168       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    169    204       Helical. {ECO:0000250}.
FT   TRANSMEM    213    236       Helical. {ECO:0000250}.
FT   INTRAMEM    245    252       Helical. {ECO:0000250}.
FT   TRANSMEM    261    279       Helical. {ECO:0000250}.
FT   TRANSMEM    286    304       Helical. {ECO:0000250}.
FT   INTRAMEM    320    332       Helical. {ECO:0000250}.
FT   INTRAMEM    336    344       Helical. {ECO:0000250}.
FT   TRANSMEM    356    373       Helical. {ECO:0000250}.
FT   TRANSMEM    402    430       Helical. {ECO:0000250}.
FT   TRANSMEM    439    458       Helical. {ECO:0000250}.
FT   TRANSMEM    511    530       Helical. {ECO:0000250}.
FT   TRANSMEM    536    555       Helical. {ECO:0000250}.
FT   INTRAMEM    576    590       Helical. {ECO:0000250}.
FT   INTRAMEM    591    592       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   INTRAMEM    593    604       Helical. {ECO:0000250}.
FT   INTRAMEM    605    609       Note=Loop between two helices.
FT                                {ECO:0000250}.
FT   TRANSMEM    610    626       Helical. {ECO:0000250}.
FT   TOPO_DOM    627   1193       Cytoplasmic. {ECO:0000250}.
FT   DOMAIN      663    723       CBS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   DOMAIN     1048   1105       CBS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00703}.
FT   MOTIF       242    246       Selectivity filter part_1. {ECO:0000250}.
FT   MOTIF       284    288       Selectivity filter part_2. {ECO:0000250}.
FT   MOTIF       536    540       Selectivity filter part_3. {ECO:0000250}.
FT   BINDING     243    243       Chloride. {ECO:0000250}.
FT   BINDING     538    538       Chloride; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     632    632       Chloride. {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MKATRNGGQLLIAPSPQTAARLLPLRTYSNASSLGH
FT                                HHDRSTLSDGDEEEGGLGYTH (in isoform G and
FT                                isoform H). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_035041.
FT   VAR_SEQ       2    107       VYFGDRQRDRNRDRSNQKVERIIHDEEFGEENVELVDSEWA
FT                                DFEKFICQLRKRRNSAMSMEEELRHVQRHPKIKSHAFYPCP
FT                                PPAENARDSDSSDDDDPIGYIDTL -> FNNSHSHQDEYIR
FT                                EYAFEPELLINREDYQRKEERSQKSTAASSASTPVRQRWDE
FT                                VIAKQKEQQRKQSIEIDPPGDDKNQIEIEIEAFYY (in
FT                                isoform A and isoform C).
FT                                {ECO:0000303|PubMed:10731132,
FT                                ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_052366.
FT   VAR_SEQ       2    105       Missing (in isoform G and isoform H).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_035042.
FT   VAR_SEQ     889   1015       Missing (in isoform F, isoform C and
FT                                isoform G). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_052367.
FT   VARIANT     249    249       K -> R (in RNA edited version).
FT                                {ECO:0000269|PubMed:17018572}.
FT   VARIANT     276    276       T -> A (in RNA edited version).
FT                                {ECO:0000269|PubMed:17018572}.
FT   VARIANT     285    285       K -> R (in RNA edited version).
FT                                {ECO:0000269|PubMed:17018572}.
FT   VARIANT     286    286       E -> G (in RNA edited version).
FT                                {ECO:0000269|PubMed:17018572}.
FT   CONFLICT    529    529       S -> P (in Ref. 4; AAQ22442).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1193 AA;  133648 MW;  6CD0508E6DBCB9A6 CRC64;
     MVYFGDRQRD RNRDRSNQKV ERIIHDEEFG EENVELVDSE WADFEKFICQ LRKRRNSAMS
     MEEELRHVQR HPKIKSHAFY PCPPPAENAR DSDSSDDDDP IGYIDTLMYG RYTKDLGEFA
     KDEARKLKIL EKRRKQEDKQ RNKELLGKHS TRAKRVSSWI WRHTVARLGE DWVFLALLGI
     IMALLSFIMD KGISICTNAR IWLYRDLTSQ PFVQYIAWVS LPVCLILFSA GFVHLIAPQS
     IGSGIPEMKT ILRGVQLKEY LTFKTLVAKV IGLTATLGSG MPLGKEGPFV HIASIVAQLL
     SKLVTSFQGI YENESRNSEM LAAACAVGVG ACFAAPVGGV LFSIEVTTTY FAVRNYWRGF
     FAAVCGATVF RLLAVWFQNA DTVRALFLTN FTTEFPFDPQ ELFVFALIGL VCGLGGASYV
     WVHRRYVLFM RSNKRMNKFL QKNRFLYPGF LALLVSSISF PLGTGQFLAG ELSTHEQVTQ
     LFSNFTWSRD DLTVEQAAVV THWMTSYTSV FGNLVIYTLF TFVVSIIAST IPVPSGMFIP
     VFKIGAGFGR LVGEFMAVTF PHGVRYGGRL SPIMPGGYAV VGAAAFSGSV THTVSVAVII
     FEMTGQITHV VPVMIAVLVA NAVAALLQPS IYDSIILIKK LPYLPDLLPS SSGMYSIFVE
     DFMVRDVKYI WHGISYQKLK EVLKLNKTLR SLPLVDSPDN MILLGSVQRY ELIKMIEKHI
     GREKRMEVAQ KWQKEAQERA LEEEKKKQEV ELKMRRPSRF EVLPAPDILS LRQIANDEML
     PPKKRAETMH GSLAPRKSIL KKTNSFNLKT YAQPMGHSPS ITPYTTITGN SEFRIRSAFE
     AIFKKSTTLQ DVQPDPETGS LSPAASNHEV EVPRTPSTPG VSKKVQLPAQ SNWDFVTDQI
     MLQVNPISTE SNKMPAEKDF TDKALSNNGD SSKQSPSIKF KANKVADVNR SPQTAKRCSK
     IRFANEVGVN GSPTRTKCKI KPENVLGYSI EDVDETTNPE SLAESIQKPK SVRLPRERVI
     DMSPEDQKQW ELEEMLKPID LQKANVHIDP SPFQLVERTS ILKVHSLFSM VGINHAYVTK
     IGRLVGVVGL KELRKAIEDI NSNSFVPPTR DEDADEKPAV EKPLLSTNSS DKAVDMTVTS
     MDSALSNSEN CSDIEMEHIK HTDKGTVSLT MPPQESKQSP SADKSNTENG NHA
//
ID   CLIC4_HUMAN             Reviewed;         253 AA.
AC   Q9Y696; Q9UFW9; Q9UQJ6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   25-OCT-2017, entry version 166.
DE   RecName: Full=Chloride intracellular channel protein 4;
DE   AltName: Full=Intracellular chloride ion channel protein p64H1;
GN   Name=CLIC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10070163;
RA   Edwards J.C.;
RT   "A novel p64-related Cl- channel: subcellular distribution and nephron
RT   segment-specific expression.";
RL   Am. J. Physiol. 276:F398-F408(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10191309;
RA   Chuang J.Z., Milner T.A., Zhu M., Sung C.H.;
RT   "A 29 kDa intracellular chloride channel p64H1 is associated with
RT   large dense-core vesicles in rat hippocampal neurons.";
RL   J. Neurosci. 19:2919-2928(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-24; 41-60; 62-85 AND 125-130, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (FEB-2006) to UniProtKB.
RN   [6]
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=10793131; DOI=10.1091/mbc.11.5.1509;
RA   Berryman M., Bretscher A.;
RT   "Identification of a novel member of the chloride intracellular
RT   channel gene family (CLIC5) that associates with the actin
RT   cytoskeleton of placental microvilli.";
RL   Mol. Biol. Cell 11:1509-1521(2000).
RN   [7]
RP   INDUCTION, AND FUNCTION.
RX   PubMed=12163372; DOI=10.1016/S0002-9440(10)64203-4;
RA   Ronnov-Jessen L., Villadsen R., Edwards J.C., Petersen O.W.;
RT   "Differential expression of a chloride intracellular channel gene,
RT   CLIC4, in transforming growth factor-beta1-mediated conversion of
RT   fibroblasts to myofibroblasts.";
RL   Am. J. Pathol. 161:471-480(2002).
RN   [8]
RP   INTERACTION WITH AKAP9.
RX   PubMed=12163479; DOI=10.1074/jbc.M112277200;
RA   Shanks R.A., Larocca M.C., Berryman M., Edwards J.C., Urushidani T.,
RA   Navarre J., Goldenring J.R.;
RT   "AKAP350 at the Golgi apparatus. II. Association of AKAP350 with a
RT   novel chloride intracellular channel (CLIC) family member.";
RL   J. Biol. Chem. 277:40973-40980(2002).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=14569596; DOI=10.1002/cm.10141;
RA   Berryman M.A., Goldenring J.R.;
RT   "CLIC4 is enriched at cell-cell junctions and colocalizes with AKAP350
RT   at the centrosome and midbody of cultured mammalian cells.";
RL   Cell Motil. Cytoskeleton 56:159-172(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=16239224; DOI=10.1074/jbc.M506724200;
RA   Bohman S., Matsumoto T., Suh K., Dimberg A., Jakobsson L., Yuspa S.,
RA   Claesson-Welsh L.;
RT   "Proteomic analysis of vascular endothelial growth factor-induced
RT   endothelial cell differentiation reveals a role for chloride
RT   intracellular channel 4 (CLIC4) in tubular morphogenesis.";
RL   J. Biol. Chem. 280:42397-42404(2005).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17200346; DOI=10.1158/1078-0432.CCR-06-1562;
RA   Suh K.S., Crutchley J.M., Koochek A., Ryscavage A., Bhat K.,
RA   Tanaka T., Oshima A., Fitzgerald P., Yuspa S.H.;
RT   "Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark
RT   malignant progression of multiple human cancers.";
RL   Clin. Cancer Res. 13:121-131(2007).
RN   [12]
RP   TISSUE SPECIFICITY, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17636002; DOI=10.1242/jcs.002741;
RA   Suh K.S., Mutoh M., Mutoh T., Li L., Ryscavage A., Crutchley J.M.,
RA   Dumont R.A., Cheng C., Yuspa S.H.;
RT   "CLIC4 mediates and is required for Ca2+-induced keratinocyte
RT   differentiation.";
RL   J. Cell Sci. 120:2631-2640(2007).
RN   [13]
RP   INTERACTION WITH HRH3, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18302930; DOI=10.1016/j.bbrc.2008.02.071;
RA   Maeda K., Haraguchi M., Kuramasu A., Sato T., Ariake K., Sakagami H.,
RA   Kondo H., Yanai K., Fukunaga K., Yanagisawa T., Sukegawa J.;
RT   "CLIC4 interacts with histamine H3 receptor and enhances the receptor
RT   cell surface expression.";
RL   Biochem. Biophys. Res. Commun. 369:603-608(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19247789; DOI=10.1007/s10456-009-9139-3;
RA   Tung J.J., Hobert O., Berryman M., Kitajewski J.;
RT   "Chloride intracellular channel 4 is involved in endothelial
RT   proliferation and morphogenesis in vitro.";
RL   Angiogenesis 12:209-220(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-130, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-4, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SUBUNIT, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16176272; DOI=10.1111/j.1742-4658.2005.04909.x;
RA   Littler D.R., Assaad N.N., Harrop S.J., Brown L.J., Pankhurst G.J.,
RA   Luciani P., Aguilar M.-I., Mazzanti M., Berryman M.A., Breit S.N.,
RA   Curmi P.M.G.;
RT   "Crystal structure of the soluble form of the redox-regulated chloride
RT   ion channel protein CLIC4.";
RL   FEBS J. 272:4996-5007(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS), AND DOMAIN.
RX   PubMed=16581025; DOI=10.1016/j.bbrc.2006.03.099;
RA   Li Y., Li D., Zeng Z., Wang D.;
RT   "Trimeric structure of the wild soluble chloride intracellular ion
RT   channel CLIC4 observed in crystals.";
RL   Biochem. Biophys. Res. Commun. 343:1272-1278(2006).
CC   -!- FUNCTION: Can insert into membranes and form poorly selective ion
CC       channels that may also transport chloride ions. Channel activity
CC       depends on the pH. Membrane insertion seems to be redox-regulated
CC       and may occur only under oxydizing conditions. Promotes cell-
CC       surface expression of HRH3. Has alternate cellular functions like
CC       a potential role in angiogenesis or in maintaining apical-
CC       basolateral membrane polarity during mitosis and cytokinesis.
CC       Could also promote endothelial cell proliferation and regulate
CC       endothelial morphogenesis (tubulogenesis).
CC       {ECO:0000269|PubMed:12163372, ECO:0000269|PubMed:14569596,
CC       ECO:0000269|PubMed:16176272, ECO:0000269|PubMed:16239224,
CC       ECO:0000269|PubMed:18302930, ECO:0000269|PubMed:19247789}.
CC   -!- SUBUNIT: Component of a multimeric complex consisting of several
CC       cytoskeletal proteins, including actin, ezrin, alpha-actinin,
CC       gelsolin, IQGAP1 and CLIC5A. Binds directly to brain dynamin I in
CC       a complex containing actin, tubulin and 14-3-3 isoforms. Monomer.
CC       Interacts with HRH3. Interacts with AKAP9.
CC       {ECO:0000269|PubMed:10793131, ECO:0000269|PubMed:12163479,
CC       ECO:0000269|PubMed:16176272, ECO:0000269|PubMed:18302930}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome. Cytoplasmic vesicle membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Nucleus
CC       matrix. Cell membrane {ECO:0000305}; Single-pass membrane protein
CC       {ECO:0000305}. Mitochondrion. Cell junction. Note=Colocalized with
CC       AKAP9 at the centrosome and midbody. Exists both as soluble
CC       cytoplasmic protein and as membrane protein with probably a single
CC       transmembrane domain. Present in an intracellular vesicular
CC       compartment that likely represent trans-Golgi network vesicles.
CC   -!- TISSUE SPECIFICITY: Detected in epithelial cells from colon,
CC       esophagus and kidney (at protein level). Expression is prominent
CC       in heart, kidney, placenta and skeletal muscle.
CC       {ECO:0000269|PubMed:10793131, ECO:0000269|PubMed:17200346,
CC       ECO:0000269|PubMed:17636002}.
CC   -!- INDUCTION: Up-regulated by calcium ions in differentiating
CC       keratinocytes. Up-regulated in myofibroblasts.
CC       {ECO:0000269|PubMed:12163372, ECO:0000269|PubMed:17636002}.
CC   -!- DOMAIN: Members of this family may change from a globular, soluble
CC       state to a state where the N-terminal domain is inserted into the
CC       membrane and functions as chloride channel. A conformation change
CC       of the N-terminal domain is thought to expose hydrophobic surfaces
CC       that trigger membrane insertion. {ECO:0000269|PubMed:16581025}.
CC   -!- SIMILARITY: Belongs to the chloride channel CLIC family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLIC4ID40102ch1p36.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF097330; AAD38446.1; -; mRNA.
DR   EMBL; AF109196; AAD26136.1; -; mRNA.
DR   EMBL; AL117424; CAB55916.1; -; mRNA.
DR   EMBL; BC012444; AAH12444.1; -; mRNA.
DR   CCDS; CCDS256.1; -.
DR   PIR; T17226; T17226.
DR   RefSeq; NP_039234.1; NM_013943.2.
DR   UniGene; Hs.440544; -.
DR   PDB; 2AHE; X-ray; 1.80 A; A=1-251.
DR   PDB; 2D2Z; X-ray; 2.20 A; A/B/C=1-253.
DR   PDB; 3OQS; X-ray; 2.00 A; B=198-207.
DR   PDBsum; 2AHE; -.
DR   PDBsum; 2D2Z; -.
DR   PDBsum; 3OQS; -.
DR   ProteinModelPortal; Q9Y696; -.
DR   SMR; Q9Y696; -.
DR   BioGrid; 117431; 47.
DR   IntAct; Q9Y696; 5.
DR   MINT; MINT-3087884; -.
DR   STRING; 9606.ENSP00000363500; -.
DR   TCDB; 1.A.12.1.6; the intracellular chloride channel (clic) family.
DR   iPTMnet; Q9Y696; -.
DR   PhosphoSitePlus; Q9Y696; -.
DR   SwissPalm; Q9Y696; -.
DR   BioMuta; CLIC4; -.
DR   DMDM; 20141285; -.
DR   OGP; Q9Y696; -.
DR   REPRODUCTION-2DPAGE; IPI00001960; -.
DR   EPD; Q9Y696; -.
DR   MaxQB; Q9Y696; -.
DR   PaxDb; Q9Y696; -.
DR   PeptideAtlas; Q9Y696; -.
DR   PRIDE; Q9Y696; -.
DR   TopDownProteomics; Q9Y696; -.
DR   DNASU; 25932; -.
DR   Ensembl; ENST00000374379; ENSP00000363500; ENSG00000169504.
DR   Ensembl; ENST00000488683; ENSP00000436538; ENSG00000169504.
DR   GeneID; 25932; -.
DR   KEGG; hsa:25932; -.
DR   UCSC; uc001bjo.3; human.
DR   CTD; 25932; -.
DR   DisGeNET; 25932; -.
DR   EuPathDB; HostDB:ENSG00000169504.14; -.
DR   GeneCards; CLIC4; -.
DR   HGNC; HGNC:13518; CLIC4.
DR   HPA; HPA008019; -.
DR   HPA; HPA060804; -.
DR   MIM; 606536; gene.
DR   neXtProt; NX_Q9Y696; -.
DR   OpenTargets; ENSG00000169504; -.
DR   PharmGKB; PA26591; -.
DR   eggNOG; KOG1422; Eukaryota.
DR   eggNOG; ENOG410ZRK6; LUCA.
DR   GeneTree; ENSGT00550000074477; -.
DR   HOGENOM; HOG000231548; -.
DR   HOVERGEN; HBG050994; -.
DR   InParanoid; Q9Y696; -.
DR   KO; K05024; -.
DR   OMA; IDHNSIE; -.
DR   OrthoDB; EOG091G0IHT; -.
DR   PhylomeDB; Q9Y696; -.
DR   TreeFam; TF315438; -.
DR   ChiTaRS; CLIC4; human.
DR   EvolutionaryTrace; Q9Y696; -.
DR   GeneWiki; CLIC4; -.
DR   GenomeRNAi; 25932; -.
DR   PRO; PR:Q9Y696; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000169504; -.
DR   CleanEx; HS_CLIC4; -.
DR   ExpressionAtlas; Q9Y696; baseline and differential.
DR   Genevisible; Q9Y696; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0045177; C:apical part of cell; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005254; F:chloride channel activity; IBA:GO_Central.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IBA:GO_Central.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; TAS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; NAS:UniProtKB.
DR   GO; GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0035088; P:establishment or maintenance of apical/basal cell polarity; NAS:UniProtKB.
DR   GO; GO:0009566; P:fertilization; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0007035; P:vacuolar acidification; IEA:Ensembl.
DR   InterPro; IPR002946; CLIC.
DR   InterPro; IPR030257; CLIC-4.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR43920:SF7; PTHR43920:SF7; 1.
DR   PRINTS; PR01263; INTCLCHANNEL.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR00862; O-ClC; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Cytoskeleton; Direct protein sequencing; Ion channel; Ion transport;
KW   Membrane; Mitochondrion; Nucleus; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    253       Chloride intracellular channel protein 4.
FT                                /FTId=PRO_0000144210.
FT   TRANSMEM     37     57       Helical; Note=After insertion into the
FT                                membrane. {ECO:0000255}.
FT   DOMAIN      104    244       GST C-terminal.
FT   REGION        2    101       Required for insertion into the membrane.
FT                                {ECO:0000305}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     130    130       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QYB1}.
FT   CONFLICT     14     14       D -> Y (in Ref. 2; AAD26136).
FT                                {ECO:0000305}.
FT   CONFLICT    133    134       RP -> SA (in Ref. 1; AAD38446 and 2;
FT                                AAD26136). {ECO:0000305}.
FT   CONFLICT    225    225       Y -> S (in Ref. 2; AAD26136).
FT                                {ECO:0000305}.
FT   CONFLICT    233    233       T -> A (in Ref. 2; AAD26136).
FT                                {ECO:0000305}.
FT   STRAND       19     25       {ECO:0000244|PDB:2AHE}.
FT   STRAND       29     32       {ECO:0000244|PDB:2AHE}.
FT   HELIX        36     48       {ECO:0000244|PDB:2AHE}.
FT   STRAND       53     57       {ECO:0000244|PDB:2AHE}.
FT   HELIX        64     69       {ECO:0000244|PDB:2AHE}.
FT   STRAND       77     80       {ECO:0000244|PDB:2AHE}.
FT   STRAND       83     85       {ECO:0000244|PDB:2AHE}.
FT   HELIX        88     98       {ECO:0000244|PDB:2AHE}.
FT   TURN        101    103       {ECO:0000244|PDB:2AHE}.
FT   HELIX       112    115       {ECO:0000244|PDB:2AHE}.
FT   TURN        116    120       {ECO:0000244|PDB:2AHE}.
FT   HELIX       121    130       {ECO:0000244|PDB:2AHE}.
FT   HELIX       134    136       {ECO:0000244|PDB:2AHE}.
FT   HELIX       137    156       {ECO:0000244|PDB:2AHE}.
FT   STRAND      181    183       {ECO:0000244|PDB:2AHE}.
FT   HELIX       186    206       {ECO:0000244|PDB:2AHE}.
FT   HELIX       215    225       {ECO:0000244|PDB:2AHE}.
FT   HELIX       228    231       {ECO:0000244|PDB:2AHE}.
FT   HELIX       237    243       {ECO:0000244|PDB:2AHE}.
FT   TURN        244    247       {ECO:0000244|PDB:2AHE}.
SQ   SEQUENCE   253 AA;  28772 MW;  3DD21A33C66626A5 CRC64;
     MALSMPLNGL KEEDKEPLIE LFVKAGSDGE SIGNCPFSQR LFMILWLKGV VFSVTTVDLK
     RKPADLQNLA PGTHPPFITF NSEVKTDVNK IEEFLEEVLC PPKYLKLSPK HPESNTAGMD
     IFAKFSAYIK NSRPEANEAL ERGLLKTLQK LDEYLNSPLP DEIDENSMED IKFSTRKFLD
     GNEMTLADCN LLPKLHIVKV VAKKYRNFDI PKEMTGIWRY LTNAYSRDEF TNTCPSDKEV
     EIAYSDVAKR LTK
//
